[
  {
    "text": "--- Page 1 ---\nCOLUMN 1:\nyi\nCarpal Tunnel Syndrome\nClinical Practice Guidelines Linked to the International\nClassification of Functioning, Disability and Health From\nthe Academy of Hand and Upper Extremity Physical \nTherapy and the Academy of Orthopaedic Physical \nTherapy of the American Physical Therapy Association\nJ Orthop Sports Phys Ther. CPG5\nCLINICAL PRACTICE GUIDELINES\nImpairment/Function-Based Diagnosis.. CPG8\nCLINICAL PRACTICE GUIDELINES:\nExamination.. CPG32\nCLINICAL PRACTICE GUIDELINES: \nInterventions.. \u0007CPG37\nAUTHOR/REVIEWER AFFILIATIONS AND CONTACTS.. CPG61\nREVIEWERS: Roy Altman MD • Paul Beattie PT PhD • Eugene Boeglin DPT • John Dewitt DPT • Lauren Detullio OT\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 0,
    "sentence_start": 0,
    "sentence_end": 390,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nClinical Practice Guidelines\nMIA ERICKSON, PT, EdD • MARSHA LAWRENCE, PT, DPT • CAROLINE W. STEGINK JANSEN, PT, PhD\nDIANE COKER, PT, DPT • PETER AMADIO, MD • CARLA CLEARY, PT, DPT\nHand Pain and Sensory Deficits: \nCarpal Tunnel Syndrome\nClinical Practice Guidelines Linked to the International \nClassification of Functioning, Disability and Health From \nthe Academy of Hand and Upper Extremity Physical \nTherapy and the Academy of Orthopaedic Physical \nTherapy of the American Physical Therapy Association\nJ Orthop Sports Phys Ther. ©2019 Academy of Orthopaedic Physical Therapy, American Physical Therapy Association (APTA), \nInc; Academy of Hand and Upper Extremity Physical Therapy, APTA, Inc; and the Journal of Orthopaedic & Sports Physical Therapy.",
    "chunk_id": 1,
    "sentence_start": 389,
    "sentence_end": 395,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "©2019 Academy of Orthopaedic Physical Therapy, American Physical Therapy Association (APTA), \nInc; Academy of Hand and Upper Extremity Physical Therapy, APTA, Inc; and the Journal of Orthopaedic & Sports Physical Therapy. The Academy of Orthopaedic Physical \nTherapy, APTA, Inc and the Journal of Orthopaedic & Sports Physical Therapy consent to reproducing and distributing this guideline for educational purposes. Address \ncorrespondence to Brenda Johnson, ICF-Based Clinical Practice Guidelines Coordinator, Academy of Orthopaedic Physical Therapy, APTA, Inc, 2920 East Avenue South, \nSuite 200, La Crosse, WI 54601. CPG5\nCLINICAL PRACTICE GUIDELINES\nImpairment/Function-Based Diagnosis.. CPG8\nCLINICAL PRACTICE GUIDELINES:\nExamination.. CPG32\nCLINICAL PRACTICE GUIDELINES: \nInterventions.. \u0007CPG37\nAUTHOR/REVIEWER AFFILIATIONS AND CONTACTS..",
    "chunk_id": 2,
    "sentence_start": 394,
    "sentence_end": 781,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "CPG61\nREVIEWERS: Roy Altman, MD • Paul Beattie, PT, PhD • Eugene Boeglin, DPT • John Dewitt, DPT • Lauren Detullio, OT\nAmanda Ferland, DPT • Christopher Hughes, PT, PhD • Sandra Kaplan, PT, PhD • David Killoran, PhD\nMurray E. Maitland, PT, PhD • Saurabh Mehta, PT, MS, PhD • Leslie Torburn, DPT • Emmanuel Yung, PT, DPT\n\n\n--- Page 2 ---\nCOLUMN 1:\nDIAGNOSIS\nA\nWhen examining a patient with suspected carpal tunnel \nsyndrome (CTS), clinicians should use Semmes-Weinstein \nmonofilament testing (SWMT), using the 2.83 or 3.22 monofila­\nment as the threshold for normal light touch sensation and static \n2-point discrimination on the middle finger to aid in determining \nthe extent of nerve damage. In those with suspected moderate to \nsevere CTS, clinicians should assess any radial finger using the \n3.22 filament as the threshold for normal. Semmes-Weinstein \nmonofilament testing should be repeated by the same provider.",
    "chunk_id": 3,
    "sentence_start": 780,
    "sentence_end": 785,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In those with suspected moderate to \nsevere CTS, clinicians should assess any radial finger using the \n3.22 filament as the threshold for normal. Semmes-Weinstein \nmonofilament testing should be repeated by the same provider. B\nIn those with suspected CTS, clinicians should use the \nKatz hand diagram, Phalen test, Tinel sign, and carpal \ncompression test to determine the likelihood of CTS and interpret \nexamination results in the context of all clinical exam findings. Clinicians should assess and document patient age (older than \n45 years), whether shaking their hands relieves their symptoms, \nsensory loss in the thumb, the wrist ratio index (greater than \n0.67), and scores from the Boston Carpal Tunnel Questionnaire-\nsymptom severity scale (CTQ-SSS) (greater than 1.9). The \npresence of more than 3 of these clinical findings has shown ac­\nceptable diagnostic accuracy.",
    "chunk_id": 4,
    "sentence_start": 784,
    "sentence_end": 788,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Clinicians should assess and document patient age (older than \n45 years), whether shaking their hands relieves their symptoms, \nsensory loss in the thumb, the wrist ratio index (greater than \n0.67), and scores from the Boston Carpal Tunnel Questionnaire-\nsymptom severity scale (CTQ-SSS) (greater than 1.9). The \npresence of more than 3 of these clinical findings has shown ac­\nceptable diagnostic accuracy. D\nThere is conflicting evidence on the diagnostic accuracy \nand clinical utility of the upper-limb neurodynamic tests, \nscratch-collapse test, and tests of vibration sense in the diagno­\nsis of CTS, and therefore no recommendation can be made. EXAMINATION – OUTCOME MEASURES: ACTIVITY \nLIMITATIONS/SELF-REPORTED MEASURES\nB\nClinicians should use the CTQ-SSS to assess symptoms \nand the Boston Carpal Tunnel Questionnaire functional \nscale (CTQ-FS) or the Disabilities of the Arm, Shoulder and Hand \n(DASH) questionnaire to assess function when examining pa­\ntients with CTS.",
    "chunk_id": 5,
    "sentence_start": 787,
    "sentence_end": 790,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "D\nThere is conflicting evidence on the diagnostic accuracy \nand clinical utility of the upper-limb neurodynamic tests, \nscratch-collapse test, and tests of vibration sense in the diagno­\nsis of CTS, and therefore no recommendation can be made. EXAMINATION – OUTCOME MEASURES: ACTIVITY \nLIMITATIONS/SELF-REPORTED MEASURES\nB\nClinicians should use the CTQ-SSS to assess symptoms \nand the Boston Carpal Tunnel Questionnaire functional \nscale (CTQ-FS) or the Disabilities of the Arm, Shoulder and Hand \n(DASH) questionnaire to assess function when examining pa­\ntients with CTS. Clinicians should use the CTQ-SSS to assess \nchange in those undergoing nonsurgical management. EXAMINATION – ACTIVITY LIMITATIONS/\nPHYSICAL PERFORMANCE MEASURES\nC\nClinicians may use the Purdue Pegboard (PPB) or the Del­\nlon-modified Moberg pick-up test (DMPUT) to quantify \ndexterity at the onset of treatment and compare scores with es­\ntablished norms.",
    "chunk_id": 6,
    "sentence_start": 789,
    "sentence_end": 792,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Clinicians should use the CTQ-SSS to assess \nchange in those undergoing nonsurgical management. EXAMINATION – ACTIVITY LIMITATIONS/\nPHYSICAL PERFORMANCE MEASURES\nC\nClinicians may use the Purdue Pegboard (PPB) or the Del­\nlon-modified Moberg pick-up test (DMPUT) to quantify \ndexterity at the onset of treatment and compare scores with es­\ntablished norms. Clinicians should not use the PPB test, Jebsen-\nTaylor Hand Function Test, or the Nine-Hole Peg Test to assess \nclinical change following carpal tunnel release (CTR) surgery. Cli­\nnicians may use the DMPUT to assess change following CTR \nsurgery. Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 7,
    "sentence_start": 791,
    "sentence_end": 799,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\ng a patient with suspected carpal tunnel \n), clinicians should use Semmes-Weinstein \nSWMT), using the 2.83 or 3.22 monofila­\nor normal light touch sensation and static \non the middle finger to aid in determining \nmage. In those with suspected moderate to \nhould assess any radial finger using the \nreshold for normal. Semmes-Weinstein \nhould be repeated by the same provider. spected CTS, clinicians should use the \nam, Phalen test, Tinel sign, and carpal \ntermine the likelihood of CTS and interpret \nhe context of all clinical exam findings. s and document patient age (older than \nking their hands relieves their symptoms, \nmb, the wrist ratio index (greater than \nthe Boston Carpal Tunnel Questionnaire-\ne (CTQ-SSS) (greater than 1.9). The \n3 of these clinical findings has shown ac­\ncuracy.",
    "chunk_id": 8,
    "sentence_start": 798,
    "sentence_end": 805,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "s and document patient age (older than \nking their hands relieves their symptoms, \nmb, the wrist ratio index (greater than \nthe Boston Carpal Tunnel Questionnaire-\ne (CTQ-SSS) (greater than 1.9). The \n3 of these clinical findings has shown ac­\ncuracy. ing evidence on the diagnostic accuracy \nty of the upper-limb neurodynamic tests, \nnd tests of vibration sense in the diagno­\ne no recommendation can be made. COME MEASURES: ACTIVITY \nEPORTED MEASURES\nd use the CTQ-SSS to assess symptoms \nCarpal Tunnel Questionnaire functional \nisabilities of the Arm, Shoulder and Hand \no assess function when examining pa­\nans should use the CTQ-SSS to assess \noing nonsurgical management.",
    "chunk_id": 9,
    "sentence_start": 804,
    "sentence_end": 807,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "ing evidence on the diagnostic accuracy \nty of the upper-limb neurodynamic tests, \nnd tests of vibration sense in the diagno­\ne no recommendation can be made. COME MEASURES: ACTIVITY \nEPORTED MEASURES\nd use the CTQ-SSS to assess symptoms \nCarpal Tunnel Questionnaire functional \nisabilities of the Arm, Shoulder and Hand \no assess function when examining pa­\nans should use the CTQ-SSS to assess \noing nonsurgical management. IVITY LIMITATIONS/\nANCE MEASURES\nuse the Purdue Pegboard (PPB) or the Del­\noberg pick-up test (DMPUT) to quantify \nf t\nt\nt\nd\nith\nEXAMINATION – ACTIVITY LIMITATIONS/\nPHYSICAL IMPAIRMENT MEASURES\nStrength Measures\nA\nClinicians should not use lateral pinch strength as an out­\ncome measure for patients with nonsurgically or surgically \nmanaged CTS. B\nClinicians should not use grip strength when assessing \nshort-term (less than 3 months) change in individuals fol­\nlowing CTR surgery.",
    "chunk_id": 10,
    "sentence_start": 806,
    "sentence_end": 809,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "IVITY LIMITATIONS/\nANCE MEASURES\nuse the Purdue Pegboard (PPB) or the Del­\noberg pick-up test (DMPUT) to quantify \nf t\nt\nt\nd\nith\nEXAMINATION – ACTIVITY LIMITATIONS/\nPHYSICAL IMPAIRMENT MEASURES\nStrength Measures\nA\nClinicians should not use lateral pinch strength as an out­\ncome measure for patients with nonsurgically or surgically \nmanaged CTS. B\nClinicians should not use grip strength when assessing \nshort-term (less than 3 months) change in individuals fol­\nlowing CTR surgery. C\nClinicians may assess grip strength and 3-point or tip \npinch strength in individuals presenting with signs and \nsymptoms of CTS and compare scores with established norms. D\nThere is conflicting evidence on the use of tip and 3-point \npinch strength and abductor pollicis brevis muscle \nstrength testing in individuals following CTR surgery.",
    "chunk_id": 11,
    "sentence_start": 808,
    "sentence_end": 811,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "C\nClinicians may assess grip strength and 3-point or tip \npinch strength in individuals presenting with signs and \nsymptoms of CTS and compare scores with established norms. D\nThere is conflicting evidence on the use of tip and 3-point \npinch strength and abductor pollicis brevis muscle \nstrength testing in individuals following CTR surgery. Sensory and Provocative Measures\nC\nClinicians should not use threshold or vibration testing to \nassess change in individuals with CTS undergoing nonsur­\ngical management until more evidence becomes available. Clini­\ncians may use the Phalen test to assess change in those with \nCTR surgery at long-term follow-ups. D\nThere is conflicting evidence on the use of sensory measures, \nincluding 2-point discrimination and threshold testing, to as­\nsess change over time in patients with surgically managed CTS.",
    "chunk_id": 12,
    "sentence_start": 810,
    "sentence_end": 814,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Clini­\ncians may use the Phalen test to assess change in those with \nCTR surgery at long-term follow-ups. D\nThere is conflicting evidence on the use of sensory measures, \nincluding 2-point discrimination and threshold testing, to as­\nsess change over time in patients with surgically managed CTS. INTERVENTIONS – ASSISTIVE TECHNOLOGY\nC\nClinicians may educate their patients regarding the effects \nof mouse use on carpal tunnel pressure and assist pa­\ntients in developing alternate strategies, including the use of ar­\nrow keys, touch screens, or alternating the mouse hand. Clinicians may recommend keyboards with reduced strike force \nfor patients with CTS who report pain with keyboard use. INTERVENTIONS – ORTHOSES\nB\nClinicians should recommend a neutral-positioned wrist \northosis worn at night for short-term symptom relief and \nfunctional improvement for individuals with CTS seeking nonsur­\ngical management.",
    "chunk_id": 13,
    "sentence_start": 813,
    "sentence_end": 817,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Clinicians may recommend keyboards with reduced strike force \nfor patients with CTS who report pain with keyboard use. INTERVENTIONS – ORTHOSES\nB\nClinicians should recommend a neutral-positioned wrist \northosis worn at night for short-term symptom relief and \nfunctional improvement for individuals with CTS seeking nonsur­\ngical management. Summary of Recommendations*\n\n\n--- Page 3 ---\nCOLUMN 1:\nB\nClinicians\nment of m\nC\nClinicians\nmanagem\nthe treatment of c\nB\nClinicians\nnets in the\nINTERVENTIONS\nC\nClinicians\ncervical sp\nmild to moderate \nD\nThere is co\nmobilizatio\nINTERVENTIONS\nC\nClinicians\ngram in in\nhave thenar atrop\nnicians should mo\nsignificant improv\ntion on pathology, risk identification, symptom self-management, \nand postures/activities that aggravate symptoms. C\nClinicians should recommend an orthosis for women experi­\nencing CTS during pregnancy and should provide a postpar­\ntum follow-up evaluation to examine the resolution of symptoms.",
    "chunk_id": 14,
    "sentence_start": 816,
    "sentence_end": 819,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Summary of Recommendations*\n\n\n--- Page 3 ---\nCOLUMN 1:\nB\nClinicians\nment of m\nC\nClinicians\nmanagem\nthe treatment of c\nB\nClinicians\nnets in the\nINTERVENTIONS\nC\nClinicians\ncervical sp\nmild to moderate \nD\nThere is co\nmobilizatio\nINTERVENTIONS\nC\nClinicians\ngram in in\nhave thenar atrop\nnicians should mo\nsignificant improv\ntion on pathology, risk identification, symptom self-management, \nand postures/activities that aggravate symptoms. C\nClinicians should recommend an orthosis for women experi­\nencing CTS during pregnancy and should provide a postpar­\ntum follow-up evaluation to examine the resolution of symptoms. INTERVENTIONS – BIOPHYSICAL AGENTS\nC\nClinicians may recommend a trial of superficial heat for \nshort-term symptom relief for individuals with CTS. C\nClinicians may recommend the application of microwave \nor shortwave diathermy for short-term pain and symptom \nrelief for patients with mild to moderate idiopathic CTS.",
    "chunk_id": 15,
    "sentence_start": 818,
    "sentence_end": 821,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "INTERVENTIONS – BIOPHYSICAL AGENTS\nC\nClinicians may recommend a trial of superficial heat for \nshort-term symptom relief for individuals with CTS. C\nClinicians may recommend the application of microwave \nor shortwave diathermy for short-term pain and symptom \nrelief for patients with mild to moderate idiopathic CTS. C\nClinicians may offer a trial of interferential current for \nshort-term pain symptom relief in adults without pace­\nmakers with idiopathic, mild to moderate CTS. As with all electri­\ncal modalities, contraindications should be taken into \nconsideration before choosing this intervention. B\nClinicians should not use low-level laser therapy or other \ntypes of nonlaser light therapy for individuals with CTS. C\nClinicians should not use thermal ultrasound in the treat­\nment of patients with mild to moderate CTS.",
    "chunk_id": 16,
    "sentence_start": 820,
    "sentence_end": 825,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "B\nClinicians should not use low-level laser therapy or other \ntypes of nonlaser light therapy for individuals with CTS. C\nClinicians should not use thermal ultrasound in the treat­\nment of patients with mild to moderate CTS. D\nThere is conflicting evidence on the use of nonthermal ul­\ntrasound in the treatment of patients with mild to moder­\nate CTS, and therefore no recommendation can be made.",
    "chunk_id": 17,
    "sentence_start": 824,
    "sentence_end": 826,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "C\nClinicians should not use thermal ultrasound in the treat­\nment of patients with mild to moderate CTS. D\nThere is conflicting evidence on the use of nonthermal ul­\ntrasound in the treatment of patients with mild to moder­\nate CTS, and therefore no recommendation can be made. *These recommendati\nscientific literature acc\nList of Abbreviations\n2PD: 2-point discrimination\nAPB: abductor pollicis brevis\nAPTA: American Physical Therapy Association\nBMI: body mass index\nCI: confidence interval\nCMAP: compound muscle action potential\nCPG: clinical practice guideline\nCTQ-6: 6-item version of the Boston Carpal Tunnel \nQuestionnaire-symptom severity scale\nCTQ-FS: Boston Carpal Tunnel Questionnaire-functional \nscale\nCTQ-SSS: Boston Carpal Tunnel Questionnaire-symptom \nseverity scale\nCTR: carpal tunnel release\nCTS: carpal tunnel syndrome\nDASH: Disabilities of the Arm, Shoulder and Hand \nquestionnaire\nDIP: distal inter\nDM: diabetes m\nDML: distal mo\nDMPUT: Dello\nDSL: distal sens\nES: effect size\nFDP: flexor digi\nFDS: flexor digi\nFPL: flexor poll\nHR: hazard rati\nICC: intraclass c\nICD: Internatio\nICF: Internation\nand Health\nIFC: interferent\nLDL: low-densi\n–LR: negative li\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 18,
    "sentence_start": 825,
    "sentence_end": 827,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "D\nThere is conflicting evidence on the use of nonthermal ul­\ntrasound in the treatment of patients with mild to moder­\nate CTS, and therefore no recommendation can be made. *These recommendati\nscientific literature acc\nList of Abbreviations\n2PD: 2-point discrimination\nAPB: abductor pollicis brevis\nAPTA: American Physical Therapy Association\nBMI: body mass index\nCI: confidence interval\nCMAP: compound muscle action potential\nCPG: clinical practice guideline\nCTQ-6: 6-item version of the Boston Carpal Tunnel \nQuestionnaire-symptom severity scale\nCTQ-FS: Boston Carpal Tunnel Questionnaire-functional \nscale\nCTQ-SSS: Boston Carpal Tunnel Questionnaire-symptom \nseverity scale\nCTR: carpal tunnel release\nCTS: carpal tunnel syndrome\nDASH: Disabilities of the Arm, Shoulder and Hand \nquestionnaire\nDIP: distal inter\nDM: diabetes m\nDML: distal mo\nDMPUT: Dello\nDSL: distal sens\nES: effect size\nFDP: flexor digi\nFDS: flexor digi\nFPL: flexor poll\nHR: hazard rati\nICC: intraclass c\nICD: Internatio\nICF: Internation\nand Health\nIFC: interferent\nLDL: low-densi\n–LR: negative li\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 19,
    "sentence_start": 826,
    "sentence_end": 828,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "*These recommendati\nscientific literature acc\nList of Abbreviations\n2PD: 2-point discrimination\nAPB: abductor pollicis brevis\nAPTA: American Physical Therapy Association\nBMI: body mass index\nCI: confidence interval\nCMAP: compound muscle action potential\nCPG: clinical practice guideline\nCTQ-6: 6-item version of the Boston Carpal Tunnel \nQuestionnaire-symptom severity scale\nCTQ-FS: Boston Carpal Tunnel Questionnaire-functional \nscale\nCTQ-SSS: Boston Carpal Tunnel Questionnaire-symptom \nseverity scale\nCTR: carpal tunnel release\nCTS: carpal tunnel syndrome\nDASH: Disabilities of the Arm, Shoulder and Hand \nquestionnaire\nDIP: distal inter\nDM: diabetes m\nDML: distal mo\nDMPUT: Dello\nDSL: distal sens\nES: effect size\nFDP: flexor digi\nFDS: flexor digi\nFPL: flexor poll\nHR: hazard rati\nICC: intraclass c\nICD: Internatio\nICF: Internation\nand Health\nIFC: interferent\nLDL: low-densi\n–LR: negative li\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 20,
    "sentence_start": 827,
    "sentence_end": 829,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nB\nClinicians should not use iontophoresis in the manage­\nment of mild to moderate CTS. C\nClinicians may perform phonophoresis within nonsurgical \nmanagement of patients with mild to moderate CTS for \nthe treatment of clinical signs and symptoms. B\nClinicians should not use or recommend the use of mag­\nnets in the intervention for individuals with CTS. INTERVENTIONS – MANUAL THERAPY TECHNIQUES\nC\nClinicians may perform manual therapy, directed at the \ncervical spine and upper extremity, for individuals with \nmild to moderate CTS in the short term. D\nThere is conflicting evidence on the use of neurodynamic \nmobilizations in the management of mild to moderate CTS.",
    "chunk_id": 21,
    "sentence_start": 828,
    "sentence_end": 836,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "INTERVENTIONS – MANUAL THERAPY TECHNIQUES\nC\nClinicians may perform manual therapy, directed at the \ncervical spine and upper extremity, for individuals with \nmild to moderate CTS in the short term. D\nThere is conflicting evidence on the use of neurodynamic \nmobilizations in the management of mild to moderate CTS. INTERVENTIONS – THERAPEUTIC EXERCISE\nC\nClinicians may use a combined orthotic/stretching pro­\ngram in individuals with mild to moderate CTS who do not \nhave thenar atrophy and have normal 2-point discrimination. Cli­\nnicians should monitor those undergoing treatment for clinically \nsignificant improvement. dentification, symptom self-management, \nhat aggravate symptoms. d recommend an orthosis for women experi­\nng pregnancy and should provide a postpar­\nto examine the resolution of symptoms. OPHYSICAL AGENTS\nrecommend a trial of superficial heat for \nptom relief for individuals with CTS.",
    "chunk_id": 22,
    "sentence_start": 835,
    "sentence_end": 841,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "d recommend an orthosis for women experi­\nng pregnancy and should provide a postpar­\nto examine the resolution of symptoms. OPHYSICAL AGENTS\nrecommend a trial of superficial heat for \nptom relief for individuals with CTS. recommend the application of microwave \nathermy for short-term pain and symptom \nmild to moderate idiopathic CTS. offer a trial of interferential current for \nsymptom relief in adults without pace­\nmild to moderate CTS. As with all electri­\ndications should be taken into \nhoosing this intervention. d not use low-level laser therapy or other \ner light therapy for individuals with CTS. d not use thermal ultrasound in the treat­\ns with mild to moderate CTS. ing evidence on the use of nonthermal ul­\ntreatment of patients with mild to moder­\nno recommendation can be made. *These recommendations and clinical practice guidelines are based on the \nscientific literature accepted for publication prior to November 2018.",
    "chunk_id": 23,
    "sentence_start": 840,
    "sentence_end": 848,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "ing evidence on the use of nonthermal ul­\ntreatment of patients with mild to moder­\nno recommendation can be made. *These recommendations and clinical practice guidelines are based on the \nscientific literature accepted for publication prior to November 2018. List of Abbreviations\nmination\nis brevis\nysical Therapy Association\nex\nal\nmuscle action potential\ne guideline\non of the Boston Carpal Tunnel \ntom severity scale\npal Tunnel Questionnaire-functional \narpal Tunnel Questionnaire-symptom \nelease\nyndrome\nf the Arm, Shoulder and Hand \nDIP: distal interphalangeal\nDM: diabetes mellitus\nDML: distal motor latency\nDMPUT: Dellon-modified Moberg pick-up test\nDSL: distal sensory latency\nES: effect size\nFDP: flexor digitorum profundus\nFDS: flexor digitorum superficialis\nFPL: flexor pollicis longus\nHR: hazard ratio\nICC: intraclass correlation coefficient\nICD: International Classification of Diseases\nICF: International Classification of Functioning, Disability \nand Health\nIFC: interferential current\nLDL: low-density lipoprotein\n–LR: negative likelihood ratio\n\n\n--- Page 4 ---\nCOLUMN 1:\nIntrod\nAIM OF THE GUIDELINES\nThe Academy of Hand and Upper Extremity Physical Therapy \nand Academy of Orthopaedic Physical Therapy of the Ameri­\ncan Physical Therapy Association (APTA) have an ongoing \neffort to create evidence-based clinical practice guidelines \n(CPGs) for management of patients with musculoskeletal \nimpairments described in the World Health Organization’s \nInternational Classification of Functioning, Disability and \nHealth (ICF).296\nThe objectives of these CPGs are as follows:\n•  \u0007Describe evidence-based practice, including diagnosis, \nprognosis, intervention, and assessments of outcomes for \nmusculoskeletal disorders\n•  \u0007Classify and define common musculoskeletal conditions \nusing the World Health Organization’s terminology related \nto impairments of body function and body structure, activ­\nity limitations, and participation restrictions\n•  \u0007Identify interventions supported by current best evidence \nto address impairments of body function and structure, ac­\ntivity limitations, and participation restrictions associated \nwith common musculoskeletal conditions\n•  \u0007Identify appropriate outcome measures to assess changes \nresulting from physical therapy interventions in body func­\ntion and structure as well as in activity and participation \nof the individual\n•  \u0007Provide a description to policy makers, using internation­\nally accepted terminology, of the practice of orthopaedic \n+LR: positive likelihood ratio\nMCID: minimal clinically important difference\nMD: mean difference\nMP: metacarpophalangealNCS: nerve conduction studies\nNCV: nerve conduction velocity\nNPV: negative predictive value\nOR: odds ratio\nPIP: proximal interphalangeal\nPPB: Purdue Pegboard\nPPV: positive predictive value\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 24,
    "sentence_start": 847,
    "sentence_end": 849,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "*These recommendations and clinical practice guidelines are based on the \nscientific literature accepted for publication prior to November 2018. List of Abbreviations\nmination\nis brevis\nysical Therapy Association\nex\nal\nmuscle action potential\ne guideline\non of the Boston Carpal Tunnel \ntom severity scale\npal Tunnel Questionnaire-functional \narpal Tunnel Questionnaire-symptom \nelease\nyndrome\nf the Arm, Shoulder and Hand \nDIP: distal interphalangeal\nDM: diabetes mellitus\nDML: distal motor latency\nDMPUT: Dellon-modified Moberg pick-up test\nDSL: distal sensory latency\nES: effect size\nFDP: flexor digitorum profundus\nFDS: flexor digitorum superficialis\nFPL: flexor pollicis longus\nHR: hazard ratio\nICC: intraclass correlation coefficient\nICD: International Classification of Diseases\nICF: International Classification of Functioning, Disability \nand Health\nIFC: interferential current\nLDL: low-density lipoprotein\n–LR: negative likelihood ratio\n\n\n--- Page 4 ---\nCOLUMN 1:\nIntrod\nAIM OF THE GUIDELINES\nThe Academy of Hand and Upper Extremity Physical Therapy \nand Academy of Orthopaedic Physical Therapy of the Ameri­\ncan Physical Therapy Association (APTA) have an ongoing \neffort to create evidence-based clinical practice guidelines \n(CPGs) for management of patients with musculoskeletal \nimpairments described in the World Health Organization’s \nInternational Classification of Functioning, Disability and \nHealth (ICF).296\nThe objectives of these CPGs are as follows:\n•  \u0007Describe evidence-based practice, including diagnosis, \nprognosis, intervention, and assessments of outcomes for \nmusculoskeletal disorders\n•  \u0007Classify and define common musculoskeletal conditions \nusing the World Health Organization’s terminology related \nto impairments of body function and body structure, activ­\nity limitations, and participation restrictions\n•  \u0007Identify interventions supported by current best evidence \nto address impairments of body function and structure, ac­\ntivity limitations, and participation restrictions associated \nwith common musculoskeletal conditions\n•  \u0007Identify appropriate outcome measures to assess changes \nresulting from physical therapy interventions in body func­\ntion and structure as well as in activity and participation \nof the individual\n•  \u0007Provide a description to policy makers, using internation­\nally accepted terminology, of the practice of orthopaedic \n+LR: positive likelihood ratio\nMCID: minimal clinically important difference\nMD: mean difference\nMP: metacarpophalangealNCS: nerve conduction studies\nNCV: nerve conduction velocity\nNPV: negative predictive value\nOR: odds ratio\nPIP: proximal interphalangeal\nPPB: Purdue Pegboard\nPPV: positive predictive value\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 25,
    "sentence_start": 848,
    "sentence_end": 850,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "List of Abbreviations\nmination\nis brevis\nysical Therapy Association\nex\nal\nmuscle action potential\ne guideline\non of the Boston Carpal Tunnel \ntom severity scale\npal Tunnel Questionnaire-functional \narpal Tunnel Questionnaire-symptom \nelease\nyndrome\nf the Arm, Shoulder and Hand \nDIP: distal interphalangeal\nDM: diabetes mellitus\nDML: distal motor latency\nDMPUT: Dellon-modified Moberg pick-up test\nDSL: distal sensory latency\nES: effect size\nFDP: flexor digitorum profundus\nFDS: flexor digitorum superficialis\nFPL: flexor pollicis longus\nHR: hazard ratio\nICC: intraclass correlation coefficient\nICD: International Classification of Diseases\nICF: International Classification of Functioning, Disability \nand Health\nIFC: interferential current\nLDL: low-density lipoprotein\n–LR: negative likelihood ratio\n\n\n--- Page 4 ---\nCOLUMN 1:\nIntrod\nAIM OF THE GUIDELINES\nThe Academy of Hand and Upper Extremity Physical Therapy \nand Academy of Orthopaedic Physical Therapy of the Ameri­\ncan Physical Therapy Association (APTA) have an ongoing \neffort to create evidence-based clinical practice guidelines \n(CPGs) for management of patients with musculoskeletal \nimpairments described in the World Health Organization’s \nInternational Classification of Functioning, Disability and \nHealth (ICF).296\nThe objectives of these CPGs are as follows:\n•  \u0007Describe evidence-based practice, including diagnosis, \nprognosis, intervention, and assessments of outcomes for \nmusculoskeletal disorders\n•  \u0007Classify and define common musculoskeletal conditions \nusing the World Health Organization’s terminology related \nto impairments of body function and body structure, activ­\nity limitations, and participation restrictions\n•  \u0007Identify interventions supported by current best evidence \nto address impairments of body function and structure, ac­\ntivity limitations, and participation restrictions associated \nwith common musculoskeletal conditions\n•  \u0007Identify appropriate outcome measures to assess changes \nresulting from physical therapy interventions in body func­\ntion and structure as well as in activity and participation \nof the individual\n•  \u0007Provide a description to policy makers, using internation­\nally accepted terminology, of the practice of orthopaedic \n+LR: positive likelihood ratio\nMCID: minimal clinically important difference\nMD: mean difference\nMP: metacarpophalangealNCS: nerve conduction studies\nNCV: nerve conduction velocity\nNPV: negative predictive value\nOR: odds ratio\nPIP: proximal interphalangeal\nPPB: Purdue Pegboard\nPPV: positive predictive value\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 26,
    "sentence_start": 849,
    "sentence_end": 851,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nIntroduction \nS\nd and Upper Extremity Physical Therapy \nopaedic Physical Therapy of the Ameri­\ny Association (APTA) have an ongoing \nence-based clinical practice guidelines \nment of patients with musculoskeletal \ned in the World Health Organization’s \nfication of Functioning, Disability and \nse CPGs are as follows:\n-based practice, including diagnosis, \nntion, and assessments of outcomes for \nsorders\ne common musculoskeletal conditions \nalth Organization’s terminology related \nbody function and body structure, activ­\nparticipation restrictions\nons supported by current best evidence \nents of body function and structure, ac­\nnd participation restrictions associated \nculoskeletal conditions\nte outcome measures to assess changes \nical therapy interventions in body func­\nas well as in activity and participation \non to policy makers, using internation­\ninology, of the practice of orthopaedic \nphysical therapists and hand rehabilitation\n•  \u0007Provide information for payers and claims reviewers re­\ngarding the practice of orthopaedic and hand therapy for \ncommon musculoskeletal conditions\n•  \u0007Create a reference publication for clinicians, academic in­\nstructors, clinical instructors, students, interns, residents, \nand fellows regarding the best current practice of ortho­\npaedic physical therapy and hand rehabilitation\nSTATEMENT OF INTENT\nThese guidelines are not intended to be construed or to \nserve as a standard of medical care.",
    "chunk_id": 27,
    "sentence_start": 852,
    "sentence_end": 854,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nIntroduction \nS\nd and Upper Extremity Physical Therapy \nopaedic Physical Therapy of the Ameri­\ny Association (APTA) have an ongoing \nence-based clinical practice guidelines \nment of patients with musculoskeletal \ned in the World Health Organization’s \nfication of Functioning, Disability and \nse CPGs are as follows:\n-based practice, including diagnosis, \nntion, and assessments of outcomes for \nsorders\ne common musculoskeletal conditions \nalth Organization’s terminology related \nbody function and body structure, activ­\nparticipation restrictions\nons supported by current best evidence \nents of body function and structure, ac­\nnd participation restrictions associated \nculoskeletal conditions\nte outcome measures to assess changes \nical therapy interventions in body func­\nas well as in activity and participation \non to policy makers, using internation­\ninology, of the practice of orthopaedic \nphysical therapists and hand rehabilitation\n•  \u0007Provide information for payers and claims reviewers re­\ngarding the practice of orthopaedic and hand therapy for \ncommon musculoskeletal conditions\n•  \u0007Create a reference publication for clinicians, academic in­\nstructors, clinical instructors, students, interns, residents, \nand fellows regarding the best current practice of ortho­\npaedic physical therapy and hand rehabilitation\nSTATEMENT OF INTENT\nThese guidelines are not intended to be construed or to \nserve as a standard of medical care. Standards of care are \ndetermined on the basis of all clinical data available for an \nindividual patient and are subject to change as scientific \nknowledge and technology advance and patterns of care \nevolve.",
    "chunk_id": 28,
    "sentence_start": 853,
    "sentence_end": 855,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nIntroduction \nS\nd and Upper Extremity Physical Therapy \nopaedic Physical Therapy of the Ameri­\ny Association (APTA) have an ongoing \nence-based clinical practice guidelines \nment of patients with musculoskeletal \ned in the World Health Organization’s \nfication of Functioning, Disability and \nse CPGs are as follows:\n-based practice, including diagnosis, \nntion, and assessments of outcomes for \nsorders\ne common musculoskeletal conditions \nalth Organization’s terminology related \nbody function and body structure, activ­\nparticipation restrictions\nons supported by current best evidence \nents of body function and structure, ac­\nnd participation restrictions associated \nculoskeletal conditions\nte outcome measures to assess changes \nical therapy interventions in body func­\nas well as in activity and participation \non to policy makers, using internation­\ninology, of the practice of orthopaedic \nphysical therapists and hand rehabilitation\n•  \u0007Provide information for payers and claims reviewers re­\ngarding the practice of orthopaedic and hand therapy for \ncommon musculoskeletal conditions\n•  \u0007Create a reference publication for clinicians, academic in­\nstructors, clinical instructors, students, interns, residents, \nand fellows regarding the best current practice of ortho­\npaedic physical therapy and hand rehabilitation\nSTATEMENT OF INTENT\nThese guidelines are not intended to be construed or to \nserve as a standard of medical care. Standards of care are \ndetermined on the basis of all clinical data available for an \nindividual patient and are subject to change as scientific \nknowledge and technology advance and patterns of care \nevolve. These parameters of practice should be considered \nguidelines only.",
    "chunk_id": 29,
    "sentence_start": 854,
    "sentence_end": 856,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Standards of care are \ndetermined on the basis of all clinical data available for an \nindividual patient and are subject to change as scientific \nknowledge and technology advance and patterns of care \nevolve. These parameters of practice should be considered \nguidelines only. Adherence to them will not ensure a suc­\ncessful outcome in every patient, nor should they be con­\nstrued as including all proper methods of care or excluding \nother acceptable methods of care aimed at the same re­\nsults. The ultimate judgment regarding a particular clini­\ncal procedure or treatment plan must be made in light of \nthe clinical data presented by the patient, the diagnostic \nand treatment options available, and the patient’s values, \nexpectations, and preferences. However, we suggest that \nsignificant departures from accepted guidelines should be \ndocumented in the patient’s medical records at the time the \nrelevant clinical decision is made.",
    "chunk_id": 30,
    "sentence_start": 855,
    "sentence_end": 859,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The ultimate judgment regarding a particular clini­\ncal procedure or treatment plan must be made in light of \nthe clinical data presented by the patient, the diagnostic \nand treatment options available, and the patient’s values, \nexpectations, and preferences. However, we suggest that \nsignificant departures from accepted guidelines should be \ndocumented in the patient’s medical records at the time the \nrelevant clinical decision is made. List of Abbreviations (continued)\nood ratio\nically important difference\ne\nangealNCS: nerve conduction studies\nion velocity\nctive value\nhalangeal\nrd\ntive value\nQuickDASH: 11-item version of the DASH\nRCT: randomized controlled trial\nSNAP: sensory nerve action potential\nSNCV: sensory nerve conduction velocity\nSRM: standardized response mean\nSSCT: subsynovial connective tissue\nSWMT: Semmes-Weinstein monofilament testing\nTENS: transcutaneous electrical nerve stimulation\nULNT: upper-limb neurodynamic test\nVAS: visual analog scale\n\n\n--- Page 5 ---\nCOLUMN 1:\nThe Academy of Hand and Upper Extremity Physical Therapy \nand the Academy of Orthopaedic Physical Therapy, APTA, Inc \nappointed content experts to develop CPGs for musculoskel­\netal conditions of the elbow, forearm, wrist, and hand.",
    "chunk_id": 31,
    "sentence_start": 858,
    "sentence_end": 860,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "However, we suggest that \nsignificant departures from accepted guidelines should be \ndocumented in the patient’s medical records at the time the \nrelevant clinical decision is made. List of Abbreviations (continued)\nood ratio\nically important difference\ne\nangealNCS: nerve conduction studies\nion velocity\nctive value\nhalangeal\nrd\ntive value\nQuickDASH: 11-item version of the DASH\nRCT: randomized controlled trial\nSNAP: sensory nerve action potential\nSNCV: sensory nerve conduction velocity\nSRM: standardized response mean\nSSCT: subsynovial connective tissue\nSWMT: Semmes-Weinstein monofilament testing\nTENS: transcutaneous electrical nerve stimulation\nULNT: upper-limb neurodynamic test\nVAS: visual analog scale\n\n\n--- Page 5 ---\nCOLUMN 1:\nThe Academy of Hand and Upper Extremity Physical Therapy \nand the Academy of Orthopaedic Physical Therapy, APTA, Inc \nappointed content experts to develop CPGs for musculoskel­\netal conditions of the elbow, forearm, wrist, and hand. These \ncontent experts were given the task to identify impairments \nof body function and structure, activity limitations, and par­\nticipation restrictions, described using ICF terminology, that \ncould (1) categorize patients into mutually exclusive impair­\nment patterns upon which to base intervention strategies, and \n(2) serve as measures of changes in function over the course \nof an episode of care.",
    "chunk_id": 32,
    "sentence_start": 859,
    "sentence_end": 861,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "List of Abbreviations (continued)\nood ratio\nically important difference\ne\nangealNCS: nerve conduction studies\nion velocity\nctive value\nhalangeal\nrd\ntive value\nQuickDASH: 11-item version of the DASH\nRCT: randomized controlled trial\nSNAP: sensory nerve action potential\nSNCV: sensory nerve conduction velocity\nSRM: standardized response mean\nSSCT: subsynovial connective tissue\nSWMT: Semmes-Weinstein monofilament testing\nTENS: transcutaneous electrical nerve stimulation\nULNT: upper-limb neurodynamic test\nVAS: visual analog scale\n\n\n--- Page 5 ---\nCOLUMN 1:\nThe Academy of Hand and Upper Extremity Physical Therapy \nand the Academy of Orthopaedic Physical Therapy, APTA, Inc \nappointed content experts to develop CPGs for musculoskel­\netal conditions of the elbow, forearm, wrist, and hand. These \ncontent experts were given the task to identify impairments \nof body function and structure, activity limitations, and par­\nticipation restrictions, described using ICF terminology, that \ncould (1) categorize patients into mutually exclusive impair­\nment patterns upon which to base intervention strategies, and \n(2) serve as measures of changes in function over the course \nof an episode of care. The second task given to the content \nexperts was to describe the supporting evidence for the iden­\ntified impairment pattern classification, as well as interven­\ntions for patients with activity limitations and impairments \nof body function and structure consistent with the identified \nimpairment pattern classification.",
    "chunk_id": 33,
    "sentence_start": 860,
    "sentence_end": 862,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "These \ncontent experts were given the task to identify impairments \nof body function and structure, activity limitations, and par­\nticipation restrictions, described using ICF terminology, that \ncould (1) categorize patients into mutually exclusive impair­\nment patterns upon which to base intervention strategies, and \n(2) serve as measures of changes in function over the course \nof an episode of care. The second task given to the content \nexperts was to describe the supporting evidence for the iden­\ntified impairment pattern classification, as well as interven­\ntions for patients with activity limitations and impairments \nof body function and structure consistent with the identified \nimpairment pattern classification. It was also acknowledged \nby the Academy of Orthopaedic Physical Therapy content \nexperts that only performing a systematic search and review \nof the evidence related to diagnostic categories based on In­\nternational Statistical Classification of Diseases and Related \nHealth Problems (ICD)297 terminology would not be sufficient \nfor these ICF-based CPGs, as most of the evidence associated \nwith changes in levels of impairment or function in homo­\ngeneous populations is not readily searchable using the ICD \nterminology.",
    "chunk_id": 34,
    "sentence_start": 861,
    "sentence_end": 863,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The second task given to the content \nexperts was to describe the supporting evidence for the iden­\ntified impairment pattern classification, as well as interven­\ntions for patients with activity limitations and impairments \nof body function and structure consistent with the identified \nimpairment pattern classification. It was also acknowledged \nby the Academy of Orthopaedic Physical Therapy content \nexperts that only performing a systematic search and review \nof the evidence related to diagnostic categories based on In­\nternational Statistical Classification of Diseases and Related \nHealth Problems (ICD)297 terminology would not be sufficient \nfor these ICF-based CPGs, as most of the evidence associated \nwith changes in levels of impairment or function in homo­\ngeneous populations is not readily searchable using the ICD \nterminology. Thus, the authors of this guideline independently \nperformed a systematic search of MEDLINE, CINAHL, and \nthe Cochrane Database of Systematic Reviews (1967 through \nNovember 2018) for any relevant articles related to classifi­\ncation, examination, and intervention strategies for carpal \ntunnel syndrome (CTS).",
    "chunk_id": 35,
    "sentence_start": 862,
    "sentence_end": 864,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "It was also acknowledged \nby the Academy of Orthopaedic Physical Therapy content \nexperts that only performing a systematic search and review \nof the evidence related to diagnostic categories based on In­\nternational Statistical Classification of Diseases and Related \nHealth Problems (ICD)297 terminology would not be sufficient \nfor these ICF-based CPGs, as most of the evidence associated \nwith changes in levels of impairment or function in homo­\ngeneous populations is not readily searchable using the ICD \nterminology. Thus, the authors of this guideline independently \nperformed a systematic search of MEDLINE, CINAHL, and \nthe Cochrane Database of Systematic Reviews (1967 through \nNovember 2018) for any relevant articles related to classifi­\ncation, examination, and intervention strategies for carpal \ntunnel syndrome (CTS). Additionally, when relevant articles \nwere identified, their reference lists were hand searched in an \nattempt to identify other relevant articles.",
    "chunk_id": 36,
    "sentence_start": 863,
    "sentence_end": 865,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Thus, the authors of this guideline independently \nperformed a systematic search of MEDLINE, CINAHL, and \nthe Cochrane Database of Systematic Reviews (1967 through \nNovember 2018) for any relevant articles related to classifi­\ncation, examination, and intervention strategies for carpal \ntunnel syndrome (CTS). Additionally, when relevant articles \nwere identified, their reference lists were hand searched in an \nattempt to identify other relevant articles. Articles from the \nsearches were compiled and reviewed for accuracy by the au­\nthors (see APPENDIX A for full search strategies and APPENDIX B \nfor search results, available at www.jospt.org). The authors declared relationships and developed a conflict \nmanagement plan, which included submitting a Conflict of \nInterest form to the Academy of Orthopaedic Physical Thera­\npy, APTA, Inc. Articles that were authored by a reviewer were \nassigned to an alternate reviewer.",
    "chunk_id": 37,
    "sentence_start": 864,
    "sentence_end": 868,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The authors declared relationships and developed a conflict \nmanagement plan, which included submitting a Conflict of \nInterest form to the Academy of Orthopaedic Physical Thera­\npy, APTA, Inc. Articles that were authored by a reviewer were \nassigned to an alternate reviewer. Funding was provided by \nthe APTA to the CPG development team for travel and ex­\npenses to the CPG development workshop. The CPG devel­\nopment team maintained editorial independence. Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nd and Upper Extremity Physical Therapy \nrthopaedic Physical Therapy, APTA, Inc \nperts to develop CPGs for musculoskel­\nelbow, forearm, wrist, and hand.",
    "chunk_id": 38,
    "sentence_start": 867,
    "sentence_end": 876,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nd and Upper Extremity Physical Therapy \nrthopaedic Physical Therapy, APTA, Inc \nperts to develop CPGs for musculoskel­\nelbow, forearm, wrist, and hand. These \ngiven the task to identify impairments \nstructure, activity limitations, and par­\n, described using ICF terminology, that \npatients into mutually exclusive impair­\nwhich to base intervention strategies, and \ns of changes in function over the course \n. The second task given to the content \nbe the supporting evidence for the iden­\nttern classification, as well as interven­\nh activity limitations and impairments \nstructure consistent with the identified \nclassification.",
    "chunk_id": 39,
    "sentence_start": 875,
    "sentence_end": 878,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "These \ngiven the task to identify impairments \nstructure, activity limitations, and par­\n, described using ICF terminology, that \npatients into mutually exclusive impair­\nwhich to base intervention strategies, and \ns of changes in function over the course \n. The second task given to the content \nbe the supporting evidence for the iden­\nttern classification, as well as interven­\nh activity limitations and impairments \nstructure consistent with the identified \nclassification. It was also acknowledged \nOrthopaedic Physical Therapy content \nforming a systematic search and review \ned to diagnostic categories based on In­\nl Classification of Diseases and Related \nD)297 terminology would not be sufficient \nCPGs, as most of the evidence associated \nls of impairment or function in homo­\nis not readily searchable using the ICD \ne authors of this guideline independently \ntic search of MEDLINE, CINAHL, and \nse of Systematic Reviews (1967 through \nany relevant articles related to classifi­\nand intervention strategies for carpal \nTS).",
    "chunk_id": 40,
    "sentence_start": 877,
    "sentence_end": 879,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The second task given to the content \nbe the supporting evidence for the iden­\nttern classification, as well as interven­\nh activity limitations and impairments \nstructure consistent with the identified \nclassification. It was also acknowledged \nOrthopaedic Physical Therapy content \nforming a systematic search and review \ned to diagnostic categories based on In­\nl Classification of Diseases and Related \nD)297 terminology would not be sufficient \nCPGs, as most of the evidence associated \nls of impairment or function in homo­\nis not readily searchable using the ICD \ne authors of this guideline independently \ntic search of MEDLINE, CINAHL, and \nse of Systematic Reviews (1967 through \nany relevant articles related to classifi­\nand intervention strategies for carpal \nTS). Additionally, when relevant articles \nreference lists were hand searched in an \nther relevant articles.",
    "chunk_id": 41,
    "sentence_start": 878,
    "sentence_end": 880,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "It was also acknowledged \nOrthopaedic Physical Therapy content \nforming a systematic search and review \ned to diagnostic categories based on In­\nl Classification of Diseases and Related \nD)297 terminology would not be sufficient \nCPGs, as most of the evidence associated \nls of impairment or function in homo­\nis not readily searchable using the ICD \ne authors of this guideline independently \ntic search of MEDLINE, CINAHL, and \nse of Systematic Reviews (1967 through \nany relevant articles related to classifi­\nand intervention strategies for carpal \nTS). Additionally, when relevant articles \nreference lists were hand searched in an \nther relevant articles. Articles from the \ned and reviewed for accuracy by the au­\nfor full search strategies and APPENDIX B \nilable at www.jospt.org). d relationships and developed a conflict \nwhich included submitting a Conflict of \ncademy of Orthopaedic Physical Thera­\nes that were authored by a reviewer were \nate reviewer.",
    "chunk_id": 42,
    "sentence_start": 879,
    "sentence_end": 882,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Articles from the \ned and reviewed for accuracy by the au­\nfor full search strategies and APPENDIX B \nilable at www.jospt.org). d relationships and developed a conflict \nwhich included submitting a Conflict of \ncademy of Orthopaedic Physical Thera­\nes that were authored by a reviewer were \nate reviewer. Funding was provided by \nG development team for travel and ex­\nevelopment workshop. The CPG devel­\nined editorial independence. of each article were reviewed independently by 2 members of \nthe CPG development team for inclusion (see APPENDIX C for \ninclusion and exclusion criteria, available at www.jospt.org). Full-text review was then similarly conducted to obtain the \nfinal set of articles for contribution to recommendations. Ad­\nditional CPG team members provided the final decision for \ndiscrepancies that were not resolved by the review team (see \nAPPENDIX B for flow chart of articles and APPENDIX E for articles \nincluded in recommendations by topic, available at www.jospt.",
    "chunk_id": 43,
    "sentence_start": 881,
    "sentence_end": 888,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Ad­\nditional CPG team members provided the final decision for \ndiscrepancies that were not resolved by the review team (see \nAPPENDIX B for flow chart of articles and APPENDIX E for articles \nincluded in recommendations by topic, available at www.jospt. For selected relevant topics that were not appropriate for \nthe development of recommendations, such as incidence and \nimaging, articles were not subject to the systematic review pro­\ncess and were not included in the flow charts. Evidence tables \nfor this CPG are available on the Clinical Practice Guidelines \npage of the Academy of Orthopaedic Physical Therapy of the \nAPTA website: www.orthopt.org. This guideline was issued in 2019 based on publications \nin the scientific literature prior to November 2018. This \nguideline will be considered for review in 2023, or sooner if \nclinically significant new evidence becomes available. Sur­\nveillance will include monitoring MEDLINE and CINAHL \nadditions using feeds related to the search terms.",
    "chunk_id": 44,
    "sentence_start": 887,
    "sentence_end": 893,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "This \nguideline will be considered for review in 2023, or sooner if \nclinically significant new evidence becomes available. Sur­\nveillance will include monitoring MEDLINE and CINAHL \nadditions using feeds related to the search terms. Any up­\ndates to the guideline in the interim period will be noted on \nthe Academy of Orthopaedic Physical Therapy of the APTA \nwebsite (www.orthopt.org). LEVELS OF EVIDENCE\nIndividual clinical research articles were graded according to \ncriteria adapted from the Centre for Evidence-Based Medi­\ncine, Oxford, United Kingdom (www.cebm.net) for diagnos­\ntic, prospective, and therapeutic studies.226 If the 2 content \nexperts did not agree on a grade of evidence for a particular \narticle, a third content expert was used to resolve the issue \n(see APPENDICES F and G for levels of evidence and details on \nprocedures used for assigning levels of evidence, available at \nwww.orthopt.org).",
    "chunk_id": 45,
    "sentence_start": 892,
    "sentence_end": 895,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Any up­\ndates to the guideline in the interim period will be noted on \nthe Academy of Orthopaedic Physical Therapy of the APTA \nwebsite (www.orthopt.org). LEVELS OF EVIDENCE\nIndividual clinical research articles were graded according to \ncriteria adapted from the Centre for Evidence-Based Medi­\ncine, Oxford, United Kingdom (www.cebm.net) for diagnos­\ntic, prospective, and therapeutic studies.226 If the 2 content \nexperts did not agree on a grade of evidence for a particular \narticle, a third content expert was used to resolve the issue \n(see APPENDICES F and G for levels of evidence and details on \nprocedures used for assigning levels of evidence, available at \nwww.orthopt.org). The evidence update was organized from \nhighest level of evidence to lowest level. An abbreviated ver­\nsion of the grading system is provided below.",
    "chunk_id": 46,
    "sentence_start": 894,
    "sentence_end": 897,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The evidence update was organized from \nhighest level of evidence to lowest level. An abbreviated ver­\nsion of the grading system is provided below. I\nEvidence obtained from systematic reviews, high-quality diagnos­\ntic studies, prospective studies, or randomized controlled trials\nII\nEvidence obtained from lesser-quality diagnostic studies, sys­\ntematic reviews, prospective studies, or randomized controlled \ntrials (eg weaker diagnostic criteria and reference standards\nMethods\n\n\n--- Page 6 ---\nCOLUMN 1:\nSTRENGTH OF EVIDENCE AND GRADES OF RECOMMENDATIONS\nThe overall strength of the evidence supporting recommen­\ndations made in these guidelines was graded according to \nguidelines described by Guyatt et al,122 as modified by Mac­\nDermid et al172 and adopted by the coordinator and reviewers \nof this project.",
    "chunk_id": 47,
    "sentence_start": 896,
    "sentence_end": 898,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "An abbreviated ver­\nsion of the grading system is provided below. I\nEvidence obtained from systematic reviews, high-quality diagnos­\ntic studies, prospective studies, or randomized controlled trials\nII\nEvidence obtained from lesser-quality diagnostic studies, sys­\ntematic reviews, prospective studies, or randomized controlled \ntrials (eg weaker diagnostic criteria and reference standards\nMethods\n\n\n--- Page 6 ---\nCOLUMN 1:\nSTRENGTH OF EVIDENCE AND GRADES OF RECOMMENDATIONS\nThe overall strength of the evidence supporting recommen­\ndations made in these guidelines was graded according to \nguidelines described by Guyatt et al,122 as modified by Mac­\nDermid et al172 and adopted by the coordinator and reviewers \nof this project. In this modified system, the typical A, B, C, \nand D grades of evidence have been modified to include the \nrole of consensus expert opinion and basic science research \nto demonstrate biological or biomechanical plausibility.",
    "chunk_id": 48,
    "sentence_start": 897,
    "sentence_end": 899,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "I\nEvidence obtained from systematic reviews, high-quality diagnos­\ntic studies, prospective studies, or randomized controlled trials\nII\nEvidence obtained from lesser-quality diagnostic studies, sys­\ntematic reviews, prospective studies, or randomized controlled \ntrials (eg weaker diagnostic criteria and reference standards\nMethods\n\n\n--- Page 6 ---\nCOLUMN 1:\nSTRENGTH OF EVIDENCE AND GRADES OF RECOMMENDATIONS\nThe overall strength of the evidence supporting recommen­\ndations made in these guidelines was graded according to \nguidelines described by Guyatt et al,122 as modified by Mac­\nDermid et al172 and adopted by the coordinator and reviewers \nof this project. In this modified system, the typical A, B, C, \nand D grades of evidence have been modified to include the \nrole of consensus expert opinion and basic science research \nto demonstrate biological or biomechanical plausibility. The strength of the evidence supporting the recommendations \nwas graded according to the information provided below.",
    "chunk_id": 49,
    "sentence_start": 898,
    "sentence_end": 900,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In this modified system, the typical A, B, C, \nand D grades of evidence have been modified to include the \nrole of consensus expert opinion and basic science research \nto demonstrate biological or biomechanical plausibility. The strength of the evidence supporting the recommendations \nwas graded according to the information provided below. Each \nteam developed recommendations based on the strength of ev­\nidence, including how directly the studies addressed the ques­\ntion on hand pain and sensory deficits: CTS. In developing \ntheir recommendations, the authors considered the strengths \nand limitations of the body of evidence and the health benefits, \nside effects, and risks of tests and interventions. GRADES OF RECOMMENDATION\nSTRENGTH OF EVIDENCE\nA\nStrong evidence\nA preponderance of level I and/or level II \nstudies support the recommendation.",
    "chunk_id": 50,
    "sentence_start": 899,
    "sentence_end": 903,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In developing \ntheir recommendations, the authors considered the strengths \nand limitations of the body of evidence and the health benefits, \nside effects, and risks of tests and interventions. GRADES OF RECOMMENDATION\nSTRENGTH OF EVIDENCE\nA\nStrong evidence\nA preponderance of level I and/or level II \nstudies support the recommendation. This \nmust include at least 1 level I study\nB\nModerate \nevidence\nA single high-quality randomized controlled \ntrial or a preponderance of level II studies \nsupport the recommendation\nC\nWeak evidence\nA single level II study or a preponderance of \nlevel III and IV studies, including statements \nof consensus by content experts, support the \nrecommendation\nD\nConflicting \nevidence\nHigher-quality studies conducted on this \ntopic disagree with respect to their conclu­\nsions.",
    "chunk_id": 51,
    "sentence_start": 902,
    "sentence_end": 904,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "GRADES OF RECOMMENDATION\nSTRENGTH OF EVIDENCE\nA\nStrong evidence\nA preponderance of level I and/or level II \nstudies support the recommendation. This \nmust include at least 1 level I study\nB\nModerate \nevidence\nA single high-quality randomized controlled \ntrial or a preponderance of level II studies \nsupport the recommendation\nC\nWeak evidence\nA single level II study or a preponderance of \nlevel III and IV studies, including statements \nof consensus by content experts, support the \nrecommendation\nD\nConflicting \nevidence\nHigher-quality studies conducted on this \ntopic disagree with respect to their conclu­\nsions. The recommendation is based on \nthese conflicting studies\nE\nTheoretical/\nfoundational \nevidence\nA preponderance of evidence from animal or \ncadaver studies, from conceptual models/\nprinciples, or from basic science/bench \nresearch support this conclusion\nF\nExpert opinion\nBest practice based on the clinical experi­\nence of the guidelines development team\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 52,
    "sentence_start": 903,
    "sentence_end": 905,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "This \nmust include at least 1 level I study\nB\nModerate \nevidence\nA single high-quality randomized controlled \ntrial or a preponderance of level II studies \nsupport the recommendation\nC\nWeak evidence\nA single level II study or a preponderance of \nlevel III and IV studies, including statements \nof consensus by content experts, support the \nrecommendation\nD\nConflicting \nevidence\nHigher-quality studies conducted on this \ntopic disagree with respect to their conclu­\nsions. The recommendation is based on \nthese conflicting studies\nE\nTheoretical/\nfoundational \nevidence\nA preponderance of evidence from animal or \ncadaver studies, from conceptual models/\nprinciples, or from basic science/bench \nresearch support this conclusion\nF\nExpert opinion\nBest practice based on the clinical experi­\nence of the guidelines development team\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 53,
    "sentence_start": 904,
    "sentence_end": 907,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nE AND GRADES OF RECOMMENDATIONS\nof the evidence supporting recommen­\nse guidelines was graded according to \nby Guyatt et al,122 as modified by Mac­\ndopted by the coordinator and reviewers \ns modified system, the typical A, B, C, \nence have been modified to include the \npert opinion and basic science research \ngical or biomechanical plausibility. idence supporting the recommendations \nto the information provided below. Each \nmmendations based on the strength of ev­\nw directly the studies addressed the ques­\nnd sensory deficits: CTS. In developing \nns, the authors considered the strengths \nbody of evidence and the health benefits, \nof tests and interventions.",
    "chunk_id": 54,
    "sentence_start": 906,
    "sentence_end": 913,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Each \nmmendations based on the strength of ev­\nw directly the studies addressed the ques­\nnd sensory deficits: CTS. In developing \nns, the authors considered the strengths \nbody of evidence and the health benefits, \nof tests and interventions. OCESS AND VALIDATION\nwho are experts in management and \nwed this CPG content and methods for \nnd that it fully represents the condition. estions, or feedback from the expert re­\ned to the author and editors to consider \nte revisions. These guidelines were also \nand a notification of this posting was sent to the members of \nthe Academy of Orthopaedic Physical Therapy, APTA, Inc. Any comments, suggestions, and feedback gathered from \npublic commentary were sent to the authors and editors to \nconsider and make appropriate revisions in the guideline.",
    "chunk_id": 55,
    "sentence_start": 912,
    "sentence_end": 917,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "These guidelines were also \nand a notification of this posting was sent to the members of \nthe Academy of Orthopaedic Physical Therapy, APTA, Inc. Any comments, suggestions, and feedback gathered from \npublic commentary were sent to the authors and editors to \nconsider and make appropriate revisions in the guideline. In \naddition, a panel of consumer/patient representatives and \nexternal stakeholders, such as claims reviewers, medical cod­\ning experts, academic educators, clinical educators, physician \nspecialists, and researchers, also reviewed the guideline and \nprovided feedback and recommendations that were given to \nthe authors and editors for further consideration and revi­\nsions.",
    "chunk_id": 56,
    "sentence_start": 916,
    "sentence_end": 918,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Any comments, suggestions, and feedback gathered from \npublic commentary were sent to the authors and editors to \nconsider and make appropriate revisions in the guideline. In \naddition, a panel of consumer/patient representatives and \nexternal stakeholders, such as claims reviewers, medical cod­\ning experts, academic educators, clinical educators, physician \nspecialists, and researchers, also reviewed the guideline and \nprovided feedback and recommendations that were given to \nthe authors and editors for further consideration and revi­\nsions. Last, a panel of consumer/patient representatives \nand external stakeholders and a panel of experts in physi­\ncal therapy CPG methodology annually review the Academy \nof Orthopaedic Physical Therapy’s ICF-based CPG policies \nand provide feedback and comments to the CPG coordinator \nand editors to improve the APTA guideline development and \nimplementation processes.",
    "chunk_id": 57,
    "sentence_start": 917,
    "sentence_end": 919,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In \naddition, a panel of consumer/patient representatives and \nexternal stakeholders, such as claims reviewers, medical cod­\ning experts, academic educators, clinical educators, physician \nspecialists, and researchers, also reviewed the guideline and \nprovided feedback and recommendations that were given to \nthe authors and editors for further consideration and revi­\nsions. Last, a panel of consumer/patient representatives \nand external stakeholders and a panel of experts in physi­\ncal therapy CPG methodology annually review the Academy \nof Orthopaedic Physical Therapy’s ICF-based CPG policies \nand provide feedback and comments to the CPG coordinator \nand editors to improve the APTA guideline development and \nimplementation processes. DISSEMINATION AND IMPLEMENTATION TOOLS\nIn addition to publishing these guidelines in the Journal \nof Orthopaedic & Sports Physical Therapy (JOSPT), these \nguidelines will be posted in the CPG areas of both the JOSPT \nand the Academy of Orthopaedic Physical Therapy, APTA, \nInc websites, and will be submitted for posting on ECRI \nGuidelines Trust (guidelines.ecri.org).",
    "chunk_id": 58,
    "sentence_start": 918,
    "sentence_end": 920,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Last, a panel of consumer/patient representatives \nand external stakeholders and a panel of experts in physi­\ncal therapy CPG methodology annually review the Academy \nof Orthopaedic Physical Therapy’s ICF-based CPG policies \nand provide feedback and comments to the CPG coordinator \nand editors to improve the APTA guideline development and \nimplementation processes. DISSEMINATION AND IMPLEMENTATION TOOLS\nIn addition to publishing these guidelines in the Journal \nof Orthopaedic & Sports Physical Therapy (JOSPT), these \nguidelines will be posted in the CPG areas of both the JOSPT \nand the Academy of Orthopaedic Physical Therapy, APTA, \nInc websites, and will be submitted for posting on ECRI \nGuidelines Trust (guidelines.ecri.org). The implementation \ntools planned to be available for patients, clinicians, educa­\ntors, payers, policy makers, and researchers, and the associ­\nated implementation strategies, are listed in TABLE 1.",
    "chunk_id": 59,
    "sentence_start": 919,
    "sentence_end": 921,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "DISSEMINATION AND IMPLEMENTATION TOOLS\nIn addition to publishing these guidelines in the Journal \nof Orthopaedic & Sports Physical Therapy (JOSPT), these \nguidelines will be posted in the CPG areas of both the JOSPT \nand the Academy of Orthopaedic Physical Therapy, APTA, \nInc websites, and will be submitted for posting on ECRI \nGuidelines Trust (guidelines.ecri.org). The implementation \ntools planned to be available for patients, clinicians, educa­\ntors, payers, policy makers, and researchers, and the associ­\nated implementation strategies, are listed in TABLE 1. CLASSIFICATION\nThe International Classification of Diseases-10th Revision-\nClinical Modification (ICD-10-CM) and ICF codes that could be \nused when managing individuals with CTS are provided below.",
    "chunk_id": 60,
    "sentence_start": 920,
    "sentence_end": 922,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The implementation \ntools planned to be available for patients, clinicians, educa­\ntors, payers, policy makers, and researchers, and the associ­\nated implementation strategies, are listed in TABLE 1. CLASSIFICATION\nThe International Classification of Diseases-10th Revision-\nClinical Modification (ICD-10-CM) and ICF codes that could be \nused when managing individuals with CTS are provided below. ICD-10-CM\nCarpal tunnel syndrome unspecified upper limb\nG56.00\nCarpal tunnel syndrome right upper limb\nG56.01\nCarpal tunnel syndrome left upper limb\nG56.02\nPain in the right hand\nM79.641\nPain in the left hand\nM79.642\nPain in unspecified hand\nM79.643\nPain in right fingers\nM79.644\nPain in left fingers\nM79.645\nPain in unspecified fingers\nM79.646\nHypoesthesia of skin\nR20.1\nParesthesia of skin\nR20.2\nUnspecified disturbances of skin sensation (includes \nR20.9\nMethods (continued)\nON\nSTRENGTH OF EVIDENCE\nA preponderance of level I and/or level II \nstudies support the recommendation.",
    "chunk_id": 61,
    "sentence_start": 921,
    "sentence_end": 923,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "CLASSIFICATION\nThe International Classification of Diseases-10th Revision-\nClinical Modification (ICD-10-CM) and ICF codes that could be \nused when managing individuals with CTS are provided below. ICD-10-CM\nCarpal tunnel syndrome unspecified upper limb\nG56.00\nCarpal tunnel syndrome right upper limb\nG56.01\nCarpal tunnel syndrome left upper limb\nG56.02\nPain in the right hand\nM79.641\nPain in the left hand\nM79.642\nPain in unspecified hand\nM79.643\nPain in right fingers\nM79.644\nPain in left fingers\nM79.645\nPain in unspecified fingers\nM79.646\nHypoesthesia of skin\nR20.1\nParesthesia of skin\nR20.2\nUnspecified disturbances of skin sensation (includes \nR20.9\nMethods (continued)\nON\nSTRENGTH OF EVIDENCE\nA preponderance of level I and/or level II \nstudies support the recommendation. This \nmust include at least 1 level I study\nA single high-quality randomized controlled \ntrial or a preponderance of level II studies \nsupport the recommendation\nA single level II study or a preponderance of \nlevel III and IV studies, including statements \nof consensus by content experts, support the \nrecommendation\nHigher-quality studies conducted on this \ntopic disagree with respect to their conclu­\nsions.",
    "chunk_id": 62,
    "sentence_start": 922,
    "sentence_end": 924,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "ICD-10-CM\nCarpal tunnel syndrome unspecified upper limb\nG56.00\nCarpal tunnel syndrome right upper limb\nG56.01\nCarpal tunnel syndrome left upper limb\nG56.02\nPain in the right hand\nM79.641\nPain in the left hand\nM79.642\nPain in unspecified hand\nM79.643\nPain in right fingers\nM79.644\nPain in left fingers\nM79.645\nPain in unspecified fingers\nM79.646\nHypoesthesia of skin\nR20.1\nParesthesia of skin\nR20.2\nUnspecified disturbances of skin sensation (includes \nR20.9\nMethods (continued)\nON\nSTRENGTH OF EVIDENCE\nA preponderance of level I and/or level II \nstudies support the recommendation. This \nmust include at least 1 level I study\nA single high-quality randomized controlled \ntrial or a preponderance of level II studies \nsupport the recommendation\nA single level II study or a preponderance of \nlevel III and IV studies, including statements \nof consensus by content experts, support the \nrecommendation\nHigher-quality studies conducted on this \ntopic disagree with respect to their conclu­\nsions. The recommendation is based on \nthese conflicting studies\nA preponderance of evidence from animal or \ncadaver studies, from conceptual models/\nprinciples, or from basic science/bench \nresearch support this conclusion\nBest practice based on the clinical experi­\nence of the guidelines development team\n\n\n--- Page 7 ---\nCOLUMN 1:\nICF body structure code\nStructure of the nervous system other specified\ns198\nStructure of hand\ns7302\nMuscles of the hand\ns73022\nICF body function codes\nSleep functions\nb134\nMaintenance of sleep cycle\nb1342\nProprioceptive function\nb260\nTouch function\nb265\nSensory functions related to temperature and \nother stimuli\nb270\nSensitivity to vibration\nb2701\nSensitivity to pressure\nb2702\nSensation of pain\nb280\nRadiating pain in a segment or region \nb2804\nPain in upper limb\nb28014\nPower of isolated muscles and muscle groups\nb7300\nControl of simple voluntary movements\nb7600\nCoordination of voluntary movements\nb7602\nProtective functions of the skin\nb810\nICF activities and participation codes\nWriting\nd170\nCarrying out daily routine\nd230\nUsing telecommunication devices and techniques\nd3600\nFine hand use\nd440\nPicking up\nd4400\nGrasping\nd4401\nManipulating\nd4402\nFine hand use other specified\nd4408\nDriving\nd475\nToileting\nd530\nDressing\nd540\nEating\nd550\nDrinking\nd560\nPreparing meals\nd630\nDoing housework\nd640\nRemunerative employment\nd850\nSCOPE AND ORGANIZATION OF THE GUIDELINE\nThis guideline includes information related to incidenc\nprevalence, anatomy, pathoanatomy, clinical course, ri\nfactors, diagnosis, outcomes assessments, and interventio\nfor CTS.",
    "chunk_id": 63,
    "sentence_start": 923,
    "sentence_end": 925,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "This \nmust include at least 1 level I study\nA single high-quality randomized controlled \ntrial or a preponderance of level II studies \nsupport the recommendation\nA single level II study or a preponderance of \nlevel III and IV studies, including statements \nof consensus by content experts, support the \nrecommendation\nHigher-quality studies conducted on this \ntopic disagree with respect to their conclu­\nsions. The recommendation is based on \nthese conflicting studies\nA preponderance of evidence from animal or \ncadaver studies, from conceptual models/\nprinciples, or from basic science/bench \nresearch support this conclusion\nBest practice based on the clinical experi­\nence of the guidelines development team\n\n\n--- Page 7 ---\nCOLUMN 1:\nICF body structure code\nStructure of the nervous system other specified\ns198\nStructure of hand\ns7302\nMuscles of the hand\ns73022\nICF body function codes\nSleep functions\nb134\nMaintenance of sleep cycle\nb1342\nProprioceptive function\nb260\nTouch function\nb265\nSensory functions related to temperature and \nother stimuli\nb270\nSensitivity to vibration\nb2701\nSensitivity to pressure\nb2702\nSensation of pain\nb280\nRadiating pain in a segment or region \nb2804\nPain in upper limb\nb28014\nPower of isolated muscles and muscle groups\nb7300\nControl of simple voluntary movements\nb7600\nCoordination of voluntary movements\nb7602\nProtective functions of the skin\nb810\nICF activities and participation codes\nWriting\nd170\nCarrying out daily routine\nd230\nUsing telecommunication devices and techniques\nd3600\nFine hand use\nd440\nPicking up\nd4400\nGrasping\nd4401\nManipulating\nd4402\nFine hand use other specified\nd4408\nDriving\nd475\nToileting\nd530\nDressing\nd540\nEating\nd550\nDrinking\nd560\nPreparing meals\nd630\nDoing housework\nd640\nRemunerative employment\nd850\nSCOPE AND ORGANIZATION OF THE GUIDELINE\nThis guideline includes information related to incidenc\nprevalence, anatomy, pathoanatomy, clinical course, ri\nfactors, diagnosis, outcomes assessments, and interventio\nfor CTS. Where appropriate, sections contain a summary \nevidence synthesis and a statement describing gaps in know\nedge.",
    "chunk_id": 64,
    "sentence_start": 924,
    "sentence_end": 926,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The recommendation is based on \nthese conflicting studies\nA preponderance of evidence from animal or \ncadaver studies, from conceptual models/\nprinciples, or from basic science/bench \nresearch support this conclusion\nBest practice based on the clinical experi­\nence of the guidelines development team\n\n\n--- Page 7 ---\nCOLUMN 1:\nICF body structure code\nStructure of the nervous system other specified\ns198\nStructure of hand\ns7302\nMuscles of the hand\ns73022\nICF body function codes\nSleep functions\nb134\nMaintenance of sleep cycle\nb1342\nProprioceptive function\nb260\nTouch function\nb265\nSensory functions related to temperature and \nother stimuli\nb270\nSensitivity to vibration\nb2701\nSensitivity to pressure\nb2702\nSensation of pain\nb280\nRadiating pain in a segment or region \nb2804\nPain in upper limb\nb28014\nPower of isolated muscles and muscle groups\nb7300\nControl of simple voluntary movements\nb7600\nCoordination of voluntary movements\nb7602\nProtective functions of the skin\nb810\nICF activities and participation codes\nWriting\nd170\nCarrying out daily routine\nd230\nUsing telecommunication devices and techniques\nd3600\nFine hand use\nd440\nPicking up\nd4400\nGrasping\nd4401\nManipulating\nd4402\nFine hand use other specified\nd4408\nDriving\nd475\nToileting\nd530\nDressing\nd540\nEating\nd550\nDrinking\nd560\nPreparing meals\nd630\nDoing housework\nd640\nRemunerative employment\nd850\nSCOPE AND ORGANIZATION OF THE GUIDELINE\nThis guideline includes information related to incidenc\nprevalence, anatomy, pathoanatomy, clinical course, ri\nfactors, diagnosis, outcomes assessments, and interventio\nfor CTS. Where appropriate, sections contain a summary \nevidence synthesis and a statement describing gaps in know\nedge. Grades of recommendation have been provided for a\neas related to clinical practice, including diagnosis, outcom\nassessment, and interventions.",
    "chunk_id": 65,
    "sentence_start": 925,
    "sentence_end": 927,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Where appropriate, sections contain a summary \nevidence synthesis and a statement describing gaps in know\nedge. Grades of recommendation have been provided for a\neas related to clinical practice, including diagnosis, outcom\nassessment, and interventions. The use of and recommend\ntions for specific diagnostic tests, such as nerve conductio\nstudies, electromyography, magnetic resonance imaging, an\nultrasonography, are beyond the scope of this guideline an\ncould serve as future CPG topics.",
    "chunk_id": 66,
    "sentence_start": 926,
    "sentence_end": 928,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Grades of recommendation have been provided for a\neas related to clinical practice, including diagnosis, outcom\nassessment, and interventions. The use of and recommend\ntions for specific diagnostic tests, such as nerve conductio\nstudies, electromyography, magnetic resonance imaging, an\nultrasonography, are beyond the scope of this guideline an\ncould serve as future CPG topics. TABLE 1\nPlanned Strategies and Tools to Support the Dissemination \nand Implementation of This Clinical Practice Guideline\nTool\nStrategy\nJOSPT’s “Perspectives for Patients” and/or “Perspectives for Practice” \narticles\nPatient-oriented and clinician-oriented guideline summaries available on \nwww.jospt.org\nMobile app of guideline-based exercises for patient/clients and health \ncare practitioners\nMarketing and distribution of app using www.orthopt.org\nClinician’s Quick-Reference Guide\nSummary or guideline recommendations available on www.orthopt.org\nJOSPT’s Read for CreditSM continuing education units\nContinuing Education Units available for physical therapists and athletic \ntrainers\nWebinars: educational offering for health care practitioners\nGuideline-based instruction available for practitioners on www.orthopt.org\nMobile and web-based app of guideline for training of health care \npractitioners\nMarketing and distribution of app using www.orthopt.org\nPhysical Therapy National Outcomes Data Registry\nSupport the ongoing usage of data registry for common musculoskeletal \nconditions (www.ptoutcomes.com)\nLogical Observation Identifiers Names and Codes mapping\nPublication of minimal data sets and their corresponding Logical Observa­\ntion Identifiers Names and Codes for the wrist/hand region on www.",
    "chunk_id": 67,
    "sentence_start": 927,
    "sentence_end": 929,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The use of and recommend\ntions for specific diagnostic tests, such as nerve conductio\nstudies, electromyography, magnetic resonance imaging, an\nultrasonography, are beyond the scope of this guideline an\ncould serve as future CPG topics. TABLE 1\nPlanned Strategies and Tools to Support the Dissemination \nand Implementation of This Clinical Practice Guideline\nTool\nStrategy\nJOSPT’s “Perspectives for Patients” and/or “Perspectives for Practice” \narticles\nPatient-oriented and clinician-oriented guideline summaries available on \nwww.jospt.org\nMobile app of guideline-based exercises for patient/clients and health \ncare practitioners\nMarketing and distribution of app using www.orthopt.org\nClinician’s Quick-Reference Guide\nSummary or guideline recommendations available on www.orthopt.org\nJOSPT’s Read for CreditSM continuing education units\nContinuing Education Units available for physical therapists and athletic \ntrainers\nWebinars: educational offering for health care practitioners\nGuideline-based instruction available for practitioners on www.orthopt.org\nMobile and web-based app of guideline for training of health care \npractitioners\nMarketing and distribution of app using www.orthopt.org\nPhysical Therapy National Outcomes Data Registry\nSupport the ongoing usage of data registry for common musculoskeletal \nconditions (www.ptoutcomes.com)\nLogical Observation Identifiers Names and Codes mapping\nPublication of minimal data sets and their corresponding Logical Observa­\ntion Identifiers Names and Codes for the wrist/hand region on www. orthopt.org\nNon-English versions of the guidelines and guideline implementation \ntools\nDevelopment and distribution of translated guidelines and tools to \nJOSPT’s international partners and global audience\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 68,
    "sentence_start": 928,
    "sentence_end": 930,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "TABLE 1\nPlanned Strategies and Tools to Support the Dissemination \nand Implementation of This Clinical Practice Guideline\nTool\nStrategy\nJOSPT’s “Perspectives for Patients” and/or “Perspectives for Practice” \narticles\nPatient-oriented and clinician-oriented guideline summaries available on \nwww.jospt.org\nMobile app of guideline-based exercises for patient/clients and health \ncare practitioners\nMarketing and distribution of app using www.orthopt.org\nClinician’s Quick-Reference Guide\nSummary or guideline recommendations available on www.orthopt.org\nJOSPT’s Read for CreditSM continuing education units\nContinuing Education Units available for physical therapists and athletic \ntrainers\nWebinars: educational offering for health care practitioners\nGuideline-based instruction available for practitioners on www.orthopt.org\nMobile and web-based app of guideline for training of health care \npractitioners\nMarketing and distribution of app using www.orthopt.org\nPhysical Therapy National Outcomes Data Registry\nSupport the ongoing usage of data registry for common musculoskeletal \nconditions (www.ptoutcomes.com)\nLogical Observation Identifiers Names and Codes mapping\nPublication of minimal data sets and their corresponding Logical Observa­\ntion Identifiers Names and Codes for the wrist/hand region on www. orthopt.org\nNon-English versions of the guidelines and guideline implementation \ntools\nDevelopment and distribution of translated guidelines and tools to \nJOSPT’s international partners and global audience\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 69,
    "sentence_start": 929,
    "sentence_end": 931,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "orthopt.org\nNon-English versions of the guidelines and guideline implementation \ntools\nDevelopment and distribution of translated guidelines and tools to \nJOSPT’s international partners and global audience\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 70,
    "sentence_start": 930,
    "sentence_end": 934,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nus system other specified\ns198\ns7302\ns73022\nb134\ncycle\nb1342\nn\nb260\nb265\nted to temperature and \nb270\nb2701\nb2702\nb280\ngment or region \nb2804\nb28014\ncles and muscle groups\nb7300\nntary movements\nb7600\nary movements\nb7602\nthe skin\nb810\npation codes\nd170\nine\nd230\nion devices and techniques\nd3600\nd440\nd4400\nGrasping\nd4401\nManipulating\nd4402\nFine hand use other specified\nd4408\nDriving\nd475\nToileting\nd530\nDressing\nd540\nEating\nd550\nDrinking\nd560\nPreparing meals\nd630\nDoing housework\nd640\nRemunerative employment\nd850\nSCOPE AND ORGANIZATION OF THE GUIDELINE\nThis guideline includes information related to incidence, \nprevalence, anatomy, pathoanatomy, clinical course, risk \nfactors, diagnosis, outcomes assessments, and interventions \nfor CTS.",
    "chunk_id": 71,
    "sentence_start": 933,
    "sentence_end": 935,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nus system other specified\ns198\ns7302\ns73022\nb134\ncycle\nb1342\nn\nb260\nb265\nted to temperature and \nb270\nb2701\nb2702\nb280\ngment or region \nb2804\nb28014\ncles and muscle groups\nb7300\nntary movements\nb7600\nary movements\nb7602\nthe skin\nb810\npation codes\nd170\nine\nd230\nion devices and techniques\nd3600\nd440\nd4400\nGrasping\nd4401\nManipulating\nd4402\nFine hand use other specified\nd4408\nDriving\nd475\nToileting\nd530\nDressing\nd540\nEating\nd550\nDrinking\nd560\nPreparing meals\nd630\nDoing housework\nd640\nRemunerative employment\nd850\nSCOPE AND ORGANIZATION OF THE GUIDELINE\nThis guideline includes information related to incidence, \nprevalence, anatomy, pathoanatomy, clinical course, risk \nfactors, diagnosis, outcomes assessments, and interventions \nfor CTS. Where appropriate, sections contain a summary or \nevidence synthesis and a statement describing gaps in knowl­\nedge.",
    "chunk_id": 72,
    "sentence_start": 934,
    "sentence_end": 936,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nus system other specified\ns198\ns7302\ns73022\nb134\ncycle\nb1342\nn\nb260\nb265\nted to temperature and \nb270\nb2701\nb2702\nb280\ngment or region \nb2804\nb28014\ncles and muscle groups\nb7300\nntary movements\nb7600\nary movements\nb7602\nthe skin\nb810\npation codes\nd170\nine\nd230\nion devices and techniques\nd3600\nd440\nd4400\nGrasping\nd4401\nManipulating\nd4402\nFine hand use other specified\nd4408\nDriving\nd475\nToileting\nd530\nDressing\nd540\nEating\nd550\nDrinking\nd560\nPreparing meals\nd630\nDoing housework\nd640\nRemunerative employment\nd850\nSCOPE AND ORGANIZATION OF THE GUIDELINE\nThis guideline includes information related to incidence, \nprevalence, anatomy, pathoanatomy, clinical course, risk \nfactors, diagnosis, outcomes assessments, and interventions \nfor CTS. Where appropriate, sections contain a summary or \nevidence synthesis and a statement describing gaps in knowl­\nedge. Grades of recommendation have been provided for ar­\neas related to clinical practice, including diagnosis, outcomes \nassessment, and interventions.",
    "chunk_id": 73,
    "sentence_start": 935,
    "sentence_end": 937,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Where appropriate, sections contain a summary or \nevidence synthesis and a statement describing gaps in knowl­\nedge. Grades of recommendation have been provided for ar­\neas related to clinical practice, including diagnosis, outcomes \nassessment, and interventions. The use of and recommenda­\ntions for specific diagnostic tests, such as nerve conduction \nstudies, electromyography, magnetic resonance imaging, and \nultrasonography, are beyond the scope of this guideline and \ncould serve as future CPG topics.",
    "chunk_id": 74,
    "sentence_start": 936,
    "sentence_end": 938,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Grades of recommendation have been provided for ar­\neas related to clinical practice, including diagnosis, outcomes \nassessment, and interventions. The use of and recommenda­\ntions for specific diagnostic tests, such as nerve conduction \nstudies, electromyography, magnetic resonance imaging, and \nultrasonography, are beyond the scope of this guideline and \ncould serve as future CPG topics. Methods (continued)\nPlanned Strategies and Tools to Support the Dissemination \nand Implementation of This Clinical Practice Guideline\nStrategy\nor Patients” and/or “Perspectives for Practice” \nPatient-oriented and clinician-oriented guideline summaries available on \nwww.jospt.org\n-based exercises for patient/clients and health \nMarketing and distribution of app using www.orthopt.org\nnce Guide\nSummary or guideline recommendations available on www.orthopt.org\nSM continuing education units\nContinuing Education Units available for physical therapists and athletic \ntrainers\nffering for health care practitioners\nGuideline-based instruction available for practitioners on www.orthopt.org\napp of guideline for training of health care \nMarketing and distribution of app using www.orthopt.org\nnal Outcomes Data Registry\nSupport the ongoing usage of data registry for common musculoskeletal \nconditions (www.ptoutcomes.com)\nntifiers Names and Codes mapping\nPublication of minimal data sets and their corresponding Logical Observa­\ntion Identifiers Names and Codes for the wrist/hand region on www.",
    "chunk_id": 75,
    "sentence_start": 937,
    "sentence_end": 939,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The use of and recommenda­\ntions for specific diagnostic tests, such as nerve conduction \nstudies, electromyography, magnetic resonance imaging, and \nultrasonography, are beyond the scope of this guideline and \ncould serve as future CPG topics. Methods (continued)\nPlanned Strategies and Tools to Support the Dissemination \nand Implementation of This Clinical Practice Guideline\nStrategy\nor Patients” and/or “Perspectives for Practice” \nPatient-oriented and clinician-oriented guideline summaries available on \nwww.jospt.org\n-based exercises for patient/clients and health \nMarketing and distribution of app using www.orthopt.org\nnce Guide\nSummary or guideline recommendations available on www.orthopt.org\nSM continuing education units\nContinuing Education Units available for physical therapists and athletic \ntrainers\nffering for health care practitioners\nGuideline-based instruction available for practitioners on www.orthopt.org\napp of guideline for training of health care \nMarketing and distribution of app using www.orthopt.org\nnal Outcomes Data Registry\nSupport the ongoing usage of data registry for common musculoskeletal \nconditions (www.ptoutcomes.com)\nntifiers Names and Codes mapping\nPublication of minimal data sets and their corresponding Logical Observa­\ntion Identifiers Names and Codes for the wrist/hand region on www. orthopt.org\nthe guidelines and guideline implementation \nDevelopment and distribution of translated guidelines and tools to \nJOSPT’s international partners and global audience\n\n\n--- Page 8 ---\nCOLUMN 1:\nPREVALENCE AND INCIDENCE\nI\nThe overall lifetime prevalence of self-reported and \nphysician-diagnosed carpal tunnel syndrome (CTS), \nregardless of work status, is 8.0%.164 Prevalence in \nthe United States working population, when confirmed by \nboth electrodiagnostic testing and clinical examination, is \n7.8%.77 For women, the prevalence is nearly twice that for men \n(10% compared to 5.8%).",
    "chunk_id": 76,
    "sentence_start": 938,
    "sentence_end": 940,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Methods (continued)\nPlanned Strategies and Tools to Support the Dissemination \nand Implementation of This Clinical Practice Guideline\nStrategy\nor Patients” and/or “Perspectives for Practice” \nPatient-oriented and clinician-oriented guideline summaries available on \nwww.jospt.org\n-based exercises for patient/clients and health \nMarketing and distribution of app using www.orthopt.org\nnce Guide\nSummary or guideline recommendations available on www.orthopt.org\nSM continuing education units\nContinuing Education Units available for physical therapists and athletic \ntrainers\nffering for health care practitioners\nGuideline-based instruction available for practitioners on www.orthopt.org\napp of guideline for training of health care \nMarketing and distribution of app using www.orthopt.org\nnal Outcomes Data Registry\nSupport the ongoing usage of data registry for common musculoskeletal \nconditions (www.ptoutcomes.com)\nntifiers Names and Codes mapping\nPublication of minimal data sets and their corresponding Logical Observa­\ntion Identifiers Names and Codes for the wrist/hand region on www. orthopt.org\nthe guidelines and guideline implementation \nDevelopment and distribution of translated guidelines and tools to \nJOSPT’s international partners and global audience\n\n\n--- Page 8 ---\nCOLUMN 1:\nPREVALENCE AND INCIDENCE\nI\nThe overall lifetime prevalence of self-reported and \nphysician-diagnosed carpal tunnel syndrome (CTS), \nregardless of work status, is 8.0%.164 Prevalence in \nthe United States working population, when confirmed by \nboth electrodiagnostic testing and clinical examination, is \n7.8%.77 For women, the prevalence is nearly twice that for men \n(10% compared to 5.8%). There is a marked increase in preva­\nlence with increasing age: 3.7% in those younger than 30 years \nof age compared to 11.9% in those over 50 years of age.77\nIncidence data have been reported for some geographic ar­\neas.",
    "chunk_id": 77,
    "sentence_start": 939,
    "sentence_end": 941,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "orthopt.org\nthe guidelines and guideline implementation \nDevelopment and distribution of translated guidelines and tools to \nJOSPT’s international partners and global audience\n\n\n--- Page 8 ---\nCOLUMN 1:\nPREVALENCE AND INCIDENCE\nI\nThe overall lifetime prevalence of self-reported and \nphysician-diagnosed carpal tunnel syndrome (CTS), \nregardless of work status, is 8.0%.164 Prevalence in \nthe United States working population, when confirmed by \nboth electrodiagnostic testing and clinical examination, is \n7.8%.77 For women, the prevalence is nearly twice that for men \n(10% compared to 5.8%). There is a marked increase in preva­\nlence with increasing age: 3.7% in those younger than 30 years \nof age compared to 11.9% in those over 50 years of age.77\nIncidence data have been reported for some geographic ar­\neas. Data reported as part of the Rochester Epidemiology \nProject, which included individuals from Olmstead County, \nMN dating from 1981 to 2005, show an incidence rate of 3.76 \nper 1000 person-years (4.91 for women and 2.58 for men).105 \nIncidence data collected from France show a lower incidence \nrate (1.4 per 1000 person-years in women and 0.6 per 1000 \nperson-years in men).248\nWhen comparing data from 1981 to 1985 to data from 2001 \nto 2005, the incidence of CTS increased from 2.58 per 1000 \nperson-years to 4.24 per 1000 person-years.105 Data from \n2007 to 2011 also show an increase in occupational-related \nCTS.247 The increase may be due to greater awareness and \nmore patients presenting for care.105\nIncidence rates derived from the working population are re­\nportedly higher than those for the general population.77,248 The \noverall incidence in this group is 23 per 1000 person-years \nwhen CTS was confirmed through both clinical exam and elec­\ntrodiagnostic studies.77 When the diagnosis was confirmed by \nsymptoms alone, the incidence was much higher (93 per 1000 \nperson-years).",
    "chunk_id": 78,
    "sentence_start": 940,
    "sentence_end": 942,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There is a marked increase in preva­\nlence with increasing age: 3.7% in those younger than 30 years \nof age compared to 11.9% in those over 50 years of age.77\nIncidence data have been reported for some geographic ar­\neas. Data reported as part of the Rochester Epidemiology \nProject, which included individuals from Olmstead County, \nMN dating from 1981 to 2005, show an incidence rate of 3.76 \nper 1000 person-years (4.91 for women and 2.58 for men).105 \nIncidence data collected from France show a lower incidence \nrate (1.4 per 1000 person-years in women and 0.6 per 1000 \nperson-years in men).248\nWhen comparing data from 1981 to 1985 to data from 2001 \nto 2005, the incidence of CTS increased from 2.58 per 1000 \nperson-years to 4.24 per 1000 person-years.105 Data from \n2007 to 2011 also show an increase in occupational-related \nCTS.247 The increase may be due to greater awareness and \nmore patients presenting for care.105\nIncidence rates derived from the working population are re­\nportedly higher than those for the general population.77,248 The \noverall incidence in this group is 23 per 1000 person-years \nwhen CTS was confirmed through both clinical exam and elec­\ntrodiagnostic studies.77 When the diagnosis was confirmed by \nsymptoms alone, the incidence was much higher (93 per 1000 \nperson-years). When electrodiagnostic tests alone were used to \nconfirm the diagnosis, the incidence was 40 per 1000 person-\nyears.77 These large differences in incidence rates found when \nusing different diagnostic criteria support the need for a better \ngold standard to confirm the CTS diagnosis.",
    "chunk_id": 79,
    "sentence_start": 941,
    "sentence_end": 943,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Data reported as part of the Rochester Epidemiology \nProject, which included individuals from Olmstead County, \nMN dating from 1981 to 2005, show an incidence rate of 3.76 \nper 1000 person-years (4.91 for women and 2.58 for men).105 \nIncidence data collected from France show a lower incidence \nrate (1.4 per 1000 person-years in women and 0.6 per 1000 \nperson-years in men).248\nWhen comparing data from 1981 to 1985 to data from 2001 \nto 2005, the incidence of CTS increased from 2.58 per 1000 \nperson-years to 4.24 per 1000 person-years.105 Data from \n2007 to 2011 also show an increase in occupational-related \nCTS.247 The increase may be due to greater awareness and \nmore patients presenting for care.105\nIncidence rates derived from the working population are re­\nportedly higher than those for the general population.77,248 The \noverall incidence in this group is 23 per 1000 person-years \nwhen CTS was confirmed through both clinical exam and elec­\ntrodiagnostic studies.77 When the diagnosis was confirmed by \nsymptoms alone, the incidence was much higher (93 per 1000 \nperson-years). When electrodiagnostic tests alone were used to \nconfirm the diagnosis, the incidence was 40 per 1000 person-\nyears.77 These large differences in incidence rates found when \nusing different diagnostic criteria support the need for a better \ngold standard to confirm the CTS diagnosis. Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 80,
    "sentence_start": 942,
    "sentence_end": 944,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "When electrodiagnostic tests alone were used to \nconfirm the diagnosis, the incidence was 40 per 1000 person-\nyears.77 These large differences in incidence rates found when \nusing different diagnostic criteria support the need for a better \ngold standard to confirm the CTS diagnosis. Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nwith bony dorsal boundaries and the stiff palmar boundary \nformed by the transverse carpal ligament. The ligament spans \nfrom the pisiform bone and hook of hamate on the ulnar side \nto the scaphoid and trapezium tubercles on the radial side.",
    "chunk_id": 81,
    "sentence_start": 943,
    "sentence_end": 950,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nwith bony dorsal boundaries and the stiff palmar boundary \nformed by the transverse carpal ligament. The ligament spans \nfrom the pisiform bone and hook of hamate on the ulnar side \nto the scaphoid and trapezium tubercles on the radial side. Nine flexor tendons pass through the carpal tunnel: 4 ten­\ndons from the flexor digitorum superficialis (FDS) muscle, \n4 from the flexor digitorum profundus (FDP) muscle, and a \nsingle tendon from the flexor pollicis longus (FPL) muscle. The tendons of the FDS and FDP are arranged in 2 rows, \nwith the FDS tendons more palmar and the FDP tendons \ndeeper, dorsal to the FDS tendons.",
    "chunk_id": 82,
    "sentence_start": 949,
    "sentence_end": 952,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Nine flexor tendons pass through the carpal tunnel: 4 ten­\ndons from the flexor digitorum superficialis (FDS) muscle, \n4 from the flexor digitorum profundus (FDP) muscle, and a \nsingle tendon from the flexor pollicis longus (FPL) muscle. The tendons of the FDS and FDP are arranged in 2 rows, \nwith the FDS tendons more palmar and the FDP tendons \ndeeper, dorsal to the FDS tendons. The carpal tunnel con­\ntains 2 bursae: the radial bursa, which encases the FPL, and \nthe ulnar bursa, which surrounds the tendons of the FDS and \nFDP.90 The median nerve is vulnerable to compression from \nexternal or internal forces, because it is the most superficial \nstructure in the carpal tunnel, lying between the transverse \ncarpal ligament and the ulnar bursa.",
    "chunk_id": 83,
    "sentence_start": 951,
    "sentence_end": 953,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The tendons of the FDS and FDP are arranged in 2 rows, \nwith the FDS tendons more palmar and the FDP tendons \ndeeper, dorsal to the FDS tendons. The carpal tunnel con­\ntains 2 bursae: the radial bursa, which encases the FPL, and \nthe ulnar bursa, which surrounds the tendons of the FDS and \nFDP.90 The median nerve is vulnerable to compression from \nexternal or internal forces, because it is the most superficial \nstructure in the carpal tunnel, lying between the transverse \ncarpal ligament and the ulnar bursa. Classic sensory and motor innervation of the median nerve \nin the hand (affected in patients with CTS) includes the \nsensory branches of the thumb, index, middle, and radial \nhalf of the ring fingers, while the motor branches innervate \nthe first and second lumbrical muscles, opponens pollicis, \nabductor pollicis brevis (APB), and the superficial portion of \nthe flexor pollicis brevis muscles.",
    "chunk_id": 84,
    "sentence_start": 952,
    "sentence_end": 954,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The carpal tunnel con­\ntains 2 bursae: the radial bursa, which encases the FPL, and \nthe ulnar bursa, which surrounds the tendons of the FDS and \nFDP.90 The median nerve is vulnerable to compression from \nexternal or internal forces, because it is the most superficial \nstructure in the carpal tunnel, lying between the transverse \ncarpal ligament and the ulnar bursa. Classic sensory and motor innervation of the median nerve \nin the hand (affected in patients with CTS) includes the \nsensory branches of the thumb, index, middle, and radial \nhalf of the ring fingers, while the motor branches innervate \nthe first and second lumbrical muscles, opponens pollicis, \nabductor pollicis brevis (APB), and the superficial portion of \nthe flexor pollicis brevis muscles. The sensation to the skin \ndirectly over the carpal tunnel and the thenar eminence is \ntypically not affected, because these areas are supplied by \nthe palmar cutaneous branch, which branches off the medi­\nan nerve approximately 5 cm proximal to the wrist crease.149 \nThe area over the scaphoid tubercle is also spared in CTS \nbecause its innervation comes from the lower antebrachial \ncutaneous nerve.",
    "chunk_id": 85,
    "sentence_start": 953,
    "sentence_end": 955,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Classic sensory and motor innervation of the median nerve \nin the hand (affected in patients with CTS) includes the \nsensory branches of the thumb, index, middle, and radial \nhalf of the ring fingers, while the motor branches innervate \nthe first and second lumbrical muscles, opponens pollicis, \nabductor pollicis brevis (APB), and the superficial portion of \nthe flexor pollicis brevis muscles. The sensation to the skin \ndirectly over the carpal tunnel and the thenar eminence is \ntypically not affected, because these areas are supplied by \nthe palmar cutaneous branch, which branches off the medi­\nan nerve approximately 5 cm proximal to the wrist crease.149 \nThe area over the scaphoid tubercle is also spared in CTS \nbecause its innervation comes from the lower antebrachial \ncutaneous nerve. CLINICAL PRACTICE GUIDELINES\nImpairment/Function-Based\nDiagnosis\nAND INCIDENCE\nerall lifetime prevalence of self-reported and \nan-diagnosed carpal tunnel syndrome (CTS), \ness of work status, is 8.0%.164 Prevalence in \nes working population, when confirmed by \ngnostic testing and clinical examination, is \nen, the prevalence is nearly twice that for men \nto 5.8%).",
    "chunk_id": 86,
    "sentence_start": 954,
    "sentence_end": 956,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The sensation to the skin \ndirectly over the carpal tunnel and the thenar eminence is \ntypically not affected, because these areas are supplied by \nthe palmar cutaneous branch, which branches off the medi­\nan nerve approximately 5 cm proximal to the wrist crease.149 \nThe area over the scaphoid tubercle is also spared in CTS \nbecause its innervation comes from the lower antebrachial \ncutaneous nerve. CLINICAL PRACTICE GUIDELINES\nImpairment/Function-Based\nDiagnosis\nAND INCIDENCE\nerall lifetime prevalence of self-reported and \nan-diagnosed carpal tunnel syndrome (CTS), \ness of work status, is 8.0%.164 Prevalence in \nes working population, when confirmed by \ngnostic testing and clinical examination, is \nen, the prevalence is nearly twice that for men \nto 5.8%). There is a marked increase in preva­\nsing age: 3.7% in those younger than 30 years \nto 11.9% in those over 50 years of age.77\nhave been reported for some geographic ar­\nted as part of the Rochester Epidemiology \nncluded individuals from Olmstead County, \n1981 to 2005, show an incidence rate of 3.76 \n-years (4.91 for women and 2.58 for men).105 \nollected from France show a lower incidence \n0 person-years in women and 0.6 per 1000 \nmen).248\ng data from 1981 to 1985 to data from 2001 \ndence of CTS increased from 2.58 per 1000 \n4.24 per 1000 person-years.105 Data from \no show an increase in occupational-related \nease may be due to greater awareness and \nresenting for care.105\nderived from the working population are re­\nhan those for the general population.77,248 The \ne in this group is 23 per 1000 person-years \nonfirmed through both clinical exam and elec­\ndies.77 When the diagnosis was confirmed by\n\n\n--- Page 9 ---\nCOLUMN 1:\nPathoanatomical Features\nClassic CTS symptoms include numbness and tingling in the \nmedian nerve distribution of the hand, and, in more severe \ncases, loss of strength of muscles innervated distally by the \nmedian nerve.",
    "chunk_id": 87,
    "sentence_start": 955,
    "sentence_end": 957,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "CLINICAL PRACTICE GUIDELINES\nImpairment/Function-Based\nDiagnosis\nAND INCIDENCE\nerall lifetime prevalence of self-reported and \nan-diagnosed carpal tunnel syndrome (CTS), \ness of work status, is 8.0%.164 Prevalence in \nes working population, when confirmed by \ngnostic testing and clinical examination, is \nen, the prevalence is nearly twice that for men \nto 5.8%). There is a marked increase in preva­\nsing age: 3.7% in those younger than 30 years \nto 11.9% in those over 50 years of age.77\nhave been reported for some geographic ar­\nted as part of the Rochester Epidemiology \nncluded individuals from Olmstead County, \n1981 to 2005, show an incidence rate of 3.76 \n-years (4.91 for women and 2.58 for men).105 \nollected from France show a lower incidence \n0 person-years in women and 0.6 per 1000 \nmen).248\ng data from 1981 to 1985 to data from 2001 \ndence of CTS increased from 2.58 per 1000 \n4.24 per 1000 person-years.105 Data from \no show an increase in occupational-related \nease may be due to greater awareness and \nresenting for care.105\nderived from the working population are re­\nhan those for the general population.77,248 The \ne in this group is 23 per 1000 person-years \nonfirmed through both clinical exam and elec­\ndies.77 When the diagnosis was confirmed by\n\n\n--- Page 9 ---\nCOLUMN 1:\nPathoanatomical Features\nClassic CTS symptoms include numbness and tingling in the \nmedian nerve distribution of the hand, and, in more severe \ncases, loss of strength of muscles innervated distally by the \nmedian nerve. Median nerve pathology impacts all nerve \nfunctions distal to the site of lesion, with some possible pain \nbeing felt proximally to the shoulder.",
    "chunk_id": 88,
    "sentence_start": 956,
    "sentence_end": 958,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There is a marked increase in preva­\nsing age: 3.7% in those younger than 30 years \nto 11.9% in those over 50 years of age.77\nhave been reported for some geographic ar­\nted as part of the Rochester Epidemiology \nncluded individuals from Olmstead County, \n1981 to 2005, show an incidence rate of 3.76 \n-years (4.91 for women and 2.58 for men).105 \nollected from France show a lower incidence \n0 person-years in women and 0.6 per 1000 \nmen).248\ng data from 1981 to 1985 to data from 2001 \ndence of CTS increased from 2.58 per 1000 \n4.24 per 1000 person-years.105 Data from \no show an increase in occupational-related \nease may be due to greater awareness and \nresenting for care.105\nderived from the working population are re­\nhan those for the general population.77,248 The \ne in this group is 23 per 1000 person-years \nonfirmed through both clinical exam and elec­\ndies.77 When the diagnosis was confirmed by\n\n\n--- Page 9 ---\nCOLUMN 1:\nPathoanatomical Features\nClassic CTS symptoms include numbness and tingling in the \nmedian nerve distribution of the hand, and, in more severe \ncases, loss of strength of muscles innervated distally by the \nmedian nerve. Median nerve pathology impacts all nerve \nfunctions distal to the site of lesion, with some possible pain \nbeing felt proximally to the shoulder. Even though the defini­\ntion seems straightforward, controversy abounds regarding \nits etiology.",
    "chunk_id": 89,
    "sentence_start": 957,
    "sentence_end": 959,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Median nerve pathology impacts all nerve \nfunctions distal to the site of lesion, with some possible pain \nbeing felt proximally to the shoulder. Even though the defini­\ntion seems straightforward, controversy abounds regarding \nits etiology. A variety of pathoanatomical factors have been \nimplicated in the development of CTS, including elevated \ncarpal tunnel pressure, ischemic changes within the nerve, \nand compression from adjacent structures. Elevated Carpal Tunnel Pressure\nII\nChen et al61 studied the validity of carpal tunnel \npressure as a source for median nerve compression. Tunnel pressure was measured at various points in \npatients undergoing carpal tunnel release (CTR) surgery. The \nhighest mean ± SD tunnel pressure before surgery was 58.9 \n± 3.4 mmHg and following surgery was 7.7 ± 0.9 mmHg, con­\nfirming preoperative elevated tunnel pressure and confirm­\ning the usefulness of CTR surgery to lower pressure.",
    "chunk_id": 90,
    "sentence_start": 958,
    "sentence_end": 963,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Tunnel pressure was measured at various points in \npatients undergoing carpal tunnel release (CTR) surgery. The \nhighest mean ± SD tunnel pressure before surgery was 58.9 \n± 3.4 mmHg and following surgery was 7.7 ± 0.9 mmHg, con­\nfirming preoperative elevated tunnel pressure and confirm­\ning the usefulness of CTR surgery to lower pressure. Chen et al61 reported moderate association between elevated \ntunnel pressure and loss of some aspects of median nerve \nfunction as measured by correlations between tunnel pres­\nsure and findings from nerve conduction studies (NCS) (r \n= 0.53 for distal motor latency [DML], r = 0.47 for sensory \nnerve action potential [SNAP], r = –0.54 for sensory nerve \nconduction velocity [SNCV]). However, preoperative pres­\nsure was not related to 3-month postoperative outcomes as \nmeasured by the Boston Carpal Tunnel Questionnaire-symp­\ntom severity scale (CTQ-SSS). Instead, Chen et al61 concluded \nthat NCS results better predicted 3-month outcome.",
    "chunk_id": 91,
    "sentence_start": 962,
    "sentence_end": 966,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "However, preoperative pres­\nsure was not related to 3-month postoperative outcomes as \nmeasured by the Boston Carpal Tunnel Questionnaire-symp­\ntom severity scale (CTQ-SSS). Instead, Chen et al61 concluded \nthat NCS results better predicted 3-month outcome. III\nAhn et al2 evaluated carpal tunnel pressures in pa­\ntients with CTS and recorded structural findings \nfrom ultrasound imaging and nerve conduction \nmeasures. Elevated pressure was confirmed preoperatively, \nwith the mean tunnel pressure being 56.7 mmHg distal to the \nincision site and 18.2 mmHg proximal to the incision site. After CTR surgery, pressure decreased to 7.4 mmHg distally \nand 7.5 mmHg proximally (P<.05). Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 92,
    "sentence_start": 965,
    "sentence_end": 974,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nIII\nGelberman et al103 compared carpal tunnel pressure \nbetween those with and without CTS. They report­\ned a statistically significant higher carpal tunnel \npressure in the patient group when compared to the controls \nwith the wrist in a neutral position (P<.001), a flexed position \n(P<.005), and an extended position (P<.010). Wrist position \naffected pressure for patients and controls, with the lowest \npressure in neutral and higher pressures in flexion and exten­\nsion. Immediately following CTR surgery, pressure decreased \nin the patient group to 5.0 mmHg. Ischemia and Nerve Fibrosis\nV\nIn a narrative review of basic science literature in­\ncluding animal and human studies, Gelberman et \nal104 described a gradual decrease in intraneural \nblood flow with experimental compression from 50 to 80 \nmmHg and complete ischemia at 80 mmHg.",
    "chunk_id": 93,
    "sentence_start": 973,
    "sentence_end": 979,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Immediately following CTR surgery, pressure decreased \nin the patient group to 5.0 mmHg. Ischemia and Nerve Fibrosis\nV\nIn a narrative review of basic science literature in­\ncluding animal and human studies, Gelberman et \nal104 described a gradual decrease in intraneural \nblood flow with experimental compression from 50 to 80 \nmmHg and complete ischemia at 80 mmHg. Findings from \nboth animal and human studies show increased epineural \nedema and endoneurial fluid pressure related to the magni­\ntude and duration of the compression. V\nIn a subsequent narrative review, Mackinnon174 de­\nscribed the mechanism between ischemia, neural \nedema, and fibrosis based on animal models. She \nindicated that nerve compression leads to breakdown in the \nblood nerve barrier at the endoneurial vessels, causing a leak­\nage of fluid into the endoneurium.",
    "chunk_id": 94,
    "sentence_start": 978,
    "sentence_end": 982,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "V\nIn a subsequent narrative review, Mackinnon174 de­\nscribed the mechanism between ischemia, neural \nedema, and fibrosis based on animal models. She \nindicated that nerve compression leads to breakdown in the \nblood nerve barrier at the endoneurial vessels, causing a leak­\nage of fluid into the endoneurium. If the barrier in the inner \nlayers of the perineurium remains intact, the endoneurial \nfluid pressure will increase and result in a mini-compartment \nsyndrome within the fascicle. She described this breakdown \nand leakage of fluid as causes that lead to the accumulation \nof proteins, lymphocytes, fibroblasts, macrophages, and \neventually scar formation, or nerve fibrosis. Compression From Adjacent Structures\nIII\nFreeland et al100 studied the presence of prostaglan­\ndins (PGE2) and interleukins (IL-1 and IL-6) in \nserum and the tenosynovium in those with CTS and \na control group.",
    "chunk_id": 95,
    "sentence_start": 981,
    "sentence_end": 985,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "She described this breakdown \nand leakage of fluid as causes that lead to the accumulation \nof proteins, lymphocytes, fibroblasts, macrophages, and \neventually scar formation, or nerve fibrosis. Compression From Adjacent Structures\nIII\nFreeland et al100 studied the presence of prostaglan­\ndins (PGE2) and interleukins (IL-1 and IL-6) in \nserum and the tenosynovium in those with CTS and \na control group. These authors found elevated IL-6 and PGE2 \nlevels in the tenosynovium in those with CTS compared to \nthe control group. These chemicals have been associated with \nstimulating tissue fibrogenesis.100 There was no significant \ndifference in IL-1 levels between the 2 groups.",
    "chunk_id": 96,
    "sentence_start": 984,
    "sentence_end": 987,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "These authors found elevated IL-6 and PGE2 \nlevels in the tenosynovium in those with CTS compared to \nthe control group. These chemicals have been associated with \nstimulating tissue fibrogenesis.100 There was no significant \ndifference in IL-1 levels between the 2 groups. This latter \nfinding supports the lack of acute inflammation in the tendon \nsheath when assessed at the time of surgery.100\nIII\nThe subsynovial connective tissue (SSCT) is a \nhighly vascular layer between the flexor tendons \nand ulnar bursa Ettema et al90 e amined the his\nures\nms include numbness and tingling in the \nution of the hand, and, in more severe \nh of muscles innervated distally by the \nan nerve pathology impacts all nerve \ne site of lesion, with some possible pain \nto the shoulder. Even though the defini­\nrward, controversy abounds regarding \nof pathoanatomical factors have been \nvelopment of CTS, including elevated \nre, ischemic changes within the nerve, \nm adjacent structures.",
    "chunk_id": 97,
    "sentence_start": 986,
    "sentence_end": 989,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "This latter \nfinding supports the lack of acute inflammation in the tendon \nsheath when assessed at the time of surgery.100\nIII\nThe subsynovial connective tissue (SSCT) is a \nhighly vascular layer between the flexor tendons \nand ulnar bursa Ettema et al90 e amined the his\nures\nms include numbness and tingling in the \nution of the hand, and, in more severe \nh of muscles innervated distally by the \nan nerve pathology impacts all nerve \ne site of lesion, with some possible pain \nto the shoulder. Even though the defini­\nrward, controversy abounds regarding \nof pathoanatomical factors have been \nvelopment of CTS, including elevated \nre, ischemic changes within the nerve, \nm adjacent structures. Pressure\n1 studied the validity of carpal tunnel \na source for median nerve compression. sure was measured at various points in \ncarpal tunnel release (CTR) surgery.",
    "chunk_id": 98,
    "sentence_start": 988,
    "sentence_end": 991,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Pressure\n1 studied the validity of carpal tunnel \na source for median nerve compression. sure was measured at various points in \ncarpal tunnel release (CTR) surgery. The \nunnel pressure before surgery was 58.9 \nowing surgery was 7.7 ± 0.9 mmHg, con­\nelevated tunnel pressure and confirm­\nCTR surgery to lower pressure. moderate association between elevated \nloss of some aspects of median nerve \nd by correlations between tunnel pres­\nom nerve conduction studies (NCS) (r \nor latency [DML], r = 0.47 for sensory \nal [SNAP], r = –0.54 for sensory nerve \n[SNCV]). However, preoperative pres­\nto 3-month postoperative outcomes as \non Carpal Tunnel Questionnaire-symp­\nTQ-SSS). Instead, Chen et al61 concluded \ner predicted 3-month outcome. valuated carpal tunnel pressures in pa­\nCTS and recorded structural findings \nound imaging and nerve conduction \npressure was confirmed preoperatively, \npressure being 56.7 mmHg distal to the \n2 mmHg proximal to the incision site.",
    "chunk_id": 99,
    "sentence_start": 990,
    "sentence_end": 996,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Instead, Chen et al61 concluded \ner predicted 3-month outcome. valuated carpal tunnel pressures in pa­\nCTS and recorded structural findings \nound imaging and nerve conduction \npressure was confirmed preoperatively, \npressure being 56.7 mmHg distal to the \n2 mmHg proximal to the incision site. ressure decreased to 7.4 mmHg distally \nmally (P<.05). at maximum tunnel pressure was not dif­\nts with moderate, severe, or extreme pa­\nd on the NCS results, even though median \narea differed between individuals with \nes Ahn et al2 suggested that intraneural\n\n\n--- Page 10 ---\nCOLUMN 1:\ngroup compared to the control group. The presence of col­\nlagen type III is important because it is inherently weak and \ncould possibly predispose an individual to a cycle of further \ninjury.90 There was also a significantly greater amount of \ntransforming growth factor-β in the patient group com­\npared to the control group.",
    "chunk_id": 100,
    "sentence_start": 995,
    "sentence_end": 999,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "at maximum tunnel pressure was not dif­\nts with moderate, severe, or extreme pa­\nd on the NCS results, even though median \narea differed between individuals with \nes Ahn et al2 suggested that intraneural\n\n\n--- Page 10 ---\nCOLUMN 1:\ngroup compared to the control group. The presence of col­\nlagen type III is important because it is inherently weak and \ncould possibly predispose an individual to a cycle of further \ninjury.90 There was also a significantly greater amount of \ntransforming growth factor-β in the patient group com­\npared to the control group. Transforming growth factor-β is \na profibrotic cytokine present during wound healing and \nplays a role in fibrosis and scarring.",
    "chunk_id": 101,
    "sentence_start": 998,
    "sentence_end": 1000,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The presence of col­\nlagen type III is important because it is inherently weak and \ncould possibly predispose an individual to a cycle of further \ninjury.90 There was also a significantly greater amount of \ntransforming growth factor-β in the patient group com­\npared to the control group. Transforming growth factor-β is \na profibrotic cytokine present during wound healing and \nplays a role in fibrosis and scarring. Authors of other level 3 \nstudies have identified similar changes in the tenosynovium \nin individuals with CTS.132,271\nSummary\nElevated carpal tunnel pressure has been implicated in the \ndevelopment of CTS, and studies support elevated pressure \nin patients just prior to surgery that decreases postoperative­\nly. The etiology behind the elevation in pressure is unknown. Bench research suggests there is a disruption in intraneural \nblood flow that contributes to intraneural edema and fibro­\nsis.",
    "chunk_id": 102,
    "sentence_start": 999,
    "sentence_end": 1003,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The etiology behind the elevation in pressure is unknown. Bench research suggests there is a disruption in intraneural \nblood flow that contributes to intraneural edema and fibro­\nsis. Enlargement of the flexor tendon synovial sheaths, such \nas in flexor tenosynovitis, has been implicated as the source \ncontributing to median nerve compression. However, models \nsuggesting acute inflammation within the sheath are not well \nsupported.100,198 Instead, there is evidence to support fibrous \nsynovial hypertrophy in individuals undergoing surgical re­\nlease for idiopathic CTS.90,100,132,271\nCLINICAL COURSE WITH AND WITHOUT TREATMENT\nII\nIn a systematic review, Burton et al49 reported that \nsome patients (28%-62%) recover without inter­\nvention, while others (32%-58%) deteriorate in the \nabsence of intervention.",
    "chunk_id": 103,
    "sentence_start": 1002,
    "sentence_end": 1005,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Enlargement of the flexor tendon synovial sheaths, such \nas in flexor tenosynovitis, has been implicated as the source \ncontributing to median nerve compression. However, models \nsuggesting acute inflammation within the sheath are not well \nsupported.100,198 Instead, there is evidence to support fibrous \nsynovial hypertrophy in individuals undergoing surgical re­\nlease for idiopathic CTS.90,100,132,271\nCLINICAL COURSE WITH AND WITHOUT TREATMENT\nII\nIn a systematic review, Burton et al49 reported that \nsome patients (28%-62%) recover without inter­\nvention, while others (32%-58%) deteriorate in the \nabsence of intervention. In patients who undergo nonsurgical \nmanagement, authors reported that 57% progress to surgery \nwithin 6 months, 58% progress to surgery in 1 year, and 62% \nto 66% progress to surgery in 3 years.49\nII\nThree studies not included in the systematic review \nby Burton et al49 reported outcomes following non­\nsurgical management in patients with CTS who did \nnot have thenar muscle atrophy.27,109,229 Povlson et al229 en­\nrolled 75 patients who were treated with a night orthosis for \n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 104,
    "sentence_start": 1004,
    "sentence_end": 1006,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "However, models \nsuggesting acute inflammation within the sheath are not well \nsupported.100,198 Instead, there is evidence to support fibrous \nsynovial hypertrophy in individuals undergoing surgical re­\nlease for idiopathic CTS.90,100,132,271\nCLINICAL COURSE WITH AND WITHOUT TREATMENT\nII\nIn a systematic review, Burton et al49 reported that \nsome patients (28%-62%) recover without inter­\nvention, while others (32%-58%) deteriorate in the \nabsence of intervention. In patients who undergo nonsurgical \nmanagement, authors reported that 57% progress to surgery \nwithin 6 months, 58% progress to surgery in 1 year, and 62% \nto 66% progress to surgery in 3 years.49\nII\nThree studies not included in the systematic review \nby Burton et al49 reported outcomes following non­\nsurgical management in patients with CTS who did \nnot have thenar muscle atrophy.27,109,229 Povlson et al229 en­\nrolled 75 patients who were treated with a night orthosis for \n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 105,
    "sentence_start": 1005,
    "sentence_end": 1007,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In patients who undergo nonsurgical \nmanagement, authors reported that 57% progress to surgery \nwithin 6 months, 58% progress to surgery in 1 year, and 62% \nto 66% progress to surgery in 3 years.49\nII\nThree studies not included in the systematic review \nby Burton et al49 reported outcomes following non­\nsurgical management in patients with CTS who did \nnot have thenar muscle atrophy.27,109,229 Povlson et al229 en­\nrolled 75 patients who were treated with a night orthosis for \n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\net al109 reported a 12-month success rate of 31% for use of a \nneutral night wrist orthosis for 6 weeks.",
    "chunk_id": 106,
    "sentence_start": 1006,
    "sentence_end": 1011,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\net al109 reported a 12-month success rate of 31% for use of a \nneutral night wrist orthosis for 6 weeks. II\nOllivere et al212 found that 14 (16%) of 89 hands of \n58 individuals with CTS of all levels of severity \n(mean ± SD symptom duration, 24 ± 29 months \n[range, 1-144 months]) improved with nonsurgical treatment \nalone, while 75 (84%) of the 89 hands underwent CTR sur­\ngery during or after 3 months of nonsurgical management \nconsisting of a steroid injection, night wrist orthosis, tendon \ngliding exercises, and simple analgesia. II\nResearchers have examined factors that predict \nprogression to surgery. Burton et al49 found that \nsymptom duration, a positive Phalen test, and the­\nnar eminence muscle wasting were associated with poor out­\ncomes with nonsurgical management.",
    "chunk_id": 107,
    "sentence_start": 1010,
    "sentence_end": 1014,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "II\nResearchers have examined factors that predict \nprogression to surgery. Burton et al49 found that \nsymptom duration, a positive Phalen test, and the­\nnar eminence muscle wasting were associated with poor out­\ncomes with nonsurgical management. Gerritsen et al109 \nreported that shorter symptom duration (less than 1 year) \nand lower severity of nighttime symptoms (score of less than \n6/10) were the best predictors of success with nonsurgical \nmanagement. Baker and Livengood27 reported that having \nmore than 1 nonsurgical intervention was a predictor of pro­\ngression to surgery (odds ratio [OR] = 24.3; 95% confidence \ninterval [CI]: 4.3, 138.2). Four studies examined the use of \nthe CTQ-SSS162 as a prognostic indicator for progression to \nsurgery, with conflicting results that will be discussed in the \nOutcome Measures section.43,109,147,212\nIV\nCapasso et al53 followed 24 individuals classified as \nhaving severe idiopathic CTS based on electrodiag­\nnostic and clinical findings.",
    "chunk_id": 108,
    "sentence_start": 1013,
    "sentence_end": 1017,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Baker and Livengood27 reported that having \nmore than 1 nonsurgical intervention was a predictor of pro­\ngression to surgery (odds ratio [OR] = 24.3; 95% confidence \ninterval [CI]: 4.3, 138.2). Four studies examined the use of \nthe CTQ-SSS162 as a prognostic indicator for progression to \nsurgery, with conflicting results that will be discussed in the \nOutcome Measures section.43,109,147,212\nIV\nCapasso et al53 followed 24 individuals classified as \nhaving severe idiopathic CTS based on electrodiag­\nnostic and clinical findings. Long-term outcomes \nfor untreated patients (n = 9) and those receiving nonsurgical \nmanagement (n = 3) were poor. At the time of the re-evalua­\ntion, which ranged from 1 to 9 years after diagnosis, 90% of \nthe untreated patients continued to have pain and/or pares­\nthesia, and all patients showed thenar eminence muscle at­\nrophy, loss of strength (“plegia”) of the APB muscle, \nhyperesthesia, and absence of median nerve conduction re­\nsponses.",
    "chunk_id": 109,
    "sentence_start": 1016,
    "sentence_end": 1019,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Long-term outcomes \nfor untreated patients (n = 9) and those receiving nonsurgical \nmanagement (n = 3) were poor. At the time of the re-evalua­\ntion, which ranged from 1 to 9 years after diagnosis, 90% of \nthe untreated patients continued to have pain and/or pares­\nthesia, and all patients showed thenar eminence muscle at­\nrophy, loss of strength (“plegia”) of the APB muscle, \nhyperesthesia, and absence of median nerve conduction re­\nsponses. The 12 individuals who had CTR surgery showed \nsigns of electrophysiological reinnervation in all but 1 case. When comparing groups, those who underwent CTR surgery \nshowed better resolution of pain and paresthesia, lower CTQ \nscores, improvement in APB muscle strength, and reappear­\nance of compound muscle action potential  (CMAP) and \nSNAP. Hyperesthesia remained unchanged in both groups.",
    "chunk_id": 110,
    "sentence_start": 1018,
    "sentence_end": 1023,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Hyperesthesia remained unchanged in both groups. The presence of col­\nrtant because it is inherently weak and \npose an individual to a cycle of further \nalso a significantly greater amount of \nh factor-β in the patient group com­\ngroup. Transforming growth factor-β is \nne present during wound healing and \ns and scarring. Authors of other level 3 i\nd similar changes in the tenosynovium \nTS.132,271\nel pressure has been implicated in the \nand studies support elevated pressure \nto surgery that decreases postoperative­\nd the elevation in pressure is unknown. ests there is a disruption in intraneural \nibutes to intraneural edema and fibro­\nhe flexor tendon synovial sheaths, such \nvitis, has been implicated as the source \nan nerve compression.",
    "chunk_id": 111,
    "sentence_start": 1022,
    "sentence_end": 1027,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Authors of other level 3 i\nd similar changes in the tenosynovium \nTS.132,271\nel pressure has been implicated in the \nand studies support elevated pressure \nto surgery that decreases postoperative­\nd the elevation in pressure is unknown. ests there is a disruption in intraneural \nibutes to intraneural edema and fibro­\nhe flexor tendon synovial sheaths, such \nvitis, has been implicated as the source \nan nerve compression. However, models l\nmmation within the sheath are not well \nad, there is evidence to support fibrous \nin individuals undergoing surgical re­\nTS.90,100,132,271\nWITH AND WITHOUT TREATMENT\natic review, Burton et al49 reported that \nnts (28%-62%) recover without inter­\nile others (32%-58%) deteriorate in the \non.",
    "chunk_id": 112,
    "sentence_start": 1026,
    "sentence_end": 1028,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "ests there is a disruption in intraneural \nibutes to intraneural edema and fibro­\nhe flexor tendon synovial sheaths, such \nvitis, has been implicated as the source \nan nerve compression. However, models l\nmmation within the sheath are not well \nad, there is evidence to support fibrous \nin individuals undergoing surgical re­\nTS.90,100,132,271\nWITH AND WITHOUT TREATMENT\natic review, Burton et al49 reported that \nnts (28%-62%) recover without inter­\nile others (32%-58%) deteriorate in the \non. In patients who undergo nonsurgical \ns reported that 57% progress to surgery \n% progress to surgery in 1 year, and 62% \nurgery in 3 years.49\nes not included in the systematic review \nt al49 reported outcomes following non­\nnagement in patients with CTS who did \ncle atrophy.27,109,229 Povlson et al229 en­\no were treated with a night orthosis for \nd of 3 months, 52 (69%) were satisfied \nwhile 17 (23%) progressed to surgery.",
    "chunk_id": 113,
    "sentence_start": 1027,
    "sentence_end": 1029,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "However, models l\nmmation within the sheath are not well \nad, there is evidence to support fibrous \nin individuals undergoing surgical re­\nTS.90,100,132,271\nWITH AND WITHOUT TREATMENT\natic review, Burton et al49 reported that \nnts (28%-62%) recover without inter­\nile others (32%-58%) deteriorate in the \non. In patients who undergo nonsurgical \ns reported that 57% progress to surgery \n% progress to surgery in 1 year, and 62% \nurgery in 3 years.49\nes not included in the systematic review \nt al49 reported outcomes following non­\nnagement in patients with CTS who did \ncle atrophy.27,109,229 Povlson et al229 en­\no were treated with a night orthosis for \nd of 3 months, 52 (69%) were satisfied \nwhile 17 (23%) progressed to surgery. Of \nisfied at 3 months, 30 responded to a \nire presented 33 months after conclud­\n\n\n--- Page 11 ---\nCOLUMN 1:\nranges from 23%229 to 84%212 after 3 months and 57% to 58% \nat 6 months and 1 year, respectively.49 There are some single \nstudies that have identified factors that predict progression to \nsurgery, but these need to be validated in larger studies.",
    "chunk_id": 114,
    "sentence_start": 1028,
    "sentence_end": 1030,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In patients who undergo nonsurgical \ns reported that 57% progress to surgery \n% progress to surgery in 1 year, and 62% \nurgery in 3 years.49\nes not included in the systematic review \nt al49 reported outcomes following non­\nnagement in patients with CTS who did \ncle atrophy.27,109,229 Povlson et al229 en­\no were treated with a night orthosis for \nd of 3 months, 52 (69%) were satisfied \nwhile 17 (23%) progressed to surgery. Of \nisfied at 3 months, 30 responded to a \nire presented 33 months after conclud­\n\n\n--- Page 11 ---\nCOLUMN 1:\nranges from 23%229 to 84%212 after 3 months and 57% to 58% \nat 6 months and 1 year, respectively.49 There are some single \nstudies that have identified factors that predict progression to \nsurgery, but these need to be validated in larger studies. More \nresearch is needed to identify the characteristics of patients \nwho benefit from nonsurgical management versus those who \ncan achieve positive outcomes only through surgical manage­\nment.",
    "chunk_id": 115,
    "sentence_start": 1029,
    "sentence_end": 1031,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Of \nisfied at 3 months, 30 responded to a \nire presented 33 months after conclud­\n\n\n--- Page 11 ---\nCOLUMN 1:\nranges from 23%229 to 84%212 after 3 months and 57% to 58% \nat 6 months and 1 year, respectively.49 There are some single \nstudies that have identified factors that predict progression to \nsurgery, but these need to be validated in larger studies. More \nresearch is needed to identify the characteristics of patients \nwho benefit from nonsurgical management versus those who \ncan achieve positive outcomes only through surgical manage­\nment. In light of a preponderance of studies reporting fairly \nhigh rates of progression to surgery, clinicians must measure \nprogress carefully and refer patients for surgical consultation \nif improvement with nonsurgical management is not observed.",
    "chunk_id": 116,
    "sentence_start": 1030,
    "sentence_end": 1032,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "More \nresearch is needed to identify the characteristics of patients \nwho benefit from nonsurgical management versus those who \ncan achieve positive outcomes only through surgical manage­\nment. In light of a preponderance of studies reporting fairly \nhigh rates of progression to surgery, clinicians must measure \nprogress carefully and refer patients for surgical consultation \nif improvement with nonsurgical management is not observed. Summary\nClinicians should assess symptom duration, severity of night­\ntime symptoms, presence of a positive Phalen test, presence \nof thenar eminence muscle wasting, and prior nonsurgical \ninterventions in individuals with CTS because these factors \nhave been shown to influence results with nonsurgical man­\nagement. There is a need for more research that helps in con­\nfirming factors that suggest the need for surgery versus a trial \nof nonsurgical intervention, especially in those with mild to \nmoderate CTS.",
    "chunk_id": 117,
    "sentence_start": 1031,
    "sentence_end": 1034,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Summary\nClinicians should assess symptom duration, severity of night­\ntime symptoms, presence of a positive Phalen test, presence \nof thenar eminence muscle wasting, and prior nonsurgical \ninterventions in individuals with CTS because these factors \nhave been shown to influence results with nonsurgical man­\nagement. There is a need for more research that helps in con­\nfirming factors that suggest the need for surgery versus a trial \nof nonsurgical intervention, especially in those with mild to \nmoderate CTS. CLASSIFICATION\nCarpal tunnel syndrome can be acute or chronic.",
    "chunk_id": 118,
    "sentence_start": 1033,
    "sentence_end": 1035,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There is a need for more research that helps in con­\nfirming factors that suggest the need for surgery versus a trial \nof nonsurgical intervention, especially in those with mild to \nmoderate CTS. CLASSIFICATION\nCarpal tunnel syndrome can be acute or chronic. Acute CTS \nis relatively rare and has various causes, such as spontaneous \nbleeding, thrombosis, dislocation of a metacarpal base, infec­\ntion, pregnancy, and fractures, with distal radius fractures \nbeing the leading cause.104 Chronic CTS has a gradual onset, \nsometimes presenting in an individual finger and later spread­\ning to the remaining median nerve distribution.270 The initial \nonset of symptoms is usually at night, but as symptoms wors­\nen, individuals may complain of symptoms throughout the day \nalong with clumsiness and difficulty with grip and pinch.270\nCarpal tunnel syndrome is most commonly classified by se­\nverity (mild, moderate, severe, or extreme).",
    "chunk_id": 119,
    "sentence_start": 1034,
    "sentence_end": 1036,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "CLASSIFICATION\nCarpal tunnel syndrome can be acute or chronic. Acute CTS \nis relatively rare and has various causes, such as spontaneous \nbleeding, thrombosis, dislocation of a metacarpal base, infec­\ntion, pregnancy, and fractures, with distal radius fractures \nbeing the leading cause.104 Chronic CTS has a gradual onset, \nsometimes presenting in an individual finger and later spread­\ning to the remaining median nerve distribution.270 The initial \nonset of symptoms is usually at night, but as symptoms wors­\nen, individuals may complain of symptoms throughout the day \nalong with clumsiness and difficulty with grip and pinch.270\nCarpal tunnel syndrome is most commonly classified by se­\nverity (mild, moderate, severe, or extreme). Classification sys­\ntems reported in the literature are largely based on data from \nelectrophysiological studies.39,56,117,137,220,286 Rempel et al238 pro­\nvided consensus criteria for classifying CTS in epidemiologic \nstudies; however, these criteria were not intended for clinical \ndiagnosis or management.",
    "chunk_id": 120,
    "sentence_start": 1035,
    "sentence_end": 1037,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Acute CTS \nis relatively rare and has various causes, such as spontaneous \nbleeding, thrombosis, dislocation of a metacarpal base, infec­\ntion, pregnancy, and fractures, with distal radius fractures \nbeing the leading cause.104 Chronic CTS has a gradual onset, \nsometimes presenting in an individual finger and later spread­\ning to the remaining median nerve distribution.270 The initial \nonset of symptoms is usually at night, but as symptoms wors­\nen, individuals may complain of symptoms throughout the day \nalong with clumsiness and difficulty with grip and pinch.270\nCarpal tunnel syndrome is most commonly classified by se­\nverity (mild, moderate, severe, or extreme). Classification sys­\ntems reported in the literature are largely based on data from \nelectrophysiological studies.39,56,117,137,220,286 Rempel et al238 pro­\nvided consensus criteria for classifying CTS in epidemiologic \nstudies; however, these criteria were not intended for clinical \ndiagnosis or management. III\nIn a recent study, Roll et al246 reported on an 8-point \nscoring system (range, 0-7, with 0 as least severe and \n7 as most se ere) that combined clinical criteria\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 121,
    "sentence_start": 1036,
    "sentence_end": 1038,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Classification sys­\ntems reported in the literature are largely based on data from \nelectrophysiological studies.39,56,117,137,220,286 Rempel et al238 pro­\nvided consensus criteria for classifying CTS in epidemiologic \nstudies; however, these criteria were not intended for clinical \ndiagnosis or management. III\nIn a recent study, Roll et al246 reported on an 8-point \nscoring system (range, 0-7, with 0 as least severe and \n7 as most se ere) that combined clinical criteria\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nIII\nCaliandro et al51 examined severity based on the \npatient’s distribution of symptoms.",
    "chunk_id": 122,
    "sentence_start": 1037,
    "sentence_end": 1043,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nIII\nCaliandro et al51 examined severity based on the \npatient’s distribution of symptoms. They found that \nthe likelihood of having a median-distribution pre­\nsentation increased with increasing severity (OR = 2.07; 95% \nCI: 1.51, 2.83) as measured with NCS. Also, patients with \nmild and moderate severities of CTS were more likely to pres­\nent with a stocking-glove paresthesia distribution. V\nThere were 2 classification systems published by \nGelberman et al104 and Szabo and Madison,270 simi­\nlarly based on a combination of clinical and electro­\ndiagnostic findings. According to Gelberman et al,104 mild \nCTS included a symptom duration of less than 1 year; diffuse \ncomplaints; intermittent numbness; normal 2-point discrim­\nination (2PD), and absence of weakness or atrophy.",
    "chunk_id": 123,
    "sentence_start": 1042,
    "sentence_end": 1047,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "V\nThere were 2 classification systems published by \nGelberman et al104 and Szabo and Madison,270 simi­\nlarly based on a combination of clinical and electro­\ndiagnostic findings. According to Gelberman et al,104 mild \nCTS included a symptom duration of less than 1 year; diffuse \ncomplaints; intermittent numbness; normal 2-point discrim­\nination (2PD), and absence of weakness or atrophy. Nerve \nconduction velocities (NCVs) were increased only by 1 to 2 \nm/s, and there were no fibrillations on electromyographic \ntesting. Intermediate CTS included constant paresthesia and \nnumbness, elevated threshold values, and increased DMLs. Advanced CTS was characterized by permanent sensory and \nmotor loss and thenar muscle atrophy. The classification out­\nlined by Szabo and Madison270 was similar in terms of elec­\ntrodiagnostic findings.",
    "chunk_id": 124,
    "sentence_start": 1046,
    "sentence_end": 1051,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Advanced CTS was characterized by permanent sensory and \nmotor loss and thenar muscle atrophy. The classification out­\nlined by Szabo and Madison270 was similar in terms of elec­\ntrodiagnostic findings. In early CTS, sensory latencies are \nmore likely to be prolonged than motor latencies; intermedi­\nate CTS included constant sensory deficits and possible mo­\ntor impairment, and advanced CTS included severe loss of \nsensory and motor function, as well as thenar muscle \natrophy. V\nMaggard et al177 also outlined a severity scale based \non a literature review. In their classification, mild \ndisease included all 3 of the following: (1) symptom \npattern at least characteristic of CTS, (2) intermittent symp­\ntoms, and (3) no abnormalities of physical exam. Moderate \nCTS included (1) symptom pattern at least characteristic of \nCTS, (2) no thenar atrophy, and (3) at least 1 of the following: \nconstant symptoms, thenar musculature weakness, or loss of \nsensory function in fingers 1, 2, or 3.",
    "chunk_id": 125,
    "sentence_start": 1050,
    "sentence_end": 1055,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In their classification, mild \ndisease included all 3 of the following: (1) symptom \npattern at least characteristic of CTS, (2) intermittent symp­\ntoms, and (3) no abnormalities of physical exam. Moderate \nCTS included (1) symptom pattern at least characteristic of \nCTS, (2) no thenar atrophy, and (3) at least 1 of the following: \nconstant symptoms, thenar musculature weakness, or loss of \nsensory function in fingers 1, 2, or 3. Severe disease included \n(1) symptom pattern at least characteristic of CTS and (2) \nthenar muscle atrophy. In a Delphi consensus study, Graham \net al116 indicated that thenar muscle atrophy, location/pres­\nence of sensory symptoms, nocturnal symptoms, and APB \nmuscle weakness were among the top 5 diagnostic criteria \nidentified by participating physicians.",
    "chunk_id": 126,
    "sentence_start": 1054,
    "sentence_end": 1057,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Severe disease included \n(1) symptom pattern at least characteristic of CTS and (2) \nthenar muscle atrophy. In a Delphi consensus study, Graham \net al116 indicated that thenar muscle atrophy, location/pres­\nence of sensory symptoms, nocturnal symptoms, and APB \nmuscle weakness were among the top 5 diagnostic criteria \nidentified by participating physicians. V\nMackinnon174 provided a classification based on the \nSunderland stages of nerve injury that included \npathoph siological changes and electrodiagnostic\no 84%212 after 3 months and 57% to 58% \nar, respectively.49 There are some single \ntified factors that predict progression to \nd to be validated in larger studies. More \nidentify the characteristics of patients \nnsurgical management versus those who \nutcomes only through surgical manage­\neponderance of studies reporting fairly \nion to surgery, clinicians must measure \nd refer patients for surgical consultation \nnonsurgical management is not observed.",
    "chunk_id": 127,
    "sentence_start": 1056,
    "sentence_end": 1059,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "V\nMackinnon174 provided a classification based on the \nSunderland stages of nerve injury that included \npathoph siological changes and electrodiagnostic\no 84%212 after 3 months and 57% to 58% \nar, respectively.49 There are some single \ntified factors that predict progression to \nd to be validated in larger studies. More \nidentify the characteristics of patients \nnsurgical management versus those who \nutcomes only through surgical manage­\neponderance of studies reporting fairly \nion to surgery, clinicians must measure \nd refer patients for surgical consultation \nnonsurgical management is not observed. ess symptom duration, severity of night­\nence of a positive Phalen test, presence \nmuscle wasting, and prior nonsurgical \nviduals with CTS because these factors \nnfluence results with nonsurgical man­\need for more research that helps in con­\nuggest the need for surgery versus a trial \nention, especially in those with mild to \nme can be acute or chronic.",
    "chunk_id": 128,
    "sentence_start": 1058,
    "sentence_end": 1060,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "More \nidentify the characteristics of patients \nnsurgical management versus those who \nutcomes only through surgical manage­\neponderance of studies reporting fairly \nion to surgery, clinicians must measure \nd refer patients for surgical consultation \nnonsurgical management is not observed. ess symptom duration, severity of night­\nence of a positive Phalen test, presence \nmuscle wasting, and prior nonsurgical \nviduals with CTS because these factors \nnfluence results with nonsurgical man­\need for more research that helps in con­\nuggest the need for surgery versus a trial \nention, especially in those with mild to \nme can be acute or chronic. Acute CTS \nhas various causes, such as spontaneous \ndislocation of a metacarpal base, infec­\nfractures, with distal radius fractures \nse.104 Chronic CTS has a gradual onset, \ng in an individual finger and later spread­\nmedian nerve distribution.270 The initial \nusually at night, but as symptoms wors­\nmplain of symptoms throughout the day \ns and difficulty with grip and pinch.270\nme is most commonly classified by se­\ne, severe, or extreme).",
    "chunk_id": 129,
    "sentence_start": 1059,
    "sentence_end": 1061,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "ess symptom duration, severity of night­\nence of a positive Phalen test, presence \nmuscle wasting, and prior nonsurgical \nviduals with CTS because these factors \nnfluence results with nonsurgical man­\need for more research that helps in con­\nuggest the need for surgery versus a trial \nention, especially in those with mild to \nme can be acute or chronic. Acute CTS \nhas various causes, such as spontaneous \ndislocation of a metacarpal base, infec­\nfractures, with distal radius fractures \nse.104 Chronic CTS has a gradual onset, \ng in an individual finger and later spread­\nmedian nerve distribution.270 The initial \nusually at night, but as symptoms wors­\nmplain of symptoms throughout the day \ns and difficulty with grip and pinch.270\nme is most commonly classified by se­\ne, severe, or extreme). Classification sys­\niterature are largely based on data from \ntudies.39,56,117,137,220,286 Rempel et al238 pro­\nria for classifying CTS in epidemiologic \nse criteria were not intended for clinical \nment.",
    "chunk_id": 130,
    "sentence_start": 1060,
    "sentence_end": 1062,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Acute CTS \nhas various causes, such as spontaneous \ndislocation of a metacarpal base, infec­\nfractures, with distal radius fractures \nse.104 Chronic CTS has a gradual onset, \ng in an individual finger and later spread­\nmedian nerve distribution.270 The initial \nusually at night, but as symptoms wors­\nmplain of symptoms throughout the day \ns and difficulty with grip and pinch.270\nme is most commonly classified by se­\ne, severe, or extreme). Classification sys­\niterature are largely based on data from \ntudies.39,56,117,137,220,286 Rempel et al238 pro­\nria for classifying CTS in epidemiologic \nse criteria were not intended for clinical \nment. tudy, Roll et al246 reported on an 8-point \nem (range, 0-7, with 0 as least severe and \nsevere) that combined clinical criteria \nn Durkan test the CTQ SSS and Boston\n\n\n--- Page 12 ---\nCOLUMN 1:\nundergo regeneration. Provocative testing that increases \npressure on the nerve is likely to result in increased paresthe­\nsia.",
    "chunk_id": 131,
    "sentence_start": 1061,
    "sentence_end": 1064,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "tudy, Roll et al246 reported on an 8-point \nem (range, 0-7, with 0 as least severe and \nsevere) that combined clinical criteria \nn Durkan test the CTQ SSS and Boston\n\n\n--- Page 12 ---\nCOLUMN 1:\nundergo regeneration. Provocative testing that increases \npressure on the nerve is likely to result in increased paresthe­\nsia. Sensory changes should be evident in the largest nerve \nfibers, and thus the patient would have diminished light \ntouch and vibration threshold sensations. A grade 2 injury \n(axonotmesis) involves axonal injury and may show signs of \nremyelination; therefore, one may suspect a positive Tinel \nsign and 2PD changes. Patients may no longer experience \nparesthesia but numbness instead, and there may be a notice­\nable loss of strength.",
    "chunk_id": 132,
    "sentence_start": 1063,
    "sentence_end": 1067,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "A grade 2 injury \n(axonotmesis) involves axonal injury and may show signs of \nremyelination; therefore, one may suspect a positive Tinel \nsign and 2PD changes. Patients may no longer experience \nparesthesia but numbness instead, and there may be a notice­\nable loss of strength. A grade 3 injury has axonal loss and \nscarring in the endoneurium, and patients have constant \nnumbness and observable thenar muscle atrophy.169,174\nSummary\nThere is a lack of consensus on clinical classification of CTS, es­\npecially in the absence of electrodiagnostic studies. Classifica­\ntions based on clinical signs and symptoms alone or combined \nwith electrodiagnostic studies are largely based on anecdotal \nevidence, expert consensus, or the pathophysiology of nerve \ncompression and lack independent validation.",
    "chunk_id": 133,
    "sentence_start": 1066,
    "sentence_end": 1069,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "A grade 3 injury has axonal loss and \nscarring in the endoneurium, and patients have constant \nnumbness and observable thenar muscle atrophy.169,174\nSummary\nThere is a lack of consensus on clinical classification of CTS, es­\npecially in the absence of electrodiagnostic studies. Classifica­\ntions based on clinical signs and symptoms alone or combined \nwith electrodiagnostic studies are largely based on anecdotal \nevidence, expert consensus, or the pathophysiology of nerve \ncompression and lack independent validation. According to \nevidence presented, the frequency of symptoms (mild dem­\nonstrating more intermittent symptoms and moderate dem­\nonstrating more constant symptoms) seems to be a factor that \ndistinguishes mild from moderate CTS, and thenar muscle at­\nrophy is the clinical sign that distinguishes patients with severe \nCTS from those with mild or moderate disease.",
    "chunk_id": 134,
    "sentence_start": 1068,
    "sentence_end": 1070,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Classifica­\ntions based on clinical signs and symptoms alone or combined \nwith electrodiagnostic studies are largely based on anecdotal \nevidence, expert consensus, or the pathophysiology of nerve \ncompression and lack independent validation. According to \nevidence presented, the frequency of symptoms (mild dem­\nonstrating more intermittent symptoms and moderate dem­\nonstrating more constant symptoms) seems to be a factor that \ndistinguishes mild from moderate CTS, and thenar muscle at­\nrophy is the clinical sign that distinguishes patients with severe \nCTS from those with mild or moderate disease. RISK FACTORS\nIntrinsic Risk Factors\nObesity\nSeveral authors suggest that obesity increases fatty tissue \nand/or hydrostatic pressure within the carpal tunnel pro­\nducing compression on the median nerve.289 Others theorize \nthat metabolic changes occur in obesity causing endoneurial \nedema and intrafascicular swelling of the median nerve.120,260 \nObesity is one component of metabolic syndrome that has \nbeen associated with nerve injury possibly through extracel­\nlular protein glycation, mitochondrial dysfunction, and/or \noxidative stress.260\nI\nIn a study of 3515 participants followed prospec­\ntively for up to 7 years, the risk of developing CTS \nin the right dominant hand was noted to increase \nlinearly as body mass index (BMI) rose.127 Having a BMI \ngreater than 30 kg/m2 nearly doubled the risk of developing \nCTS (hazard ratio [HR] = 1.67; 95% CI: 1.26, 2.21).",
    "chunk_id": 135,
    "sentence_start": 1069,
    "sentence_end": 1071,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "According to \nevidence presented, the frequency of symptoms (mild dem­\nonstrating more intermittent symptoms and moderate dem­\nonstrating more constant symptoms) seems to be a factor that \ndistinguishes mild from moderate CTS, and thenar muscle at­\nrophy is the clinical sign that distinguishes patients with severe \nCTS from those with mild or moderate disease. RISK FACTORS\nIntrinsic Risk Factors\nObesity\nSeveral authors suggest that obesity increases fatty tissue \nand/or hydrostatic pressure within the carpal tunnel pro­\nducing compression on the median nerve.289 Others theorize \nthat metabolic changes occur in obesity causing endoneurial \nedema and intrafascicular swelling of the median nerve.120,260 \nObesity is one component of metabolic syndrome that has \nbeen associated with nerve injury possibly through extracel­\nlular protein glycation, mitochondrial dysfunction, and/or \noxidative stress.260\nI\nIn a study of 3515 participants followed prospec­\ntively for up to 7 years, the risk of developing CTS \nin the right dominant hand was noted to increase \nlinearly as body mass index (BMI) rose.127 Having a BMI \ngreater than 30 kg/m2 nearly doubled the risk of developing \nCTS (hazard ratio [HR] = 1.67; 95% CI: 1.26, 2.21). II\nThe majority of prospective studies18,36,40,73 and 1 \nmeta-analysis260 demonstrated that the risk of de­\neloping CTS increases linearl\nith increasing\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 136,
    "sentence_start": 1070,
    "sentence_end": 1072,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "RISK FACTORS\nIntrinsic Risk Factors\nObesity\nSeveral authors suggest that obesity increases fatty tissue \nand/or hydrostatic pressure within the carpal tunnel pro­\nducing compression on the median nerve.289 Others theorize \nthat metabolic changes occur in obesity causing endoneurial \nedema and intrafascicular swelling of the median nerve.120,260 \nObesity is one component of metabolic syndrome that has \nbeen associated with nerve injury possibly through extracel­\nlular protein glycation, mitochondrial dysfunction, and/or \noxidative stress.260\nI\nIn a study of 3515 participants followed prospec­\ntively for up to 7 years, the risk of developing CTS \nin the right dominant hand was noted to increase \nlinearly as body mass index (BMI) rose.127 Having a BMI \ngreater than 30 kg/m2 nearly doubled the risk of developing \nCTS (hazard ratio [HR] = 1.67; 95% CI: 1.26, 2.21). II\nThe majority of prospective studies18,36,40,73 and 1 \nmeta-analysis260 demonstrated that the risk of de­\neloping CTS increases linearl\nith increasing\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 137,
    "sentence_start": 1071,
    "sentence_end": 1073,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "II\nThe majority of prospective studies18,36,40,73 and 1 \nmeta-analysis260 demonstrated that the risk of de­\neloping CTS increases linearl\nith increasing\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nn. Provocative testing that increases \nis likely to result in increased paresthe­\nshould be evident in the largest nerve \npatient would have diminished light \nthreshold sensations. A grade 2 injury \nes axonal injury and may show signs of \nfore, one may suspect a positive Tinel \nes.",
    "chunk_id": 138,
    "sentence_start": 1072,
    "sentence_end": 1079,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Provocative testing that increases \nis likely to result in increased paresthe­\nshould be evident in the largest nerve \npatient would have diminished light \nthreshold sensations. A grade 2 injury \nes axonal injury and may show signs of \nfore, one may suspect a positive Tinel \nes. Patients may no longer experience \nness instead, and there may be a notice­\n A grade 3 injury has axonal loss and \nneurium, and patients have constant \nvable thenar muscle atrophy.169,174\nensus on clinical classification of CTS, es­\ne of electrodiagnostic studies. Classifica­\n signs and symptoms alone or combined \nc studies are largely based on anecdotal \nensus, or the pathophysiology of nerve \nk independent validation. According to \nhe frequency of symptoms (mild dem­\nrmittent symptoms and moderate dem­\ntant symptoms) seems to be a factor that \nm moderate CTS, and thenar muscle at­\ngn that distinguishes patients with severe \nmild or moderate disease.",
    "chunk_id": 139,
    "sentence_start": 1078,
    "sentence_end": 1082,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Classifica­\n signs and symptoms alone or combined \nc studies are largely based on anecdotal \nensus, or the pathophysiology of nerve \nk independent validation. According to \nhe frequency of symptoms (mild dem­\nrmittent symptoms and moderate dem­\ntant symptoms) seems to be a factor that \nm moderate CTS, and thenar muscle at­\ngn that distinguishes patients with severe \nmild or moderate disease. gest that obesity increases fatty tissue \nressure within the carpal tunnel pro­\non the median nerve.289 Others theorize \nes occur in obesity causing endoneurial \ncular swelling of the median nerve.120,260 \nonent of metabolic syndrome that has \nnerve injury possibly through extracel­\non, mitochondrial dysfunction, and/or \nof 3515 participants followed prospec­\np to 7 years, the risk of developing CTS \ndominant hand was noted to increase \nss index (BMI) rose.127 Having a BMI \nm2 nearly doubled the risk of developing \nR] = 1.67; 95% CI: 1.26, 2.21).",
    "chunk_id": 140,
    "sentence_start": 1081,
    "sentence_end": 1083,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "According to \nhe frequency of symptoms (mild dem­\nrmittent symptoms and moderate dem­\ntant symptoms) seems to be a factor that \nm moderate CTS, and thenar muscle at­\ngn that distinguishes patients with severe \nmild or moderate disease. gest that obesity increases fatty tissue \nressure within the carpal tunnel pro­\non the median nerve.289 Others theorize \nes occur in obesity causing endoneurial \ncular swelling of the median nerve.120,260 \nonent of metabolic syndrome that has \nnerve injury possibly through extracel­\non, mitochondrial dysfunction, and/or \nof 3515 participants followed prospec­\np to 7 years, the risk of developing CTS \ndominant hand was noted to increase \nss index (BMI) rose.127 Having a BMI \nm2 nearly doubled the risk of developing \nR] = 1.67; 95% CI: 1.26, 2.21). ty of prospective studies18,36,40,73 and 1 \nan association suggested the reason for this was the low pow­\ner of the study (109 individuals with obesity in a sample of \n1611 workers).225 Additionally, BMI was strongly and posi­\ntively correlated with slowing of median nerve conduction \nfound in a 5-year follow-up of industrial workers.36\nIII\nA significant number of additional studies support \nobesity as a risk factor for CTS18,36,40,65,73,74,84,92,133,140,\n152,158,185,186,193,197,201,244,272 and higher BMI has been as­\nsociated with increased risk for more severe forms of CTS.74 \nThe ability to diagnose CTS using BMI and other measures \nused to quantify abdominal adiposity, which have been \nshown to be better predictors of cardiovascular and other \ndiseases, was assessed by Mondelli et al.195 Although a high \nBMI, waist-to-hip height ratio (waist circumference/hip cir­\ncumference/height greater than 0.53 for women and greater \nthan 0.54 for men) and waist-stature ratio (waist circumfer­\nence/individual’s height greater than 0.54 for women and \ngreater than 0.57 for men) predicted those with severe CTS \nwith sensitivity ranging from 72% to 92% (values varied by \nsex and whether compared to electrodiagnosis or clinical di­\nagnosis), specificity did not reach levels for acceptable diag­\nnostic accuracy (57%-66%).",
    "chunk_id": 141,
    "sentence_start": 1082,
    "sentence_end": 1084,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "gest that obesity increases fatty tissue \nressure within the carpal tunnel pro­\non the median nerve.289 Others theorize \nes occur in obesity causing endoneurial \ncular swelling of the median nerve.120,260 \nonent of metabolic syndrome that has \nnerve injury possibly through extracel­\non, mitochondrial dysfunction, and/or \nof 3515 participants followed prospec­\np to 7 years, the risk of developing CTS \ndominant hand was noted to increase \nss index (BMI) rose.127 Having a BMI \nm2 nearly doubled the risk of developing \nR] = 1.67; 95% CI: 1.26, 2.21). ty of prospective studies18,36,40,73 and 1 \nan association suggested the reason for this was the low pow­\ner of the study (109 individuals with obesity in a sample of \n1611 workers).225 Additionally, BMI was strongly and posi­\ntively correlated with slowing of median nerve conduction \nfound in a 5-year follow-up of industrial workers.36\nIII\nA significant number of additional studies support \nobesity as a risk factor for CTS18,36,40,65,73,74,84,92,133,140,\n152,158,185,186,193,197,201,244,272 and higher BMI has been as­\nsociated with increased risk for more severe forms of CTS.74 \nThe ability to diagnose CTS using BMI and other measures \nused to quantify abdominal adiposity, which have been \nshown to be better predictors of cardiovascular and other \ndiseases, was assessed by Mondelli et al.195 Although a high \nBMI, waist-to-hip height ratio (waist circumference/hip cir­\ncumference/height greater than 0.53 for women and greater \nthan 0.54 for men) and waist-stature ratio (waist circumfer­\nence/individual’s height greater than 0.54 for women and \ngreater than 0.57 for men) predicted those with severe CTS \nwith sensitivity ranging from 72% to 92% (values varied by \nsex and whether compared to electrodiagnosis or clinical di­\nagnosis), specificity did not reach levels for acceptable diag­\nnostic accuracy (57%-66%). Age and Female Sex\nThe physiologic changes associated with aging have been sug­\ngested to predispose individuals to CTS, specifically vascular \nabnormalities and age-associated decreased axon number \nand conduction velocity.18 The reason for a potential higher \nincidence of CTS in women is less clear.",
    "chunk_id": 142,
    "sentence_start": 1083,
    "sentence_end": 1085,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "ty of prospective studies18,36,40,73 and 1 \nan association suggested the reason for this was the low pow­\ner of the study (109 individuals with obesity in a sample of \n1611 workers).225 Additionally, BMI was strongly and posi­\ntively correlated with slowing of median nerve conduction \nfound in a 5-year follow-up of industrial workers.36\nIII\nA significant number of additional studies support \nobesity as a risk factor for CTS18,36,40,65,73,74,84,92,133,140,\n152,158,185,186,193,197,201,244,272 and higher BMI has been as­\nsociated with increased risk for more severe forms of CTS.74 \nThe ability to diagnose CTS using BMI and other measures \nused to quantify abdominal adiposity, which have been \nshown to be better predictors of cardiovascular and other \ndiseases, was assessed by Mondelli et al.195 Although a high \nBMI, waist-to-hip height ratio (waist circumference/hip cir­\ncumference/height greater than 0.53 for women and greater \nthan 0.54 for men) and waist-stature ratio (waist circumfer­\nence/individual’s height greater than 0.54 for women and \ngreater than 0.57 for men) predicted those with severe CTS \nwith sensitivity ranging from 72% to 92% (values varied by \nsex and whether compared to electrodiagnosis or clinical di­\nagnosis), specificity did not reach levels for acceptable diag­\nnostic accuracy (57%-66%). Age and Female Sex\nThe physiologic changes associated with aging have been sug­\ngested to predispose individuals to CTS, specifically vascular \nabnormalities and age-associated decreased axon number \nand conduction velocity.18 The reason for a potential higher \nincidence of CTS in women is less clear. A hormonal mecha­\nnism is often proposed, as well as, the smaller cross-sectional \narea of the carpal tunnel in women compared to men.79,269 \nOther hypotheses related to female sex include more com­\nmon reporting of symptoms; lower strength that necessitates \na greater percentage of maximum voluntary contraction to \ncomplete the same tasks; and smaller stature leading to \ngreater wrist deviations required at work stations.",
    "chunk_id": 143,
    "sentence_start": 1084,
    "sentence_end": 1086,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Age and Female Sex\nThe physiologic changes associated with aging have been sug­\ngested to predispose individuals to CTS, specifically vascular \nabnormalities and age-associated decreased axon number \nand conduction velocity.18 The reason for a potential higher \nincidence of CTS in women is less clear. A hormonal mecha­\nnism is often proposed, as well as, the smaller cross-sectional \narea of the carpal tunnel in women compared to men.79,269 \nOther hypotheses related to female sex include more com­\nmon reporting of symptoms; lower strength that necessitates \na greater percentage of maximum voluntary contraction to \ncomplete the same tasks; and smaller stature leading to \ngreater wrist deviations required at work stations. I\nII\nResults from level I127 and II stud­\nies205,248,282 concur that increasing age and \nthe female sex are risk factors for CTS. Specifically, the risk for CTS appears to increase linearly with \nage and more than doubles in those over the age of 50.",
    "chunk_id": 144,
    "sentence_start": 1085,
    "sentence_end": 1088,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "I\nII\nResults from level I127 and II stud­\nies205,248,282 concur that increasing age and \nthe female sex are risk factors for CTS. Specifically, the risk for CTS appears to increase linearly with \nage and more than doubles in those over the age of 50. Fe­\nmale sex increases the risk between 1.5 and 4 times compared \nto male counterparts. III\nAdditional level III studies also support increasing \nage21,36,40,74,87,92,130,152,158,186,197,201,204,242-244,269,272,289 and \nfemale sex as risk factors.21,36,87,92,158,186,197,265,272,289\n\n\n--- Page 13 ---\nCOLUMN 1:\nence the development of CTS is not completely understood. Diabetes mellitus is known to cause peripheral neuropathy \nby glycosylation of protein end products increasing circulat­\ning inflammatory cytokines and vascular endothelial growth \nfactor.",
    "chunk_id": 145,
    "sentence_start": 1087,
    "sentence_end": 1091,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "III\nAdditional level III studies also support increasing \nage21,36,40,74,87,92,130,152,158,186,197,201,204,242-244,269,272,289 and \nfemale sex as risk factors.21,36,87,92,158,186,197,265,272,289\n\n\n--- Page 13 ---\nCOLUMN 1:\nence the development of CTS is not completely understood. Diabetes mellitus is known to cause peripheral neuropathy \nby glycosylation of protein end products increasing circulat­\ning inflammatory cytokines and vascular endothelial growth \nfactor. These mediators may sensitize the median nerve to \nalterations within the carpal tunnel.227,265,278 Oktayoglu et al211 \nhypothesize that the increased osmotic pressure arising from \nintracellular sorbitol accumulation in diabetes may result in \nedema and hydropic degeneration.",
    "chunk_id": 146,
    "sentence_start": 1090,
    "sentence_end": 1092,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Diabetes mellitus is known to cause peripheral neuropathy \nby glycosylation of protein end products increasing circulat­\ning inflammatory cytokines and vascular endothelial growth \nfactor. These mediators may sensitize the median nerve to \nalterations within the carpal tunnel.227,265,278 Oktayoglu et al211 \nhypothesize that the increased osmotic pressure arising from \nintracellular sorbitol accumulation in diabetes may result in \nedema and hydropic degeneration. DM may also produce \nvascular changes and tendinopathy leading to CTS.265 In fact, \nTaser et al273 have found an increased number of fibroblasts, \nincreased collagen fiber diameter and lengths, as well as, neo­\nvascularization in the SSCT of patients with DM undergoing \nCTR surgery compared to those with idiopathic CTS or pa­\ntients with hypothyroidism. I\nHarris-Adamson et al,127 did not find DM to be a \nsignificant independent predictor for the develop­\nment of CTS when the data was adjusted for sex, \nage, and BMI.",
    "chunk_id": 147,
    "sentence_start": 1091,
    "sentence_end": 1094,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "DM may also produce \nvascular changes and tendinopathy leading to CTS.265 In fact, \nTaser et al273 have found an increased number of fibroblasts, \nincreased collagen fiber diameter and lengths, as well as, neo­\nvascularization in the SSCT of patients with DM undergoing \nCTR surgery compared to those with idiopathic CTS or pa­\ntients with hypothyroidism. I\nHarris-Adamson et al,127 did not find DM to be a \nsignificant independent predictor for the develop­\nment of CTS when the data was adjusted for sex, \nage, and BMI. II\nA random-effects meta-analysis227 and a large pro­\nspective study60 both found significantly higher risk \nof CTS in those with DM (OR = 1.69; 95% CI: 1.45, \n1.96 and HR = 1.31; 95% CI: 1.28, 1.34, respectively).",
    "chunk_id": 148,
    "sentence_start": 1093,
    "sentence_end": 1095,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "I\nHarris-Adamson et al,127 did not find DM to be a \nsignificant independent predictor for the develop­\nment of CTS when the data was adjusted for sex, \nage, and BMI. II\nA random-effects meta-analysis227 and a large pro­\nspective study60 both found significantly higher risk \nof CTS in those with DM (OR = 1.69; 95% CI: 1.45, \n1.96 and HR = 1.31; 95% CI: 1.28, 1.34, respectively). The risk \nwas similar for individuals with type 1 and 2 diabetes.227\nIII\nAuthors of 6 studies36,119,130,197,211,278 found significant \nassociations and 1 found no association between \nDM and CTS.87 Those reporting an OR found in­\ncreased risk of CTS in the presence of DM to be in the range \nof 1.24 to 2.2. Oktayoglu et al211 demonstrated that patients \nwith type 2 diabetes had significantly higher incidence of CTS \nthan even individuals with hypothyroidism or acromegaly.",
    "chunk_id": 149,
    "sentence_start": 1094,
    "sentence_end": 1097,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The risk \nwas similar for individuals with type 1 and 2 diabetes.227\nIII\nAuthors of 6 studies36,119,130,197,211,278 found significant \nassociations and 1 found no association between \nDM and CTS.87 Those reporting an OR found in­\ncreased risk of CTS in the presence of DM to be in the range \nof 1.24 to 2.2. Oktayoglu et al211 demonstrated that patients \nwith type 2 diabetes had significantly higher incidence of CTS \nthan even individuals with hypothyroidism or acromegaly. In \nthe one study, where authors found no association between \nCTS and DM, the relative risk was 1.26 (95% CI: 0.65, 2.44), \nand it did not reach statistical significance.87\nRheumatoid Arthritis\nSynovial expansion, joint erosion, and ligament laxity that \noccurs with rheumatoid arthritis (RA) may result in loss of \ncarpal tunnel height and increased pressure on the median \nnerve.250\nI\nRheumatoid arthritis was not found to be a signifi­\ncant, independent predictor for the development of \nCTS when the data were adjusted for sex, age, and \nBMI in a study by Harris-Adamson et al.127\nII\nIn contrast, even after adjusting for age and sex, \nShiri’s255 meta-analysis of studies examining risk of \nCTS in indi iduals\nith RA sho ed increased risk\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 150,
    "sentence_start": 1096,
    "sentence_end": 1098,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Oktayoglu et al211 demonstrated that patients \nwith type 2 diabetes had significantly higher incidence of CTS \nthan even individuals with hypothyroidism or acromegaly. In \nthe one study, where authors found no association between \nCTS and DM, the relative risk was 1.26 (95% CI: 0.65, 2.44), \nand it did not reach statistical significance.87\nRheumatoid Arthritis\nSynovial expansion, joint erosion, and ligament laxity that \noccurs with rheumatoid arthritis (RA) may result in loss of \ncarpal tunnel height and increased pressure on the median \nnerve.250\nI\nRheumatoid arthritis was not found to be a signifi­\ncant, independent predictor for the development of \nCTS when the data were adjusted for sex, age, and \nBMI in a study by Harris-Adamson et al.127\nII\nIn contrast, even after adjusting for age and sex, \nShiri’s255 meta-analysis of studies examining risk of \nCTS in indi iduals\nith RA sho ed increased risk\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 151,
    "sentence_start": 1097,
    "sentence_end": 1099,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In \nthe one study, where authors found no association between \nCTS and DM, the relative risk was 1.26 (95% CI: 0.65, 2.44), \nand it did not reach statistical significance.87\nRheumatoid Arthritis\nSynovial expansion, joint erosion, and ligament laxity that \noccurs with rheumatoid arthritis (RA) may result in loss of \ncarpal tunnel height and increased pressure on the median \nnerve.250\nI\nRheumatoid arthritis was not found to be a signifi­\ncant, independent predictor for the development of \nCTS when the data were adjusted for sex, age, and \nBMI in a study by Harris-Adamson et al.127\nII\nIn contrast, even after adjusting for age and sex, \nShiri’s255 meta-analysis of studies examining risk of \nCTS in indi iduals\nith RA sho ed increased risk\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 152,
    "sentence_start": 1098,
    "sentence_end": 1102,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nt of CTS is not completely understood. known to cause peripheral neuropathy \notein end products increasing circulat­\nokines and vascular endothelial growth \nors may sensitize the median nerve to \ncarpal tunnel.227,265,278 Oktayoglu et al211 \nncreased osmotic pressure arising from \naccumulation in diabetes may result in \ndegeneration. DM may also produce \ntendinopathy leading to CTS.265 In fact, \nund an increased number of fibroblasts, \ner diameter and lengths, as well as, neo­\n SSCT of patients with DM undergoing \ned to those with idiopathic CTS or pa­\noidism. mson et al,127 did not find DM to be a \nndependent predictor for the develop­\nS when the data was adjusted for sex, \neffects meta-analysis227 and a large pro­\ndy60 both found significantly higher risk \nhose with DM (OR = 1.69; 95% CI: 1.45, \n5% CI: 1.28, 1.34, respectively).",
    "chunk_id": 153,
    "sentence_start": 1101,
    "sentence_end": 1106,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "DM may also produce \ntendinopathy leading to CTS.265 In fact, \nund an increased number of fibroblasts, \ner diameter and lengths, as well as, neo­\n SSCT of patients with DM undergoing \ned to those with idiopathic CTS or pa­\noidism. mson et al,127 did not find DM to be a \nndependent predictor for the develop­\nS when the data was adjusted for sex, \neffects meta-analysis227 and a large pro­\ndy60 both found significantly higher risk \nhose with DM (OR = 1.69; 95% CI: 1.45, \n5% CI: 1.28, 1.34, respectively). The risk \nduals with type 1 and 2 diabetes.227\n6 studies36,119,130,197,211,278 found significant \ns and 1 found no association between \nTS.87 Those reporting an OR found in­\nn the presence of DM to be in the range \noglu et al211 demonstrated that patients \nad significantly higher incidence of CTS \nwith hypothyroidism or acromegaly.",
    "chunk_id": 154,
    "sentence_start": 1105,
    "sentence_end": 1107,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "mson et al,127 did not find DM to be a \nndependent predictor for the develop­\nS when the data was adjusted for sex, \neffects meta-analysis227 and a large pro­\ndy60 both found significantly higher risk \nhose with DM (OR = 1.69; 95% CI: 1.45, \n5% CI: 1.28, 1.34, respectively). The risk \nduals with type 1 and 2 diabetes.227\n6 studies36,119,130,197,211,278 found significant \ns and 1 found no association between \nTS.87 Those reporting an OR found in­\nn the presence of DM to be in the range \noglu et al211 demonstrated that patients \nad significantly higher incidence of CTS \nwith hypothyroidism or acromegaly. In \nauthors found no association between \native risk was 1.26 (95% CI: 0.65, 2.44), \ntatistical significance.87\njoint erosion, and ligament laxity that \noid arthritis (RA) may result in loss of \nIII\nTwo systematic reviews provided conflicting find­\nings,250,278 and 1 primary study87 found no associa­\ntion between RA and CTS.",
    "chunk_id": 155,
    "sentence_start": 1106,
    "sentence_end": 1108,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The risk \nduals with type 1 and 2 diabetes.227\n6 studies36,119,130,197,211,278 found significant \ns and 1 found no association between \nTS.87 Those reporting an OR found in­\nn the presence of DM to be in the range \noglu et al211 demonstrated that patients \nad significantly higher incidence of CTS \nwith hypothyroidism or acromegaly. In \nauthors found no association between \native risk was 1.26 (95% CI: 0.65, 2.44), \ntatistical significance.87\njoint erosion, and ligament laxity that \noid arthritis (RA) may result in loss of \nIII\nTwo systematic reviews provided conflicting find­\nings,250,278 and 1 primary study87 found no associa­\ntion between RA and CTS. Specifically, the pooled \ndata from 8 studies in Sakthiswary and Singh’s250 meta-anal­\nysis revealed that 5.5% of patients with RA had CTS, which \nis similar to the prevalence of CTS in the general population \n(2.7%-5.8%).",
    "chunk_id": 156,
    "sentence_start": 1107,
    "sentence_end": 1109,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In \nauthors found no association between \native risk was 1.26 (95% CI: 0.65, 2.44), \ntatistical significance.87\njoint erosion, and ligament laxity that \noid arthritis (RA) may result in loss of \nIII\nTwo systematic reviews provided conflicting find­\nings,250,278 and 1 primary study87 found no associa­\ntion between RA and CTS. Specifically, the pooled \ndata from 8 studies in Sakthiswary and Singh’s250 meta-anal­\nysis revealed that 5.5% of patients with RA had CTS, which \nis similar to the prevalence of CTS in the general population \n(2.7%-5.8%). Cardiovascular Risk Factors\nCommon cardiovascular risk factors include hypercholes­\nterolemia, hypertension, high triglycerides, increasing age, \ndiabetes, obesity and smoking. The theory on how the latter 4 \nrisk factors may predispose to CTS are described in other sec­\ntions of this CPG. Hypercholesterolemia has been associated \nwith upregulating growth factors responsible for fibrogen­\nesis in various organs and peripheral nerves.",
    "chunk_id": 157,
    "sentence_start": 1108,
    "sentence_end": 1112,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The theory on how the latter 4 \nrisk factors may predispose to CTS are described in other sec­\ntions of this CPG. Hypercholesterolemia has been associated \nwith upregulating growth factors responsible for fibrogen­\nesis in various organs and peripheral nerves. Nakamichi and \nTachibana199 hypothesize that this may increase connective \ntissue within the median nerve leading to increased risk of \nCTS. The mechanism by which other cardiovascular risk fac­\ntors (hypertension, high triglycerides, etc) may lead to CTS \nhas not been described. III\nOne study found that the prevalence of CTS and \nmedian nerve cross-sectional area within the carpal \ntunnel increased significantly as low-density lipo­\nprotein (LDL) levels increased.199 Although obesity was more \nprevalent in the CTS group, obesity was not found to be a \nsignificant factor in the logistic regression model. III\nShiri et al259 found cardiovascular risk factors to be \nassociated with CTS in a large cross-sectional study.",
    "chunk_id": 158,
    "sentence_start": 1111,
    "sentence_end": 1116,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "III\nOne study found that the prevalence of CTS and \nmedian nerve cross-sectional area within the carpal \ntunnel increased significantly as low-density lipo­\nprotein (LDL) levels increased.199 Although obesity was more \nprevalent in the CTS group, obesity was not found to be a \nsignificant factor in the logistic regression model. III\nShiri et al259 found cardiovascular risk factors to be \nassociated with CTS in a large cross-sectional study. The specific risk factors varied based on age. In the \nyounger age group (30-44 years), the following risk factors \nwere associated with CTS: obesity, high LDL cholesterol, \nhigh triglycerides, hypertension, and cardiac arrhythmia. In \nthe older age group (older than 60 years), coronary artery \ndisease, valvular heart disease, and carotid artery intima-\nmedia thickness were associated with higher risks of CTS.",
    "chunk_id": 159,
    "sentence_start": 1115,
    "sentence_end": 1119,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In the \nyounger age group (30-44 years), the following risk factors \nwere associated with CTS: obesity, high LDL cholesterol, \nhigh triglycerides, hypertension, and cardiac arrhythmia. In \nthe older age group (older than 60 years), coronary artery \ndisease, valvular heart disease, and carotid artery intima-\nmedia thickness were associated with higher risks of CTS. Hegmann et al130 found an association between CTS and the \ncardiovascular disease risk factor score which included: age, \nhypertension, tobacco use, and DM. --- Page 14 ---\nCOLUMN 1:\nal96 also propose that mechanical problems in the cervical \narea may contribute to multiple disorders of the upper limbs.",
    "chunk_id": 160,
    "sentence_start": 1118,
    "sentence_end": 1121,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Hegmann et al130 found an association between CTS and the \ncardiovascular disease risk factor score which included: age, \nhypertension, tobacco use, and DM. --- Page 14 ---\nCOLUMN 1:\nal96 also propose that mechanical problems in the cervical \narea may contribute to multiple disorders of the upper limbs. II\nIndividuals with a history of wrist or hand tendi­\nnopathies had increased odds of developing CTS in \na prospective study of employees in an automotive \nassembly plant (OR = 4.74; 95% CI: 1.09, 20.43).289 In Shi­\nri’s255 meta-analysis of individuals with OA, 2 studies consist­\ning of 19 480 participants were pooled and data were adjusted \nfor age and sex. The OR for development of CTS was 1.87 \n(95% CI: 1.64, 2.13; I2 = 0%) in individuals with OA.",
    "chunk_id": 161,
    "sentence_start": 1120,
    "sentence_end": 1123,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "II\nIndividuals with a history of wrist or hand tendi­\nnopathies had increased odds of developing CTS in \na prospective study of employees in an automotive \nassembly plant (OR = 4.74; 95% CI: 1.09, 20.43).289 In Shi­\nri’s255 meta-analysis of individuals with OA, 2 studies consist­\ning of 19 480 participants were pooled and data were adjusted \nfor age and sex. The OR for development of CTS was 1.87 \n(95% CI: 1.64, 2.13; I2 = 0%) in individuals with OA. III\nLevel III studies have found the following muscu­\nloskeletal disorders are associated with occurrence \nof CTS: (1) prior distal upper extremity disorders \n(OR = 3.48; 95% CI: 2.56, 4.73)92; (2) arm fracture, OA of the \nspine, tennis elbow, and joint pain (OR = 1.98; 95% CI: 1.61, \n2.42)96; (3) lupus, disc disease, OA, or RA (OR = 2.4; 95% CI: \n1.24, 4.67)208; (4) cervical spine complaints or previous upper \nlimb trauma (OR = 4.57; 95% CI: 2.28, 9.14 and OR = 8.09; \n95% CI: 2.35, 27.91, respectively)242; and (5) rotator cuff syn­\ndrome (OR = 1.84; CI not reported).55\nHypothyroidism\nSeveral mechanisms have been proposed to explain how \nhypothyroidism may contribute to the development of CTS \nincluding: synovial thickening surrounding flexor tendons, \ndeposition of pseudomucinous material on the median \nnerve, alterations in fluid balance, and increased peripheral \nedema.143,211,256,273\nIII\nTwo meta-analyses assessed the association be­\ntween hypothyroidism and CTS.",
    "chunk_id": 162,
    "sentence_start": 1122,
    "sentence_end": 1124,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The OR for development of CTS was 1.87 \n(95% CI: 1.64, 2.13; I2 = 0%) in individuals with OA. III\nLevel III studies have found the following muscu­\nloskeletal disorders are associated with occurrence \nof CTS: (1) prior distal upper extremity disorders \n(OR = 3.48; 95% CI: 2.56, 4.73)92; (2) arm fracture, OA of the \nspine, tennis elbow, and joint pain (OR = 1.98; 95% CI: 1.61, \n2.42)96; (3) lupus, disc disease, OA, or RA (OR = 2.4; 95% CI: \n1.24, 4.67)208; (4) cervical spine complaints or previous upper \nlimb trauma (OR = 4.57; 95% CI: 2.28, 9.14 and OR = 8.09; \n95% CI: 2.35, 27.91, respectively)242; and (5) rotator cuff syn­\ndrome (OR = 1.84; CI not reported).55\nHypothyroidism\nSeveral mechanisms have been proposed to explain how \nhypothyroidism may contribute to the development of CTS \nincluding: synovial thickening surrounding flexor tendons, \ndeposition of pseudomucinous material on the median \nnerve, alterations in fluid balance, and increased peripheral \nedema.143,211,256,273\nIII\nTwo meta-analyses assessed the association be­\ntween hypothyroidism and CTS. Shiri256 analyzed \nthe 4 studies that controlled for potential con­\nfounders and found a significant association (effect size [ES], \n1.44; 95% CI: 1.27, 1.63; I2 = 50%).",
    "chunk_id": 163,
    "sentence_start": 1123,
    "sentence_end": 1125,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "III\nLevel III studies have found the following muscu­\nloskeletal disorders are associated with occurrence \nof CTS: (1) prior distal upper extremity disorders \n(OR = 3.48; 95% CI: 2.56, 4.73)92; (2) arm fracture, OA of the \nspine, tennis elbow, and joint pain (OR = 1.98; 95% CI: 1.61, \n2.42)96; (3) lupus, disc disease, OA, or RA (OR = 2.4; 95% CI: \n1.24, 4.67)208; (4) cervical spine complaints or previous upper \nlimb trauma (OR = 4.57; 95% CI: 2.28, 9.14 and OR = 8.09; \n95% CI: 2.35, 27.91, respectively)242; and (5) rotator cuff syn­\ndrome (OR = 1.84; CI not reported).55\nHypothyroidism\nSeveral mechanisms have been proposed to explain how \nhypothyroidism may contribute to the development of CTS \nincluding: synovial thickening surrounding flexor tendons, \ndeposition of pseudomucinous material on the median \nnerve, alterations in fluid balance, and increased peripheral \nedema.143,211,256,273\nIII\nTwo meta-analyses assessed the association be­\ntween hypothyroidism and CTS. Shiri256 analyzed \nthe 4 studies that controlled for potential con­\nfounders and found a significant association (effect size [ES], \n1.44; 95% CI: 1.27, 1.63; I2 = 50%). van Dijk et al278 found a \npooled OR of 1.4 (95% CI: 1.0, 2.0) in their analysis of 9 ar­\nticles.",
    "chunk_id": 164,
    "sentence_start": 1124,
    "sentence_end": 1126,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Shiri256 analyzed \nthe 4 studies that controlled for potential con­\nfounders and found a significant association (effect size [ES], \n1.44; 95% CI: 1.27, 1.63; I2 = 50%). van Dijk et al278 found a \npooled OR of 1.4 (95% CI: 1.0, 2.0) in their analysis of 9 ar­\nticles. Two of 3 other studies157,197,211,243 not included in the \nabove meta-analyses concurred that hypothyroidism is a risk \nfactor for CTS. Genetic Predisposition\nIII\nHemminki et al131 compared hospitalized sibling \npairs affected with a nerve, nerve root, or plexus \ndisorder to hospitali ed sibling pairs\nithout an\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 165,
    "sentence_start": 1125,
    "sentence_end": 1132,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nfor development of the syndrome (OR = 2.09; 95% CI: 1.28, \n3.4) in individuals with a parent, sibling, or child with his­\ntory of CTS. Bland40 found that those with a family history \nof CTS were at increased odds for development of CTS only \nwhen under the age of 63 (OR = 1.42; 95% CI: 1.14, 1.77). In \na twin study, Hakim et al124 calculated the case-wise concor­\ndance (the probability that a twin is affected, given that the \ncotwin is affected) was 0.35 in monozygotic twins compared \nto 0.24 in dizygotic. There was a significantly increased \nmonozygotic to dizygotic ratio of 1.48 with an estimated ge­\nnetic inheritance of 46%. When adjusting for other poten­\ntial confounders, no other risk factor was significant.",
    "chunk_id": 166,
    "sentence_start": 1131,
    "sentence_end": 1137,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There was a significantly increased \nmonozygotic to dizygotic ratio of 1.48 with an estimated ge­\nnetic inheritance of 46%. When adjusting for other poten­\ntial confounders, no other risk factor was significant. Radecki233 noted significantly more individuals with CTS \n(27.3 %) also had positive family history compared to only \n13.3% of those without confirmed CTS. A positive family \nhistory was predictive (χ2 = 20.48) of positive NCS with a \nrelative risk of 1.35. Wrist/Hand Anthropometrics\nIt has been proposed that individuals with a square-shaped \nwrist (proportionally thicker in anterior/posterior plane \nwhen compared to mediolateral plane) and those with short­\ner fingers or palm may be at increased risk for CTS because \nof a greater need for flexion and extension range of motion, \nand therefore, more force required to perform tasks.18,140 Over \ntime this may increase carpal tunnel pressure.",
    "chunk_id": 167,
    "sentence_start": 1136,
    "sentence_end": 1140,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "A positive family \nhistory was predictive (χ2 = 20.48) of positive NCS with a \nrelative risk of 1.35. Wrist/Hand Anthropometrics\nIt has been proposed that individuals with a square-shaped \nwrist (proportionally thicker in anterior/posterior plane \nwhen compared to mediolateral plane) and those with short­\ner fingers or palm may be at increased risk for CTS because \nof a greater need for flexion and extension range of motion, \nand therefore, more force required to perform tasks.18,140 Over \ntime this may increase carpal tunnel pressure. Commonly measured using a sliding digital caliper, wrist and \nhand anthropometrics, include: (1) wrist width: maximum \ndistance at the level of the distal flexor wrist crease; (2) wrist \ndepth: anteroposterior depth at the level of the distal flexor \nwrist crease; (3) palm length: distance between the distal \nflexor crease of the wrist to the proximal crease of the mid­\ndle finger; (4) middle finger length: distance of the proximal \nflexor crease of the middle finger to the tip of the same finger; \n(5) hand length: distance between the distal flexor crease of \nthe wrist to the tip of the middle finger; and (6) palm width: \nmaximum distance between the heads of the second and fifth \nmetacarpals.",
    "chunk_id": 168,
    "sentence_start": 1139,
    "sentence_end": 1141,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Wrist/Hand Anthropometrics\nIt has been proposed that individuals with a square-shaped \nwrist (proportionally thicker in anterior/posterior plane \nwhen compared to mediolateral plane) and those with short­\ner fingers or palm may be at increased risk for CTS because \nof a greater need for flexion and extension range of motion, \nand therefore, more force required to perform tasks.18,140 Over \ntime this may increase carpal tunnel pressure. Commonly measured using a sliding digital caliper, wrist and \nhand anthropometrics, include: (1) wrist width: maximum \ndistance at the level of the distal flexor wrist crease; (2) wrist \ndepth: anteroposterior depth at the level of the distal flexor \nwrist crease; (3) palm length: distance between the distal \nflexor crease of the wrist to the proximal crease of the mid­\ndle finger; (4) middle finger length: distance of the proximal \nflexor crease of the middle finger to the tip of the same finger; \n(5) hand length: distance between the distal flexor crease of \nthe wrist to the tip of the middle finger; and (6) palm width: \nmaximum distance between the heads of the second and fifth \nmetacarpals. Commonly calculated indices include (1) wrist \nratio: wrist depth divided by wrist width, (2) wrist-palm ra­\ntio: wrist depth divided by palm length, (3) hand ratio: hand \nlength divided by palm width, and (4) shape index: palm \nwidth multiplied by 100 and divided by hand length.",
    "chunk_id": 169,
    "sentence_start": 1140,
    "sentence_end": 1142,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Commonly measured using a sliding digital caliper, wrist and \nhand anthropometrics, include: (1) wrist width: maximum \ndistance at the level of the distal flexor wrist crease; (2) wrist \ndepth: anteroposterior depth at the level of the distal flexor \nwrist crease; (3) palm length: distance between the distal \nflexor crease of the wrist to the proximal crease of the mid­\ndle finger; (4) middle finger length: distance of the proximal \nflexor crease of the middle finger to the tip of the same finger; \n(5) hand length: distance between the distal flexor crease of \nthe wrist to the tip of the middle finger; and (6) palm width: \nmaximum distance between the heads of the second and fifth \nmetacarpals. Commonly calculated indices include (1) wrist \nratio: wrist depth divided by wrist width, (2) wrist-palm ra­\ntio: wrist depth divided by palm length, (3) hand ratio: hand \nlength divided by palm width, and (4) shape index: palm \nwidth multiplied by 100 and divided by hand length. Wrist Ratio (Square Wrist)\nII\nIn the study by Nathan et al,203 a higher wrist ratio \n(more square wrist) was the third most predictive \nfactor (after BMI and increasing age) for maximum \nlatency difference in sensory nerve conduction.",
    "chunk_id": 170,
    "sentence_start": 1141,
    "sentence_end": 1143,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Commonly calculated indices include (1) wrist \nratio: wrist depth divided by wrist width, (2) wrist-palm ra­\ntio: wrist depth divided by palm length, (3) hand ratio: hand \nlength divided by palm width, and (4) shape index: palm \nwidth multiplied by 100 and divided by hand length. Wrist Ratio (Square Wrist)\nII\nIn the study by Nathan et al,203 a higher wrist ratio \n(more square wrist) was the third most predictive \nfactor (after BMI and increasing age) for maximum \nlatency difference in sensory nerve conduction. III\nShiri257 completed a meta-analysis of 16 papers that \nstudied the association between CTS and wrist ra­\ntio The mean\nrist ratio\nas higher in indi iduals\nt mechanical problems in the cervical \no multiple disorders of the upper limbs.",
    "chunk_id": 171,
    "sentence_start": 1142,
    "sentence_end": 1144,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Wrist Ratio (Square Wrist)\nII\nIn the study by Nathan et al,203 a higher wrist ratio \n(more square wrist) was the third most predictive \nfactor (after BMI and increasing age) for maximum \nlatency difference in sensory nerve conduction. III\nShiri257 completed a meta-analysis of 16 papers that \nstudied the association between CTS and wrist ra­\ntio The mean\nrist ratio\nas higher in indi iduals\nt mechanical problems in the cervical \no multiple disorders of the upper limbs. with a history of wrist or hand tendi­\nad increased odds of developing CTS in \nve study of employees in an automotive \n= 4.74; 95% CI: 1.09, 20.43).289 In Shi­\nf individuals with OA, 2 studies consist­\nants were pooled and data were adjusted \nOR for development of CTS was 1.87 \n2 = 0%) in individuals with OA.",
    "chunk_id": 172,
    "sentence_start": 1143,
    "sentence_end": 1145,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "III\nShiri257 completed a meta-analysis of 16 papers that \nstudied the association between CTS and wrist ra­\ntio The mean\nrist ratio\nas higher in indi iduals\nt mechanical problems in the cervical \no multiple disorders of the upper limbs. with a history of wrist or hand tendi­\nad increased odds of developing CTS in \nve study of employees in an automotive \n= 4.74; 95% CI: 1.09, 20.43).289 In Shi­\nf individuals with OA, 2 studies consist­\nants were pooled and data were adjusted \nOR for development of CTS was 1.87 \n2 = 0%) in individuals with OA. udies have found the following muscu­\nisorders are associated with occurrence \nprior distal upper extremity disorders \n2.56, 4.73)92; (2) arm fracture, OA of the \nnd joint pain (OR = 1.98; 95% CI: 1.61, \nc disease, OA, or RA (OR = 2.4; 95% CI: \nvical spine complaints or previous upper \n.57; 95% CI: 2.28, 9.14 and OR = 8.09; \nespectively)242; and (5) rotator cuff syn­\nI not reported).55\nhave been proposed to explain how \ncontribute to the development of CTS \nhickening surrounding flexor tendons, \ndomucinous material on the median \nfluid balance, and increased peripheral \nanalyses assessed the association be­\nthyroidism and CTS.",
    "chunk_id": 173,
    "sentence_start": 1144,
    "sentence_end": 1146,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "with a history of wrist or hand tendi­\nad increased odds of developing CTS in \nve study of employees in an automotive \n= 4.74; 95% CI: 1.09, 20.43).289 In Shi­\nf individuals with OA, 2 studies consist­\nants were pooled and data were adjusted \nOR for development of CTS was 1.87 \n2 = 0%) in individuals with OA. udies have found the following muscu­\nisorders are associated with occurrence \nprior distal upper extremity disorders \n2.56, 4.73)92; (2) arm fracture, OA of the \nnd joint pain (OR = 1.98; 95% CI: 1.61, \nc disease, OA, or RA (OR = 2.4; 95% CI: \nvical spine complaints or previous upper \n.57; 95% CI: 2.28, 9.14 and OR = 8.09; \nespectively)242; and (5) rotator cuff syn­\nI not reported).55\nhave been proposed to explain how \ncontribute to the development of CTS \nhickening surrounding flexor tendons, \ndomucinous material on the median \nfluid balance, and increased peripheral \nanalyses assessed the association be­\nthyroidism and CTS. Shiri256 analyzed \nes that controlled for potential con­\nsignificant association (effect size [ES], \n63; I2 = 50%).",
    "chunk_id": 174,
    "sentence_start": 1145,
    "sentence_end": 1147,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "udies have found the following muscu­\nisorders are associated with occurrence \nprior distal upper extremity disorders \n2.56, 4.73)92; (2) arm fracture, OA of the \nnd joint pain (OR = 1.98; 95% CI: 1.61, \nc disease, OA, or RA (OR = 2.4; 95% CI: \nvical spine complaints or previous upper \n.57; 95% CI: 2.28, 9.14 and OR = 8.09; \nespectively)242; and (5) rotator cuff syn­\nI not reported).55\nhave been proposed to explain how \ncontribute to the development of CTS \nhickening surrounding flexor tendons, \ndomucinous material on the median \nfluid balance, and increased peripheral \nanalyses assessed the association be­\nthyroidism and CTS. Shiri256 analyzed \nes that controlled for potential con­\nsignificant association (effect size [ES], \n63; I2 = 50%). van Dijk et al278 found a \n% CI: 1.0, 2.0) in their analysis of 9 ar­\nr studies157,197,211,243 not included in the \nconcurred that hypothyroidism is a risk \net al131 compared hospitalized sibling \ned with a nerve, nerve root, or plexus \nhospitalized sibling pairs without any \nsorder.",
    "chunk_id": 175,
    "sentence_start": 1146,
    "sentence_end": 1148,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Shiri256 analyzed \nes that controlled for potential con­\nsignificant association (effect size [ES], \n63; I2 = 50%). van Dijk et al278 found a \n% CI: 1.0, 2.0) in their analysis of 9 ar­\nr studies157,197,211,243 not included in the \nconcurred that hypothyroidism is a risk \net al131 compared hospitalized sibling \ned with a nerve, nerve root, or plexus \nhospitalized sibling pairs without any \nsorder. The calculated sibling risk for a \nplexus disorder when one sibling had \nng risk for CTS when one sibling had \n18 (95% CI: 2.88, 12.73). In a multi­\nased case-control study, Mattioli et al185 \nof CTS development increased 7-fold in \nhad a history of CTS (OR = 8.1; 95% CI: \nNordstrom et al208 found t ice the odds\n\n\n--- Page 15 ---\nCOLUMN 1:\nwith CTS compared with those without CTS (pooled mean \ndifference [MD], 0.036).",
    "chunk_id": 176,
    "sentence_start": 1147,
    "sentence_end": 1150,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The calculated sibling risk for a \nplexus disorder when one sibling had \nng risk for CTS when one sibling had \n18 (95% CI: 2.88, 12.73). In a multi­\nased case-control study, Mattioli et al185 \nof CTS development increased 7-fold in \nhad a history of CTS (OR = 8.1; 95% CI: \nNordstrom et al208 found t ice the odds\n\n\n--- Page 15 ---\nCOLUMN 1:\nwith CTS compared with those without CTS (pooled mean \ndifference [MD], 0.036). A square-shaped wrist was associ­\nated with CTS with a pooled OR of 4.56 (95% CI: 2.97, 6.99) \nand for those with a wrist ratio greater than 0.70 the OR was \n2.73 (95% CI: 1.49, 5.01). This trend was true for both men \nand women. One of the studies in this review, Hlebs et al,133 \nfound the sensitivity and specificity using the greater than \n0.70 wrist ratio in determining those with and without CTS \nto be excellent (90% and 82%, respectively).",
    "chunk_id": 177,
    "sentence_start": 1149,
    "sentence_end": 1153,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "This trend was true for both men \nand women. One of the studies in this review, Hlebs et al,133 \nfound the sensitivity and specificity using the greater than \n0.70 wrist ratio in determining those with and without CTS \nto be excellent (90% and 82%, respectively). In a more recent \nstudy, authors reported that a wrist ratio greater than 0.69 \nincreased the odds of having CTS (OR = 8.2; 95% CI: 1.2, \n53.2).215\nIII\nAuthors of 3 other studies (not reviewed in Shiri’s \nmeta-analysis257) found that a higher wrist ratio in­\ncreases an individual’s risk for CTS.74,193,233 The \nmean ± SD wrist ratio from these studies ranged from 0.68 ± \n0.04 to 0.75 ± 0.05 for patients with CTS and 0.65 ± 0.04 to \n0.69 ± 0.02 for those without. The cutoff value for the wrist \nratio was set at greater than 0.70 in the former 2 studies.",
    "chunk_id": 178,
    "sentence_start": 1152,
    "sentence_end": 1155,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In a more recent \nstudy, authors reported that a wrist ratio greater than 0.69 \nincreased the odds of having CTS (OR = 8.2; 95% CI: 1.2, \n53.2).215\nIII\nAuthors of 3 other studies (not reviewed in Shiri’s \nmeta-analysis257) found that a higher wrist ratio in­\ncreases an individual’s risk for CTS.74,193,233 The \nmean ± SD wrist ratio from these studies ranged from 0.68 ± \n0.04 to 0.75 ± 0.05 for patients with CTS and 0.65 ± 0.04 to \n0.69 ± 0.02 for those without. The cutoff value for the wrist \nratio was set at greater than 0.70 in the former 2 studies. Keeping the same cutoff value for men but setting the cut-off \nvalue for women at greater than 0.71, Mondelli et al193 found \nthe sensitivity ranged from 59% to 70% and specificity 48% \nto 59%. Positive and negative likelihood ratios were 1.35 to \n1.44 and 0.62 to 0.69, respectively.",
    "chunk_id": 179,
    "sentence_start": 1154,
    "sentence_end": 1157,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Keeping the same cutoff value for men but setting the cut-off \nvalue for women at greater than 0.71, Mondelli et al193 found \nthe sensitivity ranged from 59% to 70% and specificity 48% \nto 59%. Positive and negative likelihood ratios were 1.35 to \n1.44 and 0.62 to 0.69, respectively. III\nIn a later study using the same subject population, \nMondelli et al195 noted that the wrist ratio was better \nat predicting those with severe CTS than CTS in gen­\neral, especially for men. Values were calculated separately for \nmen and women and clinical versus electrophysiologic diag­\nnoses ranged from 69% to 79% for sensitivity, 48% to 59% for \nspecificity, 1.32 to 1.76 for positive likelihood ratios (+LRs), and \n0.43 to 0.65 for negative likelihood ratios (–LRs). Hand Ratio/Shape Index (Short, Wide Hand)\nIII\nAuthors of 8 studies found that those with CTS had \nsignificantly shorter and wider hands than those \nwithout CTS.",
    "chunk_id": 180,
    "sentence_start": 1156,
    "sentence_end": 1160,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Values were calculated separately for \nmen and women and clinical versus electrophysiologic diag­\nnoses ranged from 69% to 79% for sensitivity, 48% to 59% for \nspecificity, 1.32 to 1.76 for positive likelihood ratios (+LRs), and \n0.43 to 0.65 for negative likelihood ratios (–LRs). Hand Ratio/Shape Index (Short, Wide Hand)\nIII\nAuthors of 8 studies found that those with CTS had \nsignificantly shorter and wider hands than those \nwithout CTS. Three studies reported hand ra­\ntios,65,66,140 2 reported shape index,44,133 1 assessed both val­\nues,193 and 2 palm length/palm width.18,206 The mean ± SD \nhand ratio ranged from 2.00 ± 0.10 to 2.29 ± 0.12 for CTS \ncases and 2.20 ± 0.1 to 2.35 ± 0.11 for controls. Shape index \nranged from 44.85 ± 3.19 to 46.8 ± 2.4 for CTS cases and \n42.31 ± 2.7 to 45.0 ± 2.1 for controls.",
    "chunk_id": 181,
    "sentence_start": 1159,
    "sentence_end": 1162,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Three studies reported hand ra­\ntios,65,66,140 2 reported shape index,44,133 1 assessed both val­\nues,193 and 2 palm length/palm width.18,206 The mean ± SD \nhand ratio ranged from 2.00 ± 0.10 to 2.29 ± 0.12 for CTS \ncases and 2.20 ± 0.1 to 2.35 ± 0.11 for controls. Shape index \nranged from 44.85 ± 3.19 to 46.8 ± 2.4 for CTS cases and \n42.31 ± 2.7 to 45.0 ± 2.1 for controls. III\nOf the 2 studies that calculated sensitivities and \nspecificities,193,206 the best sensitivity (70.8%) was \nobtained for using the cutoff value of less than 1.17 \nin palm length/width measure. The best specificity (71.1%) \nwas found in using greater than 46.1 for shape index and less \nthan 2.17 for hand ratio in men. Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 182,
    "sentence_start": 1161,
    "sentence_end": 1169,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nWrist-Palm Ratio\nIII\nMondelli et al193-195 found that the wrist-palm ratio \nwas one of the best anthropometric indexes for pre­\ndicting those at risk for CTS development. When \ncontrolling for age and sex, the relative risk ratio was 1.52 for \nmild, 1.85 for moderate, and 2.39 for severe CTS. The wrist-\npalm ratio was better than the wrist ratio in its diagnostic \ncharacteristics. With a cut off value of greater than 0.39 for \nwomen and greater than 0.40 for men; values obtained for \nidentifying those with severe CTS ranged between 81% to \n96% for sensitivity, 59% to 75% for specificity, 2.09 to 3.85 \nfor +LR, and 0.06 to 0.25 for –LR. Identification of other \nseverity levels of CTS was not as successful.",
    "chunk_id": 183,
    "sentence_start": 1168,
    "sentence_end": 1174,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "With a cut off value of greater than 0.39 for \nwomen and greater than 0.40 for men; values obtained for \nidentifying those with severe CTS ranged between 81% to \n96% for sensitivity, 59% to 75% for specificity, 2.09 to 3.85 \nfor +LR, and 0.06 to 0.25 for –LR. Identification of other \nseverity levels of CTS was not as successful. Predictive value \nof the wrist-palm ratio was generally more accurate for men \nthan women and when using clinical diagnosis versus elec­\ntrophysiological data. The authors concluded that the wrist-\npalm ratio could be used to support a diagnosis of severe CTS. III\nKouyoumdjian et al155 found a significant positive \ncorrelation between the wrist-palm ratio and sever­\nity of CTS (P<.001) for those with moderate to se­\nvere CTS. Wrist-palm ratios in these patients ranged from \n0.38 to 0.40. No correlation was found between wrist-palm \nratio and mild CTS.",
    "chunk_id": 184,
    "sentence_start": 1173,
    "sentence_end": 1179,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Wrist-palm ratios in these patients ranged from \n0.38 to 0.40. No correlation was found between wrist-palm \nratio and mild CTS. Height\nIII\nSix studies65,80,84,185,193,200 found that individuals with \nCTS were significantly shorter in stature (P<.05). Height of patients with CTS ranged from a mean ± \nstandard deviation of 152.8 ± 4.4 cm in the study by Naka­\nmichi and Tachibana199 conducted in Japan to 174 ± 7 cm for \nDanish men in the de Krom et al80 study. Mondelli et al193 \ncalculated the sensitivity, specificity, +LR, and –LR using the \ncut-off height of less than 160.5 cm for females and less than \n171.5 cm for males to differentiate those with CTS from those \nwithout CTS. The results for the Italian women and men, \nrespectively, were a sensitivity of 65.5% and 56.7%; specificity \nof 46% and 62.3%; +LR of 1.21 and 1.5; and –LR of 0.76 and \n0.70, demonstrating poor diagnostic accuracy.",
    "chunk_id": 185,
    "sentence_start": 1178,
    "sentence_end": 1183,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Mondelli et al193 \ncalculated the sensitivity, specificity, +LR, and –LR using the \ncut-off height of less than 160.5 cm for females and less than \n171.5 cm for males to differentiate those with CTS from those \nwithout CTS. The results for the Italian women and men, \nrespectively, were a sensitivity of 65.5% and 56.7%; specificity \nof 46% and 62.3%; +LR of 1.21 and 1.5; and –LR of 0.76 and \n0.70, demonstrating poor diagnostic accuracy. Alcohol Use\nIII\nIn all 3 studies that investigated alcohol use, light \nto moderate drinking (fewer than 3 drinks per day) \neither did not increase the risk or decreased the risk \nof CTS.185,202,259 The results were conflicting for individuals \nwho reported consuming more than 3 drinks per day on aver­\nage or drinking more than 6 drinks on 1 day per week. Smoking\nII\nIII\nStudies40,69,110,242,282 including random ef­\nfects meta-analyses,228 assessing whether \nthere is an association bet een CTS and\nwith those without CTS (pooled mean \n36).",
    "chunk_id": 186,
    "sentence_start": 1182,
    "sentence_end": 1185,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Alcohol Use\nIII\nIn all 3 studies that investigated alcohol use, light \nto moderate drinking (fewer than 3 drinks per day) \neither did not increase the risk or decreased the risk \nof CTS.185,202,259 The results were conflicting for individuals \nwho reported consuming more than 3 drinks per day on aver­\nage or drinking more than 6 drinks on 1 day per week. Smoking\nII\nIII\nStudies40,69,110,242,282 including random ef­\nfects meta-analyses,228 assessing whether \nthere is an association bet een CTS and\nwith those without CTS (pooled mean \n36). A square-shaped wrist was associ­\npooled OR of 4.56 (95% CI: 2.97, 6.99) \nwrist ratio greater than 0.70 the OR was \n.01). This trend was true for both men \nhe studies in this review, Hlebs et al,133 \nand specificity using the greater than \ntermining those with and without CTS \nand 82%, respectively).",
    "chunk_id": 187,
    "sentence_start": 1184,
    "sentence_end": 1187,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "A square-shaped wrist was associ­\npooled OR of 4.56 (95% CI: 2.97, 6.99) \nwrist ratio greater than 0.70 the OR was \n.01). This trend was true for both men \nhe studies in this review, Hlebs et al,133 \nand specificity using the greater than \ntermining those with and without CTS \nand 82%, respectively). In a more recent \ned that a wrist ratio greater than 0.69 \nf having CTS (OR = 8.2; 95% CI: 1.2, \n3 other studies (not reviewed in Shiri’s \nsis257) found that a higher wrist ratio in­\nindividual’s risk for CTS.74,193,233 The \no from these studies ranged from 0.68 ± \nor patients with CTS and 0.65 ± 0.04 to \nwithout. The cutoff value for the wrist \nter than 0.70 in the former 2 studies. toff value for men but setting the cut-off \nreater than 0.71, Mondelli et al193 found \nd from 59% to 70% and specificity 48% \nnegative likelihood ratios were 1.35 to \n, respectively. udy using the same subject population, \nal195 noted that the wrist ratio was better \ng those with severe CTS than CTS in gen­\nn.",
    "chunk_id": 188,
    "sentence_start": 1186,
    "sentence_end": 1191,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "toff value for men but setting the cut-off \nreater than 0.71, Mondelli et al193 found \nd from 59% to 70% and specificity 48% \nnegative likelihood ratios were 1.35 to \n, respectively. udy using the same subject population, \nal195 noted that the wrist ratio was better \ng those with severe CTS than CTS in gen­\nn. Values were calculated separately for \nclinical versus electrophysiologic diag­\n% to 79% for sensitivity, 48% to 59% for \nfor positive likelihood ratios (+LRs), and \nive likelihood ratios (–LRs). ex (Short, Wide Hand)\n8 studies found that those with CTS had \ny shorter and wider hands than those \nTS. Three studies reported hand ra­\nd shape index,44,133 1 assessed both val­\nngth/palm width.18,206 The mean ± SD \nom 2.00 ± 0.10 to 2.29 ± 0.12 for CTS \nto 2.35 ± 0.11 for controls. Shape index \n 3.19 to 46.8 ± 2.4 for CTS cases and \n2.1 for controls.",
    "chunk_id": 189,
    "sentence_start": 1190,
    "sentence_end": 1195,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Three studies reported hand ra­\nd shape index,44,133 1 assessed both val­\nngth/palm width.18,206 The mean ± SD \nom 2.00 ± 0.10 to 2.29 ± 0.12 for CTS \nto 2.35 ± 0.11 for controls. Shape index \n 3.19 to 46.8 ± 2.4 for CTS cases and \n2.1 for controls. udies that calculated sensitivities and \n,193,206 the best sensitivity (70.8%) was \nr using the cutoff value of less than 1.17 \nh measure. The best specificity (71.1%) \neater than 46.1 for shape index and less \ntio in men\n\n\n--- Page 16 ---\nCOLUMN 1:\nPhysical Activity Level\nIII\nFive of the 6 studies87,110,115,201,208,259 analyzing the ef­\nfect of increased physical activity demonstrated a \nprotective effect with ORs or RRs ranging from \n0.40 to 0.97 in decreasing the risk for CTS.",
    "chunk_id": 190,
    "sentence_start": 1194,
    "sentence_end": 1197,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "udies that calculated sensitivities and \n,193,206 the best sensitivity (70.8%) was \nr using the cutoff value of less than 1.17 \nh measure. The best specificity (71.1%) \neater than 46.1 for shape index and less \ntio in men\n\n\n--- Page 16 ---\nCOLUMN 1:\nPhysical Activity Level\nIII\nFive of the 6 studies87,110,115,201,208,259 analyzing the ef­\nfect of increased physical activity demonstrated a \nprotective effect with ORs or RRs ranging from \n0.40 to 0.97 in decreasing the risk for CTS. Oral Contraceptive and Estrogen Use\nII\nIII\nDetermining whether oral contracep­\ntive use or estrogen replacement ther­\napy increase the risk for CTS is \ncomplicated by the fact that more recent studies242,243 did \nnot look at these medications in isolation, and results of \nstudies that separated oral contraceptives provide con­\nflicting results.69,80,96,110,155,228,248,249,255,282\nIII\nStudies that evaluated estrogen replacement ther­\napy alone demonstrated that women who under­\nwent therapy were twice as likely to require CTR \nsurgery than controls.84,265\nWomen’s Health Factors (Hysterectomy, Menopause, \nOophorectomy, Parity)\nHormonal imbalance has been hypothesized as a reason for \nvarious women’s factors increasing the risk of CTS.",
    "chunk_id": 191,
    "sentence_start": 1196,
    "sentence_end": 1198,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The best specificity (71.1%) \neater than 46.1 for shape index and less \ntio in men\n\n\n--- Page 16 ---\nCOLUMN 1:\nPhysical Activity Level\nIII\nFive of the 6 studies87,110,115,201,208,259 analyzing the ef­\nfect of increased physical activity demonstrated a \nprotective effect with ORs or RRs ranging from \n0.40 to 0.97 in decreasing the risk for CTS. Oral Contraceptive and Estrogen Use\nII\nIII\nDetermining whether oral contracep­\ntive use or estrogen replacement ther­\napy increase the risk for CTS is \ncomplicated by the fact that more recent studies242,243 did \nnot look at these medications in isolation, and results of \nstudies that separated oral contraceptives provide con­\nflicting results.69,80,96,110,155,228,248,249,255,282\nIII\nStudies that evaluated estrogen replacement ther­\napy alone demonstrated that women who under­\nwent therapy were twice as likely to require CTR \nsurgery than controls.84,265\nWomen’s Health Factors (Hysterectomy, Menopause, \nOophorectomy, Parity)\nHormonal imbalance has been hypothesized as a reason for \nvarious women’s factors increasing the risk of CTS. More spe­\ncifically, estrogen withdrawal may have a vasodilatory action \nexplaining menopausal hot flashes and raised pressure within \nthe carpal tunnel.224\nII\nIII\nThe studies that assessed the associa­\ntion between CTS and hysterectomy, \nmenopause, oophorectomy and the \nnumber of births or pregnancies report conflicting \nresults.80,84,91,100,111,185,190,224,243,249,269,298\nSummary\nThe intrinsic risk factors with the strongest link to CTS are \nobesity, age, and female sex.",
    "chunk_id": 192,
    "sentence_start": 1197,
    "sentence_end": 1199,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Oral Contraceptive and Estrogen Use\nII\nIII\nDetermining whether oral contracep­\ntive use or estrogen replacement ther­\napy increase the risk for CTS is \ncomplicated by the fact that more recent studies242,243 did \nnot look at these medications in isolation, and results of \nstudies that separated oral contraceptives provide con­\nflicting results.69,80,96,110,155,228,248,249,255,282\nIII\nStudies that evaluated estrogen replacement ther­\napy alone demonstrated that women who under­\nwent therapy were twice as likely to require CTR \nsurgery than controls.84,265\nWomen’s Health Factors (Hysterectomy, Menopause, \nOophorectomy, Parity)\nHormonal imbalance has been hypothesized as a reason for \nvarious women’s factors increasing the risk of CTS. More spe­\ncifically, estrogen withdrawal may have a vasodilatory action \nexplaining menopausal hot flashes and raised pressure within \nthe carpal tunnel.224\nII\nIII\nThe studies that assessed the associa­\ntion between CTS and hysterectomy, \nmenopause, oophorectomy and the \nnumber of births or pregnancies report conflicting \nresults.80,84,91,100,111,185,190,224,243,249,269,298\nSummary\nThe intrinsic risk factors with the strongest link to CTS are \nobesity, age, and female sex. The risk increases linearly with \nBMI and age.",
    "chunk_id": 193,
    "sentence_start": 1198,
    "sentence_end": 1200,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "More spe­\ncifically, estrogen withdrawal may have a vasodilatory action \nexplaining menopausal hot flashes and raised pressure within \nthe carpal tunnel.224\nII\nIII\nThe studies that assessed the associa­\ntion between CTS and hysterectomy, \nmenopause, oophorectomy and the \nnumber of births or pregnancies report conflicting \nresults.80,84,91,100,111,185,190,224,243,249,269,298\nSummary\nThe intrinsic risk factors with the strongest link to CTS are \nobesity, age, and female sex. The risk increases linearly with \nBMI and age. The risk doubles in individuals with a BMI \ngreater than 30 kg/m2 and in those over the age of 50. Female \nsex increases the risk by 1.5 to 4 times.",
    "chunk_id": 194,
    "sentence_start": 1199,
    "sentence_end": 1202,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The risk doubles in individuals with a BMI \ngreater than 30 kg/m2 and in those over the age of 50. Female \nsex increases the risk by 1.5 to 4 times. Intrinsic risk factors linked to CTS, but to a lesser extent \ninclude DM, OA, previous musculoskeletal disorders, es­\ntrogen replacement therapy, cardiovascular disease risk \nfactors, hypothyroidism, family history of CTS, lack of \nphysical activity, wrist ratio greater than 0.70, wrist-palm \nratio greater than 0.39, a short, wide hand, and short \nstature. Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 195,
    "sentence_start": 1201,
    "sentence_end": 1208,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nOccupational Risk Factors\nForceful Exertions, Repetitive Use, Vibration Exposure, and \nWrist Position\nI\nIn their prospective study to identify potential bio­\nmechanical risk factors, Harris-Adamson et al128 \nfound that for those with exposure to hand forces \nbetween 2.1 and 4 on the Borg CR10 scale (10-category scale \nwith ratio properties), the risk of CTS increased 60%, and in \nthose who rated their exposure as greater than 4, the risk in­\ncreased 117%. The risk of CTS increased linearly with forceful \nhand repetition rates between rates of 2.6 and 30 per minute. However, there was no association between CTS and total \nhand repetition, vibration, or wrist flexed or extended posture \ngreater than 30°.",
    "chunk_id": 196,
    "sentence_start": 1207,
    "sentence_end": 1211,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The risk of CTS increased linearly with forceful \nhand repetition rates between rates of 2.6 and 30 per minute. However, there was no association between CTS and total \nhand repetition, vibration, or wrist flexed or extended posture \ngreater than 30°. The authors cautioned against making con­\nclusions about vibration and wrist posture because vibration \nlevels were not measured (simply noted to be present or ab­\nsent), and the time workers were in extreme wrist postures \naveraged only 5.6% for flexion and 0.6% for extension. In a \nlater analysis of this same cohort, Harris-Adamson et al129 \nnoted that these biomechanical risk factors were not con­\nfounded by psychosocial risk factors or vice versa. II\nAll the level II studies which examined forceful ex­\nertions48,76,78,91,141 found them to be a substantial risk \nfactor for the development of CTS, with OR or HR \nbetween 1.14 and 19.57.",
    "chunk_id": 197,
    "sentence_start": 1210,
    "sentence_end": 1214,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In a \nlater analysis of this same cohort, Harris-Adamson et al129 \nnoted that these biomechanical risk factors were not con­\nfounded by psychosocial risk factors or vice versa. II\nAll the level II studies which examined forceful ex­\nertions48,76,78,91,141 found them to be a substantial risk \nfactor for the development of CTS, with OR or HR \nbetween 1.14 and 19.57. The risk of CTS increased linearly \nwith increasing number of forceful exertions, with the high­\nest HR found when exertions exceeded 60% of work time.124 \nVibration was a risk factor in 2 studies, with an OR of 2.02 \n(95% CI: 1.04, 3.9)91 and 2.74 (95% CI: 1.13, 6.65),76 respec­\ntively. The 2 studies on extreme wrist flexion/extension posi­\ntions reported conflicting results.76,225\nIII\nIn a meta-analysis of 9 studies of work involving \nnonneutral wrist posture, You et al302 found a posi­\ntive association with the development of CTS (rela­\ntive risk [RR] = 2.01; 95% CI: 1.65, 2.43).",
    "chunk_id": 198,
    "sentence_start": 1213,
    "sentence_end": 1216,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The risk of CTS increased linearly \nwith increasing number of forceful exertions, with the high­\nest HR found when exertions exceeded 60% of work time.124 \nVibration was a risk factor in 2 studies, with an OR of 2.02 \n(95% CI: 1.04, 3.9)91 and 2.74 (95% CI: 1.13, 6.65),76 respec­\ntively. The 2 studies on extreme wrist flexion/extension posi­\ntions reported conflicting results.76,225\nIII\nIn a meta-analysis of 9 studies of work involving \nnonneutral wrist posture, You et al302 found a posi­\ntive association with the development of CTS (rela­\ntive risk [RR] = 2.01; 95% CI: 1.65, 2.43). Studies using \nself-report of wrist postures had a higher relative risk than \nstudies where wrist position was observed (RR = 2.95 versus \n1.44). III\nBarcenilla et al32 performed a meta-analysis of \nstudies published between January 1980 to Decem­\nber 2009 relating to occupational risk factors.",
    "chunk_id": 199,
    "sentence_start": 1215,
    "sentence_end": 1218,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Studies using \nself-report of wrist postures had a higher relative risk than \nstudies where wrist position was observed (RR = 2.95 versus \n1.44). III\nBarcenilla et al32 performed a meta-analysis of \nstudies published between January 1980 to Decem­\nber 2009 relating to occupational risk factors. Based on the 37 studies, the strongest associations between \nCTS and occupational factors were (1) use of vibratory tools \n(OR = 5.4; 95% CI: 3.14, 9.31); (2) hand force (OR = 4.23; \n95% CI: 1.53, 11.68); and (3) repetition (OR = 2.26; 95% CI: \n1.73, 2.94). 6 studies87,110,115,201,208,259 analyzing the ef­\neased physical activity demonstrated a \neffect with ORs or RRs ranging from \nasing the risk for CTS.",
    "chunk_id": 200,
    "sentence_start": 1217,
    "sentence_end": 1220,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Based on the 37 studies, the strongest associations between \nCTS and occupational factors were (1) use of vibratory tools \n(OR = 5.4; 95% CI: 3.14, 9.31); (2) hand force (OR = 4.23; \n95% CI: 1.53, 11.68); and (3) repetition (OR = 2.26; 95% CI: \n1.73, 2.94). 6 studies87,110,115,201,208,259 analyzing the ef­\neased physical activity demonstrated a \neffect with ORs or RRs ranging from \nasing the risk for CTS. Estrogen Use\netermining whether oral contracep­\nve use or estrogen replacement ther­\npy increase the risk for CTS is \nact that more recent studies242,243 did \nedications in isolation, and results of \nted oral contraceptives provide con­\n6,110,155,228,248,249,255,282\nt evaluated estrogen replacement ther­\ndemonstrated that women who under­\npy were twice as likely to require CTR \n.84,265\ns (Hysterectomy, Menopause, \ne has been hypothesized as a reason for \nors increasing the risk of CTS.",
    "chunk_id": 201,
    "sentence_start": 1219,
    "sentence_end": 1221,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "6 studies87,110,115,201,208,259 analyzing the ef­\neased physical activity demonstrated a \neffect with ORs or RRs ranging from \nasing the risk for CTS. Estrogen Use\netermining whether oral contracep­\nve use or estrogen replacement ther­\npy increase the risk for CTS is \nact that more recent studies242,243 did \nedications in isolation, and results of \nted oral contraceptives provide con­\n6,110,155,228,248,249,255,282\nt evaluated estrogen replacement ther­\ndemonstrated that women who under­\npy were twice as likely to require CTR \n.84,265\ns (Hysterectomy, Menopause, \ne has been hypothesized as a reason for \nors increasing the risk of CTS. More spe­\nhdrawal may have a vasodilatory action \nal hot flashes and raised pressure within \nhe studies that assessed the associa­\non between CTS and hysterectomy, \nenopause, oophorectomy and the \nor pregnancies report conflicting \n90,224,243,249,269,298\ntors with the strongest link to CTS are \nale sex.",
    "chunk_id": 202,
    "sentence_start": 1220,
    "sentence_end": 1222,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Estrogen Use\netermining whether oral contracep­\nve use or estrogen replacement ther­\npy increase the risk for CTS is \nact that more recent studies242,243 did \nedications in isolation, and results of \nted oral contraceptives provide con­\n6,110,155,228,248,249,255,282\nt evaluated estrogen replacement ther­\ndemonstrated that women who under­\npy were twice as likely to require CTR \n.84,265\ns (Hysterectomy, Menopause, \ne has been hypothesized as a reason for \nors increasing the risk of CTS. More spe­\nhdrawal may have a vasodilatory action \nal hot flashes and raised pressure within \nhe studies that assessed the associa­\non between CTS and hysterectomy, \nenopause, oophorectomy and the \nor pregnancies report conflicting \n90,224,243,249,269,298\ntors with the strongest link to CTS are \nale sex. The risk increases linearly with \nsk doubles in individuals with a BMI \n2 and in those over the age of 50.",
    "chunk_id": 203,
    "sentence_start": 1221,
    "sentence_end": 1224,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The risk increases linearly with \nsk doubles in individuals with a BMI \n2 and in those over the age of 50. s linked to CTS, but to a lesser extent \nevious musculoskeletal disorders, es­\ntherapy, cardiovascular disease risk \ndism, family history of CTS, lack of \nst ratio greater than 0.70, wrist-palm \n0.39, a short, wide hand, and short\n\n\n--- Page 17 ---\nCOLUMN 1:\n9 and nonneutral wrist postures,110,123,163,207,223,243,262,279 are associ­\nated with CTS. Odds ratios were (1) 1.71 to 14.0 for use of vibra­\ntory tools, (2) 1.5 to 9.0 for forceful work, (3) 0.50 to 9.39 for \nrepetitive work, and (4) 1.2 to 8.7 for nonneutral wrist postures. Computer Use\nII\nTwo prospective studies188,225 with large numbers of \nparticipants failed to show increased risk of CTS in \nthose performing computer work. II\nAndersen et al15 performed a systematic review of \nsystematic reviews on the causal relationship be­\ntween CTS and computer use.",
    "chunk_id": 204,
    "sentence_start": 1223,
    "sentence_end": 1228,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Computer Use\nII\nTwo prospective studies188,225 with large numbers of \nparticipants failed to show increased risk of CTS in \nthose performing computer work. II\nAndersen et al15 performed a systematic review of \nsystematic reviews on the causal relationship be­\ntween CTS and computer use. The authors con­\ncluded that epidemiological evidence for computer use and \nthe occurrence of CTS is insufficient. III\nIn their meta-analysis of studies on computer use, \nShiri and Falah-Hassani258 noted different results \nbased on whether the control group used was com­\nposed of office workers versus individuals from the general \npopulation or other types of workers. The meta-analysis of 6 \nstudies of office workers demonstrated a positive association \nbetween CTS and frequent computer or typewriter use (OR \n= 1.34; 95% CI: 1.09, 1.65), frequent mouse use (pooled OR \n= 1.84; 95% CI: 1.18, 2.8), and longer duration of computer \nuse (OR = 1.92; 95% CI: 1.17, 3.17).",
    "chunk_id": 205,
    "sentence_start": 1227,
    "sentence_end": 1231,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "III\nIn their meta-analysis of studies on computer use, \nShiri and Falah-Hassani258 noted different results \nbased on whether the control group used was com­\nposed of office workers versus individuals from the general \npopulation or other types of workers. The meta-analysis of 6 \nstudies of office workers demonstrated a positive association \nbetween CTS and frequent computer or typewriter use (OR \n= 1.34; 95% CI: 1.09, 1.65), frequent mouse use (pooled OR \n= 1.84; 95% CI: 1.18, 2.8), and longer duration of computer \nuse (OR = 1.92; 95% CI: 1.17, 3.17). In contrast, the meta-\nanalysis of 6 studies that compared computer workers to the \ngeneral population or other types of workers, showed an in­\nverse relationship between computer use and CTS (OR = \n0.72; 95% CI: 0.58, 0.90). III\nMediouni et al189 did not find a significant associa­\ntion between computer use and CTS in their meta-\nanalysis of 6 studies, however they did not provide \ndetail of control group composition.",
    "chunk_id": 206,
    "sentence_start": 1230,
    "sentence_end": 1233,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In contrast, the meta-\nanalysis of 6 studies that compared computer workers to the \ngeneral population or other types of workers, showed an in­\nverse relationship between computer use and CTS (OR = \n0.72; 95% CI: 0.58, 0.90). III\nMediouni et al189 did not find a significant associa­\ntion between computer use and CTS in their meta-\nanalysis of 6 studies, however they did not provide \ndetail of control group composition. Mediouni et al’s189 review \nincluded only 1 study24 that was also reviewed in the Shiri and \nFalah-Hassani258 meta-analysis. III\nAl-Hashem and Khalid 5 found a significant negative \ncorrelation (r = 0.48) between the terminal latency \nindex of the median nerve and hours of weekly \nmouse use. No significant association was noted between \nweekly keyboard use and terminal latency index (r = 0.05).",
    "chunk_id": 207,
    "sentence_start": 1232,
    "sentence_end": 1236,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "III\nAl-Hashem and Khalid 5 found a significant negative \ncorrelation (r = 0.48) between the terminal latency \nindex of the median nerve and hours of weekly \nmouse use. No significant association was noted between \nweekly keyboard use and terminal latency index (r = 0.05). V\nRempel et al241 found significant increases in carpal \ntunnel pressure with typing and with wrist deviation \nin extension and radial deviation positioning on a key­\nboard when compared to static and neutral wrist positioning. Psychosocial Factors at Work\nI\nOne systematic review181 and 1 cohort study127 found \nhigh decision latitude and high social support to be \nprotecti e of CTS de elopment\nhereas high ps\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 208,
    "sentence_start": 1235,
    "sentence_end": 1242,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nchological demand increased the risk. When combining high \npsychological demand and low decision latitude (high job \nstrain), the chance of developing CTS was even higher (HR \n= 1.86; 95% CI: 1.11, 3.14) compared to workers with low de­\nmand and high control at work.127\nI\nHowever, Leclerc et al161 did not find an association \nbetween psychological demand or social support. Additionally, the presence of somatic complaints \nand depression were not predictive of those with CTS. Low \njob satisfaction was considered a potential risk factor for \nwomen (OR = 2.87; 95% CI: 1.13, 7.29) but not for men. II\nBurt et al48 concurred with level I studies that noted \nhigh job strain was associated with CTS (HR = 2.13; \n95% CI: 1.00, 4.54) in their 2-year prospective \nstudy.",
    "chunk_id": 209,
    "sentence_start": 1241,
    "sentence_end": 1247,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Low \njob satisfaction was considered a potential risk factor for \nwomen (OR = 2.87; 95% CI: 1.13, 7.29) but not for men. II\nBurt et al48 concurred with level I studies that noted \nhigh job strain was associated with CTS (HR = 2.13; \n95% CI: 1.00, 4.54) in their 2-year prospective \nstudy. Other level II studies46,106,225 were contradictory on \nwhether high psychological demand and low decision author­\nity individually were associated with CTS. Two studies sup­\nported these as risk factors and 1 found no association. No \nassociation was found in level II studies between CTS and the \nvariables of social support at work46,106,225 and job security.46,106 \nLikewise, no association was found in 1 study assessing job \nsatisfaction.106\nIII\nStudies92,110,160,207,244,262,279 are conflicting as to wheth­\ner job dissatisfaction, job demand, job strain, and \ndecision latitude are linked to CTS. Three stud­\nies92,262,279 found no association between social support at \nwork and CTS.",
    "chunk_id": 210,
    "sentence_start": 1246,
    "sentence_end": 1251,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "No \nassociation was found in level II studies between CTS and the \nvariables of social support at work46,106,225 and job security.46,106 \nLikewise, no association was found in 1 study assessing job \nsatisfaction.106\nIII\nStudies92,110,160,207,244,262,279 are conflicting as to wheth­\ner job dissatisfaction, job demand, job strain, and \ndecision latitude are linked to CTS. Three stud­\nies92,262,279 found no association between social support at \nwork and CTS. Summary\nThe occupational risk factor with the strongest association \nwith CTS is forceful hand exertions. Weaker associations are \npresent between CTS and the following factors: high psy­\nchological demand at work when paired with low decision \nauthority, vibration, prolonged off neutral wrist positioning, \nand repetitive work. Computer users do not have an increased risk of CTS when \ncompared to the general population or industrial workers.",
    "chunk_id": 211,
    "sentence_start": 1250,
    "sentence_end": 1254,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Weaker associations are \npresent between CTS and the following factors: high psy­\nchological demand at work when paired with low decision \nauthority, vibration, prolonged off neutral wrist positioning, \nand repetitive work. Computer users do not have an increased risk of CTS when \ncompared to the general population or industrial workers. However, when comparing office workers with short versus \nlonger duration of computer use, the odds of CTS are slightly \nincreased (1<ORs<2). t postures,110,123,163,207,223,243,262,279 are associ­\natios were (1) 1.71 to 14.0 for use of vibra­\n.0 for forceful work, (3) 0.50 to 9.39 for \n4) 1.2 to 8.7 for nonneutral wrist postures. ctive studies188,225 with large numbers of \ns failed to show increased risk of CTS in \nrming computer work. t al15 performed a systematic review of \nreviews on the causal relationship be­\nand computer use. The authors con­\nological evidence for computer use and \nS is insufficient.",
    "chunk_id": 212,
    "sentence_start": 1253,
    "sentence_end": 1259,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "t al15 performed a systematic review of \nreviews on the causal relationship be­\nand computer use. The authors con­\nological evidence for computer use and \nS is insufficient. ta-analysis of studies on computer use, \nalah-Hassani258 noted different results \nhether the control group used was com­\ners versus individuals from the general \nypes of workers. The meta-analysis of 6 \ners demonstrated a positive association \nquent computer or typewriter use (OR \n1.65), frequent mouse use (pooled OR \n2.8), and longer duration of computer \n% CI: 1.17, 3.17). In contrast, the meta-\nhat compared computer workers to the \nr other types of workers, showed an in­\netween computer use and CTS (OR = \n0.90). t al189 did not find a significant associa­\nn computer use and CTS in their meta-\n6 studies, however they did not provide \np composition. Mediouni et al’s189 review \n4 that was also reviewed in the Shiri and \na-analysis.",
    "chunk_id": 213,
    "sentence_start": 1258,
    "sentence_end": 1264,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "t al189 did not find a significant associa­\nn computer use and CTS in their meta-\n6 studies, however they did not provide \np composition. Mediouni et al’s189 review \n4 that was also reviewed in the Shiri and \na-analysis. and Khalid 5 found a significant negative \n(r = 0.48) between the terminal latency \ne median nerve and hours of weekly \nficant association was noted between \nand terminal latency index (r = 0.05). --- Page 18 ---\nCOLUMN 1:\npatient history, presence of risk factors, and the location and \ncharacteristics of symptoms are key aspects in differentiat­\ning CTS from other conditions. An upper quarter screening \nexamination is warranted to rule out proximal nerve lesions \nand serious medical conditions, as is a clearing exam for the \ncervical spine. Advanced imaging and electrodiagnostic studies have been \nused in the differential diagnosis of CTS.",
    "chunk_id": 214,
    "sentence_start": 1263,
    "sentence_end": 1268,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "An upper quarter screening \nexamination is warranted to rule out proximal nerve lesions \nand serious medical conditions, as is a clearing exam for the \ncervical spine. Advanced imaging and electrodiagnostic studies have been \nused in the differential diagnosis of CTS. According to the \nCPG published in 2016 by the American Academy of Ortho­\npaedic Surgeons,7 there is limited evidence for the use of a \nhandheld NCS device in the diagnosis of CTS and moder­\nate evidence to support the use of electrodiagnostic studies. In the guideline, there were recommendations discouraging \nthe routine use of diagnostic ultrasound (based on limited \nevidence) and MRI (based on moderate evidence) in CTS. While diagnostic ultrasound may have some value in identify­\ning anatomical variations, more research is needed on its use \nin individuals with CTS.",
    "chunk_id": 215,
    "sentence_start": 1267,
    "sentence_end": 1271,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In the guideline, there were recommendations discouraging \nthe routine use of diagnostic ultrasound (based on limited \nevidence) and MRI (based on moderate evidence) in CTS. While diagnostic ultrasound may have some value in identify­\ning anatomical variations, more research is needed on its use \nin individuals with CTS. DIAGNOSIS\nTests and measures used to assess individuals with com­\nplaints consistent with CTS include symptom assessment, \nprovocative tests, and sensory measures. An overview of each \nwill be reported here. Both kappa values and ICCs have been \nused to report reliability data.",
    "chunk_id": 216,
    "sentence_start": 1270,
    "sentence_end": 1274,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "An overview of each \nwill be reported here. Both kappa values and ICCs have been \nused to report reliability data. The scale for interpreting kap­\npa values is 0 to 0.20, poor; 0.21 to 0.40, fair; 0.41 to 0.60, \ngood; 0.61 to 0.80, substantial; and 0.81 or greater, almost \nperfect.159 The scale for interpreting ICCs is less than 0.40, \npoor; 0.41 to 0.75, fair to good; greater than 0.75, excellent.261\nSymptom Assessment\nKatz Hand Diagram\nThe Katz hand diagram is used to assess the presence and \ncharacteristics of symptoms.",
    "chunk_id": 217,
    "sentence_start": 1273,
    "sentence_end": 1275,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Both kappa values and ICCs have been \nused to report reliability data. The scale for interpreting kap­\npa values is 0 to 0.20, poor; 0.21 to 0.40, fair; 0.41 to 0.60, \ngood; 0.61 to 0.80, substantial; and 0.81 or greater, almost \nperfect.159 The scale for interpreting ICCs is less than 0.40, \npoor; 0.41 to 0.75, fair to good; greater than 0.75, excellent.261\nSymptom Assessment\nKatz Hand Diagram\nThe Katz hand diagram is used to assess the presence and \ncharacteristics of symptoms. Patients are asked to indicate \nthe location of their symptoms of pain, tingling, numbness, \nand/or decreased sensation on a picture of right and left \nhands.146 The likelihood of CTS based on the diagram is rated \nas follows: (1) classic CTS: symptoms in at least 2 of 3 fingers \ncompletely innervated by the median nerve (thumb, index, or \nmiddle fingers) but no symptoms in the palm or dorsal hand; \n(2) probable CTS: same as classic except palmar symptoms \nallowed, unless only on ulnar side of the hand; (3) possible \nCTS: symptoms in at least one of either the thumb, index, or \nmiddle fingers; or (4) unlikely CTS: no symptoms in any of \nthese fingers.",
    "chunk_id": 218,
    "sentence_start": 1274,
    "sentence_end": 1276,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The scale for interpreting kap­\npa values is 0 to 0.20, poor; 0.21 to 0.40, fair; 0.41 to 0.60, \ngood; 0.61 to 0.80, substantial; and 0.81 or greater, almost \nperfect.159 The scale for interpreting ICCs is less than 0.40, \npoor; 0.41 to 0.75, fair to good; greater than 0.75, excellent.261\nSymptom Assessment\nKatz Hand Diagram\nThe Katz hand diagram is used to assess the presence and \ncharacteristics of symptoms. Patients are asked to indicate \nthe location of their symptoms of pain, tingling, numbness, \nand/or decreased sensation on a picture of right and left \nhands.146 The likelihood of CTS based on the diagram is rated \nas follows: (1) classic CTS: symptoms in at least 2 of 3 fingers \ncompletely innervated by the median nerve (thumb, index, or \nmiddle fingers) but no symptoms in the palm or dorsal hand; \n(2) probable CTS: same as classic except palmar symptoms \nallowed, unless only on ulnar side of the hand; (3) possible \nCTS: symptoms in at least one of either the thumb, index, or \nmiddle fingers; or (4) unlikely CTS: no symptoms in any of \nthese fingers. II\nPriganc and Henry232 found nearly perfect intrarater \nreliability for the traditional scoring method of the \nKat hand diagram (κ\n0 95) Calfee et al50 anal\ned\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 219,
    "sentence_start": 1275,
    "sentence_end": 1277,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Patients are asked to indicate \nthe location of their symptoms of pain, tingling, numbness, \nand/or decreased sensation on a picture of right and left \nhands.146 The likelihood of CTS based on the diagram is rated \nas follows: (1) classic CTS: symptoms in at least 2 of 3 fingers \ncompletely innervated by the median nerve (thumb, index, or \nmiddle fingers) but no symptoms in the palm or dorsal hand; \n(2) probable CTS: same as classic except palmar symptoms \nallowed, unless only on ulnar side of the hand; (3) possible \nCTS: symptoms in at least one of either the thumb, index, or \nmiddle fingers; or (4) unlikely CTS: no symptoms in any of \nthese fingers. II\nPriganc and Henry232 found nearly perfect intrarater \nreliability for the traditional scoring method of the \nKat hand diagram (κ\n0 95) Calfee et al50 anal\ned\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 220,
    "sentence_start": 1276,
    "sentence_end": 1279,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\ntive test; (2) shading 2 or more of the volar distal surfaces of \nthe median innervated fingers; or (3) shading the volar distal \naspect of a specific median innervated finger (thumb, index, or \nmiddle). For intrarater reliability, mean kappa values were \n0.86 for traditional scoring, 0.97 for using 2 or more shaded \nfingers, and 0.97 for the middle finger score. Interrater reli­\nability improved slightly when using the middle finger score \n(ICC = 0.98) or when using 2 or more shaded fingers (ICC = \n0.96) versus the traditional method (ICC = 0.87). Calfee et al50 prospectively examined 1107 newly hired work­\ners from 11 companies and compared results from the Katz \nhand diagram (using the 3 scoring systems described above), \nNCS, Phalen test, and Tinel sign.",
    "chunk_id": 221,
    "sentence_start": 1278,
    "sentence_end": 1285,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Interrater reli­\nability improved slightly when using the middle finger score \n(ICC = 0.98) or when using 2 or more shaded fingers (ICC = \n0.96) versus the traditional method (ICC = 0.87). Calfee et al50 prospectively examined 1107 newly hired work­\ners from 11 companies and compared results from the Katz \nhand diagram (using the 3 scoring systems described above), \nNCS, Phalen test, and Tinel sign. The best sensitivity (67%) \nin comparison to the gold standard of abnormal nerve con­\nduction was obtained using the middle finger score. Specific­\nity, positive predictive value (PPV), and negative predictive \nvalue (NPV) were similar for all methods and ranged from \n65% to 81% for specificity, 29% to 59% for PPV, and 65% to \n87% for NPV. All scoring methods were significantly associ­\nated with Phalen test (P<.05) but not Tinel sign. Addition­\nally, all methods (except using the thumb alone) were good \npredictors of abnormal NCV.",
    "chunk_id": 222,
    "sentence_start": 1284,
    "sentence_end": 1289,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All scoring methods were significantly associ­\nated with Phalen test (P<.05) but not Tinel sign. Addition­\nally, all methods (except using the thumb alone) were good \npredictors of abnormal NCV. The best OR occurred when \nusing the middle finger (OR = 5.3; 95% CI: 2.9, 9.7). When \nusing the traditional method, scoring the diagram as pos­\nsible, probable, or classic did not change the odds of predict­\ning those with abnormal NCV (OR = 3.3-5.5). II\nIn a systematic review, MacDermid and Wessel173 \npooled data from 6 studies with 293 cases and 226 \ncontrols and showed sensitivity and specificity for \nthe Katz hand diagram for diagnosing CTS were equal to 75% \nand 72%, respectively. Specificity increased to 90% when \ncomparing to data from asymptomatic individuals but de­\ncreased to 60% when using data from symptomatic individu­\nals with negative electrodiagnostic testing. Provocative Tests\nReliability values for provocative tests are provided in TABLE \n2.",
    "chunk_id": 223,
    "sentence_start": 1288,
    "sentence_end": 1294,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Specificity increased to 90% when \ncomparing to data from asymptomatic individuals but de­\ncreased to 60% when using data from symptomatic individu­\nals with negative electrodiagnostic testing. Provocative Tests\nReliability values for provocative tests are provided in TABLE \n2. Intrarater reliability values show good reliability for the \nPhalen test,183,232 good to substantial reliability for the Ti­\nnel sign,183,232 and substantial to excellent reliability for the \ncarpal compression test.232,292 There was more variability in \ninterrater reliability for these measures with kappa values \nbetween 0.27 and 0.88.170,183,251,283 The reverse Phalen test,170 \nupper-limb neurodynamic test (ULNT),283 and the scratch-\ncollapse test41,62 show good to almost perfect interrater reli­\nability with kappa values between 0.63 and 0.98, but these \nhave no intrarater values available (TABLE 2).",
    "chunk_id": 224,
    "sentence_start": 1293,
    "sentence_end": 1295,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Provocative Tests\nReliability values for provocative tests are provided in TABLE \n2. Intrarater reliability values show good reliability for the \nPhalen test,183,232 good to substantial reliability for the Ti­\nnel sign,183,232 and substantial to excellent reliability for the \ncarpal compression test.232,292 There was more variability in \ninterrater reliability for these measures with kappa values \nbetween 0.27 and 0.88.170,183,251,283 The reverse Phalen test,170 \nupper-limb neurodynamic test (ULNT),283 and the scratch-\ncollapse test41,62 show good to almost perfect interrater reli­\nability with kappa values between 0.63 and 0.98, but these \nhave no intrarater values available (TABLE 2). Sensitivity, \nspecificity, PPVs, and NPVs are reported in TABLE 3.2,3,8,9,42,\nnce of risk factors, and the location and \nmptoms are key aspects in differentiat­\nconditions.",
    "chunk_id": 225,
    "sentence_start": 1294,
    "sentence_end": 1296,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Intrarater reliability values show good reliability for the \nPhalen test,183,232 good to substantial reliability for the Ti­\nnel sign,183,232 and substantial to excellent reliability for the \ncarpal compression test.232,292 There was more variability in \ninterrater reliability for these measures with kappa values \nbetween 0.27 and 0.88.170,183,251,283 The reverse Phalen test,170 \nupper-limb neurodynamic test (ULNT),283 and the scratch-\ncollapse test41,62 show good to almost perfect interrater reli­\nability with kappa values between 0.63 and 0.98, but these \nhave no intrarater values available (TABLE 2). Sensitivity, \nspecificity, PPVs, and NPVs are reported in TABLE 3.2,3,8,9,42,\nnce of risk factors, and the location and \nmptoms are key aspects in differentiat­\nconditions. An upper quarter screening \nnted to rule out proximal nerve lesions \nconditions, as is a clearing exam for the \nnd electrodiagnostic studies have been \nial diagnosis of CTS.",
    "chunk_id": 226,
    "sentence_start": 1295,
    "sentence_end": 1297,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Sensitivity, \nspecificity, PPVs, and NPVs are reported in TABLE 3.2,3,8,9,42,\nnce of risk factors, and the location and \nmptoms are key aspects in differentiat­\nconditions. An upper quarter screening \nnted to rule out proximal nerve lesions \nconditions, as is a clearing exam for the \nnd electrodiagnostic studies have been \nial diagnosis of CTS. According to the \n16 by the American Academy of Ortho­\nere is limited evidence for the use of a \ne in the diagnosis of CTS and moder­\nort the use of electrodiagnostic studies. e were recommendations discouraging \nagnostic ultrasound (based on limited \n(based on moderate evidence) in CTS. asound may have some value in identify­\nions, more research is needed on its use \nTS. used to assess individuals with com­\nth CTS include symptom assessment, \n sensory measures. An overview of each \nBoth kappa values and ICCs have been \nity data.",
    "chunk_id": 227,
    "sentence_start": 1296,
    "sentence_end": 1302,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "used to assess individuals with com­\nth CTS include symptom assessment, \n sensory measures. An overview of each \nBoth kappa values and ICCs have been \nity data. The scale for interpreting kap­\n0, poor; 0.21 to 0.40, fair; 0.41 to 0.60, \nubstantial; and 0.81 or greater, almost \nor interpreting ICCs is less than 0.40, \nr to good; greater than 0.75, excellent.261\nt\nam is used to assess the presence and \nmptoms.",
    "chunk_id": 228,
    "sentence_start": 1301,
    "sentence_end": 1303,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "An overview of each \nBoth kappa values and ICCs have been \nity data. The scale for interpreting kap­\n0, poor; 0.21 to 0.40, fair; 0.41 to 0.60, \nubstantial; and 0.81 or greater, almost \nor interpreting ICCs is less than 0.40, \nr to good; greater than 0.75, excellent.261\nt\nam is used to assess the presence and \nmptoms. Patients are asked to indicate \nsymptoms of pain, tingling, numbness, \nnsation on a picture of right and left \nod of CTS based on the diagram is rated \nCTS: symptoms in at least 2 of 3 fingers \nd by the median nerve (thumb, index, or \no symptoms in the palm or dorsal hand; \nme as classic except palmar symptoms \non ulnar side of the hand; (3) possible \nleast one of either the thumb, index, or \n) unlikely CTS: no symptoms in any of \nHenry232 found nearly perfect intrarater \nor the traditional scoring method of the\n\n\n--- Page 19 ---\nCOLUMN 1:\nThe following represents a brief summary of the best avail­\nable evidence for Phalen test, Tinel sign, carpal compression \ntest, reverse Phalen, ULNT, and the scratch-collapse test.",
    "chunk_id": 229,
    "sentence_start": 1302,
    "sentence_end": 1304,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The scale for interpreting kap­\n0, poor; 0.21 to 0.40, fair; 0.41 to 0.60, \nubstantial; and 0.81 or greater, almost \nor interpreting ICCs is less than 0.40, \nr to good; greater than 0.75, excellent.261\nt\nam is used to assess the presence and \nmptoms. Patients are asked to indicate \nsymptoms of pain, tingling, numbness, \nnsation on a picture of right and left \nod of CTS based on the diagram is rated \nCTS: symptoms in at least 2 of 3 fingers \nd by the median nerve (thumb, index, or \no symptoms in the palm or dorsal hand; \nme as classic except palmar symptoms \non ulnar side of the hand; (3) possible \nleast one of either the thumb, index, or \n) unlikely CTS: no symptoms in any of \nHenry232 found nearly perfect intrarater \nor the traditional scoring method of the\n\n\n--- Page 19 ---\nCOLUMN 1:\nThe following represents a brief summary of the best avail­\nable evidence for Phalen test, Tinel sign, carpal compression \ntest, reverse Phalen, ULNT, and the scratch-collapse test. Phalen Test\nI\nIn a systematic review of literature, MacDermid \nand Wessel173 pooled data from 29 studies with \nmore than 3000 cases and 1600 controls and \nshowed sensitivity and specificity equal to 68% and 73%, re­\nspectively, for confirming the presence of CTS.",
    "chunk_id": 230,
    "sentence_start": 1303,
    "sentence_end": 1305,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Patients are asked to indicate \nsymptoms of pain, tingling, numbness, \nnsation on a picture of right and left \nod of CTS based on the diagram is rated \nCTS: symptoms in at least 2 of 3 fingers \nd by the median nerve (thumb, index, or \no symptoms in the palm or dorsal hand; \nme as classic except palmar symptoms \non ulnar side of the hand; (3) possible \nleast one of either the thumb, index, or \n) unlikely CTS: no symptoms in any of \nHenry232 found nearly perfect intrarater \nor the traditional scoring method of the\n\n\n--- Page 19 ---\nCOLUMN 1:\nThe following represents a brief summary of the best avail­\nable evidence for Phalen test, Tinel sign, carpal compression \ntest, reverse Phalen, ULNT, and the scratch-collapse test. Phalen Test\nI\nIn a systematic review of literature, MacDermid \nand Wessel173 pooled data from 29 studies with \nmore than 3000 cases and 1600 controls and \nshowed sensitivity and specificity equal to 68% and 73%, re­\nspectively, for confirming the presence of CTS. Specificity \nincreased to 86% when comparing to data from asymptom­\natic individuals but decreased to 65% when using data from \nsymptomatic individuals with negative electrodiagnostic \ntesting.",
    "chunk_id": 231,
    "sentence_start": 1304,
    "sentence_end": 1306,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Phalen Test\nI\nIn a systematic review of literature, MacDermid \nand Wessel173 pooled data from 29 studies with \nmore than 3000 cases and 1600 controls and \nshowed sensitivity and specificity equal to 68% and 73%, re­\nspectively, for confirming the presence of CTS. Specificity \nincreased to 86% when comparing to data from asymptom­\natic individuals but decreased to 65% when using data from \nsymptomatic individuals with negative electrodiagnostic \ntesting. II\nThüngen et al274 calculated sensitivity and specific­\nity values using 4 different standards to confirm the \nCTS diagnosis (electrodiagnostics, clinical presen­\ntation, ultrasonography, and postoperative resolution of \nsymptoms). In all circumstances, sensitivity was high (83%-\n96%) and specificity was much lower (0%-33%) than that \nreported by MacDermid and Wessel.173\nII\nOther studies144,178,283 have also shown sensitivity \nranging from 59.7% to 77% for the Phalen test but \nvariable specificity (33%-73.9%).",
    "chunk_id": 232,
    "sentence_start": 1305,
    "sentence_end": 1308,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "II\nThüngen et al274 calculated sensitivity and specific­\nity values using 4 different standards to confirm the \nCTS diagnosis (electrodiagnostics, clinical presen­\ntation, ultrasonography, and postoperative resolution of \nsymptoms). In all circumstances, sensitivity was high (83%-\n96%) and specificity was much lower (0%-33%) than that \nreported by MacDermid and Wessel.173\nII\nOther studies144,178,283 have also shown sensitivity \nranging from 59.7% to 77% for the Phalen test but \nvariable specificity (33%-73.9%). Wainner et al283 \nexamined the diagnostic accuracy of the Phalen test in 82 \nconsecutive patients referred for an electrophysiologic exami­\nnation with suspected cervical radiculopathy or CTS, and \nlikelihood ratios (+LR = 1.30; –LR = 0.58) showed the Phalen \ntest was not persuasive in changing an initial hypothesis re­\ngarding the presence of a CTS diagnosis (TABLE 4). II\nPriganc and Henry232 compared results on provoca­\ntive tests to CTS severity measured by NCS.",
    "chunk_id": 233,
    "sentence_start": 1307,
    "sentence_end": 1310,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Wainner et al283 \nexamined the diagnostic accuracy of the Phalen test in 82 \nconsecutive patients referred for an electrophysiologic exami­\nnation with suspected cervical radiculopathy or CTS, and \nlikelihood ratios (+LR = 1.30; –LR = 0.58) showed the Phalen \ntest was not persuasive in changing an initial hypothesis re­\ngarding the presence of a CTS diagnosis (TABLE 4). II\nPriganc and Henry232 compared results on provoca­\ntive tests to CTS severity measured by NCS. There \nwas a significant positive trend for the Phalen test \n(P<.05) but not for the Tinel sign or carpal compression test, \nsuggesting patients with more severe CTS are more likely to \nhave a positive Phalen test. IV\nLaJoie et al157 showed substantial agreement when \ncomparing the results from NCS with results of the \nPhalen test (κ = 0.64).",
    "chunk_id": 234,
    "sentence_start": 1309,
    "sentence_end": 1312,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There \nwas a significant positive trend for the Phalen test \n(P<.05) but not for the Tinel sign or carpal compression test, \nsuggesting patients with more severe CTS are more likely to \nhave a positive Phalen test. IV\nLaJoie et al157 showed substantial agreement when \ncomparing the results from NCS with results of the \nPhalen test (κ = 0.64). Tinel Sign\nI\nMacDermid and Wessel173 reported sensitivity and \nspecificity for the Tinel sign of 50% and 77%, re­\nspecti el\nto confirm the presence of CTS This\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nII\nThüngen et al274 also reported higher specificity \nthan sensitivity (sensitivity, 39%-50%; specificity, \n65%-100%).",
    "chunk_id": 235,
    "sentence_start": 1311,
    "sentence_end": 1318,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nII\nThüngen et al274 also reported higher specificity \nthan sensitivity (sensitivity, 39%-50%; specificity, \n65%-100%). Additional studies reported sensitivity \nand specificity values.144,178,283 Wainner et al283 studied 2 varia­\ntions of the Tinel test. In the first (Tinel A), a reflex hammer, \nheld 15 cm above the patient’s wrist crease, was allowed to fall \nand strike the patient between the tendons of the flexor carpi \nradialis and palmaris longus, with a positive test being non­\npainful tingling sensation radiating distally along the path of \nthe median nerve. In the second test (Tinel B), the examiner \ntapped the patient with reflex hammer using mild-to-mod­\nerate force in the same location, attempting to reproduce \nsymptoms. In Tinel B, positive test criteria included discom­\nfort or pain at the wrist or radiating distally along the nerve’s \ncourse.",
    "chunk_id": 236,
    "sentence_start": 1317,
    "sentence_end": 1322,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In the second test (Tinel B), the examiner \ntapped the patient with reflex hammer using mild-to-mod­\nerate force in the same location, attempting to reproduce \nsymptoms. In Tinel B, positive test criteria included discom­\nfort or pain at the wrist or radiating distally along the nerve’s \ncourse. Likelihood ratios indicated the Tinel test results \nwould provide negligible change from pretest to posttest \nprobability (Tinel A: +LR = 0.98; 95% CI: 0.56, 1.7; –LR = \n1.0; 95% CI: 0.69, 1.5; Tinel B: +LR = 1.4; 95% CI: 0.84, 2.5; \n–LR = 0.78; 95% CI: 0.52, 1.2) (TABLE 4). IV\nLaJoie et al157 showed substantial agreement when \ncomparing the results from NCS with results from \nthe Tinel sign (κ = 0.71).",
    "chunk_id": 237,
    "sentence_start": 1321,
    "sentence_end": 1324,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Likelihood ratios indicated the Tinel test results \nwould provide negligible change from pretest to posttest \nprobability (Tinel A: +LR = 0.98; 95% CI: 0.56, 1.7; –LR = \n1.0; 95% CI: 0.69, 1.5; Tinel B: +LR = 1.4; 95% CI: 0.84, 2.5; \n–LR = 0.78; 95% CI: 0.52, 1.2) (TABLE 4). IV\nLaJoie et al157 showed substantial agreement when \ncomparing the results from NCS with results from \nthe Tinel sign (κ = 0.71). Carpal Compression Test\nII\nSensitivity and specificity values reported for the \ncarpal compression test are shown in TABLE 3.8,89,113,1\n44,168,173,178,184,196,274,283,292 The review by MacDermid \nand Wessel173 (classified as a level II based on the quality of \n17 studies reviewed for the carpal compression test) showed \nhigher specificity than sensitivity (specificity, 83%; sensitiv­\nity, 64%) when using data from asymptomatic controls.",
    "chunk_id": 238,
    "sentence_start": 1323,
    "sentence_end": 1325,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "IV\nLaJoie et al157 showed substantial agreement when \ncomparing the results from NCS with results from \nthe Tinel sign (κ = 0.71). Carpal Compression Test\nII\nSensitivity and specificity values reported for the \ncarpal compression test are shown in TABLE 3.8,89,113,1\n44,168,173,178,184,196,274,283,292 The review by MacDermid \nand Wessel173 (classified as a level II based on the quality of \n17 studies reviewed for the carpal compression test) showed \nhigher specificity than sensitivity (specificity, 83%; sensitiv­\nity, 64%) when using data from asymptomatic controls. When using data from symptomatic individuals with nega­\ntive electrodiagnostic tests, specificity decreased to 64%.173 \nLikelihood ratios show negligible changes in pretest to post­\ntest probability for the carpal compression test.283\nReverse Phalen Test\nII\nAccording to the MacDermid and Wessel173 system­\natic review, the reverse Phalen test has higher speci­\nficity (78%) than sensitivity (57%) values suggesting \nthat it might be useful for ruling in CTS but not for screening \nfor the presence of CTS.",
    "chunk_id": 239,
    "sentence_start": 1324,
    "sentence_end": 1326,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Carpal Compression Test\nII\nSensitivity and specificity values reported for the \ncarpal compression test are shown in TABLE 3.8,89,113,1\n44,168,173,178,184,196,274,283,292 The review by MacDermid \nand Wessel173 (classified as a level II based on the quality of \n17 studies reviewed for the carpal compression test) showed \nhigher specificity than sensitivity (specificity, 83%; sensitiv­\nity, 64%) when using data from asymptomatic controls. When using data from symptomatic individuals with nega­\ntive electrodiagnostic tests, specificity decreased to 64%.173 \nLikelihood ratios show negligible changes in pretest to post­\ntest probability for the carpal compression test.283\nReverse Phalen Test\nII\nAccording to the MacDermid and Wessel173 system­\natic review, the reverse Phalen test has higher speci­\nficity (78%) than sensitivity (57%) values suggesting \nthat it might be useful for ruling in CTS but not for screening \nfor the presence of CTS. IV\nGoloborod’ko113 also reported very high values for \nboth sensitivity (88%) and specificity (98%) after \nexamining 34 patients (41 hands).",
    "chunk_id": 240,
    "sentence_start": 1325,
    "sentence_end": 1327,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "When using data from symptomatic individuals with nega­\ntive electrodiagnostic tests, specificity decreased to 64%.173 \nLikelihood ratios show negligible changes in pretest to post­\ntest probability for the carpal compression test.283\nReverse Phalen Test\nII\nAccording to the MacDermid and Wessel173 system­\natic review, the reverse Phalen test has higher speci­\nficity (78%) than sensitivity (57%) values suggesting \nthat it might be useful for ruling in CTS but not for screening \nfor the presence of CTS. IV\nGoloborod’ko113 also reported very high values for \nboth sensitivity (88%) and specificity (98%) after \nexamining 34 patients (41 hands). Upper-Limb Neurodynamic Testing\nI\nII\nStudies on the sensitivity, specificity, PPVs, \nNPVs, and likelihood ratios of ULNT1 are \nreported in TABLES 3 and 4 45 280 281 283 In\nents a brief summary of the best avail­\nlen test, Tinel sign, carpal compression \nULNT, and the scratch-collapse test.",
    "chunk_id": 241,
    "sentence_start": 1326,
    "sentence_end": 1328,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "IV\nGoloborod’ko113 also reported very high values for \nboth sensitivity (88%) and specificity (98%) after \nexamining 34 patients (41 hands). Upper-Limb Neurodynamic Testing\nI\nII\nStudies on the sensitivity, specificity, PPVs, \nNPVs, and likelihood ratios of ULNT1 are \nreported in TABLES 3 and 4 45 280 281 283 In\nents a brief summary of the best avail­\nlen test, Tinel sign, carpal compression \nULNT, and the scratch-collapse test. matic review of literature, MacDermid \n173 pooled data from 29 studies with \n3000 cases and 1600 controls and \nd specificity equal to 68% and 73%, re­i\nming the presence of CTS.",
    "chunk_id": 242,
    "sentence_start": 1327,
    "sentence_end": 1329,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Upper-Limb Neurodynamic Testing\nI\nII\nStudies on the sensitivity, specificity, PPVs, \nNPVs, and likelihood ratios of ULNT1 are \nreported in TABLES 3 and 4 45 280 281 283 In\nents a brief summary of the best avail­\nlen test, Tinel sign, carpal compression \nULNT, and the scratch-collapse test. matic review of literature, MacDermid \n173 pooled data from 29 studies with \n3000 cases and 1600 controls and \nd specificity equal to 68% and 73%, re­i\nming the presence of CTS. Specificity \nen comparing to data from asymptom­\necreased to 65% when using data from \nduals with negative electrodiagnostic \nal274 calculated sensitivity and specific­\ning 4 different standards to confirm the \nsis (electrodiagnostics, clinical presen­\nphy, and postoperative resolution of \ncumstances, sensitivity was high (83%-\nwas much lower (0%-33%) than that \nmid and Wessel.173\nies144,178,283 have also shown sensitivity \nm 59.7% to 77% for the Phalen test but \necificity (33%-73.9%).",
    "chunk_id": 243,
    "sentence_start": 1328,
    "sentence_end": 1330,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "matic review of literature, MacDermid \n173 pooled data from 29 studies with \n3000 cases and 1600 controls and \nd specificity equal to 68% and 73%, re­i\nming the presence of CTS. Specificity \nen comparing to data from asymptom­\necreased to 65% when using data from \nduals with negative electrodiagnostic \nal274 calculated sensitivity and specific­\ning 4 different standards to confirm the \nsis (electrodiagnostics, clinical presen­\nphy, and postoperative resolution of \ncumstances, sensitivity was high (83%-\nwas much lower (0%-33%) than that \nmid and Wessel.173\nies144,178,283 have also shown sensitivity \nm 59.7% to 77% for the Phalen test but \necificity (33%-73.9%). Wainner et al283 \nostic accuracy of the Phalen test in 82 \neferred for an electrophysiologic exami­\ned cervical radiculopathy or CTS, and \nR = 1.30; –LR = 0.58) showed the Phalen \nve in changing an initial hypothesis re­\nof a CTS diagnosis (TABLE 4). d Henry232 compared results on provoca­\nCTS severity measured by NCS.",
    "chunk_id": 244,
    "sentence_start": 1329,
    "sentence_end": 1332,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Wainner et al283 \nostic accuracy of the Phalen test in 82 \neferred for an electrophysiologic exami­\ned cervical radiculopathy or CTS, and \nR = 1.30; –LR = 0.58) showed the Phalen \nve in changing an initial hypothesis re­\nof a CTS diagnosis (TABLE 4). d Henry232 compared results on provoca­\nCTS severity measured by NCS. There \nficant positive trend for the Phalen test \ne Tinel sign or carpal compression test, \nwith more severe CTS are more likely to \nn test. 157 showed substantial agreement when \nthe results from NCS with results of the \n(κ = 0.64). d and Wessel173 reported sensitivity and \nor the Tinel sign of 50% and 77%, re­\nto confirm the presence of CTS. This \nn based on results pooled from 27 stud­\nCTS cases and 1614 control subjects. d when using data from symptomatic \nnegati e electrodiagnostic tests (65%)\n\n\n--- Page 20 ---\nCOLUMN 1:\n–LRs range from 0.75 to 1.90. Studies used different criteria \nfor what was considered a positive test (TABLE 4).",
    "chunk_id": 245,
    "sentence_start": 1331,
    "sentence_end": 1338,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "d when using data from symptomatic \nnegati e electrodiagnostic tests (65%)\n\n\n--- Page 20 ---\nCOLUMN 1:\n–LRs range from 0.75 to 1.90. Studies used different criteria \nfor what was considered a positive test (TABLE 4). II\nBaselgia et al33 examined the ULNT1 and ULNT2a \nto determine the presence of a positive test in those \nwith and without CTS using electrodiagnostic test­\ning as the reference standard. Authors also compared results \nof ULNT to quantitative sensory testing. In individuals with \nelectrodiagnostically confirmed CTS, only 46% had a positive \nULNT. Those with negative ULNT demonstrated greater \ndysfunction in the unmyelinated nerve fibers according to \nfindings on the quantitative sensory testing.",
    "chunk_id": 246,
    "sentence_start": 1337,
    "sentence_end": 1342,
    "section_type": "references",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In individuals with \nelectrodiagnostically confirmed CTS, only 46% had a positive \nULNT. Those with negative ULNT demonstrated greater \ndysfunction in the unmyelinated nerve fibers according to \nfindings on the quantitative sensory testing. Scratch-Collapse Test\nII\nThere were 2 level II studies documenting sensitiv­\nity and specificity for the scratch collapse test, pro­\nviding conflicting results (TABLE 3).62,178\nSensory Measures\nSensory testing has been advocated in the diagnosis of CTS \nto determine the extent of nerve injury. Hypoxia (as thought \nto occur in CTS) is proposed to affect large diameter nerve \nfibers earlier than small diameter fibers, so sensory tests, \nwhich stimulate large A-beta fibers would, theoretically, be \nable to detect CTS in the early stages.",
    "chunk_id": 247,
    "sentence_start": 1341,
    "sentence_end": 1344,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Scratch-Collapse Test\nII\nThere were 2 level II studies documenting sensitiv­\nity and specificity for the scratch collapse test, pro­\nviding conflicting results (TABLE 3).62,178\nSensory Measures\nSensory testing has been advocated in the diagnosis of CTS \nto determine the extent of nerve injury. Hypoxia (as thought \nto occur in CTS) is proposed to affect large diameter nerve \nfibers earlier than small diameter fibers, so sensory tests, \nwhich stimulate large A-beta fibers would, theoretically, be \nable to detect CTS in the early stages. Results from studies on reliability and diagnostic accuracy of \nsensory instruments are reported in TABLES 5 through 7.59,67,107,\n126,139,170,171,173,182,183,274,291,300 Testing with the PCV50 computer­\nized vibrometer (Z tech Medical, Salt Lake City, UT) demon­\nstrated excellent intrarater reliability (TABLE 5). However, this \ninstrument may not be available for clinicians.",
    "chunk_id": 248,
    "sentence_start": 1343,
    "sentence_end": 1346,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Results from studies on reliability and diagnostic accuracy of \nsensory instruments are reported in TABLES 5 through 7.59,67,107,\n126,139,170,171,173,182,183,274,291,300 Testing with the PCV50 computer­\nized vibrometer (Z tech Medical, Salt Lake City, UT) demon­\nstrated excellent intrarater reliability (TABLE 5). However, this \ninstrument may not be available for clinicians. There were no \nstudies on the reliability of current perception threshold test­\ning, and, therefore, it is not included in the discussion. Main \nfindings from studies are summarized below.",
    "chunk_id": 249,
    "sentence_start": 1345,
    "sentence_end": 1348,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There were no \nstudies on the reliability of current perception threshold test­\ning, and, therefore, it is not included in the discussion. Main \nfindings from studies are summarized below. Semmes-Weinstein Monofilament Test\nI\nFollowing a systematic review, average sensitivity \nwas 72% (86% when comparing to asymptomatic \ncontrols and 70% when comparing to those with \nsymptoms and negative electrodiagnostic findings) with \nspecificity 62% for confirming the diagnosis of CTS.173\nII\nYildirim and Gunduz300 reported the greatest sen­\nsitivity (98%) occurred when any radial finger test­\ned higher than the 2 83 filament but the greatest\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 250,
    "sentence_start": 1347,
    "sentence_end": 1353,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nIV\nStudies on the correlation between Semmes-Wein­\nstein monofilament testing (SWMT) and NCS re­\nsults are conflicting. Raji et al235 found moderate \ncorrelations using the monofilament values taken from the \nthumb (r = –0.42, 0.44, and 0. 44 for distal sensory latency \n[DSL], SDL, sensory amplitude, and NCV, respectively). Cor­\nrelation coefficients using data from other fingers did not \nexceed 0.33, and only 52% of patients with positive NCS also \nhad abnormal SWMT findings when the 2.83 monofilament \nwas used as the threshold for normal. Elfar et al88 found no \nsignificant correlation between SWMT and electrodiagnostic \nstudies (correlation values not provided, P>.05) using data \nfrom the middle finger.",
    "chunk_id": 251,
    "sentence_start": 1352,
    "sentence_end": 1358,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Cor­\nrelation coefficients using data from other fingers did not \nexceed 0.33, and only 52% of patients with positive NCS also \nhad abnormal SWMT findings when the 2.83 monofilament \nwas used as the threshold for normal. Elfar et al88 found no \nsignificant correlation between SWMT and electrodiagnostic \nstudies (correlation values not provided, P>.05) using data \nfrom the middle finger. Static 2PD\nI\nII\nResults from 1 level I and 1 level II study \nshowed that 2PD (using less than 4 or less \nthan 5 mm as the normal value) has high­\ner values for specificity than sensitivity, suggesting it would \nbe more valuable for diagnostic confirmation (TABLE 5).107,274\nIII\nThe systematic review by MacDermid and Wessel173 \nalso showed higher specificity than sensitivity in \nidentifying those with CTS. Wolny et al295 compared \nthe results of 2PD testing in 100 people with a clinical diag­\nnosis of mild or moderate CTS.",
    "chunk_id": 252,
    "sentence_start": 1357,
    "sentence_end": 1360,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Static 2PD\nI\nII\nResults from 1 level I and 1 level II study \nshowed that 2PD (using less than 4 or less \nthan 5 mm as the normal value) has high­\ner values for specificity than sensitivity, suggesting it would \nbe more valuable for diagnostic confirmation (TABLE 5).107,274\nIII\nThe systematic review by MacDermid and Wessel173 \nalso showed higher specificity than sensitivity in \nidentifying those with CTS. Wolny et al295 compared \nthe results of 2PD testing in 100 people with a clinical diag­\nnosis of mild or moderate CTS. Results showed a significant \ndifference in 2PD scores tested at the radial 3 fingers between \nsymptomatic and asymptomatic fingers; however, mean 2PD \nscores were 6 mm and less, which is the accepted normal \nvalue for 2PD. IV\nElfar et al88 showed the middle finger was the most \ninvolved finger in CTS when examining 2PD scores.",
    "chunk_id": 253,
    "sentence_start": 1359,
    "sentence_end": 1362,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Results showed a significant \ndifference in 2PD scores tested at the radial 3 fingers between \nsymptomatic and asymptomatic fingers; however, mean 2PD \nscores were 6 mm and less, which is the accepted normal \nvalue for 2PD. IV\nElfar et al88 showed the middle finger was the most \ninvolved finger in CTS when examining 2PD scores. Using data from the middle finger, they compared \n2PD results with electrodiagnostic testing and found a mod­\nerate correlation (r = 0.42, P = .0003). There was no signifi­\ncant correlation between 2PD and electrodiagnostic tests for \nthe other fingers. Studies used different criteria \nred a positive test (TABLE 4). al33 examined the ULNT1 and ULNT2a \ne the presence of a positive test in those \nthout CTS using electrodiagnostic test­\ntandard. Authors also compared results \ntive sensory testing. In individuals with \nconfirmed CTS, only 46% had a positive \nnegative ULNT demonstrated greater \nnmyelinated nerve fibers according to \ntitative sensory testing.",
    "chunk_id": 254,
    "sentence_start": 1361,
    "sentence_end": 1369,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Authors also compared results \ntive sensory testing. In individuals with \nconfirmed CTS, only 46% had a positive \nnegative ULNT demonstrated greater \nnmyelinated nerve fibers according to \ntitative sensory testing. 2 level II studies documenting sensitiv­\nificity for the scratch collapse test, pro­l\nicting results (TABLE 3).62,178\nbeen advocated in the diagnosis of CTS \nnt of nerve injury. Hypoxia (as thought \nroposed to affect large diameter nerve \nmall diameter fibers, so sensory tests, \ne A-beta fibers would, theoretically, be \nthe early stages. on reliability and diagnostic accuracy of \nare reported in TABLES 5 through 7.59,67,107,\n300 Testing with the PCV50 computer­\nch Medical, Salt Lake City, UT) demon­\narater reliability (TABLE 5). However, this \ne available for clinicians. There were no \nity of current perception threshold test­\nis not included in the discussion. Main \nare summarized below.",
    "chunk_id": 255,
    "sentence_start": 1368,
    "sentence_end": 1375,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There were no \nity of current perception threshold test­\nis not included in the discussion. Main \nare summarized below. nofilament Test\na systematic review, average sensitivity\n\n\n--- Page 21 ---\nCOLUMN 1:\ntion in the diagnosis of CTS. Findings from studies on the \nreliability, diagnostic accuracy, and known-group validity of \nvibrometry in CTS are reported in TABLES 6 and 7. Results of \nstudies on concurrent validity are described below. There is a \nlack of consistent findings in the relationship between vibra­\ntion sense and NCS because authors have compared various \nfrequencies and various aspects of nerve conduction. I\nWerner et al291 compared testing frequencies of 8, \n16, 32, 63, 125, 256, and 500 Hz to results of elec­\ntrodiagnostic testing and physical exam results in \n167 manufacturing workers (15 had CTS symptoms and posi­\ntive findings on electrodiagnostic studies and were consid­\nered confirmed cases).",
    "chunk_id": 256,
    "sentence_start": 1374,
    "sentence_end": 1380,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There is a \nlack of consistent findings in the relationship between vibra­\ntion sense and NCS because authors have compared various \nfrequencies and various aspects of nerve conduction. I\nWerner et al291 compared testing frequencies of 8, \n16, 32, 63, 125, 256, and 500 Hz to results of elec­\ntrodiagnostic testing and physical exam results in \n167 manufacturing workers (15 had CTS symptoms and posi­\ntive findings on electrodiagnostic studies and were consid­\nered confirmed cases). Authors reported statistically \nsignificant relationships between vibration sense and median \nsensory peak latency and amplitude, but the magnitude of \nthe correlation coefficients were weak (r = 0.02-0.32). In ad­\ndition, these authors did not find any significant differences \nin vibration sense in those with CTS compared to a control \ngroup at 16, 32, 125, 250, or 500 Hz.",
    "chunk_id": 257,
    "sentence_start": 1379,
    "sentence_end": 1382,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Authors reported statistically \nsignificant relationships between vibration sense and median \nsensory peak latency and amplitude, but the magnitude of \nthe correlation coefficients were weak (r = 0.02-0.32). In ad­\ndition, these authors did not find any significant differences \nin vibration sense in those with CTS compared to a control \ngroup at 16, 32, 125, 250, or 500 Hz. There were differences \nat 8 and 63 Hz, but in another level I study, Checkosky et al59 \nfound a difference in CTS cases and controls at 10 Hz but no \ndifferences at 1 or 300 Hz. III\nIn a systematic review, MacDermid and Wessel173 \nfound the sensitivity and specificity for the 256 Hz \ntuning fork were 55% and 81%, respectively, for \nconfirming the CTS diagnosis.",
    "chunk_id": 258,
    "sentence_start": 1381,
    "sentence_end": 1384,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There were differences \nat 8 and 63 Hz, but in another level I study, Checkosky et al59 \nfound a difference in CTS cases and controls at 10 Hz but no \ndifferences at 1 or 300 Hz. III\nIn a systematic review, MacDermid and Wessel173 \nfound the sensitivity and specificity for the 256 Hz \ntuning fork were 55% and 81%, respectively, for \nconfirming the CTS diagnosis. Combining Individual Tests Into Test Batteries\nII\nWainner et al283 showed a balance between sensitiv­\nity (0.98) and specificity (0.54) with more than 3 \npositive tests from the following: shaking hands \nrelieves symptoms, wrist-ratio index greater than 0.67, CTQ-\nSSS greater than 1.9, diminished sensation in median nerve \ndistribution, and age greater than 45 years. Requiring all 5 to \nbe positive decreased sensitivity to 0.18 and increased speci­\nficity to 0.99. The greatest +LR (4.60; 95% CI: 2.5, 8.7) oc­\ncurred when 4 or more of these tests were positive (TABLE 4).",
    "chunk_id": 259,
    "sentence_start": 1383,
    "sentence_end": 1387,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Requiring all 5 to \nbe positive decreased sensitivity to 0.18 and increased speci­\nficity to 0.99. The greatest +LR (4.60; 95% CI: 2.5, 8.7) oc­\ncurred when 4 or more of these tests were positive (TABLE 4). III\nNtani et al209 examined results from 1806 hands in \n908 individuals. Sensory NCV was most diminished \nin hands\nith (1) e tensi e numbness or tingling in\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nIV\nFour studies supported the value of combining sin­\ngular tests into a test battery to improve diagnostic \naccuracy.",
    "chunk_id": 260,
    "sentence_start": 1386,
    "sentence_end": 1394,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nIV\nFour studies supported the value of combining sin­\ngular tests into a test battery to improve diagnostic \naccuracy. Koris et al153 included patients with con­\nfirmed CTS and individuals without CTS and found that \ncombining results across fingers from SWMT increased sen­\nsitivity from 16% to 82%, with specificity equal to 86%. Fertl \net al97 examined 47 patients (63 hands) with CTS confirmed \nby NCS and 20 healthy controls (39 hands) and found that \ncombining a timed Phalen test (timed to appearance of \nsymptoms) and the manual carpal compression test im­\nproved all diagnostic statistics resulting in a PPV of 95% and \nan NPV of 88%. In a retrospective, unblinded chart review, \nLaJoie et al157 reviewed data from 81 patients (162 wrists). Outcome measures were Tinel sign, Phalen test, and NCS \nfindings.",
    "chunk_id": 261,
    "sentence_start": 1393,
    "sentence_end": 1398,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In a retrospective, unblinded chart review, \nLaJoie et al157 reviewed data from 81 patients (162 wrists). Outcome measures were Tinel sign, Phalen test, and NCS \nfindings. When all 3 tests are positive, the probability of hav­\ning CTS was 99%; when Tinel and Phalen were positive, \nprobability was 92%; when Tinel and NCS were positive, \nprobability was 93%; and when Phalen and NCS were posi­\ntive, probability was 68%. The authors concluded that when \none of the provocative tests is positive and the other negative, \nthere is a large potential gain in probability of disease with \npositive findings from NCS. When both clinical tests are \nnegative or both are positive, there is little gain from per­\nforming NCS. Boland and Kiernan42 examined 86 hands (74 \nhands with electrophysiological changes and 12 without) and \nfound that the addition of sensory testing using the pinprick \ntesting tool does not improve the diagnostic accuracy for the \nPhalen test or modified carpal compression test.",
    "chunk_id": 262,
    "sentence_start": 1397,
    "sentence_end": 1402,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "When both clinical tests are \nnegative or both are positive, there is little gain from per­\nforming NCS. Boland and Kiernan42 examined 86 hands (74 \nhands with electrophysiological changes and 12 without) and \nfound that the addition of sensory testing using the pinprick \ntesting tool does not improve the diagnostic accuracy for the \nPhalen test or modified carpal compression test. Evidence Synthesis and Clinical Rationale\nThere is variability in the methods used in studies examining \naccuracy of diagnostic tests for CTS. This makes it difficult \nto compare study results and arrive at a recommendation \nfor one preferred test. Variability can be attributed to dif­\nferences in research designs, study settings, reference gold \nstandards used for confirming the CTS diagnosis, and test \nperformance and interpretation.",
    "chunk_id": 263,
    "sentence_start": 1401,
    "sentence_end": 1405,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "This makes it difficult \nto compare study results and arrive at a recommendation \nfor one preferred test. Variability can be attributed to dif­\nferences in research designs, study settings, reference gold \nstandards used for confirming the CTS diagnosis, and test \nperformance and interpretation. Also, the majority of stud­\nies used asymptomatic control groups leading to diagnostic \nresults distinguishing patients with CTS from nonpatients, \nwhereas a lesser number of studies used individuals with \nother upper extremity pathologies, leading to clinically rel­\nevant differential diagnosis. While diagnostic accuracy values \nfor some aforementioned tests may be acceptable, there is no \nevidence to support an isolated test or measure that can con­\nfirm the presence of CTS. The greatest likelihood ratios were \nfound when subjective and/or objective data were combined \nwith anthropometric measurements97,157,283; however, these \ndata need further validation in separate and larger samples.",
    "chunk_id": 264,
    "sentence_start": 1404,
    "sentence_end": 1409,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The greatest likelihood ratios were \nfound when subjective and/or objective data were combined \nwith anthropometric measurements97,157,283; however, these \ndata need further validation in separate and larger samples. Findings from studies on the \naccuracy, and known-group validity of \nre reported in TABLES 6 and 7. Results of \nt validity are described below. There is a \ndings in the relationship between vibra­\nbecause authors have compared various \nous aspects of nerve conduction. al291 compared testing frequencies of 8, \n125, 256, and 500 Hz to results of elec­\nic testing and physical exam results in \norkers (15 had CTS symptoms and posi­\nrodiagnostic studies and were consid­\nses). Authors reported statistically \nips between vibration sense and median \nand amplitude, but the magnitude of \ncients were weak (r = 0.02-0.32). In ad­\ndid not find any significant differences \nthose with CTS compared to a control \n250, or 500 Hz.",
    "chunk_id": 265,
    "sentence_start": 1408,
    "sentence_end": 1415,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Authors reported statistically \nips between vibration sense and median \nand amplitude, but the magnitude of \ncients were weak (r = 0.02-0.32). In ad­\ndid not find any significant differences \nthose with CTS compared to a control \n250, or 500 Hz. There were differences \nn another level I study, Checkosky et al59 \nCTS cases and controls at 10 Hz but no \n0 Hz. atic review, MacDermid and Wessel173 \nensitivity and specificity for the 256 Hz \n were 55% and 81%, respectively, for \ndiagnosis. Tests Into Test Batteries\nal283 showed a balance between sensitiv­\nnd specificity (0.54) with more than 3 \nts from the following: shaking hands \nrist-ratio index greater than 0.67, CTQ-\ndiminished sensation in median nerve \ngreater than 45 years. Requiring all 5 to \nsensitivity to 0.18 and increased speci­\neatest +LR (4.60; 95% CI: 2.5, 8.7) oc­\nre of these tests were positive (TABLE 4). 09 examined results from 1806 hands in \nuals.",
    "chunk_id": 266,
    "sentence_start": 1414,
    "sentence_end": 1420,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Requiring all 5 to \nsensitivity to 0.18 and increased speci­\neatest +LR (4.60; 95% CI: 2.5, 8.7) oc­\nre of these tests were positive (TABLE 4). 09 examined results from 1806 hands in \nuals. Sensory NCV was most diminished \nth (1) extensive numbness or tingling in \nsory distribution and (2) a positive Tinel \nThe authors recommended combining \nalen test to serve as diagnostic filters to \nwere not necessary. Authors concluded \nual demonstrated a negative Tinel sign\n\n\n--- Page 22 ---\nCOLUMN 1:\npression neuropathies. There is insufficient evidence avail­\nable to determine the usefulness of the finger flexion wrist \nflexion with compression test, flick test, Luthy sign, lunate \npress test, modified carpal compression (that used oscilla­\ntions over carpal tunnel) test, modified pneumatic compres­\nsion test, Tanzer test, tethered median nerve tests, current \nperception threshold tests, and moving 2PD test.",
    "chunk_id": 267,
    "sentence_start": 1419,
    "sentence_end": 1423,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Authors concluded \nual demonstrated a negative Tinel sign\n\n\n--- Page 22 ---\nCOLUMN 1:\npression neuropathies. There is insufficient evidence avail­\nable to determine the usefulness of the finger flexion wrist \nflexion with compression test, flick test, Luthy sign, lunate \npress test, modified carpal compression (that used oscilla­\ntions over carpal tunnel) test, modified pneumatic compres­\nsion test, Tanzer test, tethered median nerve tests, current \nperception threshold tests, and moving 2PD test. Recommendations\nA\nWhen examining a patient with suspected CTS, \nclinicians should use SWMT using the 2.83 or \n3.22 monofilament as the threshold for normal \nlight touch sensation and static 2PD on the middle finger to \naid in determining the extent of nerve damage. In those \nwith suspected moderate to severe CTS, clinicians should \nassess any radial finger using the 3.22 filament as the \nthreshold for normal. The SWMT should be repeated by the \nsame provider.",
    "chunk_id": 268,
    "sentence_start": 1422,
    "sentence_end": 1426,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In those \nwith suspected moderate to severe CTS, clinicians should \nassess any radial finger using the 3.22 filament as the \nthreshold for normal. The SWMT should be repeated by the \nsame provider. B\nIn those with suspected CTS, clinicians should use \nthe Katz hand diagram, Phalen test, Tinel sign, and \ncarpal compression test to determine the likelihood \nof CTS and interpret examination results in the context of all \nclinical exam findings. Clinicians should assess and document the patient’s age \n(older than 45 years), whether shaking their hands relieves \ntheir symptoms, sensory loss in the thumb, wrist-ratio index \n(greater than 0.67), and scores from the CTQ-SSS (greater \nthan 1.9). The presence of more than 3 of these clinical find­\nings has shown acceptable diagnostic accuracy.",
    "chunk_id": 269,
    "sentence_start": 1425,
    "sentence_end": 1429,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Clinicians should assess and document the patient’s age \n(older than 45 years), whether shaking their hands relieves \ntheir symptoms, sensory loss in the thumb, wrist-ratio index \n(greater than 0.67), and scores from the CTQ-SSS (greater \nthan 1.9). The presence of more than 3 of these clinical find­\nings has shown acceptable diagnostic accuracy. D\nThere is conflicting evidence on the diagnostic ac­\ncuracy and clinical utility of the ULNTs, scratch-\ncollapse test, and tests of vibration sense in the \ndiagnosis of CTS, and therefore no recommendation can be \nmade. Decision Tree Model\nCarpal tunnel syndrome is a common problem, and it is \nimportant that clinicians arrive at an accurate diagnosis \nso interventions can be aimed appropriately. The proposed \n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®.",
    "chunk_id": 270,
    "sentence_start": 1428,
    "sentence_end": 1435,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nes. There is insufficient evidence avail­\ne usefulness of the finger flexion wrist \nsion test, flick test, Luthy sign, lunate \ncarpal compression (that used oscilla­\nnel) test, modified pneumatic compres­\n, tethered median nerve tests, current \ntests, and moving 2PD test. mining a patient with suspected CTS, \nhould use SWMT using the 2.83 or \nfilament as the threshold for normal \nand static 2PD on the middle finger to \nthe extent of nerve damage. In those \nerate to severe CTS, clinicians should i\nnger using the 3.22 filament as the \n. The SWMT should be repeated by the \nth suspected CTS, clinicians should use \nnd diagram, Phalen test, Tinel sign, and \npression test to determine the likelihood \nexamination results in the context of all \ns.",
    "chunk_id": 271,
    "sentence_start": 1434,
    "sentence_end": 1441,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In those \nerate to severe CTS, clinicians should i\nnger using the 3.22 filament as the \n. The SWMT should be repeated by the \nth suspected CTS, clinicians should use \nnd diagram, Phalen test, Tinel sign, and \npression test to determine the likelihood \nexamination results in the context of all \ns. sess and document the patient’s age \n, whether shaking their hands relieves \nory loss in the thumb, wrist-ratio index \nand scores from the CTQ-SSS (greater \nce of more than 3 of these clinical find­\ntable diagnostic accuracy. nflicting evidence on the diagnostic ac­\nclinical utility of the ULNTs, scratch-\nst, and tests of vibration sense in the \nd therefore no recommendation can be \nome is a common problem, and it is \ncians arrive at an accurate diagnosis \nbe aimed appropriately. The proposed \nmodel provides an approach that includes information and \ntest results that should be gleaned during the examination.",
    "chunk_id": 272,
    "sentence_start": 1440,
    "sentence_end": 1444,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "nflicting evidence on the diagnostic ac­\nclinical utility of the ULNTs, scratch-\nst, and tests of vibration sense in the \nd therefore no recommendation can be \nome is a common problem, and it is \ncians arrive at an accurate diagnosis \nbe aimed appropriately. The proposed \nmodel provides an approach that includes information and \ntest results that should be gleaned during the examination. Clinicians should recognize that data gathered can help in \nconfirming the presence of the condition, aid in hypothesiz­\ning the severity, and provide baseline measures for treatment. Components include (1) examination, (2) evaluation, and (3) \nintervention strategies (FIGURE). Component 1\nThe combination of the history and physical examination \nfindings is crucial in determining the presence of CTS. Cli­\nnicians should also use the data gathered to help in deter­\nmining the severity of the pathology if possible. Determining \nseverity is a key component of patient care.",
    "chunk_id": 273,
    "sentence_start": 1443,
    "sentence_end": 1449,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Cli­\nnicians should also use the data gathered to help in deter­\nmining the severity of the pathology if possible. Determining \nseverity is a key component of patient care. The presence of \nsevere pathology (indicated by thenar muscle atrophy) would \nindicate a need for referral to a hand surgeon. Clinicians \nmay need to suggest NCS when the clinical examination is \ninconclusive. Component 2\nEvaluation of physical examination findings, as outlined in the \nFIGURE, should be consistent with the diagnosis of CTS and its \nseverity suggesting either nonsurgical or surgical management \nis indicated. The diagnosis and management of the patient’s \ncondition should be appropriately modified if the evaluation of \nclinical findings related to the musculoskeletal impairments of \nbody functioning (ICF) and associated tissue pathology/disease \n(ICD) suggest other upper extremity conditions or systemic or \nmedical disease.",
    "chunk_id": 274,
    "sentence_start": 1448,
    "sentence_end": 1453,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Component 2\nEvaluation of physical examination findings, as outlined in the \nFIGURE, should be consistent with the diagnosis of CTS and its \nseverity suggesting either nonsurgical or surgical management \nis indicated. The diagnosis and management of the patient’s \ncondition should be appropriately modified if the evaluation of \nclinical findings related to the musculoskeletal impairments of \nbody functioning (ICF) and associated tissue pathology/disease \n(ICD) suggest other upper extremity conditions or systemic or \nmedical disease. Component 3\nThis component includes a list of the evidence-based inter­\nventions available. The highest level of evidence supports the \nuse of the neutral wrist orthosis. Clinicians should consider \nall contraindications as well as costs associated with each \nintervention. This component also includes the outcomes \nassessment, or measurement of change over time.",
    "chunk_id": 275,
    "sentence_start": 1452,
    "sentence_end": 1457,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Clinicians should consider \nall contraindications as well as costs associated with each \nintervention. This component also includes the outcomes \nassessment, or measurement of change over time. The only \nvalidated tool for assessing change in individuals undergoing \nnonsurgical management is the CTQ-SSS. Other tools can be \nused, such as the CTQ-FS or DASH, but clinically important \nchange scores have not been identified in those undergoing \nnonsurgical management.",
    "chunk_id": 276,
    "sentence_start": 1456,
    "sentence_end": 1459,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The only \nvalidated tool for assessing change in individuals undergoing \nnonsurgical management is the CTQ-SSS. Other tools can be \nused, such as the CTQ-FS or DASH, but clinically important \nchange scores have not been identified in those undergoing \nnonsurgical management. --- Page 23 ---\nCOLUMN 1:\nHistory\n• Medical history \n• Risk factor assessment\n• Medical or diagnostic testing, including \nelectrodiagnostics\n• Social and work history\n• Symptom assessment, including duration, \nfrequency, intensity, and type\n• Symptom onset (rapid or gradual)\n• Presence of nocturnal symptoms\n• Location of symptoms (is sensation over \nscaphoid tubercle spared?)\n•  Katz hand diagram (B)*\n• Activities that increase/decrease symptoms\n• Chief complaint(s), including \nimpairments, activity limitations, and \nparticipation restrictions\n• Prior treatment and its success\n• CTQ-SSS (B)*\n• CTQ-FS or DASH questionnaire (B)\nMedical Screening\n• Cardiovascular and pulmonary system \n(heart rate, blood pressure, etc)\n• Integumentary system (trophic changes, \nscars, discoloration, swelling)\n• Musculoskeletal system (cervical and \nupper-quarter movement analysis, \npostural assessment, presence of atrophy, \nespecially thenar)\n• Neuromuscular system (upper-quarter \nscreening, including dermatomes and \nsensation in terminal branch distributions, \nmyotomes, deep tendon reﬂexes, and \npathological reﬂexes)\n• Cognition and communication\nTests and Measures\nWhen CTS is suspected:\n• Phalen test (B)\n•  Carpal compression test (B)\n• Assess for presence of Tinel sign (B)\n• Monoﬁlament threshold testing (A)\n• Static 2PD (A)\n• Baseline grip and 3-point or tip pinch \nstrength (C)\n• Dellon-modiﬁed Moberg pick-up test or \nPurdue Pegboard to assess dexterity (C)\n• Test combination looking for 3 or more of \nthe following: age >45 y, shaking hands \nprovides relief, wrist ratio greater than \n0.67, CTQ-SSS greater than 1.9, \ndiminished light touch in median nerve \ndistribution (B)\nComponent 2: Evaluation\nFollowing the examination, therapists should choose 1 of the following actions\nPatient/client is appropriate for therapy \nservices and an evidence-based \nintervention is provided\n• Examination data show ﬁndings \nconsistent with mild to moderate CTS, and \nthe patient/client agrees with a trial of \nnonsurgical management\n• Examination data show ﬁndings consistent \nwith severe CTS, and (1) the patient/client \nhas seen a surgeon, who has decided the \nindividual is not a surgical candidate due \nto comorbidities; (2) the patient/client is \nawaiting surgery; or (3) the patient/client \nhas refused surgery after counseling on \nthe negative eﬀects of long-standing nerve \ncompression\nPatient/client is appropriate for therapy but \nwould also beneﬁt from a referral to a \nphysician\n• Examination data suggest any severity of \nCTS, with concurrent signs and symptoms \nof another condition that warrant further \nmedical testing.",
    "chunk_id": 277,
    "sentence_start": 1458,
    "sentence_end": 1460,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Other tools can be \nused, such as the CTQ-FS or DASH, but clinically important \nchange scores have not been identified in those undergoing \nnonsurgical management. --- Page 23 ---\nCOLUMN 1:\nHistory\n• Medical history \n• Risk factor assessment\n• Medical or diagnostic testing, including \nelectrodiagnostics\n• Social and work history\n• Symptom assessment, including duration, \nfrequency, intensity, and type\n• Symptom onset (rapid or gradual)\n• Presence of nocturnal symptoms\n• Location of symptoms (is sensation over \nscaphoid tubercle spared?)\n•  Katz hand diagram (B)*\n• Activities that increase/decrease symptoms\n• Chief complaint(s), including \nimpairments, activity limitations, and \nparticipation restrictions\n• Prior treatment and its success\n• CTQ-SSS (B)*\n• CTQ-FS or DASH questionnaire (B)\nMedical Screening\n• Cardiovascular and pulmonary system \n(heart rate, blood pressure, etc)\n• Integumentary system (trophic changes, \nscars, discoloration, swelling)\n• Musculoskeletal system (cervical and \nupper-quarter movement analysis, \npostural assessment, presence of atrophy, \nespecially thenar)\n• Neuromuscular system (upper-quarter \nscreening, including dermatomes and \nsensation in terminal branch distributions, \nmyotomes, deep tendon reﬂexes, and \npathological reﬂexes)\n• Cognition and communication\nTests and Measures\nWhen CTS is suspected:\n• Phalen test (B)\n•  Carpal compression test (B)\n• Assess for presence of Tinel sign (B)\n• Monoﬁlament threshold testing (A)\n• Static 2PD (A)\n• Baseline grip and 3-point or tip pinch \nstrength (C)\n• Dellon-modiﬁed Moberg pick-up test or \nPurdue Pegboard to assess dexterity (C)\n• Test combination looking for 3 or more of \nthe following: age >45 y, shaking hands \nprovides relief, wrist ratio greater than \n0.67, CTQ-SSS greater than 1.9, \ndiminished light touch in median nerve \ndistribution (B)\nComponent 2: Evaluation\nFollowing the examination, therapists should choose 1 of the following actions\nPatient/client is appropriate for therapy \nservices and an evidence-based \nintervention is provided\n• Examination data show ﬁndings \nconsistent with mild to moderate CTS, and \nthe patient/client agrees with a trial of \nnonsurgical management\n• Examination data show ﬁndings consistent \nwith severe CTS, and (1) the patient/client \nhas seen a surgeon, who has decided the \nindividual is not a surgical candidate due \nto comorbidities; (2) the patient/client is \nawaiting surgery; or (3) the patient/client \nhas refused surgery after counseling on \nthe negative eﬀects of long-standing nerve \ncompression\nPatient/client is appropriate for therapy but \nwould also beneﬁt from a referral to a \nphysician\n• Examination data suggest any severity of \nCTS, with concurrent signs and symptoms \nof another condition that warrant further \nmedical testing. In these individuals, CTS \ntreatment may commence as long as \nthere would be no contraindications from \nthe suspected concurrent condition\n• Examination data suggest signs and \nsymptoms consistent with severe CTS and \nthe patient/client chooses a trial of \nnonsurgical intervention while awaiting a \nphysician visit\nPatient is not appropriate for therapy and \nrequires referral to another provider\n• Examination data reveal suspected \nneuromuscular diagnosis other than CTS \nthat is beyond the scope of physical \ntherapy treatment\nFIGURE.",
    "chunk_id": 278,
    "sentence_start": 1459,
    "sentence_end": 1461,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "--- Page 23 ---\nCOLUMN 1:\nHistory\n• Medical history \n• Risk factor assessment\n• Medical or diagnostic testing, including \nelectrodiagnostics\n• Social and work history\n• Symptom assessment, including duration, \nfrequency, intensity, and type\n• Symptom onset (rapid or gradual)\n• Presence of nocturnal symptoms\n• Location of symptoms (is sensation over \nscaphoid tubercle spared?)\n•  Katz hand diagram (B)*\n• Activities that increase/decrease symptoms\n• Chief complaint(s), including \nimpairments, activity limitations, and \nparticipation restrictions\n• Prior treatment and its success\n• CTQ-SSS (B)*\n• CTQ-FS or DASH questionnaire (B)\nMedical Screening\n• Cardiovascular and pulmonary system \n(heart rate, blood pressure, etc)\n• Integumentary system (trophic changes, \nscars, discoloration, swelling)\n• Musculoskeletal system (cervical and \nupper-quarter movement analysis, \npostural assessment, presence of atrophy, \nespecially thenar)\n• Neuromuscular system (upper-quarter \nscreening, including dermatomes and \nsensation in terminal branch distributions, \nmyotomes, deep tendon reﬂexes, and \npathological reﬂexes)\n• Cognition and communication\nTests and Measures\nWhen CTS is suspected:\n• Phalen test (B)\n•  Carpal compression test (B)\n• Assess for presence of Tinel sign (B)\n• Monoﬁlament threshold testing (A)\n• Static 2PD (A)\n• Baseline grip and 3-point or tip pinch \nstrength (C)\n• Dellon-modiﬁed Moberg pick-up test or \nPurdue Pegboard to assess dexterity (C)\n• Test combination looking for 3 or more of \nthe following: age >45 y, shaking hands \nprovides relief, wrist ratio greater than \n0.67, CTQ-SSS greater than 1.9, \ndiminished light touch in median nerve \ndistribution (B)\nComponent 2: Evaluation\nFollowing the examination, therapists should choose 1 of the following actions\nPatient/client is appropriate for therapy \nservices and an evidence-based \nintervention is provided\n• Examination data show ﬁndings \nconsistent with mild to moderate CTS, and \nthe patient/client agrees with a trial of \nnonsurgical management\n• Examination data show ﬁndings consistent \nwith severe CTS, and (1) the patient/client \nhas seen a surgeon, who has decided the \nindividual is not a surgical candidate due \nto comorbidities; (2) the patient/client is \nawaiting surgery; or (3) the patient/client \nhas refused surgery after counseling on \nthe negative eﬀects of long-standing nerve \ncompression\nPatient/client is appropriate for therapy but \nwould also beneﬁt from a referral to a \nphysician\n• Examination data suggest any severity of \nCTS, with concurrent signs and symptoms \nof another condition that warrant further \nmedical testing. In these individuals, CTS \ntreatment may commence as long as \nthere would be no contraindications from \nthe suspected concurrent condition\n• Examination data suggest signs and \nsymptoms consistent with severe CTS and \nthe patient/client chooses a trial of \nnonsurgical intervention while awaiting a \nphysician visit\nPatient is not appropriate for therapy and \nrequires referral to another provider\n• Examination data reveal suspected \nneuromuscular diagnosis other than CTS \nthat is beyond the scope of physical \ntherapy treatment\nFIGURE. Decision tree model.",
    "chunk_id": 279,
    "sentence_start": 1460,
    "sentence_end": 1462,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In these individuals, CTS \ntreatment may commence as long as \nthere would be no contraindications from \nthe suspected concurrent condition\n• Examination data suggest signs and \nsymptoms consistent with severe CTS and \nthe patient/client chooses a trial of \nnonsurgical intervention while awaiting a \nphysician visit\nPatient is not appropriate for therapy and \nrequires referral to another provider\n• Examination data reveal suspected \nneuromuscular diagnosis other than CTS \nthat is beyond the scope of physical \ntherapy treatment\nFIGURE. Decision tree model. *Letters in parentheses reflect the grade of evidence on which the recommendation for each item is based: (A) strong evidence, (B) moderate \nevidence, (C) weak evidence, (D) conflicting evidence, (E) theoretical/foundational evidence, and (F) expert opinion. Figure continues on page CPG24. Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 280,
    "sentence_start": 1461,
    "sentence_end": 1466,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 281,
    "sentence_start": 1465,
    "sentence_end": 1469,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nment\nstic testing, including \ns\nstory\nment, including duration, \nty, and type\napid or gradual)\nrnal symptoms\noms (is sensation over \nspared?)\nm (B)*\nease/decrease symptoms\n), including \nvity limitations, and \nictions\nnd its success\nquestionnaire (B)\nMedical Screening\n• Cardiovascular and pulmonary system \n(heart rate, blood pressure, etc)\n• Integumentary system (trophic changes, \nscars, discoloration, swelling)\n• Musculoskeletal system (cervical and \nupper-quarter movement analysis, \npostural assessment, presence of atrophy, \nespecially thenar)\n• Neuromuscular system (upper-quarter \nscreening, including dermatomes and \nsensation in terminal branch distributions, \nmyotomes, deep tendon reﬂexes, and \npathological reﬂexes)\n• Cognition and communication\nTests and Measures\nWhen CTS is suspected:\n• Phalen test (B)\n•  Carpal compression test (B)\n• Assess for presence of Tinel sign (B)\n• Monoﬁlament threshold testing (A)\n• Static 2PD (A)\n• Baseline grip and 3-point or tip pinch \nstrength (C)\n• Dellon-modiﬁed Moberg pick-up test or \nPurdue Pegboard to assess dexterity (C)\n• Test combination looking for 3 or more of \nthe following: age >45 y, shaking hands \nprovides relief, wrist ratio greater than \n0.67, CTQ-SSS greater than 1.9, \ndiminished light touch in median nerve \ndistribution (B)\nComponent 1: Examination\nComponent 2: Evaluation\nation, therapists should choose 1 of the following actions\nropriate for therapy \nvidence-based \novided\nshow ﬁndings \nld to moderate CTS, and \nagrees with a trial of \ngement\nshow ﬁndings consistent \nnd (1) the patient/client \nn, who has decided the \nsurgical candidate due \n(2) the patient/client is \nor (3) the patient/client \nry after counseling on \ns of long-standing nerve \nPatient/client is appropriate for therapy but \nwould also beneﬁt from a referral to a \nphysician\n• Examination data suggest any severity of \nCTS, with concurrent signs and symptoms \nof another condition that warrant further \nmedical testing.",
    "chunk_id": 282,
    "sentence_start": 1468,
    "sentence_end": 1470,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nment\nstic testing, including \ns\nstory\nment, including duration, \nty, and type\napid or gradual)\nrnal symptoms\noms (is sensation over \nspared?)\nm (B)*\nease/decrease symptoms\n), including \nvity limitations, and \nictions\nnd its success\nquestionnaire (B)\nMedical Screening\n• Cardiovascular and pulmonary system \n(heart rate, blood pressure, etc)\n• Integumentary system (trophic changes, \nscars, discoloration, swelling)\n• Musculoskeletal system (cervical and \nupper-quarter movement analysis, \npostural assessment, presence of atrophy, \nespecially thenar)\n• Neuromuscular system (upper-quarter \nscreening, including dermatomes and \nsensation in terminal branch distributions, \nmyotomes, deep tendon reﬂexes, and \npathological reﬂexes)\n• Cognition and communication\nTests and Measures\nWhen CTS is suspected:\n• Phalen test (B)\n•  Carpal compression test (B)\n• Assess for presence of Tinel sign (B)\n• Monoﬁlament threshold testing (A)\n• Static 2PD (A)\n• Baseline grip and 3-point or tip pinch \nstrength (C)\n• Dellon-modiﬁed Moberg pick-up test or \nPurdue Pegboard to assess dexterity (C)\n• Test combination looking for 3 or more of \nthe following: age >45 y, shaking hands \nprovides relief, wrist ratio greater than \n0.67, CTQ-SSS greater than 1.9, \ndiminished light touch in median nerve \ndistribution (B)\nComponent 1: Examination\nComponent 2: Evaluation\nation, therapists should choose 1 of the following actions\nropriate for therapy \nvidence-based \novided\nshow ﬁndings \nld to moderate CTS, and \nagrees with a trial of \ngement\nshow ﬁndings consistent \nnd (1) the patient/client \nn, who has decided the \nsurgical candidate due \n(2) the patient/client is \nor (3) the patient/client \nry after counseling on \ns of long-standing nerve \nPatient/client is appropriate for therapy but \nwould also beneﬁt from a referral to a \nphysician\n• Examination data suggest any severity of \nCTS, with concurrent signs and symptoms \nof another condition that warrant further \nmedical testing. In these individuals, CTS \ntreatment may commence as long as \nthere would be no contraindications from \nthe suspected concurrent condition\n• Examination data suggest signs and \nsymptoms consistent with severe CTS and \nthe patient/client chooses a trial of \nnonsurgical intervention while awaiting a \nphysician visit\nPatient is not appropriate for therapy and \nrequires referral to another provider\n• Examination data reveal suspected \nneuromuscular diagnosis other than CTS \nthat is beyond the scope of physical \ntherapy treatment\nFigure continues on page CPG24.",
    "chunk_id": 283,
    "sentence_start": 1469,
    "sentence_end": 1471,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nment\nstic testing, including \ns\nstory\nment, including duration, \nty, and type\napid or gradual)\nrnal symptoms\noms (is sensation over \nspared?)\nm (B)*\nease/decrease symptoms\n), including \nvity limitations, and \nictions\nnd its success\nquestionnaire (B)\nMedical Screening\n• Cardiovascular and pulmonary system \n(heart rate, blood pressure, etc)\n• Integumentary system (trophic changes, \nscars, discoloration, swelling)\n• Musculoskeletal system (cervical and \nupper-quarter movement analysis, \npostural assessment, presence of atrophy, \nespecially thenar)\n• Neuromuscular system (upper-quarter \nscreening, including dermatomes and \nsensation in terminal branch distributions, \nmyotomes, deep tendon reﬂexes, and \npathological reﬂexes)\n• Cognition and communication\nTests and Measures\nWhen CTS is suspected:\n• Phalen test (B)\n•  Carpal compression test (B)\n• Assess for presence of Tinel sign (B)\n• Monoﬁlament threshold testing (A)\n• Static 2PD (A)\n• Baseline grip and 3-point or tip pinch \nstrength (C)\n• Dellon-modiﬁed Moberg pick-up test or \nPurdue Pegboard to assess dexterity (C)\n• Test combination looking for 3 or more of \nthe following: age >45 y, shaking hands \nprovides relief, wrist ratio greater than \n0.67, CTQ-SSS greater than 1.9, \ndiminished light touch in median nerve \ndistribution (B)\nComponent 1: Examination\nComponent 2: Evaluation\nation, therapists should choose 1 of the following actions\nropriate for therapy \nvidence-based \novided\nshow ﬁndings \nld to moderate CTS, and \nagrees with a trial of \ngement\nshow ﬁndings consistent \nnd (1) the patient/client \nn, who has decided the \nsurgical candidate due \n(2) the patient/client is \nor (3) the patient/client \nry after counseling on \ns of long-standing nerve \nPatient/client is appropriate for therapy but \nwould also beneﬁt from a referral to a \nphysician\n• Examination data suggest any severity of \nCTS, with concurrent signs and symptoms \nof another condition that warrant further \nmedical testing. In these individuals, CTS \ntreatment may commence as long as \nthere would be no contraindications from \nthe suspected concurrent condition\n• Examination data suggest signs and \nsymptoms consistent with severe CTS and \nthe patient/client chooses a trial of \nnonsurgical intervention while awaiting a \nphysician visit\nPatient is not appropriate for therapy and \nrequires referral to another provider\n• Examination data reveal suspected \nneuromuscular diagnosis other than CTS \nthat is beyond the scope of physical \ntherapy treatment\nFigure continues on page CPG24. --- Page 24 ---\nCOLUMN 1:\nRe-evaluate\nPatient goals met\nDischarge to self-management\nNot improving/worsening occurs\nRefer\n• Consultation with other providers \nAdjust/modify interventions\n• Patient goals met\nSecondary Interventions (C)\nAssistive technology\n• May counsel patients/clients on limiting mouse use and ﬁnding a keyboard that limits key-strike force\nThermotherapy\n• May consider a trial of superﬁcial heat when patients/clients are able to understand the possibility of negative eﬀects of superﬁcial heat on \nsensory-impaired tissue and on acute inﬂammation\nElectrotherapy\n• May consider a trial of interferential current during supervised therapy sessions for short-term pain relief\nPhonophoresis\n• May consider a trial of phonophoresis during supervised therapy sessions\nManual therapy\n• May implement based on patient data from the examination\nStretching\n• May add lumbrical or general stretching to a program that includes an orthosis\nFIGURE (CONTINUED).",
    "chunk_id": 284,
    "sentence_start": 1470,
    "sentence_end": 1472,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In these individuals, CTS \ntreatment may commence as long as \nthere would be no contraindications from \nthe suspected concurrent condition\n• Examination data suggest signs and \nsymptoms consistent with severe CTS and \nthe patient/client chooses a trial of \nnonsurgical intervention while awaiting a \nphysician visit\nPatient is not appropriate for therapy and \nrequires referral to another provider\n• Examination data reveal suspected \nneuromuscular diagnosis other than CTS \nthat is beyond the scope of physical \ntherapy treatment\nFigure continues on page CPG24. --- Page 24 ---\nCOLUMN 1:\nRe-evaluate\nPatient goals met\nDischarge to self-management\nNot improving/worsening occurs\nRefer\n• Consultation with other providers \nAdjust/modify interventions\n• Patient goals met\nSecondary Interventions (C)\nAssistive technology\n• May counsel patients/clients on limiting mouse use and ﬁnding a keyboard that limits key-strike force\nThermotherapy\n• May consider a trial of superﬁcial heat when patients/clients are able to understand the possibility of negative eﬀects of superﬁcial heat on \nsensory-impaired tissue and on acute inﬂammation\nElectrotherapy\n• May consider a trial of interferential current during supervised therapy sessions for short-term pain relief\nPhonophoresis\n• May consider a trial of phonophoresis during supervised therapy sessions\nManual therapy\n• May implement based on patient data from the examination\nStretching\n• May add lumbrical or general stretching to a program that includes an orthosis\nFIGURE (CONTINUED). Decision tree model.",
    "chunk_id": 285,
    "sentence_start": 1471,
    "sentence_end": 1473,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "--- Page 24 ---\nCOLUMN 1:\nRe-evaluate\nPatient goals met\nDischarge to self-management\nNot improving/worsening occurs\nRefer\n• Consultation with other providers \nAdjust/modify interventions\n• Patient goals met\nSecondary Interventions (C)\nAssistive technology\n• May counsel patients/clients on limiting mouse use and ﬁnding a keyboard that limits key-strike force\nThermotherapy\n• May consider a trial of superﬁcial heat when patients/clients are able to understand the possibility of negative eﬀects of superﬁcial heat on \nsensory-impaired tissue and on acute inﬂammation\nElectrotherapy\n• May consider a trial of interferential current during supervised therapy sessions for short-term pain relief\nPhonophoresis\n• May consider a trial of phonophoresis during supervised therapy sessions\nManual therapy\n• May implement based on patient data from the examination\nStretching\n• May add lumbrical or general stretching to a program that includes an orthosis\nFIGURE (CONTINUED). Decision tree model. *Letters in parentheses reflect the grade of evidence on which the recommendation for each item is based: (A) strong evidence, \n(B) moderate evidence, (C) weak evidence, (D) conflicting evidence, (E) theoretical/foundational evidence, and (F) expert opinion.",
    "chunk_id": 286,
    "sentence_start": 1472,
    "sentence_end": 1474,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Decision tree model. *Letters in parentheses reflect the grade of evidence on which the recommendation for each item is based: (A) strong evidence, \n(B) moderate evidence, (C) weak evidence, (D) conflicting evidence, (E) theoretical/foundational evidence, and (F) expert opinion. Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nRe-evaluate\nPatient goals met\nDischarge to self-management\nNot improving/worsening occurs\nRefer\n• Consultation with other providers \nComponent 3: Intervention Strategies\nPrimary Interventions (B) \nOrthoses\n• Patients/clients should be instructed in the use of a neutral-positioned wrist orthosis for night wear.",
    "chunk_id": 287,
    "sentence_start": 1473,
    "sentence_end": 1480,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nRe-evaluate\nPatient goals met\nDischarge to self-management\nNot improving/worsening occurs\nRefer\n• Consultation with other providers \nComponent 3: Intervention Strategies\nPrimary Interventions (B) \nOrthoses\n• Patients/clients should be instructed in the use of a neutral-positioned wrist orthosis for night wear. Treatment should also include counseling on \npathology, risk identiﬁcation, symptom self-management, and postures/activities that aggravate symptoms.",
    "chunk_id": 288,
    "sentence_start": 1479,
    "sentence_end": 1481,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nRe-evaluate\nPatient goals met\nDischarge to self-management\nNot improving/worsening occurs\nRefer\n• Consultation with other providers \nComponent 3: Intervention Strategies\nPrimary Interventions (B) \nOrthoses\n• Patients/clients should be instructed in the use of a neutral-positioned wrist orthosis for night wear. Treatment should also include counseling on \npathology, risk identiﬁcation, symptom self-management, and postures/activities that aggravate symptoms. Duration of orthosis use may be increased \nto include daytime wear, or the metacarpophalangeal joints may be included if nighttime wrist-neutral positioning alone does not provide suﬃcient relief\nSecondary Interventions (C)\nAssistive technology\n• May counsel patients/clients on limiting mouse use and ﬁnding a keyboard that limits key-strike force\nThermotherapy\n• May consider a trial of superﬁcial heat when patients/clients are able to understand the possibility of negative eﬀects of superﬁcial heat on \nsensory-impaired tissue and on acute inﬂammation\nElectrotherapy\n• May consider a trial of interferential current during supervised therapy sessions for short-term pain relief\nPhonophoresis\n• May consider a trial of phonophoresis during supervised therapy sessions\nManual therapy\n• May implement based on patient data from the examination\nStretching\n• May add lumbrical or general stretching to a program that includes an orthosis\n\n\n--- Page 25 ---\nCOLUMN 1:\nAbbreviations: ICC, intraclass correlation coefficient; ULNT, upper-limb neurodynamic test.",
    "chunk_id": 289,
    "sentence_start": 1480,
    "sentence_end": 1482,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Treatment should also include counseling on \npathology, risk identiﬁcation, symptom self-management, and postures/activities that aggravate symptoms. Duration of orthosis use may be increased \nto include daytime wear, or the metacarpophalangeal joints may be included if nighttime wrist-neutral positioning alone does not provide suﬃcient relief\nSecondary Interventions (C)\nAssistive technology\n• May counsel patients/clients on limiting mouse use and ﬁnding a keyboard that limits key-strike force\nThermotherapy\n• May consider a trial of superﬁcial heat when patients/clients are able to understand the possibility of negative eﬀects of superﬁcial heat on \nsensory-impaired tissue and on acute inﬂammation\nElectrotherapy\n• May consider a trial of interferential current during supervised therapy sessions for short-term pain relief\nPhonophoresis\n• May consider a trial of phonophoresis during supervised therapy sessions\nManual therapy\n• May implement based on patient data from the examination\nStretching\n• May add lumbrical or general stretching to a program that includes an orthosis\n\n\n--- Page 25 ---\nCOLUMN 1:\nAbbreviations: ICC, intraclass correlation coefficient; ULNT, upper-limb neurodynamic test. *No reliability data were available for the wrist flexion with compression (Phalen test with compression), Gilliatt pneumatic compression (tourniquet), and hand elevation tests.",
    "chunk_id": 290,
    "sentence_start": 1481,
    "sentence_end": 1483,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Duration of orthosis use may be increased \nto include daytime wear, or the metacarpophalangeal joints may be included if nighttime wrist-neutral positioning alone does not provide suﬃcient relief\nSecondary Interventions (C)\nAssistive technology\n• May counsel patients/clients on limiting mouse use and ﬁnding a keyboard that limits key-strike force\nThermotherapy\n• May consider a trial of superﬁcial heat when patients/clients are able to understand the possibility of negative eﬀects of superﬁcial heat on \nsensory-impaired tissue and on acute inﬂammation\nElectrotherapy\n• May consider a trial of interferential current during supervised therapy sessions for short-term pain relief\nPhonophoresis\n• May consider a trial of phonophoresis during supervised therapy sessions\nManual therapy\n• May implement based on patient data from the examination\nStretching\n• May add lumbrical or general stretching to a program that includes an orthosis\n\n\n--- Page 25 ---\nCOLUMN 1:\nAbbreviations: ICC, intraclass correlation coefficient; ULNT, upper-limb neurodynamic test. *No reliability data were available for the wrist flexion with compression (Phalen test with compression), Gilliatt pneumatic compression (tourniquet), and hand elevation tests. †Values in parentheses are 95% confidence interval.",
    "chunk_id": 291,
    "sentence_start": 1482,
    "sentence_end": 1484,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "*No reliability data were available for the wrist flexion with compression (Phalen test with compression), Gilliatt pneumatic compression (tourniquet), and hand elevation tests. †Values in parentheses are 95% confidence interval. ‡A reflex hammer, held 6 inches above the patient’s wrist crease, is allowed to fall and strike the patient between the tendons of the flexor carpi radialis and palmaris longus, with a \npositive test being a nonpainful tingling sensation radiating distally along the path of the median nerve. §The examiner taps the patient with a reflex hammer using mild to moderate force between the tendons of the flexor carpi radialis and palmaris longus, with a positive test including \ndiscomfort or pain at the wrist or radiating distally along the nerve’s course. ‖When creating compression using low pressure (100 mmHg). ¶When creating compression using high pressure (150 mmHg).",
    "chunk_id": 292,
    "sentence_start": 1483,
    "sentence_end": 1488,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "‖When creating compression using low pressure (100 mmHg). ¶When creating compression using high pressure (150 mmHg). #With the patient positioned in supine, the examiner sequentially performed the following to the symptomatic upper extremity: (1) scapular depression; (2) shoulder abduction, \nforearm supination, wrist and finger extension; (3) shoulder lateral rotation; (4) elbow extension; and (5) contralateral and then ipsilateral sidebending. Any of the following were \nconsidered positive: (1) symptoms were reproduced, (2) side-to-side differences in elbow extension (greater than 10°) for part A or wrist flexion for part B on completion of all motion \nsequences, (3) contralateral neck sidebending increased symptoms or ipsilateral sidebending decreased symptoms in the symptomatic limb.",
    "chunk_id": 293,
    "sentence_start": 1487,
    "sentence_end": 1490,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "#With the patient positioned in supine, the examiner sequentially performed the following to the symptomatic upper extremity: (1) scapular depression; (2) shoulder abduction, \nforearm supination, wrist and finger extension; (3) shoulder lateral rotation; (4) elbow extension; and (5) contralateral and then ipsilateral sidebending. Any of the following were \nconsidered positive: (1) symptoms were reproduced, (2) side-to-side differences in elbow extension (greater than 10°) for part A or wrist flexion for part B on completion of all motion \nsequences, (3) contralateral neck sidebending increased symptoms or ipsilateral sidebending decreased symptoms in the symptomatic limb. TABLE 2\nReliability Values for Provocative Tests*\nTest/Study\nLevel of Evidence\nIntrarater Reliability†\nInterrater Reliability†\nPhalen test\nSalerno et al251\nI\nκ = 0.42 (0.26, 0.58)\nWainner et al283\nII\nκ = 0.79 (0.59, 1.00)\nPriganc and Henry232\nII\nκ = 0.58 (0.22, 0.94)\nMacDermid et al170\nII\nκ = 0.88 (0.77, 0.98)\nMarx et al183\nIV\nκ = 0.52\nκ = 0.65\nTinel sign\nSalerno et al251\nI\nκ = 0.27 (0.06, 0.50)\nWainner et al283 (Tinel A)‡\nII\nκ = 0.47 (0.21, 0.72)\nWainner et al283 (Tinel B)§\nII\nκ = 0.35 (0.10, 0.60)\nPriganc and Henry232\nII\nκ = 0.51 (0.13, 0.88)\nMacDermid et al170\nII\nκ = 0.81 (0.66, 0.98)\nMarx et al183\nIV\nκ = 0.80\nκ = 0.77\nCarpal compression test\nSalerno et al251\nI\nκ = 0.64 (0.44, 0.83)\nPriganc and Henry232\nII\nκ = 0.63 (0.33, 0.92)\nWainner et al283\nII\nκ = 0.77 (0.58, 0.96)\nWilliams et al292\nIV\nICC = 0.81‖, 0.92¶\nReverse Phalen (wrist extension) test\nMacDermid et al170\nII\nκ = 0.72 (0.55, 0.88)\nULNT1#\nWainner et al283\nII\nκ = 0.76 (0.51, 1.00)\nScratch-collapse test\nCheng et al62\nII\nκ = 0.98\nBlok et al41\nII\nκ = 0.63\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 294,
    "sentence_start": 1489,
    "sentence_end": 1491,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Any of the following were \nconsidered positive: (1) symptoms were reproduced, (2) side-to-side differences in elbow extension (greater than 10°) for part A or wrist flexion for part B on completion of all motion \nsequences, (3) contralateral neck sidebending increased symptoms or ipsilateral sidebending decreased symptoms in the symptomatic limb. TABLE 2\nReliability Values for Provocative Tests*\nTest/Study\nLevel of Evidence\nIntrarater Reliability†\nInterrater Reliability†\nPhalen test\nSalerno et al251\nI\nκ = 0.42 (0.26, 0.58)\nWainner et al283\nII\nκ = 0.79 (0.59, 1.00)\nPriganc and Henry232\nII\nκ = 0.58 (0.22, 0.94)\nMacDermid et al170\nII\nκ = 0.88 (0.77, 0.98)\nMarx et al183\nIV\nκ = 0.52\nκ = 0.65\nTinel sign\nSalerno et al251\nI\nκ = 0.27 (0.06, 0.50)\nWainner et al283 (Tinel A)‡\nII\nκ = 0.47 (0.21, 0.72)\nWainner et al283 (Tinel B)§\nII\nκ = 0.35 (0.10, 0.60)\nPriganc and Henry232\nII\nκ = 0.51 (0.13, 0.88)\nMacDermid et al170\nII\nκ = 0.81 (0.66, 0.98)\nMarx et al183\nIV\nκ = 0.80\nκ = 0.77\nCarpal compression test\nSalerno et al251\nI\nκ = 0.64 (0.44, 0.83)\nPriganc and Henry232\nII\nκ = 0.63 (0.33, 0.92)\nWainner et al283\nII\nκ = 0.77 (0.58, 0.96)\nWilliams et al292\nIV\nICC = 0.81‖, 0.92¶\nReverse Phalen (wrist extension) test\nMacDermid et al170\nII\nκ = 0.72 (0.55, 0.88)\nULNT1#\nWainner et al283\nII\nκ = 0.76 (0.51, 1.00)\nScratch-collapse test\nCheng et al62\nII\nκ = 0.98\nBlok et al41\nII\nκ = 0.63\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 295,
    "sentence_start": 1490,
    "sentence_end": 1492,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "TABLE 2\nReliability Values for Provocative Tests*\nTest/Study\nLevel of Evidence\nIntrarater Reliability†\nInterrater Reliability†\nPhalen test\nSalerno et al251\nI\nκ = 0.42 (0.26, 0.58)\nWainner et al283\nII\nκ = 0.79 (0.59, 1.00)\nPriganc and Henry232\nII\nκ = 0.58 (0.22, 0.94)\nMacDermid et al170\nII\nκ = 0.88 (0.77, 0.98)\nMarx et al183\nIV\nκ = 0.52\nκ = 0.65\nTinel sign\nSalerno et al251\nI\nκ = 0.27 (0.06, 0.50)\nWainner et al283 (Tinel A)‡\nII\nκ = 0.47 (0.21, 0.72)\nWainner et al283 (Tinel B)§\nII\nκ = 0.35 (0.10, 0.60)\nPriganc and Henry232\nII\nκ = 0.51 (0.13, 0.88)\nMacDermid et al170\nII\nκ = 0.81 (0.66, 0.98)\nMarx et al183\nIV\nκ = 0.80\nκ = 0.77\nCarpal compression test\nSalerno et al251\nI\nκ = 0.64 (0.44, 0.83)\nPriganc and Henry232\nII\nκ = 0.63 (0.33, 0.92)\nWainner et al283\nII\nκ = 0.77 (0.58, 0.96)\nWilliams et al292\nIV\nICC = 0.81‖, 0.92¶\nReverse Phalen (wrist extension) test\nMacDermid et al170\nII\nκ = 0.72 (0.55, 0.88)\nULNT1#\nWainner et al283\nII\nκ = 0.76 (0.51, 1.00)\nScratch-collapse test\nCheng et al62\nII\nκ = 0.98\nBlok et al41\nII\nκ = 0.63\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 296,
    "sentence_start": 1491,
    "sentence_end": 1493,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\n\n\n--- Page 26 ---\nCOLUMN 1:\nTABLE 3\nDiagnostic Accuracy Values for Provocative Tests\nTest/Study\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\nPhalen test\nMacDermid and \nWessel173\nI\n68\n73\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nMondelli et al196\nII\n59 (overall)a\n93\n91\n65\nClinical presentation and EDS\nAsymptomatic hands\n72\n90\n27\nClinical presentation and EDS\nPolyneuropathy\nWainner et al283\nII\n77 (61, 93)\n40 (26, 53)\n…\n…\nClinical presentation and EDS\n…\nThüngen et al274\nII\n90 (78, 97)\n33 (0, 91)\n…\n…\nEDS\n…\n83 (59, 96)\n9 (2, 24)\n…\n…\nClinical presentation\n…\n92 (78, 98)\n11 (0, 48)\n…\n…\nUltrasonography\n…\n96 (82, 99)\n0 (0, 41)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMakanji et al178\nII\n67\n33\n75\n25\nPositive EDS\nNegative EDS\nKasundra et al144\nII\n84.9\n73.9\n…\n…\nEDS\nAsymptomatic individuals or hands\nWilliams et al292\nIV\n88\n100\n…\n…\nClinical presentation\nAsymptomatic individuals\nGoloborod’ko113\nIV\n93\n93\n93\n93\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nAmirfeyz et al9\nIV\n83 (76, 91)\n98 (92, 100)\n98 (94, 100)\n85 (78, 92)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nLaJoie et al157\nIV\n92 (85, 98)\n88 (79, 97)\n…\n…\nNone described (used latent \nclass analysis)\n…\nEl Miedany et al89\nIV\n47 (40.5, 53.6)\n17 (12.5, 22.6)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nBoland and Kiernan42\nIV\n64 (52, 74)\n75 (47, 91)\n…\n…\nEDS\nContralateral asymptomatic hands\nAmirfeyz et al8\nIV\n87.1\n84.3\n84.7\n86.8\nSymptoms and EDS\nAsymptomatic individuals\nMa and Kim168\nIV\n84.4\n86.7\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nAl-Dabbagh and \nMohamad3\nIV\n78\n94\n…\n…\nEDS (NIOSH criteria)\nAsymptomatic individuals\nTinel sign\nMacDermid and \nWessel173\nI\n50\n77\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nMondelli et al196\nII\n41 (overall)b\n90\n83\n56\nClinical presentation and EDS\nAsymptomatic individuals\n56\n81\n17\nClinical presentation and EDS\nPolyneuropathy\nWainner et al283c\nII\n41 (22, 59)\n58 (45, 72)\n…\n…\nClinical presentation and EDS\n…\nWainner et al283d\nII\n48 (29, 67)\n67 (54, 79)\n…\n…\nClinical presentation and EDS\n…\nCheng et al62\nII\n32\n99\n96\n59\nClinical presentation and EDS\nAsymptomatic individuals\nThüngen et al274\nII\n39 (25, 54)\n100 (29, 100)\n…\n…\nEDS\n…\n39 (17, 64)\n65 (47, 80)\n…\n…\nClinical presentation\n…\n44 (28, 62)\n67 (30, 93)\n…\n…\nUltrasonography\n…\n50 (31, 69)\n71 (29, 96)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMakanji et al178\nII\n43\n56\n74\n25\nPositive EDS\nNegative EDS\nKasundra et al144\nII\n78.5\n91.3\n…\n…\nEDS\nAsymptomatic individuals or hands\nWilliams et al292\nIV\n67\n100\n…\n…\nClinical presentation\nAsymptomatic individuals\nGoloborod’ko113\nIV\n66\n83\n79\n71\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nAmirfeyz et al9\nIV\n48 (38, 58)\n94 (89, 99)\n88 (82, 95)\n64 (54, 73)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nLaJoie et al157\nIV\n97 (93, 100)\n91 (82, 99)\n…\n…\nNone described (used latent \nclass analysis)\n…\nEl Miedany et al89\nIV\n30 (24.3, 36.4)\n65 (58.4, 71.1)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 297,
    "sentence_start": 1494,
    "sentence_end": 1496,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\n\n\n--- Page 26 ---\nCOLUMN 1:\nTABLE 3\nDiagnostic Accuracy Values for Provocative Tests\nTest/Study\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\nPhalen test\nMacDermid and \nWessel173\nI\n68\n73\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nMondelli et al196\nII\n59 (overall)a\n93\n91\n65\nClinical presentation and EDS\nAsymptomatic hands\n72\n90\n27\nClinical presentation and EDS\nPolyneuropathy\nWainner et al283\nII\n77 (61, 93)\n40 (26, 53)\n…\n…\nClinical presentation and EDS\n…\nThüngen et al274\nII\n90 (78, 97)\n33 (0, 91)\n…\n…\nEDS\n…\n83 (59, 96)\n9 (2, 24)\n…\n…\nClinical presentation\n…\n92 (78, 98)\n11 (0, 48)\n…\n…\nUltrasonography\n…\n96 (82, 99)\n0 (0, 41)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMakanji et al178\nII\n67\n33\n75\n25\nPositive EDS\nNegative EDS\nKasundra et al144\nII\n84.9\n73.9\n…\n…\nEDS\nAsymptomatic individuals or hands\nWilliams et al292\nIV\n88\n100\n…\n…\nClinical presentation\nAsymptomatic individuals\nGoloborod’ko113\nIV\n93\n93\n93\n93\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nAmirfeyz et al9\nIV\n83 (76, 91)\n98 (92, 100)\n98 (94, 100)\n85 (78, 92)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nLaJoie et al157\nIV\n92 (85, 98)\n88 (79, 97)\n…\n…\nNone described (used latent \nclass analysis)\n…\nEl Miedany et al89\nIV\n47 (40.5, 53.6)\n17 (12.5, 22.6)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nBoland and Kiernan42\nIV\n64 (52, 74)\n75 (47, 91)\n…\n…\nEDS\nContralateral asymptomatic hands\nAmirfeyz et al8\nIV\n87.1\n84.3\n84.7\n86.8\nSymptoms and EDS\nAsymptomatic individuals\nMa and Kim168\nIV\n84.4\n86.7\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nAl-Dabbagh and \nMohamad3\nIV\n78\n94\n…\n…\nEDS (NIOSH criteria)\nAsymptomatic individuals\nTinel sign\nMacDermid and \nWessel173\nI\n50\n77\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nMondelli et al196\nII\n41 (overall)b\n90\n83\n56\nClinical presentation and EDS\nAsymptomatic individuals\n56\n81\n17\nClinical presentation and EDS\nPolyneuropathy\nWainner et al283c\nII\n41 (22, 59)\n58 (45, 72)\n…\n…\nClinical presentation and EDS\n…\nWainner et al283d\nII\n48 (29, 67)\n67 (54, 79)\n…\n…\nClinical presentation and EDS\n…\nCheng et al62\nII\n32\n99\n96\n59\nClinical presentation and EDS\nAsymptomatic individuals\nThüngen et al274\nII\n39 (25, 54)\n100 (29, 100)\n…\n…\nEDS\n…\n39 (17, 64)\n65 (47, 80)\n…\n…\nClinical presentation\n…\n44 (28, 62)\n67 (30, 93)\n…\n…\nUltrasonography\n…\n50 (31, 69)\n71 (29, 96)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMakanji et al178\nII\n43\n56\n74\n25\nPositive EDS\nNegative EDS\nKasundra et al144\nII\n78.5\n91.3\n…\n…\nEDS\nAsymptomatic individuals or hands\nWilliams et al292\nIV\n67\n100\n…\n…\nClinical presentation\nAsymptomatic individuals\nGoloborod’ko113\nIV\n66\n83\n79\n71\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nAmirfeyz et al9\nIV\n48 (38, 58)\n94 (89, 99)\n88 (82, 95)\n64 (54, 73)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nLaJoie et al157\nIV\n97 (93, 100)\n91 (82, 99)\n…\n…\nNone described (used latent \nclass analysis)\n…\nEl Miedany et al89\nIV\n30 (24.3, 36.4)\n65 (58.4, 71.1)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 298,
    "sentence_start": 1495,
    "sentence_end": 1497,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\n\n\n--- Page 26 ---\nCOLUMN 1:\nTABLE 3\nDiagnostic Accuracy Values for Provocative Tests\nTest/Study\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\nPhalen test\nMacDermid and \nWessel173\nI\n68\n73\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nMondelli et al196\nII\n59 (overall)a\n93\n91\n65\nClinical presentation and EDS\nAsymptomatic hands\n72\n90\n27\nClinical presentation and EDS\nPolyneuropathy\nWainner et al283\nII\n77 (61, 93)\n40 (26, 53)\n…\n…\nClinical presentation and EDS\n…\nThüngen et al274\nII\n90 (78, 97)\n33 (0, 91)\n…\n…\nEDS\n…\n83 (59, 96)\n9 (2, 24)\n…\n…\nClinical presentation\n…\n92 (78, 98)\n11 (0, 48)\n…\n…\nUltrasonography\n…\n96 (82, 99)\n0 (0, 41)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMakanji et al178\nII\n67\n33\n75\n25\nPositive EDS\nNegative EDS\nKasundra et al144\nII\n84.9\n73.9\n…\n…\nEDS\nAsymptomatic individuals or hands\nWilliams et al292\nIV\n88\n100\n…\n…\nClinical presentation\nAsymptomatic individuals\nGoloborod’ko113\nIV\n93\n93\n93\n93\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nAmirfeyz et al9\nIV\n83 (76, 91)\n98 (92, 100)\n98 (94, 100)\n85 (78, 92)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nLaJoie et al157\nIV\n92 (85, 98)\n88 (79, 97)\n…\n…\nNone described (used latent \nclass analysis)\n…\nEl Miedany et al89\nIV\n47 (40.5, 53.6)\n17 (12.5, 22.6)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nBoland and Kiernan42\nIV\n64 (52, 74)\n75 (47, 91)\n…\n…\nEDS\nContralateral asymptomatic hands\nAmirfeyz et al8\nIV\n87.1\n84.3\n84.7\n86.8\nSymptoms and EDS\nAsymptomatic individuals\nMa and Kim168\nIV\n84.4\n86.7\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nAl-Dabbagh and \nMohamad3\nIV\n78\n94\n…\n…\nEDS (NIOSH criteria)\nAsymptomatic individuals\nTinel sign\nMacDermid and \nWessel173\nI\n50\n77\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nMondelli et al196\nII\n41 (overall)b\n90\n83\n56\nClinical presentation and EDS\nAsymptomatic individuals\n56\n81\n17\nClinical presentation and EDS\nPolyneuropathy\nWainner et al283c\nII\n41 (22, 59)\n58 (45, 72)\n…\n…\nClinical presentation and EDS\n…\nWainner et al283d\nII\n48 (29, 67)\n67 (54, 79)\n…\n…\nClinical presentation and EDS\n…\nCheng et al62\nII\n32\n99\n96\n59\nClinical presentation and EDS\nAsymptomatic individuals\nThüngen et al274\nII\n39 (25, 54)\n100 (29, 100)\n…\n…\nEDS\n…\n39 (17, 64)\n65 (47, 80)\n…\n…\nClinical presentation\n…\n44 (28, 62)\n67 (30, 93)\n…\n…\nUltrasonography\n…\n50 (31, 69)\n71 (29, 96)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMakanji et al178\nII\n43\n56\n74\n25\nPositive EDS\nNegative EDS\nKasundra et al144\nII\n78.5\n91.3\n…\n…\nEDS\nAsymptomatic individuals or hands\nWilliams et al292\nIV\n67\n100\n…\n…\nClinical presentation\nAsymptomatic individuals\nGoloborod’ko113\nIV\n66\n83\n79\n71\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nAmirfeyz et al9\nIV\n48 (38, 58)\n94 (89, 99)\n88 (82, 95)\n64 (54, 73)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nLaJoie et al157\nIV\n97 (93, 100)\n91 (82, 99)\n…\n…\nNone described (used latent \nclass analysis)\n…\nEl Miedany et al89\nIV\n30 (24.3, 36.4)\n65 (58.4, 71.1)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 299,
    "sentence_start": 1496,
    "sentence_end": 1498,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nDiagnostic Accuracy Values for Provocative Tests\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\nI\n68\n73\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nII\n59 (overall)a\n93\n91\n65\nClinical presentation and EDS\nAsymptomatic hands\n72\n90\n27\nClinical presentation and EDS\nPolyneuropathy\nII\n77 (61, 93)\n40 (26, 53)\n…\n…\nClinical presentation and EDS\n…\nII\n90 (78, 97)\n33 (0, 91)\n…\n…\nEDS\n…\n83 (59, 96)\n9 (2, 24)\n…\n…\nClinical presentation\n…\n92 (78, 98)\n11 (0, 48)\n…\n…\nUltrasonography\n…\n96 (82, 99)\n0 (0, 41)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nII\n67\n33\n75\n25\nPositive EDS\nNegative EDS\nII\n84.9\n73.9\n…\n…\nEDS\nAsymptomatic individuals or hands\nIV\n88\n100\n…\n…\nClinical presentation\nAsymptomatic individuals\nIV\n93\n93\n93\n93\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n83 (76, 91)\n98 (92, 100)\n98 (94, 100)\n85 (78, 92)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n92 (85, 98)\n88 (79, 97)\n…\n…\nNone described (used latent \nclass analysis)\n…\nIV\n47 (40.5, 53.6)\n17 (12.5, 22.6)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nIV\n64 (52, 74)\n75 (47, 91)\n…\n…\nEDS\nContralateral asymptomatic hands\nIV\n87.1\n84.3\n84.7\n86.8\nSymptoms and EDS\nAsymptomatic individuals\nIV\n84.4\n86.7\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nIV\n78\n94\n…\n…\nEDS (NIOSH criteria)\nAsymptomatic individuals\nI\n50\n77\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nII\n41 (overall)b\n90\n83\n56\nClinical presentation and EDS\nAsymptomatic individuals\n56\n81\n17\nClinical presentation and EDS\nPolyneuropathy\nII\n41 (22, 59)\n58 (45, 72)\n…\n…\nClinical presentation and EDS\n…\nII\n48 (29, 67)\n67 (54, 79)\n…\n…\nClinical presentation and EDS\n…\nII\n32\n99\n96\n59\nClinical presentation and EDS\nAsymptomatic individuals\nII\n39 (25, 54)\n100 (29, 100)\n…\n…\nEDS\n…\n39 (17, 64)\n65 (47, 80)\n…\n…\nClinical presentation\n…\n44 (28, 62)\n67 (30, 93)\n…\n…\nUltrasonography\n…\n50 (31, 69)\n71 (29, 96)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nII\n43\n56\n74\n25\nPositive EDS\nNegative EDS\nII\n78.5\n91.3\n…\n…\nEDS\nAsymptomatic individuals or hands\nIV\n67\n100\n…\n…\nClinical presentation\nAsymptomatic individuals\nIV\n66\n83\n79\n71\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n48 (38, 58)\n94 (89, 99)\n88 (82, 95)\n64 (54, 73)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n97 (93, 100)\n91 (82, 99)\n…\n…\nNone described (used latent \nclass analysis)\n…\n\n\n--- Page 27 ---\nCOLUMN 1:\nTABLE 3\nDiagnostic Accuracy Values for Provocative Tests (continued)\nTest/Study\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\nAmirfeyz et al8\nIV\n52.9\n92.9\n88.1\n66.3\nSymptoms and EDS\nAsymptomatic individuals\nMa and Kim168\nIV\n82.2\n88.9\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nAl-Dabbagh and \nMohamad3\nIV\n66\n77\n…\n…\nEDS (NIOSH criteria)\nAsymptomatic individuals\nCarpal compression test\nMassy-Westropp \net al184\nII\n49, 87\n54, 90\n…\n…\nSystematic review\nNA\nMondelli et al196\nII\n42 (overall)e\n99\n97\n58\nClinical presentation and EDS\nAsymptomatic individuals\n95\n97\n26\nClinical presentation and EDS\nPolyneuropathy\nMacDermid and \nWessel173\nII\n64\n83\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nWainner et al283\nII\n64 (45, 83)\n30 (17, 42)\n…\n…\nClinical presentation and EDS\n…\nThüngen et al274\nII\n90 (78, 97)\n33 (0, 91)\n…\n…\nEDS\n…\n100 (81, 100)\n18 (7, 35)\n…\n…\nClinical presentation\n…\n92 (78, 98)\n11 (0, 48)\n…\n…\nUltrasonography\n…\n93 (77, 99)\n29 (4, 71)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMakanji et al178\nII\n77\n18\n73\n21\nPositive EDS\nNegative EDS\nKasundra et al144\nII\n81.7\n69.6\n…\n…\nEDS\nAsymptomatic individuals or hands\nWilliams et al292f\nIV\n100\n97\n100\n…\nClinical presentation\nAsymptomatic individuals\nWilliams et al292g\nIV\n97\n100\n97\n…\nClinical presentation\nAsymptomatic individuals\nGoloborod’ko113\nIV\n90\n88\n88\n90\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nEl Miedany et al89\nIV\n46 (39.5, 52.6)\n25 (19.7, 31.2)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nAmirfeyz et al8\nIV\n84.3\n78.6\n79.7\n83.3\nSymptoms and EDS\nAsymptomatic individuals\nMa and Kim168\nIV\n84.4\n82.2\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nWrist flexion with com­\npression (Phalen test \nwith compression)\nCheng et al62\nII\n44\n99\n98\n65\nClinical presentation and EDS\nAsymptomatic individuals\nThüngen et al274\nII\n78 (63, 88)\n33 (0, 91)\n…\n…\nEDS\n…\n89 (65, 99)\n29 (15, 48)\n…\n…\nClinical presentation\n…\n83 (67, 94)\n33 (8, 70)\n…\n…\nUltrasonography\n…\n82 (63, 94)\n43 (10, 82)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMacDermid and \nWessel173\nIV\n80\n92\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nReverse Phalen test\nMondelli et al196\nII\n55 (overall)h\n96\n94\n63\nClinical presentation and EDS\nAsymptomatic individuals\n82\n93\n26\nClinical presentation and EDS\nPolyneuropathy\nMacDermid and \nWessel173\nII\n57\n78\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nGoloborod’ko113\nIV\n88\n98\n98\n98\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nGilliatt pneumatic com­\npression (tourniquet)\nThüngen et al274i\nI\n67 (53, 80)\n33 (0, 91)\n…\n…\nEDS\n…\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 300,
    "sentence_start": 1499,
    "sentence_end": 1501,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nDiagnostic Accuracy Values for Provocative Tests\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\nI\n68\n73\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nII\n59 (overall)a\n93\n91\n65\nClinical presentation and EDS\nAsymptomatic hands\n72\n90\n27\nClinical presentation and EDS\nPolyneuropathy\nII\n77 (61, 93)\n40 (26, 53)\n…\n…\nClinical presentation and EDS\n…\nII\n90 (78, 97)\n33 (0, 91)\n…\n…\nEDS\n…\n83 (59, 96)\n9 (2, 24)\n…\n…\nClinical presentation\n…\n92 (78, 98)\n11 (0, 48)\n…\n…\nUltrasonography\n…\n96 (82, 99)\n0 (0, 41)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nII\n67\n33\n75\n25\nPositive EDS\nNegative EDS\nII\n84.9\n73.9\n…\n…\nEDS\nAsymptomatic individuals or hands\nIV\n88\n100\n…\n…\nClinical presentation\nAsymptomatic individuals\nIV\n93\n93\n93\n93\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n83 (76, 91)\n98 (92, 100)\n98 (94, 100)\n85 (78, 92)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n92 (85, 98)\n88 (79, 97)\n…\n…\nNone described (used latent \nclass analysis)\n…\nIV\n47 (40.5, 53.6)\n17 (12.5, 22.6)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nIV\n64 (52, 74)\n75 (47, 91)\n…\n…\nEDS\nContralateral asymptomatic hands\nIV\n87.1\n84.3\n84.7\n86.8\nSymptoms and EDS\nAsymptomatic individuals\nIV\n84.4\n86.7\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nIV\n78\n94\n…\n…\nEDS (NIOSH criteria)\nAsymptomatic individuals\nI\n50\n77\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nII\n41 (overall)b\n90\n83\n56\nClinical presentation and EDS\nAsymptomatic individuals\n56\n81\n17\nClinical presentation and EDS\nPolyneuropathy\nII\n41 (22, 59)\n58 (45, 72)\n…\n…\nClinical presentation and EDS\n…\nII\n48 (29, 67)\n67 (54, 79)\n…\n…\nClinical presentation and EDS\n…\nII\n32\n99\n96\n59\nClinical presentation and EDS\nAsymptomatic individuals\nII\n39 (25, 54)\n100 (29, 100)\n…\n…\nEDS\n…\n39 (17, 64)\n65 (47, 80)\n…\n…\nClinical presentation\n…\n44 (28, 62)\n67 (30, 93)\n…\n…\nUltrasonography\n…\n50 (31, 69)\n71 (29, 96)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nII\n43\n56\n74\n25\nPositive EDS\nNegative EDS\nII\n78.5\n91.3\n…\n…\nEDS\nAsymptomatic individuals or hands\nIV\n67\n100\n…\n…\nClinical presentation\nAsymptomatic individuals\nIV\n66\n83\n79\n71\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n48 (38, 58)\n94 (89, 99)\n88 (82, 95)\n64 (54, 73)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n97 (93, 100)\n91 (82, 99)\n…\n…\nNone described (used latent \nclass analysis)\n…\n\n\n--- Page 27 ---\nCOLUMN 1:\nTABLE 3\nDiagnostic Accuracy Values for Provocative Tests (continued)\nTest/Study\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\nAmirfeyz et al8\nIV\n52.9\n92.9\n88.1\n66.3\nSymptoms and EDS\nAsymptomatic individuals\nMa and Kim168\nIV\n82.2\n88.9\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nAl-Dabbagh and \nMohamad3\nIV\n66\n77\n…\n…\nEDS (NIOSH criteria)\nAsymptomatic individuals\nCarpal compression test\nMassy-Westropp \net al184\nII\n49, 87\n54, 90\n…\n…\nSystematic review\nNA\nMondelli et al196\nII\n42 (overall)e\n99\n97\n58\nClinical presentation and EDS\nAsymptomatic individuals\n95\n97\n26\nClinical presentation and EDS\nPolyneuropathy\nMacDermid and \nWessel173\nII\n64\n83\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nWainner et al283\nII\n64 (45, 83)\n30 (17, 42)\n…\n…\nClinical presentation and EDS\n…\nThüngen et al274\nII\n90 (78, 97)\n33 (0, 91)\n…\n…\nEDS\n…\n100 (81, 100)\n18 (7, 35)\n…\n…\nClinical presentation\n…\n92 (78, 98)\n11 (0, 48)\n…\n…\nUltrasonography\n…\n93 (77, 99)\n29 (4, 71)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMakanji et al178\nII\n77\n18\n73\n21\nPositive EDS\nNegative EDS\nKasundra et al144\nII\n81.7\n69.6\n…\n…\nEDS\nAsymptomatic individuals or hands\nWilliams et al292f\nIV\n100\n97\n100\n…\nClinical presentation\nAsymptomatic individuals\nWilliams et al292g\nIV\n97\n100\n97\n…\nClinical presentation\nAsymptomatic individuals\nGoloborod’ko113\nIV\n90\n88\n88\n90\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nEl Miedany et al89\nIV\n46 (39.5, 52.6)\n25 (19.7, 31.2)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nAmirfeyz et al8\nIV\n84.3\n78.6\n79.7\n83.3\nSymptoms and EDS\nAsymptomatic individuals\nMa and Kim168\nIV\n84.4\n82.2\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nWrist flexion with com­\npression (Phalen test \nwith compression)\nCheng et al62\nII\n44\n99\n98\n65\nClinical presentation and EDS\nAsymptomatic individuals\nThüngen et al274\nII\n78 (63, 88)\n33 (0, 91)\n…\n…\nEDS\n…\n89 (65, 99)\n29 (15, 48)\n…\n…\nClinical presentation\n…\n83 (67, 94)\n33 (8, 70)\n…\n…\nUltrasonography\n…\n82 (63, 94)\n43 (10, 82)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMacDermid and \nWessel173\nIV\n80\n92\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nReverse Phalen test\nMondelli et al196\nII\n55 (overall)h\n96\n94\n63\nClinical presentation and EDS\nAsymptomatic individuals\n82\n93\n26\nClinical presentation and EDS\nPolyneuropathy\nMacDermid and \nWessel173\nII\n57\n78\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nGoloborod’ko113\nIV\n88\n98\n98\n98\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nGilliatt pneumatic com­\npression (tourniquet)\nThüngen et al274i\nI\n67 (53, 80)\n33 (0, 91)\n…\n…\nEDS\n…\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 301,
    "sentence_start": 1500,
    "sentence_end": 1502,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nDiagnostic Accuracy Values for Provocative Tests\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\nI\n68\n73\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nII\n59 (overall)a\n93\n91\n65\nClinical presentation and EDS\nAsymptomatic hands\n72\n90\n27\nClinical presentation and EDS\nPolyneuropathy\nII\n77 (61, 93)\n40 (26, 53)\n…\n…\nClinical presentation and EDS\n…\nII\n90 (78, 97)\n33 (0, 91)\n…\n…\nEDS\n…\n83 (59, 96)\n9 (2, 24)\n…\n…\nClinical presentation\n…\n92 (78, 98)\n11 (0, 48)\n…\n…\nUltrasonography\n…\n96 (82, 99)\n0 (0, 41)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nII\n67\n33\n75\n25\nPositive EDS\nNegative EDS\nII\n84.9\n73.9\n…\n…\nEDS\nAsymptomatic individuals or hands\nIV\n88\n100\n…\n…\nClinical presentation\nAsymptomatic individuals\nIV\n93\n93\n93\n93\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n83 (76, 91)\n98 (92, 100)\n98 (94, 100)\n85 (78, 92)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n92 (85, 98)\n88 (79, 97)\n…\n…\nNone described (used latent \nclass analysis)\n…\nIV\n47 (40.5, 53.6)\n17 (12.5, 22.6)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nIV\n64 (52, 74)\n75 (47, 91)\n…\n…\nEDS\nContralateral asymptomatic hands\nIV\n87.1\n84.3\n84.7\n86.8\nSymptoms and EDS\nAsymptomatic individuals\nIV\n84.4\n86.7\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nIV\n78\n94\n…\n…\nEDS (NIOSH criteria)\nAsymptomatic individuals\nI\n50\n77\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nII\n41 (overall)b\n90\n83\n56\nClinical presentation and EDS\nAsymptomatic individuals\n56\n81\n17\nClinical presentation and EDS\nPolyneuropathy\nII\n41 (22, 59)\n58 (45, 72)\n…\n…\nClinical presentation and EDS\n…\nII\n48 (29, 67)\n67 (54, 79)\n…\n…\nClinical presentation and EDS\n…\nII\n32\n99\n96\n59\nClinical presentation and EDS\nAsymptomatic individuals\nII\n39 (25, 54)\n100 (29, 100)\n…\n…\nEDS\n…\n39 (17, 64)\n65 (47, 80)\n…\n…\nClinical presentation\n…\n44 (28, 62)\n67 (30, 93)\n…\n…\nUltrasonography\n…\n50 (31, 69)\n71 (29, 96)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nII\n43\n56\n74\n25\nPositive EDS\nNegative EDS\nII\n78.5\n91.3\n…\n…\nEDS\nAsymptomatic individuals or hands\nIV\n67\n100\n…\n…\nClinical presentation\nAsymptomatic individuals\nIV\n66\n83\n79\n71\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n48 (38, 58)\n94 (89, 99)\n88 (82, 95)\n64 (54, 73)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n97 (93, 100)\n91 (82, 99)\n…\n…\nNone described (used latent \nclass analysis)\n…\n\n\n--- Page 27 ---\nCOLUMN 1:\nTABLE 3\nDiagnostic Accuracy Values for Provocative Tests (continued)\nTest/Study\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\nAmirfeyz et al8\nIV\n52.9\n92.9\n88.1\n66.3\nSymptoms and EDS\nAsymptomatic individuals\nMa and Kim168\nIV\n82.2\n88.9\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nAl-Dabbagh and \nMohamad3\nIV\n66\n77\n…\n…\nEDS (NIOSH criteria)\nAsymptomatic individuals\nCarpal compression test\nMassy-Westropp \net al184\nII\n49, 87\n54, 90\n…\n…\nSystematic review\nNA\nMondelli et al196\nII\n42 (overall)e\n99\n97\n58\nClinical presentation and EDS\nAsymptomatic individuals\n95\n97\n26\nClinical presentation and EDS\nPolyneuropathy\nMacDermid and \nWessel173\nII\n64\n83\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nWainner et al283\nII\n64 (45, 83)\n30 (17, 42)\n…\n…\nClinical presentation and EDS\n…\nThüngen et al274\nII\n90 (78, 97)\n33 (0, 91)\n…\n…\nEDS\n…\n100 (81, 100)\n18 (7, 35)\n…\n…\nClinical presentation\n…\n92 (78, 98)\n11 (0, 48)\n…\n…\nUltrasonography\n…\n93 (77, 99)\n29 (4, 71)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMakanji et al178\nII\n77\n18\n73\n21\nPositive EDS\nNegative EDS\nKasundra et al144\nII\n81.7\n69.6\n…\n…\nEDS\nAsymptomatic individuals or hands\nWilliams et al292f\nIV\n100\n97\n100\n…\nClinical presentation\nAsymptomatic individuals\nWilliams et al292g\nIV\n97\n100\n97\n…\nClinical presentation\nAsymptomatic individuals\nGoloborod’ko113\nIV\n90\n88\n88\n90\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nEl Miedany et al89\nIV\n46 (39.5, 52.6)\n25 (19.7, 31.2)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nAmirfeyz et al8\nIV\n84.3\n78.6\n79.7\n83.3\nSymptoms and EDS\nAsymptomatic individuals\nMa and Kim168\nIV\n84.4\n82.2\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nWrist flexion with com­\npression (Phalen test \nwith compression)\nCheng et al62\nII\n44\n99\n98\n65\nClinical presentation and EDS\nAsymptomatic individuals\nThüngen et al274\nII\n78 (63, 88)\n33 (0, 91)\n…\n…\nEDS\n…\n89 (65, 99)\n29 (15, 48)\n…\n…\nClinical presentation\n…\n83 (67, 94)\n33 (8, 70)\n…\n…\nUltrasonography\n…\n82 (63, 94)\n43 (10, 82)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMacDermid and \nWessel173\nIV\n80\n92\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nReverse Phalen test\nMondelli et al196\nII\n55 (overall)h\n96\n94\n63\nClinical presentation and EDS\nAsymptomatic individuals\n82\n93\n26\nClinical presentation and EDS\nPolyneuropathy\nMacDermid and \nWessel173\nII\n57\n78\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negat\nelectrodiagnostic tests\nGoloborod’ko113\nIV\n88\n98\n98\n98\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nGilliatt pneumatic com­\npression (tourniquet)\nThüngen et al274i\nI\n67 (53, 80)\n33 (0, 91)\n…\n…\nEDS\n…\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 302,
    "sentence_start": 1501,
    "sentence_end": 1503,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nDiagnostic Accuracy Values for Provocative Tests (continued)\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\nIV\n52.9\n92.9\n88.1\n66.3\nSymptoms and EDS\nAsymptomatic individuals\nIV\n82.2\n88.9\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nIV\n66\n77\n…\n…\nEDS (NIOSH criteria)\nAsymptomatic individuals\nII\n49, 87\n54, 90\n…\n…\nSystematic review\nNA\nII\n42 (overall)e\n99\n97\n58\nClinical presentation and EDS\nAsymptomatic individuals\n95\n97\n26\nClinical presentation and EDS\nPolyneuropathy\nII\n64\n83\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nII\n64 (45, 83)\n30 (17, 42)\n…\n…\nClinical presentation and EDS\n…\nII\n90 (78, 97)\n33 (0, 91)\n…\n…\nEDS\n…\n100 (81, 100)\n18 (7, 35)\n…\n…\nClinical presentation\n…\n92 (78, 98)\n11 (0, 48)\n…\n…\nUltrasonography\n…\n93 (77, 99)\n29 (4, 71)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nII\n77\n18\n73\n21\nPositive EDS\nNegative EDS\nII\n81.7\n69.6\n…\n…\nEDS\nAsymptomatic individuals or hands\nIV\n100\n97\n100\n…\nClinical presentation\nAsymptomatic individuals\nIV\n97\n100\n97\n…\nClinical presentation\nAsymptomatic individuals\nIV\n90\n88\n88\n90\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n46 (39.5, 52.6)\n25 (19.7, 31.2)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nIV\n84.3\n78.6\n79.7\n83.3\nSymptoms and EDS\nAsymptomatic individuals\nIV\n84.4\n82.2\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nII\n44\n99\n98\n65\nClinical presentation and EDS\nAsymptomatic individuals\nII\n78 (63, 88)\n33 (0, 91)\n…\n…\nEDS\n…\n89 (65, 99)\n29 (15, 48)\n…\n…\nClinical presentation\n…\n83 (67, 94)\n33 (8, 70)\n…\n…\nUltrasonography\n…\n82 (63, 94)\n43 (10, 82)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nIV\n80\n92\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nII\n55 (overall)h\n96\n94\n63\nClinical presentation and EDS\nAsymptomatic individuals\n82\n93\n26\nClinical presentation and EDS\nPolyneuropathy\nII\n57\n78\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nIV\n88\n98\n98\n98\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nI\n67 (53, 80)\n33 (0, 91)\n…\n…\nEDS\n…\n67 (41, 87)\n32 (17, 51)\n…\n…\nClinical presentation\n…\n\n\n--- Page 28 ---\nCOLUMN 1:\nTABLE 3\nDiagnostic Accuracy Values for Provocative Tests (continued)\nAbbreviations: EDS, electrodiagnostic studies; NA, not applicable; NIOSH, National Institute for Occupational Safety and Health; NPV, negative predictive value; PPV, positive predictive \nvalue; ULNT, upper-limb neurodynamic test.",
    "chunk_id": 303,
    "sentence_start": 1504,
    "sentence_end": 1506,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nDiagnostic Accuracy Values for Provocative Tests (continued)\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\nIV\n52.9\n92.9\n88.1\n66.3\nSymptoms and EDS\nAsymptomatic individuals\nIV\n82.2\n88.9\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nIV\n66\n77\n…\n…\nEDS (NIOSH criteria)\nAsymptomatic individuals\nII\n49, 87\n54, 90\n…\n…\nSystematic review\nNA\nII\n42 (overall)e\n99\n97\n58\nClinical presentation and EDS\nAsymptomatic individuals\n95\n97\n26\nClinical presentation and EDS\nPolyneuropathy\nII\n64\n83\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nII\n64 (45, 83)\n30 (17, 42)\n…\n…\nClinical presentation and EDS\n…\nII\n90 (78, 97)\n33 (0, 91)\n…\n…\nEDS\n…\n100 (81, 100)\n18 (7, 35)\n…\n…\nClinical presentation\n…\n92 (78, 98)\n11 (0, 48)\n…\n…\nUltrasonography\n…\n93 (77, 99)\n29 (4, 71)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nII\n77\n18\n73\n21\nPositive EDS\nNegative EDS\nII\n81.7\n69.6\n…\n…\nEDS\nAsymptomatic individuals or hands\nIV\n100\n97\n100\n…\nClinical presentation\nAsymptomatic individuals\nIV\n97\n100\n97\n…\nClinical presentation\nAsymptomatic individuals\nIV\n90\n88\n88\n90\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n46 (39.5, 52.6)\n25 (19.7, 31.2)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nIV\n84.3\n78.6\n79.7\n83.3\nSymptoms and EDS\nAsymptomatic individuals\nIV\n84.4\n82.2\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nII\n44\n99\n98\n65\nClinical presentation and EDS\nAsymptomatic individuals\nII\n78 (63, 88)\n33 (0, 91)\n…\n…\nEDS\n…\n89 (65, 99)\n29 (15, 48)\n…\n…\nClinical presentation\n…\n83 (67, 94)\n33 (8, 70)\n…\n…\nUltrasonography\n…\n82 (63, 94)\n43 (10, 82)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nIV\n80\n92\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nII\n55 (overall)h\n96\n94\n63\nClinical presentation and EDS\nAsymptomatic individuals\n82\n93\n26\nClinical presentation and EDS\nPolyneuropathy\nII\n57\n78\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nIV\n88\n98\n98\n98\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nI\n67 (53, 80)\n33 (0, 91)\n…\n…\nEDS\n…\n67 (41, 87)\n32 (17, 51)\n…\n…\nClinical presentation\n…\n\n\n--- Page 28 ---\nCOLUMN 1:\nTABLE 3\nDiagnostic Accuracy Values for Provocative Tests (continued)\nAbbreviations: EDS, electrodiagnostic studies; NA, not applicable; NIOSH, National Institute for Occupational Safety and Health; NPV, negative predictive value; PPV, positive predictive \nvalue; ULNT, upper-limb neurodynamic test. *Values in parentheses are 95% confidence interval.",
    "chunk_id": 304,
    "sentence_start": 1505,
    "sentence_end": 1507,
    "section_type": "references",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nDiagnostic Accuracy Values for Provocative Tests (continued)\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\nIV\n52.9\n92.9\n88.1\n66.3\nSymptoms and EDS\nAsymptomatic individuals\nIV\n82.2\n88.9\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nIV\n66\n77\n…\n…\nEDS (NIOSH criteria)\nAsymptomatic individuals\nII\n49, 87\n54, 90\n…\n…\nSystematic review\nNA\nII\n42 (overall)e\n99\n97\n58\nClinical presentation and EDS\nAsymptomatic individuals\n95\n97\n26\nClinical presentation and EDS\nPolyneuropathy\nII\n64\n83\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nII\n64 (45, 83)\n30 (17, 42)\n…\n…\nClinical presentation and EDS\n…\nII\n90 (78, 97)\n33 (0, 91)\n…\n…\nEDS\n…\n100 (81, 100)\n18 (7, 35)\n…\n…\nClinical presentation\n…\n92 (78, 98)\n11 (0, 48)\n…\n…\nUltrasonography\n…\n93 (77, 99)\n29 (4, 71)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nII\n77\n18\n73\n21\nPositive EDS\nNegative EDS\nII\n81.7\n69.6\n…\n…\nEDS\nAsymptomatic individuals or hands\nIV\n100\n97\n100\n…\nClinical presentation\nAsymptomatic individuals\nIV\n97\n100\n97\n…\nClinical presentation\nAsymptomatic individuals\nIV\n90\n88\n88\n90\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n46 (39.5, 52.6)\n25 (19.7, 31.2)\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nIV\n84.3\n78.6\n79.7\n83.3\nSymptoms and EDS\nAsymptomatic individuals\nIV\n84.4\n82.2\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nII\n44\n99\n98\n65\nClinical presentation and EDS\nAsymptomatic individuals\nII\n78 (63, 88)\n33 (0, 91)\n…\n…\nEDS\n…\n89 (65, 99)\n29 (15, 48)\n…\n…\nClinical presentation\n…\n83 (67, 94)\n33 (8, 70)\n…\n…\nUltrasonography\n…\n82 (63, 94)\n43 (10, 82)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nIV\n80\n92\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nII\n55 (overall)h\n96\n94\n63\nClinical presentation and EDS\nAsymptomatic individuals\n82\n93\n26\nClinical presentation and EDS\nPolyneuropathy\nII\n57\n78\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nIV\n88\n98\n98\n98\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nI\n67 (53, 80)\n33 (0, 91)\n…\n…\nEDS\n…\n67 (41, 87)\n32 (17, 51)\n…\n…\nClinical presentation\n…\n\n\n--- Page 28 ---\nCOLUMN 1:\nTABLE 3\nDiagnostic Accuracy Values for Provocative Tests (continued)\nAbbreviations: EDS, electrodiagnostic studies; NA, not applicable; NIOSH, National Institute for Occupational Safety and Health; NPV, negative predictive value; PPV, positive predictive \nvalue; ULNT, upper-limb neurodynamic test. *Values in parentheses are 95% confidence interval. aVaried by EDS stage, from 10 to 72.",
    "chunk_id": 305,
    "sentence_start": 1506,
    "sentence_end": 1508,
    "section_type": "references",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "*Values in parentheses are 95% confidence interval. aVaried by EDS stage, from 10 to 72. bVaried by EDS stage, from 10 to 53. cA reflex hammer, held 6 inches above the patient’s wrist crease, is allowed to fall and strike the patient between the tendons of the flexor carpi radialis and palmaris longus, with a \npositive test being a nonpainful tingling sensation radiating distally along the path of the median nerve. dThe examiner taps the patient with a reflex hammer using mild to moderate force between the tendons of the flexor carpi radialis and palmaris longus, with a positive test including \ndiscomfort or pain at the wrist or radiating distally along the nerve’s course. eVaried by EDS stage, from 0 to 62. fUsing a sphygmomanometer at 150 mmHg. gUsing a sphygmomanometer at 100 mmHg. hVaried by EDS stage, from 10 to 60. iCompression applied at suprasystolic blood pressure (approximately 140-160 mmHg). jCompression applied at infrasystolic blood pressure (approximately 70 mmHg).",
    "chunk_id": 306,
    "sentence_start": 1507,
    "sentence_end": 1518,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "jCompression applied at infrasystolic blood pressure (approximately 70 mmHg). Hand elevation: a new test for carpal tunnel syndrome. Ann Plast Surg. lPositive if the patient’s clinical symptoms are provoked at the wrist or hand and changed during structural differentiation. mPositive if any symptoms were provoked at the wrist or radial 3 digits and changed during structural differentiation. nAny of the following were considered positive: (1) symptoms were reproduced, (2) side-to-side differences in elbow extension (greater than 10°) for part A or wrist flexion (part B) on \ncompletion of all motion sequences, (3) contralateral neck sidebending increased symptoms or ipsilateral sidebending decreased symptoms in the symptomatic limb. oPositive if symptoms are in the radial 3 digits. pPositive if symptoms are in the radial 3 digits and increased with contralateral cervical sidebending.",
    "chunk_id": 307,
    "sentence_start": 1517,
    "sentence_end": 1526,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "oPositive if symptoms are in the radial 3 digits. pPositive if symptoms are in the radial 3 digits and increased with contralateral cervical sidebending. qPositive if symptoms are in the radial 3 digits and decreased with spine ipsilateral cervical sidebending.",
    "chunk_id": 308,
    "sentence_start": 1525,
    "sentence_end": 1527,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "pPositive if symptoms are in the radial 3 digits and increased with contralateral cervical sidebending. qPositive if symptoms are in the radial 3 digits and decreased with spine ipsilateral cervical sidebending. Test/Study\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\n69 (52, 84)\n56 (21, 86)\n…\n…\nUltrasonography\n…\n75 (55, 89)\n57 (18, 90)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nThüngen et al274j\nI\n55 (40, 69)\n100 (29, 100)\n…\n…\nEDS\n…\n50 (26, 74)\n47 (30, 65)\n…\n…\nClinical presentation\n…\n53 (36, 70)\n67 (30, 93)\n…\n…\nUltrasonography\n…\n54 (34, 73)\n43 (10, 82)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMacDermid and \nWessel173\nIV\n59\n61\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nGoloborod’ko113\nIV\n85\n95\n95\n87\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nAmirfeyz et al8\nIV\n93\n64\n72\n90\nSymptoms and EDS\nAsymptomatic individuals\nHand elevation test\nAhnk\nIII\n75.5\n98.8\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nAmirfeyz et al9\nIV\n88 (81, 94)\n98 (95, 100)\n98 (95, 100)\n88 (82, 95)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nAmirfeyz et al8\nIV\n98.6\n91.4\n92\n98.5\nSymptoms and EDS\nAsymptomatic individuals\nMa and Kim168\nIV\n86.7\n88.9\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nScratch-collapse test\nCheng et al62\nII\n99\n86\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nMakanji et al178\nII\n34\n61\n71\n25\nPositive EDS\nNegative EDS\nULNT1\nBueno-Gracia et al45l\nI\n58 (45, 71)\n84 (72, 96)\n…\n…\nClinical presentation and EDS\n…\nBueno-Gracia et al45m\nI\n74 (61, 83)\n50 (35, 65)\n…\n…\nClinical presentation and EDS\n…\nWainner et al283n\nII\n75 (58, 92)\n13 (4, 22)\n…\n…\nClinical presentation and EDS\n…\nVanti et al280n\nII\n92 (74, 98)\n15 (5, 36)\n…\n…\nClinical presentation and EDS\n…\nVanti et al281o\nII\n54 (35, 72)\n70 (48, 85)\n…\n…\nClinical presentation and EDS\n…\nVanti et al281o\nII\n40 (26, 56)\n79 (66, 88)\n58 (39, 76)\n65 (52, 76)\nClinical presentation and EDS\n…\nVanti et al281p\nII\n29 (16, 45)\n82 (69, 91)\n56 (34, 75)\n60 (47, 70)\nClinical presentation and EDS\n…\nVanti et al281q\nII\n6 (2, 19)\n93 (82, 98)\n40 (12, 77)\n56 (45, 67)\nClinical presentation and EDS\n…\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 309,
    "sentence_start": 1526,
    "sentence_end": 1528,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "qPositive if symptoms are in the radial 3 digits and decreased with spine ipsilateral cervical sidebending. Test/Study\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\n69 (52, 84)\n56 (21, 86)\n…\n…\nUltrasonography\n…\n75 (55, 89)\n57 (18, 90)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nThüngen et al274j\nI\n55 (40, 69)\n100 (29, 100)\n…\n…\nEDS\n…\n50 (26, 74)\n47 (30, 65)\n…\n…\nClinical presentation\n…\n53 (36, 70)\n67 (30, 93)\n…\n…\nUltrasonography\n…\n54 (34, 73)\n43 (10, 82)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMacDermid and \nWessel173\nIV\n59\n61\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nGoloborod’ko113\nIV\n85\n95\n95\n87\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nAmirfeyz et al8\nIV\n93\n64\n72\n90\nSymptoms and EDS\nAsymptomatic individuals\nHand elevation test\nAhnk\nIII\n75.5\n98.8\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nAmirfeyz et al9\nIV\n88 (81, 94)\n98 (95, 100)\n98 (95, 100)\n88 (82, 95)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nAmirfeyz et al8\nIV\n98.6\n91.4\n92\n98.5\nSymptoms and EDS\nAsymptomatic individuals\nMa and Kim168\nIV\n86.7\n88.9\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nScratch-collapse test\nCheng et al62\nII\n99\n86\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nMakanji et al178\nII\n34\n61\n71\n25\nPositive EDS\nNegative EDS\nULNT1\nBueno-Gracia et al45l\nI\n58 (45, 71)\n84 (72, 96)\n…\n…\nClinical presentation and EDS\n…\nBueno-Gracia et al45m\nI\n74 (61, 83)\n50 (35, 65)\n…\n…\nClinical presentation and EDS\n…\nWainner et al283n\nII\n75 (58, 92)\n13 (4, 22)\n…\n…\nClinical presentation and EDS\n…\nVanti et al280n\nII\n92 (74, 98)\n15 (5, 36)\n…\n…\nClinical presentation and EDS\n…\nVanti et al281o\nII\n54 (35, 72)\n70 (48, 85)\n…\n…\nClinical presentation and EDS\n…\nVanti et al281o\nII\n40 (26, 56)\n79 (66, 88)\n58 (39, 76)\n65 (52, 76)\nClinical presentation and EDS\n…\nVanti et al281p\nII\n29 (16, 45)\n82 (69, 91)\n56 (34, 75)\n60 (47, 70)\nClinical presentation and EDS\n…\nVanti et al281q\nII\n6 (2, 19)\n93 (82, 98)\n40 (12, 77)\n56 (45, 67)\nClinical presentation and EDS\n…\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 310,
    "sentence_start": 1527,
    "sentence_end": 1529,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Test/Study\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\n69 (52, 84)\n56 (21, 86)\n…\n…\nUltrasonography\n…\n75 (55, 89)\n57 (18, 90)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nThüngen et al274j\nI\n55 (40, 69)\n100 (29, 100)\n…\n…\nEDS\n…\n50 (26, 74)\n47 (30, 65)\n…\n…\nClinical presentation\n…\n53 (36, 70)\n67 (30, 93)\n…\n…\nUltrasonography\n…\n54 (34, 73)\n43 (10, 82)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nMacDermid and \nWessel173\nIV\n59\n61\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nGoloborod’ko113\nIV\n85\n95\n95\n87\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nAmirfeyz et al8\nIV\n93\n64\n72\n90\nSymptoms and EDS\nAsymptomatic individuals\nHand elevation test\nAhnk\nIII\n75.5\n98.8\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nAmirfeyz et al9\nIV\n88 (81, 94)\n98 (95, 100)\n98 (95, 100)\n88 (82, 95)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nAmirfeyz et al8\nIV\n98.6\n91.4\n92\n98.5\nSymptoms and EDS\nAsymptomatic individuals\nMa and Kim168\nIV\n86.7\n88.9\n…\n…\nEDS and ultrasonography\nAsymptomatic individuals\nScratch-collapse test\nCheng et al62\nII\n99\n86\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nMakanji et al178\nII\n34\n61\n71\n25\nPositive EDS\nNegative EDS\nULNT1\nBueno-Gracia et al45l\nI\n58 (45, 71)\n84 (72, 96)\n…\n…\nClinical presentation and EDS\n…\nBueno-Gracia et al45m\nI\n74 (61, 83)\n50 (35, 65)\n…\n…\nClinical presentation and EDS\n…\nWainner et al283n\nII\n75 (58, 92)\n13 (4, 22)\n…\n…\nClinical presentation and EDS\n…\nVanti et al280n\nII\n92 (74, 98)\n15 (5, 36)\n…\n…\nClinical presentation and EDS\n…\nVanti et al281o\nII\n54 (35, 72)\n70 (48, 85)\n…\n…\nClinical presentation and EDS\n…\nVanti et al281o\nII\n40 (26, 56)\n79 (66, 88)\n58 (39, 76)\n65 (52, 76)\nClinical presentation and EDS\n…\nVanti et al281p\nII\n29 (16, 45)\n82 (69, 91)\n56 (34, 75)\n60 (47, 70)\nClinical presentation and EDS\n…\nVanti et al281q\nII\n6 (2, 19)\n93 (82, 98)\n40 (12, 77)\n56 (45, 67)\nClinical presentation and EDS\n…\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 311,
    "sentence_start": 1528,
    "sentence_end": 1530,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nDiagnostic Accuracy Values for Provocative Tests (continued)\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\n69 (52, 84)\n56 (21, 86)\n…\n…\nUltrasonography\n…\n75 (55, 89)\n57 (18, 90)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nI\n55 (40, 69)\n100 (29, 100)\n…\n…\nEDS\n…\n50 (26, 74)\n47 (30, 65)\n…\n…\nClinical presentation\n…\n53 (36, 70)\n67 (30, 93)\n…\n…\nUltrasonography\n…\n54 (34, 73)\n43 (10, 82)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nIV\n59\n61\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nIV\n85\n95\n95\n87\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n93\n64\n72\n90\nSymptoms and EDS\nAsymptomatic individuals\nIII\n75.5\n98.8\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nIV\n88 (81, 94)\n98 (95, 100)\n98 (95, 100)\n88 (82, 95)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\n\n\n--- Page 29 ---\nCOLUMN 1:\nAbbreviations: CTQ-SSS, Boston Carpal Tunnel Questionnaire-symptom severity scale; –LR, negative likelihood ratio; +LR, positive likelihood ratio; ULNT, upper-limb neurodynamic \ntest.",
    "chunk_id": 312,
    "sentence_start": 1531,
    "sentence_end": 1533,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nDiagnostic Accuracy Values for Provocative Tests (continued)\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\n69 (52, 84)\n56 (21, 86)\n…\n…\nUltrasonography\n…\n75 (55, 89)\n57 (18, 90)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nI\n55 (40, 69)\n100 (29, 100)\n…\n…\nEDS\n…\n50 (26, 74)\n47 (30, 65)\n…\n…\nClinical presentation\n…\n53 (36, 70)\n67 (30, 93)\n…\n…\nUltrasonography\n…\n54 (34, 73)\n43 (10, 82)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nIV\n59\n61\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nIV\n85\n95\n95\n87\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n93\n64\n72\n90\nSymptoms and EDS\nAsymptomatic individuals\nIII\n75.5\n98.8\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nIV\n88 (81, 94)\n98 (95, 100)\n98 (95, 100)\n88 (82, 95)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\n\n\n--- Page 29 ---\nCOLUMN 1:\nAbbreviations: CTQ-SSS, Boston Carpal Tunnel Questionnaire-symptom severity scale; –LR, negative likelihood ratio; +LR, positive likelihood ratio; ULNT, upper-limb neurodynamic \ntest. *Values in parentheses are 95% confidence interval.",
    "chunk_id": 313,
    "sentence_start": 1532,
    "sentence_end": 1534,
    "section_type": "references",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nDiagnostic Accuracy Values for Provocative Tests (continued)\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nReference Standard\nComparison Group\n69 (52, 84)\n56 (21, 86)\n…\n…\nUltrasonography\n…\n75 (55, 89)\n57 (18, 90)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nI\n55 (40, 69)\n100 (29, 100)\n…\n…\nEDS\n…\n50 (26, 74)\n47 (30, 65)\n…\n…\nClinical presentation\n…\n53 (36, 70)\n67 (30, 93)\n…\n…\nUltrasonography\n…\n54 (34, 73)\n43 (10, 82)\n…\n…\nPostoperative resolution of \nsymptoms\n…\nIV\n59\n61\n…\n…\nSystematic review\nAverage across asymptomatic and \nsymptomatic subjects with negative \nelectrodiagnostic tests\nIV\n85\n95\n95\n87\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\nIV\n93\n64\n72\n90\nSymptoms and EDS\nAsymptomatic individuals\nIII\n75.5\n98.8\n…\n…\nClinical presentation and EDS\nAsymptomatic individuals\nIV\n88 (81, 94)\n98 (95, 100)\n98 (95, 100)\n88 (82, 95)\nPostoperative resolution of \nsymptoms\nAsymptomatic hands\n\n\n--- Page 29 ---\nCOLUMN 1:\nAbbreviations: CTQ-SSS, Boston Carpal Tunnel Questionnaire-symptom severity scale; –LR, negative likelihood ratio; +LR, positive likelihood ratio; ULNT, upper-limb neurodynamic \ntest. *Values in parentheses are 95% confidence interval. aA reflex hammer, held 6 inches above the patient’s wrist crease, is allowed to fall and strike the patient between the tendons of the flexor carpi radialis and palmaris longus, with a \npositive test being a nonpainful tingling sensation radiating distally along the path of the median nerve.",
    "chunk_id": 314,
    "sentence_start": 1533,
    "sentence_end": 1535,
    "section_type": "references",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "*Values in parentheses are 95% confidence interval. aA reflex hammer, held 6 inches above the patient’s wrist crease, is allowed to fall and strike the patient between the tendons of the flexor carpi radialis and palmaris longus, with a \npositive test being a nonpainful tingling sensation radiating distally along the path of the median nerve. bThe examiner taps the patient with a reflex hammer using mild to moderate force between the tendons of the flexor carpi radialis and palmaris longus, with a positive test including \ndiscomfort or pain at the wrist or radiating distally along the nerve’s course. cPositive if the patient’s clinical symptoms are provoked at the wrist or hand and changed during structural differentiation. dPositive if any symptoms were provoked at the wrist or radial 3 digits and changed during structural differentiation.",
    "chunk_id": 315,
    "sentence_start": 1534,
    "sentence_end": 1538,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "cPositive if the patient’s clinical symptoms are provoked at the wrist or hand and changed during structural differentiation. dPositive if any symptoms were provoked at the wrist or radial 3 digits and changed during structural differentiation. eAny of the following were considered positive: (1) symptoms were reproduced, (2) side-to-side differences in elbow extension (greater than 10°) for part A or wrist flexion (part B) on \ncompletion of all motion sequences, (3) contralateral neck sidebending increased symptoms or ipsilateral sidebending decreased symptoms in the symptomatic limb. fPositive if symptoms are in the radial 3 digits. gPositive if symptoms are in the radial 3 digits and increased with contralateral cervical sidebending. hPositive if symptoms are in the radial 3 digits and decreased with spine ipsilateral cervical sidebending.",
    "chunk_id": 316,
    "sentence_start": 1537,
    "sentence_end": 1542,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "gPositive if symptoms are in the radial 3 digits and increased with contralateral cervical sidebending. hPositive if symptoms are in the radial 3 digits and decreased with spine ipsilateral cervical sidebending. TABLE 4\nLikelihood Ratios for Provocative Tests\nTest/Study\nLevel of \nEvidence\n+LR*\n–LR*\nPhalen test\nWainner et al283\nII\n1.30 (0.94, 1.7)\n0.58 (0.27, 1.3)\nBoland and Kiernan42\nIV\n2.54 (0.94, 6.87)\n0.49 (0.31, 0.76)\nTinel sign\nWainner et al283a\nII\n0.98 (0.56, 1.7)\n0.78 (0.52, 1.2)\nWainner et al283b\nII\n1.4 (0.84, 2.5)\n1.0 (0.69, 1.5)\nCarpal compression test\nWainner et al283\nII\n0.91 (0.65, 1.3)\n1.20 (0.62, 2.4)\nULNT1\nBueno-Gracia et al45c\nI\n3.67 (1.70, 7.89)\n0.50 (0.36, 0.70)\nBueno-Gracia et al45d\nI\n1.47 (1.03, 2.10)\n0.53 (0.31, 0.90)\nWainner et al283e\nII\n0.86 (0.67, 1.1)\n1.90 (0.72, 5.1)\nVanti et al280e\nII\n1.08 (0.38, 3.08)\n0.56 (0.19, 1.59)\nVanti et al280f\nII\n1.80 (1.13, 2.88)\n0.65 (0.41, 1.04)\nVanti et al281f\nII\n1.96 (1.28, 3.01)\n0.75 (0.49, 1.16)\nVanti et al281g\nII\n1.61 (0.94, 2.76)\n0.87 (0.51, 1.49)\nVanti et al281h\nII\n0.86 (0.22, 3.30)\n1.01 (0.26, 3.89)\nCombinations\nBoland and Kiernan42 (Phalen and thenar pinprick sensation)\nIV\n2.22 (0.81, 6.03)\n0.60 (0.39, 0.90)\nBoland and Kiernan42 (carpal compression and thenar pinprick sensation)\nIV\n3.29 (0.20, 53.20)\n0.91 (0.79, 1.04)\nWainner et al283 (shaking hands relieves symptoms, wrist ratio index greater than \n0.67, CTQ-SSS score greater than 1.9, diminished sensation in median nerve \ndistribution, and aged older than 45 y)\nII\n1.10 (1.0, 1.3) with 2 or more positive tests\n2.10 (1.6, 2.8) with 3 or more positive tests\n4.60 (2.5, 8.7) with 4 or more positive tests\n18.30 (1.0, 328.3) with all 5 tests positive\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 317,
    "sentence_start": 1541,
    "sentence_end": 1543,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "hPositive if symptoms are in the radial 3 digits and decreased with spine ipsilateral cervical sidebending. TABLE 4\nLikelihood Ratios for Provocative Tests\nTest/Study\nLevel of \nEvidence\n+LR*\n–LR*\nPhalen test\nWainner et al283\nII\n1.30 (0.94, 1.7)\n0.58 (0.27, 1.3)\nBoland and Kiernan42\nIV\n2.54 (0.94, 6.87)\n0.49 (0.31, 0.76)\nTinel sign\nWainner et al283a\nII\n0.98 (0.56, 1.7)\n0.78 (0.52, 1.2)\nWainner et al283b\nII\n1.4 (0.84, 2.5)\n1.0 (0.69, 1.5)\nCarpal compression test\nWainner et al283\nII\n0.91 (0.65, 1.3)\n1.20 (0.62, 2.4)\nULNT1\nBueno-Gracia et al45c\nI\n3.67 (1.70, 7.89)\n0.50 (0.36, 0.70)\nBueno-Gracia et al45d\nI\n1.47 (1.03, 2.10)\n0.53 (0.31, 0.90)\nWainner et al283e\nII\n0.86 (0.67, 1.1)\n1.90 (0.72, 5.1)\nVanti et al280e\nII\n1.08 (0.38, 3.08)\n0.56 (0.19, 1.59)\nVanti et al280f\nII\n1.80 (1.13, 2.88)\n0.65 (0.41, 1.04)\nVanti et al281f\nII\n1.96 (1.28, 3.01)\n0.75 (0.49, 1.16)\nVanti et al281g\nII\n1.61 (0.94, 2.76)\n0.87 (0.51, 1.49)\nVanti et al281h\nII\n0.86 (0.22, 3.30)\n1.01 (0.26, 3.89)\nCombinations\nBoland and Kiernan42 (Phalen and thenar pinprick sensation)\nIV\n2.22 (0.81, 6.03)\n0.60 (0.39, 0.90)\nBoland and Kiernan42 (carpal compression and thenar pinprick sensation)\nIV\n3.29 (0.20, 53.20)\n0.91 (0.79, 1.04)\nWainner et al283 (shaking hands relieves symptoms, wrist ratio index greater than \n0.67, CTQ-SSS score greater than 1.9, diminished sensation in median nerve \ndistribution, and aged older than 45 y)\nII\n1.10 (1.0, 1.3) with 2 or more positive tests\n2.10 (1.6, 2.8) with 3 or more positive tests\n4.60 (2.5, 8.7) with 4 or more positive tests\n18.30 (1.0, 328.3) with all 5 tests positive\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 318,
    "sentence_start": 1542,
    "sentence_end": 1544,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "TABLE 4\nLikelihood Ratios for Provocative Tests\nTest/Study\nLevel of \nEvidence\n+LR*\n–LR*\nPhalen test\nWainner et al283\nII\n1.30 (0.94, 1.7)\n0.58 (0.27, 1.3)\nBoland and Kiernan42\nIV\n2.54 (0.94, 6.87)\n0.49 (0.31, 0.76)\nTinel sign\nWainner et al283a\nII\n0.98 (0.56, 1.7)\n0.78 (0.52, 1.2)\nWainner et al283b\nII\n1.4 (0.84, 2.5)\n1.0 (0.69, 1.5)\nCarpal compression test\nWainner et al283\nII\n0.91 (0.65, 1.3)\n1.20 (0.62, 2.4)\nULNT1\nBueno-Gracia et al45c\nI\n3.67 (1.70, 7.89)\n0.50 (0.36, 0.70)\nBueno-Gracia et al45d\nI\n1.47 (1.03, 2.10)\n0.53 (0.31, 0.90)\nWainner et al283e\nII\n0.86 (0.67, 1.1)\n1.90 (0.72, 5.1)\nVanti et al280e\nII\n1.08 (0.38, 3.08)\n0.56 (0.19, 1.59)\nVanti et al280f\nII\n1.80 (1.13, 2.88)\n0.65 (0.41, 1.04)\nVanti et al281f\nII\n1.96 (1.28, 3.01)\n0.75 (0.49, 1.16)\nVanti et al281g\nII\n1.61 (0.94, 2.76)\n0.87 (0.51, 1.49)\nVanti et al281h\nII\n0.86 (0.22, 3.30)\n1.01 (0.26, 3.89)\nCombinations\nBoland and Kiernan42 (Phalen and thenar pinprick sensation)\nIV\n2.22 (0.81, 6.03)\n0.60 (0.39, 0.90)\nBoland and Kiernan42 (carpal compression and thenar pinprick sensation)\nIV\n3.29 (0.20, 53.20)\n0.91 (0.79, 1.04)\nWainner et al283 (shaking hands relieves symptoms, wrist ratio index greater than \n0.67, CTQ-SSS score greater than 1.9, diminished sensation in median nerve \ndistribution, and aged older than 45 y)\nII\n1.10 (1.0, 1.3) with 2 or more positive tests\n2.10 (1.6, 2.8) with 3 or more positive tests\n4.60 (2.5, 8.7) with 4 or more positive tests\n18.30 (1.0, 328.3) with all 5 tests positive\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 319,
    "sentence_start": 1543,
    "sentence_end": 1545,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nLikelihood Ratios for Provocative Tests\nLevel of \nEvidence\n+LR*\n–LR*\nII\n1.30 (0.94, 1.7)\n0.58 (0.27\nIV\n2.54 (0.94, 6.87)\n0.49 (0.31, \nII\n0.98 (0.56, 1.7)\n0.78 (0.52\nII\n1.4 (0.84, 2.5)\n1.0 (0.69, \nII\n0.91 (0.65, 1.3)\n1.20 (0.62\nI\n3.67 (1.70, 7.89)\n0.50 (0.36,\nI\n1.47 (1.03, 2.10)\n0.53 (0.31, \nII\n0.86 (0.67, 1.1)\n1.90 (0.72\nII\n1.08 (0.38, 3.08)\n0.56 (0.19, \nII\n1.80 (1.13, 2.88)\n0.65 (0.41, \nII\n1.96 (1.28, 3.01)\n0.75 (0.49,\nII\n1.61 (0.94, 2.76)\n0.87 (0.51, \nII\n0.86 (0.22, 3.30)\n1.01 (0.26, \nn and thenar pinprick sensation)\nIV\n2.22 (0.81, 6.03)\n0.60 (0.39, \ncompression and thenar pinprick sensation)\nIV\n3.29 (0.20, 53.20)\n0.91 (0.79, \nds relieves symptoms, wrist ratio index greater than \ner than 1.9, diminished sensation in median nerve \ner than 45 y)\nII\n1.10 (1.0, 1.3) with 2 or more positive tests\n2.10 (1.6, 2.8) with 3 or more positive tests\n4.60 (2.5, 8.7) with 4 or more positive tests\n18.30 (1.0, 328.3) with all 5 tests positive\n\n\n--- Page 30 ---\nCOLUMN 1:\nAbbreviation: ICC, intraclass correlation coefficient; NPV, negative predictive value; PPV, positive predictive value.",
    "chunk_id": 320,
    "sentence_start": 1546,
    "sentence_end": 1548,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nLikelihood Ratios for Provocative Tests\nLevel of \nEvidence\n+LR*\n–LR*\nII\n1.30 (0.94, 1.7)\n0.58 (0.27\nIV\n2.54 (0.94, 6.87)\n0.49 (0.31, \nII\n0.98 (0.56, 1.7)\n0.78 (0.52\nII\n1.4 (0.84, 2.5)\n1.0 (0.69, \nII\n0.91 (0.65, 1.3)\n1.20 (0.62\nI\n3.67 (1.70, 7.89)\n0.50 (0.36,\nI\n1.47 (1.03, 2.10)\n0.53 (0.31, \nII\n0.86 (0.67, 1.1)\n1.90 (0.72\nII\n1.08 (0.38, 3.08)\n0.56 (0.19, \nII\n1.80 (1.13, 2.88)\n0.65 (0.41, \nII\n1.96 (1.28, 3.01)\n0.75 (0.49,\nII\n1.61 (0.94, 2.76)\n0.87 (0.51, \nII\n0.86 (0.22, 3.30)\n1.01 (0.26, \nn and thenar pinprick sensation)\nIV\n2.22 (0.81, 6.03)\n0.60 (0.39, \ncompression and thenar pinprick sensation)\nIV\n3.29 (0.20, 53.20)\n0.91 (0.79, \nds relieves symptoms, wrist ratio index greater than \ner than 1.9, diminished sensation in median nerve \ner than 45 y)\nII\n1.10 (1.0, 1.3) with 2 or more positive tests\n2.10 (1.6, 2.8) with 3 or more positive tests\n4.60 (2.5, 8.7) with 4 or more positive tests\n18.30 (1.0, 328.3) with all 5 tests positive\n\n\n--- Page 30 ---\nCOLUMN 1:\nAbbreviation: ICC, intraclass correlation coefficient; NPV, negative predictive value; PPV, positive predictive value. *Values in parentheses are 95% confidence interval.",
    "chunk_id": 321,
    "sentence_start": 1547,
    "sentence_end": 1549,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nLikelihood Ratios for Provocative Tests\nLevel of \nEvidence\n+LR*\n–LR*\nII\n1.30 (0.94, 1.7)\n0.58 (0.27\nIV\n2.54 (0.94, 6.87)\n0.49 (0.31, \nII\n0.98 (0.56, 1.7)\n0.78 (0.52\nII\n1.4 (0.84, 2.5)\n1.0 (0.69, \nII\n0.91 (0.65, 1.3)\n1.20 (0.62\nI\n3.67 (1.70, 7.89)\n0.50 (0.36,\nI\n1.47 (1.03, 2.10)\n0.53 (0.31, \nII\n0.86 (0.67, 1.1)\n1.90 (0.72\nII\n1.08 (0.38, 3.08)\n0.56 (0.19, \nII\n1.80 (1.13, 2.88)\n0.65 (0.41, \nII\n1.96 (1.28, 3.01)\n0.75 (0.49,\nII\n1.61 (0.94, 2.76)\n0.87 (0.51, \nII\n0.86 (0.22, 3.30)\n1.01 (0.26, \nn and thenar pinprick sensation)\nIV\n2.22 (0.81, 6.03)\n0.60 (0.39, \ncompression and thenar pinprick sensation)\nIV\n3.29 (0.20, 53.20)\n0.91 (0.79, \nds relieves symptoms, wrist ratio index greater than \ner than 1.9, diminished sensation in median nerve \ner than 45 y)\nII\n1.10 (1.0, 1.3) with 2 or more positive tests\n2.10 (1.6, 2.8) with 3 or more positive tests\n4.60 (2.5, 8.7) with 4 or more positive tests\n18.30 (1.0, 328.3) with all 5 tests positive\n\n\n--- Page 30 ---\nCOLUMN 1:\nAbbreviation: ICC, intraclass correlation coefficient; NPV, negative predictive value; PPV, positive predictive value. *Values in parentheses are 95% confidence interval. aUsing the 2.83 filament as normal.",
    "chunk_id": 322,
    "sentence_start": 1548,
    "sentence_end": 1550,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "*Values in parentheses are 95% confidence interval. aUsing the 2.83 filament as normal. Sensitivity and specificity were reported as part of the systematic review by MacDermid and Wessel.173\nbThe highest value of any radial digit was used. cThe long finger was used. dUsing the 3.22 filament as normal. Sensitivity and specificity were reported as part of the systematic review by MacDermid and Wessel.173\neUsing the 2.83 filament as normal, with any radial digit testing higher than 2.83. fUsing the 3.22 filament as normal and comparing the middle finger with the small finger. gPatients with moderate to severe carpal tunnel syndrome (determined by electrodiagnostic studies). hUsing the 3.22 filament as normal, with any radial digit testing higher than 3.22. iUsing the 2.83 filament as normal. jUsing the 3.61 filament as normal. kLess than 4 mm is considered normal. lLess than 5 mm is considered normal; electrodiagnostic tests were used as the gold standard.",
    "chunk_id": 323,
    "sentence_start": 1549,
    "sentence_end": 1561,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "kLess than 4 mm is considered normal. lLess than 5 mm is considered normal; electrodiagnostic tests were used as the gold standard. mLess than 5 mm is considered normal; clinical examination was used as the gold standard.",
    "chunk_id": 324,
    "sentence_start": 1560,
    "sentence_end": 1562,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "lLess than 5 mm is considered normal; electrodiagnostic tests were used as the gold standard. mLess than 5 mm is considered normal; clinical examination was used as the gold standard. TABLE 5\nDiagnostic Accuracy and Reliability Values for Sensory Measures\nTest/Study\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nIntrarater Reliability\nInterrater Reliability*\nSemmes-Weinstein mono­\nfilament testing\nMacDermid and \nWessel173\nI\n72\n62\n…\n…\n…\n…\nMacDermid et al171a\nII\n…\n…\n…\nκ = 0.49b, κ = 0.44c\nMacDermid et al171d\nII\n…\n…\n…\nκ = 0.39b, κ = 0.51c\nMacDermid et al170\nII\n…\n…\n…\n…\n…\nκ = 0.22 (0.26, 0.42)\nYildirim and Gunduz300\nII\n98e\n17\n44\n93\n…\n…\n29\n97f\n88\n68\n…\n…\nYildirim and Gunduz300g\nII\n80h\n93\n83\n92\n…\n…\nClark et al67i\nIV\nThenar eminence, 73; thumb, 59; index, \n61; middle, 64; ring, 52; small, 44\n<14\n…\n…\n…\n…\nClark et al67j\nIV\nThenar eminence, 28; thumb, 20; index, \n22; middle, 22; ring, 16; small, 13\n<14\n…\n…\n…\n…\nMarx et al183\nIV\n…\n…\n…\n…\nICC = 0.71\nICC = 0.15\n2-point discrimination\nGerr and Letz107\nI\n28k\n88\n42\n80\n…\n…\nThüngen et al274\nII\n33 (20, 48)l\n67 (9, 99)l\n…\n…\n…\n…\n38 (18, 62)m\n71 (52, 86)m\n…\n…\n…\n…\nMarlowe et al182\nIII\n25\n87.5\n85\n29.2\n…\n…\nMacDermid and \nWessel173\nIII\n24\n95\n…\n…\n…\n…\nMarx et al183\nIV\n...",
    "chunk_id": 325,
    "sentence_start": 1561,
    "sentence_end": 1566,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Static ICC = 0.77; moving \nICC = 0.58\nStatic ICC = 0.66; movin\nICC = 0.45\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 326,
    "sentence_start": 1565,
    "sentence_end": 1571,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nDiagnostic Accuracy and Reliability Values for Sensory Measures\nLevel of \nEvidence\nSensitivity, %*\nSpecificity, %*\nPPV, %*\nNPV, %*\nIntrarater Reliability\nInterrater Reliability*\nI\n72\n62\n…\n…\n…\n…\nII\n…\n…\n…\nκ = 0.49b, κ = 0.44c\nII\n…\n…\n…\nκ = 0.39b, κ = 0.51c\nII\n…\n…\n…\n…\n…\nκ = 0.22 (0.26, 0.42)\nII\n98e\n17\n44\n93\n…\n…\n29\n97f\n88\n68\n…\n…\nII\n80h\n93\n83\n92\n…\n…\nIV\nThenar eminence, 73; thumb, 59; index, \n61; middle, 64; ring, 52; small, 44\n<14\n…\n…\n…\n…\nIV\nThenar eminence, 28; thumb, 20; index, \n22; middle, 22; ring, 16; small, 13\n<14\n…\n…\n…\n…\nIV\n…\n…\n…\n…\nICC = 0.71\nICC = 0.15\nI\n28k\n88\n42\n80\n…\n…\nII\n33 (20, 48)l\n67 (9, 99)l\n…\n…\n…\n…\n38 (18, 62)m\n71 (52, 86)m\n…\n…\n…\n…\nIII\n25\n87.5\n85\n29.2\n…\n…\nIII\n24\n95\n…\n…\n…\n…\nIV\n...",
    "chunk_id": 327,
    "sentence_start": 1570,
    "sentence_end": 1575,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Static ICC = 0.77; moving \nICC = 0.58\nStatic ICC = 0.66; moving \nICC = 0.45\n\n\n--- Page 31 ---\nCOLUMN 1:\nAbbreviations: CTS, carpal tunnel syndrome; NPV, negative predictive value; PPV, positive predictive value.",
    "chunk_id": 328,
    "sentence_start": 1574,
    "sentence_end": 1576,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Static ICC = 0.77; moving \nICC = 0.58\nStatic ICC = 0.66; moving \nICC = 0.45\n\n\n--- Page 31 ---\nCOLUMN 1:\nAbbreviations: CTS, carpal tunnel syndrome; NPV, negative predictive value; PPV, positive predictive value. *Sensitivity and specificity were reported as part of the systematic review by MacDermid and Wessel.173\nTABLE 7\nDiagnostic Accuracy Values and Known-Groups \nValidity for Vibration Sense Testing\nStudy\nLevel of \nEvidence\nVibration Frequency\nSensitivity, %\nSpecificity, %\nPPV, %\nNPV, %\nDifference Versus Control Group\nCheckosky et al59*\nI\n1 Hz\n…\n…\nP = .81\n10 Hz\n…\n…\nP = .028\n300 Hz\n…\n…\nP = .43\nWerner et al291\nI\n8 Hz\n…\n…\n…\n…\nP = .002\n16 Hz\n…\n…\n…\n…\nP = .11\n32.5 Hz\n…\n…\n…\n…\nP = .16\n63 Hz\n…\n…\n…\n…\nP = .02\n125 Hz\n…\n…\n…\n…\nP = .23\n250 Hz\n…\n…\n…\n…\nP = .29\n500 Hz\n…\n…\n…\n…\nP = .18\nMultifrequency\n69.7\n57.5\n28.8\n88.5\nGerr and Letz107*\nI\n128 Hz\n57\n82\nHardy et al126\nIII\n50 Hz\n78\n53\n…\n…\n150 Hz\n58\n68\n…\n…\nMacDermid and Wessel173\nIII\n256 Hz\n55\n81\n…\n…\nMultifrequency\n50\n73\n…\n…\nJetzer139\nIV\nMultifrequency\n…\n…\n…\n…\nWorkers with CTS symptoms compared to those \nwithout (P<.01); workers with confirmed CTS using \nelectrodiagnostic studies compared to other workers\n(P<.0001)\nAbbreviations: ICC, intraclass correlation coefficient; SEM, standard error of the measurement.",
    "chunk_id": 329,
    "sentence_start": 1575,
    "sentence_end": 1577,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Static ICC = 0.77; moving \nICC = 0.58\nStatic ICC = 0.66; moving \nICC = 0.45\n\n\n--- Page 31 ---\nCOLUMN 1:\nAbbreviations: CTS, carpal tunnel syndrome; NPV, negative predictive value; PPV, positive predictive value. *Sensitivity and specificity were reported as part of the systematic review by MacDermid and Wessel.173\nTABLE 7\nDiagnostic Accuracy Values and Known-Groups \nValidity for Vibration Sense Testing\nStudy\nLevel of \nEvidence\nVibration Frequency\nSensitivity, %\nSpecificity, %\nPPV, %\nNPV, %\nDifference Versus Control Group\nCheckosky et al59*\nI\n1 Hz\n…\n…\nP = .81\n10 Hz\n…\n…\nP = .028\n300 Hz\n…\n…\nP = .43\nWerner et al291\nI\n8 Hz\n…\n…\n…\n…\nP = .002\n16 Hz\n…\n…\n…\n…\nP = .11\n32.5 Hz\n…\n…\n…\n…\nP = .16\n63 Hz\n…\n…\n…\n…\nP = .02\n125 Hz\n…\n…\n…\n…\nP = .23\n250 Hz\n…\n…\n…\n…\nP = .29\n500 Hz\n…\n…\n…\n…\nP = .18\nMultifrequency\n69.7\n57.5\n28.8\n88.5\nGerr and Letz107*\nI\n128 Hz\n57\n82\nHardy et al126\nIII\n50 Hz\n78\n53\n…\n…\n150 Hz\n58\n68\n…\n…\nMacDermid and Wessel173\nIII\n256 Hz\n55\n81\n…\n…\nMultifrequency\n50\n73\n…\n…\nJetzer139\nIV\nMultifrequency\n…\n…\n…\n…\nWorkers with CTS symptoms compared to those \nwithout (P<.01); workers with confirmed CTS using \nelectrodiagnostic studies compared to other workers\n(P<.0001)\nAbbreviations: ICC, intraclass correlation coefficient; SEM, standard error of the measurement. *Values in parentheses are 95% confidence interval.",
    "chunk_id": 330,
    "sentence_start": 1576,
    "sentence_end": 1578,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "*Sensitivity and specificity were reported as part of the systematic review by MacDermid and Wessel.173\nTABLE 7\nDiagnostic Accuracy Values and Known-Groups \nValidity for Vibration Sense Testing\nStudy\nLevel of \nEvidence\nVibration Frequency\nSensitivity, %\nSpecificity, %\nPPV, %\nNPV, %\nDifference Versus Control Group\nCheckosky et al59*\nI\n1 Hz\n…\n…\nP = .81\n10 Hz\n…\n…\nP = .028\n300 Hz\n…\n…\nP = .43\nWerner et al291\nI\n8 Hz\n…\n…\n…\n…\nP = .002\n16 Hz\n…\n…\n…\n…\nP = .11\n32.5 Hz\n…\n…\n…\n…\nP = .16\n63 Hz\n…\n…\n…\n…\nP = .02\n125 Hz\n…\n…\n…\n…\nP = .23\n250 Hz\n…\n…\n…\n…\nP = .29\n500 Hz\n…\n…\n…\n…\nP = .18\nMultifrequency\n69.7\n57.5\n28.8\n88.5\nGerr and Letz107*\nI\n128 Hz\n57\n82\nHardy et al126\nIII\n50 Hz\n78\n53\n…\n…\n150 Hz\n58\n68\n…\n…\nMacDermid and Wessel173\nIII\n256 Hz\n55\n81\n…\n…\nMultifrequency\n50\n73\n…\n…\nJetzer139\nIV\nMultifrequency\n…\n…\n…\n…\nWorkers with CTS symptoms compared to those \nwithout (P<.01); workers with confirmed CTS using \nelectrodiagnostic studies compared to other workers\n(P<.0001)\nAbbreviations: ICC, intraclass correlation coefficient; SEM, standard error of the measurement. *Values in parentheses are 95% confidence interval. aHubbard MC, MacDermid JC, Kramer JF, Birmingham TB.",
    "chunk_id": 331,
    "sentence_start": 1577,
    "sentence_end": 1579,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "*Values in parentheses are 95% confidence interval. aHubbard MC, MacDermid JC, Kramer JF, Birmingham TB. Quantitative vibration threshold testing in carpal tunnel syndrome: analysis strategies for optimizing reliability. Reliability of sensory threshold measurement using a digital vibrogram. cAuthors recommend 1 practice trial. TABLE 6\nReliability Values for Vibration Sense Testing\nStudy\nLevel of \nEvidence\nVibration Frequency\nInstrument\nIntrarater Reliability*\nInterrater Reliability*\nHubbard et ala\nII\n50 Hz\nPVC50 computerized \nvibrometer\nRight hand: ICC = 0.86 (0.77, 0.92); \nSEM, 5.9\nLeft hand: ICC = 0.89 (0.81, 0.93); \nSEM, 4.8\n…\nMacDermid et al170\nII\n256 Hz\nTuning fork\n…\nκ = 0.71 (0.56, 0.86)\nGrunert et alb\nIV\n8, 16, 32.5, 63, 125, 250, 500 Hz\nBruel and Kjaer vibrometer\nr = 0.72-0.87c\n…\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 332,
    "sentence_start": 1578,
    "sentence_end": 1590,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nDiagnostic Accuracy Values and Known-Groups \nValidity for Vibration Sense Testing\nLevel of \nEvidence\nVibration Frequency\nSensitivity, %\nSpecificity, %\nPPV, %\nNPV, %\nDifference Versus Control Group\nI\n1 Hz\n…\n…\nP = .81\n10 Hz\n…\n…\nP = .028\n300 Hz\n…\n…\nP = .43\nI\n8 Hz\n…\n…\n…\n…\nP = .002\n16 Hz\n…\n…\n…\n…\nP = .11\n32.5 Hz\n…\n…\n…\n…\nP = .16\n63 Hz\n…\n…\n…\n…\nP = .02\n125 Hz\n…\n…\n…\n…\nP = .23\n250 Hz\n…\n…\n…\n…\nP = .29\n500 Hz\n…\n…\n…\n…\nP = .18\nMultifrequency\n69.7\n57.5\n28.8\n88.5\nI\n128 Hz\n57\n82\nIII\n50 Hz\n78\n53\n…\n…\n150 Hz\n58\n68\n…\n…\nIII\n256 Hz\n55\n81\n…\n…\nMultifrequency\n50\n73\n…\n…\nIV\nMultifrequency\n…\n…\n…\n…\nWorkers with CTS symptoms compared to those \nwithout (P<.01); workers with confirmed CTS using \nelectrodiagnostic studies compared to other workers \n(P<.0001)\nass correlation coefficient; SEM, standard error of the measurement. JC, Kramer JF, Birmingham TB.",
    "chunk_id": 333,
    "sentence_start": 1591,
    "sentence_end": 1595,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "JC, Kramer JF, Birmingham TB. Quantitative vibration threshold testing in carpal tunnel syndrome: analysis strategies for optimizing reliability. Reliability of sensory threshold measurement using a digital vibrogram. Reliability Values for Vibration Sense Testing\nLevel of \nEvidence\nVibration Frequency\nInstrument\nIntrarater Reliability*\nInterrater Reliability*\nII\n50 Hz\nPVC50 computerized \nvibrometer\nRight hand: ICC = 0.86 (0.77, 0.92); \nSEM, 5.9\nLeft hand: ICC = 0.89 (0.81, 0.93); \nSEM, 4.8\n…\nII\n256 Hz\nTuning fork\n…\nκ = 0.71 (0.56, 0.86)\nIV\n8, 16, 32.5, 63, 125, 250, 500 Hz\nBruel and Kjaer vibrometer\nr = 0.72-0.87c\n…\n\n\n--- Page 32 ---\nCOLUMN 1:\nCLINICAL PRACTICE GUIDELINES\nExamination\nOUTCOME MEASURES\nActivity Limitations/Self-reported Measures\nBoston Carpal Tunnel Questionnaire-Symptom Severity Scale\nII\nThe Boston Carpal Tunnel Questionnaire-symptom \nseverity scale (CTQ-SSS) is an 11-item questionnaire \nused to assess symptom severity in individuals with \nCTS.",
    "chunk_id": 334,
    "sentence_start": 1594,
    "sentence_end": 1603,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Reliability Values for Vibration Sense Testing\nLevel of \nEvidence\nVibration Frequency\nInstrument\nIntrarater Reliability*\nInterrater Reliability*\nII\n50 Hz\nPVC50 computerized \nvibrometer\nRight hand: ICC = 0.86 (0.77, 0.92); \nSEM, 5.9\nLeft hand: ICC = 0.89 (0.81, 0.93); \nSEM, 4.8\n…\nII\n256 Hz\nTuning fork\n…\nκ = 0.71 (0.56, 0.86)\nIV\n8, 16, 32.5, 63, 125, 250, 500 Hz\nBruel and Kjaer vibrometer\nr = 0.72-0.87c\n…\n\n\n--- Page 32 ---\nCOLUMN 1:\nCLINICAL PRACTICE GUIDELINES\nExamination\nOUTCOME MEASURES\nActivity Limitations/Self-reported Measures\nBoston Carpal Tunnel Questionnaire-Symptom Severity Scale\nII\nThe Boston Carpal Tunnel Questionnaire-symptom \nseverity scale (CTQ-SSS) is an 11-item questionnaire \nused to assess symptom severity in individuals with \nCTS. Each item is scored on a Likert scale from 1 to 5 (5 being \nworst), with the patient’s CTQ-SSS score being the average \nscore of all items. Final scores can range from 1 (no symptoms) \nto 5 (worst symptoms).",
    "chunk_id": 335,
    "sentence_start": 1602,
    "sentence_end": 1605,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Each item is scored on a Likert scale from 1 to 5 (5 being \nworst), with the patient’s CTQ-SSS score being the average \nscore of all items. Final scores can range from 1 (no symptoms) \nto 5 (worst symptoms). Internal consistency (Cronbach α = \n.89162 and .9630) and test-retest reliability (r = 0.82-0.95)30,118,162 \nare excellent.",
    "chunk_id": 336,
    "sentence_start": 1604,
    "sentence_end": 1606,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Final scores can range from 1 (no symptoms) \nto 5 (worst symptoms). Internal consistency (Cronbach α = \n.89162 and .9630) and test-retest reliability (r = 0.82-0.95)30,118,162 \nare excellent. The CTQ-SSS shows a strong correlation with \nthe Disabilities of the Arm, Shoulder and Hand (DASH) ques­\ntionnaire (r = 0.74-0.77).30,101 CTQ-SSS scores have shown \nweak to no correlation with NCS,30,83,162 but it has demonstrat­\ned higher sensitivity to change than any other outcome mea­\nsure in individuals following surgery at 6 weeks,30,101 3 \nmonths,6,23,101,118 4 months,138 6 months,19,58 8 months,138 and 14 \nmonths.162 The CTQ-SSS has also been shown to be responsive \nin individuals following 6 weeks of orthosis management64 and \n3 weeks following cortisone injection.219\nII\nConflicting results have been published on the pre­\ndictive and discriminant validity of the CTQ-SSS.",
    "chunk_id": 337,
    "sentence_start": 1605,
    "sentence_end": 1607,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Internal consistency (Cronbach α = \n.89162 and .9630) and test-retest reliability (r = 0.82-0.95)30,118,162 \nare excellent. The CTQ-SSS shows a strong correlation with \nthe Disabilities of the Arm, Shoulder and Hand (DASH) ques­\ntionnaire (r = 0.74-0.77).30,101 CTQ-SSS scores have shown \nweak to no correlation with NCS,30,83,162 but it has demonstrat­\ned higher sensitivity to change than any other outcome mea­\nsure in individuals following surgery at 6 weeks,30,101 3 \nmonths,6,23,101,118 4 months,138 6 months,19,58 8 months,138 and 14 \nmonths.162 The CTQ-SSS has also been shown to be responsive \nin individuals following 6 weeks of orthosis management64 and \n3 weeks following cortisone injection.219\nII\nConflicting results have been published on the pre­\ndictive and discriminant validity of the CTQ-SSS. Baker and Livengood27 reported that baseline score \nwas a significant predictor of progression to surgery in patients \nwithout atrophy in the thenar muscles (OR = 12.5; 95% CI: 3.1, \n50.7), and Boyd et al43 concluded that baseline CTQ-SSS was \na predictor of failed nonsurgical management whereas the \nBoston Carpal Tunnel Questionnaire-functional scale (CTQ-\nFS), the DASH, the Medical Outcomes Study 36-Item Short-\nForm Health Survey, and age were not.",
    "chunk_id": 338,
    "sentence_start": 1606,
    "sentence_end": 1608,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The CTQ-SSS shows a strong correlation with \nthe Disabilities of the Arm, Shoulder and Hand (DASH) ques­\ntionnaire (r = 0.74-0.77).30,101 CTQ-SSS scores have shown \nweak to no correlation with NCS,30,83,162 but it has demonstrat­\ned higher sensitivity to change than any other outcome mea­\nsure in individuals following surgery at 6 weeks,30,101 3 \nmonths,6,23,101,118 4 months,138 6 months,19,58 8 months,138 and 14 \nmonths.162 The CTQ-SSS has also been shown to be responsive \nin individuals following 6 weeks of orthosis management64 and \n3 weeks following cortisone injection.219\nII\nConflicting results have been published on the pre­\ndictive and discriminant validity of the CTQ-SSS. Baker and Livengood27 reported that baseline score \nwas a significant predictor of progression to surgery in patients \nwithout atrophy in the thenar muscles (OR = 12.5; 95% CI: 3.1, \n50.7), and Boyd et al43 concluded that baseline CTQ-SSS was \na predictor of failed nonsurgical management whereas the \nBoston Carpal Tunnel Questionnaire-functional scale (CTQ-\nFS), the DASH, the Medical Outcomes Study 36-Item Short-\nForm Health Survey, and age were not. Ollivere et al212 found \nthe CTQ-SSS was the best predictor of success with nonsurgi­\ncal management in that baseline scores less than 2.5 were 89% \nspecific for success.",
    "chunk_id": 339,
    "sentence_start": 1607,
    "sentence_end": 1609,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Baker and Livengood27 reported that baseline score \nwas a significant predictor of progression to surgery in patients \nwithout atrophy in the thenar muscles (OR = 12.5; 95% CI: 3.1, \n50.7), and Boyd et al43 concluded that baseline CTQ-SSS was \na predictor of failed nonsurgical management whereas the \nBoston Carpal Tunnel Questionnaire-functional scale (CTQ-\nFS), the DASH, the Medical Outcomes Study 36-Item Short-\nForm Health Survey, and age were not. Ollivere et al212 found \nthe CTQ-SSS was the best predictor of success with nonsurgi­\ncal management in that baseline scores less than 2.5 were 89% \nspecific for success. Kaye and Reynolds147 reported that people \nwith a mean CTQ-SSS score of 3.0 had a 72% probability of \nprogression to surgery and a score of 3.5 had an 86% probabil­\nity.",
    "chunk_id": 340,
    "sentence_start": 1608,
    "sentence_end": 1610,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Ollivere et al212 found \nthe CTQ-SSS was the best predictor of success with nonsurgi­\ncal management in that baseline scores less than 2.5 were 89% \nspecific for success. Kaye and Reynolds147 reported that people \nwith a mean CTQ-SSS score of 3.0 had a 72% probability of \nprogression to surgery and a score of 3.5 had an 86% probabil­\nity. However, Gerritsen et al109 identified the CTQ-SSS as a \npredictor of outcome at 12 months in a single variable analysis, \nbut the measure did not remain significant when placed into \na multiple logistic backward regression model. Reported val­\nues for the minimal clinically important difference (MCID) for \nthe CTQ-SSS are reported in TABLE 8.",
    "chunk_id": 341,
    "sentence_start": 1609,
    "sentence_end": 1612,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "However, Gerritsen et al109 identified the CTQ-SSS as a \npredictor of outcome at 12 months in a single variable analysis, \nbut the measure did not remain significant when placed into \na multiple logistic backward regression model. Reported val­\nues for the minimal clinically important difference (MCID) for \nthe CTQ-SSS are reported in TABLE 8. II\nOne study investigated the factor structure of the \nCTQ-SSS.25 Following factor analysis, authors sug­\ngested shortening the original 11 item instrument to\na 6-item instrument (CT\n(Cronbach α = .86) and te\nCI: 0.90, 0.98) of the 6-it\nrelation, measured usin\nwith the original, 11-item\n0.86) and with the 11-item\nwas 0.87 (95% CI: 0.82, 0\nevaluated within a year f\n(ES was 2.03 for all patie\nimprovement).26 The MC\ndiscriminated between d\nsatisfaction.25 However, \npatients managed nonsu\ndently validated outside \nBoston Carpal Tunnel Ques\nII\nThe CTQ-FS i\nthe functional\nitem is scored \nworst), with the score be\nscores can range from 1\nfunction possible).",
    "chunk_id": 342,
    "sentence_start": 1611,
    "sentence_end": 1613,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Reported val­\nues for the minimal clinically important difference (MCID) for \nthe CTQ-SSS are reported in TABLE 8. II\nOne study investigated the factor structure of the \nCTQ-SSS.25 Following factor analysis, authors sug­\ngested shortening the original 11 item instrument to\na 6-item instrument (CT\n(Cronbach α = .86) and te\nCI: 0.90, 0.98) of the 6-it\nrelation, measured usin\nwith the original, 11-item\n0.86) and with the 11-item\nwas 0.87 (95% CI: 0.82, 0\nevaluated within a year f\n(ES was 2.03 for all patie\nimprovement).26 The MC\ndiscriminated between d\nsatisfaction.25 However, \npatients managed nonsu\ndently validated outside \nBoston Carpal Tunnel Ques\nII\nThe CTQ-FS i\nthe functional\nitem is scored \nworst), with the score be\nscores can range from 1\nfunction possible). Int\n.91)30,162 and test-retest r\nexcellent. The CTQ-FS\nDASH (r = 0.8730 and \nshown no correlation wi\nDisabilities of the Arm, Sh\nII\nThe DASH is a\nassess disabilit\npathology.",
    "chunk_id": 343,
    "sentence_start": 1612,
    "sentence_end": 1615,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Int\n.91)30,162 and test-retest r\nexcellent. The CTQ-FS\nDASH (r = 0.8730 and \nshown no correlation wi\nDisabilities of the Arm, Sh\nII\nThe DASH is a\nassess disabilit\npathology. Me\nternal consistency (Cron\nretest reliability (r = 0. The DASH has\nQuickDASH\nIII\nThe test-retest\n= 0.69)263 is low\nand the DASH\nDASH scores and electr\nsignificant (r = –0.18, P \nResponsiveness and MCID \nII\nResponsiveness\nand QuickDAS\nundergoing no\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 344,
    "sentence_start": 1614,
    "sentence_end": 1623,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nCLINICAL PRACTICE GUIDELINES\nExamination\nRES\nSelf-reported Measures\nQuestionnaire-Symptom Severity Scale\nCarpal Tunnel Questionnaire-symptom \ne (CTQ-SSS) is an 11-item questionnaire \nss symptom severity in individuals with \nred on a Likert scale from 1 to 5 (5 being \nent’s CTQ-SSS score being the average \nal scores can range from 1 (no symptoms) \ns).",
    "chunk_id": 345,
    "sentence_start": 1622,
    "sentence_end": 1624,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nCLINICAL PRACTICE GUIDELINES\nExamination\nRES\nSelf-reported Measures\nQuestionnaire-Symptom Severity Scale\nCarpal Tunnel Questionnaire-symptom \ne (CTQ-SSS) is an 11-item questionnaire \nss symptom severity in individuals with \nred on a Likert scale from 1 to 5 (5 being \nent’s CTQ-SSS score being the average \nal scores can range from 1 (no symptoms) \ns). Internal consistency (Cronbach α = \nest-retest reliability (r = 0.82-0.95)30,118,162 \nQ-SSS shows a strong correlation with \nArm, Shoulder and Hand (DASH) ques­\n0.77).30,101 CTQ-SSS scores have shown \nn with NCS,30,83,162 but it has demonstrat­\no change than any other outcome mea­\nfollowing surgery at 6 weeks,30,101 3 \nnths,138 6 months,19,58 8 months,138 and 14 \nSSS has also been shown to be responsive \nng 6 weeks of orthosis management64 and \ntisone injection.219\nresults have been published on the pre­\ndiscriminant validity of the CTQ-SSS.",
    "chunk_id": 346,
    "sentence_start": 1623,
    "sentence_end": 1625,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nCLINICAL PRACTICE GUIDELINES\nExamination\nRES\nSelf-reported Measures\nQuestionnaire-Symptom Severity Scale\nCarpal Tunnel Questionnaire-symptom \ne (CTQ-SSS) is an 11-item questionnaire \nss symptom severity in individuals with \nred on a Likert scale from 1 to 5 (5 being \nent’s CTQ-SSS score being the average \nal scores can range from 1 (no symptoms) \ns). Internal consistency (Cronbach α = \nest-retest reliability (r = 0.82-0.95)30,118,162 \nQ-SSS shows a strong correlation with \nArm, Shoulder and Hand (DASH) ques­\n0.77).30,101 CTQ-SSS scores have shown \nn with NCS,30,83,162 but it has demonstrat­\no change than any other outcome mea­\nfollowing surgery at 6 weeks,30,101 3 \nnths,138 6 months,19,58 8 months,138 and 14 \nSSS has also been shown to be responsive \nng 6 weeks of orthosis management64 and \ntisone injection.219\nresults have been published on the pre­\ndiscriminant validity of the CTQ-SSS. Livengood27 reported that baseline score \nctor of progression to surgery in patients \ne thenar muscles (OR = 12.5; 95% CI: 3.1, \n3 concluded that baseline CTQ-SSS was \nnonsurgical management whereas the \nl Questionnaire-functional scale (CTQ-\nMedical Outcomes Study 36-Item Short-\nand age were not.",
    "chunk_id": 347,
    "sentence_start": 1624,
    "sentence_end": 1626,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Internal consistency (Cronbach α = \nest-retest reliability (r = 0.82-0.95)30,118,162 \nQ-SSS shows a strong correlation with \nArm, Shoulder and Hand (DASH) ques­\n0.77).30,101 CTQ-SSS scores have shown \nn with NCS,30,83,162 but it has demonstrat­\no change than any other outcome mea­\nfollowing surgery at 6 weeks,30,101 3 \nnths,138 6 months,19,58 8 months,138 and 14 \nSSS has also been shown to be responsive \nng 6 weeks of orthosis management64 and \ntisone injection.219\nresults have been published on the pre­\ndiscriminant validity of the CTQ-SSS. Livengood27 reported that baseline score \nctor of progression to surgery in patients \ne thenar muscles (OR = 12.5; 95% CI: 3.1, \n3 concluded that baseline CTQ-SSS was \nnonsurgical management whereas the \nl Questionnaire-functional scale (CTQ-\nMedical Outcomes Study 36-Item Short-\nand age were not. Ollivere et al212 found \nbest predictor of success with nonsurgi­\nat baseline scores less than 2.5 were 89% \naye and Reynolds147 reported that people \nS score of 3.0 had a 72% probability of \ny and a score of 3.5 had an 86% probabil­\nen et al109 identified the CTQ-SSS as a \nat 12 months in a single variable analysis, \nnot remain significant when placed into \nckward regression model.",
    "chunk_id": 348,
    "sentence_start": 1625,
    "sentence_end": 1627,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Livengood27 reported that baseline score \nctor of progression to surgery in patients \ne thenar muscles (OR = 12.5; 95% CI: 3.1, \n3 concluded that baseline CTQ-SSS was \nnonsurgical management whereas the \nl Questionnaire-functional scale (CTQ-\nMedical Outcomes Study 36-Item Short-\nand age were not. Ollivere et al212 found \nbest predictor of success with nonsurgi­\nat baseline scores less than 2.5 were 89% \naye and Reynolds147 reported that people \nS score of 3.0 had a 72% probability of \ny and a score of 3.5 had an 86% probabil­\nen et al109 identified the CTQ-SSS as a \nat 12 months in a single variable analysis, \nnot remain significant when placed into \nckward regression model. Reported val­\ninically important difference (MCID) for \norted in TABLE 8.",
    "chunk_id": 349,
    "sentence_start": 1626,
    "sentence_end": 1628,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Ollivere et al212 found \nbest predictor of success with nonsurgi­\nat baseline scores less than 2.5 were 89% \naye and Reynolds147 reported that people \nS score of 3.0 had a 72% probability of \ny and a score of 3.5 had an 86% probabil­\nen et al109 identified the CTQ-SSS as a \nat 12 months in a single variable analysis, \nnot remain significant when placed into \nckward regression model. Reported val­\ninically important difference (MCID) for \norted in TABLE 8. investigated the factor structure of the \nFollowing factor analysis, authors sug­\ntening the original 11 item instrument to\na 6-item instrument (CTQ-6).25,26,167 The internal consistency \n(Cronbach α = .86) and test-retest reliability (ICC = 0.95; 95% \nCI: 0.90, 0.98) of the 6-item instrument were excellent.25 Cor­\nrelation, measured using Pearson’s correlation coefficients, \nwith the original, 11-item instrument was 0.80 (95% CI: 0.73, \n0.86) and with the 11-item version of the DASH (QuickDASH) \nwas 0.87 (95% CI: 0.82, 0.91).25 Responsiveness for the CTQ-6 \nevaluated within a year following CTR surgery was excellent \n(ES was 2.03 for all patients and 2.53 for those reporting large \nimprovement).26 The MCID is 0.90.25,26,167 The instrument also \ndiscriminated between different levels of change and patient \nsatisfaction.25 However, there are no data on the CTQ-6 on \npatients managed nonsurgically, and it has not been indepen­\ndently validated outside the original authors.",
    "chunk_id": 350,
    "sentence_start": 1627,
    "sentence_end": 1629,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Reported val­\ninically important difference (MCID) for \norted in TABLE 8. investigated the factor structure of the \nFollowing factor analysis, authors sug­\ntening the original 11 item instrument to\na 6-item instrument (CTQ-6).25,26,167 The internal consistency \n(Cronbach α = .86) and test-retest reliability (ICC = 0.95; 95% \nCI: 0.90, 0.98) of the 6-item instrument were excellent.25 Cor­\nrelation, measured using Pearson’s correlation coefficients, \nwith the original, 11-item instrument was 0.80 (95% CI: 0.73, \n0.86) and with the 11-item version of the DASH (QuickDASH) \nwas 0.87 (95% CI: 0.82, 0.91).25 Responsiveness for the CTQ-6 \nevaluated within a year following CTR surgery was excellent \n(ES was 2.03 for all patients and 2.53 for those reporting large \nimprovement).26 The MCID is 0.90.25,26,167 The instrument also \ndiscriminated between different levels of change and patient \nsatisfaction.25 However, there are no data on the CTQ-6 on \npatients managed nonsurgically, and it has not been indepen­\ndently validated outside the original authors. Boston Carpal Tunnel Questionnaire-Functional Scale\nII\nThe CTQ-FS is an 8-item questionnaire to assess \nthe functional status of patients with CTS.",
    "chunk_id": 351,
    "sentence_start": 1628,
    "sentence_end": 1630,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "investigated the factor structure of the \nFollowing factor analysis, authors sug­\ntening the original 11 item instrument to\na 6-item instrument (CTQ-6).25,26,167 The internal consistency \n(Cronbach α = .86) and test-retest reliability (ICC = 0.95; 95% \nCI: 0.90, 0.98) of the 6-item instrument were excellent.25 Cor­\nrelation, measured using Pearson’s correlation coefficients, \nwith the original, 11-item instrument was 0.80 (95% CI: 0.73, \n0.86) and with the 11-item version of the DASH (QuickDASH) \nwas 0.87 (95% CI: 0.82, 0.91).25 Responsiveness for the CTQ-6 \nevaluated within a year following CTR surgery was excellent \n(ES was 2.03 for all patients and 2.53 for those reporting large \nimprovement).26 The MCID is 0.90.25,26,167 The instrument also \ndiscriminated between different levels of change and patient \nsatisfaction.25 However, there are no data on the CTQ-6 on \npatients managed nonsurgically, and it has not been indepen­\ndently validated outside the original authors. Boston Carpal Tunnel Questionnaire-Functional Scale\nII\nThe CTQ-FS is an 8-item questionnaire to assess \nthe functional status of patients with CTS. Each \nitem is scored on a Likert scale from 1 to 5 (5 being \nworst), with the score being the average of all 8 items.",
    "chunk_id": 352,
    "sentence_start": 1629,
    "sentence_end": 1631,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Boston Carpal Tunnel Questionnaire-Functional Scale\nII\nThe CTQ-FS is an 8-item questionnaire to assess \nthe functional status of patients with CTS. Each \nitem is scored on a Likert scale from 1 to 5 (5 being \nworst), with the score being the average of all 8 items. Final \nscores can range from 1 (no functional deficits) to 5 (worst \nfunction possible). Internal consistency (Cronbach α = \n.91)30,162 and test-retest reliability (r = 0.8530 and 0.93162) are \nexcellent. The CTQ-FS shows a strong correlation to the \nDASH (r = 0.8730 and r = 0.88, 0.91).101 The CTQ-FS has \nshown no correlation with NCS.30,162\nDisabilities of the Arm, Shoulder and Hand Questionnaire\nII\nThe DASH is a 30-item questionnaire designed to \nassess disability in patients with upper extremity \npathology. Measurement properties, including in­\nternal consistency (Cronbach α = .97134 and .9530) and test-\nretest reliability (r = 0.7730 and 0.8810; ICC = 0.90118) are \nexcellent.",
    "chunk_id": 353,
    "sentence_start": 1630,
    "sentence_end": 1635,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The CTQ-FS shows a strong correlation to the \nDASH (r = 0.8730 and r = 0.88, 0.91).101 The CTQ-FS has \nshown no correlation with NCS.30,162\nDisabilities of the Arm, Shoulder and Hand Questionnaire\nII\nThe DASH is a 30-item questionnaire designed to \nassess disability in patients with upper extremity \npathology. Measurement properties, including in­\nternal consistency (Cronbach α = .97134 and .9530) and test-\nretest reliability (r = 0.7730 and 0.8810; ICC = 0.90118) are \nexcellent. As reported above, it strongly correlates to the \nCTQ-FS. The DASH has shown no correlation with NCS.30\nQuickDASH\nIII\nThe test-retest reliability for the QuickDASH (ICC \n= 0.69)263 is lower than the CTQ-SSS, the CTQ-FS, \nand the DASH.",
    "chunk_id": 354,
    "sentence_start": 1634,
    "sentence_end": 1637,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "As reported above, it strongly correlates to the \nCTQ-FS. The DASH has shown no correlation with NCS.30\nQuickDASH\nIII\nThe test-retest reliability for the QuickDASH (ICC \n= 0.69)263 is lower than the CTQ-SSS, the CTQ-FS, \nand the DASH. The correlation between Quick­\nDASH scores and electrodiagnostic findings is not statically \nsignificant (r = –0.18, P = .08).276\nResponsiveness and MCID for the CTQ-FS, DASH, and QuickDASH\nII\nResponsiveness and MCID of the CTQ-FS, DASH, \nand QuickDASH have not been evaluated in those \nundergoing nonsurgical management Neither the\n\n\n--- Page 33 ---\nCOLUMN 1:\nCTQ-FS nor the DASH were able to predict progression to sur­\ngery.43 Post CTR surgery, the CTQ-FS,6,10,19,30,58,101,118,138,303 \nDASH,10,30,101,118,134,154,187,303 and QuickDASH26,167 have been shown \nresponsive to change and values are similar, ranging from mod­\nerate to high.",
    "chunk_id": 355,
    "sentence_start": 1636,
    "sentence_end": 1638,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The DASH has shown no correlation with NCS.30\nQuickDASH\nIII\nThe test-retest reliability for the QuickDASH (ICC \n= 0.69)263 is lower than the CTQ-SSS, the CTQ-FS, \nand the DASH. The correlation between Quick­\nDASH scores and electrodiagnostic findings is not statically \nsignificant (r = –0.18, P = .08).276\nResponsiveness and MCID for the CTQ-FS, DASH, and QuickDASH\nII\nResponsiveness and MCID of the CTQ-FS, DASH, \nand QuickDASH have not been evaluated in those \nundergoing nonsurgical management Neither the\n\n\n--- Page 33 ---\nCOLUMN 1:\nCTQ-FS nor the DASH were able to predict progression to sur­\ngery.43 Post CTR surgery, the CTQ-FS,6,10,19,30,58,101,118,138,303 \nDASH,10,30,101,118,134,154,187,303 and QuickDASH26,167 have been shown \nresponsive to change and values are similar, ranging from mod­\nerate to high. The CTQ-SSS showed greater responsiveness \ncompared with the CTQ-FS and DASH.101,118 Bessette et al38 re­\nported the MCID for the CTQ-FS at 6 months postsurgery was \n0.74.",
    "chunk_id": 356,
    "sentence_start": 1637,
    "sentence_end": 1639,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The correlation between Quick­\nDASH scores and electrodiagnostic findings is not statically \nsignificant (r = –0.18, P = .08).276\nResponsiveness and MCID for the CTQ-FS, DASH, and QuickDASH\nII\nResponsiveness and MCID of the CTQ-FS, DASH, \nand QuickDASH have not been evaluated in those \nundergoing nonsurgical management Neither the\n\n\n--- Page 33 ---\nCOLUMN 1:\nCTQ-FS nor the DASH were able to predict progression to sur­\ngery.43 Post CTR surgery, the CTQ-FS,6,10,19,30,58,101,118,138,303 \nDASH,10,30,101,118,134,154,187,303 and QuickDASH26,167 have been shown \nresponsive to change and values are similar, ranging from mod­\nerate to high. The CTQ-SSS showed greater responsiveness \ncompared with the CTQ-FS and DASH.101,118 Bessette et al38 re­\nported the MCID for the CTQ-FS at 6 months postsurgery was \n0.74. Ozer et al216 reported the MCID for the CTQ-FS was 1.95 \nfor individuals with diabetes and 1.25 for those without (also \nevaluated 6 months post surgery).",
    "chunk_id": 357,
    "sentence_start": 1638,
    "sentence_end": 1640,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The CTQ-SSS showed greater responsiveness \ncompared with the CTQ-FS and DASH.101,118 Bessette et al38 re­\nported the MCID for the CTQ-FS at 6 months postsurgery was \n0.74. Ozer et al216 reported the MCID for the CTQ-FS was 1.95 \nfor individuals with diabetes and 1.25 for those without (also \nevaluated 6 months post surgery). The MCID for the DASH \nreported at 6 weeks post CTR surgery was 21%.10 Amirfeyz et \nal10 reported the MCID at 6 weeks postsurgery for the CTQ-SSS \nand CTQ-FS were 0.16 and 0.47, respectively. The total score \nfrom the CTQ-SSS and CTQ-FS has also been shown to be re­\nsponsive following surgery.38,101\nEvidence Synthesis and Clinical Rationale\nPsychometric properties of the CTQ-SSS, CTQ-FS, and the \nDASH are excellent. There is more evidence available on \nthose undergoing surgical management and only limited evi­\ndence on those undergoing nonsurgical management. Only \nthe CTQ-SSS has been shown to be responsive to change in \nthose undergoing nonsurgical management.",
    "chunk_id": 358,
    "sentence_start": 1639,
    "sentence_end": 1644,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There is more evidence available on \nthose undergoing surgical management and only limited evi­\ndence on those undergoing nonsurgical management. Only \nthe CTQ-SSS has been shown to be responsive to change in \nthose undergoing nonsurgical management. Gaps in Knowledge\nMore research is needed to validate the shorter version of the \nCTQ-SSS and to examine the psychometric properties of the \nfunctional measures in patients with CTS undergoing nonsur­\ngical management. While higher baseline CTQ-SSS scores have \nshown to predict progression to CTR surgery in some studies,43,147 \nfurther validation in larger, independent samples is needed. Recommendation\nB\nClinicians should use the CTQ-SSS to assess symp­\ntoms and the CTQ-FS or the DASH questionnaire \nto assess function when examining patients with \nCTS. Clinicians should use the CTQ-SSS to assess change in \nthose undergoing nonsurgical management.",
    "chunk_id": 359,
    "sentence_start": 1643,
    "sentence_end": 1648,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Recommendation\nB\nClinicians should use the CTQ-SSS to assess symp­\ntoms and the CTQ-FS or the DASH questionnaire \nto assess function when examining patients with \nCTS. Clinicians should use the CTQ-SSS to assess change in \nthose undergoing nonsurgical management. ACTIVITY LIMITATIONS\nPhysical Performance Measures\nWhile activity limitations and participation restrictions can \nbe evaluated in part using self-report measures, there are \ndata available on patient-performance measures including \nthe Purdue Pegboard (PPB), the Dellon-modified Moberg \npick-up test (DMPUT), the Jebsen-Taylor Hand Function \nTest, and the Nine-Hole Peg Test in individuals with CTS. Purdue Pegboard\nIII\nNormative data for the PPB test exist.1,82,299 Test-\nretest reliability as a measure of dexterous hand \nfunction in indi iduals\nith CTS has been reported\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 360,
    "sentence_start": 1647,
    "sentence_end": 1652,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nH were able to predict progression to sur­\nurgery, the CTQ-FS,6,10,19,30,58,101,118,138,303 \n303 and QuickDASH26,167 have been shown \nand values are similar, ranging from mod­\nTQ-SSS showed greater responsiveness \nTQ-FS and DASH.101,118 Bessette et al38 re­\nhe CTQ-FS at 6 months postsurgery was \nrted the MCID for the CTQ-FS was 1.95 \niabetes and 1.25 for those without (also \npost surgery). The MCID for the DASH \nost CTR surgery was 21%.10 Amirfeyz et \nD at 6 weeks postsurgery for the CTQ-SSS \n6 and 0.47, respectively. The total score \nd CTQ-FS has also been shown to be re­\ngery.38,101\nnd Clinical Rationale\nties of the CTQ-SSS, CTQ-FS, and the \nThere is more evidence available on \ngical management and only limited evi­\nrgoing nonsurgical management.",
    "chunk_id": 361,
    "sentence_start": 1651,
    "sentence_end": 1657,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The MCID for the DASH \nost CTR surgery was 21%.10 Amirfeyz et \nD at 6 weeks postsurgery for the CTQ-SSS \n6 and 0.47, respectively. The total score \nd CTQ-FS has also been shown to be re­\ngery.38,101\nnd Clinical Rationale\nties of the CTQ-SSS, CTQ-FS, and the \nThere is more evidence available on \ngical management and only limited evi­\nrgoing nonsurgical management. Only \nen shown to be responsive to change in \nnsurgical management. ded to validate the shorter version of the \nmine the psychometric properties of the \nn patients with CTS undergoing nonsur­\nhile higher baseline CTQ-SSS scores have \nession to CTR surgery in some studies,43,147 \nrger, independent samples is needed. hould use the CTQ-SSS to assess symp­\nhe CTQ-FS or the DASH questionnaire \nnction when examining patients with \nld use the CTQ-SSS to assess change in \nnsurgical management.",
    "chunk_id": 362,
    "sentence_start": 1656,
    "sentence_end": 1660,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "ded to validate the shorter version of the \nmine the psychometric properties of the \nn patients with CTS undergoing nonsur­\nhile higher baseline CTQ-SSS scores have \nession to CTR surgery in some studies,43,147 \nrger, independent samples is needed. hould use the CTQ-SSS to assess symp­\nhe CTQ-FS or the DASH questionnaire \nnction when examining patients with \nld use the CTQ-SSS to assess change in \nnsurgical management. ONS\ne Measures\ntions and participation restrictions can \nusing self-report measures, there are \ntient-performance measures including \nd (PPB), the Dellon-modified Moberg \nUT), the Jebsen-Taylor Hand Function \nole Peg Test in individuals with CTS.",
    "chunk_id": 363,
    "sentence_start": 1659,
    "sentence_end": 1661,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "hould use the CTQ-SSS to assess symp­\nhe CTQ-FS or the DASH questionnaire \nnction when examining patients with \nld use the CTQ-SSS to assess change in \nnsurgical management. ONS\ne Measures\ntions and participation restrictions can \nusing self-report measures, there are \ntient-performance measures including \nd (PPB), the Dellon-modified Moberg \nUT), the Jebsen-Taylor Hand Function \nole Peg Test in individuals with CTS. in a sample of 51 individuals (20-86 years old) with electro­\nphysiologically confirmed CTS and is excellent (ICC = 0.97).13 \nThe PPB discriminates between those with and without CTS \nin individuals 66 years old and under (P<.001).81,95\nIII\nAmirjani et al13 included people with CTS aged 20 \nto 86 years old and found decreased PPB test scores \nin young (age, 20-39 years) and middle-aged (age, \n40-59 years) participants compared with controls, but in the \nelderly (age, 60 years or older), there was only a difference in \nparticipants with moderate and severe CTS.",
    "chunk_id": 364,
    "sentence_start": 1660,
    "sentence_end": 1662,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "ONS\ne Measures\ntions and participation restrictions can \nusing self-report measures, there are \ntient-performance measures including \nd (PPB), the Dellon-modified Moberg \nUT), the Jebsen-Taylor Hand Function \nole Peg Test in individuals with CTS. in a sample of 51 individuals (20-86 years old) with electro­\nphysiologically confirmed CTS and is excellent (ICC = 0.97).13 \nThe PPB discriminates between those with and without CTS \nin individuals 66 years old and under (P<.001).81,95\nIII\nAmirjani et al13 included people with CTS aged 20 \nto 86 years old and found decreased PPB test scores \nin young (age, 20-39 years) and middle-aged (age, \n40-59 years) participants compared with controls, but in the \nelderly (age, 60 years or older), there was only a difference in \nparticipants with moderate and severe CTS. Authors con­\ncluded that performance on the PPB declines with age re­\ngardless of carpal tunnel pathology.13 Atalay et al20 found \nlower PPB subtest scores in those with severe CTS compared \nto those with mild disease.",
    "chunk_id": 365,
    "sentence_start": 1661,
    "sentence_end": 1663,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "in a sample of 51 individuals (20-86 years old) with electro­\nphysiologically confirmed CTS and is excellent (ICC = 0.97).13 \nThe PPB discriminates between those with and without CTS \nin individuals 66 years old and under (P<.001).81,95\nIII\nAmirjani et al13 included people with CTS aged 20 \nto 86 years old and found decreased PPB test scores \nin young (age, 20-39 years) and middle-aged (age, \n40-59 years) participants compared with controls, but in the \nelderly (age, 60 years or older), there was only a difference in \nparticipants with moderate and severe CTS. Authors con­\ncluded that performance on the PPB declines with age re­\ngardless of carpal tunnel pathology.13 Atalay et al20 found \nlower PPB subtest scores in those with severe CTS compared \nto those with mild disease. III\nWhen compared to NCS, there were no meaningful \nassociations between PPB test scores and DSL or \nDML (r<0.15, P>.05),81 or between PPB test scores \nand the total CTQ score for younger individuals (r<0.22, \nP>.05).13 The correlations between the subtests of the PPB \nand CTQ scores for individuals 60 and older were higher (r \n= 0.33 to 0.45, P<.05).13 PPB test scores have moderate to \nhigh correlations (r = –0.50 to –0.76, P<.001) with pain dura­\ntion and severity.95\nIII\nThere is conflicting evidence on the ability of the \nPPB to discriminate between individuals with dif­\nferent CTS severities.",
    "chunk_id": 366,
    "sentence_start": 1662,
    "sentence_end": 1664,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Authors con­\ncluded that performance on the PPB declines with age re­\ngardless of carpal tunnel pathology.13 Atalay et al20 found \nlower PPB subtest scores in those with severe CTS compared \nto those with mild disease. III\nWhen compared to NCS, there were no meaningful \nassociations between PPB test scores and DSL or \nDML (r<0.15, P>.05),81 or between PPB test scores \nand the total CTQ score for younger individuals (r<0.22, \nP>.05).13 The correlations between the subtests of the PPB \nand CTQ scores for individuals 60 and older were higher (r \n= 0.33 to 0.45, P<.05).13 PPB test scores have moderate to \nhigh correlations (r = –0.50 to –0.76, P<.001) with pain dura­\ntion and severity.95\nIII\nThere is conflicting evidence on the ability of the \nPPB to discriminate between individuals with dif­\nferent CTS severities. de la Llave-Rincón et al81 \nfound no difference in scores of all PPB subtests in individu­\nals with mild, moderate, or severe CTS, while Atalay et al20 \nreported a significant difference in PPB scores between indi­\nviduals with mild CTS and those with severe CTS, but only \nfor the dominant hand.",
    "chunk_id": 367,
    "sentence_start": 1663,
    "sentence_end": 1665,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "III\nWhen compared to NCS, there were no meaningful \nassociations between PPB test scores and DSL or \nDML (r<0.15, P>.05),81 or between PPB test scores \nand the total CTQ score for younger individuals (r<0.22, \nP>.05).13 The correlations between the subtests of the PPB \nand CTQ scores for individuals 60 and older were higher (r \n= 0.33 to 0.45, P<.05).13 PPB test scores have moderate to \nhigh correlations (r = –0.50 to –0.76, P<.001) with pain dura­\ntion and severity.95\nIII\nThere is conflicting evidence on the ability of the \nPPB to discriminate between individuals with dif­\nferent CTS severities. de la Llave-Rincón et al81 \nfound no difference in scores of all PPB subtests in individu­\nals with mild, moderate, or severe CTS, while Atalay et al20 \nreported a significant difference in PPB scores between indi­\nviduals with mild CTS and those with severe CTS, but only \nfor the dominant hand. Last, authors have reported bilateral \ndeficits in fine hand use measured by the PPB in patients \nwith unilateral mild to moderate CTS.95\nII\nOlsen and Knudson213 examined recovery of fine \nhand use using the PPB in 11 patients, 5 months \nfollowing CTR surgery using trend analysis.",
    "chunk_id": 368,
    "sentence_start": 1664,
    "sentence_end": 1666,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "de la Llave-Rincón et al81 \nfound no difference in scores of all PPB subtests in individu­\nals with mild, moderate, or severe CTS, while Atalay et al20 \nreported a significant difference in PPB scores between indi­\nviduals with mild CTS and those with severe CTS, but only \nfor the dominant hand. Last, authors have reported bilateral \ndeficits in fine hand use measured by the PPB in patients \nwith unilateral mild to moderate CTS.95\nII\nOlsen and Knudson213 examined recovery of fine \nhand use using the PPB in 11 patients, 5 months \nfollowing CTR surgery using trend analysis. Recov­\nery followed a linear path with a flat slope, suggesting that \nsurgery did not result in a marked improvement in PPB \nscores even though the preoperative scores were well below \nnormal.",
    "chunk_id": 369,
    "sentence_start": 1665,
    "sentence_end": 1667,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Last, authors have reported bilateral \ndeficits in fine hand use measured by the PPB in patients \nwith unilateral mild to moderate CTS.95\nII\nOlsen and Knudson213 examined recovery of fine \nhand use using the PPB in 11 patients, 5 months \nfollowing CTR surgery using trend analysis. Recov­\nery followed a linear path with a flat slope, suggesting that \nsurgery did not result in a marked improvement in PPB \nscores even though the preoperative scores were well below \nnormal. Dellon-modified Moberg Pick-up Test\nIII\nNormative data for the DMPUT have been reported \nfor 116 individuals 20 years and older and indicate \nbetter performance for\nomen compared to men\n\n\n--- Page 34 ---\nCOLUMN 1:\ngroups validity, authors found significant differences in \nscores between those with and without CTS, suggesting the \nDMPUT is useful in discriminating between those with and \nwithout CTS.",
    "chunk_id": 370,
    "sentence_start": 1666,
    "sentence_end": 1668,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Recov­\nery followed a linear path with a flat slope, suggesting that \nsurgery did not result in a marked improvement in PPB \nscores even though the preoperative scores were well below \nnormal. Dellon-modified Moberg Pick-up Test\nIII\nNormative data for the DMPUT have been reported \nfor 116 individuals 20 years and older and indicate \nbetter performance for\nomen compared to men\n\n\n--- Page 34 ---\nCOLUMN 1:\ngroups validity, authors found significant differences in \nscores between those with and without CTS, suggesting the \nDMPUT is useful in discriminating between those with and \nwithout CTS. However, when stratifying by age, the authors \nfound similar scores in the elderly individuals with mild CTS \nand the control group.12\nII\nAppleby et al16 reported a statistically significant \nchange in DMPUT scores in 29 patients tested be­\nfore and 12 weeks following CTR surgery.",
    "chunk_id": 371,
    "sentence_start": 1667,
    "sentence_end": 1669,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Dellon-modified Moberg Pick-up Test\nIII\nNormative data for the DMPUT have been reported \nfor 116 individuals 20 years and older and indicate \nbetter performance for\nomen compared to men\n\n\n--- Page 34 ---\nCOLUMN 1:\ngroups validity, authors found significant differences in \nscores between those with and without CTS, suggesting the \nDMPUT is useful in discriminating between those with and \nwithout CTS. However, when stratifying by age, the authors \nfound similar scores in the elderly individuals with mild CTS \nand the control group.12\nII\nAppleby et al16 reported a statistically significant \nchange in DMPUT scores in 29 patients tested be­\nfore and 12 weeks following CTR surgery. Using the \nmeans and standard deviations reported in the study, respon­\nsiveness could be calculated (standardized response mean \n[SRM], 0.90 and ES, 0.71) suggesting the DMPUT is accept­\nable at assessing change following surgery.",
    "chunk_id": 372,
    "sentence_start": 1668,
    "sentence_end": 1670,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "However, when stratifying by age, the authors \nfound similar scores in the elderly individuals with mild CTS \nand the control group.12\nII\nAppleby et al16 reported a statistically significant \nchange in DMPUT scores in 29 patients tested be­\nfore and 12 weeks following CTR surgery. Using the \nmeans and standard deviations reported in the study, respon­\nsiveness could be calculated (standardized response mean \n[SRM], 0.90 and ES, 0.71) suggesting the DMPUT is accept­\nable at assessing change following surgery. There are no data \non the responsiveness of the DMPUT in individuals undergo­\ning nonsurgical management. Jebsen-Taylor Hand Function Test and Nine-Hole Peg Test\nII\nNeither the Jebsen-Taylor Hand Function Test nor \nthe Nine-Hole Peg Test have established reliability \nin individuals with CTS. Sears and Chung254 exam­\nined the responsiveness of the Jebsen-Taylor Hand Function \nTest and reported it was a poor indicator for improvement \nafter CTR surgery (ES, 0.05; SRM, 0.04).",
    "chunk_id": 373,
    "sentence_start": 1669,
    "sentence_end": 1673,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Jebsen-Taylor Hand Function Test and Nine-Hole Peg Test\nII\nNeither the Jebsen-Taylor Hand Function Test nor \nthe Nine-Hole Peg Test have established reliability \nin individuals with CTS. Sears and Chung254 exam­\nined the responsiveness of the Jebsen-Taylor Hand Function \nTest and reported it was a poor indicator for improvement \nafter CTR surgery (ES, 0.05; SRM, 0.04). Hobby et al134 stud­\nied responsiveness of the Nine-Hole Peg test following CTR \nsurgery and found this measure was also not responsive to \nchange (ES, 0.16; SRM, 0.12). There are no data on these \nmeasures \nfor \nindividuals \nundergoing \nnonsurgical \nmanagement. Evidence Synthesis and Clinical Rationale\nNorms are available for both the PPB and the DMPUT. While \nthe PPB test discriminates between those with and without \nCTS aged 60 and under, it is not useful in monitoring prog­\nress after CTR surgery.",
    "chunk_id": 374,
    "sentence_start": 1672,
    "sentence_end": 1677,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Evidence Synthesis and Clinical Rationale\nNorms are available for both the PPB and the DMPUT. While \nthe PPB test discriminates between those with and without \nCTS aged 60 and under, it is not useful in monitoring prog­\nress after CTR surgery. The DMPUT also discriminates be­\ntween those with and without CTS in younger patients and \ncan help in assessing change following CTR surgery because \ndata presented on responsiveness of this instrument are from \nindividuals who underwent CTR surgery. Gaps in Knowledge\nMore research is needed to establish reliability of the Jeb­\nsen-Taylor Hand Function Test and the Nine-Hole Peg Test \nin individuals with CTS. Also, more research is needed to \ndetermine responsiveness of all physical performance-based \nmeasures in individuals with CTS undergoing nonsurgical \nmanagement.",
    "chunk_id": 375,
    "sentence_start": 1676,
    "sentence_end": 1680,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Gaps in Knowledge\nMore research is needed to establish reliability of the Jeb­\nsen-Taylor Hand Function Test and the Nine-Hole Peg Test \nin individuals with CTS. Also, more research is needed to \ndetermine responsiveness of all physical performance-based \nmeasures in individuals with CTS undergoing nonsurgical \nmanagement. C\nClinicians may use the PPB or the DMPUT to quan­\ntify dexterity at the onset of treatment and compare \nscores\nith established norms Clinicians should\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nCTR surgery. Clinicians may use the DMPUT to assess \nchange following CTR surgery.",
    "chunk_id": 376,
    "sentence_start": 1679,
    "sentence_end": 1687,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nCTR surgery. Clinicians may use the DMPUT to assess \nchange following CTR surgery. ACTIVITY LIMITATIONS\nPhysical Impairment Measures\nStrength Measures\nII\nFor predictive validity, Boyd et al43 reported no sig­\nnificant difference in grip strength between indi­\nviduals with CTS who progressed to surgery and \nthose who did not. Studies on sensitivity to change of grip \nstrength have been done following CTR surgery.",
    "chunk_id": 377,
    "sentence_start": 1686,
    "sentence_end": 1689,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "ACTIVITY LIMITATIONS\nPhysical Impairment Measures\nStrength Measures\nII\nFor predictive validity, Boyd et al43 reported no sig­\nnificant difference in grip strength between indi­\nviduals with CTS who progressed to surgery and \nthose who did not. Studies on sensitivity to change of grip \nstrength have been done following CTR surgery. In those \nstudies, grip strength was not sensitive to change over \ntime.6,19,134,138,145,230 Following surgery, grip strength actually \ndecreases and doesn’t begin to increase until the third post­\noperative month.102,303\nII\nLateral pinch is not sensitive to change following \nCTR surgery.102 Additionally, lateral pinch receives \nmotor input from median and ulnar-innervated \nmuscles making it an invalid measure in individuals with \nCTS.102 While tip and 3-point pinch both target more median-\ninnervated muscles, there are no data on the sensitivity to \nchange of tip or 3-point pinch in patients managed nonsurgi­\ncally.",
    "chunk_id": 378,
    "sentence_start": 1688,
    "sentence_end": 1690,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Studies on sensitivity to change of grip \nstrength have been done following CTR surgery. In those \nstudies, grip strength was not sensitive to change over \ntime.6,19,134,138,145,230 Following surgery, grip strength actually \ndecreases and doesn’t begin to increase until the third post­\noperative month.102,303\nII\nLateral pinch is not sensitive to change following \nCTR surgery.102 Additionally, lateral pinch receives \nmotor input from median and ulnar-innervated \nmuscles making it an invalid measure in individuals with \nCTS.102 While tip and 3-point pinch both target more median-\ninnervated muscles, there are no data on the sensitivity to \nchange of tip or 3-point pinch in patients managed nonsurgi­\ncally. There is conflicting evidence on the sensitivity to change \nof tip and 3-point pinch following CTR surgery.102 Existing \ndata on assessment of APB muscle strength from patients fol­\nlowing CTR surgery also present conflicting results.102,138,145\nIII\nReliability values of strength measures in patients \nwith CTS including grip,4,72 tip pinch,95 3-point \npinch,4 and lateral (key) pinch4 are all greater than \n0.81.",
    "chunk_id": 379,
    "sentence_start": 1689,
    "sentence_end": 1691,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In those \nstudies, grip strength was not sensitive to change over \ntime.6,19,134,138,145,230 Following surgery, grip strength actually \ndecreases and doesn’t begin to increase until the third post­\noperative month.102,303\nII\nLateral pinch is not sensitive to change following \nCTR surgery.102 Additionally, lateral pinch receives \nmotor input from median and ulnar-innervated \nmuscles making it an invalid measure in individuals with \nCTS.102 While tip and 3-point pinch both target more median-\ninnervated muscles, there are no data on the sensitivity to \nchange of tip or 3-point pinch in patients managed nonsurgi­\ncally. There is conflicting evidence on the sensitivity to change \nof tip and 3-point pinch following CTR surgery.102 Existing \ndata on assessment of APB muscle strength from patients fol­\nlowing CTR surgery also present conflicting results.102,138,145\nIII\nReliability values of strength measures in patients \nwith CTS including grip,4,72 tip pinch,95 3-point \npinch,4 and lateral (key) pinch4 are all greater than \n0.81. For grip strength, reliability is best when using a single \ntrial or using the highest score of 3 trials.72 Known-groups \nvalidity has also been studied in this population.28,95 Signifi­\ncant differences in grip strength, 3-point pinch, lateral \npinch,28 and tip pinch95 have been found between those with \nand without CTS.",
    "chunk_id": 380,
    "sentence_start": 1690,
    "sentence_end": 1692,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There is conflicting evidence on the sensitivity to change \nof tip and 3-point pinch following CTR surgery.102 Existing \ndata on assessment of APB muscle strength from patients fol­\nlowing CTR surgery also present conflicting results.102,138,145\nIII\nReliability values of strength measures in patients \nwith CTS including grip,4,72 tip pinch,95 3-point \npinch,4 and lateral (key) pinch4 are all greater than \n0.81. For grip strength, reliability is best when using a single \ntrial or using the highest score of 3 trials.72 Known-groups \nvalidity has also been studied in this population.28,95 Signifi­\ncant differences in grip strength, 3-point pinch, lateral \npinch,28 and tip pinch95 have been found between those with \nand without CTS. Atalay et al20 reported significant differ­\nences in tip and 3-point pinch between those with mild and \nmoderate CTS compared to those with severe CTS but no \ndifferences in grip strength.",
    "chunk_id": 381,
    "sentence_start": 1691,
    "sentence_end": 1693,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "For grip strength, reliability is best when using a single \ntrial or using the highest score of 3 trials.72 Known-groups \nvalidity has also been studied in this population.28,95 Signifi­\ncant differences in grip strength, 3-point pinch, lateral \npinch,28 and tip pinch95 have been found between those with \nand without CTS. Atalay et al20 reported significant differ­\nences in tip and 3-point pinch between those with mild and \nmoderate CTS compared to those with severe CTS but no \ndifferences in grip strength. hors found significant differences in \nwith and without CTS, suggesting the \ndiscriminating between those with and \ner, when stratifying by age, the authors \nn the elderly individuals with mild CTS \np.12\nal16 reported a statistically significant \nDMPUT scores in 29 patients tested be­\nweeks following CTR surgery. Using the \ndeviations reported in the study, respon­\nlculated (standardized response mean \n0.71) suggesting the DMPUT is accept­\nnge following surgery.",
    "chunk_id": 382,
    "sentence_start": 1692,
    "sentence_end": 1695,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "hors found significant differences in \nwith and without CTS, suggesting the \ndiscriminating between those with and \ner, when stratifying by age, the authors \nn the elderly individuals with mild CTS \np.12\nal16 reported a statistically significant \nDMPUT scores in 29 patients tested be­\nweeks following CTR surgery. Using the \ndeviations reported in the study, respon­\nlculated (standardized response mean \n0.71) suggesting the DMPUT is accept­\nnge following surgery. There are no data \n of the DMPUT in individuals undergo­\nagement. nction Test and Nine-Hole Peg Test\nJebsen-Taylor Hand Function Test nor \nole Peg Test have established reliability \nals with CTS. Sears and Chung254 exam­\ness of the Jebsen-Taylor Hand Function \nwas a poor indicator for improvement \nS, 0.05; SRM, 0.04). Hobby et al134 stud­\n the Nine-Hole Peg test following CTR \nhis measure was also not responsive to \nRM, 0.12).",
    "chunk_id": 383,
    "sentence_start": 1694,
    "sentence_end": 1699,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Sears and Chung254 exam­\ness of the Jebsen-Taylor Hand Function \nwas a poor indicator for improvement \nS, 0.05; SRM, 0.04). Hobby et al134 stud­\n the Nine-Hole Peg test following CTR \nhis measure was also not responsive to \nRM, 0.12). There are no data on these \ndividuals \nundergoing \nnonsurgical \nnd Clinical Rationale\nor both the PPB and the DMPUT. While \ninates between those with and without \nder, it is not useful in monitoring prog­\nry. The DMPUT also discriminates be­\nd without CTS in younger patients and \nchange following CTR surgery because \nponsiveness of this instrument are from \nerwent CTR surgery. --- Page 35 ---\nCOLUMN 1:\nGaps in Knowledge\nThere are no data on the sensitivity to change of instruments \nto assess strength in individuals with CTS being managed \nnonsurgically. All available data are on individuals being \nmanaged with CTR and suggest that strength measures are \nnot useful in these individuals.",
    "chunk_id": 384,
    "sentence_start": 1698,
    "sentence_end": 1704,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "--- Page 35 ---\nCOLUMN 1:\nGaps in Knowledge\nThere are no data on the sensitivity to change of instruments \nto assess strength in individuals with CTS being managed \nnonsurgically. All available data are on individuals being \nmanaged with CTR and suggest that strength measures are \nnot useful in these individuals. However, due to the presence \nof a postsurgical wound/scar, one should not expect to apply \nthese results for patients managed nonsurgically. Also, there \nis conflicting evidence on the presence of grip strength weak­\nness in individuals with CTS, and there is a need for more \nresearch in this area. Recommendations\nA\nClinicians should not use lateral pinch strength as \nan outcome measure for patients with nonsurgi­\ncally or surgically managed CTS. B\nClinicians should not use grip strength when assess­\ning short-term (less than 3 months) change in indi­\nviduals following CTR surgery.",
    "chunk_id": 385,
    "sentence_start": 1703,
    "sentence_end": 1708,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Recommendations\nA\nClinicians should not use lateral pinch strength as \nan outcome measure for patients with nonsurgi­\ncally or surgically managed CTS. B\nClinicians should not use grip strength when assess­\ning short-term (less than 3 months) change in indi­\nviduals following CTR surgery. C\nClinicians may assess grip strength and 3-point or \ntip pinch strength in individuals presenting with \nsigns and symptoms of CTS and compare scores with \nestablished norms. D\nThere is conflicting evidence on the use of tip and \n3-point pinch strength and abductor pollicis brevis \nmuscle strength testing in individuals following \nCTR surgery. Sensory and Provocative Measures\nReliability for provocative and sensory measures have been \nreported in the Diagnosis section of this guideline and are \nshown in TABLES 2 and 5, respectively. Here, these instruments \nwill be discussed with regards to their ability to detect change \nover time.",
    "chunk_id": 386,
    "sentence_start": 1707,
    "sentence_end": 1712,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Sensory and Provocative Measures\nReliability for provocative and sensory measures have been \nreported in the Diagnosis section of this guideline and are \nshown in TABLES 2 and 5, respectively. Here, these instruments \nwill be discussed with regards to their ability to detect change \nover time. II\nThere are no studies assessing sensitivity to change \nof static 2PD in patients undergoing nonsurgical \nmanagement for CTS. There were 5 studies using the \ninterpretation provided by Cohen’s criteria (small d = 0.2, me­\ndium d = 0.5, large d = 0.8)70 following CTR with conflicting \nresults. Authors of 4 studies reported small-to-medium ES at \n1, 3, 4, and 8 months after CTR surgery (0.39,135 0.51,145 0.22,138 \nand 0.33,138 respectively).",
    "chunk_id": 387,
    "sentence_start": 1711,
    "sentence_end": 1715,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There were 5 studies using the \ninterpretation provided by Cohen’s criteria (small d = 0.2, me­\ndium d = 0.5, large d = 0.8)70 following CTR with conflicting \nresults. Authors of 4 studies reported small-to-medium ES at \n1, 3, 4, and 8 months after CTR surgery (0.39,135 0.51,145 0.22,138 \nand 0.33,138 respectively). Authors of a study deemed to be \nlower in quality reported a large ES of 0.88 at 18 weeks follow­\ning surgery.134 Other authors found low-to-moderate SRMs at \n3, 4, 6, and 8 months after surgery (0.30-0.76,22,134,145 0.57,138 \n0.40,22 and 0.51,138 respectively). There was 1 study on the sen­\nsitivity to change of moving 2PD following CTR (ES, 0.44) at \n1 month following surgery.135\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 388,
    "sentence_start": 1714,
    "sentence_end": 1721,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nII\nThere was only 1 published study on the responsive­\nness of threshold testing in individuals undergoing \nnonsurgical management.64 Authors used both dis­\ntribution-based methods to assess sensitivity to change, and \nanchor-based methods for determining responsiveness of the \nPressure Specified Sensory Device in individuals treated with \nan orthosis for 6 weeks. Results indicated low sensitivity to \nchange (ES less than 0.08 and SRM less than 0.09) for those \nwho responded to treatment as measured by change score on \nthe CTQ-SSS. Based on the receiver operating curve (area un­\nder the curve = 0.46), authors concluded the instrument did \nnot discriminate between those who improved and those who \ndid not. Five studies reported low-to-moderate responsiveness \nfor threshold testing following CTR surgery.",
    "chunk_id": 389,
    "sentence_start": 1720,
    "sentence_end": 1725,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Based on the receiver operating curve (area un­\nder the curve = 0.46), authors concluded the instrument did \nnot discriminate between those who improved and those who \ndid not. Five studies reported low-to-moderate responsiveness \nfor threshold testing following CTR surgery. Effect size values \nwere 0.76 (1 month post CTR),135 0.41 (3 months post CTR),145 \n0.55 (4 months post CTR), and 0.73 (8 months post CTR).138 \nStandardized response means were 0.30 to 0.70 (3 months \npost CTR),6,22,145 0.59 (4 months post CTR),138 and 0.60 (6 \nmonths post CTR).22 The highest quality study reported a large \nSRM (0.84) at 8 months post release.138 These values are lower \ncompared to ESs and SRMs reported for the CTQ-SSS which \nexceeded 1.0 in many of the same studies.6,22,138,145\nII\nVibration sense before and after intervention has \nbeen evaluated using a tuning fork and different \nvibrometers.",
    "chunk_id": 390,
    "sentence_start": 1724,
    "sentence_end": 1726,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Five studies reported low-to-moderate responsiveness \nfor threshold testing following CTR surgery. Effect size values \nwere 0.76 (1 month post CTR),135 0.41 (3 months post CTR),145 \n0.55 (4 months post CTR), and 0.73 (8 months post CTR).138 \nStandardized response means were 0.30 to 0.70 (3 months \npost CTR),6,22,145 0.59 (4 months post CTR),138 and 0.60 (6 \nmonths post CTR).22 The highest quality study reported a large \nSRM (0.84) at 8 months post release.138 These values are lower \ncompared to ESs and SRMs reported for the CTQ-SSS which \nexceeded 1.0 in many of the same studies.6,22,138,145\nII\nVibration sense before and after intervention has \nbeen evaluated using a tuning fork and different \nvibrometers. There was no published evidence on \nthe sensitivity or responsiveness of using a tuning fork in \nthose undergoing nonsurgical management.",
    "chunk_id": 391,
    "sentence_start": 1725,
    "sentence_end": 1727,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Effect size values \nwere 0.76 (1 month post CTR),135 0.41 (3 months post CTR),145 \n0.55 (4 months post CTR), and 0.73 (8 months post CTR).138 \nStandardized response means were 0.30 to 0.70 (3 months \npost CTR),6,22,145 0.59 (4 months post CTR),138 and 0.60 (6 \nmonths post CTR).22 The highest quality study reported a large \nSRM (0.84) at 8 months post release.138 These values are lower \ncompared to ESs and SRMs reported for the CTQ-SSS which \nexceeded 1.0 in many of the same studies.6,22,138,145\nII\nVibration sense before and after intervention has \nbeen evaluated using a tuning fork and different \nvibrometers. There was no published evidence on \nthe sensitivity or responsiveness of using a tuning fork in \nthose undergoing nonsurgical management. There was only \n1 study on the sensitivity to change of vibration sense mea­\nsured using a 50-Hz computer-controlled vibrometer in in­\ndividuals undergoing nonsurgical management.64 Cheung et \nal64 reported moderate sensitivity using the vibrometer in \nthose that responded to treatment (ES, 0.46; 95% CI: 0.05, \n0.47; SRM, 0.61; 95% CI:0.20, 1.02).",
    "chunk_id": 392,
    "sentence_start": 1726,
    "sentence_end": 1728,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There was no published evidence on \nthe sensitivity or responsiveness of using a tuning fork in \nthose undergoing nonsurgical management. There was only \n1 study on the sensitivity to change of vibration sense mea­\nsured using a 50-Hz computer-controlled vibrometer in in­\ndividuals undergoing nonsurgical management.64 Cheung et \nal64 reported moderate sensitivity using the vibrometer in \nthose that responded to treatment (ES, 0.46; 95% CI: 0.05, \n0.47; SRM, 0.61; 95% CI:0.20, 1.02). However, these authors \nconcluded that their results did not provide sufficient evi­\ndence that it was useful for clinical decision making in deter­\nmining whether a clinically important difference occurred.",
    "chunk_id": 393,
    "sentence_start": 1727,
    "sentence_end": 1729,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There was only \n1 study on the sensitivity to change of vibration sense mea­\nsured using a 50-Hz computer-controlled vibrometer in in­\ndividuals undergoing nonsurgical management.64 Cheung et \nal64 reported moderate sensitivity using the vibrometer in \nthose that responded to treatment (ES, 0.46; 95% CI: 0.05, \n0.47; SRM, 0.61; 95% CI:0.20, 1.02). However, these authors \nconcluded that their results did not provide sufficient evi­\ndence that it was useful for clinical decision making in deter­\nmining whether a clinically important difference occurred. II\nPransky et al230 assessed sensitivity to change in the \nUpper Extremity Functional Scale scores, pain, \nsymptom severity, Phalen test, grip strength, pinch \nstrength, and median nerve motor conduction across the \nwrist in a group of patients post CTR surgery who reported \nimprovement (average follow-up, 18 months). The Phalen \ntest was more sensitive to change (SRM, 0.92) than grip \n(SRM, 0.38) or pinch strength (SRM, 0.39).",
    "chunk_id": 394,
    "sentence_start": 1728,
    "sentence_end": 1731,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "II\nPransky et al230 assessed sensitivity to change in the \nUpper Extremity Functional Scale scores, pain, \nsymptom severity, Phalen test, grip strength, pinch \nstrength, and median nerve motor conduction across the \nwrist in a group of patients post CTR surgery who reported \nimprovement (average follow-up, 18 months). The Phalen \ntest was more sensitive to change (SRM, 0.92) than grip \n(SRM, 0.38) or pinch strength (SRM, 0.39). Evidence Synthesis and Clinical Rationale\nFor 2PD and SWMT, there is conflicting evidence on the sen­\nsitivity to change following CTR surgery. Data available for \nthreshold and vibration sense are limited and do not support \nuse of these measures. the sensitivity to change of instruments \nindividuals with CTS being managed \nailable data are on individuals being \nand suggest that strength measures are \ndividuals. However, due to the presence \nnd/scar, one should not expect to apply \nnts managed nonsurgically.",
    "chunk_id": 395,
    "sentence_start": 1730,
    "sentence_end": 1735,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "the sensitivity to change of instruments \nindividuals with CTS being managed \nailable data are on individuals being \nand suggest that strength measures are \ndividuals. However, due to the presence \nnd/scar, one should not expect to apply \nnts managed nonsurgically. Also, there \ne on the presence of grip strength weak­\nwith CTS, and there is a need for more \nhould not use lateral pinch strength as \ne measure for patients with nonsurgi­\ngically managed CTS. hould not use grip strength when assess­\nrm (less than 3 months) change in indi­\nowing CTR surgery. may assess grip strength and 3-point or \ntrength in individuals presenting with \nmptoms of CTS and compare scores with \nnflicting evidence on the use of tip and \nch strength and abductor pollicis brevis \nength testing in individuals following \nive Measures\ncative and sensory measures have been \nnosis section of this guideline and are \n5, respectively.",
    "chunk_id": 396,
    "sentence_start": 1734,
    "sentence_end": 1738,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "hould not use grip strength when assess­\nrm (less than 3 months) change in indi­\nowing CTR surgery. may assess grip strength and 3-point or \ntrength in individuals presenting with \nmptoms of CTS and compare scores with \nnflicting evidence on the use of tip and \nch strength and abductor pollicis brevis \nength testing in individuals following \nive Measures\ncative and sensory measures have been \nnosis section of this guideline and are \n5, respectively. Here, these instruments \nregards to their ability to detect change \no studies assessing sensitivity to change \nD in patients undergoing nonsurgical \nnt for CTS. There were 5 studies using the \ned by Cohen’s criteria (small d = 0.2, me­\n= 0.8)70 following CTR with conflicting \ntudies reported small-to-medium ES at \nfter CTR surgery (0.39,135 0.51,145 0.22,138 \nvely). Authors of a study deemed to be \nted a large ES of 0.88 at 18 weeks follow­\nauthors found low-to-moderate SRMs at \n after surgery (0.30-0.76,22,134,145 0.57,138 \npectively).",
    "chunk_id": 397,
    "sentence_start": 1737,
    "sentence_end": 1741,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There were 5 studies using the \ned by Cohen’s criteria (small d = 0.2, me­\n= 0.8)70 following CTR with conflicting \ntudies reported small-to-medium ES at \nfter CTR surgery (0.39,135 0.51,145 0.22,138 \nvely). Authors of a study deemed to be \nted a large ES of 0.88 at 18 weeks follow­\nauthors found low-to-moderate SRMs at \n after surgery (0.30-0.76,22,134,145 0.57,138 \npectively). There was 1 study on the sen­\nmoving 2PD following CTR (ES, 0.44) at \nrgery.135\n\n\n--- Page 36 ---\nCOLUMN 1:\nExamination\n•  \u0007Patient age\n•  \u0007Katz hand diagram (location of symptoms)\n•  \u0007Wrist ratio index\n•  \u0007Whether shaking hands provides relief\n•  \u0007Duration of symptoms\n•  \u0007Intensity of symptoms\n•  Frequency of symptoms\n•  \u0007Prior nonsurgical interventions\n•  \u0007Presence of thenar atrophy (indication of severe CTS)\nActivity Limitations – Self-report Measures\n• CTQ-SSSa,b and the CTQ-FSb or the DASHb\nActivity Limitations – Physical Performance Measures\n• PPB or the DMPUTb to assess dexterity (compare to est\nlished normative values for age and sex)\nPhysical Impairment Measures\n•\t SWMT (compare to normal value of 2.83 or 3.22)\n•  \u0007Static 2PD on the middle finger (compare to normal va\nof 6 mm)\n•  \u0007Phalen test,b Tinel sign, and carpal compression test\n•  \u0007Grip strengthc and tip or 3-point pinch strength to as\nstrength (compare to established normative values for \nand sex)\naMeasures validated to assess change over time in those undergoing nonsurgical \nmanagement.",
    "chunk_id": 398,
    "sentence_start": 1740,
    "sentence_end": 1742,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Authors of a study deemed to be \nted a large ES of 0.88 at 18 weeks follow­\nauthors found low-to-moderate SRMs at \n after surgery (0.30-0.76,22,134,145 0.57,138 \npectively). There was 1 study on the sen­\nmoving 2PD following CTR (ES, 0.44) at \nrgery.135\n\n\n--- Page 36 ---\nCOLUMN 1:\nExamination\n•  \u0007Patient age\n•  \u0007Katz hand diagram (location of symptoms)\n•  \u0007Wrist ratio index\n•  \u0007Whether shaking hands provides relief\n•  \u0007Duration of symptoms\n•  \u0007Intensity of symptoms\n•  Frequency of symptoms\n•  \u0007Prior nonsurgical interventions\n•  \u0007Presence of thenar atrophy (indication of severe CTS)\nActivity Limitations – Self-report Measures\n• CTQ-SSSa,b and the CTQ-FSb or the DASHb\nActivity Limitations – Physical Performance Measures\n• PPB or the DMPUTb to assess dexterity (compare to est\nlished normative values for age and sex)\nPhysical Impairment Measures\n•\t SWMT (compare to normal value of 2.83 or 3.22)\n•  \u0007Static 2PD on the middle finger (compare to normal va\nof 6 mm)\n•  \u0007Phalen test,b Tinel sign, and carpal compression test\n•  \u0007Grip strengthc and tip or 3-point pinch strength to as\nstrength (compare to established normative values for \nand sex)\naMeasures validated to assess change over time in those undergoing nonsurgical \nmanagement. bMeasures validated to assess change over time following CTR surgery.",
    "chunk_id": 399,
    "sentence_start": 1741,
    "sentence_end": 1743,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There was 1 study on the sen­\nmoving 2PD following CTR (ES, 0.44) at \nrgery.135\n\n\n--- Page 36 ---\nCOLUMN 1:\nExamination\n•  \u0007Patient age\n•  \u0007Katz hand diagram (location of symptoms)\n•  \u0007Wrist ratio index\n•  \u0007Whether shaking hands provides relief\n•  \u0007Duration of symptoms\n•  \u0007Intensity of symptoms\n•  Frequency of symptoms\n•  \u0007Prior nonsurgical interventions\n•  \u0007Presence of thenar atrophy (indication of severe CTS)\nActivity Limitations – Self-report Measures\n• CTQ-SSSa,b and the CTQ-FSb or the DASHb\nActivity Limitations – Physical Performance Measures\n• PPB or the DMPUTb to assess dexterity (compare to est\nlished normative values for age and sex)\nPhysical Impairment Measures\n•\t SWMT (compare to normal value of 2.83 or 3.22)\n•  \u0007Static 2PD on the middle finger (compare to normal va\nof 6 mm)\n•  \u0007Phalen test,b Tinel sign, and carpal compression test\n•  \u0007Grip strengthc and tip or 3-point pinch strength to as\nstrength (compare to established normative values for \nand sex)\naMeasures validated to assess change over time in those undergoing nonsurgical \nmanagement. bMeasures validated to assess change over time following CTR surgery. cGrip strength should not be used to assess change following surgery until the 12th \npostoperative week.",
    "chunk_id": 400,
    "sentence_start": 1742,
    "sentence_end": 1744,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "bMeasures validated to assess change over time following CTR surgery. cGrip strength should not be used to assess change following surgery until the 12th \npostoperative week. Gaps in Knowledge\nThere is a need for research examining the use of 2PD and \nprovocative measures in individuals undergoing nonsurgical \nmanagement. The use of the Phalen test to assess change in \nCTS needs further validation. Recommendations\nC\nClinicians should not use threshold or vibration \ntesting to assess change in individuals with CTS \nundergoing nonsurgical management until more \nevidence becomes available. Clinicians may use the Phalen \ntest to assess change in those with CTR surgery at long-term \nfollow-ups. D\nThere is conflicting evidence on the use of sensory \nmeasures, including 2PD and threshold testing, to \nassess change over time in patients with surgically \nmanaged CTS.",
    "chunk_id": 401,
    "sentence_start": 1743,
    "sentence_end": 1749,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Clinicians may use the Phalen \ntest to assess change in those with CTR surgery at long-term \nfollow-ups. D\nThere is conflicting evidence on the use of sensory \nmeasures, including 2PD and threshold testing, to \nassess change over time in patients with surgically \nmanaged CTS. BEST-PRACTICE POINT\nEssential Data Elements\nIn the course of the examination and episode of care, clini­\ncians should document results of the following questions, \ntests, and measures. Upon collection of the initial patient/\nclient data, clinicians should differentiate CTS from other \nnerve injuries and then assess the CTS severity to determine \nif an immediate surgical referral is warranted. Patients may \nrequire electrodiagnostic studies when the clinical exam is in­\nconclusive. When assessing effectiveness of nonsurgical man­\nagement, results should be documented again at discharge or \nat 1 other follow-up point.",
    "chunk_id": 402,
    "sentence_start": 1748,
    "sentence_end": 1753,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Patients may \nrequire electrodiagnostic studies when the clinical exam is in­\nconclusive. When assessing effectiveness of nonsurgical man­\nagement, results should be documented again at discharge or \nat 1 other follow-up point. Documentation of standard ele­\nments supports standardization for quality improvement in \nclinical care and research. Abbreviations: AUC, area under the curve; CTR, carpal tunnel release; MCID, minimal clinically important difference.",
    "chunk_id": 403,
    "sentence_start": 1752,
    "sentence_end": 1755,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Documentation of standard ele­\nments supports standardization for quality improvement in \nclinical care and research. Abbreviations: AUC, area under the curve; CTR, carpal tunnel release; MCID, minimal clinically important difference. TABLE 8\nMinimal Clinically Important Difference for the Boston \nCarpal Tunnel Questionnaire-Symptom Severity Scale\nStudy\nCondition\nMCID Value\nSample Size\nCheung et al64\n6 wk of orthosis use\n0.50\n63\nÖzyürekoğlu et al219\n3 wk following steroid injection\n1.04 (AUC = 0.82)\n28\nAmirfeyz et al10\n6 wk post CTR surgery\n0.16\n43\nJerosch-Herold et al138\n4 mo post CTR surgery\n1.25\n57 at 4-mo assessment; 55 at 8-mo assessment\nAstifidis et al19\n6 mo post CTR surgery\n1.36 (unilateral involvement)\n635\n6 mo post CTR surgery\n1.55 (bilateral involvement)\n635\nOzer et al216\n3 mo post CTR surgery\n1.45 (diabetics)\n114 (87 nondiabetic, 27 diabetic)\n3 mo post CTR surgery\n0.80 (nondiabetics)\n114 (87 nondiabetic, 27 diabetic)\n6 mo post CTR surgery\n1.55 (diabetics)\n114 (87 nondiabetic, 27 diabetic)\n6 mo post CTR surgery\n1.60 (nondiabetics)\n114 (87 nondiabetic, 27 diabetic)\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 404,
    "sentence_start": 1754,
    "sentence_end": 1756,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Abbreviations: AUC, area under the curve; CTR, carpal tunnel release; MCID, minimal clinically important difference. TABLE 8\nMinimal Clinically Important Difference for the Boston \nCarpal Tunnel Questionnaire-Symptom Severity Scale\nStudy\nCondition\nMCID Value\nSample Size\nCheung et al64\n6 wk of orthosis use\n0.50\n63\nÖzyürekoğlu et al219\n3 wk following steroid injection\n1.04 (AUC = 0.82)\n28\nAmirfeyz et al10\n6 wk post CTR surgery\n0.16\n43\nJerosch-Herold et al138\n4 mo post CTR surgery\n1.25\n57 at 4-mo assessment; 55 at 8-mo assessment\nAstifidis et al19\n6 mo post CTR surgery\n1.36 (unilateral involvement)\n635\n6 mo post CTR surgery\n1.55 (bilateral involvement)\n635\nOzer et al216\n3 mo post CTR surgery\n1.45 (diabetics)\n114 (87 nondiabetic, 27 diabetic)\n3 mo post CTR surgery\n0.80 (nondiabetics)\n114 (87 nondiabetic, 27 diabetic)\n6 mo post CTR surgery\n1.55 (diabetics)\n114 (87 nondiabetic, 27 diabetic)\n6 mo post CTR surgery\n1.60 (nondiabetics)\n114 (87 nondiabetic, 27 diabetic)\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 405,
    "sentence_start": 1755,
    "sentence_end": 1757,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "TABLE 8\nMinimal Clinically Important Difference for the Boston \nCarpal Tunnel Questionnaire-Symptom Severity Scale\nStudy\nCondition\nMCID Value\nSample Size\nCheung et al64\n6 wk of orthosis use\n0.50\n63\nÖzyürekoğlu et al219\n3 wk following steroid injection\n1.04 (AUC = 0.82)\n28\nAmirfeyz et al10\n6 wk post CTR surgery\n0.16\n43\nJerosch-Herold et al138\n4 mo post CTR surgery\n1.25\n57 at 4-mo assessment; 55 at 8-mo assessment\nAstifidis et al19\n6 mo post CTR surgery\n1.36 (unilateral involvement)\n635\n6 mo post CTR surgery\n1.55 (bilateral involvement)\n635\nOzer et al216\n3 mo post CTR surgery\n1.45 (diabetics)\n114 (87 nondiabetic, 27 diabetic)\n3 mo post CTR surgery\n0.80 (nondiabetics)\n114 (87 nondiabetic, 27 diabetic)\n6 mo post CTR surgery\n1.55 (diabetics)\n114 (87 nondiabetic, 27 diabetic)\n6 mo post CTR surgery\n1.60 (nondiabetics)\n114 (87 nondiabetic, 27 diabetic)\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 406,
    "sentence_start": 1756,
    "sentence_end": 1758,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nExamination\n•  \u0007Patient age\n•  \u0007Katz hand diagram (location of symptoms)\n•  \u0007Wrist ratio index\n•  \u0007Whether shaking hands provides relief\n•  \u0007Duration of symptoms\n•  \u0007Intensity of symptoms\n•  Frequency of symptoms\n•  \u0007Prior nonsurgical interventions\n•  \u0007Presence of thenar atrophy (indication of severe CTS)\nActivity Limitations – Self-report Measures\n• CTQ-SSSa,b and the CTQ-FSb or the DASHb\nActivity Limitations – Physical Performance Measures\n• PPB or the DMPUTb to assess dexterity (compare to estab­\nlished normative values for age and sex)\nPhysical Impairment Measures\n•\t SWMT (compare to normal value of 2.83 or 3.22)\n•  \u0007Static 2PD on the middle finger (compare to normal value \nof 6 mm)\n•  \u0007Phalen test,b Tinel sign, and carpal compression test\n•  \u0007Grip strengthc and tip or 3-point pinch strength to assess \nstrength (compare to established normative values for age \nand sex)\naMeasures validated to assess change over time in those undergoing nonsurgical \nmanagement.",
    "chunk_id": 407,
    "sentence_start": 1759,
    "sentence_end": 1761,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nExamination\n•  \u0007Patient age\n•  \u0007Katz hand diagram (location of symptoms)\n•  \u0007Wrist ratio index\n•  \u0007Whether shaking hands provides relief\n•  \u0007Duration of symptoms\n•  \u0007Intensity of symptoms\n•  Frequency of symptoms\n•  \u0007Prior nonsurgical interventions\n•  \u0007Presence of thenar atrophy (indication of severe CTS)\nActivity Limitations – Self-report Measures\n• CTQ-SSSa,b and the CTQ-FSb or the DASHb\nActivity Limitations – Physical Performance Measures\n• PPB or the DMPUTb to assess dexterity (compare to estab­\nlished normative values for age and sex)\nPhysical Impairment Measures\n•\t SWMT (compare to normal value of 2.83 or 3.22)\n•  \u0007Static 2PD on the middle finger (compare to normal value \nof 6 mm)\n•  \u0007Phalen test,b Tinel sign, and carpal compression test\n•  \u0007Grip strengthc and tip or 3-point pinch strength to assess \nstrength (compare to established normative values for age \nand sex)\naMeasures validated to assess change over time in those undergoing nonsurgical \nmanagement. bMeasures validated to assess change over time following CTR surgery.",
    "chunk_id": 408,
    "sentence_start": 1760,
    "sentence_end": 1762,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nExamination\n•  \u0007Patient age\n•  \u0007Katz hand diagram (location of symptoms)\n•  \u0007Wrist ratio index\n•  \u0007Whether shaking hands provides relief\n•  \u0007Duration of symptoms\n•  \u0007Intensity of symptoms\n•  Frequency of symptoms\n•  \u0007Prior nonsurgical interventions\n•  \u0007Presence of thenar atrophy (indication of severe CTS)\nActivity Limitations – Self-report Measures\n• CTQ-SSSa,b and the CTQ-FSb or the DASHb\nActivity Limitations – Physical Performance Measures\n• PPB or the DMPUTb to assess dexterity (compare to estab­\nlished normative values for age and sex)\nPhysical Impairment Measures\n•\t SWMT (compare to normal value of 2.83 or 3.22)\n•  \u0007Static 2PD on the middle finger (compare to normal value \nof 6 mm)\n•  \u0007Phalen test,b Tinel sign, and carpal compression test\n•  \u0007Grip strengthc and tip or 3-point pinch strength to assess \nstrength (compare to established normative values for age \nand sex)\naMeasures validated to assess change over time in those undergoing nonsurgical \nmanagement. bMeasures validated to assess change over time following CTR surgery. cGrip strength should not be used to assess change following surgery until the 12th \npostoperative week.",
    "chunk_id": 409,
    "sentence_start": 1761,
    "sentence_end": 1763,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "bMeasures validated to assess change over time following CTR surgery. cGrip strength should not be used to assess change following surgery until the 12th \npostoperative week. esearch examining the use of 2PD and \ns in individuals undergoing nonsurgical \ne of the Phalen test to assess change in \nlidation. should not use threshold or vibration \nassess change in individuals with CTS \nnonsurgical management until more \nailable. Clinicians may use the Phalen \nin those with CTR surgery at long-term \nnflicting evidence on the use of sensory \nncluding 2PD and threshold testing, to \nge over time in patients with surgically \nOINT\nnts\nexamination and episode of care, clini­\nent results of the following questions, \nUpon collection of the initial patient/\ns should differentiate CTS from other \nen assess the CTS severity to determine \nical referral is warranted.",
    "chunk_id": 410,
    "sentence_start": 1762,
    "sentence_end": 1766,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "should not use threshold or vibration \nassess change in individuals with CTS \nnonsurgical management until more \nailable. Clinicians may use the Phalen \nin those with CTR surgery at long-term \nnflicting evidence on the use of sensory \nncluding 2PD and threshold testing, to \nge over time in patients with surgically \nOINT\nnts\nexamination and episode of care, clini­\nent results of the following questions, \nUpon collection of the initial patient/\ns should differentiate CTS from other \nen assess the CTS severity to determine \nical referral is warranted. Patients may \nstic studies when the clinical exam is in­\nessing effectiveness of nonsurgical man­\nuld be documented again at discharge or \npoint. Documentation of standard ele­\ndardization for quality improvement in \narch.",
    "chunk_id": 411,
    "sentence_start": 1765,
    "sentence_end": 1768,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Patients may \nstic studies when the clinical exam is in­\nessing effectiveness of nonsurgical man­\nuld be documented again at discharge or \npoint. Documentation of standard ele­\ndardization for quality improvement in \narch. Minimal Clinically Important Difference for the Boston \nCarpal Tunnel Questionnaire-Symptom Severity Scale\nCondition\nMCID Value\nSample Size\n6 wk of orthosis use\n0.50\n63\n3 wk following steroid injection\n1.04 (AUC = 0.82)\n28\n6 wk post CTR surgery\n0.16\n43\n4 mo post CTR surgery\n1.25\n57 at 4-mo assessment; 55 at 8-mo assessment\n6 mo post CTR surgery\n1.36 (unilateral involvement)\n635\n6 mo post CTR surgery\n1.55 (bilateral involvement)\n635\n3 mo post CTR surgery\n1.45 (diabetics)\n114 (87 nondiabetic, 27 diabetic)\n3 mo post CTR surgery\n0.80 (nondiabetics)\n114 (87 nondiabetic, 27 diabetic)\n6 mo post CTR surgery\n1.55 (diabetics)\n114 (87 nondiabetic, 27 diabetic)\n6 mo post CTR surgery\n1.60 (nondiabetics)\n114 (87 nondiabetic, 27 diabetic)\n\n\n--- Page 37 ---\nCOLUMN 1:\nASSISTIVE TECHNOLOGY\nComputer Component Design\nThe benefits attributed to ergonomically designed computer \nequipment include (1) reduction of carpal tunnel pressure103; \n(2) alignment of the wrist in the position that maximizes the \nspace in the carpal tunnel210; (3) reduction of the work of the \ntendons within the carpal tunnel through reduced force out­\nput240; (4) reduction of the velocity and frequency of relative \nsliding between the contents of the carpal tunnel98,151; and (5) \nreduction of finger flexion range of motion, thereby prevent­\ning migration of the extrinsic or intrinsic muscle bellies into \nthe carpal tunnel.68\nII\nIn a Cochrane review, O’Connor et al210 analyzed 2 \nrandomized placebo-controlled trials evaluating \nthe effectiveness of ergonomic keyboards.239,275 \nRempel et al239 compared self-reported pain level, symptom \nrelief, hand function, and NCS in individuals with CTS (all \nseverities) using an ergonomic keyboard to those using a \nstandard keyboard for 6 and 12 weeks.",
    "chunk_id": 412,
    "sentence_start": 1767,
    "sentence_end": 1769,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Documentation of standard ele­\ndardization for quality improvement in \narch. Minimal Clinically Important Difference for the Boston \nCarpal Tunnel Questionnaire-Symptom Severity Scale\nCondition\nMCID Value\nSample Size\n6 wk of orthosis use\n0.50\n63\n3 wk following steroid injection\n1.04 (AUC = 0.82)\n28\n6 wk post CTR surgery\n0.16\n43\n4 mo post CTR surgery\n1.25\n57 at 4-mo assessment; 55 at 8-mo assessment\n6 mo post CTR surgery\n1.36 (unilateral involvement)\n635\n6 mo post CTR surgery\n1.55 (bilateral involvement)\n635\n3 mo post CTR surgery\n1.45 (diabetics)\n114 (87 nondiabetic, 27 diabetic)\n3 mo post CTR surgery\n0.80 (nondiabetics)\n114 (87 nondiabetic, 27 diabetic)\n6 mo post CTR surgery\n1.55 (diabetics)\n114 (87 nondiabetic, 27 diabetic)\n6 mo post CTR surgery\n1.60 (nondiabetics)\n114 (87 nondiabetic, 27 diabetic)\n\n\n--- Page 37 ---\nCOLUMN 1:\nASSISTIVE TECHNOLOGY\nComputer Component Design\nThe benefits attributed to ergonomically designed computer \nequipment include (1) reduction of carpal tunnel pressure103; \n(2) alignment of the wrist in the position that maximizes the \nspace in the carpal tunnel210; (3) reduction of the work of the \ntendons within the carpal tunnel through reduced force out­\nput240; (4) reduction of the velocity and frequency of relative \nsliding between the contents of the carpal tunnel98,151; and (5) \nreduction of finger flexion range of motion, thereby prevent­\ning migration of the extrinsic or intrinsic muscle bellies into \nthe carpal tunnel.68\nII\nIn a Cochrane review, O’Connor et al210 analyzed 2 \nrandomized placebo-controlled trials evaluating \nthe effectiveness of ergonomic keyboards.239,275 \nRempel et al239 compared self-reported pain level, symptom \nrelief, hand function, and NCS in individuals with CTS (all \nseverities) using an ergonomic keyboard to those using a \nstandard keyboard for 6 and 12 weeks. Both keyboards in­\ncluded a conventional layout but differed in the required \nforce needed for key displacement.",
    "chunk_id": 413,
    "sentence_start": 1768,
    "sentence_end": 1770,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Minimal Clinically Important Difference for the Boston \nCarpal Tunnel Questionnaire-Symptom Severity Scale\nCondition\nMCID Value\nSample Size\n6 wk of orthosis use\n0.50\n63\n3 wk following steroid injection\n1.04 (AUC = 0.82)\n28\n6 wk post CTR surgery\n0.16\n43\n4 mo post CTR surgery\n1.25\n57 at 4-mo assessment; 55 at 8-mo assessment\n6 mo post CTR surgery\n1.36 (unilateral involvement)\n635\n6 mo post CTR surgery\n1.55 (bilateral involvement)\n635\n3 mo post CTR surgery\n1.45 (diabetics)\n114 (87 nondiabetic, 27 diabetic)\n3 mo post CTR surgery\n0.80 (nondiabetics)\n114 (87 nondiabetic, 27 diabetic)\n6 mo post CTR surgery\n1.55 (diabetics)\n114 (87 nondiabetic, 27 diabetic)\n6 mo post CTR surgery\n1.60 (nondiabetics)\n114 (87 nondiabetic, 27 diabetic)\n\n\n--- Page 37 ---\nCOLUMN 1:\nASSISTIVE TECHNOLOGY\nComputer Component Design\nThe benefits attributed to ergonomically designed computer \nequipment include (1) reduction of carpal tunnel pressure103; \n(2) alignment of the wrist in the position that maximizes the \nspace in the carpal tunnel210; (3) reduction of the work of the \ntendons within the carpal tunnel through reduced force out­\nput240; (4) reduction of the velocity and frequency of relative \nsliding between the contents of the carpal tunnel98,151; and (5) \nreduction of finger flexion range of motion, thereby prevent­\ning migration of the extrinsic or intrinsic muscle bellies into \nthe carpal tunnel.68\nII\nIn a Cochrane review, O’Connor et al210 analyzed 2 \nrandomized placebo-controlled trials evaluating \nthe effectiveness of ergonomic keyboards.239,275 \nRempel et al239 compared self-reported pain level, symptom \nrelief, hand function, and NCS in individuals with CTS (all \nseverities) using an ergonomic keyboard to those using a \nstandard keyboard for 6 and 12 weeks. Both keyboards in­\ncluded a conventional layout but differed in the required \nforce needed for key displacement. Rempel et al239 found im­\nprovement in pain levels between 6 and 12 weeks for those in \nthe reduced key-strike force group (weighted MD [WMD], \n–2.40; 95% CI: –4.45, –0.35).210 Tittiranonda et al275 com­\npared pain severity in 80 individuals with CTS (unspecified \nseverity) using 1 of 3 ergonomic keyboards or a standard key­\nboard and found no significant difference in pain severity at \n6 months compared to baseline.",
    "chunk_id": 414,
    "sentence_start": 1769,
    "sentence_end": 1771,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Both keyboards in­\ncluded a conventional layout but differed in the required \nforce needed for key displacement. Rempel et al239 found im­\nprovement in pain levels between 6 and 12 weeks for those in \nthe reduced key-strike force group (weighted MD [WMD], \n–2.40; 95% CI: –4.45, –0.35).210 Tittiranonda et al275 com­\npared pain severity in 80 individuals with CTS (unspecified \nseverity) using 1 of 3 ergonomic keyboards or a standard key­\nboard and found no significant difference in pain severity at \n6 months compared to baseline. Neither study reported ad­\nverse effects associated with the use of the keyboards. O’Connor et al210 concluded there was insufficient evidence \nfor or against the short or long-term effectiveness of the stud­\nied ergonomic keyboards in patients with CTS.",
    "chunk_id": 415,
    "sentence_start": 1770,
    "sentence_end": 1773,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Neither study reported ad­\nverse effects associated with the use of the keyboards. O’Connor et al210 concluded there was insufficient evidence \nfor or against the short or long-term effectiveness of the stud­\nied ergonomic keyboards in patients with CTS. II\nIn a cohort study consisting of 21 individuals with \nmild or moderate CTS, Schmid et al253 compared \nthe effects of a\nertical mouse a standard mouse\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 416,
    "sentence_start": 1772,
    "sentence_end": 1778,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nOLOGY\nt Design\ned to ergonomically designed computer \n) reduction of carpal tunnel pressure103; \nwrist in the position that maximizes the \nnnel210; (3) reduction of the work of the \narpal tunnel through reduced force out­\nof the velocity and frequency of relative \nontents of the carpal tunnel98,151; and (5) l\nexion range of motion, thereby prevent­\nextrinsic or intrinsic muscle bellies into \nne review, O’Connor et al210 analyzed 2 \nd placebo-controlled trials evaluating \nveness of ergonomic keyboards.239,275 \nared self-reported pain level, symptom \n and NCS in individuals with CTS (all \nergonomic keyboard to those using a \nor 6 and 12 weeks. Both keyboards in­\nal layout but differed in the required \ndisplacement.",
    "chunk_id": 417,
    "sentence_start": 1777,
    "sentence_end": 1780,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nOLOGY\nt Design\ned to ergonomically designed computer \n) reduction of carpal tunnel pressure103; \nwrist in the position that maximizes the \nnnel210; (3) reduction of the work of the \narpal tunnel through reduced force out­\nof the velocity and frequency of relative \nontents of the carpal tunnel98,151; and (5) l\nexion range of motion, thereby prevent­\nextrinsic or intrinsic muscle bellies into \nne review, O’Connor et al210 analyzed 2 \nd placebo-controlled trials evaluating \nveness of ergonomic keyboards.239,275 \nared self-reported pain level, symptom \n and NCS in individuals with CTS (all \nergonomic keyboard to those using a \nor 6 and 12 weeks. Both keyboards in­\nal layout but differed in the required \ndisplacement. Rempel et al239 found im­\nvels between 6 and 12 weeks for those in \nke force group (weighted MD [WMD], \n5, –0.35).210 Tittiranonda et al275 com­\nn 80 individuals with CTS (unspecified \nergonomic keyboards or a standard key­\nsignificant difference in pain severity at \nto baseline.",
    "chunk_id": 418,
    "sentence_start": 1779,
    "sentence_end": 1781,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Both keyboards in­\nal layout but differed in the required \ndisplacement. Rempel et al239 found im­\nvels between 6 and 12 weeks for those in \nke force group (weighted MD [WMD], \n5, –0.35).210 Tittiranonda et al275 com­\nn 80 individuals with CTS (unspecified \nergonomic keyboards or a standard key­\nsignificant difference in pain severity at \nto baseline. Neither study reported ad­\nated with the use of the keyboards. ncluded there was insufficient evidence \nrt or long-term effectiveness of the stud­\nards in patients with CTS. study consisting of 21 individuals with \nderate CTS, Schmid et al253 compared \nof a vertical mouse, a standard mouse \nchange radio-ulnar deviation angles (P>.07). The vertical \nmouse showed the largest extension angle (P<.001) but the \nsmallest ulnar deviation angle (P<.006). There was no differ­\nence in patient-reported comfort across the 4 devices (P = \n.71).",
    "chunk_id": 419,
    "sentence_start": 1780,
    "sentence_end": 1786,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The vertical \nmouse showed the largest extension angle (P<.001) but the \nsmallest ulnar deviation angle (P<.006). There was no differ­\nence in patient-reported comfort across the 4 devices (P = \n.71). Schmid et al253 concluded there was insufficient evidence \nto make recommendations for or against any of the devices \nstudied. Evidence Synthesis and Clinical Rationale\nErgonomic devices are more expensive than standard devic­\nes.210 There is insufficient evidence to support the use of the \nstudied ergonomic keyboards, mice, or mouse pads to reduce \nrisk of developing CTS. Evidence suggests that mouse use \nfurther increases carpal tunnel pressure with all the studied \nmouse designs. As noted earlier in this guideline, increased \ncarpal tunnel pressure above 30 mmHg165 and forceful hand \nexertions are strongly associated with CTS.128 The mean pres­\nsures recorded with all studied mouse designs exceeded the \n30-mmHg diagnostic minimum.",
    "chunk_id": 420,
    "sentence_start": 1785,
    "sentence_end": 1790,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Evidence suggests that mouse use \nfurther increases carpal tunnel pressure with all the studied \nmouse designs. As noted earlier in this guideline, increased \ncarpal tunnel pressure above 30 mmHg165 and forceful hand \nexertions are strongly associated with CTS.128 The mean pres­\nsures recorded with all studied mouse designs exceeded the \n30-mmHg diagnostic minimum. Gaps in Knowledge\nHigh-quality studies to evaluate the effectiveness of nonstan­\ndard keyboards, mice, and mouse pads using valid, reliable, \nand responsive outcome measures in individuals with CTS \nare needed. These studies should also include device use for \ntime periods reflecting a typical 8-hour work day. More stud­\nies are needed to identify equipment designs justifying the \nadditional expense.",
    "chunk_id": 421,
    "sentence_start": 1789,
    "sentence_end": 1793,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "These studies should also include device use for \ntime periods reflecting a typical 8-hour work day. More stud­\nies are needed to identify equipment designs justifying the \nadditional expense. Recommendation\nC\nClinicians may educate their patients regarding the \neffects of mouse use on carpal tunnel pressure and \nassist patients in developing alternate strategies \nincluding the use of arrow keys, touch screens, or alternating \nthe mouse hand. Clinicians may recommend keyboards with \nreduced strike force for patients with CTS who report pain \nwith keyboard use. CLINICAL PRACTICE GUIDELINES\nInterventions\n\n\n--- Page 38 ---\nCOLUMN 1:\nfingers to prevent the lumbrical muscle origins from migrat­\ning proximally into the carpal tunnel or prevent the proximal \nmuscles from advancing distally.75,86,148,237\nIn a Cochrane review, Page et al221 reviewed 19 studies pub­\nlished before January 2012.",
    "chunk_id": 422,
    "sentence_start": 1792,
    "sentence_end": 1796,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Clinicians may recommend keyboards with \nreduced strike force for patients with CTS who report pain \nwith keyboard use. CLINICAL PRACTICE GUIDELINES\nInterventions\n\n\n--- Page 38 ---\nCOLUMN 1:\nfingers to prevent the lumbrical muscle origins from migrat­\ning proximally into the carpal tunnel or prevent the proximal \nmuscles from advancing distally.75,86,148,237\nIn a Cochrane review, Page et al221 reviewed 19 studies pub­\nlished before January 2012. They performed subanalyses on \nthe effectiveness of orthoses versus no intervention, orthoses \nversus other nonsurgical interventions, and orthosis design and \nposition. The review also reported on the combined effects of \northoses and steroid injection, orthoses and nonsteroidal anti-\ninflammatory drugs (NSAIDs), and orthoses and ergonomic \neducation. The results of the subanalyses are included below in \naddition to studies published after the Cochrane review.",
    "chunk_id": 423,
    "sentence_start": 1795,
    "sentence_end": 1799,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The review also reported on the combined effects of \northoses and steroid injection, orthoses and nonsteroidal anti-\ninflammatory drugs (NSAIDs), and orthoses and ergonomic \neducation. The results of the subanalyses are included below in \naddition to studies published after the Cochrane review. Orthosis Versus No Intervention\nII\nPage et al221 reviewed 2 level II studies comparing \northosis use to no intervention. In the first study, a \nrandomized controlled trial, Manente et al180 evalu­\nated 80 individuals using a soft, hand-based support at night. Use of the support for 4 weeks resulted in short-term symp­\ntom improvement in the CTQ-SSS (MD, –1.07; 95% CI: \n–1.29, –0.85) and the CTQ-FS (MD, –0.55; 95% CI: –0.82, \n–0.28).221 Page et al221 concluded that the orthosis group was \nmore than 3 times as likely to report improvement than the \nno-orthosis group (RR = 3.86; 95% CI: 2.29, 6.51).",
    "chunk_id": 424,
    "sentence_start": 1798,
    "sentence_end": 1802,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In the first study, a \nrandomized controlled trial, Manente et al180 evalu­\nated 80 individuals using a soft, hand-based support at night. Use of the support for 4 weeks resulted in short-term symp­\ntom improvement in the CTQ-SSS (MD, –1.07; 95% CI: \n–1.29, –0.85) and the CTQ-FS (MD, –0.55; 95% CI: –0.82, \n–0.28).221 Page et al221 concluded that the orthosis group was \nmore than 3 times as likely to report improvement than the \nno-orthosis group (RR = 3.86; 95% CI: 2.29, 6.51). In the \nsecond study, a quasi-randomized trial, Premoselli et al231 \nevaluated symptom and functional improvement in 50 wrists \nat 3 (n = 48) and 6 months (n = 34) following use of a custom-\nfabricated, volar, neutral wrist orthoses worn at night com­\npared to no intervention.",
    "chunk_id": 425,
    "sentence_start": 1801,
    "sentence_end": 1803,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Use of the support for 4 weeks resulted in short-term symp­\ntom improvement in the CTQ-SSS (MD, –1.07; 95% CI: \n–1.29, –0.85) and the CTQ-FS (MD, –0.55; 95% CI: –0.82, \n–0.28).221 Page et al221 concluded that the orthosis group was \nmore than 3 times as likely to report improvement than the \nno-orthosis group (RR = 3.86; 95% CI: 2.29, 6.51). In the \nsecond study, a quasi-randomized trial, Premoselli et al231 \nevaluated symptom and functional improvement in 50 wrists \nat 3 (n = 48) and 6 months (n = 34) following use of a custom-\nfabricated, volar, neutral wrist orthoses worn at night com­\npared to no intervention. At 3 months, the difference in \nscores between the orthosis group and the control favored the \northosis group on the CTQ-SSS (MD, – 0.94; 95% CI: –1.10, \n–0.78) and the CTQ-FS (MD, –0.22; 95% CI: –0.40, \n–0.04).221 At 6 months, the difference between groups per­\nsisted on the CTQ-SSS (MD, –0.90; 95% CI: –1.11, –0.69) \nand CTQ-FS (MD, –0.25; 95% CI: –0.68, 0.18).",
    "chunk_id": 426,
    "sentence_start": 1802,
    "sentence_end": 1804,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In the \nsecond study, a quasi-randomized trial, Premoselli et al231 \nevaluated symptom and functional improvement in 50 wrists \nat 3 (n = 48) and 6 months (n = 34) following use of a custom-\nfabricated, volar, neutral wrist orthoses worn at night com­\npared to no intervention. At 3 months, the difference in \nscores between the orthosis group and the control favored the \northosis group on the CTQ-SSS (MD, – 0.94; 95% CI: –1.10, \n–0.78) and the CTQ-FS (MD, –0.22; 95% CI: –0.40, \n–0.04).221 At 6 months, the difference between groups per­\nsisted on the CTQ-SSS (MD, –0.90; 95% CI: –1.11, –0.69) \nand CTQ-FS (MD, –0.25; 95% CI: –0.68, 0.18). Results from \nthe NCS parameters were conflicting. Page et al221 concluded \nthe precision of the effect estimates was low and both studies \nwere determined to have a high risk of bias.",
    "chunk_id": 427,
    "sentence_start": 1803,
    "sentence_end": 1806,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Results from \nthe NCS parameters were conflicting. Page et al221 concluded \nthe precision of the effect estimates was low and both studies \nwere determined to have a high risk of bias. Adverse effects \nwere reported in the orthosis group in the Manente et al180 \nstudy which included difficulty falling asleep (3/40 individu­\nals) and transient morning paresthesias (4/40 individuals). Orthosis Design and Position\nOrthosis design includes material (cloth, thermoplastic, plas­\nter), limb placement (volar, dorsal, or ulnar) and the specific \njoints included in the orthosis (wrist, thumb, metacarpophalan­\ngeal  [MP] joints, interphalangeal [IP] joints). Orthosis posi­\ntion describes the angle of immobilization of the included joints. II\nPage et al221 analyzed 5 level II studies comparing \northosis design and position, including wrist im­\nmobili ation ranging from 30° of e tension to\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 428,
    "sentence_start": 1805,
    "sentence_end": 1810,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Orthosis posi­\ntion describes the angle of immobilization of the included joints. II\nPage et al221 analyzed 5 level II studies comparing \northosis design and position, including wrist im­\nmobili ation ranging from 30° of e tension to\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nlumbrical muscle origins from migrat­\nhe carpal tunnel or prevent the proximal \ning distally.75,86,148,237\nw, Page et al221 reviewed 19 studies pub­\ny 2012.",
    "chunk_id": 429,
    "sentence_start": 1809,
    "sentence_end": 1815,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nlumbrical muscle origins from migrat­\nhe carpal tunnel or prevent the proximal \ning distally.75,86,148,237\nw, Page et al221 reviewed 19 studies pub­\ny 2012. They performed subanalyses on \nrthoses versus no intervention, orthoses \ncal interventions, and orthosis design and \nalso reported on the combined effects of \nnjection, orthoses and nonsteroidal anti-\nNSAIDs), and orthoses and ergonomic \nof the subanalyses are included below in \nblished after the Cochrane review. tervention\n reviewed 2 level II studies comparing \ne to no intervention. In the first study, a \nd controlled trial, Manente et al180 evalu­\nsing a soft, hand-based support at night. r 4 weeks resulted in short-term symp­\nn the CTQ-SSS (MD, –1.07; 95% CI: \ne CTQ-FS (MD, –0.55; 95% CI: –0.82, \n1 concluded that the orthosis group was \nlikely to report improvement than the \nRR = 3.86; 95% CI: 2.29, 6.51).",
    "chunk_id": 430,
    "sentence_start": 1814,
    "sentence_end": 1819,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In the first study, a \nd controlled trial, Manente et al180 evalu­\nsing a soft, hand-based support at night. r 4 weeks resulted in short-term symp­\nn the CTQ-SSS (MD, –1.07; 95% CI: \ne CTQ-FS (MD, –0.55; 95% CI: –0.82, \n1 concluded that the orthosis group was \nlikely to report improvement than the \nRR = 3.86; 95% CI: 2.29, 6.51). In the \ni-randomized trial, Premoselli et al231 \nnd functional improvement in 50 wrists \nonths (n = 34) following use of a custom-\ntral wrist orthoses worn at night com­\nntion. At 3 months, the difference in \nthosis group and the control favored the \n CTQ-SSS (MD, – 0.94; 95% CI: –1.10, \nQ-FS (MD, –0.22; 95% CI: –0.40, \nhs the difference bet een groups per\nneutral, inclusion of MP joint immobilization, and/or \nthumb immobilization. They concluded there was insuffi­\ncient evidence to recommend one design or position over \nanother.",
    "chunk_id": 431,
    "sentence_start": 1818,
    "sentence_end": 1822,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "At 3 months, the difference in \nthosis group and the control favored the \n CTQ-SSS (MD, – 0.94; 95% CI: –1.10, \nQ-FS (MD, –0.22; 95% CI: –0.40, \nhs the difference bet een groups per\nneutral, inclusion of MP joint immobilization, and/or \nthumb immobilization. They concluded there was insuffi­\ncient evidence to recommend one design or position over \nanother. Wrist Position\nIV\nÖzgen et al217 used sonography to determine the im­\nmobilization position associated with the greatest \nmedian nerve area for 21 individuals (37 wrists) \nwith idiopathic CTS of all severity levels. Median nerve di­\nmensions in the carpal tunnel were taken in 4 wrist positions. The results showed individual variation. Forty-three percent \nof wrists showed the greatest median nerve area at 15° of \nwrist flexion, 32% at 0°, 16% at 15° of extension, and 8% at \n30° of extension.",
    "chunk_id": 432,
    "sentence_start": 1821,
    "sentence_end": 1826,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The results showed individual variation. Forty-three percent \nof wrists showed the greatest median nerve area at 15° of \nwrist flexion, 32% at 0°, 16% at 15° of extension, and 8% at \n30° of extension. Participants were immobilized in the posi­\ntion that demonstrated their greatest median nerve dimen­\nsion for 6 weeks with a custom-fabricated volar wrist orthosis. Outcome measures included CTQ-SSS, CTQ-FS, pinch \nstrength, and grip strength. The participants positioned in \n30° of wrist extension were eliminated due to the small group \nsize and were not accounted for in the final analysis. The re­\nmaining 3 groups demonstrated significantly improved CTQ-\nSSS scores (P≤.05). For the CTQ-FS, only the wrist flexion \ngroup demonstrated a significant improvement (MD, –3.0; \nP<.05), and for grip strength, only the neutral position group \ndemonstrated significant improvement (MD, 1.85 kg; P<.05).",
    "chunk_id": 433,
    "sentence_start": 1825,
    "sentence_end": 1831,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The re­\nmaining 3 groups demonstrated significantly improved CTQ-\nSSS scores (P≤.05). For the CTQ-FS, only the wrist flexion \ngroup demonstrated a significant improvement (MD, –3.0; \nP<.05), and for grip strength, only the neutral position group \ndemonstrated significant improvement (MD, 1.85 kg; P<.05). Despite the differences within the groups, there were no sta­\ntistically significant differences between the groups for any \noutcome measure (P>.05).",
    "chunk_id": 434,
    "sentence_start": 1830,
    "sentence_end": 1832,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "For the CTQ-FS, only the wrist flexion \ngroup demonstrated a significant improvement (MD, –3.0; \nP<.05), and for grip strength, only the neutral position group \ndemonstrated significant improvement (MD, 1.85 kg; P<.05). Despite the differences within the groups, there were no sta­\ntistically significant differences between the groups for any \noutcome measure (P>.05). No group demonstrated improve­\nment in pinch.217\nIII\nThe following cross-sectional studies provide \nfoundational, or physiological justification for \nneutral (0°)\nrist positioning of the orthosis based\n\n\n--- Page 39 ---\nCOLUMN 1:\nMP Joint Position\nII\nBulut et al47 compared the use of a prefabricated, \ncotton polyester wrist orthosis (0°-5° of extension) \nto a volar, custom-fabricated, thermoplastic wrist \n(0°-5°of extension) and MP joint (0°-10° of flexion) orthosis \nin a nonblinded trial of 33 patients (54 hands) with mild to \nmoderate CTS in a RCT.",
    "chunk_id": 435,
    "sentence_start": 1831,
    "sentence_end": 1833,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Despite the differences within the groups, there were no sta­\ntistically significant differences between the groups for any \noutcome measure (P>.05). No group demonstrated improve­\nment in pinch.217\nIII\nThe following cross-sectional studies provide \nfoundational, or physiological justification for \nneutral (0°)\nrist positioning of the orthosis based\n\n\n--- Page 39 ---\nCOLUMN 1:\nMP Joint Position\nII\nBulut et al47 compared the use of a prefabricated, \ncotton polyester wrist orthosis (0°-5° of extension) \nto a volar, custom-fabricated, thermoplastic wrist \n(0°-5°of extension) and MP joint (0°-10° of flexion) orthosis \nin a nonblinded trial of 33 patients (54 hands) with mild to \nmoderate CTS in a RCT. After 4 weeks of night use, both \ngroups improved in all clinical, subjective, and electrophysi­\nological outcome measures.",
    "chunk_id": 436,
    "sentence_start": 1832,
    "sentence_end": 1834,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "No group demonstrated improve­\nment in pinch.217\nIII\nThe following cross-sectional studies provide \nfoundational, or physiological justification for \nneutral (0°)\nrist positioning of the orthosis based\n\n\n--- Page 39 ---\nCOLUMN 1:\nMP Joint Position\nII\nBulut et al47 compared the use of a prefabricated, \ncotton polyester wrist orthosis (0°-5° of extension) \nto a volar, custom-fabricated, thermoplastic wrist \n(0°-5°of extension) and MP joint (0°-10° of flexion) orthosis \nin a nonblinded trial of 33 patients (54 hands) with mild to \nmoderate CTS in a RCT. After 4 weeks of night use, both \ngroups improved in all clinical, subjective, and electrophysi­\nological outcome measures. The only statistically significant \ndifference between groups was the CTQ-FS in favor of the \ncustom-fabricated wrist and MP joint orthosis (MD, –0.61 ± \n0.52) versus the prefabricated wrist-only support (MD, –0.06 \n± 0.84; P = .012).",
    "chunk_id": 437,
    "sentence_start": 1833,
    "sentence_end": 1835,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "After 4 weeks of night use, both \ngroups improved in all clinical, subjective, and electrophysi­\nological outcome measures. The only statistically significant \ndifference between groups was the CTQ-FS in favor of the \ncustom-fabricated wrist and MP joint orthosis (MD, –0.61 ± \n0.52) versus the prefabricated wrist-only support (MD, –0.06 \n± 0.84; P = .012). II\nIn a nonblinded, randomized trial, Golriz et al114 \ncompared the use of 6 weeks of wrist immobiliza­\ntion with either a custom-fabricated volar, neutral \nwrist orthosis or the same orthosis with the MP joints posi­\ntioned in 0° to 10° of flexion in 24 individuals with mild to \nmoderate CTS symptoms. Outcome measures were pain vi­\nsual analog scale (VAS), the DASH questionnaire, and grip \nand lateral pinch strength.",
    "chunk_id": 438,
    "sentence_start": 1834,
    "sentence_end": 1837,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "II\nIn a nonblinded, randomized trial, Golriz et al114 \ncompared the use of 6 weeks of wrist immobiliza­\ntion with either a custom-fabricated volar, neutral \nwrist orthosis or the same orthosis with the MP joints posi­\ntioned in 0° to 10° of flexion in 24 individuals with mild to \nmoderate CTS symptoms. Outcome measures were pain vi­\nsual analog scale (VAS), the DASH questionnaire, and grip \nand lateral pinch strength. Participants wore the orthoses at \nnight and during the day “as much as possible.” Both groups \nimproved in all outcome measures (P≤.040) but differences \nbetween the groups were significant for pain VAS (P = .02) \nand the DASH questionnaire (P = .03), both favoring the \nwrist plus MP joint orthosis.114\nIII\nIn a cross-sectional study, Manente et al179 mea­\nsured carpal tunnel and flexor retinaculum dimen­\nsions and lumbrical insertion to flexor retinaculum \ndistances via ultrasound imaging in individuals with mild to \nmoderate CTS (n = 5) and a control group (n = 5) with and \nwithout an orthosis.",
    "chunk_id": 439,
    "sentence_start": 1836,
    "sentence_end": 1838,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcome measures were pain vi­\nsual analog scale (VAS), the DASH questionnaire, and grip \nand lateral pinch strength. Participants wore the orthoses at \nnight and during the day “as much as possible.” Both groups \nimproved in all outcome measures (P≤.040) but differences \nbetween the groups were significant for pain VAS (P = .02) \nand the DASH questionnaire (P = .03), both favoring the \nwrist plus MP joint orthosis.114\nIII\nIn a cross-sectional study, Manente et al179 mea­\nsured carpal tunnel and flexor retinaculum dimen­\nsions and lumbrical insertion to flexor retinaculum \ndistances via ultrasound imaging in individuals with mild to \nmoderate CTS (n = 5) and a control group (n = 5) with and \nwithout an orthosis. The orthosis was a prefabricated, soft, \nhand-based orthosis that immobilized the middle and ring \nfingers in composite extension, the MP joints of the small and \nindex fingers at 0° of extension and the IP joints of the index \nand small fingers free to move from 0° of extension to full \nflexion.",
    "chunk_id": 440,
    "sentence_start": 1837,
    "sentence_end": 1839,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Participants wore the orthoses at \nnight and during the day “as much as possible.” Both groups \nimproved in all outcome measures (P≤.040) but differences \nbetween the groups were significant for pain VAS (P = .02) \nand the DASH questionnaire (P = .03), both favoring the \nwrist plus MP joint orthosis.114\nIII\nIn a cross-sectional study, Manente et al179 mea­\nsured carpal tunnel and flexor retinaculum dimen­\nsions and lumbrical insertion to flexor retinaculum \ndistances via ultrasound imaging in individuals with mild to \nmoderate CTS (n = 5) and a control group (n = 5) with and \nwithout an orthosis. The orthosis was a prefabricated, soft, \nhand-based orthosis that immobilized the middle and ring \nfingers in composite extension, the MP joints of the small and \nindex fingers at 0° of extension and the IP joints of the index \nand small fingers free to move from 0° of extension to full \nflexion. Participants were positioned with their wrists in \n“neutral” during sonographic measurements of the carpal \ntunnel.",
    "chunk_id": 441,
    "sentence_start": 1838,
    "sentence_end": 1840,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The orthosis was a prefabricated, soft, \nhand-based orthosis that immobilized the middle and ring \nfingers in composite extension, the MP joints of the small and \nindex fingers at 0° of extension and the IP joints of the index \nand small fingers free to move from 0° of extension to full \nflexion. Participants were positioned with their wrists in \n“neutral” during sonographic measurements of the carpal \ntunnel. Measurements were taken at the level of the pisiform \n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nflexor retinaculum distance (P<.05). The author concluded \nthe use of the support increased carpal tunnel space and pre­\nvented lumbrical muscle incursion into the tunnel.",
    "chunk_id": 442,
    "sentence_start": 1839,
    "sentence_end": 1847,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nflexor retinaculum distance (P<.05). The author concluded \nthe use of the support increased carpal tunnel space and pre­\nvented lumbrical muscle incursion into the tunnel. These \nresults should be interpreted with caution due to the small \nsample size, lack of blinding and opportunity for bias, as the \nlead author was the inventor of the orthosis.179\nIII\nIn additional cross-sectional studies, Keir et al148 \nand Rempel et al237 noted the impact of MP joint \nand forearm position on carpal tunnel pressure. Keir et al148 reported that the position of the MP joints had a \nsignificant effect on carpal tunnel pressure during passive \nwrist motion in all planes, with 0° of MP flexion producing \nthe highest pressures, 90° of MP flexion the next highest, and \n45° of MP flexion the least pressure in 14 asymptomatic237 \nindividuals.",
    "chunk_id": 443,
    "sentence_start": 1846,
    "sentence_end": 1849,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "These \nresults should be interpreted with caution due to the small \nsample size, lack of blinding and opportunity for bias, as the \nlead author was the inventor of the orthosis.179\nIII\nIn additional cross-sectional studies, Keir et al148 \nand Rempel et al237 noted the impact of MP joint \nand forearm position on carpal tunnel pressure. Keir et al148 reported that the position of the MP joints had a \nsignificant effect on carpal tunnel pressure during passive \nwrist motion in all planes, with 0° of MP flexion producing \nthe highest pressures, 90° of MP flexion the next highest, and \n45° of MP flexion the least pressure in 14 asymptomatic237 \nindividuals. Rempel et al237 reported the highest carpal tun­\nnel pressures were recorded during active forearm supination \nwith 90° of MP joint flexion and the lowest were recorded \nwith the forearm actively positioned in 45° of pronation with \n45° of MP joint flexion.",
    "chunk_id": 444,
    "sentence_start": 1848,
    "sentence_end": 1850,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Keir et al148 reported that the position of the MP joints had a \nsignificant effect on carpal tunnel pressure during passive \nwrist motion in all planes, with 0° of MP flexion producing \nthe highest pressures, 90° of MP flexion the next highest, and \n45° of MP flexion the least pressure in 14 asymptomatic237 \nindividuals. Rempel et al237 reported the highest carpal tun­\nnel pressures were recorded during active forearm supination \nwith 90° of MP joint flexion and the lowest were recorded \nwith the forearm actively positioned in 45° of pronation with \n45° of MP joint flexion. Participants (n = 17) maintained a \nneutral wrist position (0° of flexion/extension, 0° of ulnar/\nradial deviation) during the trial. Orthosis Prescription\nOrthosis prescription consists of duration and length of wear.",
    "chunk_id": 445,
    "sentence_start": 1849,
    "sentence_end": 1852,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Participants (n = 17) maintained a \nneutral wrist position (0° of flexion/extension, 0° of ulnar/\nradial deviation) during the trial. Orthosis Prescription\nOrthosis prescription consists of duration and length of wear. II\nIn a randomized clinical trial, Walker et al284 com­\npared full-time use of a custom-fabricated, thermo­\nplastic neutral wrist orthosis with night-only use in \n17 individuals (24 hands) with CTS symptoms of all severity \nlevels. Following 6 weeks of treatment, both groups showed \nimprovement in median DSL, CTQ-SSS, and the CTQ-FS. The \nfull-time orthosis group also demonstrated improved DML \ncompared to the night-only group. Adverse effects were not \nreported.",
    "chunk_id": 446,
    "sentence_start": 1851,
    "sentence_end": 1856,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The \nfull-time orthosis group also demonstrated improved DML \ncompared to the night-only group. Adverse effects were not \nreported. Page et al’s221 analysis revealed MDs favoring the full \ntime wear group (CTQ-SSS MD, –0.21; 95% CI: –0.83, 0.41; \nCTQ–FS MD, –0.21; 95% CI: –0.87, 0.45; DML MD, –0.63; \n95% CI: –2.05, 0.79; and DSL MD, 0.05; 95% CI: –0.87, 0.45) \ncompared to night use but concluded the bidirectional ESs and \nlow effect estimate precision prevented identification of a ben­\nefit of full-time use compared to night-only use. Orthosis Versus Tendon and Nerve Gliding Exercises\nII\nIn a RCT, Schmid et al252 compared the short-term \neffects of a prefabricated, night wrist orthosis (un­\nspecified\nrist position)\nersus tendon and ner e\n7 compared the use of a prefabricated, \nester wrist orthosis (0°-5° of extension) \ncustom-fabricated, thermoplastic wrist \nnd MP joint (0°-10° of flexion) orthosis \nof 33 patients (54 hands) with mild to \nRCT.",
    "chunk_id": 447,
    "sentence_start": 1855,
    "sentence_end": 1858,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Page et al’s221 analysis revealed MDs favoring the full \ntime wear group (CTQ-SSS MD, –0.21; 95% CI: –0.83, 0.41; \nCTQ–FS MD, –0.21; 95% CI: –0.87, 0.45; DML MD, –0.63; \n95% CI: –2.05, 0.79; and DSL MD, 0.05; 95% CI: –0.87, 0.45) \ncompared to night use but concluded the bidirectional ESs and \nlow effect estimate precision prevented identification of a ben­\nefit of full-time use compared to night-only use. Orthosis Versus Tendon and Nerve Gliding Exercises\nII\nIn a RCT, Schmid et al252 compared the short-term \neffects of a prefabricated, night wrist orthosis (un­\nspecified\nrist position)\nersus tendon and ner e\n7 compared the use of a prefabricated, \nester wrist orthosis (0°-5° of extension) \ncustom-fabricated, thermoplastic wrist \nnd MP joint (0°-10° of flexion) orthosis \nof 33 patients (54 hands) with mild to \nRCT. After 4 weeks of night use, both \nll clinical, subjective, and electrophysi­\nasures.",
    "chunk_id": 448,
    "sentence_start": 1857,
    "sentence_end": 1859,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Orthosis Versus Tendon and Nerve Gliding Exercises\nII\nIn a RCT, Schmid et al252 compared the short-term \neffects of a prefabricated, night wrist orthosis (un­\nspecified\nrist position)\nersus tendon and ner e\n7 compared the use of a prefabricated, \nester wrist orthosis (0°-5° of extension) \ncustom-fabricated, thermoplastic wrist \nnd MP joint (0°-10° of flexion) orthosis \nof 33 patients (54 hands) with mild to \nRCT. After 4 weeks of night use, both \nll clinical, subjective, and electrophysi­\nasures. The only statistically significant \nroups was the CTQ-FS in favor of the \nrist and MP joint orthosis (MD, –0.61 ± \nbricated wrist-only support (MD, –0.06 \nnded, randomized trial, Golriz et al114 \nhe use of 6 weeks of wrist immobiliza­\nther a custom-fabricated volar, neutral \nsame orthosis with the MP joints posi­\nf flexion in 24 individuals with mild to \noms. Outcome measures were pain vi­\nAS), the DASH questionnaire, and grip \nngth.",
    "chunk_id": 449,
    "sentence_start": 1858,
    "sentence_end": 1861,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The only statistically significant \nroups was the CTQ-FS in favor of the \nrist and MP joint orthosis (MD, –0.61 ± \nbricated wrist-only support (MD, –0.06 \nnded, randomized trial, Golriz et al114 \nhe use of 6 weeks of wrist immobiliza­\nther a custom-fabricated volar, neutral \nsame orthosis with the MP joints posi­\nf flexion in 24 individuals with mild to \noms. Outcome measures were pain vi­\nAS), the DASH questionnaire, and grip \nngth. Participants wore the orthoses at \nday “as much as possible.” Both groups \nome measures (P≤.040) but differences \nwere significant for pain VAS (P = .02) \ntionnaire (P = .03), both favoring the \nrthosis.114\nsectional study, Manente et al179 mea­\nl tunnel and flexor retinaculum dimen­\nmbrical insertion to flexor retinaculum \nund imaging in individuals with mild to \n) and a control group (n = 5) with and \nThe orthosis was a prefabricated, soft, \nthat immobilized the middle and ring \nxtension, the MP joints of the small and \nextension and the IP joints of the index \ne to move from 0° of extension to full \nwere positioned with their wrists in \nographic measurements of the carpal \nts were taken at the level of the pisiform \nhamate.",
    "chunk_id": 450,
    "sentence_start": 1860,
    "sentence_end": 1862,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcome measures were pain vi­\nAS), the DASH questionnaire, and grip \nngth. Participants wore the orthoses at \nday “as much as possible.” Both groups \nome measures (P≤.040) but differences \nwere significant for pain VAS (P = .02) \ntionnaire (P = .03), both favoring the \nrthosis.114\nsectional study, Manente et al179 mea­\nl tunnel and flexor retinaculum dimen­\nmbrical insertion to flexor retinaculum \nund imaging in individuals with mild to \n) and a control group (n = 5) with and \nThe orthosis was a prefabricated, soft, \nthat immobilized the middle and ring \nxtension, the MP joints of the small and \nextension and the IP joints of the index \ne to move from 0° of extension to full \nwere positioned with their wrists in \nographic measurements of the carpal \nts were taken at the level of the pisiform \nhamate. With the orthosis in place, the \nand total carpal tunnel area increased in \n(P<.05), as did the transverse diameter \nwhile wearing the support.",
    "chunk_id": 451,
    "sentence_start": 1861,
    "sentence_end": 1863,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Participants wore the orthoses at \nday “as much as possible.” Both groups \nome measures (P≤.040) but differences \nwere significant for pain VAS (P = .02) \ntionnaire (P = .03), both favoring the \nrthosis.114\nsectional study, Manente et al179 mea­\nl tunnel and flexor retinaculum dimen­\nmbrical insertion to flexor retinaculum \nund imaging in individuals with mild to \n) and a control group (n = 5) with and \nThe orthosis was a prefabricated, soft, \nthat immobilized the middle and ring \nxtension, the MP joints of the small and \nextension and the IP joints of the index \ne to move from 0° of extension to full \nwere positioned with their wrists in \nographic measurements of the carpal \nts were taken at the level of the pisiform \nhamate. With the orthosis in place, the \nand total carpal tunnel area increased in \n(P<.05), as did the transverse diameter \nwhile wearing the support. The same \nhen measurements\nere taken at the\n\n\n--- Page 40 ---\nCOLUMN 1:\nvention.",
    "chunk_id": 452,
    "sentence_start": 1862,
    "sentence_end": 1864,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "With the orthosis in place, the \nand total carpal tunnel area increased in \n(P<.05), as did the transverse diameter \nwhile wearing the support. The same \nhen measurements\nere taken at the\n\n\n--- Page 40 ---\nCOLUMN 1:\nvention. Results following 1 week of treatment indicated that \nboth groups improved in median nerve signal intensity at the \ncarpal tunnel inlet (P = .036), combined CTQ scores (MD, \n–0.3 for both groups; P = .001), and the patient-specific func­\ntional scale (MD, 2.1 for exercise and 2.9 for the orthosis; \nP<.05). Numbness VAS scores did not change significantly \nfollowing either treatment. Authors concluded the decrease \nin MRI signal intensity could represent either a decrease in \nedema or a decrease in blood flow.252\nOrthosis Versus Oral Steroid\nII\nIn a RCT, Mishra et al192 (n = 40) compared a neu­\ntral prefabricated orthosis worn for 4 weeks at \nnight and “as much as possible” during the day with \n4 weeks of oral steroid use.",
    "chunk_id": 453,
    "sentence_start": 1863,
    "sentence_end": 1867,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Numbness VAS scores did not change significantly \nfollowing either treatment. Authors concluded the decrease \nin MRI signal intensity could represent either a decrease in \nedema or a decrease in blood flow.252\nOrthosis Versus Oral Steroid\nII\nIn a RCT, Mishra et al192 (n = 40) compared a neu­\ntral prefabricated orthosis worn for 4 weeks at \nnight and “as much as possible” during the day with \n4 weeks of oral steroid use. Both groups improved on the \nCTQ-SSS and CTQ-FS at the end of 4 and 12 weeks (P<.001). Both groups improved on DSL and SNCV at 12 weeks com­\npared to baseline (P<.03). The oral steroid group also im­\nproved on DML at 12 weeks (P = .001). The only significant \ndifferences between the 2 groups were for the CTQ-FS at 4 \nand 12 weeks (P<.03) and for SNCV at 4 weeks (P<.047), \nfavoring the steroid intervention.",
    "chunk_id": 454,
    "sentence_start": 1866,
    "sentence_end": 1871,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The oral steroid group also im­\nproved on DML at 12 weeks (P = .001). The only significant \ndifferences between the 2 groups were for the CTQ-FS at 4 \nand 12 weeks (P<.03) and for SNCV at 4 weeks (P<.047), \nfavoring the steroid intervention. Madjdinasab et al176 com­\npared 6 weeks of orthosis use (commercially available ortho­\nsis worn at night and as long as possible during the day) to 2 \nweeks of oral prednisolone (20 mg/d) use in 43 individuals \nwith mild to moderate CTS. Outcome measures included me­\ndian DSL, DML, and sensory and motor conduction velocity \nand were evaluated at baseline and 6 weeks. Both groups \nshowed improvement in DSL and SNCV at 6 weeks (P = \n.0001). There were no statistically significant differences on \nany outcome measure between the 2 groups.",
    "chunk_id": 455,
    "sentence_start": 1870,
    "sentence_end": 1875,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Both groups \nshowed improvement in DSL and SNCV at 6 weeks (P = \n.0001). There were no statistically significant differences on \nany outcome measure between the 2 groups. Orthosis Versus Steroid Injection\nII\nIn a randomized, parallel clinical trial, So et al264 \ncompared the effects of a local steroid injection ver­\nsus a cotton-polyester, neutral wrist orthosis after 4 \nweeks of treatment in 50 individuals (25 per group) with CTS \n(all severities). Outcome measures included the CTQ-SSS, \nCTQ-FS, patient satisfaction, the Nine-Hole Peg Test, duration \nof sick leave, pain medication use, and side effects. Both groups \nshowed statistically significant improvement on the CTQ-SSS \n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 456,
    "sentence_start": 1874,
    "sentence_end": 1882,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nII\nIn a RCT, Chesterton et al63 compared the effects of \na steroid injection (n = 96) to 6 weeks of night-time \nprefabricated wrist orthosis use (n = 96). The or­\nthoses were positioned from “neutral to 20° of extension.” \nOutcomes were collected at 6 weeks and 6 months. Measures \nincluded CTQ-total score, CTQ-SSS, CTQ-FS, pain intensity, \ninsomnia due to hand/wrist pain, referral to surgery, surgery, \nuse of herbal remedies at 6 months, and use of over-the-\ncounter or prescription medication use at 6 months.",
    "chunk_id": 457,
    "sentence_start": 1881,
    "sentence_end": 1885,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The or­\nthoses were positioned from “neutral to 20° of extension.” \nOutcomes were collected at 6 weeks and 6 months. Measures \nincluded CTQ-total score, CTQ-SSS, CTQ-FS, pain intensity, \ninsomnia due to hand/wrist pain, referral to surgery, surgery, \nuse of herbal remedies at 6 months, and use of over-the-\ncounter or prescription medication use at 6 months. Authors \nreported significant improvement in the injection group at 6 \nweeks in the CTQ total score (adjusted MD, –0.32; 95% CI: \n–0.48, –0.16; P = .0001) and similar findings in the CTQ-SSS \n(adjusted MD, –0.35; 95% CI: –0.53, –0.17; P = .0001), CTQ-\nFS scales (adjusted MD, –0.26; 95% CI: –0.43, –0.09; P = \n.0031), and pain intensity (adjusted MD, –0.97; 95% CI: \n–1.64, –0.30; P = .0049) compared to the orthosis group.",
    "chunk_id": 458,
    "sentence_start": 1884,
    "sentence_end": 1886,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Measures \nincluded CTQ-total score, CTQ-SSS, CTQ-FS, pain intensity, \ninsomnia due to hand/wrist pain, referral to surgery, surgery, \nuse of herbal remedies at 6 months, and use of over-the-\ncounter or prescription medication use at 6 months. Authors \nreported significant improvement in the injection group at 6 \nweeks in the CTQ total score (adjusted MD, –0.32; 95% CI: \n–0.48, –0.16; P = .0001) and similar findings in the CTQ-SSS \n(adjusted MD, –0.35; 95% CI: –0.53, –0.17; P = .0001), CTQ-\nFS scales (adjusted MD, –0.26; 95% CI: –0.43, –0.09; P = \n.0031), and pain intensity (adjusted MD, –0.97; 95% CI: \n–1.64, –0.30; P = .0049) compared to the orthosis group. However, at the 6-month follow-up, the orthosis group con­\ntinued to improve on the CTQ scales and in pain intensity \nwhile the injection group did not, and there were no signifi­\ncant differences between the 2 groups on any of the outcome \nvariables studied at this time point. Adverse effects were re­\nported by both groups.",
    "chunk_id": 459,
    "sentence_start": 1885,
    "sentence_end": 1888,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "However, at the 6-month follow-up, the orthosis group con­\ntinued to improve on the CTQ scales and in pain intensity \nwhile the injection group did not, and there were no signifi­\ncant differences between the 2 groups on any of the outcome \nvariables studied at this time point. Adverse effects were re­\nported by both groups. The steroid group adverse effects in­\ncluded skin changes (3%), hot flushes (15%), and transient \nincrease in wrist or hand pain (46%), with 34% reported pain \nlasting greater than 3 days.",
    "chunk_id": 460,
    "sentence_start": 1887,
    "sentence_end": 1889,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Adverse effects were re­\nported by both groups. The steroid group adverse effects in­\ncluded skin changes (3%), hot flushes (15%), and transient \nincrease in wrist or hand pain (46%), with 34% reported pain \nlasting greater than 3 days. In the night support group, 6% \nreported the supports were uncomfortable, resulting in in­\nconsistent use.63\nOrthosis Versus CTR\nII\nIn a single-blinded trial, Gerritsen et al108 compared \nthe short and long-term effectiveness of orthoses \n(fabricated or off the shelf\norn at night and dur\nwing 1 week of treatment indicated that \nd in median nerve signal intensity at the \nP = .036), combined CTQ scores (MD, \nP = .001), and the patient-specific func­\n1 for exercise and 2.9 for the orthosis; \nAS scores did not change significantly \nment.",
    "chunk_id": 461,
    "sentence_start": 1888,
    "sentence_end": 1890,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The steroid group adverse effects in­\ncluded skin changes (3%), hot flushes (15%), and transient \nincrease in wrist or hand pain (46%), with 34% reported pain \nlasting greater than 3 days. In the night support group, 6% \nreported the supports were uncomfortable, resulting in in­\nconsistent use.63\nOrthosis Versus CTR\nII\nIn a single-blinded trial, Gerritsen et al108 compared \nthe short and long-term effectiveness of orthoses \n(fabricated or off the shelf\norn at night and dur\nwing 1 week of treatment indicated that \nd in median nerve signal intensity at the \nP = .036), combined CTQ scores (MD, \nP = .001), and the patient-specific func­\n1 for exercise and 2.9 for the orthosis; \nAS scores did not change significantly \nment. Authors concluded the decrease \nity could represent either a decrease in \nin blood flow.252\neroid\nMishra et al192 (n = 40) compared a neu­\nricated orthosis worn for 4 weeks at \nas much as possible” during the day with \noid use.",
    "chunk_id": 462,
    "sentence_start": 1889,
    "sentence_end": 1891,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In the night support group, 6% \nreported the supports were uncomfortable, resulting in in­\nconsistent use.63\nOrthosis Versus CTR\nII\nIn a single-blinded trial, Gerritsen et al108 compared \nthe short and long-term effectiveness of orthoses \n(fabricated or off the shelf\norn at night and dur\nwing 1 week of treatment indicated that \nd in median nerve signal intensity at the \nP = .036), combined CTQ scores (MD, \nP = .001), and the patient-specific func­\n1 for exercise and 2.9 for the orthosis; \nAS scores did not change significantly \nment. Authors concluded the decrease \nity could represent either a decrease in \nin blood flow.252\neroid\nMishra et al192 (n = 40) compared a neu­\nricated orthosis worn for 4 weeks at \nas much as possible” during the day with \noid use. Both groups improved on the \nS at the end of 4 and 12 weeks (P<.001). d on DSL and SNCV at 12 weeks com­\n<.03). The oral steroid group also im­\n2 weeks (P = .001).",
    "chunk_id": 463,
    "sentence_start": 1890,
    "sentence_end": 1894,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "d on DSL and SNCV at 12 weeks com­\n<.03). The oral steroid group also im­\n2 weeks (P = .001). The only significant \nthe 2 groups were for the CTQ-FS at 4 \n3) and for SNCV at 4 weeks (P<.047), \nntervention. Madjdinasab et al176 com­\nosis use (commercially available ortho­\nas long as possible during the day) to 2 \nsolone (20 mg/d) use in 43 individuals \ne CTS. Outcome measures included me­\nsensory and motor conduction velocity \nat baseline and 6 weeks. Both groups \nnt in DSL and SNCV at 6 weeks (P = \no statistically significant differences on \ne between the 2 groups. --- Page 41 ---\nCOLUMN 1:\ncomplex regional pain syndrome, pillar pain, swelling, dis­\ncomfort from the orthosis, wound complications, skin irrita­\ntion, wrist stiffness, and painful or hypertrophic scars. Because these were reported in the original assigned groups, \ncomparison of the rates of adverse effects between interven­\ntions could not be made.",
    "chunk_id": 464,
    "sentence_start": 1893,
    "sentence_end": 1900,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "--- Page 41 ---\nCOLUMN 1:\ncomplex regional pain syndrome, pillar pain, swelling, dis­\ncomfort from the orthosis, wound complications, skin irrita­\ntion, wrist stiffness, and painful or hypertrophic scars. Because these were reported in the original assigned groups, \ncomparison of the rates of adverse effects between interven­\ntions could not be made. II\nIn a nonblinded, randomized trial, Ucan et al277 stud­\nied 57 participants with mild to moderate CTS di­\nvided \ninto \n3 \ngroups: \nneutral-positioned, \nprefabricated wrist orthosis worn at night and during the day \n“whenever possible” (n = 23), a local steroid injection and or­\nthosis (n = 23), or open CTR surgery (n = 11). Nonsurgically-\nmanaged participants wore the orthoses for 3 months. Outcomes were evaluated using the NCS results and CTQ \nscales at 3 and 6 months. At 3 months, all 3 groups demon­\nstrated statistically significant improvements in median DML, \nCMAP, SNCV, and CTQ scales (P<.006).",
    "chunk_id": 465,
    "sentence_start": 1899,
    "sentence_end": 1904,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcomes were evaluated using the NCS results and CTQ \nscales at 3 and 6 months. At 3 months, all 3 groups demon­\nstrated statistically significant improvements in median DML, \nCMAP, SNCV, and CTQ scales (P<.006). For the CTQ-SSS, the \nCTR group score was higher (indicating greater symptoms) \nthan the other 2 groups (P≤.011), and for the CTQ-FS, the or­\nthosis and CTR group demonstrated higher scores (indicating \nmore difficulty with function) than the injection and orthosis \ngroup (P = .001). At 6 months, all groups remained statistically \nimproved in DML, CMAP, SNCV, and CTQ scales. For the \nCTQ scales, the CTR group scores continued to improve com­\npared to the other groups (CTQ-FS, P = .03; CTQ-SSS, P = \n.004) while the other 2 groups’ scores worsened.",
    "chunk_id": 466,
    "sentence_start": 1903,
    "sentence_end": 1907,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "At 6 months, all groups remained statistically \nimproved in DML, CMAP, SNCV, and CTQ scales. For the \nCTQ scales, the CTR group scores continued to improve com­\npared to the other groups (CTQ-FS, P = .03; CTQ-SSS, P = \n.004) while the other 2 groups’ scores worsened. Complica­\ntions were reported for 2 of the participants in the CTR surgery \ngroup: one with scar tenderness which resolved and one devel­\noped complex regional pain syndrome.277\nOrthosis Combined With Patient Instruction\nII\nHall et al125 concluded CTS management consisting \nof a full-time, neutral-positioned wrist orthosis plus \npatient instruction was more effective than no in­\ntervention.",
    "chunk_id": 467,
    "sentence_start": 1906,
    "sentence_end": 1908,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "For the \nCTQ scales, the CTR group scores continued to improve com­\npared to the other groups (CTQ-FS, P = .03; CTQ-SSS, P = \n.004) while the other 2 groups’ scores worsened. Complica­\ntions were reported for 2 of the participants in the CTR surgery \ngroup: one with scar tenderness which resolved and one devel­\noped complex regional pain syndrome.277\nOrthosis Combined With Patient Instruction\nII\nHall et al125 concluded CTS management consisting \nof a full-time, neutral-positioned wrist orthosis plus \npatient instruction was more effective than no in­\ntervention. In this randomized, single-blinded trial, 30 pa­\ntients with all severity levels of CTS wore 1 of 3 commercially \navailable supports or a custom-fabricated wrist orthosis for \n8 weeks and attended 2 sessions of patient instruction (pa­\nthology, risk identification, symptom self-management, and \npostures/activities that aggravate symptoms including sleep­\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 468,
    "sentence_start": 1907,
    "sentence_end": 1909,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Complica­\ntions were reported for 2 of the participants in the CTR surgery \ngroup: one with scar tenderness which resolved and one devel­\noped complex regional pain syndrome.277\nOrthosis Combined With Patient Instruction\nII\nHall et al125 concluded CTS management consisting \nof a full-time, neutral-positioned wrist orthosis plus \npatient instruction was more effective than no in­\ntervention. In this randomized, single-blinded trial, 30 pa­\ntients with all severity levels of CTS wore 1 of 3 commercially \navailable supports or a custom-fabricated wrist orthosis for \n8 weeks and attended 2 sessions of patient instruction (pa­\nthology, risk identification, symptom self-management, and \npostures/activities that aggravate symptoms including sleep­\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 469,
    "sentence_start": 1908,
    "sentence_end": 1913,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nOrthosis Combined With Steroid Injection\nII\nWang et al285 studied the effect of an ultrasound-\nguided steroid injection into the carpal tunnel com­\nbined with orthosis use compared to the injection \nalone in 52 individuals with mild or moderate CTS in a RCT. Participants in the experimental group wore a volar, custom-\nfabricated neutral wrist orthosis during sleep and as much as \npossible during the day for 12 weeks following injection. Out­\ncome measures included CTQ scores, pain VAS, and NCS \nresults, and they were evaluated at baseline and 6 and 12 \nweeks. Both groups showed significant improvement in CTQ \nscores, VAS, DML, SNCV, and SNAP at 6 and 12 weeks \n(P<.001). There were no differences between the groups at 6 \nor 12 weeks.",
    "chunk_id": 470,
    "sentence_start": 1912,
    "sentence_end": 1918,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Both groups showed significant improvement in CTQ \nscores, VAS, DML, SNCV, and SNAP at 6 and 12 weeks \n(P<.001). There were no differences between the groups at 6 \nor 12 weeks. At 12 weeks, the response to treatment dimin­\nished in the injection-alone group (CTQ-SSS increased, \nwhich suggests worsening symptoms from 1.28 to 1.49 be­\ntween 6 and 12 weeks), while the effects of treatment in the \ncombined group remained. There were statistical differences \nin change scores between groups at 12 weeks in the CTQ-SSS \n(MD, 0.48; 95% CI: 0.09, 0.88; P = .032), CTQ-FS (MD, \n0.37; 95% CI: 0.06, 0.67; P = .019), SNCV (MD, 3.38; 95% \nCI: 0.54, 6.22; P = .015), and SNAP (MD, 3.21; 95% CI: 0, \n6.46; P = .025) favoring the combined treatment.",
    "chunk_id": 471,
    "sentence_start": 1917,
    "sentence_end": 1920,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "At 12 weeks, the response to treatment dimin­\nished in the injection-alone group (CTQ-SSS increased, \nwhich suggests worsening symptoms from 1.28 to 1.49 be­\ntween 6 and 12 weeks), while the effects of treatment in the \ncombined group remained. There were statistical differences \nin change scores between groups at 12 weeks in the CTQ-SSS \n(MD, 0.48; 95% CI: 0.09, 0.88; P = .032), CTQ-FS (MD, \n0.37; 95% CI: 0.06, 0.67; P = .019), SNCV (MD, 3.38; 95% \nCI: 0.54, 6.22; P = .015), and SNAP (MD, 3.21; 95% CI: 0, \n6.46; P = .025) favoring the combined treatment. The au­\nthors concluded the combined treatment had sustained ef­\nfects on sensation, function, and NCS that were not present \nin the injection-only group.285\nOrthosis During Pregnancy\nIV\nCourts75 evaluated grip, pinch, and symptom reduc­\ntion following the use of a wrist orthosis positioned \nin 10° to 15° of extension in a group of women who \ndeveloped CTS during pregnancy (n = 82). The orthoses were \nworn at night and during the day.",
    "chunk_id": 472,
    "sentence_start": 1919,
    "sentence_end": 1922,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The au­\nthors concluded the combined treatment had sustained ef­\nfects on sensation, function, and NCS that were not present \nin the injection-only group.285\nOrthosis During Pregnancy\nIV\nCourts75 evaluated grip, pinch, and symptom reduc­\ntion following the use of a wrist orthosis positioned \nin 10° to 15° of extension in a group of women who \ndeveloped CTS during pregnancy (n = 82). The orthoses were \nworn at night and during the day. After 1 week, grip and \npinch strength improved and symptoms were reduced. Of the \n58% participants who returned postpartum, 76% reported \ncomplete resolution of symptoms. Ekman-Ordeberg et al86 \nreported that 82% of 56 pregnant women with carpal tunnel \nsymptoms improved after wearing a night wrist orthosis for \n2 weeks and 93% were resolved postpartum. n syndrome, pillar pain, swelling, dis­\nhosis, wound complications, skin irrita­\n and painful or hypertrophic scars. eported in the original assigned groups, \ntes of adverse effects between interven­\nade.",
    "chunk_id": 473,
    "sentence_start": 1921,
    "sentence_end": 1927,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "n syndrome, pillar pain, swelling, dis­\nhosis, wound complications, skin irrita­\n and painful or hypertrophic scars. eported in the original assigned groups, \ntes of adverse effects between interven­\nade. ded, randomized trial, Ucan et al277 stud­\ncipants with mild to moderate CTS di­\no \n3 \ngroups: \nneutral-positioned, \nthosis worn at night and during the day \nn = 23), a local steroid injection and or­\nen CTR surgery (n = 11). Nonsurgically-\nts wore the orthoses for 3 months. uated using the NCS results and CTQ \nnths. At 3 months, all 3 groups demon­\ngnificant improvements in median DML, \nQ scales (P<.006). For the CTQ-SSS, the \ns higher (indicating greater symptoms) \nps (P≤.011), and for the CTQ-FS, the or­\ndemonstrated higher scores (indicating \nunction) than the injection and orthosis \nmonths, all groups remained statistically \nCMAP, SNCV, and CTQ scales. For the \ngroup scores continued to improve com­\noups (CTQ-FS, P = .03; CTQ-SSS, P = \nr 2 groups’ scores worsened.",
    "chunk_id": 474,
    "sentence_start": 1926,
    "sentence_end": 1933,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "For the CTQ-SSS, the \ns higher (indicating greater symptoms) \nps (P≤.011), and for the CTQ-FS, the or­\ndemonstrated higher scores (indicating \nunction) than the injection and orthosis \nmonths, all groups remained statistically \nCMAP, SNCV, and CTQ scales. For the \ngroup scores continued to improve com­\noups (CTQ-FS, P = .03; CTQ-SSS, P = \nr 2 groups’ scores worsened. Complica­\nr 2 of the participants in the CTR surgery \nenderness which resolved and one devel­\nal pain syndrome.277\nh Patient Instruction\nconcluded CTS management consisting \ne, neutral-positioned wrist orthosis plus \nruction was more effective than no in­\nndomized, single-blinded trial, 30 pa­\ny levels of CTS wore 1 of 3 commercially \na custom-fabricated wrist orthosis for \nd 2 sessions of patient instruction (pa­\n\n\n--- Page 42 ---\nCOLUMN 1:\nindividual variation has been demonstrated.",
    "chunk_id": 475,
    "sentence_start": 1932,
    "sentence_end": 1934,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "For the \ngroup scores continued to improve com­\noups (CTQ-FS, P = .03; CTQ-SSS, P = \nr 2 groups’ scores worsened. Complica­\nr 2 of the participants in the CTR surgery \nenderness which resolved and one devel­\nal pain syndrome.277\nh Patient Instruction\nconcluded CTS management consisting \ne, neutral-positioned wrist orthosis plus \nruction was more effective than no in­\nndomized, single-blinded trial, 30 pa­\ny levels of CTS wore 1 of 3 commercially \na custom-fabricated wrist orthosis for \nd 2 sessions of patient instruction (pa­\n\n\n--- Page 42 ---\nCOLUMN 1:\nindividual variation has been demonstrated. Including the MP \njoints has shown positive effects in clinical and bench studies, \nalthough the evidence on the desired angle is conflicting (0°-\n10° versus 45°) and MP joint inclusion further limits func­\ntional use during wear.",
    "chunk_id": 476,
    "sentence_start": 1933,
    "sentence_end": 1935,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Complica­\nr 2 of the participants in the CTR surgery \nenderness which resolved and one devel­\nal pain syndrome.277\nh Patient Instruction\nconcluded CTS management consisting \ne, neutral-positioned wrist orthosis plus \nruction was more effective than no in­\nndomized, single-blinded trial, 30 pa­\ny levels of CTS wore 1 of 3 commercially \na custom-fabricated wrist orthosis for \nd 2 sessions of patient instruction (pa­\n\n\n--- Page 42 ---\nCOLUMN 1:\nindividual variation has been demonstrated. Including the MP \njoints has shown positive effects in clinical and bench studies, \nalthough the evidence on the desired angle is conflicting (0°-\n10° versus 45°) and MP joint inclusion further limits func­\ntional use during wear. There are conflicting results comparing an orthosis to oral \nsteroid use in the short term; however, when an orthosis was \ncompared to steroid injection, results favored the injection in \nthe short term.63,264 However, the effects of the 2 treatments \nwhen implemented separately, were equal at 6 months post \ntreatment.63 When an orthosis was combined with a steroid \ninjection, the effects were superior to the injection alone.277,285 \nDrawing conclusions is difficult in these studies due to the \nlack of a control group.",
    "chunk_id": 477,
    "sentence_start": 1934,
    "sentence_end": 1936,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Including the MP \njoints has shown positive effects in clinical and bench studies, \nalthough the evidence on the desired angle is conflicting (0°-\n10° versus 45°) and MP joint inclusion further limits func­\ntional use during wear. There are conflicting results comparing an orthosis to oral \nsteroid use in the short term; however, when an orthosis was \ncompared to steroid injection, results favored the injection in \nthe short term.63,264 However, the effects of the 2 treatments \nwhen implemented separately, were equal at 6 months post \ntreatment.63 When an orthosis was combined with a steroid \ninjection, the effects were superior to the injection alone.277,285 \nDrawing conclusions is difficult in these studies due to the \nlack of a control group. Adverse reactions for the steroid in­\njection include thinning skin, pigment changes, hot flushes, \nand increased pain.63\nWhen comparing an orthosis to surgery, the orthosis dem­\nonstrated improvement over surgery in the short term, but \nlong-term results favored surgery.109,277 Surgery is associated \nwith increased cost and may have a higher rate of compli­\ncation as reported in these studies.",
    "chunk_id": 478,
    "sentence_start": 1935,
    "sentence_end": 1937,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There are conflicting results comparing an orthosis to oral \nsteroid use in the short term; however, when an orthosis was \ncompared to steroid injection, results favored the injection in \nthe short term.63,264 However, the effects of the 2 treatments \nwhen implemented separately, were equal at 6 months post \ntreatment.63 When an orthosis was combined with a steroid \ninjection, the effects were superior to the injection alone.277,285 \nDrawing conclusions is difficult in these studies due to the \nlack of a control group. Adverse reactions for the steroid in­\njection include thinning skin, pigment changes, hot flushes, \nand increased pain.63\nWhen comparing an orthosis to surgery, the orthosis dem­\nonstrated improvement over surgery in the short term, but \nlong-term results favored surgery.109,277 Surgery is associated \nwith increased cost and may have a higher rate of compli­\ncation as reported in these studies. Reported surgical risks \nincluded pillar pain, wound complications, swelling, and hy­\npertrophic or painful scars.",
    "chunk_id": 479,
    "sentence_start": 1936,
    "sentence_end": 1938,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Adverse reactions for the steroid in­\njection include thinning skin, pigment changes, hot flushes, \nand increased pain.63\nWhen comparing an orthosis to surgery, the orthosis dem­\nonstrated improvement over surgery in the short term, but \nlong-term results favored surgery.109,277 Surgery is associated \nwith increased cost and may have a higher rate of compli­\ncation as reported in these studies. Reported surgical risks \nincluded pillar pain, wound complications, swelling, and hy­\npertrophic or painful scars. Reported orthosis risks included \ndifficulty falling asleep, temporary paresthesia upon removal, \nstiffness, skin irritation, discomfort, and swelling. An addi­\ntional risk is skin breakdown, especially when sensation is \nimpaired and the orthosis does not fit properly.",
    "chunk_id": 480,
    "sentence_start": 1937,
    "sentence_end": 1940,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Reported orthosis risks included \ndifficulty falling asleep, temporary paresthesia upon removal, \nstiffness, skin irritation, discomfort, and swelling. An addi­\ntional risk is skin breakdown, especially when sensation is \nimpaired and the orthosis does not fit properly. The availabil­\nity of prefabricated orthoses and the lower cost make this a \nconvenient intervention; however, the angle of wrist immobi­\nlization varies among manufacturers and should be checked \nand adjusted by a practitioner to find the most comfortable \nangle for the patient. The use of a neutral-positioned orthosis \nmay reduce symptoms for individuals considering or waiting \nfor surgery. There is evidence to support orthosis use in the \nshort term for relieving symptoms and improving strength in \nwomen who develop CTS during pregnancy. Gaps in Knowledge\nThere is no consensus on the most appropriate orthosis ma­\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 481,
    "sentence_start": 1939,
    "sentence_end": 1944,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There is evidence to support orthosis use in the \nshort term for relieving symptoms and improving strength in \nwomen who develop CTS during pregnancy. Gaps in Knowledge\nThere is no consensus on the most appropriate orthosis ma­\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nrespect to the effects of orthoses on those with severe CTS. A \nnoninvasive tool for measuring carpal tunnel pressure could \nprovide guidance regarding individual wrist and MP joint \npositioning. Recommendations\nB\nClinicians should recommend a neutral-positioned \nwrist orthosis worn at night for short-term symp­\ntom relief and functional improvement for indi­\nviduals with CTS seeking nonsurgical management.",
    "chunk_id": 482,
    "sentence_start": 1943,
    "sentence_end": 1951,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "A \nnoninvasive tool for measuring carpal tunnel pressure could \nprovide guidance regarding individual wrist and MP joint \npositioning. Recommendations\nB\nClinicians should recommend a neutral-positioned \nwrist orthosis worn at night for short-term symp­\ntom relief and functional improvement for indi­\nviduals with CTS seeking nonsurgical management. C\nClinicians may suggest adjusting wear time to in­\nclude daytime, symptomatic, or full-time use when \nnight-only use is ineffective at controlling symp­\ntoms in individuals with mild to moderate CTS. Clinicians \nmay also add MP joint immobilization or modify the wrist \njoint position for individuals with CTS who fail to experience \nrelief. Clinicians may add patient education on pathology, \nrisk identification, symptom self-management, and postures/\nactivities that aggravate symptoms.",
    "chunk_id": 483,
    "sentence_start": 1950,
    "sentence_end": 1954,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Clinicians \nmay also add MP joint immobilization or modify the wrist \njoint position for individuals with CTS who fail to experience \nrelief. Clinicians may add patient education on pathology, \nrisk identification, symptom self-management, and postures/\nactivities that aggravate symptoms. C\nClinicians should recommend an orthosis for wom­\nen experiencing CTS during pregnancy and should \nprovide a postpartum follow-up evaluation to ex­\namine the resolution of symptoms. BIOPHYSICAL AGENTS\nThermotherapy\nDry Heat\nII\nIn a randomized, single-blinded trial, Michlovitz et \nal191 compared the effect of a disposable wrist low-\nlevel heat wrap to an oral placebo in 24 individuals \ndiagnosed with CTS (all severities). The heat wrap was worn \nfor 8 hours per day while the control group took an oral pla­\ncebo 4 times per day. Both groups were treated for 3 days and \nfollowed for an additional 2 days.",
    "chunk_id": 484,
    "sentence_start": 1953,
    "sentence_end": 1958,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The heat wrap was worn \nfor 8 hours per day while the control group took an oral pla­\ncebo 4 times per day. Both groups were treated for 3 days and \nfollowed for an additional 2 days. After 3 days, the heat wrap \ngroup demonstrated improved outcomes relative to the pla­\ncebo group including reduced pain (MD, –2.18 versus –0.95; \nP = .001); reduced joint stiffness (MD, –21.8 versus –4.9; P = \n.004); increased grip strength (MD, 6.6 versus –0.3; P = \n.003); self-reported disability scores (MD, –27.1 versus –2.67; \nP = .0015); CTQ-SSS (MD, –0.90 versus –0.20; P = .001) and \nCTQ-FS (MD, –0.65 versus 0.00; P = .006). While the symp­\ntom improvements for both groups persisted to day 5, im­\nprovement in CTQ-FS scores did not.",
    "chunk_id": 485,
    "sentence_start": 1957,
    "sentence_end": 1960,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "After 3 days, the heat wrap \ngroup demonstrated improved outcomes relative to the pla­\ncebo group including reduced pain (MD, –2.18 versus –0.95; \nP = .001); reduced joint stiffness (MD, –21.8 versus –4.9; P = \n.004); increased grip strength (MD, 6.6 versus –0.3; P = \n.003); self-reported disability scores (MD, –27.1 versus –2.67; \nP = .0015); CTQ-SSS (MD, –0.90 versus –0.20; P = .001) and \nCTQ-FS (MD, –0.65 versus 0.00; P = .006). While the symp­\ntom improvements for both groups persisted to day 5, im­\nprovement in CTQ-FS scores did not. Adverse effects \nreported for the heat wrap included coldness in the fingers \nand for the oral placebo, dyspepsia.191\nParaffin\nII\nChang et al57 compared the use of paraffin (dip-and-\nwrap applied for 20 minutes) to pulsed, direct-\ncontact ultrasound (1 MH\n1 0 W/cm2 1 4 dut\nas been demonstrated. Including the MP \ntive effects in clinical and bench studies, \ne on the desired angle is conflicting (0°-\nMP joint inclusion further limits func­\nr.",
    "chunk_id": 486,
    "sentence_start": 1959,
    "sentence_end": 1962,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Adverse effects \nreported for the heat wrap included coldness in the fingers \nand for the oral placebo, dyspepsia.191\nParaffin\nII\nChang et al57 compared the use of paraffin (dip-and-\nwrap applied for 20 minutes) to pulsed, direct-\ncontact ultrasound (1 MH\n1 0 W/cm2 1 4 dut\nas been demonstrated. Including the MP \ntive effects in clinical and bench studies, \ne on the desired angle is conflicting (0°-\nMP joint inclusion further limits func­\nr. g results comparing an orthosis to oral \nrt term; however, when an orthosis was \nnjection, results favored the injection in \nHowever, the effects of the 2 treatments \neparately, were equal at 6 months post \nn orthosis was combined with a steroid \nwere superior to the injection alone.277,285 \nis difficult in these studies due to the \np.",
    "chunk_id": 487,
    "sentence_start": 1961,
    "sentence_end": 1963,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Including the MP \ntive effects in clinical and bench studies, \ne on the desired angle is conflicting (0°-\nMP joint inclusion further limits func­\nr. g results comparing an orthosis to oral \nrt term; however, when an orthosis was \nnjection, results favored the injection in \nHowever, the effects of the 2 treatments \neparately, were equal at 6 months post \nn orthosis was combined with a steroid \nwere superior to the injection alone.277,285 \nis difficult in these studies due to the \np. Adverse reactions for the steroid in­\ning skin, pigment changes, hot flushes, \northosis to surgery, the orthosis dem­\nent over surgery in the short term, but \nored surgery.109,277 Surgery is associated \nand may have a higher rate of compli­\nthese studies. Reported surgical risks \nwound complications, swelling, and hy­\nscars. Reported orthosis risks included \np, temporary paresthesia upon removal, \non, discomfort, and swelling. An addi­\neakdown, especially when sensation is \nhosis does not fit properly.",
    "chunk_id": 488,
    "sentence_start": 1962,
    "sentence_end": 1967,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Reported orthosis risks included \np, temporary paresthesia upon removal, \non, discomfort, and swelling. An addi­\neakdown, especially when sensation is \nhosis does not fit properly. The availabil­\nrthoses and the lower cost make this a \non; however, the angle of wrist immobi­\ng manufacturers and should be checked \nactitioner to find the most comfortable \nThe use of a neutral-positioned orthosis \ns for individuals considering or waiting \nevidence to support orthosis use in the \nng symptoms and improving strength in \nCTS during pregnancy. s on the most appropriate orthosis ma­\niption, or position, or evidence to ac­\nal candidates for orthosis intervention. a control group, an adequate sample \nmization, and/or blinding. Most studies \nmpliance data for orthosis use, as well \nl, validated outcome measures. Many \nnded by the use of multiple interven­\nffect of any single intervention.",
    "chunk_id": 489,
    "sentence_start": 1966,
    "sentence_end": 1972,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Most studies \nmpliance data for orthosis use, as well \nl, validated outcome measures. Many \nnded by the use of multiple interven­\nffect of any single intervention. Identi­\nffective orthosis characteristics should \nto investigating combining nonsurgical \najority of studies enrolled patients with \nS and no conclusion can be dra n\nith\n\n\n--- Page 43 ---\nCOLUMN 1:\ncycle, 5-cm2 sound head, 5 minutes) given twice per week for \n8 weeks in 47 patients with CTS (all severities) in a RCT. Participants in both groups wore a custom-fabricated neutral \nwrist orthosis at night for 8 weeks. Outcome measures in­\ncluded the CTQ-SSS and CTQ-FS, pain scale, sensory thresh­\nold, palmar pinch strength, DML, and DSL. After 8 weeks, \nboth groups improved on the CTQ-SSS (ES for both groups \nwas equal to 0.63) and sensory threshold (P<.03).",
    "chunk_id": 490,
    "sentence_start": 1971,
    "sentence_end": 1976,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcome measures in­\ncluded the CTQ-SSS and CTQ-FS, pain scale, sensory thresh­\nold, palmar pinch strength, DML, and DSL. After 8 weeks, \nboth groups improved on the CTQ-SSS (ES for both groups \nwas equal to 0.63) and sensory threshold (P<.03). The ultra­\nsound group demonstrated significant improvement in CTQ-\nFS, pain scale, and palmar pinch following treatment when \ncompared to baseline; however, the only significant differ­\nence between the paraffin and ultrasound groups was the \nCTQ-FS score favoring ultrasound (MD, –0.3 compared to \nparaffin MD, 0.1; P = .04; ES, 0.38). A limitation of this study \nwas that there was no control group. No adverse effects were \nreported.57\nMicrowave and Shortwave Diathermy\nII\nFrasca et al99 compared the effectiveness of micro­\nwave diathermy to sham diathermy in patients with \nidiopathic mild to moderate CTS.",
    "chunk_id": 491,
    "sentence_start": 1975,
    "sentence_end": 1979,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "A limitation of this study \nwas that there was no control group. No adverse effects were \nreported.57\nMicrowave and Shortwave Diathermy\nII\nFrasca et al99 compared the effectiveness of micro­\nwave diathermy to sham diathermy in patients with \nidiopathic mild to moderate CTS. In this double-\nblind trial, 22 patients (34 hands) were randomized to re­\nceive active or sham microwave diathermy for 20-minute \nsessions, twice weekly for 3 weeks. Outcome measures in­\ncluded pain VAS, CTQ-SSS, CTQ-FS, and NCS (DML and \nsensory NCV). At the end of 3 weeks, the active treatment \ngroup demonstrated statistically significant improvement in \npain severity (MD, –2.0; P = .002), CTQ-SSS (MD, –0.54; P \n= .0001), and CTQ-FS (MD, –0.50; P = .002). There were \nsignificant differences between the active and sham treat­\nment groups in pain severity (P = .004) and CTQ-SSS (P = \n.009) but not in the CTQ-FS. There were no significant dif­\nferences for either group in electrophysiology parameters \nstudied.",
    "chunk_id": 492,
    "sentence_start": 1978,
    "sentence_end": 1984,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There were \nsignificant differences between the active and sham treat­\nment groups in pain severity (P = .004) and CTQ-SSS (P = \n.009) but not in the CTQ-FS. There were no significant dif­\nferences for either group in electrophysiology parameters \nstudied. There were no reported adverse effects.99\nII\nIncebiyik et al136 compared the effectiveness of \nshortwave diathermy combined with a hot pack and \nnerve and tendon gliding exercises to sham short­\nwave diathermy in 28 patients (52 wrists) with mild to mod­\nerate severity CTS in a randomized, double-blinded, \nplacebo-controlled study. Participants received a hot pack \n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 493,
    "sentence_start": 1983,
    "sentence_end": 1990,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nEvidence Synthesis and Clinical Rationale\nStudies have shown positive, short-term effects of using \nsuperficial heat in individuals with CTS. Heat wraps, par­\naffin, and shortwave and microwave diathermy have shown \npositive effects in the short term. When combined with an \northosis, the use of paraffin was not superior to pulsed ul­\ntrasound.57 Individuals with CTS should be instructed in the \nrisks of applying thermal agents to sensory-impaired tissue \nand should be advised to perform frequent skin checks. Heat \nshould not be used in the presence of inflammation. Diathermy is contraindicated in areas where sensation is se­\nverely impaired and over areas with metal implants.",
    "chunk_id": 494,
    "sentence_start": 1989,
    "sentence_end": 1995,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Heat \nshould not be used in the presence of inflammation. Diathermy is contraindicated in areas where sensation is se­\nverely impaired and over areas with metal implants. It should \nnot be performed on a patient who is pregnant or be per­\nformed by a pregnant operator.37 Other forms of superficial \nheat (wrist heat wrap) have shown similar results and can \nbe done without concerns for pregnancy, metal implants, or \nneed for clinic visits and can be delivered at lower expense. Recommendations\nC\nClinicians may recommend a trial of superficial \nheat for short-term symptom relief for individuals \nwith CTS. C\nClinicians may recommend the application of mi­\ncrowave or shortwave diathermy for short-term \npain and symptom relief for patients with mild to \nmoderate idiopathic CTS.",
    "chunk_id": 495,
    "sentence_start": 1994,
    "sentence_end": 1998,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Recommendations\nC\nClinicians may recommend a trial of superficial \nheat for short-term symptom relief for individuals \nwith CTS. C\nClinicians may recommend the application of mi­\ncrowave or shortwave diathermy for short-term \npain and symptom relief for patients with mild to \nmoderate idiopathic CTS. Electrical Stimulation\nInterferential Current\nII\nKoca et al150 randomly allocated 63 individuals with \nmild to moderate CTS to a prefabricated, night-\near\nrist orthosis group ( rist positioned in 0° to\nad, 5 minutes) given twice per week for \nnts with CTS (all severities) in a RCT. roups wore a custom-fabricated neutral \nht for 8 weeks. Outcome measures in­\nand CTQ-FS, pain scale, sensory thresh­\nrength, DML, and DSL. After 8 weeks, \nd on the CTQ-SSS (ES for both groups \nd sensory threshold (P<.03).",
    "chunk_id": 496,
    "sentence_start": 1997,
    "sentence_end": 2002,
    "section_type": "conclusion",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcome measures in­\nand CTQ-FS, pain scale, sensory thresh­\nrength, DML, and DSL. After 8 weeks, \nd on the CTQ-SSS (ES for both groups \nd sensory threshold (P<.03). The ultra­\ntrated significant improvement in CTQ-\nalmar pinch following treatment when \ne; however, the only significant differ­\nraffin and ultrasound groups was the \nng ultrasound (MD, –0.3 compared to \n.04; ES, 0.38). A limitation of this study \no control group. No adverse effects were \nave Diathermy\n99 compared the effectiveness of micro­\nrmy to sham diathermy in patients with \nmild to moderate CTS. In this double-\nts (34 hands) were randomized to re­\nmicrowave diathermy for 20-minute \nly for 3 weeks. Outcome measures in­\nTQ-SSS, CTQ-FS, and NCS (DML and \ne end of 3 weeks, the active treatment \nstatistically significant improvement in \n2.0; P = .002), CTQ-SSS (MD, –0.54; P \nFS (MD, –0.50; P = .002). There were \nes between the active and sham treat­\nseverity (P = .004) and CTQ-SSS (P = \nCTQ-FS.",
    "chunk_id": 497,
    "sentence_start": 2001,
    "sentence_end": 2008,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcome measures in­\nTQ-SSS, CTQ-FS, and NCS (DML and \ne end of 3 weeks, the active treatment \nstatistically significant improvement in \n2.0; P = .002), CTQ-SSS (MD, –0.54; P \nFS (MD, –0.50; P = .002). There were \nes between the active and sham treat­\nseverity (P = .004) and CTQ-SSS (P = \nCTQ-FS. There were no significant dif­\nroup in electrophysiology parameters \nno reported ad erse effects 99\n\n\n--- Page 44 ---\nCOLUMN 1:\nThe IFC group demonstrated significant improvement over \nthe TENS group for CTQ-SSS (MD, –1.2 compared to TENS \nMD, –0.69; P<.05) and CTQ–FS (MD, –0.90 versus TENS \nMD, –0.43; P<.05), but there was no difference compared to \nthe orthosis scores. In this study, IFC demonstrated greater \npain change scores than orthosis or TENS; however, the \nsmall sample size and lack of a control group weaken the \nresult. The frequency of IFC treatment (5 days per week) and \nadditional cost may not be justified in light of other nonsurgi­\ncal interventions.",
    "chunk_id": 498,
    "sentence_start": 2007,
    "sentence_end": 2011,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In this study, IFC demonstrated greater \npain change scores than orthosis or TENS; however, the \nsmall sample size and lack of a control group weaken the \nresult. The frequency of IFC treatment (5 days per week) and \nadditional cost may not be justified in light of other nonsurgi­\ncal interventions. Interferential current should not be used \nin patients with a pacemaker.37\nC\nClinicians may offer a trial of IFC for short-term \npain symptom relief in adults with idiopathic, mild \nto moderate CTS. As with all electrical modalities, \ncontraindications should be taken into consideration before \nchoosing this intervention. Light Agents\nII\nLow-level laser therapy (LLLT) is a form of electro­\nmagnetic energy that is monochromatic (single \nwavelength) and coherent (in phase).52 In a recent, \nhigh-quality Cochrane review, Rankin et al236 reviewed 22 \nRCTs on LLLT for treatment of CTS published through De­\ncember 2016. Trials compared LLLT to placebo and other \nnonsurgical interventions.",
    "chunk_id": 499,
    "sentence_start": 2010,
    "sentence_end": 2015,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Light Agents\nII\nLow-level laser therapy (LLLT) is a form of electro­\nmagnetic energy that is monochromatic (single \nwavelength) and coherent (in phase).52 In a recent, \nhigh-quality Cochrane review, Rankin et al236 reviewed 22 \nRCTs on LLLT for treatment of CTS published through De­\ncember 2016. Trials compared LLLT to placebo and other \nnonsurgical interventions. Authors concluded there was in­\nsufficient evidence of a clinical effect of LLLT in the nonsur­\ngical management of CTS. They also concluded there was \ninsufficient evidence to support long-term benefits of LLLT \nversus placebo or ultrasound.236\nII\nRaeissadat et al234 used Bioptron light therapy, a \nform of nonlaser, low-energy light therapy (poly­\nchromatic, incoherent) with wavelengths ranging \nfrom 480 to 3400 nm in 44 adult patients with mild or mod­\nerate CTS in a nonblinded, RCT.",
    "chunk_id": 500,
    "sentence_start": 2014,
    "sentence_end": 2017,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Authors concluded there was in­\nsufficient evidence of a clinical effect of LLLT in the nonsur­\ngical management of CTS. They also concluded there was \ninsufficient evidence to support long-term benefits of LLLT \nversus placebo or ultrasound.236\nII\nRaeissadat et al234 used Bioptron light therapy, a \nform of nonlaser, low-energy light therapy (poly­\nchromatic, incoherent) with wavelengths ranging \nfrom 480 to 3400 nm in 44 adult patients with mild or mod­\nerate CTS in a nonblinded, RCT. The experimental group \nreceived 12 eight-minute light treatments over a 4-week pe­\nriod and wore a neutral wrist orthosis full time except for \nhygiene. The control group also wore the orthosis but did not \nreceive the light therapy. Outcome measures included pain \nVAS and electrophysiological parameters.",
    "chunk_id": 501,
    "sentence_start": 2016,
    "sentence_end": 2020,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The control group also wore the orthosis but did not \nreceive the light therapy. Outcome measures included pain \nVAS and electrophysiological parameters. At 8 weeks, both \ngroups demonstrated improvement in pain VAS (control \nMD, –2.28; P<.05 and light therapy MD, –2.42; P<.05) and \nmedian DSL (control MD, 0.23 m/s; P<.05 and light therapy \nMD, 0.18 m/s; P<.05), but there were no statistical differ­\nences between the 2 groups on any measure (P>.05). There \nwere no adverse effects.234\nIV\nStasinopoulos et al268 also applied Bioptron light \ntherapy for 6 minutes 3 times per week for 4 weeks \nin patients\nith idiopathic mild to moderate CTS\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 502,
    "sentence_start": 2019,
    "sentence_end": 2026,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\npain and 84% reported improvement in paresthesia. At the \n6-month follow-up, 100% reported improvement in night \npain and 36% were pain free. Paresthesia improved in 92% \nof participants and 28% had complete resolution. The results \nof this study are inconclusive due the lack of blinding, not \nusing validated outcome measures, a small sample size, and \nlack of a control group.268\nEvidence Synthesis and Clinical Rationale\nThere is no evidence of a biological effect of LLLT or light \ntherapy on CTS. There is a lack of consensus regarding the \noptimal wavelength, dosage, frequency, and duration of treat­\nment. Side effects of LLLT, including pain and tingling that \nsubsided after the treatment, have been reported236; however, \nRankin et al236 concluded there is insufficient evidence on \nadverse events.",
    "chunk_id": 503,
    "sentence_start": 2025,
    "sentence_end": 2032,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There is a lack of consensus regarding the \noptimal wavelength, dosage, frequency, and duration of treat­\nment. Side effects of LLLT, including pain and tingling that \nsubsided after the treatment, have been reported236; however, \nRankin et al236 concluded there is insufficient evidence on \nadverse events. Recommendation\nB\nClinicians should not use LLLT or other types of \nnonlaser light therapy for individuals with CTS. Sound Agents\nUltrasound\nII\nOztas et al218 compared 2 different continuous ul­\ntrasound intensities to sham ultrasound in 18 fe­\nmale participants (30 hands; 10 per group) with \nmild to moderate idiopathic CTS of more than 6 months du­\nration in a single-blinded, randomized, placebo-controlled \nstudy. Groups were treated with 3-MHz ultrasound applied \nfor 5 minutes at either 1.5 W/cm2, 0.8 W/cm2, or 0.0 W/cm2 \n(sham), 5 times per week for 2 weeks.",
    "chunk_id": 504,
    "sentence_start": 2031,
    "sentence_end": 2035,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Sound Agents\nUltrasound\nII\nOztas et al218 compared 2 different continuous ul­\ntrasound intensities to sham ultrasound in 18 fe­\nmale participants (30 hands; 10 per group) with \nmild to moderate idiopathic CTS of more than 6 months du­\nration in a single-blinded, randomized, placebo-controlled \nstudy. Groups were treated with 3-MHz ultrasound applied \nfor 5 minutes at either 1.5 W/cm2, 0.8 W/cm2, or 0.0 W/cm2 \n(sham), 5 times per week for 2 weeks. Outcomes were mea­\nsured 5 days after the last session and included pain VAS, \nnight or day pain or paresthesia (4-point scale), frequency of \nnight waking (4-point scale), and NCS. All groups improved \nsignificantly in all outcome measures (P<.05) except NCS \n(P>.05).",
    "chunk_id": 505,
    "sentence_start": 2034,
    "sentence_end": 2037,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcomes were mea­\nsured 5 days after the last session and included pain VAS, \nnight or day pain or paresthesia (4-point scale), frequency of \nnight waking (4-point scale), and NCS. All groups improved \nsignificantly in all outcome measures (P<.05) except NCS \n(P>.05). There were no statistically significant differences \nbetween the 3 groups on any outcome measure.218\nII\nArmagan et al17 compared pulsed (1:4) and continu­\nous ultrasound (1.0 MHz, 1.0 W/cm2) to sham ultra­\nsound (0 0 W/cm2) in 46 females\nith mild to\nnstrated significant improvement over \nCTQ-SSS (MD, –1.2 compared to TENS \nnd CTQ–FS (MD, –0.90 versus TENS \nut there was no difference compared to \nn this study, IFC demonstrated greater \nthan orthosis or TENS; however, the \nnd lack of a control group weaken the \nof IFC treatment (5 days per week) and \not be justified in light of other nonsurgi­\nerferential current should not be used \ncemaker.37\nmay offer a trial of IFC for short-term \nom relief in adults with idiopathic, mild \ne CTS.",
    "chunk_id": 506,
    "sentence_start": 2036,
    "sentence_end": 2038,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All groups improved \nsignificantly in all outcome measures (P<.05) except NCS \n(P>.05). There were no statistically significant differences \nbetween the 3 groups on any outcome measure.218\nII\nArmagan et al17 compared pulsed (1:4) and continu­\nous ultrasound (1.0 MHz, 1.0 W/cm2) to sham ultra­\nsound (0 0 W/cm2) in 46 females\nith mild to\nnstrated significant improvement over \nCTQ-SSS (MD, –1.2 compared to TENS \nnd CTQ–FS (MD, –0.90 versus TENS \nut there was no difference compared to \nn this study, IFC demonstrated greater \nthan orthosis or TENS; however, the \nnd lack of a control group weaken the \nof IFC treatment (5 days per week) and \not be justified in light of other nonsurgi­\nerferential current should not be used \ncemaker.37\nmay offer a trial of IFC for short-term \nom relief in adults with idiopathic, mild \ne CTS. As with all electrical modalities, \nould be taken into consideration before \nntion.",
    "chunk_id": 507,
    "sentence_start": 2037,
    "sentence_end": 2039,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There were no statistically significant differences \nbetween the 3 groups on any outcome measure.218\nII\nArmagan et al17 compared pulsed (1:4) and continu­\nous ultrasound (1.0 MHz, 1.0 W/cm2) to sham ultra­\nsound (0 0 W/cm2) in 46 females\nith mild to\nnstrated significant improvement over \nCTQ-SSS (MD, –1.2 compared to TENS \nnd CTQ–FS (MD, –0.90 versus TENS \nut there was no difference compared to \nn this study, IFC demonstrated greater \nthan orthosis or TENS; however, the \nnd lack of a control group weaken the \nof IFC treatment (5 days per week) and \not be justified in light of other nonsurgi­\nerferential current should not be used \ncemaker.37\nmay offer a trial of IFC for short-term \nom relief in adults with idiopathic, mild \ne CTS. As with all electrical modalities, \nould be taken into consideration before \nntion. aser therapy (LLLT) is a form of electro­\nnergy that is monochromatic (single \n) and coherent (in phase).52 In a recent, \nne review, Rankin et al236 reviewed 22 \neatment of CTS published through De­\ncompared LLLT to placebo and other \ntions.",
    "chunk_id": 508,
    "sentence_start": 2038,
    "sentence_end": 2040,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "As with all electrical modalities, \nould be taken into consideration before \nntion. aser therapy (LLLT) is a form of electro­\nnergy that is monochromatic (single \n) and coherent (in phase).52 In a recent, \nne review, Rankin et al236 reviewed 22 \neatment of CTS published through De­\ncompared LLLT to placebo and other \ntions. Authors concluded there was in­\na clinical effect of LLLT in the nonsur­\nf CTS. They also concluded there was \nto support long-term benefits of LLLT \nrasound.236\net al234 used Bioptron light therapy, a \nnlaser, low-energy light therapy (poly­\nincoherent) with wavelengths ranging \nm in 44 adult patients with mild or mod­\nlinded, RCT. The experimental group \nnute light treatments over a 4-week pe­\ntral wrist orthosis full time except for \ngroup also wore the orthosis but did not \napy.",
    "chunk_id": 509,
    "sentence_start": 2039,
    "sentence_end": 2043,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "They also concluded there was \nto support long-term benefits of LLLT \nrasound.236\net al234 used Bioptron light therapy, a \nnlaser, low-energy light therapy (poly­\nincoherent) with wavelengths ranging \nm in 44 adult patients with mild or mod­\nlinded, RCT. The experimental group \nnute light treatments over a 4-week pe­\ntral wrist orthosis full time except for \ngroup also wore the orthosis but did not \napy. Outcome measures included pain \niological parameters At 8\neeks both\n\n\n--- Page 45 ---\nCOLUMN 1:\nfor any NCS values (P>.09).17 Due to the lack of a true control \ngroup, the difference could have been due to the orthosis or the \nnatural course of the disease. II\nIn a randomized double-blinded trial, Ebenbichler et \nal85 compared sham ultrasound to pulsed ultrasound \n(25% duty cycle; 1 MHz; 1.0 W/cm2) applied for 15 \nminutes in 34 adults with bilateral, mild to moderate idiopathic \nCTS (duration greater than 6 months).",
    "chunk_id": 510,
    "sentence_start": 2042,
    "sentence_end": 2045,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcome measures included pain \niological parameters At 8\neeks both\n\n\n--- Page 45 ---\nCOLUMN 1:\nfor any NCS values (P>.09).17 Due to the lack of a true control \ngroup, the difference could have been due to the orthosis or the \nnatural course of the disease. II\nIn a randomized double-blinded trial, Ebenbichler et \nal85 compared sham ultrasound to pulsed ultrasound \n(25% duty cycle; 1 MHz; 1.0 W/cm2) applied for 15 \nminutes in 34 adults with bilateral, mild to moderate idiopathic \nCTS (duration greater than 6 months). Participants were treat­\ned for 7 weeks (5 times per week for 2 weeks and twice weekly \nfor 5 weeks) for a total of 20 sessions. Outcome measures in­\ncluded grip and pinch strength, NCS (DML and SNCV), VAS \nfor pain, paresthesia, worst complaint, sensory loss, and overall \nimprovement (5-point scale). Changes in scores were evaluated \nbetween baseline and 2 weeks, 7 weeks (end of treatment), and \n6 months post treatment.",
    "chunk_id": 511,
    "sentence_start": 2044,
    "sentence_end": 2048,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcome measures in­\ncluded grip and pinch strength, NCS (DML and SNCV), VAS \nfor pain, paresthesia, worst complaint, sensory loss, and overall \nimprovement (5-point scale). Changes in scores were evaluated \nbetween baseline and 2 weeks, 7 weeks (end of treatment), and \n6 months post treatment. Self-reported measures favored the \nactive treatment at each time point (P<.05) except for worst \npain at 2 weeks (P = .125). Grip strength was better in the active \ntreatment group at 7 weeks (active treatment MD, 3.87 kg ver­\nsus sham MD, –0.09 kg; P<.0005) and 6 months (active treat­\nment MD, 5.44 kg versus sham MD, –1.99 kg; P<.0005). Pinch \nstrength was better in the treatment group compared to the \ncontrol group at 6 months (active treatment MD, 0.49 kg ver­\nsus sham MD, –0.22 kg; P = .014). All nerve conduction study \ndata favored the active treatment group at each time point \n(P<.001).",
    "chunk_id": 512,
    "sentence_start": 2047,
    "sentence_end": 2052,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Pinch \nstrength was better in the treatment group compared to the \ncontrol group at 6 months (active treatment MD, 0.49 kg ver­\nsus sham MD, –0.22 kg; P = .014). All nerve conduction study \ndata favored the active treatment group at each time point \n(P<.001). Good or excellent results were reported by 76% of \nindividuals in the active treatment group compared to 32% of \nindividuals in the sham group.85 No adverse effects of ultra­\nsound treatment were reported. II\nIn a randomized, single-blinded trial of 46 wrists \nwith bilateral mild-to-moderate CTS, Baysal et al35 \ncompared 3 groups: (1) pulsed ultrasound plus an \northosis; (2) tendon and nerve gliding plus an orthosis; and \n(3) pulsed ultrasound plus tendon and nerve gliding plus an \northosis. All orthoses were custom-fabricated (volar, neutral \nposition, worn day and night for 3 weeks), and ultrasound \ntreatments were provided using 1:4 duty cycle, 1.0 MHz at 1.0 \nW/cm2 for 15 minutes.",
    "chunk_id": 513,
    "sentence_start": 2051,
    "sentence_end": 2055,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "II\nIn a randomized, single-blinded trial of 46 wrists \nwith bilateral mild-to-moderate CTS, Baysal et al35 \ncompared 3 groups: (1) pulsed ultrasound plus an \northosis; (2) tendon and nerve gliding plus an orthosis; and \n(3) pulsed ultrasound plus tendon and nerve gliding plus an \northosis. All orthoses were custom-fabricated (volar, neutral \nposition, worn day and night for 3 weeks), and ultrasound \ntreatments were provided using 1:4 duty cycle, 1.0 MHz at 1.0 \nW/cm2 for 15 minutes. The ultrasound was delivered 5 times \nper week for 3 weeks. Outcomes were assessed at the end of \ntreatment and at an 8-week follow-up, and included pain \n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 514,
    "sentence_start": 2054,
    "sentence_end": 2061,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nthe combination of interventions due to the lack of a control \ngroup. Evidence Synthesis and Clinical Rationale\nBased on the results of 2 level II randomized studies, ther­\nmal ultrasound has not been shown to be better than sham \nultrasound.17,218 Evidence on pulsed ultrasound is conflicting.",
    "chunk_id": 515,
    "sentence_start": 2060,
    "sentence_end": 2063,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nthe combination of interventions due to the lack of a control \ngroup. Evidence Synthesis and Clinical Rationale\nBased on the results of 2 level II randomized studies, ther­\nmal ultrasound has not been shown to be better than sham \nultrasound.17,218 Evidence on pulsed ultrasound is conflicting. One study found positive benefits, but authors reported a pri­\nori differences between groups in subjective complaints and \ngrip strength (active ultrasound treatment being worse) that \nmay suggest greater severity in this group.85 Also, based on \nfindings from studies where ultrasound was combined with \nother treatments, there is conflicting evidence on the benefit \nof adding nonthermal ultrasound to treatment regimens that \ninclude an orthosis and/or tendon and nerve gliding exer­\ncises.17,35,57 Last, there is insufficient evidence to support 1.5 \nW/cm2 versus 0.8 W/cm2, and there is insufficient evidence to \nsupport 1 MHz versus 3 MHz.218 Given the additional treat­\nment expense and time commitment, there is not enough \nevidence for or against the use of nonthermal ultrasound in \npatients with mild to moderate CTS.",
    "chunk_id": 516,
    "sentence_start": 2062,
    "sentence_end": 2064,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Evidence Synthesis and Clinical Rationale\nBased on the results of 2 level II randomized studies, ther­\nmal ultrasound has not been shown to be better than sham \nultrasound.17,218 Evidence on pulsed ultrasound is conflicting. One study found positive benefits, but authors reported a pri­\nori differences between groups in subjective complaints and \ngrip strength (active ultrasound treatment being worse) that \nmay suggest greater severity in this group.85 Also, based on \nfindings from studies where ultrasound was combined with \nother treatments, there is conflicting evidence on the benefit \nof adding nonthermal ultrasound to treatment regimens that \ninclude an orthosis and/or tendon and nerve gliding exer­\ncises.17,35,57 Last, there is insufficient evidence to support 1.5 \nW/cm2 versus 0.8 W/cm2, and there is insufficient evidence to \nsupport 1 MHz versus 3 MHz.218 Given the additional treat­\nment expense and time commitment, there is not enough \nevidence for or against the use of nonthermal ultrasound in \npatients with mild to moderate CTS. Gaps in Knowledge\nHigh-quality, controlled studies on the effects of both thermal \nand pulsed ultrasound in individuals with CTS are needed.",
    "chunk_id": 517,
    "sentence_start": 2063,
    "sentence_end": 2065,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "One study found positive benefits, but authors reported a pri­\nori differences between groups in subjective complaints and \ngrip strength (active ultrasound treatment being worse) that \nmay suggest greater severity in this group.85 Also, based on \nfindings from studies where ultrasound was combined with \nother treatments, there is conflicting evidence on the benefit \nof adding nonthermal ultrasound to treatment regimens that \ninclude an orthosis and/or tendon and nerve gliding exer­\ncises.17,35,57 Last, there is insufficient evidence to support 1.5 \nW/cm2 versus 0.8 W/cm2, and there is insufficient evidence to \nsupport 1 MHz versus 3 MHz.218 Given the additional treat­\nment expense and time commitment, there is not enough \nevidence for or against the use of nonthermal ultrasound in \npatients with mild to moderate CTS. Gaps in Knowledge\nHigh-quality, controlled studies on the effects of both thermal \nand pulsed ultrasound in individuals with CTS are needed. Recommendations\nC\nClinicians should not use thermal ultrasound in the \ntreatment of patients with mild to moderate CTS.",
    "chunk_id": 518,
    "sentence_start": 2064,
    "sentence_end": 2066,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Gaps in Knowledge\nHigh-quality, controlled studies on the effects of both thermal \nand pulsed ultrasound in individuals with CTS are needed. Recommendations\nC\nClinicians should not use thermal ultrasound in the \ntreatment of patients with mild to moderate CTS. D\nThere is conflicting evidence on the use of nonther­\nmal ultrasound in the treatment of patients with \nmild to moderate CTS, and therefore no recom­\nmendation can be made. Transdermal Drug Delivery\nThe use of topical anti-inflammatory drugs, both steroid and \nnonsteroid, has been investigated for treatment of CTS based \non the inflammatory model of pathology.",
    "chunk_id": 519,
    "sentence_start": 2065,
    "sentence_end": 2068,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "D\nThere is conflicting evidence on the use of nonther­\nmal ultrasound in the treatment of patients with \nmild to moderate CTS, and therefore no recom­\nmendation can be made. Transdermal Drug Delivery\nThe use of topical anti-inflammatory drugs, both steroid and \nnonsteroid, has been investigated for treatment of CTS based \non the inflammatory model of pathology. Localized inflam­\nmation has been suggested to contribute to the pathology of \nCTS in 1 of 4 ways: by decreasing the space in the tunnel due \nto the presence of inflammatory infiltrates, decreasing the \ncirculation within the median nerve due to intraneural infil­\ntrates, fibrosis of the nerve due to inflammatory infiltrates, \nor increasing the work of the flexor tendons gliding through \nresistance produced by inflammatory infiltrates.",
    "chunk_id": 520,
    "sentence_start": 2067,
    "sentence_end": 2069,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Transdermal Drug Delivery\nThe use of topical anti-inflammatory drugs, both steroid and \nnonsteroid, has been investigated for treatment of CTS based \non the inflammatory model of pathology. Localized inflam­\nmation has been suggested to contribute to the pathology of \nCTS in 1 of 4 ways: by decreasing the space in the tunnel due \nto the presence of inflammatory infiltrates, decreasing the \ncirculation within the median nerve due to intraneural infil­\ntrates, fibrosis of the nerve due to inflammatory infiltrates, \nor increasing the work of the flexor tendons gliding through \nresistance produced by inflammatory infiltrates. Phonophoresis\nII\nIn a double-blinded trial, Yildiz et al301 randomized \n51 adults (76 hands) with idiopathic mild to moder­\nate CTS to 1 of 3 groups sham ultrasound acti e\n>.09).17 Due to the lack of a true control \ncould have been due to the orthosis or the \ndisease.",
    "chunk_id": 521,
    "sentence_start": 2068,
    "sentence_end": 2070,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Localized inflam­\nmation has been suggested to contribute to the pathology of \nCTS in 1 of 4 ways: by decreasing the space in the tunnel due \nto the presence of inflammatory infiltrates, decreasing the \ncirculation within the median nerve due to intraneural infil­\ntrates, fibrosis of the nerve due to inflammatory infiltrates, \nor increasing the work of the flexor tendons gliding through \nresistance produced by inflammatory infiltrates. Phonophoresis\nII\nIn a double-blinded trial, Yildiz et al301 randomized \n51 adults (76 hands) with idiopathic mild to moder­\nate CTS to 1 of 3 groups sham ultrasound acti e\n>.09).17 Due to the lack of a true control \ncould have been due to the orthosis or the \ndisease. mized double-blinded trial, Ebenbichler et \ned sham ultrasound to pulsed ultrasound \ncycle; 1 MHz; 1.0 W/cm2) applied for 15 \nwith bilateral, mild to moderate idiopathic \nthan 6 months). Participants were treat­\ns per week for 2 weeks and twice weekly \nal of 20 sessions.",
    "chunk_id": 522,
    "sentence_start": 2069,
    "sentence_end": 2072,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "mized double-blinded trial, Ebenbichler et \ned sham ultrasound to pulsed ultrasound \ncycle; 1 MHz; 1.0 W/cm2) applied for 15 \nwith bilateral, mild to moderate idiopathic \nthan 6 months). Participants were treat­\ns per week for 2 weeks and twice weekly \nal of 20 sessions. Outcome measures in­\nh strength, NCS (DML and SNCV), VAS \nworst complaint, sensory loss, and overall \nt scale). Changes in scores were evaluated \n2 weeks, 7 weeks (end of treatment), and \nent. Self-reported measures favored the \nach time point (P<.05) except for worst \n25). Grip strength was better in the active \nweeks (active treatment MD, 3.87 kg ver­\nkg; P<.0005) and 6 months (active treat­\nsus sham MD, –1.99 kg; P<.0005). Pinch \nn the treatment group compared to the \nnths (active treatment MD, 0.49 kg ver­\nkg; P = .014).",
    "chunk_id": 523,
    "sentence_start": 2071,
    "sentence_end": 2077,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Grip strength was better in the active \nweeks (active treatment MD, 3.87 kg ver­\nkg; P<.0005) and 6 months (active treat­\nsus sham MD, –1.99 kg; P<.0005). Pinch \nn the treatment group compared to the \nnths (active treatment MD, 0.49 kg ver­\nkg; P = .014). All nerve conduction study \nve treatment group at each time point \ncellent results were reported by 76% of \nve treatment group compared to 32% of \nam group.85 No adverse effects of ultra­\n reported. mized, single-blinded trial of 46 wrists \nal mild-to-moderate CTS, Baysal et al35 \n3 groups: (1) pulsed ultrasound plus an \nand nerve gliding plus an orthosis; and \nd plus tendon and nerve gliding plus an \nwere custom-fabricated (volar, neutral \nnd night for 3 weeks), and ultrasound \nided using 1:4 duty cycle, 1.0 MHz at 1.0 \ns. The ultrasound was delivered 5 times \n. Outcomes were assessed at the end of \n8-week follow-up, and included pain \nositive Tinel sign and Phalen test, grip \n2PD, CTQ-SSS, CTQ-FS, DSL, DML, \non.",
    "chunk_id": 524,
    "sentence_start": 2076,
    "sentence_end": 2081,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The ultrasound was delivered 5 times \n. Outcomes were assessed at the end of \n8-week follow-up, and included pain \nositive Tinel sign and Phalen test, grip \n2PD, CTQ-SSS, CTQ-FS, DSL, DML, \non. All groups improved in all measures \nk follow-ups (P<.05) except 2PD and \nroved; P>.05), and DSL (only the ultra­\nltrasound-exercise-orthosis groups im­\nr patient satisfaction, 25% of the \nup reported excellent/good satisfaction, \nise-ultrasound-orthosis group reported \naction There\nere no significant differ\n\n\n--- Page 46 ---\nCOLUMN 1:\nIntention-to-treat analysis was performed using all partici­\npants who were initially randomized. Ultrasound parameters \nfor the active treatment groups were: 1 MHz frequency, 1.0 \nW/cm2, and 25% duty cycle. Participants were treated for 15 \nminutes, 5 times per week for 2 weeks. Participants also wore \ncustom-fabricated volar wrist orthoses (0°-5° of wrist exten­\nsion) full time for 8 weeks.",
    "chunk_id": 525,
    "sentence_start": 2080,
    "sentence_end": 2085,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Participants were treated for 15 \nminutes, 5 times per week for 2 weeks. Participants also wore \ncustom-fabricated volar wrist orthoses (0°-5° of wrist exten­\nsion) full time for 8 weeks. Outcomes were measured at 2 and \n8 weeks, and included CTQ scales, pain VAS, and NCS. All \ngroups improved in all measures; however, the phonophore­\nsis group improvement for the pain VAS (MD, –5.06) was \nstatistically greater than the other 2 groups (sham ultrasound \nMD, –2.48; P = .002; pulsed ultrasound MD, –2.19; P = \n.004). There were no other statistically significant differences \nbetween the 3 groups.301 Authors reported there were no \ncomplications from the interventions. II\nSoyupek et al266 compared 4 different interventions \nfor mild to moderate CTS.",
    "chunk_id": 526,
    "sentence_start": 2084,
    "sentence_end": 2089,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There were no other statistically significant differences \nbetween the 3 groups.301 Authors reported there were no \ncomplications from the interventions. II\nSoyupek et al266 compared 4 different interventions \nfor mild to moderate CTS. In this randomized, sin­\ngle-blinded (assessors) trial, 51 patients (84 hands) \nwere assigned to 1 of 4 groups: local steroid injection (LSI \ngroup), corticosteroid (0.1% betamethasone valerate cream) \nphonophoresis (PCS group), NSAID (diclofenac diethylam­\nmonium gel) phonophoresis (PNS group), or a volar, neutral \nwrist orthosis. Phonophoresis was applied at 3 MHz, 1.5 W/\ncm2 for 10 minutes, 5 days per week for 3 weeks using a 5-cm2 \nsound head. The orthoses were worn full time for 15 days, and \nonly when symptomatic for the remaining 6 days. Outcome \ndata were collected at baseline and 3 months following treat­\nment.",
    "chunk_id": 527,
    "sentence_start": 2088,
    "sentence_end": 2093,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The orthoses were worn full time for 15 days, and \nonly when symptomatic for the remaining 6 days. Outcome \ndata were collected at baseline and 3 months following treat­\nment. There were significant baseline differences for some \noutcome measures between the groups (Duruöz Hand Index, \nSNCV, SNAP, DSL), but no baseline differences for grip \nstrength, hand dexterity, sensory threshold (SWMT), Phalen \nsign, Tinel test, VAS. The only statistically significant differ­\nence between groups was for Tinel sign, favoring PCS group \n(P = .04). Pretreatment and posttreatment differences for the \nPCS group were significant for Tinel’s (P≤.003), grip \n(P≤.003), SWMT of the middle finger (P = .046) and NCS \n(SNCV, MDL, DSL) (P≤.049). The PNS group demonstrated \nimprovement in pain VAS, grip and dexterity (P≤.003) The \northosis group demonstrated improved pain VAS (P = .006) \nand DSL (P = .002), and the LSI group improved in the Du­\nruöz Hand Index  and pain VAS (P≤.006).",
    "chunk_id": 528,
    "sentence_start": 2092,
    "sentence_end": 2097,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Pretreatment and posttreatment differences for the \nPCS group were significant for Tinel’s (P≤.003), grip \n(P≤.003), SWMT of the middle finger (P = .046) and NCS \n(SNCV, MDL, DSL) (P≤.049). The PNS group demonstrated \nimprovement in pain VAS, grip and dexterity (P≤.003) The \northosis group demonstrated improved pain VAS (P = .006) \nand DSL (P = .002), and the LSI group improved in the Du­\nruöz Hand Index  and pain VAS (P≤.006). Authors concluded \nthe greatest improvements were observed with the PCS \ngroup in strength, function, SNCV, DSL, and DML, and with \nthe PNS group for pain.266\nII\nIn another study, Soyupek et al267 compared phono­\nphoresis with corticosteroid (PCS), phonophoresis \nith NSAID (PNS) (medications listed abo e) and\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 529,
    "sentence_start": 2096,
    "sentence_end": 2102,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nsound head. After 3 months, all groups improved in all clinical \nmeasures. The PCS group scores improved for VAS (MD, –30; \nP<.017), CTQ (MD, –1.5; P<.017), percentage of participants \nwith positive Phalen test (MD, –32.1%; P<.017), Tinel sign \n(MD, –39.3%; P<.017), and nerve dimensions, as measured by \nultrasound imaging (anterior-posterior MD, –0.24; cross-\nsectional area MD, –0.03; P<.017) (unit of measure not re­\nported). The PNS group scores improved in VAS (MD, –23.48; \nP<.017), CTQ (MD, –1.18; P<.017) and percentage of subjects \nwith positive Phalen sign (MD, –32.9%; P<.017). The orthosis \ngroup scores improved in CTQ-SSS (MD, –1.54; P<.017). No \ngroup improved in nerve conduction measures (P>.017).",
    "chunk_id": 530,
    "sentence_start": 2101,
    "sentence_end": 2108,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The orthosis \ngroup scores improved in CTQ-SSS (MD, –1.54; P<.017). No \ngroup improved in nerve conduction measures (P>.017). 267\nIontophoresis\nII\nAmirjani et al14 performed a randomized, double-\nblinded study of 17 individuals with mild to moder­\nate CTS comparing iontophoresis with 0.4% \ndexamethasone sodium phosphate to distilled water iontopho­\nresis. The treatment was administered every other day for 2 \nweeks, for a total of 6 treatments at a rate of 2 mA-min, for a \ntotal treatment dosage of 80 mA-min. Participants were fol­\nlowed monthly for 6 months after treatment. Outcome mea­\nsures included CTQ total score (SSS and FS), sensory threshold \n(measured using the SWMT), and NCS. At 6 months post \ntreatment, both the treatment and sham group showed similar \nimprovements on CTQ scores (distilled-water iontophoresis \nmedian difference, –2.0; P = .028; steroid iontophoresis me­\ndian difference, –12; P<.05), and the difference between the \ngroups was not significant (P = .25).",
    "chunk_id": 531,
    "sentence_start": 2107,
    "sentence_end": 2113,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcome mea­\nsures included CTQ total score (SSS and FS), sensory threshold \n(measured using the SWMT), and NCS. At 6 months post \ntreatment, both the treatment and sham group showed similar \nimprovements on CTQ scores (distilled-water iontophoresis \nmedian difference, –2.0; P = .028; steroid iontophoresis me­\ndian difference, –12; P<.05), and the difference between the \ngroups was not significant (P = .25). There were no significant \nimprovements for either group in sensory threshold (P≥.10) or \nnerve conduction (P≥.10). One participant reported skin ery­\nthema under the electrode which resolved in a few hours.14\nII\nIn a randomized, unblinded trial, Gökoğlu et al112 \ncompared a single 40-mg methyl prednisone ace­\ntate injection\nith 3 sessions of iontophoresis\nalysis was performed using all partici­\nlly randomized. Ultrasound parameters \nent groups were: 1 MHz frequency, 1.0 \ny cycle. Participants were treated for 15 \nweek for 2 weeks.",
    "chunk_id": 532,
    "sentence_start": 2112,
    "sentence_end": 2117,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Ultrasound parameters \nent groups were: 1 MHz frequency, 1.0 \ny cycle. Participants were treated for 15 \nweek for 2 weeks. Participants also wore \nlar wrist orthoses (0°-5° of wrist exten­\neeks. Outcomes were measured at 2 and \nd CTQ scales, pain VAS, and NCS. All \nll measures; however, the phonophore­\nent for the pain VAS (MD, –5.06) was \nan the other 2 groups (sham ultrasound \n2; pulsed ultrasound MD, –2.19; P = \nother statistically significant differences \nps.301 Authors reported there were no \nhe interventions. al266 compared 4 different interventions \nmoderate CTS. In this randomized, sin­\n(assessors) trial, 51 patients (84 hands) \nf 4 groups: local steroid injection (LSI \nd (0.1% betamethasone valerate cream) \ngroup), NSAID (diclofenac diethylam­\nhoresis (PNS group), or a volar, neutral \nphoresis was applied at 3 MHz, 1.5 W/\ndays per week for 3 weeks using a 5-cm2 \noses were worn full time for 15 days, and \natic for the remaining 6 days.",
    "chunk_id": 533,
    "sentence_start": 2116,
    "sentence_end": 2122,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "al266 compared 4 different interventions \nmoderate CTS. In this randomized, sin­\n(assessors) trial, 51 patients (84 hands) \nf 4 groups: local steroid injection (LSI \nd (0.1% betamethasone valerate cream) \ngroup), NSAID (diclofenac diethylam­\nhoresis (PNS group), or a volar, neutral \nphoresis was applied at 3 MHz, 1.5 W/\ndays per week for 3 weeks using a 5-cm2 \noses were worn full time for 15 days, and \natic for the remaining 6 days. Outcome \nt baseline and 3 months following treat­\ngnificant baseline differences for some \ntween the groups (Duruöz Hand Index, \nbut no baseline differences for grip \nrity, sensory threshold (SWMT), Phalen \nThe only statistically significant differ­\nwas for Tinel sign, favoring PCS group \nnt and posttreatment differences for the \ngnificant for Tinel’s (P≤003)\ngrip\n\n\n--- Page 47 ---\nCOLUMN 1:\nPhonophoresis Versus Iontophoresis\nII\nIn a single-blind, randomized trial, Bakhtiary et al31 \ncompared phonophoresis and iontophoresis in 34 \nindividuals (52 hands) diagnosed with mild to \nmoderate CTS who were randomized into 1 of 2 groups.",
    "chunk_id": 534,
    "sentence_start": 2121,
    "sentence_end": 2123,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In this randomized, sin­\n(assessors) trial, 51 patients (84 hands) \nf 4 groups: local steroid injection (LSI \nd (0.1% betamethasone valerate cream) \ngroup), NSAID (diclofenac diethylam­\nhoresis (PNS group), or a volar, neutral \nphoresis was applied at 3 MHz, 1.5 W/\ndays per week for 3 weeks using a 5-cm2 \noses were worn full time for 15 days, and \natic for the remaining 6 days. Outcome \nt baseline and 3 months following treat­\ngnificant baseline differences for some \ntween the groups (Duruöz Hand Index, \nbut no baseline differences for grip \nrity, sensory threshold (SWMT), Phalen \nThe only statistically significant differ­\nwas for Tinel sign, favoring PCS group \nnt and posttreatment differences for the \ngnificant for Tinel’s (P≤003)\ngrip\n\n\n--- Page 47 ---\nCOLUMN 1:\nPhonophoresis Versus Iontophoresis\nII\nIn a single-blind, randomized trial, Bakhtiary et al31 \ncompared phonophoresis and iontophoresis in 34 \nindividuals (52 hands) diagnosed with mild to \nmoderate CTS who were randomized into 1 of 2 groups. Each \ngroup was treated 5 times weekly for 2 weeks with 0.4% \ndexamethasone sodium phosphate.",
    "chunk_id": 535,
    "sentence_start": 2122,
    "sentence_end": 2124,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcome \nt baseline and 3 months following treat­\ngnificant baseline differences for some \ntween the groups (Duruöz Hand Index, \nbut no baseline differences for grip \nrity, sensory threshold (SWMT), Phalen \nThe only statistically significant differ­\nwas for Tinel sign, favoring PCS group \nnt and posttreatment differences for the \ngnificant for Tinel’s (P≤003)\ngrip\n\n\n--- Page 47 ---\nCOLUMN 1:\nPhonophoresis Versus Iontophoresis\nII\nIn a single-blind, randomized trial, Bakhtiary et al31 \ncompared phonophoresis and iontophoresis in 34 \nindividuals (52 hands) diagnosed with mild to \nmoderate CTS who were randomized into 1 of 2 groups. Each \ngroup was treated 5 times weekly for 2 weeks with 0.4% \ndexamethasone sodium phosphate. Phonophoresis was ap­\nplied at a frequency of 1 MHz, 1.0-W/cm2 intensity, and 25% \nduty cycle for 5 minutes. Iontophoresis was applied with the \nsteroid under the negative electrode at 2 mA-min for 20 min­\nutes (total dose, 40 mA-min).",
    "chunk_id": 536,
    "sentence_start": 2123,
    "sentence_end": 2126,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Phonophoresis was ap­\nplied at a frequency of 1 MHz, 1.0-W/cm2 intensity, and 25% \nduty cycle for 5 minutes. Iontophoresis was applied with the \nsteroid under the negative electrode at 2 mA-min for 20 min­\nutes (total dose, 40 mA-min). Outcome measures included \npain VAS, motor and sensory nerve latencies, action potential \namplitudes, pinch strength, and grip strength. At 2 weeks, \nboth groups improved in all parameters, but changes in the \nphonophoresis group were significantly larger than those in \nthe iontophoresis group (pain VAS MD, 2.1; 95% CI: 1.3, 2.9; \nP = .001; grip strength MD, 27.1 N; 95% CI: 13.5, 40.5; P = \n.006; pinch strength MD, 31.6 N; 95% CI: 15.9, 47.3; P = \n.0002; DML MD, 0.8; 95% CI: 0.5, 1.1; P = .0008; CMAP \nMD, 4.1; 95% CI: 3.0, 5.2; P = .0001; thumb DSL MD, 8.8; \n95% CI: 5.6, 12.1; P = .004; index DSL MD, 0.8; 95% CI: 0.5, \n1.1; P = .0001).",
    "chunk_id": 537,
    "sentence_start": 2125,
    "sentence_end": 2128,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcome measures included \npain VAS, motor and sensory nerve latencies, action potential \namplitudes, pinch strength, and grip strength. At 2 weeks, \nboth groups improved in all parameters, but changes in the \nphonophoresis group were significantly larger than those in \nthe iontophoresis group (pain VAS MD, 2.1; 95% CI: 1.3, 2.9; \nP = .001; grip strength MD, 27.1 N; 95% CI: 13.5, 40.5; P = \n.006; pinch strength MD, 31.6 N; 95% CI: 15.9, 47.3; P = \n.0002; DML MD, 0.8; 95% CI: 0.5, 1.1; P = .0008; CMAP \nMD, 4.1; 95% CI: 3.0, 5.2; P = .0001; thumb DSL MD, 8.8; \n95% CI: 5.6, 12.1; P = .004; index DSL MD, 0.8; 95% CI: 0.5, \n1.1; P = .0001). At 4 weeks, both groups demonstrated wors­\nening in all outcome measures except pain VAS in the ionto­\nphoresis group and DML and DSL in the phonophoresis \ngroup.",
    "chunk_id": 538,
    "sentence_start": 2127,
    "sentence_end": 2129,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "At 2 weeks, \nboth groups improved in all parameters, but changes in the \nphonophoresis group were significantly larger than those in \nthe iontophoresis group (pain VAS MD, 2.1; 95% CI: 1.3, 2.9; \nP = .001; grip strength MD, 27.1 N; 95% CI: 13.5, 40.5; P = \n.006; pinch strength MD, 31.6 N; 95% CI: 15.9, 47.3; P = \n.0002; DML MD, 0.8; 95% CI: 0.5, 1.1; P = .0008; CMAP \nMD, 4.1; 95% CI: 3.0, 5.2; P = .0001; thumb DSL MD, 8.8; \n95% CI: 5.6, 12.1; P = .004; index DSL MD, 0.8; 95% CI: 0.5, \n1.1; P = .0001). At 4 weeks, both groups demonstrated wors­\nening in all outcome measures except pain VAS in the ionto­\nphoresis group and DML and DSL in the phonophoresis \ngroup. Despite the declines, the phonophoresis improve­\nments remained significant for all outcome measures \n(P≤.032).31\nII\nIn a randomized, controlled, nonblinded study, \nGurcay et al121 compared phonophoresis (0.1% be­\ntamethasone; 1 MHz, 1.0 W/cm2, 10 minutes 3 \ntimes per week for 3 weeks, continuous mode) to iontopho­\nresis (0.1% betamethasone; 2 mA for 10 minutes; 3 days per \nweeks for 3 weeks) to a control group in individuals with mild \nto moderate CTS.",
    "chunk_id": 539,
    "sentence_start": 2128,
    "sentence_end": 2130,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "At 4 weeks, both groups demonstrated wors­\nening in all outcome measures except pain VAS in the ionto­\nphoresis group and DML and DSL in the phonophoresis \ngroup. Despite the declines, the phonophoresis improve­\nments remained significant for all outcome measures \n(P≤.032).31\nII\nIn a randomized, controlled, nonblinded study, \nGurcay et al121 compared phonophoresis (0.1% be­\ntamethasone; 1 MHz, 1.0 W/cm2, 10 minutes 3 \ntimes per week for 3 weeks, continuous mode) to iontopho­\nresis (0.1% betamethasone; 2 mA for 10 minutes; 3 days per \nweeks for 3 weeks) to a control group in individuals with mild \nto moderate CTS. All participants (n = 52) wore a night-time, \nvolar wrist orthosis for 3 weeks (custom; thermoplastic; neu­\ntral position). Outcome measures, including the CTQ-SSS, \ngrip strength, and dexterity measured by the nine-hole peg \ntest, were assessed at baseline and 3 months after treatment.",
    "chunk_id": 540,
    "sentence_start": 2129,
    "sentence_end": 2132,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All participants (n = 52) wore a night-time, \nvolar wrist orthosis for 3 weeks (custom; thermoplastic; neu­\ntral position). Outcome measures, including the CTQ-SSS, \ngrip strength, and dexterity measured by the nine-hole peg \ntest, were assessed at baseline and 3 months after treatment. Results were reported in bar graph and narrative form, and \nno baseline or outcome scores were provided. The CTQ-SSS \nscores improved in all groups (P≤.001). There was a statisti­\ncally significant difference between the change scores in the \nphonophoresis and control groups in favor of the phonopho­\nresis group (P = .012). There were no other significant differ­\nences between the groups.121 There was no report of adverse \neffects of the interventions.",
    "chunk_id": 541,
    "sentence_start": 2131,
    "sentence_end": 2136,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There was a statisti­\ncally significant difference between the change scores in the \nphonophoresis and control groups in favor of the phonopho­\nresis group (P = .012). There were no other significant differ­\nences between the groups.121 There was no report of adverse \neffects of the interventions. II\nIn another nonblinded randomized trial, Karatay et \nal142 compared a single 4 mg injection of dexameth­\nasone plus local anesthetic to 3\neeks (15 sessions)\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nsodium phosphate delivered at 1 MHz, 1.0 W/cm2, 25% duty \ncycle) in patients with CTS. Forty-five individuals (90 hands) \nwith early, mild, bilateral CTS were randomly assigned to 1 \nof the 3 groups.",
    "chunk_id": 542,
    "sentence_start": 2135,
    "sentence_end": 2143,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nsodium phosphate delivered at 1 MHz, 1.0 W/cm2, 25% duty \ncycle) in patients with CTS. Forty-five individuals (90 hands) \nwith early, mild, bilateral CTS were randomly assigned to 1 \nof the 3 groups. Outcome measures (night pain VAS, CTQ-\nSSS, CTQ-FS, DML, and DSL) were measured at 1 and 6 \nmonths after the start of the study. At 1 month, there were \nsignificant improvements in clinical and electrophysiological \nparameters for the injection and phonophoresis groups \n(P<.001). In the iontophoresis group, there were significant \nchanges for the clinical parameters only (P<.001). At 6 \nmonths, the injection group outcomes remained significantly \nimproved on all parameters (P<.01), the phonophoresis \ngroup remained significantly improved in clinical parameters \nonly (P<.001), and the iontophoresis group did not demon­\nstrate significant improvement over baseline for any param­\neter.",
    "chunk_id": 543,
    "sentence_start": 2142,
    "sentence_end": 2147,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In the iontophoresis group, there were significant \nchanges for the clinical parameters only (P<.001). At 6 \nmonths, the injection group outcomes remained significantly \nimproved on all parameters (P<.01), the phonophoresis \ngroup remained significantly improved in clinical parameters \nonly (P<.001), and the iontophoresis group did not demon­\nstrate significant improvement over baseline for any param­\neter. The injection group outcomes were significantly better \nthan the iontophoresis group for night pain at 6 months (P = \n.020), CTQ-SSS at 1 (P = .031) and 6 months (P = .003), \nCTQ-FS at 6 months (P = .011) and DSL at 1 month (P = \n.036). The injection group outcomes were better than the \nphonophoresis group for night pain at 6 months (P = .022) \nand CTQ-SSS at 6 months (P = .030) but the injection and \nphonophoresis were similar on all other outcome measures.",
    "chunk_id": 544,
    "sentence_start": 2146,
    "sentence_end": 2149,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The injection group outcomes were significantly better \nthan the iontophoresis group for night pain at 6 months (P = \n.020), CTQ-SSS at 1 (P = .031) and 6 months (P = .003), \nCTQ-FS at 6 months (P = .011) and DSL at 1 month (P = \n.036). The injection group outcomes were better than the \nphonophoresis group for night pain at 6 months (P = .022) \nand CTQ-SSS at 6 months (P = .030) but the injection and \nphonophoresis were similar on all other outcome measures. Authors concluded that injection or steroid phonophoresis \ncould be used in the management of CTS.142 Authors did not \nreport between-group differences for iontophoresis versus \nphonophoresis. Evidence Synthesis and Clinical Rationale\nWhile there is evidence that iontophoresis with 0.4% dexa­\nmethasone sodium phosphate resulted in a positive effect on \nself-reported outcomes, distilled-water iontophoresis pro­\nduced similar results, suggesting the active agent could be the \nelectrical stimulation.",
    "chunk_id": 545,
    "sentence_start": 2148,
    "sentence_end": 2151,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Authors concluded that injection or steroid phonophoresis \ncould be used in the management of CTS.142 Authors did not \nreport between-group differences for iontophoresis versus \nphonophoresis. Evidence Synthesis and Clinical Rationale\nWhile there is evidence that iontophoresis with 0.4% dexa­\nmethasone sodium phosphate resulted in a positive effect on \nself-reported outcomes, distilled-water iontophoresis pro­\nduced similar results, suggesting the active agent could be the \nelectrical stimulation. Steroid and nonsteroid phonophoresis \ndemonstrated positive effects in the short term for individu­\nals with mild or moderate severity CTS.",
    "chunk_id": 546,
    "sentence_start": 2150,
    "sentence_end": 2152,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Evidence Synthesis and Clinical Rationale\nWhile there is evidence that iontophoresis with 0.4% dexa­\nmethasone sodium phosphate resulted in a positive effect on \nself-reported outcomes, distilled-water iontophoresis pro­\nduced similar results, suggesting the active agent could be the \nelectrical stimulation. Steroid and nonsteroid phonophoresis \ndemonstrated positive effects in the short term for individu­\nals with mild or moderate severity CTS. There is evidence \ndemonstrating improvement for short term pain relief, clini­\ncal signs, weakness, functional deficits, sensory deficits and \nnerve cross-sectional area.121,266,267,301 Changes in NCS were \nconflicting.142,266,267 No study included a control group, and \nthe magnitude of improvement due to the treatment com­\npared to the natural course of CTS could not be determined. Two of the 3 studies combined phonophoresis or iontopho­\nresis with an orthosis masking the magnitude of the effect of \nthe drug administration alone.",
    "chunk_id": 547,
    "sentence_start": 2151,
    "sentence_end": 2154,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There is evidence \ndemonstrating improvement for short term pain relief, clini­\ncal signs, weakness, functional deficits, sensory deficits and \nnerve cross-sectional area.121,266,267,301 Changes in NCS were \nconflicting.142,266,267 No study included a control group, and \nthe magnitude of improvement due to the treatment com­\npared to the natural course of CTS could not be determined. Two of the 3 studies combined phonophoresis or iontopho­\nresis with an orthosis masking the magnitude of the effect of \nthe drug administration alone. For patients considering the \nuse of anti-inflammatory medications, a local steroid injec­\ntion combined with a neutral wrist orthosis may be more cost \neffective and efficient. Iontophoresis\nblind, randomized trial, Bakhtiary et al31 \nphonophoresis and iontophoresis in 34 \n(52 hands) diagnosed with mild to \nere randomized into 1 of 2 groups. Each \ntimes weekly for 2 weeks with 0.4% \num phosphate.",
    "chunk_id": 548,
    "sentence_start": 2153,
    "sentence_end": 2157,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Iontophoresis\nblind, randomized trial, Bakhtiary et al31 \nphonophoresis and iontophoresis in 34 \n(52 hands) diagnosed with mild to \nere randomized into 1 of 2 groups. Each \ntimes weekly for 2 weeks with 0.4% \num phosphate. Phonophoresis was ap­\nf 1 MHz, 1.0-W/cm2 intensity, and 25% \ntes. Iontophoresis was applied with the \native electrode at 2 mA-min for 20 min­\nmA-min). Outcome measures included \nsensory nerve latencies, action potential \nrength, and grip strength.",
    "chunk_id": 549,
    "sentence_start": 2156,
    "sentence_end": 2160,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Iontophoresis was applied with the \native electrode at 2 mA-min for 20 min­\nmA-min). Outcome measures included \nsensory nerve latencies, action potential \nrength, and grip strength. At 2 weeks, \nd in all parameters, but changes in the \n were significantly larger than those in \nup (pain VAS MD, 2.1; 95% CI: 1.3, 2.9; \nth MD, 27.1 N; 95% CI: 13.5, 40.5; P = \nMD, 31.6 N; 95% CI: 15.9, 47.3; P = \n8; 95% CI: 0.5, 1.1; P = .0008; CMAP \n0, 5.2; P = .0001; thumb DSL MD, 8.8; \n.004; index DSL MD, 0.8; 95% CI: 0.5, \nweeks, both groups demonstrated wors­\nmeasures except pain VAS in the ionto­\nDML and DSL in the phonophoresis \ndeclines, the phonophoresis improve­\ngnificant for all outcome measures \nmized, controlled, nonblinded study, \nl121 compared phonophoresis (0.1% be­\nne; 1 MHz, 1.0 W/cm2, 10 minutes 3 \nweeks, continuous mode) to iontopho­\nasone; 2 mA for 10 minutes; 3 days per \na control group in individuals with mild \nparticipants (n = 52) wore a night-time, \nr 3 weeks (custom; thermoplastic; neu­\nme measures, including the CTQ-SSS, \nexterity measured by the nine-hole peg \nbaseline and 3 months after treatment.",
    "chunk_id": 550,
    "sentence_start": 2159,
    "sentence_end": 2161,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcome measures included \nsensory nerve latencies, action potential \nrength, and grip strength. At 2 weeks, \nd in all parameters, but changes in the \n were significantly larger than those in \nup (pain VAS MD, 2.1; 95% CI: 1.3, 2.9; \nth MD, 27.1 N; 95% CI: 13.5, 40.5; P = \nMD, 31.6 N; 95% CI: 15.9, 47.3; P = \n8; 95% CI: 0.5, 1.1; P = .0008; CMAP \n0, 5.2; P = .0001; thumb DSL MD, 8.8; \n.004; index DSL MD, 0.8; 95% CI: 0.5, \nweeks, both groups demonstrated wors­\nmeasures except pain VAS in the ionto­\nDML and DSL in the phonophoresis \ndeclines, the phonophoresis improve­\ngnificant for all outcome measures \nmized, controlled, nonblinded study, \nl121 compared phonophoresis (0.1% be­\nne; 1 MHz, 1.0 W/cm2, 10 minutes 3 \nweeks, continuous mode) to iontopho­\nasone; 2 mA for 10 minutes; 3 days per \na control group in individuals with mild \nparticipants (n = 52) wore a night-time, \nr 3 weeks (custom; thermoplastic; neu­\nme measures, including the CTQ-SSS, \nexterity measured by the nine-hole peg \nbaseline and 3 months after treatment. d in bar graph and narrative form, and \nme scores were provided.",
    "chunk_id": 551,
    "sentence_start": 2160,
    "sentence_end": 2162,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "At 2 weeks, \nd in all parameters, but changes in the \n were significantly larger than those in \nup (pain VAS MD, 2.1; 95% CI: 1.3, 2.9; \nth MD, 27.1 N; 95% CI: 13.5, 40.5; P = \nMD, 31.6 N; 95% CI: 15.9, 47.3; P = \n8; 95% CI: 0.5, 1.1; P = .0008; CMAP \n0, 5.2; P = .0001; thumb DSL MD, 8.8; \n.004; index DSL MD, 0.8; 95% CI: 0.5, \nweeks, both groups demonstrated wors­\nmeasures except pain VAS in the ionto­\nDML and DSL in the phonophoresis \ndeclines, the phonophoresis improve­\ngnificant for all outcome measures \nmized, controlled, nonblinded study, \nl121 compared phonophoresis (0.1% be­\nne; 1 MHz, 1.0 W/cm2, 10 minutes 3 \nweeks, continuous mode) to iontopho­\nasone; 2 mA for 10 minutes; 3 days per \na control group in individuals with mild \nparticipants (n = 52) wore a night-time, \nr 3 weeks (custom; thermoplastic; neu­\nme measures, including the CTQ-SSS, \nexterity measured by the nine-hole peg \nbaseline and 3 months after treatment. d in bar graph and narrative form, and \nme scores were provided. The CTQ-SSS \nl groups (P≤.001).",
    "chunk_id": 552,
    "sentence_start": 2161,
    "sentence_end": 2163,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "d in bar graph and narrative form, and \nme scores were provided. The CTQ-SSS \nl groups (P≤.001). There was a statisti­\nrence between the change scores in the \nontrol groups in favor of the phonopho­\n. There were no other significant differ­\noups.121 There was no report of adverse \nntions. --- Page 48 ---\nCOLUMN 1:\nsodium phosphate or diphosphate, while the phonophoresis \nstudies used a variety of steroid and nonsteroid active drugs. No evidence was presented for the choice of drug or concen­\ntration or for treatment variables including dosage, frequen­\ncy, and treatment duration. Well-designed trials with control \ngroups and appropriate outcome measures are needed. Recommendations\nB\nClinicians should not use iontophoresis in the man­\nagement of mild to moderate CTS. C\nClinicians may perform phonophoresis within non­\nsurgical management of patients with mild to mod­\nerate CTS for the treatment of clinical signs and \nsymptoms but should consider other interventions.",
    "chunk_id": 553,
    "sentence_start": 2162,
    "sentence_end": 2170,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Recommendations\nB\nClinicians should not use iontophoresis in the man­\nagement of mild to moderate CTS. C\nClinicians may perform phonophoresis within non­\nsurgical management of patients with mild to mod­\nerate CTS for the treatment of clinical signs and \nsymptoms but should consider other interventions. Athermal Agents\nMagnet Therapy\nII\nThere were 2 studies comparing the effects of mag­\nnet therapy with a placebo in individuals with CTS. In a randomized, double-blind, placebo-controlled \ntrial, Carter et al54 studied 30 individuals with CTS (all se­\nverities) who wore a 1000 gauss magnet or placebo magnet \nstrapped to their wrist for 45 minutes. Outcomes were mea­\nsured at 15-minute intervals during treatment and 2 weeks \npost treatment. At the end of treatment, both groups report­\ned significant pain reduction (MD for both groups, –2.4) as \nmeasured by an 11-point VAS with no statistical difference in \nimprovement between groups.",
    "chunk_id": 554,
    "sentence_start": 2169,
    "sentence_end": 2174,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcomes were mea­\nsured at 15-minute intervals during treatment and 2 weeks \npost treatment. At the end of treatment, both groups report­\ned significant pain reduction (MD for both groups, –2.4) as \nmeasured by an 11-point VAS with no statistical difference in \nimprovement between groups. At 2 weeks post treatment, \nmean pain was identical for both (4.3/10), and remained be­\nlow baseline levels. In a randomized, controlled, double-\nblinded study of 60 individuals with CTS of all severity levels, \nColbert et al71 compared 2 static magnetic field strengths (15 \nand 45 mT) with a sham magnet applied over the carpal tun­\nnel nightly for 6 weeks. At 6 and 18 weeks, all groups demon­\nstrated statistically significant improvements in CTQ scales, \nbut there were no differences between the groups (P≥.463). In summary, neither of these studies showed any benefits of \nusing magnet therapy over sham.",
    "chunk_id": 555,
    "sentence_start": 2173,
    "sentence_end": 2178,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "At 6 and 18 weeks, all groups demon­\nstrated statistically significant improvements in CTQ scales, \nbut there were no differences between the groups (P≥.463). In summary, neither of these studies showed any benefits of \nusing magnet therapy over sham. Adverse effects included \npain under the 45-mT magnet (n = 1) which resolved in 2 \ndays, and skin rash under the adhesive (n = 2) used to secure \nthe magnets which also resolved with topical ointment. Recommendation\nB\nClinicians should not use or recommend the use of \nmagnets in the intervention for individuals with \nCTS. MANUAL THERAPY TECHNIQUES\nII\nA variety of different exercise and manual therapy \ninterventions have been studied as potential non­\nsurgical treatment for CTS A Cochrane re ie\nas\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®.",
    "chunk_id": 556,
    "sentence_start": 2177,
    "sentence_end": 2184,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\npublished in 2012 based on 16 Level II studies evaluating the \neffects of exercise and mobilization interventions for CTS.222 \nIncluded studies were randomized or quasi-randomized \nstudies comparing the exercise or mobilization interventions \nto a control group, placebo, or other nonsurgical interven­\ntion. Interventions included were carpal bone mobilization, \nyoga, tendon and nerve gliding exercises, neurodynamic mo­\nbilization, instrument-assisted soft tissue massage, and stan­\ndard soft tissue massage. Exercise and manual interventions \nwere delivered as components of single or multi-intervention \ntreatments, and they were compared to one or more other \nnonsurgical interventions including orthotic devices, steroid \ninjections, or other physical agents.",
    "chunk_id": 557,
    "sentence_start": 2183,
    "sentence_end": 2188,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Interventions included were carpal bone mobilization, \nyoga, tendon and nerve gliding exercises, neurodynamic mo­\nbilization, instrument-assisted soft tissue massage, and stan­\ndard soft tissue massage. Exercise and manual interventions \nwere delivered as components of single or multi-intervention \ntreatments, and they were compared to one or more other \nnonsurgical interventions including orthotic devices, steroid \ninjections, or other physical agents. Authors of the review \nconsistently found bias, lack of blinding, small between group \ndifferences, and CIs including effects in both directions. The \nuse of multiple interventions precluded identifying the effect \nof a specific intervention.",
    "chunk_id": 558,
    "sentence_start": 2187,
    "sentence_end": 2190,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Authors of the review \nconsistently found bias, lack of blinding, small between group \ndifferences, and CIs including effects in both directions. The \nuse of multiple interventions precluded identifying the effect \nof a specific intervention. Authors of the review concluded \nthere was limited and very low-quality evidence of any ben­\nefit for exercise and mobilization interventions for CTS and \nthere is a need for higher-quality studies to investigate the \nlong-term effects of these interventions compared to \northoses.222\nThe remainder of this summary includes studies published \nsince the Cochrane review. Neural Tissue Mobilization\nII\nIn a systematic review of randomized clinical tri­\nals, Basson et al34 investigated the use of neurody­\nnamic mobilization for the treatment of \nneuromusculoskeletal conditions, including CTS.",
    "chunk_id": 559,
    "sentence_start": 2189,
    "sentence_end": 2192,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Authors of the review concluded \nthere was limited and very low-quality evidence of any ben­\nefit for exercise and mobilization interventions for CTS and \nthere is a need for higher-quality studies to investigate the \nlong-term effects of these interventions compared to \northoses.222\nThe remainder of this summary includes studies published \nsince the Cochrane review. Neural Tissue Mobilization\nII\nIn a systematic review of randomized clinical tri­\nals, Basson et al34 investigated the use of neurody­\nnamic mobilization for the treatment of \nneuromusculoskeletal conditions, including CTS. The au­\nthors analyzed 12 papers evaluating the effect of neural mo­\nbilization in individuals with CTS, only 3214,252,295 of which \nwere published after the Cochrane review222 described \nabove. Meta-analysis was performed on patient-reported \noutcome measures including pain VAS (WMD, –0.22; 95% \nCI: –0.74, 0.30) and the DASH questionnaire (WMD, –1.55; \n95% CI: –7.84, 4.75).",
    "chunk_id": 560,
    "sentence_start": 2191,
    "sentence_end": 2194,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The au­\nthors analyzed 12 papers evaluating the effect of neural mo­\nbilization in individuals with CTS, only 3214,252,295 of which \nwere published after the Cochrane review222 described \nabove. Meta-analysis was performed on patient-reported \noutcome measures including pain VAS (WMD, –0.22; 95% \nCI: –0.74, 0.30) and the DASH questionnaire (WMD, –1.55; \n95% CI: –7.84, 4.75). Clinical outcome measures included \ntimed Phalen’s test (relative effect, 0.81; 95% CI: 0.87, 1.86), \ngrip strength (relative effect, 1.18; 95% CI: –1.29, 3.66), and \n2PD (relative effect, 0.36; 95% CI: –0.8, 0.08). Basson et \nal34 found high or uncertain risk of bias in 7 of the 12 stud­\nies, and no statistically significant effects (small ESs and \nlarge CIs, reflecting bidirectional effects). Authors conclud­\ned the evidence was insufficient to support the effectiveness \nof neural mobilization for improving clinical outcomes in \npatients with CTS.",
    "chunk_id": 561,
    "sentence_start": 2193,
    "sentence_end": 2197,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Basson et \nal34 found high or uncertain risk of bias in 7 of the 12 stud­\nies, and no statistically significant effects (small ESs and \nlarge CIs, reflecting bidirectional effects). Authors conclud­\ned the evidence was insufficient to support the effectiveness \nof neural mobilization for improving clinical outcomes in \npatients with CTS. II\nWolny and Linek293 studied the effects of neurody­\nnamic techniques (provided twice weekly for 10 \neeks)\nersus no treatment in indi iduals\nith\ndiphosphate, while the phonophoresis \nof steroid and nonsteroid active drugs. ented for the choice of drug or concen­\nnt variables including dosage, frequen­\nation. Well-designed trials with control \nate outcome measures are needed. hould not use iontophoresis in the man­\nmild to moderate CTS. may perform phonophoresis within non­\nnagement of patients with mild to mod­\nor the treatment of clinical signs and \nd consider other interventions.",
    "chunk_id": 562,
    "sentence_start": 2196,
    "sentence_end": 2202,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "hould not use iontophoresis in the man­\nmild to moderate CTS. may perform phonophoresis within non­\nnagement of patients with mild to mod­\nor the treatment of clinical signs and \nd consider other interventions. 2 studies comparing the effects of mag­\nwith a placebo in individuals with CTS. mized, double-blind, placebo-controlled \nudied 30 individuals with CTS (all se­\n1000 gauss magnet or placebo magnet \nst for 45 minutes. Outcomes were mea­\nntervals during treatment and 2 weeks \ne end of treatment, both groups report­\nduction (MD for both groups, –2.4) as \nint VAS with no statistical difference in \nen groups. At 2 weeks post treatment, \ncal for both (4.3/10), and remained be­\nIn a randomized, controlled, double-\nndividuals with CTS of all severity levels, \nred 2 static magnetic field strengths (15 \nam magnet applied over the carpal tun­\ns. At 6 and 18 weeks, all groups demon­\ngnificant improvements in CTQ scales, \nfferences between the groups (P≥.463).",
    "chunk_id": 563,
    "sentence_start": 2201,
    "sentence_end": 2207,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "At 2 weeks post treatment, \ncal for both (4.3/10), and remained be­\nIn a randomized, controlled, double-\nndividuals with CTS of all severity levels, \nred 2 static magnetic field strengths (15 \nam magnet applied over the carpal tun­\ns. At 6 and 18 weeks, all groups demon­\ngnificant improvements in CTQ scales, \nfferences between the groups (P≥.463). of these studies showed any benefits of \ny over sham. Adverse effects included \nmT magnet (n = 1) which resolved in 2 \nnder the adhesive (n = 2) used to secure \nso resolved with topical ointment. hould not use or recommend the use of \nthe intervention for individuals with \nTECHNIQUES\n different e ercise and manual therap\n\n\n--- Page 49 ---\nCOLUMN 1:\nrating scale (NPRS), grip and pinch strength, the CTQ-SSS \nand CTQ-FS. Measurements were taken at baseline and 10 \nweeks.",
    "chunk_id": 564,
    "sentence_start": 2206,
    "sentence_end": 2211,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "hould not use or recommend the use of \nthe intervention for individuals with \nTECHNIQUES\n different e ercise and manual therap\n\n\n--- Page 49 ---\nCOLUMN 1:\nrating scale (NPRS), grip and pinch strength, the CTQ-SSS \nand CTQ-FS. Measurements were taken at baseline and 10 \nweeks. Authors reported statistically significant differences \nbetween the treatment and control groups in SNCV (MD, \n12.4; 95% CI: 9.1, 15.6), DML (MD, 0.92; 95% CI: 0.58, \n1.23), NPRS (MD, 4.08; 95% CI: 3.73, 4.43), CTQ-SSS (MD, \n1.79; 95% CI: 0.91, 1.31), and CTQ-FS (MD, 0.91; 95% CI: \n0.78, 1.24) in favor of the neurodynamic techniques.",
    "chunk_id": 565,
    "sentence_start": 2210,
    "sentence_end": 2212,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Measurements were taken at baseline and 10 \nweeks. Authors reported statistically significant differences \nbetween the treatment and control groups in SNCV (MD, \n12.4; 95% CI: 9.1, 15.6), DML (MD, 0.92; 95% CI: 0.58, \n1.23), NPRS (MD, 4.08; 95% CI: 3.73, 4.43), CTQ-SSS (MD, \n1.79; 95% CI: 0.91, 1.31), and CTQ-FS (MD, 0.91; 95% CI: \n0.78, 1.24) in favor of the neurodynamic techniques. The \nsame authors found similar results in another randomized \nstudy comparing the effects of neurodynamic treatment to a \nsham nerve gliding technique (n = 150).294 Differences be­\ntween groups were as follows: SNCV (MD, 14.7; 95% CI: \n10.5, 15.9), 2PD (long finger) (MD, 2.38; 95% CI: 2.09, 2.65), \nDML (MD, 0.90; 95% CI: 0.63, 1.15), NPRS (MD, 4.0; 95% \nCI: 3.71, 4.28), CTQ-SSS (MD, 1.09; 95% CI: 0.93, 1.27), and \nCTQ-FS (MD, 1.15; 95% CI: 0.91, 1.27). Adverse effects were \nnot reported.",
    "chunk_id": 566,
    "sentence_start": 2211,
    "sentence_end": 2214,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The \nsame authors found similar results in another randomized \nstudy comparing the effects of neurodynamic treatment to a \nsham nerve gliding technique (n = 150).294 Differences be­\ntween groups were as follows: SNCV (MD, 14.7; 95% CI: \n10.5, 15.9), 2PD (long finger) (MD, 2.38; 95% CI: 2.09, 2.65), \nDML (MD, 0.90; 95% CI: 0.63, 1.15), NPRS (MD, 4.0; 95% \nCI: 3.71, 4.28), CTQ-SSS (MD, 1.09; 95% CI: 0.93, 1.27), and \nCTQ-FS (MD, 1.15; 95% CI: 0.91, 1.27). Adverse effects were \nnot reported. Manual Therapy\nII\nMaddali Bongi et al175 investigated the effect of bi­\nweekly manual therapy on 22 participants (41 \nhands) with CTS of all severity levels using a re­\npeated-measures, crossover design. In the initial phase, 9 \nparticipants (16 hands) were tested on all outcome measures \nand followed without intervention for 12 weeks and then re­\nassessed.",
    "chunk_id": 567,
    "sentence_start": 2213,
    "sentence_end": 2216,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Manual Therapy\nII\nMaddali Bongi et al175 investigated the effect of bi­\nweekly manual therapy on 22 participants (41 \nhands) with CTS of all severity levels using a re­\npeated-measures, crossover design. In the initial phase, 9 \nparticipants (16 hands) were tested on all outcome measures \nand followed without intervention for 12 weeks and then re­\nassessed. Outcome measures included CTQ-SSS, CTQ-FS, \nsensory NCV, DML, severity and clinical signs including \npresence of pain, night waking frequency, hypoesthesia, \nstrength, Phalen test time, hand sensitivity, and thenar mus­\ncle atrophy. There were no significant differences on any out­\ncome measures in this phase, except the number of hands \nwith a positive Phalen test increased from 6 to 11 (P = .0041). While 16 hands were in the control group, data were only \nprovided on 14 hands.",
    "chunk_id": 568,
    "sentence_start": 2215,
    "sentence_end": 2219,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "There were no significant differences on any out­\ncome measures in this phase, except the number of hands \nwith a positive Phalen test increased from 6 to 11 (P = .0041). While 16 hands were in the control group, data were only \nprovided on 14 hands. Participants then entered the treat­\nment phase and received two, 45-minute sessions of educa­\ntion including activity modifications for performing work \nand home tasks followed by manual therapy sessions twice \nper week for 3 weeks. Manual therapy techniques included \nsoft tissue and wrist joint mobilization performed by the \nsame provider. Outcome measures were assessed at 3 and 24 \nweeks following the initial treatment. For both data collec­\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 569,
    "sentence_start": 2218,
    "sentence_end": 2227,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nManual Therapy Versus Surgery\nII\nFernández-de-las-Peñas et al93 compared manual \ntherapy interventions to carpal tunnel decompres­\nsion surgery in 94 women diagnosed with CTS in a \nrandomized, single-blinded trial. Manual therapy and cervical \nmuscle stretches were performed during 30-minute sessions \nonce per week for 3 weeks. Surgical decompression was either \nopen or endoscopic, depending on patient and surgeon prefer­\nence. Individuals treated with surgery received an educational \nsession for performing the cervical muscle stretches. Outcome \nmeasures included the CTQ-FS, the CTQ-SSS, cervical range \nof motion, and tip pinch strength (thumb to index and thumb \nto small fingers). Outcomes were measured at 0, 1, 3, 6, and 12 \nmonths post intervention.",
    "chunk_id": 570,
    "sentence_start": 2226,
    "sentence_end": 2233,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcome \nmeasures included the CTQ-FS, the CTQ-SSS, cervical range \nof motion, and tip pinch strength (thumb to index and thumb \nto small fingers). Outcomes were measured at 0, 1, 3, 6, and 12 \nmonths post intervention. The authors reported statistically \nsignificant differences between groups on the CTQ-FS (MD, \n0.6; 95% CI: 0.45, 0.75), thumb-to-index pinch strength (MD, \n2.2; 95% CI: 1.8, 2.6), and thumb-to-little pinch strength (MD, \n0.8; 95% CI: 0.5, 1.1) at 1 month favoring manual therapy. The \nESs for these differences were large (1.6 and 1.1). Otherwise, \nboth groups showed similar improvements on all variables at \nall data collection time points. Authors reported there were no \nadverse effects or postoperative complications.93\nII\nFernández-de-las-Peñas et al94 compared manual \ntherapy interventions to carpal tunnel decompres­\nsion surgery in 111 women diagnosed with CTS in a \nrandomized, single-blinded trial.",
    "chunk_id": 571,
    "sentence_start": 2232,
    "sentence_end": 2237,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Otherwise, \nboth groups showed similar improvements on all variables at \nall data collection time points. Authors reported there were no \nadverse effects or postoperative complications.93\nII\nFernández-de-las-Peñas et al94 compared manual \ntherapy interventions to carpal tunnel decompres­\nsion surgery in 111 women diagnosed with CTS in a \nrandomized, single-blinded trial. Manual therapy was per­\nformed for 30 minutes, once per week for 3 weeks. Treatment \nvaried based on clinical findings and provider judgement, and \ncould include vertebral glides, soft tissue and neural mobiliza­\ntion, and tendon gliding. Surgical decompression was either \nopen or endoscopic, depending on patient and surgeon prefer­\nence. Outcome measures were average pain, worst pain NPRS, \nCTQ-SSS, CTQ-FS, and global rating of change (GROC) and \nwere measured at 0, 1, 3, 6, and 12 months post intervention.",
    "chunk_id": 572,
    "sentence_start": 2236,
    "sentence_end": 2241,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Surgical decompression was either \nopen or endoscopic, depending on patient and surgeon prefer­\nence. Outcome measures were average pain, worst pain NPRS, \nCTQ-SSS, CTQ-FS, and global rating of change (GROC) and \nwere measured at 0, 1, 3, 6, and 12 months post intervention. At 1 and 3 months post treatment, the manual therapy group \nreported greater pain reduction (MD, –3.4 versus –1.5 and \nMD, –3.7 versus –2.4, respectively), with a large ES favoring \nmanual therapy (1.1 greater than standardized MD greater \nthan 1.8). CTQ-FS scores at 1 month and 3 months also favored \nthe manual therapy group, with standardized MD of 1.2 (large \nES) and 0.8 (medium ES), respectively. No significant differ­\nences between groups were found at any point for the CTQ-\nSSS or at 6 or 12 months for pain or the CTQ-FS. Reported ESs \nfor groups pretreatment and posttreatment were large for both \ngroups (standardized MD greater than 1.3).",
    "chunk_id": 573,
    "sentence_start": 2240,
    "sentence_end": 2245,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "No significant differ­\nences between groups were found at any point for the CTQ-\nSSS or at 6 or 12 months for pain or the CTQ-FS. Reported ESs \nfor groups pretreatment and posttreatment were large for both \ngroups (standardized MD greater than 1.3). GROC was similar \nfor both groups at 6 (P = .663) and 12 months (P = .169). Au­\nthors reported there were no clinically important adverse \nevents or surgical complications.94\ngrip and pinch strength, the CTQ-SSS \nrements were taken at baseline and 10 \nrted statistically significant differences \nnt and control groups in SNCV (MD, \n5.6), DML (MD, 0.92; 95% CI: 0.58, \n08; 95% CI: 3.73, 4.43), CTQ-SSS (MD, \n.31), and CTQ-FS (MD, 0.91; 95% CI: \nof the neurodynamic techniques.",
    "chunk_id": 574,
    "sentence_start": 2244,
    "sentence_end": 2247,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "GROC was similar \nfor both groups at 6 (P = .663) and 12 months (P = .169). Au­\nthors reported there were no clinically important adverse \nevents or surgical complications.94\ngrip and pinch strength, the CTQ-SSS \nrements were taken at baseline and 10 \nrted statistically significant differences \nnt and control groups in SNCV (MD, \n5.6), DML (MD, 0.92; 95% CI: 0.58, \n08; 95% CI: 3.73, 4.43), CTQ-SSS (MD, \n.31), and CTQ-FS (MD, 0.91; 95% CI: \nof the neurodynamic techniques. The \nsimilar results in another randomized \neffects of neurodynamic treatment to a \nechnique (n = 150).294 Differences be­\nas follows: SNCV (MD, 14.7; 95% CI: \nfinger) (MD, 2.38; 95% CI: 2.09, 2.65), \n% CI: 0.63, 1.15), NPRS (MD, 4.0; 95% \nSSS (MD, 1.09; 95% CI: 0.93, 1.27), and \n5% CI: 0.91, 1.27). Adverse effects were \nngi et al175 investigated the effect of bi­\nnual therapy on 22 participants (41 \nh CTS of all severity levels using a re­\nossover design.",
    "chunk_id": 575,
    "sentence_start": 2246,
    "sentence_end": 2249,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The \nsimilar results in another randomized \neffects of neurodynamic treatment to a \nechnique (n = 150).294 Differences be­\nas follows: SNCV (MD, 14.7; 95% CI: \nfinger) (MD, 2.38; 95% CI: 2.09, 2.65), \n% CI: 0.63, 1.15), NPRS (MD, 4.0; 95% \nSSS (MD, 1.09; 95% CI: 0.93, 1.27), and \n5% CI: 0.91, 1.27). Adverse effects were \nngi et al175 investigated the effect of bi­\nnual therapy on 22 participants (41 \nh CTS of all severity levels using a re­\nossover design. In the initial phase, 9 \ns) were tested on all outcome measures \nintervention for 12 weeks and then re­\nmeasures included CTQ-SSS, CTQ-FS, \nseverity and clinical signs including \night waking frequency, hypoesthesia, \ntime, hand sensitivity, and thenar mus­\nre no significant differences on any out­\nhis phase, except the number of hands \nn test increased from 6 to 11 (P = .0041). e in the control group, data were only \ns.",
    "chunk_id": 576,
    "sentence_start": 2248,
    "sentence_end": 2251,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "In the initial phase, 9 \ns) were tested on all outcome measures \nintervention for 12 weeks and then re­\nmeasures included CTQ-SSS, CTQ-FS, \nseverity and clinical signs including \night waking frequency, hypoesthesia, \ntime, hand sensitivity, and thenar mus­\nre no significant differences on any out­\nhis phase, except the number of hands \nn test increased from 6 to 11 (P = .0041). e in the control group, data were only \ns. Participants then entered the treat­\nived two, 45-minute sessions of educa­\nty modifications for performing work \nwed by manual therapy sessions twice \ns. Manual therapy techniques included \n joint mobilization performed by the \nme measures were assessed at 3 and 24 \ninitial treatment. For both data collec­\nSS scores improved (3-week MD, –8.14 \n4.49; P<.05). The CTQ-FS scores also \nMD, –3.78 and 24-week MD, –3.12; \nno differences in nerve conduction or \nks.",
    "chunk_id": 577,
    "sentence_start": 2250,
    "sentence_end": 2255,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "For both data collec­\nSS scores improved (3-week MD, –8.14 \n4.49; P<.05). The CTQ-FS scores also \nMD, –3.78 and 24-week MD, –3.12; \nno differences in nerve conduction or \nks. Reports of paresthesia, pain, night \nnsitivity improved significantly (P<.05) \nweeks, some scores worsened yet re­\ner the baseline scores; however, no sta­\n\n\n--- Page 50 ---\nCOLUMN 1:\nis limited by potential for bias, lack of control groups, and \nnonuniformity in examination and intervention techniques, \nsometimes within the same study. Early advantages of man­\nual therapy compared to surgical intervention are most likely \ndue to postoperative healing, leading to greater short-term \npain and dysfunction in surgically managed individuals. The \ndecision to use manual therapy should be based on patient \npreference and therapist experience. Clinicians must discon­\ntinue any manual therapy intervention if symptoms increase \nor do not improve.",
    "chunk_id": 578,
    "sentence_start": 2254,
    "sentence_end": 2259,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The \ndecision to use manual therapy should be based on patient \npreference and therapist experience. Clinicians must discon­\ntinue any manual therapy intervention if symptoms increase \nor do not improve. While no adverse effects were reported \nfrom either surgery or a variety of manual therapies in these \nstudies, surgical complications have been reported elsewhere \nin this guideline. Gaps in Knowledge\nThere is a need for high-quality randomized controlled stud­\nies using valid, condition-appropriate outcome measures \ncomparing specific, reproducible, manual therapy interven­\ntions to identify the most effective techniques and the ap­\npropriate dosage. Use of control groups, blinded assessors, \nuniform interventions, and evaluation of long-term outcomes \nare needed.",
    "chunk_id": 579,
    "sentence_start": 2258,
    "sentence_end": 2262,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Gaps in Knowledge\nThere is a need for high-quality randomized controlled stud­\nies using valid, condition-appropriate outcome measures \ncomparing specific, reproducible, manual therapy interven­\ntions to identify the most effective techniques and the ap­\npropriate dosage. Use of control groups, blinded assessors, \nuniform interventions, and evaluation of long-term outcomes \nare needed. There is no evidence that neural mobilization in­\ncreases longitudinal, lateral, or anterior-posterior movement \nof the median nerve in the carpal tunnel in individuals with \nCTS, or that an increase in movement is associated with a re­\nduction in carpal tunnel pressure or carpal tunnel symptoms. Recommendations\nC\nClinicians may perform manual therapy, directed at \nthe cervical spine and upper extremity, for indi­\nviduals with mild to moderate CTS in the short \nterm. D\nThere is conflicting evidence on the use of neurody­\nnamic mobilizations in the management of mild or \nmoderate CTS.",
    "chunk_id": 580,
    "sentence_start": 2261,
    "sentence_end": 2265,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Recommendations\nC\nClinicians may perform manual therapy, directed at \nthe cervical spine and upper extremity, for indi­\nviduals with mild to moderate CTS in the short \nterm. D\nThere is conflicting evidence on the use of neurody­\nnamic mobilizations in the management of mild or \nmoderate CTS. THERAPEUTIC EXERCISE\nStretching\nII\nBaker et al29 examined 4 different orthosis-stretch­\ning combinations and progression to surgery in 103 \nparticipants with mild to moderate CTS without \nthenar atrophy and normal 2PD. Participants were random­\nized into 4 different treatment protocols that combined or­\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nthotic intervention and stretching.",
    "chunk_id": 581,
    "sentence_start": 2264,
    "sentence_end": 2272,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nthotic intervention and stretching. Individuals wore 1 of 3 \northosis designs during sleep (a custom-fabricated orthosis \nwith the wrist at 0° and the MP joints at 0° to 10° [lumbrical \northosis], or 1 of 2 prefabricated wrist orthoses [general or­\nthosis]) and were randomly assigned to 1 of 2 stretching \ngroups (lumbrical stretches or general stretches) to be done \n6 times per day. Outcome measures were the CTQ-SSS, CTQ-\nFS, and the DASH, and authors determined the clinically \nimportant change (CIC) for the instruments as –0.16, –0.47, \nand –20.9 points, respectively. There were no differences be­\ntween groups at any time points except for 12 weeks.",
    "chunk_id": 582,
    "sentence_start": 2271,
    "sentence_end": 2275,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Outcome measures were the CTQ-SSS, CTQ-\nFS, and the DASH, and authors determined the clinically \nimportant change (CIC) for the instruments as –0.16, –0.47, \nand –20.9 points, respectively. There were no differences be­\ntween groups at any time points except for 12 weeks. The post \nhoc analysis showed the lumbrical orthosis/general stretch \nand general orthosis/lumbrical stretch were significantly im­\nproved compared to the lumbrical orthosis/lumbrical stretch \nfor CTQ-FS, and the lumbrical orthosis/general stretch was \nsignificantly improved compared to the lumbrical orthosis/\nlumbrical stretch for the DASH. There were no significant \n3-way interactions at 4 or 24 weeks. When considering the CIC for CTQ-SSS, CTQ-FS, and DASH \nin the Baker et al29 study, at 4 weeks, 66%, 34%, and 8% of \nparticipants demonstrated a CIC, respectively. At 12 weeks, \n68%, 37%, and 18% of participants reached a CIC, respec­\ntively, and at 24 weeks, 72%, 41%, and 22% reached CIC, \nrespectively.",
    "chunk_id": 583,
    "sentence_start": 2274,
    "sentence_end": 2279,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "When considering the CIC for CTQ-SSS, CTQ-FS, and DASH \nin the Baker et al29 study, at 4 weeks, 66%, 34%, and 8% of \nparticipants demonstrated a CIC, respectively. At 12 weeks, \n68%, 37%, and 18% of participants reached a CIC, respec­\ntively, and at 24 weeks, 72%, 41%, and 22% reached CIC, \nrespectively. At 24 weeks, 25.5% of participants progressed to \nsurgery, with no difference between groups. No intervention \nwas shown to be superior, and the absence of a control group \nand the use of multiple interventions prevents recommend­\ning one intervention. No adverse effects were reported. Gaps in Knowledge\nMore evidence is needed on the effects of general and lumbri­\ncal muscle stretching in individuals with CTS that include a \ncontrol group. Studies are needed that examine the effects of \nstretching versus other types of exercise. Studies examining \nthe combined effects of stretching and orthoses versus ortho­\nses alone are also needed.",
    "chunk_id": 584,
    "sentence_start": 2278,
    "sentence_end": 2285,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Studies are needed that examine the effects of \nstretching versus other types of exercise. Studies examining \nthe combined effects of stretching and orthoses versus ortho­\nses alone are also needed. Recommendation\nC\nClinicians may use a combined orthotic/stretching \nprogram in individuals with mild to moderate CTS \nwho do not have thenar atrophy and have normal \n2PD. Clinicians should monitor those undergoing treatment \nfor clinically significant improvement. al for bias, lack of control groups, and \nmination and intervention techniques, \ne same study. Early advantages of man­\nd to surgical intervention are most likely \nhealing, leading to greater short-term \nin surgically managed individuals. The \nual therapy should be based on patient \npist experience.",
    "chunk_id": 585,
    "sentence_start": 2284,
    "sentence_end": 2290,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Early advantages of man­\nd to surgical intervention are most likely \nhealing, leading to greater short-term \nin surgically managed individuals. The \nual therapy should be based on patient \npist experience. Clinicians must discon­\nrapy intervention if symptoms increase \nWhile no adverse effects were reported \nr a variety of manual therapies in these \nplications have been reported elsewhere \ngh-quality randomized controlled stud­\ndition-appropriate outcome measures \neproducible, manual therapy interven­\nmost effective techniques and the ap­\ne of control groups, blinded assessors, \ns, and evaluation of long-term outcomes \nno evidence that neural mobilization in­\nlateral, or anterior-posterior movement \nin the carpal tunnel in individuals with \nase in movement is associated with a re­\nnel pressure or carpal tunnel symptoms.",
    "chunk_id": 586,
    "sentence_start": 2289,
    "sentence_end": 2291,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The \nual therapy should be based on patient \npist experience. Clinicians must discon­\nrapy intervention if symptoms increase \nWhile no adverse effects were reported \nr a variety of manual therapies in these \nplications have been reported elsewhere \ngh-quality randomized controlled stud­\ndition-appropriate outcome measures \neproducible, manual therapy interven­\nmost effective techniques and the ap­\ne of control groups, blinded assessors, \ns, and evaluation of long-term outcomes \nno evidence that neural mobilization in­\nlateral, or anterior-posterior movement \nin the carpal tunnel in individuals with \nase in movement is associated with a re­\nnel pressure or carpal tunnel symptoms. may perform manual therapy, directed at \nl spine and upper extremity, for indi­\nh mild to moderate CTS in the short \nnflicting evidence on the use of neurody­\nilizations in the management of mild or \nTS.",
    "chunk_id": 587,
    "sentence_start": 2290,
    "sentence_end": 2292,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Clinicians must discon­\nrapy intervention if symptoms increase \nWhile no adverse effects were reported \nr a variety of manual therapies in these \nplications have been reported elsewhere \ngh-quality randomized controlled stud­\ndition-appropriate outcome measures \neproducible, manual therapy interven­\nmost effective techniques and the ap­\ne of control groups, blinded assessors, \ns, and evaluation of long-term outcomes \nno evidence that neural mobilization in­\nlateral, or anterior-posterior movement \nin the carpal tunnel in individuals with \nase in movement is associated with a re­\nnel pressure or carpal tunnel symptoms. may perform manual therapy, directed at \nl spine and upper extremity, for indi­\nh mild to moderate CTS in the short \nnflicting evidence on the use of neurody­\nilizations in the management of mild or \nTS. CISE\n9 examined 4 different orthosis-stretch­\nations and progression to surgery in 103 \ns with mild to moderate CTS without \normal 2PD.",
    "chunk_id": 588,
    "sentence_start": 2291,
    "sentence_end": 2293,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "may perform manual therapy, directed at \nl spine and upper extremity, for indi­\nh mild to moderate CTS in the short \nnflicting evidence on the use of neurody­\nilizations in the management of mild or \nTS. CISE\n9 examined 4 different orthosis-stretch­\nations and progression to surgery in 103 \ns with mild to moderate CTS without \normal 2PD. Participants were random­\ntreatment protocols that combined or­\n\n\n--- Page 51 ---\nCOLUMN 1:\nAUTHORS\nMia Erickson, PT, EdD\nProfessor\nCollege of Health Sciences\nPhysical Therapy Program\nMidwestern University\nGlendale, AZ\nmerick@midwestern.edu\nMarsha Lawrence, PT, DPT\nSenior Physical Therapist\nUniversity of Iowa Hospitals & Clinics\nIowa City, IA\nmarsha-lawrence@uiowa.edu\nCaroline W.",
    "chunk_id": 589,
    "sentence_start": 2292,
    "sentence_end": 2294,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "CISE\n9 examined 4 different orthosis-stretch­\nations and progression to surgery in 103 \ns with mild to moderate CTS without \normal 2PD. Participants were random­\ntreatment protocols that combined or­\n\n\n--- Page 51 ---\nCOLUMN 1:\nAUTHORS\nMia Erickson, PT, EdD\nProfessor\nCollege of Health Sciences\nPhysical Therapy Program\nMidwestern University\nGlendale, AZ\nmerick@midwestern.edu\nMarsha Lawrence, PT, DPT\nSenior Physical Therapist\nUniversity of Iowa Hospitals & Clinics\nIowa City, IA\nmarsha-lawrence@uiowa.edu\nCaroline W. Stegink Jansen, PT, PhD\nAssociate Professor\nSchool of Medicine\nDepartment of Orthopaedic Surgery \nand Rehabilitation\nUniversity of Texas Medical Branch\nGalveston, TX\ncwsjansen@gmail.com\nDiane Coker, PT, DPT\nSouth County Hand Center\nLaguna Woods, CA\ndacoker@cox.net\nPeter Amadio, MD\nOrthopaedic Surgeon\nMayo Clinic\nRochester, MN\npamadio@mayo.edu\nCarla Cleary, PT, DPT\nAssistant Director\nSt Dominic’s Hand Management Center\nJackson, MS\nckcleary@hotmail.com\nREVIEWERS\nRoy Altman, MD\nProfessor of Medicine\nDivision of Rheumatology and \nImmunology\nDavid Geffen School of Medicine at \nUCLA\nLos Angeles, CA\njournals@royaltman.com\nPaul Beattie, PT, PhD\nClinical Professor\nDoctoral Program in Physical Therapy, \nDepartment of Exercise Science\nArnold School of Public Health\nUniversity of South Carolina\nColumbia, SC\npbeattie@mailbox.sc.edu\nEugene Boeglin, DPT\nHand Therapist\nPhysical and Occupational Therapy at \nBeth Israel Deaconess HealthCare-\nChestnut Hill\nNewton, MA\nerboeglin@verizon.net\nJohn Dewitt, DPT\nDirector of Physical Therapy \nResidencies and Fellowships\nThe Ohio State University\nColumbus, OH\njohn.dewitt@osumc.edu\nLauren Detullio, OT\nAssistant Clinical Director\nPhiladelphia Hand to Shoulder Center\nPhiladelphia, PA\nldetullio@handcenters.com\nAmanda Ferland, DPT\nClinical Faculty\nTongji University/USC Division of \nBiokinesiology and Physical Therapy\nOrthopaedic Physical Therapy \nResidency \nand\nSpine Rehabilitation Fellowship\nShanghai, China\nAmandaFerland@incarehab.com\nChristopher Hughes, PT, PhD\nProfessor\nSlippery Rock University\nSlippery Rock, PA\nChristopher.hughes@sru.edu\nSandra Kaplan, PT, PhD\nClinical Practice Gui\nAcademy of Pediatri\nAPTA, Inc\nAlexandria, VA\nand\nProfessor\nDoctoral Programs i\nRutgers University\nNewark, NJ\nkaplansa@shp.rutge\nDavid Killoran, PhD\nPatient/Consumer R\nfor the ICF-Based\nGuidelines\nAcademy of Orthopa\nTherapy, APTA, In\nLa Crosse, WI\nand\nProfessor Emeritus\nLoyola Marymount U\nLos Angeles, CA\ndavid.killoran@lmu.e\nMurray E.",
    "chunk_id": 590,
    "sentence_start": 2293,
    "sentence_end": 2295,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Participants were random­\ntreatment protocols that combined or­\n\n\n--- Page 51 ---\nCOLUMN 1:\nAUTHORS\nMia Erickson, PT, EdD\nProfessor\nCollege of Health Sciences\nPhysical Therapy Program\nMidwestern University\nGlendale, AZ\nmerick@midwestern.edu\nMarsha Lawrence, PT, DPT\nSenior Physical Therapist\nUniversity of Iowa Hospitals & Clinics\nIowa City, IA\nmarsha-lawrence@uiowa.edu\nCaroline W. Stegink Jansen, PT, PhD\nAssociate Professor\nSchool of Medicine\nDepartment of Orthopaedic Surgery \nand Rehabilitation\nUniversity of Texas Medical Branch\nGalveston, TX\ncwsjansen@gmail.com\nDiane Coker, PT, DPT\nSouth County Hand Center\nLaguna Woods, CA\ndacoker@cox.net\nPeter Amadio, MD\nOrthopaedic Surgeon\nMayo Clinic\nRochester, MN\npamadio@mayo.edu\nCarla Cleary, PT, DPT\nAssistant Director\nSt Dominic’s Hand Management Center\nJackson, MS\nckcleary@hotmail.com\nREVIEWERS\nRoy Altman, MD\nProfessor of Medicine\nDivision of Rheumatology and \nImmunology\nDavid Geffen School of Medicine at \nUCLA\nLos Angeles, CA\njournals@royaltman.com\nPaul Beattie, PT, PhD\nClinical Professor\nDoctoral Program in Physical Therapy, \nDepartment of Exercise Science\nArnold School of Public Health\nUniversity of South Carolina\nColumbia, SC\npbeattie@mailbox.sc.edu\nEugene Boeglin, DPT\nHand Therapist\nPhysical and Occupational Therapy at \nBeth Israel Deaconess HealthCare-\nChestnut Hill\nNewton, MA\nerboeglin@verizon.net\nJohn Dewitt, DPT\nDirector of Physical Therapy \nResidencies and Fellowships\nThe Ohio State University\nColumbus, OH\njohn.dewitt@osumc.edu\nLauren Detullio, OT\nAssistant Clinical Director\nPhiladelphia Hand to Shoulder Center\nPhiladelphia, PA\nldetullio@handcenters.com\nAmanda Ferland, DPT\nClinical Faculty\nTongji University/USC Division of \nBiokinesiology and Physical Therapy\nOrthopaedic Physical Therapy \nResidency \nand\nSpine Rehabilitation Fellowship\nShanghai, China\nAmandaFerland@incarehab.com\nChristopher Hughes, PT, PhD\nProfessor\nSlippery Rock University\nSlippery Rock, PA\nChristopher.hughes@sru.edu\nSandra Kaplan, PT, PhD\nClinical Practice Gui\nAcademy of Pediatri\nAPTA, Inc\nAlexandria, VA\nand\nProfessor\nDoctoral Programs i\nRutgers University\nNewark, NJ\nkaplansa@shp.rutge\nDavid Killoran, PhD\nPatient/Consumer R\nfor the ICF-Based\nGuidelines\nAcademy of Orthopa\nTherapy, APTA, In\nLa Crosse, WI\nand\nProfessor Emeritus\nLoyola Marymount U\nLos Angeles, CA\ndavid.killoran@lmu.e\nMurray E. Maitland, \nAssociate Professor\nUniversity of Washin\nDepartment of Reha\nDivision of Physical T\nSeattle, WA\nmmaitlan@uw.edu\nSaurabh Mehta, PT, \nAssistant Professor\nSchool of Physical T\nMarshall University\nHuntington, WV\nmehtas@marshall.ed\nLeslie Torburn, DPT\nPrincipal and Consu\nSilhouette Consultin\nSacramento, CA\ntorburn@yahoo.com\nEmmanuel Yung, PT,\nAssistant Clinical Pr\nPhysical Therapy\nSacred Heart Univer\nAFFILIATIONS AND CONTACTS\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 591,
    "sentence_start": 2294,
    "sentence_end": 2296,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Stegink Jansen, PT, PhD\nAssociate Professor\nSchool of Medicine\nDepartment of Orthopaedic Surgery \nand Rehabilitation\nUniversity of Texas Medical Branch\nGalveston, TX\ncwsjansen@gmail.com\nDiane Coker, PT, DPT\nSouth County Hand Center\nLaguna Woods, CA\ndacoker@cox.net\nPeter Amadio, MD\nOrthopaedic Surgeon\nMayo Clinic\nRochester, MN\npamadio@mayo.edu\nCarla Cleary, PT, DPT\nAssistant Director\nSt Dominic’s Hand Management Center\nJackson, MS\nckcleary@hotmail.com\nREVIEWERS\nRoy Altman, MD\nProfessor of Medicine\nDivision of Rheumatology and \nImmunology\nDavid Geffen School of Medicine at \nUCLA\nLos Angeles, CA\njournals@royaltman.com\nPaul Beattie, PT, PhD\nClinical Professor\nDoctoral Program in Physical Therapy, \nDepartment of Exercise Science\nArnold School of Public Health\nUniversity of South Carolina\nColumbia, SC\npbeattie@mailbox.sc.edu\nEugene Boeglin, DPT\nHand Therapist\nPhysical and Occupational Therapy at \nBeth Israel Deaconess HealthCare-\nChestnut Hill\nNewton, MA\nerboeglin@verizon.net\nJohn Dewitt, DPT\nDirector of Physical Therapy \nResidencies and Fellowships\nThe Ohio State University\nColumbus, OH\njohn.dewitt@osumc.edu\nLauren Detullio, OT\nAssistant Clinical Director\nPhiladelphia Hand to Shoulder Center\nPhiladelphia, PA\nldetullio@handcenters.com\nAmanda Ferland, DPT\nClinical Faculty\nTongji University/USC Division of \nBiokinesiology and Physical Therapy\nOrthopaedic Physical Therapy \nResidency \nand\nSpine Rehabilitation Fellowship\nShanghai, China\nAmandaFerland@incarehab.com\nChristopher Hughes, PT, PhD\nProfessor\nSlippery Rock University\nSlippery Rock, PA\nChristopher.hughes@sru.edu\nSandra Kaplan, PT, PhD\nClinical Practice Gui\nAcademy of Pediatri\nAPTA, Inc\nAlexandria, VA\nand\nProfessor\nDoctoral Programs i\nRutgers University\nNewark, NJ\nkaplansa@shp.rutge\nDavid Killoran, PhD\nPatient/Consumer R\nfor the ICF-Based\nGuidelines\nAcademy of Orthopa\nTherapy, APTA, In\nLa Crosse, WI\nand\nProfessor Emeritus\nLoyola Marymount U\nLos Angeles, CA\ndavid.killoran@lmu.e\nMurray E. Maitland, \nAssociate Professor\nUniversity of Washin\nDepartment of Reha\nDivision of Physical T\nSeattle, WA\nmmaitlan@uw.edu\nSaurabh Mehta, PT, \nAssistant Professor\nSchool of Physical T\nMarshall University\nHuntington, WV\nmehtas@marshall.ed\nLeslie Torburn, DPT\nPrincipal and Consu\nSilhouette Consultin\nSacramento, CA\ntorburn@yahoo.com\nEmmanuel Yung, PT,\nAssistant Clinical Pr\nPhysical Therapy\nSacred Heart Univer\nAFFILIATIONS AND CONTACTS\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 592,
    "sentence_start": 2295,
    "sentence_end": 2297,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Maitland, \nAssociate Professor\nUniversity of Washin\nDepartment of Reha\nDivision of Physical T\nSeattle, WA\nmmaitlan@uw.edu\nSaurabh Mehta, PT, \nAssistant Professor\nSchool of Physical T\nMarshall University\nHuntington, WV\nmehtas@marshall.ed\nLeslie Torburn, DPT\nPrincipal and Consu\nSilhouette Consultin\nSacramento, CA\ntorburn@yahoo.com\nEmmanuel Yung, PT,\nAssistant Clinical Pr\nPhysical Therapy\nSacred Heart Univer\nAFFILIATIONS AND CONTACTS\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 593,
    "sentence_start": 2296,
    "sentence_end": 2300,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\n& Clinics\ndu\nPT, PhD\nSurgery \nBranch\nment Center\nnd \ncine at \njournals@royaltman.com\nPaul Beattie, PT, PhD\nClinical Professor\nDoctoral Program in Physical Therapy, \nDepartment of Exercise Science\nArnold School of Public Health\nUniversity of South Carolina\nColumbia, SC\npbeattie@mailbox.sc.edu\nEugene Boeglin, DPT\nHand Therapist\nPhysical and Occupational Therapy at \nBeth Israel Deaconess HealthCare-\nChestnut Hill\nNewton, MA\nerboeglin@verizon.net\nJohn Dewitt, DPT\nDirector of Physical Therapy \nResidencies and Fellowships\nThe Ohio State University\nColumbus, OH\njohn.dewitt@osumc.edu\nLauren Detullio, OT\nAssistant Clinical Director\nPhiladelphia Hand to Shoulder Center\nPhiladelphia, PA\nldetullio@handcenters.com\nAmanda Ferland, DPT\nClinical Faculty\nTongji University/USC Division of \nBiokinesiology and Physical Therapy\nOrthopaedic Physical Therapy \nResidency \nand\nSpine Rehabilitation Fellowship\nShanghai, China\nAmandaFerland@incarehab.com\nChristopher Hughes, PT, PhD\nProfessor\nSlippery Rock University\nSlippery Rock, PA\nChristopher.hughes@sru.edu\nSandra Kaplan, PT, PhD\nClinical Practice Guidelines Coordinator\nAcademy of Pediatric Physical Therapy, \nAPTA, Inc\nAlexandria, VA\nand\nProfessor\nDoctoral Programs in Physical Therapy\nRutgers University\nNewark, NJ\nkaplansa@shp.rutgers.edu\nDavid Killoran, PhD\nPatient/Consumer Representative \nfor the ICF-Based Clinical Practice \nGuidelines\nAcademy of Orthopaedic Physical \nTherapy, APTA, Inc\nLa Crosse, WI\nand\nProfessor Emeritus\nLoyola Marymount University\nLos Angeles, CA\ndavid.killoran@lmu.edu\nMurray E.",
    "chunk_id": 594,
    "sentence_start": 2299,
    "sentence_end": 2301,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\n& Clinics\ndu\nPT, PhD\nSurgery \nBranch\nment Center\nnd \ncine at \njournals@royaltman.com\nPaul Beattie, PT, PhD\nClinical Professor\nDoctoral Program in Physical Therapy, \nDepartment of Exercise Science\nArnold School of Public Health\nUniversity of South Carolina\nColumbia, SC\npbeattie@mailbox.sc.edu\nEugene Boeglin, DPT\nHand Therapist\nPhysical and Occupational Therapy at \nBeth Israel Deaconess HealthCare-\nChestnut Hill\nNewton, MA\nerboeglin@verizon.net\nJohn Dewitt, DPT\nDirector of Physical Therapy \nResidencies and Fellowships\nThe Ohio State University\nColumbus, OH\njohn.dewitt@osumc.edu\nLauren Detullio, OT\nAssistant Clinical Director\nPhiladelphia Hand to Shoulder Center\nPhiladelphia, PA\nldetullio@handcenters.com\nAmanda Ferland, DPT\nClinical Faculty\nTongji University/USC Division of \nBiokinesiology and Physical Therapy\nOrthopaedic Physical Therapy \nResidency \nand\nSpine Rehabilitation Fellowship\nShanghai, China\nAmandaFerland@incarehab.com\nChristopher Hughes, PT, PhD\nProfessor\nSlippery Rock University\nSlippery Rock, PA\nChristopher.hughes@sru.edu\nSandra Kaplan, PT, PhD\nClinical Practice Guidelines Coordinator\nAcademy of Pediatric Physical Therapy, \nAPTA, Inc\nAlexandria, VA\nand\nProfessor\nDoctoral Programs in Physical Therapy\nRutgers University\nNewark, NJ\nkaplansa@shp.rutgers.edu\nDavid Killoran, PhD\nPatient/Consumer Representative \nfor the ICF-Based Clinical Practice \nGuidelines\nAcademy of Orthopaedic Physical \nTherapy, APTA, Inc\nLa Crosse, WI\nand\nProfessor Emeritus\nLoyola Marymount University\nLos Angeles, CA\ndavid.killoran@lmu.edu\nMurray E. Maitland, PT, PhD\nAssociate Professor\nUniversity of Washington\nDepartment of Rehabilitation Medicine\nDivision of Physical Therapy\nSeattle, WA\nmmaitlan@uw.edu\nSaurabh Mehta, PT, MS, PhD\nAssistant Professor\nSchool of Physical Therapy\nMarshall University\nHuntington, WV\nmehtas@marshall.edu\nLeslie Torburn, DPT\nPrincipal and Consultant\nSilhouette Consulting, Inc\nSacramento, CA\ntorburn@yahoo.com\nEmmanuel Yung, PT, DPT\nAssistant Clinical Professor\nPhysical Therapy\nSacred Heart University\nFairfield, CT\nyunge@sacredheart.edu\nGUIDELINES EDITORS\nChristine M.",
    "chunk_id": 595,
    "sentence_start": 2300,
    "sentence_end": 2302,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\n& Clinics\ndu\nPT, PhD\nSurgery \nBranch\nment Center\nnd \ncine at \njournals@royaltman.com\nPaul Beattie, PT, PhD\nClinical Professor\nDoctoral Program in Physical Therapy, \nDepartment of Exercise Science\nArnold School of Public Health\nUniversity of South Carolina\nColumbia, SC\npbeattie@mailbox.sc.edu\nEugene Boeglin, DPT\nHand Therapist\nPhysical and Occupational Therapy at \nBeth Israel Deaconess HealthCare-\nChestnut Hill\nNewton, MA\nerboeglin@verizon.net\nJohn Dewitt, DPT\nDirector of Physical Therapy \nResidencies and Fellowships\nThe Ohio State University\nColumbus, OH\njohn.dewitt@osumc.edu\nLauren Detullio, OT\nAssistant Clinical Director\nPhiladelphia Hand to Shoulder Center\nPhiladelphia, PA\nldetullio@handcenters.com\nAmanda Ferland, DPT\nClinical Faculty\nTongji University/USC Division of \nBiokinesiology and Physical Therapy\nOrthopaedic Physical Therapy \nResidency \nand\nSpine Rehabilitation Fellowship\nShanghai, China\nAmandaFerland@incarehab.com\nChristopher Hughes, PT, PhD\nProfessor\nSlippery Rock University\nSlippery Rock, PA\nChristopher.hughes@sru.edu\nSandra Kaplan, PT, PhD\nClinical Practice Guidelines Coordinator\nAcademy of Pediatric Physical Therapy, \nAPTA, Inc\nAlexandria, VA\nand\nProfessor\nDoctoral Programs in Physical Therapy\nRutgers University\nNewark, NJ\nkaplansa@shp.rutgers.edu\nDavid Killoran, PhD\nPatient/Consumer Representative \nfor the ICF-Based Clinical Practice \nGuidelines\nAcademy of Orthopaedic Physical \nTherapy, APTA, Inc\nLa Crosse, WI\nand\nProfessor Emeritus\nLoyola Marymount University\nLos Angeles, CA\ndavid.killoran@lmu.edu\nMurray E. Maitland, PT, PhD\nAssociate Professor\nUniversity of Washington\nDepartment of Rehabilitation Medicine\nDivision of Physical Therapy\nSeattle, WA\nmmaitlan@uw.edu\nSaurabh Mehta, PT, MS, PhD\nAssistant Professor\nSchool of Physical Therapy\nMarshall University\nHuntington, WV\nmehtas@marshall.edu\nLeslie Torburn, DPT\nPrincipal and Consultant\nSilhouette Consulting, Inc\nSacramento, CA\ntorburn@yahoo.com\nEmmanuel Yung, PT, DPT\nAssistant Clinical Professor\nPhysical Therapy\nSacred Heart University\nFairfield, CT\nyunge@sacredheart.edu\nGUIDELINES EDITORS\nChristine M. McDonough, PT, PhD\nICF-Based Clinical Practice Guidelines \nEditor\nAcademy of Orthopaedic Physical \nTherapy, APTA, Inc\nLa Crosse, WI\nand\nAssistant Professor of Physical Therapy\nSchool of Health and Rehabilitation \nSciences\nUniversity of Pittsburgh\nPittsburgh, PA\ncmm295@pitt.edu\nGuy G.",
    "chunk_id": 596,
    "sentence_start": 2301,
    "sentence_end": 2303,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Maitland, PT, PhD\nAssociate Professor\nUniversity of Washington\nDepartment of Rehabilitation Medicine\nDivision of Physical Therapy\nSeattle, WA\nmmaitlan@uw.edu\nSaurabh Mehta, PT, MS, PhD\nAssistant Professor\nSchool of Physical Therapy\nMarshall University\nHuntington, WV\nmehtas@marshall.edu\nLeslie Torburn, DPT\nPrincipal and Consultant\nSilhouette Consulting, Inc\nSacramento, CA\ntorburn@yahoo.com\nEmmanuel Yung, PT, DPT\nAssistant Clinical Professor\nPhysical Therapy\nSacred Heart University\nFairfield, CT\nyunge@sacredheart.edu\nGUIDELINES EDITORS\nChristine M. McDonough, PT, PhD\nICF-Based Clinical Practice Guidelines \nEditor\nAcademy of Orthopaedic Physical \nTherapy, APTA, Inc\nLa Crosse, WI\nand\nAssistant Professor of Physical Therapy\nSchool of Health and Rehabilitation \nSciences\nUniversity of Pittsburgh\nPittsburgh, PA\ncmm295@pitt.edu\nGuy G. Simoneau, PT, PhD, FAPTA\nICF-Based Clinical Practice Guidelines \nEditor\nAcademy of Orthopaedic Physical \nTherapy, APTA, Inc\nLa Crosse, WI\nand\nProfessor\nPhysical Therapy Department\nMarquette University\nMilwaukee, WI\nguy.simoneau@marquette.edu\nRobroy L.",
    "chunk_id": 597,
    "sentence_start": 2302,
    "sentence_end": 2304,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "McDonough, PT, PhD\nICF-Based Clinical Practice Guidelines \nEditor\nAcademy of Orthopaedic Physical \nTherapy, APTA, Inc\nLa Crosse, WI\nand\nAssistant Professor of Physical Therapy\nSchool of Health and Rehabilitation \nSciences\nUniversity of Pittsburgh\nPittsburgh, PA\ncmm295@pitt.edu\nGuy G. Simoneau, PT, PhD, FAPTA\nICF-Based Clinical Practice Guidelines \nEditor\nAcademy of Orthopaedic Physical \nTherapy, APTA, Inc\nLa Crosse, WI\nand\nProfessor\nPhysical Therapy Department\nMarquette University\nMilwaukee, WI\nguy.simoneau@marquette.edu\nRobroy L. Martin, PT, PhD\nICF-Based Clinical Practice Guidelines \nEditor\nAcademy of Orthopaedic Physical \nTherapy, APTA, Inc\nLa Crosse, WI\nand\nProfessor\nRangos School of Health Sciences\nDuquesne University\nPittsburgh, PA\nand\nStaff Physical Therapist\nUPMC Center for Sports Medicine\nPittsburgh, PA\nmartinr280@duq.edu\nAFFILIATIONS AND CONTACTS\n\n\n--- Page 52 ---\nCOLUMN 1:\n\u00071. \u0007Agnew J, Bolla-Wilson K, Kawas CH, Bleecker ML.",
    "chunk_id": 598,
    "sentence_start": 2303,
    "sentence_end": 2306,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Martin, PT, PhD\nICF-Based Clinical Practice Guidelines \nEditor\nAcademy of Orthopaedic Physical \nTherapy, APTA, Inc\nLa Crosse, WI\nand\nProfessor\nRangos School of Health Sciences\nDuquesne University\nPittsburgh, PA\nand\nStaff Physical Therapist\nUPMC Center for Sports Medicine\nPittsburgh, PA\nmartinr280@duq.edu\nAFFILIATIONS AND CONTACTS\n\n\n--- Page 52 ---\nCOLUMN 1:\n\u00071. \u0007Agnew J, Bolla-Wilson K, Kawas CH, Bleecker ML. Purdue Pegboard age \nand sex norms for people 40 years old and older. \u0007Ahn SY, Hong YH, Koh YH, Chung YS, Lee SH, Yang HJ. Pressure measure­\nment in carpal tunnel syndrome: correlation with electrodiagnostic and \nultrasonographic findings. J Korean Neurosurg Soc. Sensitivity and specificity of Phalen’s test \nand Tinel’s test in patients with carpal tunnel syndrome. The Alderson-McGall hand function questionnaire \nfor patients with carpal tunnel syndrome: a pilot evaluation of a future \noutcome measure.",
    "chunk_id": 599,
    "sentence_start": 2305,
    "sentence_end": 2326,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The effect of long-term use of computer \nmouse devices on median nerve entrapment. \u0007Amadio PC, Silverstein MD, Ilstrup DM, Schleck CD, Jensen LM. Outcome \nassessment for carpal tunnel surgery: the relative responsiveness of \ngeneric, arthritis-specific, disease-specific, and physical examination \nmeasures. J Hand Surg Am. \u0007American Academy of Orthopaedic Surgeons. Management of Carpal Tun­\nnel Syndrome: Evidence-Based Clinical Practice Guideline. Rosemont, IL: \nAmerican Academy of Orthopaedic Surgeons; 2016. \u0007Amirfeyz R, Clark D, Parsons B, et al. Clinical tests for carpal tunnel syn­\ndrome in contemporary practice. Arch Orthop Trauma Surg. \u0007Amirfeyz R, Gozzard C, Leslie IJ. Hand elevation test for assessment of \ncarpal tunnel syndrome. J Hand Surg Br. \u0007Amirfeyz R, Pentlow A, Foote J, Leslie I. Assessing the clinical significance \nof change scores following carpal tunnel surgery. \u0007Amirjani N, Ashworth NL, Gordon T, Edwards DC, Chan KM.",
    "chunk_id": 600,
    "sentence_start": 2325,
    "sentence_end": 2356,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Amirjani N, Ashworth NL, Gordon T, Edwards DC, Chan KM. Normative val­\nues and the effects of age, gender, and handedness on the Moberg Pick-Up \nTest. \u0007Amirjani N, Ashworth NL, Olson JL, Morhart M, Chan KM. Discriminative \nvalidity and test-retest reliability of the Dellon-modified Moberg pick-up \ntest in carpal tunnel syndrome patients. J Peripher Nerv Syst. \u0007Amirjani N, Ashworth NL, Olson JL, Morhart M, Chan KM. Validity and \nreliability of the Purdue Pegboard Test in carpal tunnel syndrome. \u0007Amirjani N, Ashworth NL, Watt MJ, Gordon T, Chan KM. Corticosteroid \niontophoresis to treat carpal tunnel syndrome: a double-blind randomized \ncontrolled trial. \u0007Andersen JH, Fallentin N, Thomsen JF, Mikkelsen S. Risk factors for neck \nand upper extremity disorders among computers (sic) users and the \neffect of interventions: an overview of systematic reviews. Functional outcomes post car­\npal tunnel release: a modified replication of a previous study.",
    "chunk_id": 601,
    "sentence_start": 2355,
    "sentence_end": 2385,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Armagan O, Bakilan F, Ozgen M, Mehmetoglu O, Oner S. Effects of placebo-\ncontrolled continuous and pulsed ultrasound treatments on carpal tunnel \nsyndrome: a randomized trial. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nK, Kawas CH, Bleecker ML. Purdue Pegboard age \nple 40 years old and older. oi.org/10.1080/87565648809540388\nYH, Chung YS, Lee SH, Yang HJ. Pressure measure­\nyndrome: correlation with electrodiagnostic and \ngs. J Korean Neurosurg Soc. Sensitivity and specificity of Phalen’s test \nnts with carpal tunnel syndrome. The Alderson-McGall hand function questionnaire \n tunnel syndrome: a pilot evaluation of a future \nand Ther. The effect of long-term use of computer \nian nerve entrapment. MD, Ilstrup DM, Schleck CD, Jensen LM.",
    "chunk_id": 602,
    "sentence_start": 2384,
    "sentence_end": 2410,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "MD, Ilstrup DM, Schleck CD, Jensen LM. Outcome \ntunnel surgery: the relative responsiveness of \nfic, disease-specific, and physical examination \ng Am. Management of Carpal Tun­\ne-Based Clinical Practice Guideline. Clinical tests for carpal tunnel syn­\ny practice. Arch Orthop Trauma Surg. Hand elevation test for assessment of \ne. J Hand Surg Br. 5.04.007\n, Foote J, Leslie I. Assessing the clinical significance \nwing carpal tunnel surgery. 2009;33:181-\n0.1007/s00264-007-0471-1\nNL, Gordon T, Edwards DC, Chan KM. Normative val­\nage, gender, and handedness on the Moberg Pick-Up \n007;35:788-792. Discriminative \nt reliability of the Dellon-modified Moberg pick-up \nyndrome patients. J Peripher Nerv Syst. 2011;16:51-\n.1111/j.1529-8027.2011.00312.x\nNL, Olson JL, Morhart M, Chan KM. Validity and \ne Pegboard Test in carpal tunnel syndrome. Corticosteroid \ncarpal tunnel syndrome: a double-blind randomized \ne Nerve.",
    "chunk_id": 603,
    "sentence_start": 2409,
    "sentence_end": 2438,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Risk factors for neck \nisorders among computers (sic) users and the \nan overview of systematic reviews. /doi.org/10.1371/journal.pone.0019691\nmith M, Parrott MW. Functional outcomes post car­\nmodified replication of a previous study. Effects of placebo-\nand pulsed ultrasound treatments on carpal tunnel \ned trial. \u0007Arslan Y, Bülbül I, Öcek L, Şener U, Zorlu Y. Effect of hand volume and \nother anthropometric measurements on carpal tunnel syndrome. \u0007Astifidis RP, Koczan BJ, Dubin NH, Burke FD, Wilgis EFS. Patient satisfac­\ntion with carpal tunnel surgery: self-administered questionnaires versus \nphysical testing. \u0007Atalay NS, Sarsan A, Akkaya N, Yildiz N, Topuz O. The impact of disease \nseverity in carpal tunnel syndrome on grip strength, pinch strength, fine \nmotor skill and depression. J Phys Ther Sci. \u0007Atcheson SG, Ward JR, Lowe W. Concurrent medical disease in work-\nrelated carpal tunnel syndrome. Arch Intern Med. \u0007Atroshi I, Gummesson C, Johnsson R, Sprinchorn A.",
    "chunk_id": 604,
    "sentence_start": 2437,
    "sentence_end": 2471,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Atroshi I, Gummesson C, Johnsson R, Sprinchorn A. Symptoms, disability, \nand quality of life in patients with carpal tunnel syndrome. J Hand Surg \nAm. \u0007Atroshi I, Gummesson C, McCabe SJ, Ornstein E. The SF-6D health utility \nindex in carpal tunnel syndrome. J Hand Surg Eur Vol. \u0007Atroshi I, Gummesson C, Ornstein E, Johnsson R, Ranstam J. Carpal \ntunnel syndrome and keyboard use at work: a population-based study. \u0007Atroshi I, Lyrén PE, Gummesson C. The 6-item CTS symptoms scale: \na brief outcomes measure for carpal tunnel syndrome. \u0007Atroshi I, Lyrén PE, Ornstein E, Gummesson C. The six-item CTS symp­\ntoms scale and palmar pain scale in carpal tunnel syndrome. J Hand \nSurg Am. Symptom severity and conservative treatment \nfor carpal tunnel syndrome in association with eventual carpal tunnel \nrelease. J Hand Surg Am. \u0007Baker NA, Moehling KK, Desai AR, Gustafson NP. Effect of carpal tunnel \nsyndrome on grip and pinch strength compared with sex- and age-\nmatched normative data.",
    "chunk_id": 605,
    "sentence_start": 2470,
    "sentence_end": 2503,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Baker NA, Moehling KK, Desai AR, Gustafson NP. Effect of carpal tunnel \nsyndrome on grip and pinch strength compared with sex- and age-\nmatched normative data. Arthritis Care Res (Hoboken). \u0007Baker NA, Moehling KK, Rubinstein EN, Wollstein R, Gustafson NP, \nBaratz M. The comparative effectiveness of combined lumbrical muscle \nsplints and stretches on symptoms and function in carpal tunnel syn­\ndrome. Arch Phys Med Rehabil. \u0007Bakhsh H, Ibrahim I, Khan W, Smitham P, Goddard N. Assessment of va­\nlidity, reliability, responsiveness and bias of three commonly used patient-\nreported outcome measures in carpal tunnel syndrome. Ortop Traumatol \nRehabil. \u0007Bakhtiary AH, Fatemi E, Emami M, Malek M. Phonophoresis of dexameth­\nasone sodium phosphate may manage pain and symptoms of patients \nwith carpal tunnel syndrome. \u0007Barcenilla A, March LM, Chen JS, Sambrook PN. Carpal tunnel syndrome \nand its relationship to occupation: a meta-analysis. \u0007Baselgia LT, Bennett DL, Silbiger RM, Schmid AB.",
    "chunk_id": 606,
    "sentence_start": 2502,
    "sentence_end": 2529,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Baselgia LT, Bennett DL, Silbiger RM, Schmid AB. Negative neurodynamic \ntests do not exclude neural dysfunction in patients with entrapment \nneuropathies. Arch Phys Med Rehabil. \u0007Basson A, Olivier B, Ellis R, Coppieters M, Stewart A, Mudzi W. The ef­\nfectiveness of neural mobilization for neuromusculoskeletal conditions: \na systematic review and meta-analysis. J Orthop Sports Phys Ther. \u0007Baysal O, Altay Z, Ozcan C, Ertem K, Yologlu S, Kayhan A. Com­\nparison of three conservative treatment protocols in carpal tun­\nnel syndrome. Int J Clin Pract. \u0007Becker J, Nora DB, Gomes I, et al. An evaluation of gender, obesity, \nage and diabetes mellitus as risk factors for carpal tunnel syndrome. Therapeutic Electrophysical Agents: Evidence Behind \nPractice. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & \nWilkins; 2015. \u0007Bessette L, Sangha O, Kuntz KM, et al.",
    "chunk_id": 607,
    "sentence_start": 2528,
    "sentence_end": 2555,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Bessette L, Sangha O, Kuntz KM, et al. Comparative responsiveness of \ngeneric versus disease-specific and weighted versus unweighted health \nstatus measures in carpal tunnel syndrome. A neurophysiological grading scale for carpal tun­\nnel syndrome. The relationship of obesity, age, and carpal tunnel syndrome: \nmore complex than was thought? \u0007Blok RD, Becker SJ, Ring DC. Diagnosis of carpal tunnel syndrome: \ninterobserver reliability of the blinded scratch-collapse test. Assessing the accuracy of a combination of \nclinical tests for identifying carpal tunnel syndrome. \u0007Boyd KU, Gan BS, Ross DC, Richards RS, Roth JH, MacDermid JC. Out­\ncomes in carpal tunnel syndrome: symptom severity, conservative man­\nagement and progression to surgery. Clin Invest Med. \u0007Boz C, Ozmenoglu M, Altunayoglu V, Velioglu S, Alioglu Z. Individual risk \nfactors for carpal tunnel syndrome: an evaluation of body mass index, \nwrist index and hand anthropometric measurements. Clin Neurol Neuro­\nsurg.",
    "chunk_id": 608,
    "sentence_start": 2554,
    "sentence_end": 2591,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Validity of the \nUpper Limb Neurodynamic Test 1 for the diagnosis of carpal tunnel syn­\ndrome. The role of structural differentiation. Psychological \nfactors at work and musculoskeletal disorders: a one year prospec­\ntive study. \u0007Bulut GT, Caglar NS, Aytekin E, Ozgonenel L, Tutun S, Demir SE. Compari­\nson of static wrist splint with static wrist and metacarpophalangeal splint \nin carpal tunnel syndrome. J Back Musculoskelet Rehabil. \u0007Burt S, Deddens JA, Crombie K, Jin Y, Wurzelbacher S, Ramsey J. A pro­\nspective study of carpal tunnel syndrome: workplace and individual risk \nfactors. Occup Environ Med. \u0007Burton CL, Chesterton LS, Chen Y, van der Windt DA. Clinical course and \nprognostic factors in conservatively managed carpal tunnel syndrome: a \nsystematic review. Arch Phys Med Rehabil. \u0007Calfee RP, Dale AM, Ryan D, Descatha A, Franzblau A, Evanoff B. Per­\nformance of simplified scoring systems for hand diagrams in carpal \ntunnel syndrome screening. J Hand Surg Am.",
    "chunk_id": 609,
    "sentence_start": 2590,
    "sentence_end": 2623,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Caliandro P, La Torre G, Aprile I, et al. Distribution of paresthesias \nin carpal tunnel syndrome reflects the degree of nerve damage at \nwrist. clinph.2005.09.001\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nan C, Ertem K, Yologlu S, Kayhan A. Com­\nervative treatment protocols in carpal tun­\nin Pract. An evaluation of gender, obesity, \nlitus as risk factors for carpal tunnel syndrome. Comparative responsiveness of \ne-specific and weighted versus unweighted health \narpal tunnel syndrome. 97/00005650-199804000-00005\nsiological grading scale for carpal tun­\n Nerve. 98(200008)23:8<1280::AID-MUS20>3.0.CO;2-Y\nnship of obesity, age, and carpal tunnel syndrome: \nas thought?",
    "chunk_id": 610,
    "sentence_start": 2622,
    "sentence_end": 2651,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Diagnosis of carpal tunnel syndrome: \ny of the blinded scratch-collapse test. Assessing the accuracy of a combination of \nifying carpal tunnel syndrome. ps://doi.org/10.1016/j.jocn.2008.09.004\ns DC, Richards RS, Roth JH, MacDermid JC. Out­\nsyndrome: symptom severity, conservative man­\non to surgery. Clin Invest Med. Altunayoglu V, Velioglu S, Alioglu Z. Individual risk \nnel syndrome: an evaluation of body mass index, \nanthropometric measurements. Clin Neurol Neuro­\n99. Validity of the \nnamic Test 1 for the diagnosis of carpal tunnel syn­\nuctural differentiation. Psychological \nmusculoskeletal disorders: a one year prospec­\nInt. Compari­\nnt with static wrist and metacarpophalangeal splint \nome. J Back Musculoskelet Rehabil. 2015;28:761-\n0.3233/BMR-140580\nCrombie K, Jin Y, Wurzelbacher S, Ramsey J. A pro­\npal tunnel syndrome: workplace and individual risk \nn Med. Clinical course and \nonservatively managed carpal tunnel syndrome: a \nh Phys Med Rehabil.",
    "chunk_id": 611,
    "sentence_start": 2650,
    "sentence_end": 2679,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "15.09.013\nyan D, Descatha A, Franzblau A, Evanoff B. Per­\nd scoring systems for hand diagrams in carpal \nening. J Hand Surg Am. Distribution of paresthesias \nome reflects the degree of nerve damage at \nol. Physical Agents in Rehabilitation: An Evidence-Based Ap­\nproach to Practice. \u0007Capasso M, Manzoli C, Uncini A. Management of extreme carpal tunnel \nsyndrome: evidence from a long-term follow-up study. \u0007Carter R, Aspy CB, Mold J. The effectiveness of magnet therapy for treat­\nment of wrist pain attributed to carpal tunnel syndrome. \u0007Cartwright MS, Yeboah S, Walker FO, et al. Examining the association be­\ntween musculoskeletal injuries and carpal tunnel syndrome in manual la­\nborers. \u0007Chang CW, Wang YC, Chang KF. A practical electrophysiological guide for \nnon-surgical and surgical treatment of carpal tunnel syndrome. J Hand \nSurg Eur Vol. \u0007Chang YW, Hsieh SF, Horng YS, Chen HL, Lee KC, Horng YS.",
    "chunk_id": 612,
    "sentence_start": 2678,
    "sentence_end": 2715,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Chang YW, Hsieh SF, Horng YS, Chen HL, Lee KC, Horng YS. Compara­\ntive effectiveness of ultrasound and paraffin therapy in patients with \ncarpal tunnel syndrome: a randomized trial. BMC Musculoskelet Disord. Comparative responsiveness of the Michigan \nHand Outcomes Questionnaire and the Carpal Tunnel Questionnaire after \ncarpal tunnel release. J Hand Surg Am. \u0007Checkosky CM, Bolanowski SJ, Cohen JC. Assessment of vibrotactile \nsensitivity in patients with carpal tunnel syndrome. J Occup Environ Med. Risk of hand syndromes in patients with dia­\nbetes mellitus: a population-based cohort study in Taiwan. \u0007Chen SJ, Lin HS, Hsieh CH. Carpal tunnel pressure is correlated with elec­\ntrophysiological parameters but not the 3 month surgical outcome. \u0007Cheng CJ, Mackinnon-Patterson B, Beck JL, Mackinnon SE. Scratch col­\nlapse test for evaluation of carpal and cubital tunnel syndrome. J Hand \nSurg Am.",
    "chunk_id": 613,
    "sentence_start": 2714,
    "sentence_end": 2746,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The clinical and \ncost-effectiveness of corticosteroid injection versus night splints for \ncarpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, \nrandomised controlled trial. \u0007Cheung DK, MacDermid J, Walton D, Grewal R. The construct valid­\nity and responsiveness of sensory tests in patients with carpal \ntunnel syndrome. \u0007Chiotis K, Dimisianos N, Rigopoulou A, Chrysanthopoulou A, Chroni \nE. Role of anthropometric characteristics in idiopathic carpal tun­\nnel syndrome. Arch Phys Med Rehabil. \u0007Chroni E, Paschalis C, Arvaniti C, Zotou K, Nikolakopoulou A, Papapetro­\npoulos T. Carpal tunnel syndrome and hand configuration. \u0007Clark D, Amirfeyz R, Leslie I, Bannister G. The distribution \nof sensory disturbance in carpal tunnel syndrome. Ann R Coll Surg Engl. Effect of lumbrical muscle incur­\nsion within the carpal tunnel on carpal tunnel pressure: a cadaveric \nstudy. J Hand Surg Am. \u0007Coggon D, Ntani G, Harris EC, et al.",
    "chunk_id": 614,
    "sentence_start": 2745,
    "sentence_end": 2780,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Coggon D, Ntani G, Harris EC, et al. Differences in risk factors for \nneurophysiologically confirmed carpal tunnel syndrome and illness \nwith similar symptoms but normal median nerve function: a case-\ncontrol study. BMC Musculoskelet Disord. org/10.1186/1471-2474-14-240\n\n\n--- Page 54 ---\nCOLUMN 1:\n\u000770. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988. \u0007Colbert AP, Markov MS, Carlson N, Gregory WL, Carlson H, Elmer PJ. Static \nmagnetic field therapy for carpal tunnel syndrome: a feasibility study. Arch Phys Med Rehabil. \u0007Coldham F, Lewis J, Lee H. The reliability of one vs. three grip trials in \nsymptomatic and asymptomatic subjects. Upper extremity mononeuropathy among engi­\nneers. J Occup Environ Med. \u0007Cosgrove JL, Chase PM, Mast NJ, Reeves R. Carpal tunnel syndrome in \nrailroad workers. Am J Phys Med Rehabil. Splinting for symptoms of carpal tunnel syndrome dur­\ning pregnancy. \u0007Dale AM, Gardner BT, Zeringue A, et al.",
    "chunk_id": 615,
    "sentence_start": 2779,
    "sentence_end": 2818,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Dale AM, Gardner BT, Zeringue A, et al. Self-reported physical work expo­\nsures and incident carpal tunnel syndrome. Prevalence and incidence \nof carpal tunnel syndrome in US working populations: pooled analysis of \nsix prospective studies. Scand J Work Environ Health. General population job expo­\nsure matrix applied to a pooled study of prevalent carpal tunnel syndrome. \u0007Dekel S, Papaioannou T, Rushworth G, Coates R. Idiopathic carpal tunnel \nsyndrome caused by carpal stenosis. \u0007de Krom MC, Kester AD, Knipschild PG, Spaans F. Risk factors for carpal \ntunnel syndrome. \u0007de la Llave-Rincón AI, Fernández-de-las-Peñas C, Pérez-de-Heredia-Torres \nM, Martínez-Perez A, Valenza MC, Pareja JA. Bilateral deficits in fine mo­\ntor control and pinch grip force are not associated with electrodiagnostic \nfindings in women with carpal tunnel syndrome. Am J Phys Med Rehabil. \u0007Desrosiers J, Hébert R, Bravo G, Dutil E. The Purdue Pegboard Test: nor­\nmative data for people aged 60 and over.",
    "chunk_id": 616,
    "sentence_start": 2817,
    "sentence_end": 2853,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Dhong ES, Han SK, Lee BI, Kim WK. Correlation of electrodiagnostic \nfindings with subjective symptoms in carpal tunnel syndrome. Ann Plast \nSurg. An epidemiologic study of the carpal tunnel syn­\ndrome in an adult female population. \u0007Ebenbichler GR, Resch KL, Nicolakis P, et al. Ultrasound treatment for \ntreating the carpal tunnel syndrome: randomised “sham” controlled trial. \u0007Ekman-Ordeberg G, Sälgeback S, Ordeberg G. Carpal tunnel syndrome in \npregnancy. Acta Obstet Gynecol Scand. \u0007Eleftheriou A, Rachiotis G, Varitimidis SE, Koutis C, Malizos KN, Hadji­\nchristodoulou C. Cumulative keyboard strokes: a possible risk factor for \ncarpal tunnel syndrome. J Occup Med Toxicol. \u0007Elfar JC, Yaseen Z, Stern PJ, Kiefhaber TR. Individual finger sensibility in \ncarpal tunnel syndrome. J Hand Surg Am. \u0007El Miedany Y, Ashour S, Youssef S, Mehanna A, Meky FA. Clinical diagno­\nsis of carpal tunnel syndrome: old tests–new concepts. Joint Bone Spine. For personal use only.",
    "chunk_id": 617,
    "sentence_start": 2852,
    "sentence_end": 2892,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nower Analysis for the Behavioral Sciences. S, Carlson N, Gregory WL, Carlson H, Elmer PJ. Static \ny for carpal tunnel syndrome: a feasibility study. The reliability of one vs. three grip trials in \nmptomatic subjects. Upper extremity mononeuropathy among engi­\nn Med. M, Mast NJ, Reeves R. Carpal tunnel syndrome in \nJ Phys Med Rehabil. or symptoms of carpal tunnel syndrome dur­\nd Ther. Self-reported physical work expo­\nrpal tunnel syndrome. 2014;57:1246-\n10.1002/ajim.22359\nson C, Rempel D, et al. Prevalence and incidence \nome in US working populations: pooled analysis of \ns. Scand J Work Environ Health. General population job expo­\na pooled study of prevalent carpal tunnel syndrome. Idiopathic carpal tunnel \ncarpal stenosis. AD, Knipschild PG, Spaans F.",
    "chunk_id": 618,
    "sentence_start": 2891,
    "sentence_end": 2930,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "AD, Knipschild PG, Spaans F. Risk factors for carpal \nJ Epidemiol. urnals.aje.a115753\nFernández-de-las-Peñas C, Pérez-de-Heredia-Torres \nValenza MC, Pareja JA. Bilateral deficits in fine mo­\ngrip force are not associated with electrodiagnostic \nh carpal tunnel syndrome. Am J Phys Med Rehabil. s://doi.org/10.1097/PHM.0b013e31821a7170\nR, Bravo G, Dutil E. The Purdue Pegboard Test: nor­\ne aged 60 and over. Correlation of electrodiagnostic \nve symptoms in carpal tunnel syndrome. An epidemiologic study of the carpal tunnel syn­\nmale population. Ultrasound treatment for \nnnel syndrome: randomised “sham” controlled trial. Carpal tunnel syndrome in \ntive study. Acta Obstet Gynecol Scand. 1987;66:233-\n0.3109/00016348709020753\ns G, Varitimidis SE, Koutis C, Malizos KN, Hadji­\nulative keyboard strokes: a possible risk factor for \nme. J Occup Med Toxicol. 3-7-16\nern PJ, Kiefhaber TR. Individual finger sensibility in \nme. J Hand Surg Am. 10.08.013\nS, Youssef S, Mehanna A, Meky FA.",
    "chunk_id": 619,
    "sentence_start": 2929,
    "sentence_end": 2962,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "10.08.013\nS, Youssef S, Mehanna A, Meky FA. Clinical diagno­\nndrome: old tests–new concepts. Joint Bone Spine. \u0007Ettema AM, Amadio PC, Zhao C, Wold LE, An KN. A histological \nand immunohistochemical study of the subsynovial connective tis­\nsue in idiopathic carpal tunnel syndrome. J Bone Joint Surg Am. \u0007Evanoff B, Dale AM, Deych E, Ryan D, Franzblau A. Risk factors for incident \ncarpal tunnel syndrome: results of a prospective cohort study of newly-\nhired workers. Associations between workplace \nfactors and carpal tunnel syndrome: a multi-site cross sectional study. \u0007Fernández-de-las-Peñas C, Cleland J, Palacios-Ceña M, Fuensalida-Novo \nS, Pareja JA, Alonso-Blanco C. The effectiveness of manual therapy \nversus surgery on self-reported function, cervical range of motion, and \npinch grip force in carpal tunnel syndrome: a randomized clinical trial. J Orthop Sports Phys Ther. Manual physical therapy versus surgery for carpal tunnel syndrome: \na randomized parallel-group trial.",
    "chunk_id": 620,
    "sentence_start": 2961,
    "sentence_end": 2992,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Bilateral deficits in fine motor \ncontrol and pinch grip force in patients with unilateral carpal tunnel \nsyndrome. \u0007Ferry S, Hannaford P, Warskyj M, Lewis M, Croft P. Carpal tunnel syn­\ndrome: a nested case-control study of risk factors in women. \u0007Fertl E, Wöber C, Zeitlhofer J. The serial use of two provocative tests in \nthe clinical diagnosis of carpal tunnel syndrome. Acta Neurol Scand. \u0007Filius A, Thoreson AR, Yang TH, et al. The effect of low- and high-velocity \ntendon excursion on the mechanical properties of human cadaver sub­\nsynovial connective tissue. \u0007Frasca G, Maggi L, Padua L, et al. Short-term effects of local mi­\ncrowave hyperthermia on pain and function in patients with mild \nto moderate carpal tunnel syndrome: a double blind randomized \nsham-controlled trial. \u0007Freeland AE, Tucci MA, Barbieri RA, Angel MF, Nick TG. Biochemical \nevaluation of serum and flexor tenosynovium in carpal tunnel syndrome. \u0007Gay RE, Amadio PC, Johnson JC.",
    "chunk_id": 621,
    "sentence_start": 2991,
    "sentence_end": 3025,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Gay RE, Amadio PC, Johnson JC. Comparative responsiveness of the \nDisabilities of the Arm, Shoulder, and Hand, the Carpal Tunnel Question­\nnaire, and the SF-36 to clinical change after carpal tunnel release. J Hand \nSurg Am. \u0007Geere J, Chester R, Kale S, Jerosch-Herold C. Power grip, pinch grip, \nmanual muscle testing or thenar atrophy – which should be as­\nsessed as a motor outcome after carpal tunnel decompression? BMC Musculoskelet Disord. \u0007Gelberman RH, Hergenroeder PT, Hargens AR, Lundborg GN, Akeson \nWH. The carpal tunnel syndrome. A study of carpal canal pressures. J \nBone Joint Surg Am. \u0007Gelberman RH, Rydevik BL, Pess GM, Szabo RM, Lundborg G. Carpal \ntunnel syndrome. A scientific basis for clinical care. Orthop Clin North \nAm. \u0007Gelfman R, Melton LJ, 3rd, Yawn BP, Wollan PC, Amadio PC, Stevens JC. Long-term trends in carpal tunnel syndrome. \u0007Gell N, Werner RA, Franzblau A, Ulin SS, Armstrong TJ.",
    "chunk_id": 622,
    "sentence_start": 3024,
    "sentence_end": 3054,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Gell N, Werner RA, Franzblau A, Ulin SS, Armstrong TJ. A longitudinal \nstudy of industrial and clerical workers: incidence of carpal tunnel syn­\ndrome and assessment of risk factors. The sensitivity and specificity of tests for carpal tun­\nnel syndrome vary with the comparison subjects. J Hand Surg Br. \u0007Gerritsen AA, de Vet HC, Scholten RJ, Bertelsmann FW, de Krom MC, \nBouter LM. Splinting vs surgery in the treatment of carpal tunnel \nsyndrome: a randomized controlled trial. \u0007Gerritsen AA, Korthals-de Bos IB, Laboyrie PM, de Vet HC, Scholten RJ, \nBouter LM. Splinting for carpal tunnel syndrome: prognostic indicators \nof success. J Neurol Neurosurg Psychiatry. \u0007Ghasemi M, Rezaee M, Chavoshi F, Mojtahed M, Shams Koushki E. Carpal \ntunnel syndrome: the role of occupational factors among 906 workers. \u0007Giersiepen K, Eberle A, Pohlabeln H. Gender differences in carpal tunnel \nsyndrome? Occupational and non-occupational risk factors in a popula­\ntion-based case-control study [abstract].",
    "chunk_id": 623,
    "sentence_start": 3053,
    "sentence_end": 3084,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Gökoğlu F, Fndkoğlu G, Yorgancoğlu ZR, Okumuş M, Ceceli E, Kocaoğlu S. Evaluation of iontophoresis and local corticosteroid injection in the treat­\nment of carpal tunnel syndrome. Am J Phys Med Rehabil. Provocative test for carpal tunnel syndrome. \u0007Golriz B, Ahmadi Bani M, Arazpour M, et al. Comparison of the efficacy \nof a neutral wrist splint and a wrist splint incorporating a lumbrical unit \nfor the treatment of patients with carpal tunnel syndrome. Prosthet Or­\nthot Int. \u0007Goodson JT, DeBerard MS, Wheeler AJ, Colledge AL. Occupa­\ntional and biopsychosocial risk factors for carpal tunnel syndrome. J Occup Environ Med. \u0007Graham B, Regehr G, Wright JG. Delphi as a method to establish consen­\nsus for diagnostic criteria. \u0007Greathouse DG, Ernst G, Halle JS, Shaffer SW. GEHS neurophysiological \nclassification system for patients with carpal tunnel syndrome. US Army \nMed Dep J. \u0007Greenslade JR, Mehta RL, Belward P, Warwick DJ.",
    "chunk_id": 624,
    "sentence_start": 3083,
    "sentence_end": 3115,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Greenslade JR, Mehta RL, Belward P, Warwick DJ. DASH and Boston \nquestionnaire assessment of carpal tunnel syndrome outcome: what \nis the responsiveness of an outcome questionnaire? J Hand Surg Br. \u0007Gulliford MC, Latinovic R, Charlton J, Hughes RA. Increased incidence of \ncarpal tunnel syndrome up to 10 years before diagnosis of diabetes. \u0007Gül Yurdakul F, Bodur H, Öztop Çakmak Ö, et al. On the severity of \ncarpal tunnel syndrome: diabetes or metabolic syndrome. \u0007Gurcay E, Unlu E, Gurcay AG, Tuncay R, Cakci A. Assessment of phono­\nphoresis and iontophoresis in the treatment of carpal tunnel syndrome: a \nrandomized controlled trial. \u0007Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. Users’ guides to the medical literature. A method for grading \nhealth care recommendations. Evidence-Based Medicine Work­\ning Group. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 625,
    "sentence_start": 3114,
    "sentence_end": 3147,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\n12/01.wnl.0000338533.88960.b9\nranzblau A, Ulin SS, Armstrong TJ. A longitudinal \nnd clerical workers: incidence of carpal tunnel syn­\nent of risk factors. 007/s10926-005-0873-0\nnsitivity and specificity of tests for carpal tun­\nth the comparison subjects. J Hand Surg Br. s://doi.org/10.1016/S0266-7681(98)80163-0\nHC, Scholten RJ, Bertelsmann FW, de Krom MC, \nvs surgery in the treatment of carpal tunnel \nmized controlled trial. 001/jama.288.10.1245\nls-de Bos IB, Laboyrie PM, de Vet HC, Scholten RJ, \nfor carpal tunnel syndrome: prognostic indicators \nNeurosurg Psychiatry. Carpal \ne role of occupational factors among 906 workers. Gender differences in carpal tunnel \nonal and non-occupational risk factors in a popula­\nrol study [abstract]. 16/S1047-2797(00)00133-2\nG, Yorgancoğlu ZR, Okumuş M, Ceceli E, Kocaoğlu S.",
    "chunk_id": 626,
    "sentence_start": 3146,
    "sentence_end": 3166,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "16/S1047-2797(00)00133-2\nG, Yorgancoğlu ZR, Okumuş M, Ceceli E, Kocaoğlu S. oresis and local corticosteroid injection in the treat­\nl syndrome. Am J Phys Med Rehabil. 2005;84:92-\n0.1097/01.PHM.0000151942.49031.DD\novocative test for carpal tunnel syndrome. Comparison of the efficacy \nnt and a wrist splint incorporating a lumbrical unit \npatients with carpal tunnel syndrome. Occupa­\nsocial risk factors for carpal tunnel syndrome. Delphi as a method to establish consen­\nteria. GEHS neurophysiological \nfor patients with carpal tunnel syndrome. a RL, Belward P, Warwick DJ. DASH and Boston \nment of carpal tunnel syndrome outcome: what \ns of an outcome questionnaire? J Hand Surg Br. ps://doi.org/10.1016/j.jhsb.2003.10.010\nic R, Charlton J, Hughes RA. Increased incidence of \nme up to 10 years before diagnosis of diabetes. On the severity of \nme: diabetes or metabolic syndrome. ps://doi.org/10.3988/jcn.2015.11.3.234\nrcay AG, Tuncay R, Cakci A.",
    "chunk_id": 627,
    "sentence_start": 3165,
    "sentence_end": 3194,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "ps://doi.org/10.3988/jcn.2015.11.3.234\nrcay AG, Tuncay R, Cakci A. Assessment of phono­\noresis in the treatment of carpal tunnel syndrome: a \ned trial. 010-1706-9\nDL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. A method for grading \nendations. \u0007Hagberg M, Morgenstern H, Kelsh M. Impact of occupations and job \ntasks on the prevalence of carpal tunnel syndrome. Scand J Work Envi­\nron Health. \u0007Hakim AJ, Cherkas L, El Zayat S, MacGregor AJ, Spector TD. The genetic \ncontribution to carpal tunnel syndrome in women: a twin study. \u0007Hall B, Lee HC, Fitzgerald H, Byrne B, Barton A, Lee AH. Investigating the \neffectiveness of full-time wrist splinting and education in the treatment \nof carpal tunnel syndrome: a randomized controlled trial. \u0007Hardy M, Jimenez S, Jabaley M, Horch K. Evaluation of nerve compres­\nsion with the Automated Tactile Tester. J Hand Surg Am. \u0007Harris-Adamson C, Eisen EA, Dale AM, et al.",
    "chunk_id": 628,
    "sentence_start": 3193,
    "sentence_end": 3225,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Harris-Adamson C, Eisen EA, Dale AM, et al. Personal and workplace \npsychosocial risk factors for carpal tunnel syndrome: a pooled study \ncohort. Occup Environ Med. \u0007Harris-Adamson C, Eisen EA, Kapellusch J, et al. Biomechanical risk \nfactors for carpal tunnel syndrome: a pooled study of 2474 work­\ners. Occup Environ Med. \u0007Harris-Adamson C, Eisen EA, Neophytou A, et al. Biomechanical and \npsychosocial exposures are independent risk factors for carpal tun­\nnel syndrome: assessment of confounding using causal diagrams. Occup Environ Med. \u0007Hegmann KT, Thiese MS, Kapellusch J, et al. Association between cardio­\nvascular risk factors and carpal tunnel syndrome in pooled occupational \ncohorts. J Occup Environ Med. Familial risks for nerve, nerve root and \nplexus disorders in siblings based on hospitalisations in Sweden. J \nEpidemiol Community Health. \u0007Hirata H, Nagakura T, Tsujii M, Morita A, Fujisawa K, Uchida A.",
    "chunk_id": 629,
    "sentence_start": 3224,
    "sentence_end": 3250,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Hirata H, Nagakura T, Tsujii M, Morita A, Fujisawa K, Uchida A. The \nrelationship of VEGF and PGE2 expression to extracellular matrix re­\nmodelling of the tenosynovium in the carpal tunnel syndrome. \u0007Hlebs S, Majhenic K, Vidmar G. Body mass index and anthropometric \ncharacteristics of the hand as risk factors for carpal tunnel syndrome. \u0007Hobby JL, Watts C, Elliot D. Validity and responsiveness of the patient \nevaluation measure as an outcome measure for carpal tunnel syn­\ndrome. J Hand Surg Br. \u0007Hsu HY, Su FC, Kuo YL, Jou IM, Chiu HY, Kuo LC. Assessment from \nfunctional perspectives: using sensorimotor control in the hand as \nan outcome indicator in the surgical treatment of carpal tunnel syn­\ndrome. \u0007Incebiyik S, Boyaci A, Tutoglu A. Short-term effectiveness of short-wave \ndiathermy treatment on pain, clinical symptoms, and hand function in \npatients with mild or moderate idiopathic carpal tunnel syndrome. J \nBack Musculoskelet Rehabil. \u0007Jablecki CK, Andary MT, Floeter MK, et al.",
    "chunk_id": 630,
    "sentence_start": 3249,
    "sentence_end": 3277,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Jablecki CK, Andary MT, Floeter MK, et al. Practice parameter: electro­\ndiagnostic studies in carpal tunnel syndrome. Report of the American \nAssociation of Electrodiagnostic Medicine, American Academy of Neurol­\nogy, and the American Academy of Physical Medicine and Rehabilitation. \u0007Jerosch-Herold C, Shepstone L, Miller L, Chapman P. The responsiveness \nof sensibility and strength tests in patients undergoing carpal tunnel\n\n\n--- Page 56 ---\nCOLUMN 1:\ndecompression. BMC Musculoskelet Disord. Use of vibration testing in the early evaluation of workers with \ncarpal tunnel syndrome. \u0007Kamolz LP, Beck H, Haslik W, et al. Carpal tunnel syndrome: a question \nof hand and wrist configurations? J Hand Surg Br. \u0007Kapellusch JM, Gerr FE, Malloy EJ, et al. Exposure-response relationships \nfor the ACGIH threshold limit value for hand-activity level: results from \na pooled data study of carpal tunnel syndrome. Scand J Work Environ \nHealth. \u0007Karatay S, Aygul R, Melikoglu MA, et al.",
    "chunk_id": 631,
    "sentence_start": 3276,
    "sentence_end": 3304,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Karatay S, Aygul R, Melikoglu MA, et al. The comparison of phonophore­\nsis, iontophoresis and local steroid injection in carpal tunnel syndrome \ntreatment [letter]. Joint Bone Spine. Carpal tunnel syndrome in hypothyroid­\nism. J Clin Diagn Res. \u0007Kasundra GM, Sood I, Bhargava AN, et al. Carpal tunnel syndrome: \nanalyzing efficacy and utility of clinical tests and various diagnostic \nmodalities. J Neurosci Rural Pract. \u0007Katz JN, Gelberman RH, Wright EA, Lew RA, Liang MH. Responsiveness \nof self-reported and objective measures of disease severity in carpal tun­\nnel syndrome. \u0007Katz JN, Stirrat CR, Larson MG, Fossel AH, Eaton HM, Liang MH. A self-\nadministered hand symptom diagram for the diagnosis and epidemio­\nlogic study of carpal tunnel syndrome. Carpal tunnel syndrome: using self-report mea­\nsures of disease to predict treatment response. Am J Orthop (Belle Mead \nNJ). \u0007Keir PJ, Bach JM, Rempel DM. Effects of finger posture on carpal tunnel \npressure during wrist motion.",
    "chunk_id": 632,
    "sentence_start": 3303,
    "sentence_end": 3337,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Keir PJ, Bach JM, Rempel DM. Effects of finger posture on carpal tunnel \npressure during wrist motion. J Hand Surg Am. \u0007Kerwin G, Williams CS, Seiler JG, 3rd. The pathophysiology of carpal tun­\nnel syndrome. \u0007Koca I, Boyaci A, Tutoglu A, Ucar M, Kocaturk O. Assessment of the effec­\ntiveness of interferential current therapy and TENS in the management \nof carpal tunnel syndrome: a randomized controlled study. \u0007Kociolek AM, Tat J, Keir PJ. Biomechanical risk factors and flexor tendon \nfrictional work in the cadaveric carpal tunnel. \u0007Komurcu HF, Kilic S, Anlar O. Relationship of age, body mass index, wrist \nand waist circumferences to carpal tunnel syndrome severity. Neurol \nMed Chir (Tokyo). \u0007Koris M, Gelberman RH, Duncan K, Boublick M, Smith B. Carpal tunnel \nsyndrome. Evaluation of a quantitative provocational diagnostic test. Clin \nOrthop Relat Res.",
    "chunk_id": 633,
    "sentence_start": 3336,
    "sentence_end": 3368,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Responsiveness of the Michigan Hand Outcomes \nQuestionnaire and the Disabilities of the Arm, Shoulder and Hand \nquestionnaire in carpal tunnel surgery. J Hand Surg Am. \u0007Kouyoumdjian JA, Morita MP, Rocha PR, Miranda RC, Gou­\nveia GM. Wrist and palm indexes in carpal tunnel syndrome. \u0007Kuo MH, Leong CP, Cheng YF, Chang HW. Static wrist position as­\nsociated with least median nerve compression: sonographic \nevaluation. Am J Phys Med Rehabil. Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nC Musculoskelet Disord. 74-12-244\nration testing in the early evaluation of workers with \nme. Carpal tunnel syndrome: a question \nnfigurations? J Hand Surg Br.",
    "chunk_id": 634,
    "sentence_start": 3367,
    "sentence_end": 3398,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Exposure-response relationships \nold limit value for hand-activity level: results from \nof carpal tunnel syndrome. Scand J Work Environ \n620. The comparison of phonophore­\nd local steroid injection in carpal tunnel syndrome \noint Bone Spine. Carpal tunnel syndrome in hypothyroid­\n. Carpal tunnel syndrome: \nd utility of clinical tests and various diagnostic \nci Rural Pract. 147.169867\nRH, Wright EA, Lew RA, Liang MH. Responsiveness \nobjective measures of disease severity in carpal tun­\nCare. arson MG, Fossel AH, Eaton HM, Liang MH. A self-\nymptom diagram for the diagnosis and epidemio­\ntunnel syndrome. Carpal tunnel syndrome: using self-report mea­\nedict treatment response. Am J Orthop (Belle Mead \n2. Effects of finger posture on carpal tunnel \nt motion. J Hand Surg Am. The pathophysiology of carpal tun­\nClin. oglu A, Ucar M, Kocaturk O. Assessment of the effec­\ntial current therapy and TENS in the management \nrome: a randomized controlled study.",
    "chunk_id": 635,
    "sentence_start": 3397,
    "sentence_end": 3432,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Biomechanical risk factors and flexor tendon \ncadaveric carpal tunnel. Relationship of age, body mass index, wrist \nnces to carpal tunnel syndrome severity. RH, Duncan K, Boublick M, Smith B. Carpal tunnel \nn of a quantitative provocational diagnostic test. Responsiveness of the Michigan Hand Outcomes \ne Disabilities of the Arm, Shoulder and Hand \npal tunnel surgery. J Hand Surg Am. 16/j.jhsa.2004.10.006\norita MP, Rocha PR, Miranda RC, Gou­\nalm indexes in carpal tunnel syndrome. Static wrist position as­\nmedian nerve compression: sonographic \nys Med Rehabil. \u0007LaJoie AS, McCabe SJ, Thomas B, Edgell SE. Determining the sensitivity \nand specificity of common diagnostic tests for carpal tunnel syndrome \nusing latent class analysis. Plast Reconstr Surg. Association of obesity, gender, age and occupation \nwith carpal tunnel syndrome. The measurement of observer agreement \nfor categorical data. \u0007Leclerc A, Franchi P, Cristofari MF, et al.",
    "chunk_id": 636,
    "sentence_start": 3431,
    "sentence_end": 3468,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Leclerc A, Franchi P, Cristofari MF, et al. Carpal tunnel syndrome and \nwork organisation in repetitive work: a cross sectional study in France. Study Group on Repetitive Work. Occup Environ Med. \u0007Leclerc A, Landre MF, Chastang JF, Niedhammer I, Roquelaure Y, Study \nGroup on Repetitive Work. Upper-limb disorders in repetitive work. Scand J Work Environ Health. \u0007Levine DW, Simmons BP, Koris MJ, et al. A self-administered question­\nnaire for the assessment of severity of symptoms and functional status \nin carpal tunnel syndrome. J Bone Joint Surg Am. \u0007Liu CW, Chen TW, Wang MC, Chen CH, Lee CL, Huang MH. Relationship \nbetween carpal tunnel syndrome and wrist angle in computer work­\ners. Kaohsiung J Med Sci. \u0007Luckhaupt SE, Dahlhamer JM, Ward BW, Sweeney MH, Sestito JP, Calvert \nGM. Prevalence and work-relatedness of carpal tunnel syndrome in \nthe working population, United States, 2010 National Health Interview \nSurvey. \u0007Lundborg G, Gelberman RH, Minteer-Convery M, Lee YF, Hargens AR.",
    "chunk_id": 637,
    "sentence_start": 3467,
    "sentence_end": 3494,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Lundborg G, Gelberman RH, Minteer-Convery M, Lee YF, Hargens AR. Median nerve compression in the carpal tunnel—functional response \nto experimentally induced controlled pressure. J Hand Surg Am. \u0007Lundborg G, Lie-Stenström AK, Sollerman C, Strömberg T, Pyykkö I. Digi­\ntal vibrogram: a new diagnostic tool for sensory testing in compression \nneuropathy. J Hand Surg Am. Using item response theory improved responsiveness \nof patient-reported outcomes measures in carpal tunnel syndrome. The diagnostic assessment of hand elevation test in carpal \ntunnel syndrome. J Korean Neurosurg Soc. Clinical and electrodiagnostic testing of \ncarpal tunnel syndrome: a narrative review. J Orthop Sports Phys Ther. \u0007MacDermid JC, Kramer JF, McFarlane RM, Roth JH. Inter-rater agree­\nment and accuracy of clinical tests used in diagnosis of carpal tunnel \nsyndrome. \u0007MacDermid JC, Kramer JF, Roth JH. Decision making in detecting \nabnormal Semmes-Weinstein monofilament thresholds in carpal tun­\nnel syndrome.",
    "chunk_id": 638,
    "sentence_start": 3493,
    "sentence_end": 3529,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007MacDermid JC, Walton DM, Law M. Critical appraisal of research evi­\ndence for its validity and usefulness. Clinical diagnosis of carpal tunnel syndrome: \na systematic review. Pathophysiology of nerve compression. --- Page 57 ---\nCOLUMN 1:\n2002;18:231-241. \u0007Maddali Bongi S, Signorini M, Bassetti M, Del Rosso A, Orlandi M, De \nScisciolo G. A manual therapy intervention improves symptoms in \npatients with carpal tunnel syndrome: a pilot study. \u0007Madjdinasab N, Zadeh NS, Assarzadegan F, Ali AMA, Pipelzadeh M. Ef­\nficacy comparison of splint and oral steroid therapy in nerve conduction \nvelocity and latency median nerve in carpal tunnel syndrome. Pak J Med \nSci. \u0007Maggard MA, Harness NG, Chang WT, et al. Indications for performing \ncarpal tunnel surgery: clinical quality measures. Plast Reconstr Surg. \u0007Makanji HS, Becker SJ, Mudgal CS, Jupiter JB, Ring D. Evaluation of the \nscratch collapse test for the diagnosis of carpal tunnel syndrome. J Hand \nSurg Eur Vol.",
    "chunk_id": 639,
    "sentence_start": 3528,
    "sentence_end": 3565,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Manente G, Melchionda D, Staniscia T, D’Archivio C, Mazzone V, Macarini \nL. Changes in the carpal tunnel while wearing the Manu soft hand brace: \na sonographic study. J Hand Surg Eur Vol. \u0007Manente G, Torrieri F, Di Blasio F, Staniscia T, Romano F, Uncini A. An in­\nnovative hand brace for carpal tunnel syndrome: a randomized controlled \ntrial. \u0007Mansfield M, Thacker M, Sandford F. Psychosocial risk factors and the \nassociation with carpal tunnel syndrome: a systematic review. \u0007Marlowe ES, Bonner FJ, Jr., Berkowitz AR. Correlation between \ntwo-point discrimination and median nerve sensory response. \u0007Marx RG, Hudak PL, Bombardier C, Graham B, Goldsmith C, Wright \nJG. The reliability of physical examination for carpal tunnel syn­\ndrome. J Hand Surg Br. \u0007Massy-Westropp N, Grimmer K, Bain G. A systematic review of the \nclinical diagnostic tests for carpal tunnel syndrome. J Hand Surg Am. \u0007Mattioli S, Baldasseroni A, Bovenzi M, et al.",
    "chunk_id": 640,
    "sentence_start": 3564,
    "sentence_end": 3597,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Mattioli S, Baldasseroni A, Bovenzi M, et al. Risk factors for oper­\nated carpal tunnel syndrome: a multicenter population-based \ncase-control study. BMC Public Health. \u0007Mattioli S, Baldasseroni A, Curti S, et al. Incidence rates of in-hospital \ncarpal tunnel syndrome in the general population and possible associa­\ntions with marital status. BMC Public Health. Which outcome measure is the best? Evaluating responsiveness of the Disabilities of the Arm, Shoulder, and \nHand Questionnaire, the Michigan Hand Questionnaire and the Patient-\nSpecific Functional Scale following hand and wrist surgery. \u0007Mediouni Z, Bodin J, Dale AM, et al. Carpal tunnel syndrome and com­\nputer exposure at work in two large complementary cohorts. \u0007Mediouni Z, de Roquemaurel A, Dumontier C, et al. Is carpal tunnel syn­\ndrome related to computer exposure at work? A review and meta-anal­\nysis. J Occup Environ Med. \u0007Meems M, Den Oudsten B, Meems BJ, Pop V.",
    "chunk_id": 641,
    "sentence_start": 3596,
    "sentence_end": 3626,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Meems M, Den Oudsten B, Meems BJ, Pop V. Effectiveness of mechani­\ncal traction as a non-surgical treatment for carpal tunnel syndrome \ncompared to care as usual: study protocol for a randomized controlled \ntrial. \u0007Michlovitz S, Hun L, Erasala GN, Hengehold DA, Weingand KW. Con­\ntinuous low-level heat wrap therapy is effective for treating wrist pain. Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nps://doi.org/10.1016/S0749-0712(01)00012-9\nnorini M, Bassetti M, Del Rosso A, Orlandi M, De \nal therapy intervention improves symptoms in \ntunnel syndrome: a pilot study. ttps://doi.org/10.1007/s00296-012-2507-0\neh NS, Assarzadegan F, Ali AMA, Pipelzadeh M.",
    "chunk_id": 642,
    "sentence_start": 3625,
    "sentence_end": 3640,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "ttps://doi.org/10.1007/s00296-012-2507-0\neh NS, Assarzadegan F, Ali AMA, Pipelzadeh M. Ef­\nf splint and oral steroid therapy in nerve conduction \nmedian nerve in carpal tunnel syndrome. Indications for performing \n: clinical quality measures. Plast Reconstr Surg. ps://doi.org/10.1097/PRS.0b013e3181da8685\nSJ, Mudgal CS, Jupiter JB, Ring D. Evaluation of the \nfor the diagnosis of carpal tunnel syndrome. 412446112\nDi Blasio F, Staniscia T, Romano F, Uncini A. An in­\nfor carpal tunnel syndrome: a randomized controlled \n001;24:1020-1025. Psychosocial risk factors and the \npal tunnel syndrome: a systematic review. Correlation between \ntion and median nerve sensory response. A systematic review of the \nsts for carpal tunnel syndrome. J Hand Surg Am. ps://doi.org/10.1053/jhsu.2000.jhsu025a0120\noni A, Bovenzi M, et al. Risk factors for oper­\nyndrome: a multicenter population-based \nBMC Public Health. 58-9-343\noni A, Curti S, et al.",
    "chunk_id": 643,
    "sentence_start": 3639,
    "sentence_end": 3668,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "58-9-343\noni A, Curti S, et al. Incidence rates of in-hospital \nme in the general population and possible associa­\natus. BMC Public Health. Which outcome measure is the best? eness of the Disabilities of the Arm, Shoulder, and \nthe Michigan Hand Questionnaire and the Patient-\ncale following hand and wrist surgery. Carpal tunnel syndrome and com­\nork in two large complementary cohorts. ps://doi.org/10.1136/bmjopen-2015-008156\nemaurel A, Dumontier C, et al. Is carpal tunnel syn­\nmputer exposure at work? A review and meta-anal­\nn Med. Effectiveness of mechani­\n-surgical treatment for carpal tunnel syndrome \nusual: study protocol for a randomized controlled \n80. Con­\nt wrap therapy is effective for treating wrist pain. Arch Phys Med Rehabil. \u0007Mishra S, Prabhakar S, Lal V, Modi M, Das CP, Khurana D. Efficacy of \nsplinting and oral steroids in the treatment of carpal tunnel syndrome: a \nprospective randomized clinical and electrophysiological study. \u0007Mondelli M, Curti S, Farioli A, et al.",
    "chunk_id": 644,
    "sentence_start": 3667,
    "sentence_end": 3697,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Mondelli M, Curti S, Farioli A, et al. Anthropometric measurements as \na screening test for carpal tunnel syndrome: receiver operating charac­\nteristic curves and accuracy. Arthritis Care Res (Hoboken). \u0007Mondelli M, Curti S, Mattioli S, et al. Associations between body \nanthropometric measures and severity of carpal tunnel syndrome. Arch Phys Med Rehabil. \u0007Mondelli M, Farioli A, Mattioli S, et al. Severity of carpal tunnel syn­\ndrome and diagnostic accuracy of hand and body anthropometric \nmeasures. \u0007Mondelli M, Passero S, Giannini F. Provocative tests in different stages \nof carpal tunnel syndrome. Clin Neurol Neurosurg. \u0007Musolin K, Ramsey JG, Wassell JT, Hard DL. Prevalence of carpal tunnel \nsyndrome among employees at a poultry processing plant. Histology of the transverse carpal liga­\nment and flexor tenosynovium in idiopathic carpal tunnel syndrome. J Hand Surg Am. Hypercholesterolemia as a risk factor for \nidiopathic carpal tunnel syndrome.",
    "chunk_id": 645,
    "sentence_start": 3696,
    "sentence_end": 3734,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Small hand as a risk factor for idiopathic \ncarpal tunnel syndrome. Carpal tunnel syndrome and its relation to gen­\neral physical condition. \u0007Nathan PA, Keniston RC, Lockwood RS, Meadows KD. Tobacco, caffeine, \nalcohol, and carpal tunnel syndrome in American industry. A cross-sec­\ntional study of 1464 workers. J Occup Environ Med. \u0007Nathan PA, Keniston RC, Myers LD, Meadows KD. Obesity as a risk fac­\ntor for slowing of sensory conduction of the median nerve in industry. A \ncross-sectional and longitudinal study involving 429 workers. \u0007Nathan PA, Meadows KD, Doyle LS. Occupation as a risk fac­\ntor for impaired sensory conduction of the median nerve at \nthe carpal tunnel. J Hand Surg Br. \u0007Nathan PA, Meadows KD, Istvan JA. Predictors of carpal tunnel \nsyndrome: an 11-year study of industrial workers. J Hand Surg Am. \u0007Neral M, Winger D, Imbriglia J, Wollstein R. Hand shape and carpal tun­\nnel syndrome. Curr Rheumatol Rev. \u0007Nordander C, Ohlsson K, Åkesson I, et al.",
    "chunk_id": 646,
    "sentence_start": 3733,
    "sentence_end": 3774,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Nordander C, Ohlsson K, Åkesson I, et al. Exposure-response relation­\nships in work-related musculoskeletal disorders in elbows and hands \n– a synthesis of group-level data on exposure and response obtained \nusing uniform methods of data collection. \u0007Nordstrom DL, Vierkant RA, DeStefano F, Layde PM. Risk factors for \ncarpal tunnel syndrome in a general population. Occup Environ Med. \u0007Ntani G, Palmer KT, Linaker C, et al. Symptoms, signs and nerve \nconduction velocities in patients with suspected carpal tunnel \nsyndrome. BMC Musculoskelet Disord. \u0007O’Connor D, Page MJ, Marshall SC, Massy-Westropp N. Ergonomic posi­\ntioning or equipment for treating carpal tunnel syndrome. Cochrane Da­\ntabase Syst Rev. \u0007Oktayoglu P, Nas K, Kilinç F, Tasdemir N, Bozkurt M, Yildiz I. Assessment \nof the presence of carpal tunnel syndrome in patients with diabetes \nmellitus, hypothyroidism and acromegaly. J Clin Diagn Res. \u0007Ollivere BJ, Logan K, Ellahee N, Miller-Jones JC, Wood M, Nairn DS.",
    "chunk_id": 647,
    "sentence_start": 3773,
    "sentence_end": 3801,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Ollivere BJ, Logan K, Ellahee N, Miller-Jones JC, Wood M, Nairn DS. Severity scoring in carpal tunnel syndrome helps predict the value of \nconservative therapy. J Hand Surg Eur Vol. Change in strength and dexterity after open \ncarpal tunnel release. Int J Sports Med. \u0007Oskouei AE, Talebi GA, Shakouri SK, Ghabili K. Effects of neuromobiliza­\ntion maneuver on clinical and electrophysiological measures of patients \nwith carpal tunnel syndrome. J Phys Ther Sci. \u0007Ozcakir S, Sigirli D, Avsaroglu H. High wrist ratio is a risk factor for carpal \ntunnel syndrome. \u0007Ozer K, Malay S, Toker S, Chung KC. Minimal clinically important dif­\nference of carpal tunnel release in diabetic and nondiabetic patients. Plast Reconstr Surg. \u0007Özgen M, Güngen G, Sarsan A, et al. Determination of the position on \nwhich the median nerve compression is at the lowest in carpal tunnel \nsyndrome and clinical effectiveness of custom splint application. \u0007Oztas O, Turan B, Bora I, Karakaya MK.",
    "chunk_id": 648,
    "sentence_start": 3800,
    "sentence_end": 3833,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Oztas O, Turan B, Bora I, Karakaya MK. Ultrasound therapy effect in \ncarpal tunnel syndrome. Arch Phys Med Rehabil. \u0007Özyürekoğlu T, McCabe SJ, Goldsmith LJ, LaJoie AS. The minimal clini­\ncally important difference of the Carpal Tunnel Syndrome Symptom \nSeverity Scale. J Hand Surg Am. \u0007Padua L, LoMonaco M, Gregori B, Valente EM, Padua R, Tonali P. Neurophysiological classification and sensitivity in 500 carpal tun­\nnel syndrome hands. Acta Neurol Scand. Splinting for carpal tun­\nnel syndrome. Cochrane Database Syst Rev. Exercise and mobilisa­\ntion interventions for carpal tunnel syndrome. Cochrane Database Syst \nRev. \u0007Palmer KT, Harris EC, Coggon D. Carpal tunnel syndrome and its rela­\ntion to occupation: a systematic literature review. Occup Med (Lond). \u0007Pascual E, Giner V, Aróstegui A, Conill J, Ruiz MT, Picó A. Higher \nincidence of carpal tunnel syndrome in oophorectomized wom­\nen.",
    "chunk_id": 649,
    "sentence_start": 3832,
    "sentence_end": 3869,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Risk factors for carpal tunnel syndrome re­\nlated to the work organization: a prospective surveillance study in a large \nworking population. apergo.2014.08.007\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nLinaker C, et al. Symptoms, signs and nerve \ns in patients with suspected carpal tunnel \nsculoskelet Disord. Ergonomic posi­\n for treating carpal tunnel syndrome. ilinç F, Tasdemir N, Bozkurt M, Yildiz I. Assessment \nrpal tunnel syndrome in patients with diabetes \nism and acromegaly. J Clin Diagn Res. 2015;9:OC14-\n/10.7860/JCDR/2015/13149.6101\nEllahee N, Miller-Jones JC, Wood M, Nairn DS. arpal tunnel syndrome helps predict the value of \n. J Hand Surg Eur Vol. Change in strength and dexterity after open \n.",
    "chunk_id": 650,
    "sentence_start": 3868,
    "sentence_end": 3896,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Change in strength and dexterity after open \n. Int J Sports Med. 13815\nA, Shakouri SK, Ghabili K. Effects of neuromobiliza­\nnical and electrophysiological measures of patients \nndrome. J Phys Ther Sci. High wrist ratio is a risk factor for carpal \nn Anat. Minimal clinically important dif­\nnel release in diabetic and nondiabetic patients. Determination of the position on \nrve compression is at the lowest in carpal tunnel \nl effectiveness of custom splint application. Ultrasound therapy effect in \nme. Arch Phys Med Rehabil. 16/S0003-9993(98)90416-6\nbe SJ, Goldsmith LJ, LaJoie AS. The minimal clini­\nence of the Carpal Tunnel Syndrome Symptom \nd Surg Am. 16/j.jhsa.2006.01.012\nM, Gregori B, Valente EM, Padua R, Tonali P. classification and sensitivity in 500 carpal tun­\n. Acta Neurol Scand. 404.1997.tb00271.x\ntropp N, O’Connor D, Pitt V. Splinting for carpal tun­\nane Database Syst Rev. Exercise and mobilisa­\nr carpal tunnel syndrome. Cochrane Database Syst \n9.",
    "chunk_id": 651,
    "sentence_start": 3895,
    "sentence_end": 3931,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Cochrane Database Syst \n9. Carpal tunnel syndrome and its rela­\nsystematic literature review. Occup Med (Lond). ://doi.org/10.1093/occmed/kql125\nróstegui A, Conill J, Ruiz MT, Picó A. Higher \nunnel syndrome in oophorectomized wom­\n1991;30:60-62. Risk factors for carpal tunnel syndrome re­\nanization: a prospective surveillance study in a large \nAppl Ergon. \u0007Phillips B, Ball C, Sackett D, et al. Oxford Centre for Evidence-based \nMedicine - Levels of Evidence (March 2009). Accessed March 25, 2019. Diabetes as a risk factor for carpal tunnel syn­\ndrome: a systematic review and meta-analysis. Smoking and carpal tunnel \nsyndrome: a meta-analysis. \u0007Povlsen B, Bashir M, Wong F. Long-term result and patient reported \noutcome of wrist splint treatment for carpal tunnel syndrome. J Plast \nSurg Hand Surg. \u0007Pransky G, Feuerstein M, Himmelstein J, Katz JN, Vickers-Lahti M. Mea­\nsuring functional outcomes in work-related upper extremity disorders.",
    "chunk_id": 652,
    "sentence_start": 3930,
    "sentence_end": 3964,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Pransky G, Feuerstein M, Himmelstein J, Katz JN, Vickers-Lahti M. Mea­\nsuring functional outcomes in work-related upper extremity disorders. Development and validation of the Upper Extremity Function Scale. J \nOccup Environ Med. \u0007Premoselli S, Sioli P, Grossi A, Cerri C. Neutral wrist splinting in carpal \ntunnel syndrome: a 3- and 6-months clinical and neurophysiologic \nfollow-up evaluation of night-only splint therapy. The relationship among five common carpal tunnel \nsyndrome tests and the severity of carpal tunnel syndrome. A gender specific wrist ratio and the likelihood of a median \nnerve abnormality at the carpal tunnel. Am J Phys Med Rehabil. \u0007Raeissadat SA, Rayegani SM, Rezaei S, et al. The effect of polarized poly­\nchromatic noncoherent light (Bioptron) therapy on patients with carpal \ntunnel syndrome. J Lasers Med Sci. \u0007Raji P, Ansari NN, Naghdi S, Forogh B, Hasson S.",
    "chunk_id": 653,
    "sentence_start": 3963,
    "sentence_end": 3989,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Raji P, Ansari NN, Naghdi S, Forogh B, Hasson S. Relationship between \nSemmes-Weinstein monofilaments perception test and sensory nerve \nconduction studies in carpal tunnel syndrome. \u0007Rankin IA, Sargeant H, Rehman H, Gurusamy KF. Low‐level laser \ntherapy for carpal tunnel syndrome. Cochrane Database Syst Rev. \u0007Rempel D, Bach JM, Gordon L, So Y. Effects of forearm pronation/supina­\ntion on carpal tunnel pressure. J Hand Surg Am. \u0007Rempel D, Evanoff B, Amadio PC, et al. Consensus criteria for the classi­\nfication of carpal tunnel syndrome in epidemiologic studies. \u0007Rempel D, Tittiranonda P, Burastero S, Hudes M, So Y. Effect of keyboard \nkeyswitch design on hand pain. J Occup Environ Med. Entrapment neuropathies: pathophysiology and \npathogenesis. \u0007Rempel DM, Keir PJ, Bach JM. Effect of wrist posture on carpal tunnel \npressure while typing. \u0007Riccò M, Cattani S, Signorelli C. Personal risk factors for carpal tunnel \nsyndrome in female visual display unit workers.",
    "chunk_id": 654,
    "sentence_start": 3988,
    "sentence_end": 4027,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Riccò M, Cattani S, Signorelli C. Personal risk factors for carpal tunnel \nsyndrome in female visual display unit workers. Int J Occup Med Environ \nHealth. Personal and occupational risk factors for carpal \ntunnel syndrome in meat processing industry workers in Northern Italy. Organizational and psychosocial risk \nfactors for carpal tunnel syndrome: a cross-sectional study of French \nworkers. Int Arch Occup Environ Health. org/10.1007/s00420-013-0846-0\n\n\n--- Page 59 ---\nCOLUMN 1:\n\u0007245. \u0007Rojviroj S, Sirichativapee W, Kowsuwon W, Wongwiwattananon J, \nTamnanthong N, Jeeravipoolvarn P. Pressures in the carpal tunnel. A \ncomparison between patients with carpal tunnel syndrome and normal \nsubjects. J Bone Joint Surg Br. \u0007Roll SC, Volz KR, Fahy CM, Evans KD. Carpal tunnel syndrome sever­\nity staging using sonographic and clinical measures. \u0007Roquelaure Y, Chazelle E, Gautier L, et al.",
    "chunk_id": 655,
    "sentence_start": 4026,
    "sentence_end": 4053,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Roquelaure Y, Chazelle E, Gautier L, et al. Time trends in incidence and \nprevalence of carpal tunnel syndrome over eight years according to mul­\ntiple data sources: Pays de la Loire study. Scand J Work Environ Health. Work increases the incidence \nof carpal tunnel syndrome in the general population. \u0007Roquelaure Y, Mechali S, Dano C, et al. Occupational and personal risk \nfactors for carpal tunnel syndrome in industrial workers. Scand J Work \nEnviron Health. Has the median nerve involvement in rheu­\nmatoid arthritis been overemphasized? Rev Bras Reumatol Engl Ed. \u0007Salerno DF, Franzblau A, Werner RA, et al. Reliability of physi­\ncal examination of the upper extremity among keyboard op­\nerators. \u0007Schmid AB, Elliott JM, Strudwick MW, Little M, Coppieters MW. Effect of \nsplinting and exercise on intraneural edema of the median nerve in car­\npal tunnel syndrome—an MRI study to reveal therapeutic mechanisms. \u0007Schmid AB, Kubler PA, Johnston V, Coppieters MW.",
    "chunk_id": 656,
    "sentence_start": 4052,
    "sentence_end": 4083,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Schmid AB, Kubler PA, Johnston V, Coppieters MW. A vertical mouse \nand ergonomic mouse pads alter wrist position but do not reduce carpal \ntunnel pressure in patients with carpal tunnel syndrome. Validity and responsiveness of the Jebsen-Taylor \nHand Function Test. J Hand Surg Am. Arthritis as a risk factor for carpal tunnel syndrome: a meta-\nanalysis. Hypothyroidism and carpal tunnel syndrome: a meta-analysis. A square-shaped wrist as a predictor of carpal tunnel syn­\ndrome: a meta-analysis. Computer use and carpal tunnel syndrome: a \nmeta-analysis. \u0007Shiri R, Heliövaara M, Moilanen L, Viikari J, Liira H, Viikari-Juntura \nE. Associations of cardiovascular risk factors, carotid intima-media \nthickness and manifest atherosclerotic vascular disease with carpal \ntunnel syndrome. BMC Musculoskelet Disord. The ef­\nfect of excess body mass on the risk of carpal tunnel syndrome: a \nmeta-analysis of 58 studies. Intraclass correlations: uses in assess­\ning rater reliability.",
    "chunk_id": 657,
    "sentence_start": 4082,
    "sentence_end": 4133,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Silverstein B, Fan ZJ, Smith CK, et al. Gender adjustment or stratifica­\ntion in discerning upper extremity musculoskeletal disorder risk? Scand \nJ Work Environ Health. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\napee W, Kowsuwon W, Wongwiwattananon J, \nravipoolvarn P. Pressures in the carpal tunnel. A \nn patients with carpal tunnel syndrome and normal \nnt Surg Br. Carpal tunnel syndrome sever­\nographic and clinical measures. Time trends in incidence and \ntunnel syndrome over eight years according to mul­\nays de la Loire study. Scand J Work Environ Health. Work increases the incidence \ndrome in the general population. tps://doi.org/10.1002/mus.20952\nali S, Dano C, et al. Occupational and personal risk \nnnel syndrome in industrial workers. Scand J Work \n;23:364-369.",
    "chunk_id": 658,
    "sentence_start": 4132,
    "sentence_end": 4159,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Scand J Work \n;23:364-369. Has the median nerve involvement in rheu­\nn overemphasized? Rev Bras Reumatol Engl Ed. Reliability of physi­\ne upper extremity among keyboard op­\nd. Effect of \ne on intraneural edema of the median nerve in car­\n—an MRI study to reveal therapeutic mechanisms. A vertical mouse \nse pads alter wrist position but do not reduce carpal \natients with carpal tunnel syndrome. Validity and responsiveness of the Jebsen-Taylor \nJ Hand Surg Am. 009.09.008\n risk factor for carpal tunnel syndrome: a meta-\neumatol. Computer use and carpal tunnel syndrome: a \nurol Sci. M, Moilanen L, Viikari J, Liira H, Viikari-Juntura \nrdiovascular risk factors, carotid intima-media \nest atherosclerotic vascular disease with carpal \nMC Musculoskelet Disord. The ef­\nmass on the risk of carpal tunnel syndrome: a \nstudies. 4\nIntraclass correlations: uses in assess­\nsychol Bull. Gender adjustment or stratifica­\nper extremity musculoskeletal disorder risk?",
    "chunk_id": 659,
    "sentence_start": 4158,
    "sentence_end": 4202,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Smith-Forbes EV, Howell DM, Willoughby J, Pitts DG, Uhl TL. Specificity \nof the minimal clinically important difference of the quick Disabilities of \nthe Arm, Shoulder and Hand (QDASH) for distal upper extremity condi­\ntions. \u0007So H, Chung VCH, Cheng JCK, Yip RML. Local steroid injection versus \nwrist splinting for carpal tunnel syndrome: a randomized clinical trial. Int \nJ Rheum Dis. \u0007Solomon DH, Katz JN, Bohn R, Mogun H, Avorn J. Nonoccupational risk \nfactors for carpal tunnel syndrome. J Gen Intern Med. \u0007Soyupek F, Kutluhan S, Uslusoy G, Ilgun E, Eris S, Askin A. The efficacy \nof phonophoresis on electrophysiological studies of the patients with \ncarpal tunnel syndrome. \u0007Soyupek F, Yesildag A, Kutluhan S, et al. Determining the effectiveness of \nvarious treatment modalities in carpal tunnel syndrome by ultrasonogra­\nphy and comparing ultrasonographic findings with other outcomes. \u0007Stasinopoulos D, Stasinopoulos I, Johnson MI.",
    "chunk_id": 660,
    "sentence_start": 4201,
    "sentence_end": 4230,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Stasinopoulos D, Stasinopoulos I, Johnson MI. Treatment of carpal tun­\nnel syndrome with polarized polychromatic noncoherent light (Bioptron \nlight): a preliminary, prospective, open clinical trial. Photomed Laser \nSurg. \u0007Stevens JC, Beard CM, O’Fallon WM, Kurland LT. Conditions associated \nwith carpal tunnel syndrome. Mayo Clin Proc. Carpal tunnel syndrome. Orthop Clin North Am. \u0007Talmor M, Patel MP, Spann MD, et al. COX-2 up-regulation in idiopathic \ncarpal tunnel syndrome. Plast Reconstr Surg. \u0007Tanaka S, Wild DK, Seligman PJ, Halperin WE, Behrens VJ, Putz-Anderson \nV. Prevalence and work-relatedness of self-reported carpal tunnel \nsyndrome among U.S. workers: analysis of the Occupational Health \nSupplement data of 1988 National Health Interview Survey. \u0007Taser F, Deger AN, Deger H. Comparative histopathological evaluation of \npatients with diabetes, hypothyroidism and idiopathic carpal tunnel syn­\ndrome. \u0007Thüngen T, Sadowski M, El Kazzi W, Schuind F.",
    "chunk_id": 661,
    "sentence_start": 4229,
    "sentence_end": 4261,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Thüngen T, Sadowski M, El Kazzi W, Schuind F. Value of Gilliatt’s pneu­\nmatic tourniquet test for diagnosis of carpal tunnel syndrome. \u0007Tittiranonda P, Rempel D, Armstrong T, Burastero S. Effect of four com­\nputer keyboards in computer users with upper extremity musculoskel­\netal disorders. \u0007Tulipan JE, Lutsky KF, Maltenfort MG, Freedman MK, Beredjiklian PK. Patient-reported disability measures do not correlate with electrodi­\nagnostic severity in carpal tunnel syndrome. Plast Reconstr Surg Glob \nOpen. \u0007Ucan H, Yagci I, Yilmaz L, Yagmurlu F, Keskin D, Bodur H. Comparison \nof splinting, splinting plus local steroid injection and open carpal tunnel \nrelease outcomes in idiopathic carpal tunnel syndrome. \u0007van Dijk MA, Reitsma JB, Fischer JC, Sanders GT. Indications for re­\nquesting laboratory tests for concurrent diseases in patients with carpal \ntunnel syndrome: a systematic review. \u0007van Rijn RM, Huisstede BM, Koes BW, Burdorf A.",
    "chunk_id": 662,
    "sentence_start": 4260,
    "sentence_end": 4286,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007van Rijn RM, Huisstede BM, Koes BW, Burdorf A. Associations between \nwork-related factors and the carpal tunnel syndrome—a systematic \nreview. Scand J Work Environ Health. org/10.5271/sjweh.1306\n\n\n--- Page 60 ---\nCOLUMN 1:\n\u0007280. \u0007Vanti C, Bonfiglioli R, Calabrese M, et al. Upper Limb Neurodynamic \nTest 1 and symptoms reproduction in carpal tunnel syndrome. \u0007Vanti C, Bonfiglioli R, Calabrese M, Marinelli F, Violante FS, Pillastrini P. Relationship between interpretation and accuracy of the Upper Limb \nNeurodynamic Test 1 in carpal tunnel syndrome. J Manipulative Physiol \nTher. Epidemiology of carpal tun­\nnel syndrome in women of childbearing age. Findings in a large cohort \nstudy. \u0007Wainner RS, Fritz JM, Irrgang JJ, Delitto A, Allison S, Boninger ML. Development of a clinical prediction rule for the diagnosis of carpal tun­\nnel syndrome. Arch Phys Med Rehabil. \u0007Walker WC, Metzler M, Cifu DX, Swartz Z.",
    "chunk_id": 663,
    "sentence_start": 4285,
    "sentence_end": 4316,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Walker WC, Metzler M, Cifu DX, Swartz Z. Neutral wrist splinting in carpal \ntunnel syndrome: a comparison of night-only versus full-time wear \ninstructions. Arch Phys Med Rehabil. \u0007Wang JC, Liao KK, Lin KP, et al. Efficacy of combined ultrasound-guided \nsteroid injection and splinting in patients with carpal tunnel syndrome: \na randomized controlled trial. Arch Phys Med Rehabil. Carpal tunnel syndrome: a system for categorizing and grad­\ning electrophysiologic abnormalities. Electromyogr Clin Neurophysiol. \u0007Weiss ND, Gordon L, Bloom T, So Y, Rempel DM. Position of the wrist \nassociated with the lowest carpal-tunnel pressure: implications for splint \ndesign. J Bone Joint Surg Am. Evaluation of work-related carpal tunnel syndrome. \u0007Werner RA, Albers JW, Franzblau A, Armstrong TJ. The relationship \nbetween body mass index and the diagnosis of carpal tunnel syndrome. \u0007Werner RA, Franzblau A, Gell N, Hartigan AG, Ebersole M, Armstrong \nTJ.",
    "chunk_id": 664,
    "sentence_start": 4315,
    "sentence_end": 4347,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Werner RA, Franzblau A, Gell N, Hartigan AG, Ebersole M, Armstrong \nTJ. Incidence of carpal tunnel syndrome among automobile assem­\nbly workers and assessment of risk factors. J Occup Environ Med. \u0007Werner RA, Franzblau A, Johnston E. Comparison of multiple frequency \nvibrometry testing and sensory nerve conduction measures in screen­\ning for carpal tunnel syndrome in an industrial setting. Am J Phys Med \nRehabil. \u0007Williams TM, Mackinnon SE, Novak CB, McCabe S, Kelly L. Verification \nof the pressure provocative test in carpal tunnel syndrome. Ann Plast \nSurg. Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\n, Calabrese M, et al. Upper Limb Neurodynamic \ns reproduction in carpal tunnel syndrome.",
    "chunk_id": 665,
    "sentence_start": 4346,
    "sentence_end": 4370,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Calabrese M, Marinelli F, Violante FS, Pillastrini P. n interpretation and accuracy of the Upper Limb \n1 in carpal tunnel syndrome. Epidemiology of carpal tun­\nmen of childbearing age. Findings in a large cohort \nol. nical prediction rule for the diagnosis of carpal tun­\nPhys Med Rehabil. 2004.11.008\nM, Cifu DX, Swartz Z. Neutral wrist splinting in carpal \ncomparison of night-only versus full-time wear \nhys Med Rehabil. Efficacy of combined ultrasound-guided \nsplinting in patients with carpal tunnel syndrome: \nolled trial. Arch Phys Med Rehabil. 016/j.apmr.2017.01.018\nel syndrome: a system for categorizing and grad­\nic abnormalities. Electromyogr Clin Neurophysiol. Bloom T, So Y, Rempel DM. Position of the wrist \nowest carpal-tunnel pressure: implications for splint \nSurg Am. on of work-related carpal tunnel syndrome. The relationship \nindex and the diagnosis of carpal tunnel syndrome. J Occup Environ Med.",
    "chunk_id": 666,
    "sentence_start": 4369,
    "sentence_end": 4401,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "J Occup Environ Med. Comparison of multiple frequency \nnd sensory nerve conduction measures in screen­\nsyndrome in an industrial setting. Am J Phys Med \n106. nnon SE, Novak CB, McCabe S, Kelly L. Verification \nocative test in carpal tunnel syndrome. Ann Plast \n  \u0007293. Is manual therapy based on neurodynamic tech­\nniques effective in the treatment of carpal tunnel syndrome? A ran­\ndomized controlled trial. Neurodynamic techniques versus “sham” therapy \nin the treatment of carpal tunnel syndrome: a randomized placebo-\ncontrolled trial. Arch Phys Med Rehabil. \u0007Wolny T, Saulicz E, Linek P, Myśliwiec A, Saulicz M. Effect of manual \ntherapy and neurodynamic techniques vs ultrasound and laser on \n2PD in patients with CTS: a randomized controlled trial. International Classification of Functioning, \nDisability and Health: ICF. Geneva, Switzerland: World Health \nOrganization; 2001. International Statistical Classification of Dis­\neases and Related Health Problems.",
    "chunk_id": 667,
    "sentence_start": 4400,
    "sentence_end": 4430,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "International Statistical Classification of Dis­\neases and Related Health Problems. Geneva, Switzerland: World Health \nOrganization; 2009. \u0007Wright C, Smith B, Wright S, Weiner M, Wright K, Rubin D. Who develops \ncarpal tunnel syndrome during pregnancy: an analysis of obesity, ges­\ntational weight gain, and parity. \u0007Yeudall LT, Fromm D, Reddon JR, Stefanyk WO. Normative data \nstratified by age and sex for 12 neuropsychological tests. What is the role of Semmes-Weinstein \nmonofilament testing in the diagnosis of electrophysiologically \ngraded carpal tunnel syndrome? J Phys Ther Sci. \u0007Yildiz N, Atalay NS, Gungen GO, Sanal E, Akkaya N, Topuz O. Comparison \nof ultrasound and ketoprofen phonophoresis in the treatment of carpal \ntunnel syndrome. J Back Musculoskelet Rehabil. \u0007You D, Smith AH, Rempel D. Meta-analysis: association between wrist \nposture and carpal tunnel syndrome among workers. Saf Health Work.",
    "chunk_id": 668,
    "sentence_start": 4429,
    "sentence_end": 4459,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "A comparison of DASH, PEM and Levine questionnaires \nin outcome measurement of carpal tunnel release. Handchir Mikrochir \nPlast Chir. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 669,
    "sentence_start": 4458,
    "sentence_end": 4467,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX A\nES FOR ALL DATABASES \nL\nme” OR “median nerve compression”) \nvalence) AND (2008 [PDat]: 2018 [PDat]; \nme” OR “median nerve compression”) \nhophysiology OR pathoanatomy OR \npressure”; (“carpal tunnel syndrome” OR \nssion”) AND classification; (“carpal tunnel \nn nerve compression”) AND (inflammation \nrpal tunnel syndrome” OR “median nerve \nnservative AND (outcome OR “clinical \nme” OR “median nerve compression”) AND \n(“carpal tunnel syndrome” OR “median \nND “patient-report measures”; (“carpal \nmedian nerve compression”) AND “inter­\npal tunnel syndrome” OR “median nerve \nability; (“carpal tunnel syndrome” OR \nssion”) AND validity; DASH AND (“carpal \nmedian nerve compression”); DASH AND \nes”; “Katz hand diagram” AND (“carpal \nmedian nerve compression”); “Brigham \nrpal tunnel questionnaire”; “6-item carpal \ntoms scale”; QuickDASH AND (“carpal \nmedian nerve compression”); Quick­\ntric properties”; “Palmar pain scale” AND \nme” OR “median nerve compression”); \nD “psychometric properties”; “Boston \nnaire”; “Boston carpal tunnel question­\ntric properties”; “Michigan hand outcome \narpal tunnel syndrome” OR “median nerve \ngan hand outcome questionnaire” AND \nes”; “patient evaluation measure” AND \nme” OR “median nerve compression”); \nnel syndrome” OR “median nerve com­\n“psychometric properties”; “patient-rated \nonnaire” AND (“carpal tunnel syndrome” \npression”); “patient-rated wrist evalu­\nND “psychometric properties”; “upper \nale” AND (“carpal tunnel syndrome” OR \nssion”); “upper extremity functional scale” \noperties”; “Mcgill pain questionnaire” \nndrome” OR “median nerve compres­\nnce screening tool” AND (“carpal tunnel \nn nerve compression”); “7 item satisfac­\n tunnel syndrome” OR “median nerve \nm brief Michigan hand questionnaire” AND \nme” OR “median nerve compression”)\n” AND (“carpal tunnel syndrome” OR “me­\n”) “f\nti\nl\nt\n” AND\n(“carpal tunnel syndrome” OR “median nerve compression”); “in­\nternal consistency” AND (“carpal tunnel syndrome” OR “median \nnerve compression”); reliability AND (“carpal tunnel syndrome” \nOR “median nerve compression”); validity AND (“carpal tunnel \nsyndrome” OR “median nerve compression”)\n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND “grip strength” AND “measurement”; (“carpal tunnel syn­\ndrome” OR “median nerve compression”) AND “grip strength” \nAND “reliability”; (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND “grip strength” AND “measurement” and \n“standardization”; (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND “grip strength” AND “minimal detectable \nchange”.",
    "chunk_id": 670,
    "sentence_start": 4466,
    "sentence_end": 4468,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX A\nES FOR ALL DATABASES \nL\nme” OR “median nerve compression”) \nvalence) AND (2008 [PDat]: 2018 [PDat]; \nme” OR “median nerve compression”) \nhophysiology OR pathoanatomy OR \npressure”; (“carpal tunnel syndrome” OR \nssion”) AND classification; (“carpal tunnel \nn nerve compression”) AND (inflammation \nrpal tunnel syndrome” OR “median nerve \nnservative AND (outcome OR “clinical \nme” OR “median nerve compression”) AND \n(“carpal tunnel syndrome” OR “median \nND “patient-report measures”; (“carpal \nmedian nerve compression”) AND “inter­\npal tunnel syndrome” OR “median nerve \nability; (“carpal tunnel syndrome” OR \nssion”) AND validity; DASH AND (“carpal \nmedian nerve compression”); DASH AND \nes”; “Katz hand diagram” AND (“carpal \nmedian nerve compression”); “Brigham \nrpal tunnel questionnaire”; “6-item carpal \ntoms scale”; QuickDASH AND (“carpal \nmedian nerve compression”); Quick­\ntric properties”; “Palmar pain scale” AND \nme” OR “median nerve compression”); \nD “psychometric properties”; “Boston \nnaire”; “Boston carpal tunnel question­\ntric properties”; “Michigan hand outcome \narpal tunnel syndrome” OR “median nerve \ngan hand outcome questionnaire” AND \nes”; “patient evaluation measure” AND \nme” OR “median nerve compression”); \nnel syndrome” OR “median nerve com­\n“psychometric properties”; “patient-rated \nonnaire” AND (“carpal tunnel syndrome” \npression”); “patient-rated wrist evalu­\nND “psychometric properties”; “upper \nale” AND (“carpal tunnel syndrome” OR \nssion”); “upper extremity functional scale” \noperties”; “Mcgill pain questionnaire” \nndrome” OR “median nerve compres­\nnce screening tool” AND (“carpal tunnel \nn nerve compression”); “7 item satisfac­\n tunnel syndrome” OR “median nerve \nm brief Michigan hand questionnaire” AND \nme” OR “median nerve compression”)\n” AND (“carpal tunnel syndrome” OR “me­\n”) “f\nti\nl\nt\n” AND\n(“carpal tunnel syndrome” OR “median nerve compression”); “in­\nternal consistency” AND (“carpal tunnel syndrome” OR “median \nnerve compression”); reliability AND (“carpal tunnel syndrome” \nOR “median nerve compression”); validity AND (“carpal tunnel \nsyndrome” OR “median nerve compression”)\n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND “grip strength” AND “measurement”; (“carpal tunnel syn­\ndrome” OR “median nerve compression”) AND “grip strength” \nAND “reliability”; (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND “grip strength” AND “measurement” and \n“standardization”; (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND “grip strength” AND “minimal detectable \nchange”. (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND “grip strength” AND “clinically relevant change”.",
    "chunk_id": 671,
    "sentence_start": 4467,
    "sentence_end": 4469,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX A\nES FOR ALL DATABASES \nL\nme” OR “median nerve compression”) \nvalence) AND (2008 [PDat]: 2018 [PDat]; \nme” OR “median nerve compression”) \nhophysiology OR pathoanatomy OR \npressure”; (“carpal tunnel syndrome” OR \nssion”) AND classification; (“carpal tunnel \nn nerve compression”) AND (inflammation \nrpal tunnel syndrome” OR “median nerve \nnservative AND (outcome OR “clinical \nme” OR “median nerve compression”) AND \n(“carpal tunnel syndrome” OR “median \nND “patient-report measures”; (“carpal \nmedian nerve compression”) AND “inter­\npal tunnel syndrome” OR “median nerve \nability; (“carpal tunnel syndrome” OR \nssion”) AND validity; DASH AND (“carpal \nmedian nerve compression”); DASH AND \nes”; “Katz hand diagram” AND (“carpal \nmedian nerve compression”); “Brigham \nrpal tunnel questionnaire”; “6-item carpal \ntoms scale”; QuickDASH AND (“carpal \nmedian nerve compression”); Quick­\ntric properties”; “Palmar pain scale” AND \nme” OR “median nerve compression”); \nD “psychometric properties”; “Boston \nnaire”; “Boston carpal tunnel question­\ntric properties”; “Michigan hand outcome \narpal tunnel syndrome” OR “median nerve \ngan hand outcome questionnaire” AND \nes”; “patient evaluation measure” AND \nme” OR “median nerve compression”); \nnel syndrome” OR “median nerve com­\n“psychometric properties”; “patient-rated \nonnaire” AND (“carpal tunnel syndrome” \npression”); “patient-rated wrist evalu­\nND “psychometric properties”; “upper \nale” AND (“carpal tunnel syndrome” OR \nssion”); “upper extremity functional scale” \noperties”; “Mcgill pain questionnaire” \nndrome” OR “median nerve compres­\nnce screening tool” AND (“carpal tunnel \nn nerve compression”); “7 item satisfac­\n tunnel syndrome” OR “median nerve \nm brief Michigan hand questionnaire” AND \nme” OR “median nerve compression”)\n” AND (“carpal tunnel syndrome” OR “me­\n”) “f\nti\nl\nt\n” AND\n(“carpal tunnel syndrome” OR “median nerve compression”); “in­\nternal consistency” AND (“carpal tunnel syndrome” OR “median \nnerve compression”); reliability AND (“carpal tunnel syndrome” \nOR “median nerve compression”); validity AND (“carpal tunnel \nsyndrome” OR “median nerve compression”)\n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND “grip strength” AND “measurement”; (“carpal tunnel syn­\ndrome” OR “median nerve compression”) AND “grip strength” \nAND “reliability”; (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND “grip strength” AND “measurement” and \n“standardization”; (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND “grip strength” AND “minimal detectable \nchange”. (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND “grip strength” AND “clinically relevant change”. (“carpal tunnel syndrome” OR “median nerve compression”) \nAND “grip strength” AND “responsiveness.” The same strategy \nwas used for fingertip pinch, lateral pinch, tripod pinch, manual \nmuscle testing, abductor pollicis brevis strength, range of motion, \nGrooved Peg Board Test, Functional Dexterity Test, Minnesota \nManual Dexterity Test, Minnesota Rate of Manipulation, Moberg \nPick Up Test, Purdue Peg Board, 9-hole Peg Test, Jebsen–Taylor \nHand Function Test, NK Dexterity Test, Bennett Hand Tool Dexter­\nity Test, Box and Block Test, O’Neil Hand Function Assessment, \nRosenbusch Test of Finger Dexterity, Radboud Skills Test, Sequen­\ntial Occupational Dexterity Test, Smith Hand Function Evaluation, \nSollerman Hand Function Test; Southhampton Hand Assessment \nProcedure; Upper Extremity Functional Test; Hand Function Sort; \nCrawford Small Parts Dexterity Test; Valpar Worksample, shape-\ntexture identification, vibration, sensory testing, Semmes-Wein­\nstein Monofilaments, static and moving 2-point discrimination\n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND (“risk factors”); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (obesity); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND “Body Mass Index”); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \n(hypothyroidism OR “Thyroid dysfunction” OR “Graves disease’; \n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND (“Female gender”); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (“diabetes mellitus”); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (“rheuma­\ntoid arthritis”); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (osteoarthritis); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND (anthropometrics); (“car­\npal tunnel syndrome” OR “median nerve compression”) AND \n(“square wrist”); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (“hand dimensions”); (“carpal tunnel syn­\ndrome” OR “median nerve compression”) AND (“hand shape”); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \n(“family history”); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (“genetic predisposition”); (“carpal tun­\nnel syndrome” OR “median nerve compression”) AND (height); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND\n\n\n--- Page 62 ---\nCOLUMN 1:\nAPPENDIX A\n(alcohol); (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND (smoking OR tobacco);(“carpal tunnel syndrome” OR \n“median nerve compression”) AND (“physical activity”); (“carpal \ntunnel syndrome” OR “median nerve compression”) AND (“hor­\nmone therapy” OR “oral contraceptives” OR “estrogen”); (“carpal \ntunnel syndrome” OR “median nerve compression”) AND (hys­\nterectomy OR menopause OR oophorectomy); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (parity); (“car­\npal tunnel syndrome” OR “median nerve compression”) AND (oc­\ncupational risk factors); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (“forceful exertions”); ); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (repetition); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \n(“repetitive work”); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (vibration); (“carpal tunnel syndrome” OR \n“median nerve compression”) AND (“wrist position”); (“carpal \ntunnel syndrome” OR “median nerve compression”) AND (“com­\nputer use” OR “keyboard use” or “mouse use” ); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (“psychosocial \nfactors”)\n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND (intervention OR treatment NOT surgical); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (“physical \ntherapy” OR “occupational therapy’); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND (orthoses OR orthosis \nOR splinting); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND education; (“carpal tunnel syndrome” OR \n“median nerve compression”) AND ergonomics; (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (“electrical \nstimulation” OR “TENS”); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (“dry needling”); (“carpal tunnel syn­\ndrome” OR “median nerve compression”) AND (“low level laser \ntherapy”); (“carpal tunnel syndrome” OR “median nerve com­\npression”) AND (iontophoresis OR phonophoresis); (“carpal tun­\nnel syndrome” OR “median nerve compression”) AND (massage \nOR “myofascial release”); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (mobilization OR “soft tissue mobili­\nzation” OR “joint mobilization”); (“carpal tunnel syndrome” OR \n“med\nglidin\nsion”\nOR “\n(“car\n(exer\n“med\nties” \ncom\ntherm\nsion”\nOR “\n(“car\nAND\ncom\nnerve\n“med\n(“car\nAND\n“med\ntunn\nfilam\nsion”\nnerve\nsynd\n(“car\nvibra\nsion”\nnerve\n“med\nsynd\ncom\npress\nnerve\nCoch\n“Car\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 672,
    "sentence_start": 4468,
    "sentence_end": 4470,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "(“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND “grip strength” AND “clinically relevant change”. (“carpal tunnel syndrome” OR “median nerve compression”) \nAND “grip strength” AND “responsiveness.” The same strategy \nwas used for fingertip pinch, lateral pinch, tripod pinch, manual \nmuscle testing, abductor pollicis brevis strength, range of motion, \nGrooved Peg Board Test, Functional Dexterity Test, Minnesota \nManual Dexterity Test, Minnesota Rate of Manipulation, Moberg \nPick Up Test, Purdue Peg Board, 9-hole Peg Test, Jebsen–Taylor \nHand Function Test, NK Dexterity Test, Bennett Hand Tool Dexter­\nity Test, Box and Block Test, O’Neil Hand Function Assessment, \nRosenbusch Test of Finger Dexterity, Radboud Skills Test, Sequen­\ntial Occupational Dexterity Test, Smith Hand Function Evaluation, \nSollerman Hand Function Test; Southhampton Hand Assessment \nProcedure; Upper Extremity Functional Test; Hand Function Sort; \nCrawford Small Parts Dexterity Test; Valpar Worksample, shape-\ntexture identification, vibration, sensory testing, Semmes-Wein­\nstein Monofilaments, static and moving 2-point discrimination\n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND (“risk factors”); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (obesity); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND “Body Mass Index”); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \n(hypothyroidism OR “Thyroid dysfunction” OR “Graves disease’; \n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND (“Female gender”); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (“diabetes mellitus”); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (“rheuma­\ntoid arthritis”); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (osteoarthritis); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND (anthropometrics); (“car­\npal tunnel syndrome” OR “median nerve compression”) AND \n(“square wrist”); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (“hand dimensions”); (“carpal tunnel syn­\ndrome” OR “median nerve compression”) AND (“hand shape”); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \n(“family history”); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (“genetic predisposition”); (“carpal tun­\nnel syndrome” OR “median nerve compression”) AND (height); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND\n\n\n--- Page 62 ---\nCOLUMN 1:\nAPPENDIX A\n(alcohol); (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND (smoking OR tobacco);(“carpal tunnel syndrome” OR \n“median nerve compression”) AND (“physical activity”); (“carpal \ntunnel syndrome” OR “median nerve compression”) AND (“hor­\nmone therapy” OR “oral contraceptives” OR “estrogen”); (“carpal \ntunnel syndrome” OR “median nerve compression”) AND (hys­\nterectomy OR menopause OR oophorectomy); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (parity); (“car­\npal tunnel syndrome” OR “median nerve compression”) AND (oc­\ncupational risk factors); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (“forceful exertions”); ); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (repetition); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \n(“repetitive work”); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (vibration); (“carpal tunnel syndrome” OR \n“median nerve compression”) AND (“wrist position”); (“carpal \ntunnel syndrome” OR “median nerve compression”) AND (“com­\nputer use” OR “keyboard use” or “mouse use” ); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (“psychosocial \nfactors”)\n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND (intervention OR treatment NOT surgical); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (“physical \ntherapy” OR “occupational therapy’); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND (orthoses OR orthosis \nOR splinting); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND education; (“carpal tunnel syndrome” OR \n“median nerve compression”) AND ergonomics; (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (“electrical \nstimulation” OR “TENS”); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (“dry needling”); (“carpal tunnel syn­\ndrome” OR “median nerve compression”) AND (“low level laser \ntherapy”); (“carpal tunnel syndrome” OR “median nerve com­\npression”) AND (iontophoresis OR phonophoresis); (“carpal tun­\nnel syndrome” OR “median nerve compression”) AND (massage \nOR “myofascial release”); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (mobilization OR “soft tissue mobili­\nzation” OR “joint mobilization”); (“carpal tunnel syndrome” OR \n“med\nglidin\nsion”\nOR “\n(“car\n(exer\n“med\nties” \ncom\ntherm\nsion”\nOR “\n(“car\nAND\ncom\nnerve\n“med\n(“car\nAND\n“med\ntunn\nfilam\nsion”\nnerve\nsynd\n(“car\nvibra\nsion”\nnerve\n“med\nsynd\ncom\npress\nnerve\nCoch\n“Car\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 673,
    "sentence_start": 4469,
    "sentence_end": 4471,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "(“carpal tunnel syndrome” OR “median nerve compression”) \nAND “grip strength” AND “responsiveness.” The same strategy \nwas used for fingertip pinch, lateral pinch, tripod pinch, manual \nmuscle testing, abductor pollicis brevis strength, range of motion, \nGrooved Peg Board Test, Functional Dexterity Test, Minnesota \nManual Dexterity Test, Minnesota Rate of Manipulation, Moberg \nPick Up Test, Purdue Peg Board, 9-hole Peg Test, Jebsen–Taylor \nHand Function Test, NK Dexterity Test, Bennett Hand Tool Dexter­\nity Test, Box and Block Test, O’Neil Hand Function Assessment, \nRosenbusch Test of Finger Dexterity, Radboud Skills Test, Sequen­\ntial Occupational Dexterity Test, Smith Hand Function Evaluation, \nSollerman Hand Function Test; Southhampton Hand Assessment \nProcedure; Upper Extremity Functional Test; Hand Function Sort; \nCrawford Small Parts Dexterity Test; Valpar Worksample, shape-\ntexture identification, vibration, sensory testing, Semmes-Wein­\nstein Monofilaments, static and moving 2-point discrimination\n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND (“risk factors”); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (obesity); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND “Body Mass Index”); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \n(hypothyroidism OR “Thyroid dysfunction” OR “Graves disease’; \n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND (“Female gender”); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (“diabetes mellitus”); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (“rheuma­\ntoid arthritis”); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (osteoarthritis); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND (anthropometrics); (“car­\npal tunnel syndrome” OR “median nerve compression”) AND \n(“square wrist”); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (“hand dimensions”); (“carpal tunnel syn­\ndrome” OR “median nerve compression”) AND (“hand shape”); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \n(“family history”); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (“genetic predisposition”); (“carpal tun­\nnel syndrome” OR “median nerve compression”) AND (height); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND\n\n\n--- Page 62 ---\nCOLUMN 1:\nAPPENDIX A\n(alcohol); (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND (smoking OR tobacco);(“carpal tunnel syndrome” OR \n“median nerve compression”) AND (“physical activity”); (“carpal \ntunnel syndrome” OR “median nerve compression”) AND (“hor­\nmone therapy” OR “oral contraceptives” OR “estrogen”); (“carpal \ntunnel syndrome” OR “median nerve compression”) AND (hys­\nterectomy OR menopause OR oophorectomy); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (parity); (“car­\npal tunnel syndrome” OR “median nerve compression”) AND (oc­\ncupational risk factors); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (“forceful exertions”); ); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (repetition); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \n(“repetitive work”); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (vibration); (“carpal tunnel syndrome” OR \n“median nerve compression”) AND (“wrist position”); (“carpal \ntunnel syndrome” OR “median nerve compression”) AND (“com­\nputer use” OR “keyboard use” or “mouse use” ); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (“psychosocial \nfactors”)\n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND (intervention OR treatment NOT surgical); (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (“physical \ntherapy” OR “occupational therapy’); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND (orthoses OR orthosis \nOR splinting); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND education; (“carpal tunnel syndrome” OR \n“median nerve compression”) AND ergonomics; (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND (“electrical \nstimulation” OR “TENS”); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (“dry needling”); (“carpal tunnel syn­\ndrome” OR “median nerve compression”) AND (“low level laser \ntherapy”); (“carpal tunnel syndrome” OR “median nerve com­\npression”) AND (iontophoresis OR phonophoresis); (“carpal tun­\nnel syndrome” OR “median nerve compression”) AND (massage \nOR “myofascial release”); (“carpal tunnel syndrome” OR “median \nnerve compression”) AND (mobilization OR “soft tissue mobili­\nzation” OR “joint mobilization”); (“carpal tunnel syndrome” OR \n“med\nglidin\nsion”\nOR “\n(“car\n(exer\n“med\nties” \ncom\ntherm\nsion”\nOR “\n(“car\nAND\ncom\nnerve\n“med\n(“car\nAND\n“med\ntunn\nfilam\nsion”\nnerve\nsynd\n(“car\nvibra\nsion”\nnerve\n“med\nsynd\ncom\npress\nnerve\nCoch\n“Car\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 674,
    "sentence_start": 4470,
    "sentence_end": 4472,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX A\nel syndrome” OR “median nerve compres­\nR tobacco);(“carpal tunnel syndrome” OR \nssion”) AND (“physical activity”); (“carpal \nmedian nerve compression”) AND (“hor­\nl contraceptives” OR “estrogen”); (“carpal \nmedian nerve compression”) AND (hys­\nuse OR oophorectomy); (“carpal tunnel \nn nerve compression”) AND (parity); (“car­\nOR “median nerve compression”) AND (oc­\n; (“carpal tunnel syndrome” OR “median \nND (“forceful exertions”); ); (“carpal tunnel \nn nerve compression”) AND (repetition); \nme” OR “median nerve compression”) AND \narpal tunnel syndrome” OR “median nerve \nbration); (“carpal tunnel syndrome” OR \nssion”) AND (“wrist position”); (“carpal \nmedian nerve compression”) AND (“com­\nrd use” or “mouse use” ); (“carpal tunnel \nn nerve compression”) AND (“psychosocial \nme” OR “median nerve compression”) \nreatment NOT surgical); (“carpal tunnel \nn nerve compression”) AND (“physical \nonal therapy’); (“carpal tunnel syndrome” \npression”) AND (orthoses OR orthosis \ntunnel syndrome” OR “median nerve \nucation; (“carpal tunnel syndrome” OR \nssion”) AND ergonomics; (“carpal tunnel \nn nerve compression”) AND (“electrical \n”); (“carpal tunnel syndrome” OR “median \nND (“dry needling”); (“carpal tunnel syn­\nrve compression”) AND (“low level laser \nnel syndrome” OR “median nerve com­\nhoresis OR phonophoresis); (“carpal tun­\ndian nerve compression”) AND (massage \n”); (“carpal tunnel syndrome” OR “median \nND (mobilization OR “soft tissue mobili­\nzation”); (“carpal tunnel syndrome” OR \n“median nerve compression”) AND (“nerve gliding” OR “tendon \ngliding”); (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND (“chiropractic treatment”); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND (“postural training”); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \n(exercise OR yoga OR Pilates); (“carpal tunnel syndrome” OR \n“median nerve compression”) AND (heat OR “thermal modali­\nties” OR paraffin); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (“short wave diathermy or “microwave dia­\nthermy”); (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND (“therapeutic exercise”); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND (ultrasound)\n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND diagnosis; (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND Tinel; (“carpal tunnel syndrome” OR “median \nnerve compression”) AND Phalen; (“carpal tunnel syndrome” OR \n“median nerve compression”) AND carpal-compression; AND \n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND upper-limb-neurodynamic; (“carpal tunnel syndrome” OR \n“median nerve compression”) AND scratch-collapse; (“carpal \ntunnel syndrome” OR “median nerve compression”) AND mono­\nfilament; (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND threshold; (“carpal tunnel syndrome” OR “median \nnerve compression”) AND Semmes-Weinstein; (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND two-point; \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \nvibrat*; (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND finger-flexion; (“carpal tunnel syndrome” OR “median \nnerve compression”) AND Luthy; (“carpal tunnel syndrome” OR \n“median nerve compression”) AND lunate-press; (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND pneumatic-\ncompression; (“carpal tunnel syndrome” OR “median nerve com­\npression”) AND Tanzer; (“carpal tunnel syndrome” OR “median \nnerve compression”) AND tethered-median-nerve\nCochrane Database of Systematic Reviews\n“Carpal tunnel syndrome” OR “median nerve compression”\n\n\n--- Page 63 ---\nCOLUMN 1:\nAPPENDIX B\nPRISMA FLOW DIAGRAMS\nDiagnosis\nRecords identiﬁed through database \nsearching, n = 1132\nAdditional records identiﬁed throug\nother sources, n = 127\nDuplicates removed, n = 844\nRecords screened, n = 415\nFull-text articles assessed for eligibility, \nn = 95\nStudies included in clinical practice \nguideline, n = 45\nRecords exclud\nFull-text article\n• In a systema\n• Descriptive,\n• Narrow pop\n• Instrument \n• Single test o\n• Narrative re\n• Thoracic ou\n• Not peer rev\n• Unable to d\n• Did not prov\nOutcome Measures\nRecords identiﬁed through database \nsearching, n = 6626\nAdditional records identiﬁed throug\nother sources, n = 3080\nDuplicates removed, n = 454\nRecords screened, n = 9252\nFull-text articles assessed for eligibility, \nn = 140\nStudies included in clinical practice \nguideline, n = 50\nRecords exclud\nFull-text article\n• Instrument \n• Non-CTS, n \n• Non-English\n• Psychometr\n• Prognostic s\n• Test/measu\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 675,
    "sentence_start": 4473,
    "sentence_end": 4475,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX A\nel syndrome” OR “median nerve compres­\nR tobacco);(“carpal tunnel syndrome” OR \nssion”) AND (“physical activity”); (“carpal \nmedian nerve compression”) AND (“hor­\nl contraceptives” OR “estrogen”); (“carpal \nmedian nerve compression”) AND (hys­\nuse OR oophorectomy); (“carpal tunnel \nn nerve compression”) AND (parity); (“car­\nOR “median nerve compression”) AND (oc­\n; (“carpal tunnel syndrome” OR “median \nND (“forceful exertions”); ); (“carpal tunnel \nn nerve compression”) AND (repetition); \nme” OR “median nerve compression”) AND \narpal tunnel syndrome” OR “median nerve \nbration); (“carpal tunnel syndrome” OR \nssion”) AND (“wrist position”); (“carpal \nmedian nerve compression”) AND (“com­\nrd use” or “mouse use” ); (“carpal tunnel \nn nerve compression”) AND (“psychosocial \nme” OR “median nerve compression”) \nreatment NOT surgical); (“carpal tunnel \nn nerve compression”) AND (“physical \nonal therapy’); (“carpal tunnel syndrome” \npression”) AND (orthoses OR orthosis \ntunnel syndrome” OR “median nerve \nucation; (“carpal tunnel syndrome” OR \nssion”) AND ergonomics; (“carpal tunnel \nn nerve compression”) AND (“electrical \n”); (“carpal tunnel syndrome” OR “median \nND (“dry needling”); (“carpal tunnel syn­\nrve compression”) AND (“low level laser \nnel syndrome” OR “median nerve com­\nhoresis OR phonophoresis); (“carpal tun­\ndian nerve compression”) AND (massage \n”); (“carpal tunnel syndrome” OR “median \nND (mobilization OR “soft tissue mobili­\nzation”); (“carpal tunnel syndrome” OR \n“median nerve compression”) AND (“nerve gliding” OR “tendon \ngliding”); (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND (“chiropractic treatment”); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND (“postural training”); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \n(exercise OR yoga OR Pilates); (“carpal tunnel syndrome” OR \n“median nerve compression”) AND (heat OR “thermal modali­\nties” OR paraffin); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (“short wave diathermy or “microwave dia­\nthermy”); (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND (“therapeutic exercise”); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND (ultrasound)\n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND diagnosis; (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND Tinel; (“carpal tunnel syndrome” OR “median \nnerve compression”) AND Phalen; (“carpal tunnel syndrome” OR \n“median nerve compression”) AND carpal-compression; AND \n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND upper-limb-neurodynamic; (“carpal tunnel syndrome” OR \n“median nerve compression”) AND scratch-collapse; (“carpal \ntunnel syndrome” OR “median nerve compression”) AND mono­\nfilament; (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND threshold; (“carpal tunnel syndrome” OR “median \nnerve compression”) AND Semmes-Weinstein; (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND two-point; \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \nvibrat*; (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND finger-flexion; (“carpal tunnel syndrome” OR “median \nnerve compression”) AND Luthy; (“carpal tunnel syndrome” OR \n“median nerve compression”) AND lunate-press; (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND pneumatic-\ncompression; (“carpal tunnel syndrome” OR “median nerve com­\npression”) AND Tanzer; (“carpal tunnel syndrome” OR “median \nnerve compression”) AND tethered-median-nerve\nCochrane Database of Systematic Reviews\n“Carpal tunnel syndrome” OR “median nerve compression”\n\n\n--- Page 63 ---\nCOLUMN 1:\nAPPENDIX B\nPRISMA FLOW DIAGRAMS\nDiagnosis\nRecords identiﬁed through database \nsearching, n = 1132\nAdditional records identiﬁed throug\nother sources, n = 127\nDuplicates removed, n = 844\nRecords screened, n = 415\nFull-text articles assessed for eligibility, \nn = 95\nStudies included in clinical practice \nguideline, n = 45\nRecords exclud\nFull-text article\n• In a systema\n• Descriptive,\n• Narrow pop\n• Instrument \n• Single test o\n• Narrative re\n• Thoracic ou\n• Not peer rev\n• Unable to d\n• Did not prov\nOutcome Measures\nRecords identiﬁed through database \nsearching, n = 6626\nAdditional records identiﬁed throug\nother sources, n = 3080\nDuplicates removed, n = 454\nRecords screened, n = 9252\nFull-text articles assessed for eligibility, \nn = 140\nStudies included in clinical practice \nguideline, n = 50\nRecords exclud\nFull-text article\n• Instrument \n• Non-CTS, n \n• Non-English\n• Psychometr\n• Prognostic s\n• Test/measu\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 676,
    "sentence_start": 4474,
    "sentence_end": 4476,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX A\nel syndrome” OR “median nerve compres­\nR tobacco);(“carpal tunnel syndrome” OR \nssion”) AND (“physical activity”); (“carpal \nmedian nerve compression”) AND (“hor­\nl contraceptives” OR “estrogen”); (“carpal \nmedian nerve compression”) AND (hys­\nuse OR oophorectomy); (“carpal tunnel \nn nerve compression”) AND (parity); (“car­\nOR “median nerve compression”) AND (oc­\n; (“carpal tunnel syndrome” OR “median \nND (“forceful exertions”); ); (“carpal tunnel \nn nerve compression”) AND (repetition); \nme” OR “median nerve compression”) AND \narpal tunnel syndrome” OR “median nerve \nbration); (“carpal tunnel syndrome” OR \nssion”) AND (“wrist position”); (“carpal \nmedian nerve compression”) AND (“com­\nrd use” or “mouse use” ); (“carpal tunnel \nn nerve compression”) AND (“psychosocial \nme” OR “median nerve compression”) \nreatment NOT surgical); (“carpal tunnel \nn nerve compression”) AND (“physical \nonal therapy’); (“carpal tunnel syndrome” \npression”) AND (orthoses OR orthosis \ntunnel syndrome” OR “median nerve \nucation; (“carpal tunnel syndrome” OR \nssion”) AND ergonomics; (“carpal tunnel \nn nerve compression”) AND (“electrical \n”); (“carpal tunnel syndrome” OR “median \nND (“dry needling”); (“carpal tunnel syn­\nrve compression”) AND (“low level laser \nnel syndrome” OR “median nerve com­\nhoresis OR phonophoresis); (“carpal tun­\ndian nerve compression”) AND (massage \n”); (“carpal tunnel syndrome” OR “median \nND (mobilization OR “soft tissue mobili­\nzation”); (“carpal tunnel syndrome” OR \n“median nerve compression”) AND (“nerve gliding” OR “tendon \ngliding”); (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND (“chiropractic treatment”); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND (“postural training”); \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \n(exercise OR yoga OR Pilates); (“carpal tunnel syndrome” OR \n“median nerve compression”) AND (heat OR “thermal modali­\nties” OR paraffin); (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND (“short wave diathermy or “microwave dia­\nthermy”); (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND (“therapeutic exercise”); (“carpal tunnel syndrome” \nOR “median nerve compression”) AND (ultrasound)\n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND diagnosis; (“carpal tunnel syndrome” OR “median nerve \ncompression”) AND Tinel; (“carpal tunnel syndrome” OR “median \nnerve compression”) AND Phalen; (“carpal tunnel syndrome” OR \n“median nerve compression”) AND carpal-compression; AND \n(“carpal tunnel syndrome” OR “median nerve compression”) \nAND upper-limb-neurodynamic; (“carpal tunnel syndrome” OR \n“median nerve compression”) AND scratch-collapse; (“carpal \ntunnel syndrome” OR “median nerve compression”) AND mono­\nfilament; (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND threshold; (“carpal tunnel syndrome” OR “median \nnerve compression”) AND Semmes-Weinstein; (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND two-point; \n(“carpal tunnel syndrome” OR “median nerve compression”) AND \nvibrat*; (“carpal tunnel syndrome” OR “median nerve compres­\nsion”) AND finger-flexion; (“carpal tunnel syndrome” OR “median \nnerve compression”) AND Luthy; (“carpal tunnel syndrome” OR \n“median nerve compression”) AND lunate-press; (“carpal tunnel \nsyndrome” OR “median nerve compression”) AND pneumatic-\ncompression; (“carpal tunnel syndrome” OR “median nerve com­\npression”) AND Tanzer; (“carpal tunnel syndrome” OR “median \nnerve compression”) AND tethered-median-nerve\nCochrane Database of Systematic Reviews\n“Carpal tunnel syndrome” OR “median nerve compression”\n\n\n--- Page 63 ---\nCOLUMN 1:\nAPPENDIX B\nPRISMA FLOW DIAGRAMS\nDiagnosis\nRecords identiﬁed through database \nsearching, n = 1132\nAdditional records identiﬁed throug\nother sources, n = 127\nDuplicates removed, n = 844\nRecords screened, n = 415\nFull-text articles assessed for eligibility, \nn = 95\nStudies included in clinical practice \nguideline, n = 45\nRecords exclud\nFull-text article\n• In a systema\n• Descriptive,\n• Narrow pop\n• Instrument \n• Single test o\n• Narrative re\n• Thoracic ou\n• Not peer rev\n• Unable to d\n• Did not prov\nOutcome Measures\nRecords identiﬁed through database \nsearching, n = 6626\nAdditional records identiﬁed throug\nother sources, n = 3080\nDuplicates removed, n = 454\nRecords screened, n = 9252\nFull-text articles assessed for eligibility, \nn = 140\nStudies included in clinical practice \nguideline, n = 50\nRecords exclud\nFull-text article\n• Instrument \n• Non-CTS, n \n• Non-English\n• Psychometr\n• Prognostic s\n• Test/measu\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 677,
    "sentence_start": 4475,
    "sentence_end": 4477,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\nPRISMA FLOW DIAGRAMS\ntiﬁed through database \nn = 1132\nAdditional records identiﬁed through \nother sources, n = 127\nDuplicates removed, n = 844\nRecords screened, n = 415\nFull-text articles assessed for eligibility, \nn = 95\nStudies included in clinical practice \nguideline, n = 45\nRecords excluded, n = 320\nFull-text articles excluded, n = 50\n• In a systematic review, n = 12\n• Descriptive, n = 11\n• Narrow population, n = 1\n• Instrument dated or not used in clinical practice, n = 15\n• Single test only reported in 1 study, n = 4\n• Narrative review/clinical commentary, n = 3\n• Thoracic outlet syndrome, n = 1\n• Not peer reviewed, n = 1\n• Unable to discern bilateral from unilateral data, n = 1\n• Did not provide criteria for conﬁrming CTS diagnosis, n = 1\ntiﬁed through database \nn = 6626\nAdditional records identiﬁed through \nother sources, n = 3080\nDuplicates removed, n = 454\nRecords screened, n = 9252\nFull-text articles assessed for eligibility, \nn = 140\nStudies included in clinical practice \nguideline, n = 50\nRecords excluded, n = 9112\nFull-text articles excluded, n = 90\n• Instrument description only, n = 3\n• Non-CTS, n = 6\n• Non-English, n = 5\n• Psychometric properties not reported, n = 6\n• Prognostic study, n = 5\n• Test/measure not included in guideline, n = 23\n• Diagnostic accuracy study, n = 29\n• Outcomes study, n = 2\n• Review, n = 9\n• Low quality, n = 1\n• Adequate data not reported, n = 1\n\n\n--- Page 64 ---\nCOLUMN 1:\nAPPENDIX B\nAssistive Technology\nRecords identiﬁed through database \nsearching, n = 9869\nAdditional records ident\nother sources, n = 0\nDuplicates removed, n = 1545\nRecords screened, n = 8324\nFull-text articles assessed for eligibility, \nn = 18\nStudies included in clinical practice \nguideline, n = 2\nRec\nFull\n• In\n• C\n• N\n• N\n• N\nOrthoses\nRecords identiﬁed through database \nsearching, n = 262\nAdditional records identi\nother sources, n = 4\nDuplicates removed, n = 48\nRecords screened, n = 218\nFull-text articles assessed for eligibility, \nn = 73\nStudies included in clinical practice \nguideline, n = 23\nReco\nFull-\n• In\n• A\n• C\n• In\n• N\n• N\n• O\n• R\n• S\n• P\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 678,
    "sentence_start": 4478,
    "sentence_end": 4480,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\nPRISMA FLOW DIAGRAMS\ntiﬁed through database \nn = 1132\nAdditional records identiﬁed through \nother sources, n = 127\nDuplicates removed, n = 844\nRecords screened, n = 415\nFull-text articles assessed for eligibility, \nn = 95\nStudies included in clinical practice \nguideline, n = 45\nRecords excluded, n = 320\nFull-text articles excluded, n = 50\n• In a systematic review, n = 12\n• Descriptive, n = 11\n• Narrow population, n = 1\n• Instrument dated or not used in clinical practice, n = 15\n• Single test only reported in 1 study, n = 4\n• Narrative review/clinical commentary, n = 3\n• Thoracic outlet syndrome, n = 1\n• Not peer reviewed, n = 1\n• Unable to discern bilateral from unilateral data, n = 1\n• Did not provide criteria for conﬁrming CTS diagnosis, n = 1\ntiﬁed through database \nn = 6626\nAdditional records identiﬁed through \nother sources, n = 3080\nDuplicates removed, n = 454\nRecords screened, n = 9252\nFull-text articles assessed for eligibility, \nn = 140\nStudies included in clinical practice \nguideline, n = 50\nRecords excluded, n = 9112\nFull-text articles excluded, n = 90\n• Instrument description only, n = 3\n• Non-CTS, n = 6\n• Non-English, n = 5\n• Psychometric properties not reported, n = 6\n• Prognostic study, n = 5\n• Test/measure not included in guideline, n = 23\n• Diagnostic accuracy study, n = 29\n• Outcomes study, n = 2\n• Review, n = 9\n• Low quality, n = 1\n• Adequate data not reported, n = 1\n\n\n--- Page 64 ---\nCOLUMN 1:\nAPPENDIX B\nAssistive Technology\nRecords identiﬁed through database \nsearching, n = 9869\nAdditional records ident\nother sources, n = 0\nDuplicates removed, n = 1545\nRecords screened, n = 8324\nFull-text articles assessed for eligibility, \nn = 18\nStudies included in clinical practice \nguideline, n = 2\nRec\nFull\n• In\n• C\n• N\n• N\n• N\nOrthoses\nRecords identiﬁed through database \nsearching, n = 262\nAdditional records identi\nother sources, n = 4\nDuplicates removed, n = 48\nRecords screened, n = 218\nFull-text articles assessed for eligibility, \nn = 73\nStudies included in clinical practice \nguideline, n = 23\nReco\nFull-\n• In\n• A\n• C\n• In\n• N\n• N\n• O\n• R\n• S\n• P\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 679,
    "sentence_start": 4479,
    "sentence_end": 4481,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\nPRISMA FLOW DIAGRAMS\ntiﬁed through database \nn = 1132\nAdditional records identiﬁed through \nother sources, n = 127\nDuplicates removed, n = 844\nRecords screened, n = 415\nFull-text articles assessed for eligibility, \nn = 95\nStudies included in clinical practice \nguideline, n = 45\nRecords excluded, n = 320\nFull-text articles excluded, n = 50\n• In a systematic review, n = 12\n• Descriptive, n = 11\n• Narrow population, n = 1\n• Instrument dated or not used in clinical practice, n = 15\n• Single test only reported in 1 study, n = 4\n• Narrative review/clinical commentary, n = 3\n• Thoracic outlet syndrome, n = 1\n• Not peer reviewed, n = 1\n• Unable to discern bilateral from unilateral data, n = 1\n• Did not provide criteria for conﬁrming CTS diagnosis, n = 1\ntiﬁed through database \nn = 6626\nAdditional records identiﬁed through \nother sources, n = 3080\nDuplicates removed, n = 454\nRecords screened, n = 9252\nFull-text articles assessed for eligibility, \nn = 140\nStudies included in clinical practice \nguideline, n = 50\nRecords excluded, n = 9112\nFull-text articles excluded, n = 90\n• Instrument description only, n = 3\n• Non-CTS, n = 6\n• Non-English, n = 5\n• Psychometric properties not reported, n = 6\n• Prognostic study, n = 5\n• Test/measure not included in guideline, n = 23\n• Diagnostic accuracy study, n = 29\n• Outcomes study, n = 2\n• Review, n = 9\n• Low quality, n = 1\n• Adequate data not reported, n = 1\n\n\n--- Page 64 ---\nCOLUMN 1:\nAPPENDIX B\nAssistive Technology\nRecords identiﬁed through database \nsearching, n = 9869\nAdditional records ident\nother sources, n = 0\nDuplicates removed, n = 1545\nRecords screened, n = 8324\nFull-text articles assessed for eligibility, \nn = 18\nStudies included in clinical practice \nguideline, n = 2\nRec\nFull\n• In\n• C\n• N\n• N\n• N\nOrthoses\nRecords identiﬁed through database \nsearching, n = 262\nAdditional records identi\nother sources, n = 4\nDuplicates removed, n = 48\nRecords screened, n = 218\nFull-text articles assessed for eligibility, \nn = 73\nStudies included in clinical practice \nguideline, n = 23\nReco\nFull-\n• In\n• A\n• C\n• In\n• N\n• N\n• O\n• R\n• S\n• P\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 680,
    "sentence_start": 4480,
    "sentence_end": 4482,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\ntiﬁed through database \nn = 9869\nAdditional records identiﬁed through \nother sources, n = 0\nDuplicates removed, n = 1545\nRecords screened, n = 8324\nFull-text articles assessed for eligibility, \nn = 18\nStudies included in clinical practice \nguideline, n = 2\nRecords excluded, n = 8306\nFull-text articles excluded, n = 16\n• Included in/completed prior to systematic review, n = 11\n• Clinical perspective paper, n = 1\n• Not an intervention study, n = 1\n• Normal population, n = 1\n• Not on subjects with CTS, n = 2\niﬁed through database \nn = 262\nAdditional records identiﬁed through \nother sources, n = 4\nDuplicates removed, n = 48\nRecords screened, n = 218\nFull-text articles assessed for eligibility, \nn = 73\nStudies included in clinical practice \nguideline, n = 23\nRecords excluded, n = 145\nFull-text articles excluded, n = 50\n• Included in systematic review, n = 15\n• Additional or dated systematic review, n = 7\n• Combined treatments and unable to draw conclusion, n = 4\n• Included elsewhere in guideline, n = 2\n• Narrative review, n = 2\n• No comparison group, n = 7\n• Overall low quality, n = 4\n• Retrospective chart review, n = 2\n• Sample size, n = 1\n• Poorly speciﬁed treatment parameters, n = 5\n• Narrow scope, n = 1\n\n\n--- Page 65 ---\nCOLUMN 1:\nAPPENDIX B\nThermotherapy\nRecords identiﬁed through database \nsearching, n = 69\nAdditional records identi\nother sources, n = 0\nDuplicates removed, n = 24\nRecords screened, n = 45\nFull-text articles assessed for eligibility, \nn = 6\nStudies included in clinical practice \nguideline, n = 4\nReco\nFull-\n• Sy\n• Le\nElectrotherapy\nRecords identiﬁed through database \nsearching, n = 13\nAdditional records identi\nother sources, n = 1\nDuplicates removed, n = 9\nRecords screened, n = 5\nFull-text articles assessed for eligibility, \nn = 5\nStudies included in clinical practice \nguideline, n = 1\nReco\nFull-\n• Po\n• N\n• Lo\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 681,
    "sentence_start": 4483,
    "sentence_end": 4485,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\ntiﬁed through database \nn = 9869\nAdditional records identiﬁed through \nother sources, n = 0\nDuplicates removed, n = 1545\nRecords screened, n = 8324\nFull-text articles assessed for eligibility, \nn = 18\nStudies included in clinical practice \nguideline, n = 2\nRecords excluded, n = 8306\nFull-text articles excluded, n = 16\n• Included in/completed prior to systematic review, n = 11\n• Clinical perspective paper, n = 1\n• Not an intervention study, n = 1\n• Normal population, n = 1\n• Not on subjects with CTS, n = 2\niﬁed through database \nn = 262\nAdditional records identiﬁed through \nother sources, n = 4\nDuplicates removed, n = 48\nRecords screened, n = 218\nFull-text articles assessed for eligibility, \nn = 73\nStudies included in clinical practice \nguideline, n = 23\nRecords excluded, n = 145\nFull-text articles excluded, n = 50\n• Included in systematic review, n = 15\n• Additional or dated systematic review, n = 7\n• Combined treatments and unable to draw conclusion, n = 4\n• Included elsewhere in guideline, n = 2\n• Narrative review, n = 2\n• No comparison group, n = 7\n• Overall low quality, n = 4\n• Retrospective chart review, n = 2\n• Sample size, n = 1\n• Poorly speciﬁed treatment parameters, n = 5\n• Narrow scope, n = 1\n\n\n--- Page 65 ---\nCOLUMN 1:\nAPPENDIX B\nThermotherapy\nRecords identiﬁed through database \nsearching, n = 69\nAdditional records identi\nother sources, n = 0\nDuplicates removed, n = 24\nRecords screened, n = 45\nFull-text articles assessed for eligibility, \nn = 6\nStudies included in clinical practice \nguideline, n = 4\nReco\nFull-\n• Sy\n• Le\nElectrotherapy\nRecords identiﬁed through database \nsearching, n = 13\nAdditional records identi\nother sources, n = 1\nDuplicates removed, n = 9\nRecords screened, n = 5\nFull-text articles assessed for eligibility, \nn = 5\nStudies included in clinical practice \nguideline, n = 1\nReco\nFull-\n• Po\n• N\n• Lo\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 682,
    "sentence_start": 4484,
    "sentence_end": 4486,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\ntiﬁed through database \nn = 9869\nAdditional records identiﬁed through \nother sources, n = 0\nDuplicates removed, n = 1545\nRecords screened, n = 8324\nFull-text articles assessed for eligibility, \nn = 18\nStudies included in clinical practice \nguideline, n = 2\nRecords excluded, n = 8306\nFull-text articles excluded, n = 16\n• Included in/completed prior to systematic review, n = 11\n• Clinical perspective paper, n = 1\n• Not an intervention study, n = 1\n• Normal population, n = 1\n• Not on subjects with CTS, n = 2\niﬁed through database \nn = 262\nAdditional records identiﬁed through \nother sources, n = 4\nDuplicates removed, n = 48\nRecords screened, n = 218\nFull-text articles assessed for eligibility, \nn = 73\nStudies included in clinical practice \nguideline, n = 23\nRecords excluded, n = 145\nFull-text articles excluded, n = 50\n• Included in systematic review, n = 15\n• Additional or dated systematic review, n = 7\n• Combined treatments and unable to draw conclusion, n = 4\n• Included elsewhere in guideline, n = 2\n• Narrative review, n = 2\n• No comparison group, n = 7\n• Overall low quality, n = 4\n• Retrospective chart review, n = 2\n• Sample size, n = 1\n• Poorly speciﬁed treatment parameters, n = 5\n• Narrow scope, n = 1\n\n\n--- Page 65 ---\nCOLUMN 1:\nAPPENDIX B\nThermotherapy\nRecords identiﬁed through database \nsearching, n = 69\nAdditional records identi\nother sources, n = 0\nDuplicates removed, n = 24\nRecords screened, n = 45\nFull-text articles assessed for eligibility, \nn = 6\nStudies included in clinical practice \nguideline, n = 4\nReco\nFull-\n• Sy\n• Le\nElectrotherapy\nRecords identiﬁed through database \nsearching, n = 13\nAdditional records identi\nother sources, n = 1\nDuplicates removed, n = 9\nRecords screened, n = 5\nFull-text articles assessed for eligibility, \nn = 5\nStudies included in clinical practice \nguideline, n = 1\nReco\nFull-\n• Po\n• N\n• Lo\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 683,
    "sentence_start": 4485,
    "sentence_end": 4487,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\niﬁed through database \nn = 69\nAdditional records identiﬁed through \nother sources, n = 0\nDuplicates removed, n = 24\nRecords screened, n = 45\nFull-text articles assessed for eligibility, \nn = 6\nStudies included in clinical practice \nguideline, n = 4\nRecords excluded, n = 39\nFull-text articles excluded, n = 2\n• Systematic review with 1 randomized controlled trial, n = 1\n• Length of follow-up, n = 1\niﬁed through database \nn = 13\nAdditional records identiﬁed through \nother sources, n = 1\nDuplicates removed, n = 9\nRecords screened, n = 5\nFull-text articles assessed for eligibility, \nn = 5\nSt di\ni\nl d d i\nli i\nl\nti\nRecords excluded, n = 0\nFull-text articles excluded, n = 4\n• Postoperative care for CTS, n = 1\n• Not an intervention study, n = 1\n• Low quality, n = 2\n\n\n--- Page 66 ---\nCOLUMN 1:\nAPPENDIX B\nLight Agents\nRecords identiﬁed through database \nsearching, n = 79\nAdditional records identiﬁ\nother sources, n = 25\nDuplicates removed, n = 39\nRecords screened, n = 65\nFull-text articles assessed for eligibility, \nn = 39\nStudies included in clinical practice \nguideline, n = 3\n• Low-level laser therapy, n = 1\n• Light therapy, n = 2\nReco\nFull-\n• D\n• U\nn \nSound Agents\nRecords identiﬁed through database \nsearching, n = 556\nAdditional records identiﬁ\nother sources, n = 1\nDuplicates removed, n = 143\nRecords screened, n = 414\nFull-text articles assessed for eligibility, \nn = 29\nStudies included in clinical practice \nguideline, n = 5\nReco\nFull-\n• C\n• D\n• In\n• O\n• La\n• In\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 684,
    "sentence_start": 4488,
    "sentence_end": 4490,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\niﬁed through database \nn = 69\nAdditional records identiﬁed through \nother sources, n = 0\nDuplicates removed, n = 24\nRecords screened, n = 45\nFull-text articles assessed for eligibility, \nn = 6\nStudies included in clinical practice \nguideline, n = 4\nRecords excluded, n = 39\nFull-text articles excluded, n = 2\n• Systematic review with 1 randomized controlled trial, n = 1\n• Length of follow-up, n = 1\niﬁed through database \nn = 13\nAdditional records identiﬁed through \nother sources, n = 1\nDuplicates removed, n = 9\nRecords screened, n = 5\nFull-text articles assessed for eligibility, \nn = 5\nSt di\ni\nl d d i\nli i\nl\nti\nRecords excluded, n = 0\nFull-text articles excluded, n = 4\n• Postoperative care for CTS, n = 1\n• Not an intervention study, n = 1\n• Low quality, n = 2\n\n\n--- Page 66 ---\nCOLUMN 1:\nAPPENDIX B\nLight Agents\nRecords identiﬁed through database \nsearching, n = 79\nAdditional records identiﬁ\nother sources, n = 25\nDuplicates removed, n = 39\nRecords screened, n = 65\nFull-text articles assessed for eligibility, \nn = 39\nStudies included in clinical practice \nguideline, n = 3\n• Low-level laser therapy, n = 1\n• Light therapy, n = 2\nReco\nFull-\n• D\n• U\nn \nSound Agents\nRecords identiﬁed through database \nsearching, n = 556\nAdditional records identiﬁ\nother sources, n = 1\nDuplicates removed, n = 143\nRecords screened, n = 414\nFull-text articles assessed for eligibility, \nn = 29\nStudies included in clinical practice \nguideline, n = 5\nReco\nFull-\n• C\n• D\n• In\n• O\n• La\n• In\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 685,
    "sentence_start": 4489,
    "sentence_end": 4491,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\niﬁed through database \nn = 69\nAdditional records identiﬁed through \nother sources, n = 0\nDuplicates removed, n = 24\nRecords screened, n = 45\nFull-text articles assessed for eligibility, \nn = 6\nStudies included in clinical practice \nguideline, n = 4\nRecords excluded, n = 39\nFull-text articles excluded, n = 2\n• Systematic review with 1 randomized controlled trial, n = 1\n• Length of follow-up, n = 1\niﬁed through database \nn = 13\nAdditional records identiﬁed through \nother sources, n = 1\nDuplicates removed, n = 9\nRecords screened, n = 5\nFull-text articles assessed for eligibility, \nn = 5\nSt di\ni\nl d d i\nli i\nl\nti\nRecords excluded, n = 0\nFull-text articles excluded, n = 4\n• Postoperative care for CTS, n = 1\n• Not an intervention study, n = 1\n• Low quality, n = 2\n\n\n--- Page 66 ---\nCOLUMN 1:\nAPPENDIX B\nLight Agents\nRecords identiﬁed through database \nsearching, n = 79\nAdditional records identiﬁ\nother sources, n = 25\nDuplicates removed, n = 39\nRecords screened, n = 65\nFull-text articles assessed for eligibility, \nn = 39\nStudies included in clinical practice \nguideline, n = 3\n• Low-level laser therapy, n = 1\n• Light therapy, n = 2\nReco\nFull-\n• D\n• U\nn \nSound Agents\nRecords identiﬁed through database \nsearching, n = 556\nAdditional records identiﬁ\nother sources, n = 1\nDuplicates removed, n = 143\nRecords screened, n = 414\nFull-text articles assessed for eligibility, \nn = 29\nStudies included in clinical practice \nguideline, n = 5\nReco\nFull-\n• C\n• D\n• In\n• O\n• La\n• In\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 686,
    "sentence_start": 4490,
    "sentence_end": 4492,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\nﬁed through database \nn = 79\nAdditional records identiﬁed through \nother sources, n = 25\nDuplicates removed, n = 39\nRecords screened, n = 65\nFull-text articles assessed for eligibility, \nn = 39\nStudies included in clinical practice \nguideline, n = 3\n• Low-level laser therapy, n = 1\n• Light therapy, n = 2\nRecords excluded, n = 26\nFull-text articles excluded, n = 36\n• Done prior to high-quality systematic review, n = 35\n• Unable to separate CTS from other peripheral neuropathies, \nn = 1\nﬁed through database \nn = 556\nAdditional records identiﬁed through \nother sources, n = 1\nDuplicates removed, n = 143\nRecords screened, n = 414\nFull-text articles assessed for eligibility, \nn = 29\nStudies included in clinical practice \nguideline, n = 5\nRecords excluded, n = 385\nFull-text articles excluded, n = 24\n• Combined treatments, n = 2\n• Dated or systematic reviews with fewer than 3 papers, n = 11\n• Included in other parts of the review, n = 6\n• Overall low quality, n = 2\n• Lacked suﬃcient detail on treatment parameters, n = 2\n• Inadequate power, n = 1\n\n\n--- Page 67 ---\nCOLUMN 1:\nAPPENDIX B\nTransdermal Drug Delivery\nRecords identiﬁed through database \nsearching, n = 43\nAdditional records identiﬁ\nother sources, n = 12\nDuplicates removed, n = 25\nRecords screened, n = 30\nFull-text articles assessed for eligibility, \nn = 19\nStudies included in clinical practice \nguideline, n = 8\nReco\nFull-\n• Sy\nco\n• In\nMagnet Therapy\nRecords identiﬁed through database \nsearching, n = 48\nAdditional records identi\nother sources, n = 1\nDuplicates removed, n = 28\nRecords screened, n = 21\nFull-text articles assessed for eligibility, \nn = 6\nStudies included in clinical practice \nguideline, n = 2\nReco\nFull-\n• Sy\n• D\n• O\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 687,
    "sentence_start": 4493,
    "sentence_end": 4495,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\nﬁed through database \nn = 79\nAdditional records identiﬁed through \nother sources, n = 25\nDuplicates removed, n = 39\nRecords screened, n = 65\nFull-text articles assessed for eligibility, \nn = 39\nStudies included in clinical practice \nguideline, n = 3\n• Low-level laser therapy, n = 1\n• Light therapy, n = 2\nRecords excluded, n = 26\nFull-text articles excluded, n = 36\n• Done prior to high-quality systematic review, n = 35\n• Unable to separate CTS from other peripheral neuropathies, \nn = 1\nﬁed through database \nn = 556\nAdditional records identiﬁed through \nother sources, n = 1\nDuplicates removed, n = 143\nRecords screened, n = 414\nFull-text articles assessed for eligibility, \nn = 29\nStudies included in clinical practice \nguideline, n = 5\nRecords excluded, n = 385\nFull-text articles excluded, n = 24\n• Combined treatments, n = 2\n• Dated or systematic reviews with fewer than 3 papers, n = 11\n• Included in other parts of the review, n = 6\n• Overall low quality, n = 2\n• Lacked suﬃcient detail on treatment parameters, n = 2\n• Inadequate power, n = 1\n\n\n--- Page 67 ---\nCOLUMN 1:\nAPPENDIX B\nTransdermal Drug Delivery\nRecords identiﬁed through database \nsearching, n = 43\nAdditional records identiﬁ\nother sources, n = 12\nDuplicates removed, n = 25\nRecords screened, n = 30\nFull-text articles assessed for eligibility, \nn = 19\nStudies included in clinical practice \nguideline, n = 8\nReco\nFull-\n• Sy\nco\n• In\nMagnet Therapy\nRecords identiﬁed through database \nsearching, n = 48\nAdditional records identi\nother sources, n = 1\nDuplicates removed, n = 28\nRecords screened, n = 21\nFull-text articles assessed for eligibility, \nn = 6\nStudies included in clinical practice \nguideline, n = 2\nReco\nFull-\n• Sy\n• D\n• O\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 688,
    "sentence_start": 4494,
    "sentence_end": 4496,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\nﬁed through database \nn = 79\nAdditional records identiﬁed through \nother sources, n = 25\nDuplicates removed, n = 39\nRecords screened, n = 65\nFull-text articles assessed for eligibility, \nn = 39\nStudies included in clinical practice \nguideline, n = 3\n• Low-level laser therapy, n = 1\n• Light therapy, n = 2\nRecords excluded, n = 26\nFull-text articles excluded, n = 36\n• Done prior to high-quality systematic review, n = 35\n• Unable to separate CTS from other peripheral neuropathies, \nn = 1\nﬁed through database \nn = 556\nAdditional records identiﬁed through \nother sources, n = 1\nDuplicates removed, n = 143\nRecords screened, n = 414\nFull-text articles assessed for eligibility, \nn = 29\nStudies included in clinical practice \nguideline, n = 5\nRecords excluded, n = 385\nFull-text articles excluded, n = 24\n• Combined treatments, n = 2\n• Dated or systematic reviews with fewer than 3 papers, n = 11\n• Included in other parts of the review, n = 6\n• Overall low quality, n = 2\n• Lacked suﬃcient detail on treatment parameters, n = 2\n• Inadequate power, n = 1\n\n\n--- Page 67 ---\nCOLUMN 1:\nAPPENDIX B\nTransdermal Drug Delivery\nRecords identiﬁed through database \nsearching, n = 43\nAdditional records identiﬁ\nother sources, n = 12\nDuplicates removed, n = 25\nRecords screened, n = 30\nFull-text articles assessed for eligibility, \nn = 19\nStudies included in clinical practice \nguideline, n = 8\nReco\nFull-\n• Sy\nco\n• In\nMagnet Therapy\nRecords identiﬁed through database \nsearching, n = 48\nAdditional records identi\nother sources, n = 1\nDuplicates removed, n = 28\nRecords screened, n = 21\nFull-text articles assessed for eligibility, \nn = 6\nStudies included in clinical practice \nguideline, n = 2\nReco\nFull-\n• Sy\n• D\n• O\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 689,
    "sentence_start": 4495,
    "sentence_end": 4497,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\nivery\niﬁed through database \nn = 43\nAdditional records identiﬁed through \nother sources, n = 12\nDuplicates removed, n = 25\nRecords screened, n = 30\nFull-text articles assessed for eligibility, \nn = 19\nStudies included in clinical practice \nguideline, n = 8\nRecords excluded, n = 11\nFull-text articles excluded, n = 11\n• Systematic reviews with fewer than 2 randomized \ncontrolled trials, n = 4\n• Incorrect or insuﬃcient treatment parameters, n = 7\niﬁed through database \nn = 48\nAdditional records identiﬁed through \nother sources, n = 1\nDuplicates removed, n = 28\nRecords screened, n = 21\nFull-text articles assessed for eligibility, \nn = 6\nStudies included in clinical practice \nRecords excluded, n = 15\nFull-text articles excluded, n = 4\n• Systematic review with only 1 study, n = 1\n• Dated systematic review, n = 1\n• Outside physical therapy scope of practice, n = 2\n\n\n--- Page 68 ---\nCOLUMN 1:\nAPPENDIX B\nManual Therapy and Stretching\nRecords identiﬁed through database \nsearching, n = 206\nAdditional records ident\nother sources, n = 31\nDuplicates removed, n = 49\nRecords screened, n = 188\nFull-text articles assessed for eligibility, \nn = 47\nStudies included in clinical practice \nguideline, n = 8\nRec\nFull\n• In\n• D\n• C\n• D\n• H\n• N\n• N\n• O\n• S\n• T\n• N\nAbbreviation: CTS, carpal tunnel syndrome.",
    "chunk_id": 690,
    "sentence_start": 4498,
    "sentence_end": 4500,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\nivery\niﬁed through database \nn = 43\nAdditional records identiﬁed through \nother sources, n = 12\nDuplicates removed, n = 25\nRecords screened, n = 30\nFull-text articles assessed for eligibility, \nn = 19\nStudies included in clinical practice \nguideline, n = 8\nRecords excluded, n = 11\nFull-text articles excluded, n = 11\n• Systematic reviews with fewer than 2 randomized \ncontrolled trials, n = 4\n• Incorrect or insuﬃcient treatment parameters, n = 7\niﬁed through database \nn = 48\nAdditional records identiﬁed through \nother sources, n = 1\nDuplicates removed, n = 28\nRecords screened, n = 21\nFull-text articles assessed for eligibility, \nn = 6\nStudies included in clinical practice \nRecords excluded, n = 15\nFull-text articles excluded, n = 4\n• Systematic review with only 1 study, n = 1\n• Dated systematic review, n = 1\n• Outside physical therapy scope of practice, n = 2\n\n\n--- Page 68 ---\nCOLUMN 1:\nAPPENDIX B\nManual Therapy and Stretching\nRecords identiﬁed through database \nsearching, n = 206\nAdditional records ident\nother sources, n = 31\nDuplicates removed, n = 49\nRecords screened, n = 188\nFull-text articles assessed for eligibility, \nn = 47\nStudies included in clinical practice \nguideline, n = 8\nRec\nFull\n• In\n• D\n• C\n• D\n• H\n• N\n• N\n• O\n• S\n• T\n• N\nAbbreviation: CTS, carpal tunnel syndrome. Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 691,
    "sentence_start": 4499,
    "sentence_end": 4501,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\nivery\niﬁed through database \nn = 43\nAdditional records identiﬁed through \nother sources, n = 12\nDuplicates removed, n = 25\nRecords screened, n = 30\nFull-text articles assessed for eligibility, \nn = 19\nStudies included in clinical practice \nguideline, n = 8\nRecords excluded, n = 11\nFull-text articles excluded, n = 11\n• Systematic reviews with fewer than 2 randomized \ncontrolled trials, n = 4\n• Incorrect or insuﬃcient treatment parameters, n = 7\niﬁed through database \nn = 48\nAdditional records identiﬁed through \nother sources, n = 1\nDuplicates removed, n = 28\nRecords screened, n = 21\nFull-text articles assessed for eligibility, \nn = 6\nStudies included in clinical practice \nRecords excluded, n = 15\nFull-text articles excluded, n = 4\n• Systematic review with only 1 study, n = 1\n• Dated systematic review, n = 1\n• Outside physical therapy scope of practice, n = 2\n\n\n--- Page 68 ---\nCOLUMN 1:\nAPPENDIX B\nManual Therapy and Stretching\nRecords identiﬁed through database \nsearching, n = 206\nAdditional records ident\nother sources, n = 31\nDuplicates removed, n = 49\nRecords screened, n = 188\nFull-text articles assessed for eligibility, \nn = 47\nStudies included in clinical practice \nguideline, n = 8\nRec\nFull\n• In\n• D\n• C\n• D\n• H\n• N\n• N\n• O\n• S\n• T\n• N\nAbbreviation: CTS, carpal tunnel syndrome. Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 692,
    "sentence_start": 4500,
    "sentence_end": 4502,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 693,
    "sentence_start": 4501,
    "sentence_end": 4505,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\nStretching\ntiﬁed through database \nn = 206\nAdditional records identiﬁed through \nother sources, n = 31\nDuplicates removed, n = 49\nRecords screened, n = 188\nFull-text articles assessed for eligibility, \nn = 47\nStudies included in clinical practice \nguideline, n = 8\nRecords excluded, n = 141\nFull-text articles excluded, n = 39\n• Included in systematic review, n = 18\n• Dated systematic review, n = 1\n• Cadaver study, n = 2\n• Diagnostic criteria poorly deﬁned, n = 1\n• Healthy subjects, n = 1\n• Narrative review, n = 1\n• Not an intervention study, n = 9\n• Outside physical therapy scope of practice, n = 2\n• Sample size, n = 1\n• Treatment parameters poorly deﬁned, n = 2\n• No comparison group, n = 1\n\n\n--- Page 69 ---\nCOLUMN 1:\nAPPENDIX C\nINCLUSION AND EXCLUSION CRITERIA\nInclusion Criteria\nWe included papers that used the following research designs: sys­\ntematic reviews, meta-analyses, experimental and quasi-exper­\nimental, prospective and retrospective cohort, cross-sectional, \nand case-series studies pertaining to the following areas:\n•  \u0007Incidence or prevalence of carpal tunnel syndrome in the gen­\neral and working populations\n•  \u0007Pathoanatomy of carpal tunnel syndrome\n•  \u0007Classification of carpal tunnel syndrome using measures other \nthan electrodiagnostic instruments\n•  \u0007Identification of risk factors for carpal tunnel syndrome\n•  \u0007Diagnostic tests and measures for identifying carpal tunnel \nsyndrome within the scope of physical therapist practice\n•  \u0007Outcome or clinical measures used to assess change in indi­\nviduals with carpal tunnel syndrome, including the identifica­\ntion of psychometric properties\n•  \u0007Interventions used in the nonsurgical management of carpal \ntunnel syndrome within the scope of physical therapist practice\nWe included expert review papers when they were developed us­\ning results from basic science, bench, or animal research AND \nwhen higher-level papers were not available.",
    "chunk_id": 694,
    "sentence_start": 4504,
    "sentence_end": 4506,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\nStretching\ntiﬁed through database \nn = 206\nAdditional records identiﬁed through \nother sources, n = 31\nDuplicates removed, n = 49\nRecords screened, n = 188\nFull-text articles assessed for eligibility, \nn = 47\nStudies included in clinical practice \nguideline, n = 8\nRecords excluded, n = 141\nFull-text articles excluded, n = 39\n• Included in systematic review, n = 18\n• Dated systematic review, n = 1\n• Cadaver study, n = 2\n• Diagnostic criteria poorly deﬁned, n = 1\n• Healthy subjects, n = 1\n• Narrative review, n = 1\n• Not an intervention study, n = 9\n• Outside physical therapy scope of practice, n = 2\n• Sample size, n = 1\n• Treatment parameters poorly deﬁned, n = 2\n• No comparison group, n = 1\n\n\n--- Page 69 ---\nCOLUMN 1:\nAPPENDIX C\nINCLUSION AND EXCLUSION CRITERIA\nInclusion Criteria\nWe included papers that used the following research designs: sys­\ntematic reviews, meta-analyses, experimental and quasi-exper­\nimental, prospective and retrospective cohort, cross-sectional, \nand case-series studies pertaining to the following areas:\n•  \u0007Incidence or prevalence of carpal tunnel syndrome in the gen­\neral and working populations\n•  \u0007Pathoanatomy of carpal tunnel syndrome\n•  \u0007Classification of carpal tunnel syndrome using measures other \nthan electrodiagnostic instruments\n•  \u0007Identification of risk factors for carpal tunnel syndrome\n•  \u0007Diagnostic tests and measures for identifying carpal tunnel \nsyndrome within the scope of physical therapist practice\n•  \u0007Outcome or clinical measures used to assess change in indi­\nviduals with carpal tunnel syndrome, including the identifica­\ntion of psychometric properties\n•  \u0007Interventions used in the nonsurgical management of carpal \ntunnel syndrome within the scope of physical therapist practice\nWe included expert review papers when they were developed us­\ning results from basic science, bench, or animal research AND \nwhen higher-level papers were not available. Exclusion Criteria\n•  \u0007Studies written in a language other than English\n•  \u0007Studies in which the sample of patients with carpal tunnel syn­\ndrome cannot be separated from the remaining sample\n•  \u0007Studies with fewer than 10 participants\n•  \u0007Nonsystematic or narrative reviews\n•  \u0007Lo\nme\n•  \u0007St\nwh\n•  \u0007Ba\nhig\n•  \u0007St\nhig\n•  \u0007St\n-  \u0007A\n-  \u0007I\n-  \u0007N\no\n-  \u0007T\nm\n•  \u0007St\n•  \u0007Inc\nge\n•  \u0007Ins\noth\n•  \u0007Int\nsu\nme\n•  \u0007Int\ntio\n•  \u0007Int\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 695,
    "sentence_start": 4505,
    "sentence_end": 4507,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX B\nStretching\ntiﬁed through database \nn = 206\nAdditional records identiﬁed through \nother sources, n = 31\nDuplicates removed, n = 49\nRecords screened, n = 188\nFull-text articles assessed for eligibility, \nn = 47\nStudies included in clinical practice \nguideline, n = 8\nRecords excluded, n = 141\nFull-text articles excluded, n = 39\n• Included in systematic review, n = 18\n• Dated systematic review, n = 1\n• Cadaver study, n = 2\n• Diagnostic criteria poorly deﬁned, n = 1\n• Healthy subjects, n = 1\n• Narrative review, n = 1\n• Not an intervention study, n = 9\n• Outside physical therapy scope of practice, n = 2\n• Sample size, n = 1\n• Treatment parameters poorly deﬁned, n = 2\n• No comparison group, n = 1\n\n\n--- Page 69 ---\nCOLUMN 1:\nAPPENDIX C\nINCLUSION AND EXCLUSION CRITERIA\nInclusion Criteria\nWe included papers that used the following research designs: sys­\ntematic reviews, meta-analyses, experimental and quasi-exper­\nimental, prospective and retrospective cohort, cross-sectional, \nand case-series studies pertaining to the following areas:\n•  \u0007Incidence or prevalence of carpal tunnel syndrome in the gen­\neral and working populations\n•  \u0007Pathoanatomy of carpal tunnel syndrome\n•  \u0007Classification of carpal tunnel syndrome using measures other \nthan electrodiagnostic instruments\n•  \u0007Identification of risk factors for carpal tunnel syndrome\n•  \u0007Diagnostic tests and measures for identifying carpal tunnel \nsyndrome within the scope of physical therapist practice\n•  \u0007Outcome or clinical measures used to assess change in indi­\nviduals with carpal tunnel syndrome, including the identifica­\ntion of psychometric properties\n•  \u0007Interventions used in the nonsurgical management of carpal \ntunnel syndrome within the scope of physical therapist practice\nWe included expert review papers when they were developed us­\ning results from basic science, bench, or animal research AND \nwhen higher-level papers were not available. Exclusion Criteria\n•  \u0007Studies written in a language other than English\n•  \u0007Studies in which the sample of patients with carpal tunnel syn­\ndrome cannot be separated from the remaining sample\n•  \u0007Studies with fewer than 10 participants\n•  \u0007Nonsystematic or narrative reviews\n•  \u0007Lo\nme\n•  \u0007St\nwh\n•  \u0007Ba\nhig\n•  \u0007St\nhig\n•  \u0007St\n-  \u0007A\n-  \u0007I\n-  \u0007N\no\n-  \u0007T\nm\n•  \u0007St\n•  \u0007Inc\nge\n•  \u0007Ins\noth\n•  \u0007Int\nsu\nme\n•  \u0007Int\ntio\n•  \u0007Int\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 696,
    "sentence_start": 4506,
    "sentence_end": 4508,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Exclusion Criteria\n•  \u0007Studies written in a language other than English\n•  \u0007Studies in which the sample of patients with carpal tunnel syn­\ndrome cannot be separated from the remaining sample\n•  \u0007Studies with fewer than 10 participants\n•  \u0007Nonsystematic or narrative reviews\n•  \u0007Lo\nme\n•  \u0007St\nwh\n•  \u0007Ba\nhig\n•  \u0007St\nhig\n•  \u0007St\n-  \u0007A\n-  \u0007I\n-  \u0007N\no\n-  \u0007T\nm\n•  \u0007St\n•  \u0007Inc\nge\n•  \u0007Ins\noth\n•  \u0007Int\nsu\nme\n•  \u0007Int\ntio\n•  \u0007Int\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 697,
    "sentence_start": 4507,
    "sentence_end": 4511,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX C\nXCLUSION CRITERIA\nt used the following research designs: sys­\nanalyses, experimental and quasi-exper­\nd retrospective cohort, cross-sectional, \ns pertaining to the following areas:\nnce of carpal tunnel syndrome in the gen­\nulations\npal tunnel syndrome\npal tunnel syndrome using measures other \nic instruments\nfactors for carpal tunnel syndrome\nmeasures for identifying carpal tunnel \nscope of physical therapist practice\nmeasures used to assess change in indi­\nunnel syndrome, including the identifica­\nproperties\nthe nonsurgical management of carpal \nhin the scope of physical therapist practice\new papers when they were developed us­\ncience, bench, or animal research AND \nrs were not available.",
    "chunk_id": 698,
    "sentence_start": 4510,
    "sentence_end": 4512,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX C\nXCLUSION CRITERIA\nt used the following research designs: sys­\nanalyses, experimental and quasi-exper­\nd retrospective cohort, cross-sectional, \ns pertaining to the following areas:\nnce of carpal tunnel syndrome in the gen­\nulations\npal tunnel syndrome\npal tunnel syndrome using measures other \nic instruments\nfactors for carpal tunnel syndrome\nmeasures for identifying carpal tunnel \nscope of physical therapist practice\nmeasures used to assess change in indi­\nunnel syndrome, including the identifica­\nproperties\nthe nonsurgical management of carpal \nhin the scope of physical therapist practice\new papers when they were developed us­\ncience, bench, or animal research AND \nrs were not available. anguage other than English\nsample of patients with carpal tunnel syn­\nparated from the remaining sample\nan 10 participants\nrrative reviews\n•  \u0007Low-quality case series that lacked adequate outcome \nmeasures\n•  \u0007Studies that included individuals with carpal tunnel syndrome \nwho were younger than 18 years of age\n•  \u0007Basic science, bench, cadaveric, and animal studies when \nhigher-level human studies were available\n•  \u0007Studies without a comparison group when a preponderance of \nhigher-level studies was available\n•  \u0007Studies pertaining to:\n-  \u0007Acute carpal tunnel syndrome\n-  \u0007Induction of acute carpal tunnel symptoms in healthy \nindividuals\n-  \u0007Numbness and tingling related to diseases or conditions \nother than carpal tunnel syndrome, such as cervical radicu­\nlopathy and diabetic polyneuropathy\n-  \u0007Tests and measures not readily or routinely available to the \nmajority of physical therapist practitioners, such as:\n•  \u0007Electromyography and nerve conduction\n•  \u0007Diagnostic ultrasound\n•  \u0007Magnetic resonance imaging\n•  \u0007Studies on incidence or prevalence greater than 10 years old\n•  \u0007Incidence or prevalence in narrow populations that limits \ngeneralizability\n•  \u0007Instrument measurement properties developed in a population \nother than those with carpal tunnel syndrome\n•  \u0007Interventions outside the scope of physical therapist practice, \nsuch as extracorporeal shockwave therapy and prescription \nmedications\n•  \u0007Interventions that were not reproducible based on the descrip­\ntion provided by authors\n•  \u0007Interventions assessed in more than 2 level IV studies\n\n\n--- Page 70 ---\nCOLUMN 1:\nCRITICAL APPRAISAL SCORES\nProvocative Tests\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\nTotal\nAhn et al2\n0\n1\n0\n0\n0\n0\n1\n1\n1\n0\n1\n1\n1\n1\n8\nAl-Dabbagh and \nMohamad3\n0\n1\n0\n1\n0\n0\n1\n0\n0\n0\n1\n1\n0\n0\n5\nAmirfeyz et al9\n0\n1\n0\n0\n0\n1\n1\n1\n1\n0\n0\n1\n0\n0\n6\nAmirfeyz et al8\n0\n1\n0\n0\n0\n0\n1\n0\n1\n0\n1\n1\n0\n0\n5\nBaselgia et al33\n0\n1\n1\n1\n0\n0\n1\n1\n1\n1\n1\n0\n1\n1\n10\nBlok et al41\n1\n1\n1\n1\n1\n0\n0\n1\n1\n1\n1\n1\n1\n1\n12\nBoland and Kiernan42\n0\n1\n1\n1\n0\n0\n0\n1\n1\n0\n1\n1\n0\n0\n7\nBueno-Gracia et al45\n1\n1\n1\n1\n1\n1\n1\n1\n1\n0\n1\n1\n1\n1\n13\nCalfee et al50\n0\n1\n0\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n12\nCheng et al62\n0\n1\n0\n0\n0\n0\n1\n1\n1\n1\n1\n1\n1\n1\n9\nEl Miedany et al89\n0\n1\n1\n1\n0\n0\n1\n1\n1\n0\n1\n1\n0\n0\n8\nFertl et al97\n0\n1\n1\n1\n0\n0\n1\n1\n1\n0\n1\n1\n0\n0\n8\nGoloborod’ko113\n0\n1\n0\n0\n0\n0\n0\n0\n0\n0\n1\n1\n1\n1\n5\nKasundra et al144\n0\n1\n1\n1\n1\n1\n1\n0\n0\n0\n1\n1\n0\n0\n8\nKoris et al153\n0\n1\n0\n1\n0\n0\n0\n1\n1\n0\n0\n0\n1\n0\n5\nLaJoie et al157\n0\n1\n1\n1\n1\n1\n1\n1\n1\n0\n1\n1\n1\n1\n12\nMa and Kim168\n0\n1\n0\n0\n0\n0\n1\n1\n1\n0\n1\n1\n1\n1\n8\nMacDermid et al170\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n14\nMakanji et al178\n1\n1\n1\n1\n1\n0\n0\n0\n0\n0\n1\n1\n1\n1\n9\nMondelli et al196\n0\n1\n1\n1\n1\n1\n1\n1\n1\n0\n1\n1\n0\n0\n10\nNtani et al209\n1\n1\n1\n1\n1\n0\n1\n1\n1\n0\n0\n0\n1\n1\n10\nThüngen et al274\n1\n1\n1\n1\n1\n1\n1\n1\n1\n0\n1\n1\n0\n0\n11\nVanti et al280\n1\n1\n1\n1\n0\n0\n0\n1\n1\n0\n1\n1\n1\n1\n10\nVanti et al281\n1\n1\n1\n0\n1\n0\n1\n1\n1\n0\n1\n1\n1\n1\n11\nWainner et al283\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n14\nWilliams et al292\n0\n0\n0\n0\n0\n0\n0\n1\n1\n0\n0\n1\n1\n1\n5\nWolny et al295\n0\n0\n1\n1\n0\n0\n1\n1\n0\n0\n0\n0\n1\n0\n5\n*Criteria from Law M, MacDermid J.",
    "chunk_id": 699,
    "sentence_start": 4511,
    "sentence_end": 4516,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, \ncriterion met. Items: (1) Independent blind comparison with a reference standard test; (2) Reference standard/true diagnosis selected is considered the gold standard or a reasonable \nalternative; (3) Reference standard applied to all patients; (4) Actual cases included appropriate spectrum of symptom severity; (5) Noncases might reasonably present for diagnosis; \n(6) Noncases included appropriate spectrum of patients with alternative diagnosis; (7) Adequate sample size; (8) Description of the test maneuver described in sufficient detail to \npermit replication; (9) Exact criteria for interpreting test results provided; (10) Reliability of the test documented; (11) Number of positive and negative results reported for both cases \nand noncases; (12) Appropriate statistics (sensitivity, specificity, likelihood ratios) presented; (13) If test required examiner interpretation, qualifications and skills of examiner were \nprovided; (14) Training, skills, and experience of the examiner were appropriate to the test conducted.",
    "chunk_id": 700,
    "sentence_start": 4516,
    "sentence_end": 4518,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, \ncriterion met. Items: (1) Independent blind comparison with a reference standard test; (2) Reference standard/true diagnosis selected is considered the gold standard or a reasonable \nalternative; (3) Reference standard applied to all patients; (4) Actual cases included appropriate spectrum of symptom severity; (5) Noncases might reasonably present for diagnosis; \n(6) Noncases included appropriate spectrum of patients with alternative diagnosis; (7) Adequate sample size; (8) Description of the test maneuver described in sufficient detail to \npermit replication; (9) Exact criteria for interpreting test results provided; (10) Reliability of the test documented; (11) Number of positive and negative results reported for both cases \nand noncases; (12) Appropriate statistics (sensitivity, specificity, likelihood ratios) presented; (13) If test required examiner interpretation, qualifications and skills of examiner were \nprovided; (14) Training, skills, and experience of the examiner were appropriate to the test conducted. APPENDIX D\nEvaluation Criteria*\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 701,
    "sentence_start": 4517,
    "sentence_end": 4519,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Independent blind comparison with a reference standard test; (2) Reference standard/true diagnosis selected is considered the gold standard or a reasonable \nalternative; (3) Reference standard applied to all patients; (4) Actual cases included appropriate spectrum of symptom severity; (5) Noncases might reasonably present for diagnosis; \n(6) Noncases included appropriate spectrum of patients with alternative diagnosis; (7) Adequate sample size; (8) Description of the test maneuver described in sufficient detail to \npermit replication; (9) Exact criteria for interpreting test results provided; (10) Reliability of the test documented; (11) Number of positive and negative results reported for both cases \nand noncases; (12) Appropriate statistics (sensitivity, specificity, likelihood ratios) presented; (13) If test required examiner interpretation, qualifications and skills of examiner were \nprovided; (14) Training, skills, and experience of the examiner were appropriate to the test conducted. APPENDIX D\nEvaluation Criteria*\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 702,
    "sentence_start": 4518,
    "sentence_end": 4520,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "APPENDIX D\nEvaluation Criteria*\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nCRITICAL APPRAISAL SCORES\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\nTota\n0\n1\n0\n0\n0\n0\n1\n1\n1\n0\n1\n1\n1\n1\n8\n0\n1\n0\n1\n0\n0\n1\n0\n0\n0\n1\n1\n0\n0\n5\nAPPENDIX D\nEvaluation Criteria*\n\n\n--- Page 71 ---\nCOLUMN 1:\nKatz Hand Diagram and Provocative Tests: Reliability\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\nTotal\nCalfee et al50\n2\n2\n2\n2\n0\n1\n2\n1\n2\n2\n2\n2\n20\nMarx et al183\n2\n2\n1\n1\n0\n2\n0\n2\n2\n2\n2\n2\n18\nPriganc and Henry232\n2\n2\n1\n2\n0\n2\n2\n2\n2\n2\n2\n2\n21\nSalerno et al251\n2\n2\n1\n2\n0\n1\n2\n2\n2\n2\n2\n2\n20\n*Criteria from Law M, MacDermid J. Items are scored as follows: 0, criterion not met; 1, \nmarginally met criterion; 2, met criterion.",
    "chunk_id": 703,
    "sentence_start": 4519,
    "sentence_end": 4528,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, \nmarginally met criterion; 2, met criterion. Items: (1) Comprehensive literature review to justify the research question; (2) Specific inclusion/exclusion criteria; (3) Specific hypotheses; \n(4) Appropriate scope of measurement properties; (5) Sample-size justification; (6) Minimal loss to follow-up; (7) Detailing the test procedures; (8) Standardization of measurement \ntechniques; (9) Data presented for each hypothesis; (10) Appropriate statistical tests; (11) Range of analyses for each measurement property; (12) Proper presentation of the conclu­\nsions and clinical recommendations.",
    "chunk_id": 704,
    "sentence_start": 4527,
    "sentence_end": 4529,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, \nmarginally met criterion; 2, met criterion. Items: (1) Comprehensive literature review to justify the research question; (2) Specific inclusion/exclusion criteria; (3) Specific hypotheses; \n(4) Appropriate scope of measurement properties; (5) Sample-size justification; (6) Minimal loss to follow-up; (7) Detailing the test procedures; (8) Standardization of measurement \ntechniques; (9) Data presented for each hypothesis; (10) Appropriate statistical tests; (11) Range of analyses for each measurement property; (12) Proper presentation of the conclu­\nsions and clinical recommendations. Sensory Testing Measures\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\nTotal\nCheckosky et al59\n0\n1\n0\n0\n0\n0\n0\n1\n0\n0\n1\n1\n0\n0\n4\nClark et al67\n0\n1\n1\n0\n0\n0\n1\n1\n1\n0\n1\n1\n0\n0\n7\nElfar et al88\n1\n1\n1\n0\n1\n0\n0\n1\n0\n0\n0\n0\n1\n1\n7\nGerr and Letz107\n1\n1\n1\n1\n1\n0\n1\n1\n1\n0\n1\n0\n1\n1\n11\nHardy et al126\n1\n1\n1\n1\n1\n1\n1\n0\n1\n0\n0\n0\n1\n1\n10\nJetzer139\n0\n1\n0\n1\n1\n0\n1\n0\n1\n0\n0\n0\n0\n0\n5\nMacDermid et al171\n1\n1\n1\n1\n1\n1\n0\n1\n1\n1\n1\n1\n1\n1\n13\nMacDermid et al170\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n14\nMarlow et al182\n0\n1\n1\n1\n1\n0\n1\n1\n1\n0\n1\n1\n1\n1\n11\nWerner et al291\n1\n1\n1\n1\n1\n1\n1\n1\n1\n0\n1\n1\n1\n1\n13\nYildirim and Gunduz300\n1\n0\n1\n1\n1\n1\n1\n0\n1\n0\n1\n1\n1\n1\n11\n*Criteria from Law M, MacDermid J.",
    "chunk_id": 705,
    "sentence_start": 4528,
    "sentence_end": 4533,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, \ncriterion met. Items: (1) Independent blind comparison with a reference standard test; (2) Reference standard/true diagnosis selected is considered the gold standard or a reasonable \nalternative; (3) Reference standard applied to all patients; (4) Actual cases included appropriate spectrum of symptom severity; (5) Noncases might reasonably present for diagnosis; \n(6) Noncases included appropriate spectrum of patients with alternative diagnosis; (7) Adequate sample size; (8) Description of the test maneuver described in sufficient detail to \npermit replication; (9) Exact criteria for interpreting test results provided; (10) Reliability of the test documented; (11) Number of positive and negative results reported for both cases \nand noncases; (12) Appropriate statistics (sensitivity, specificity, likelihood ratios) presented; (13) If test required examiner interpretation, qualifications and skills of examiner were \nprovided; (14) Training, skills, and experience of the examiner were appropriate to the test conducted.",
    "chunk_id": 706,
    "sentence_start": 4533,
    "sentence_end": 4535,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, \ncriterion met. Items: (1) Independent blind comparison with a reference standard test; (2) Reference standard/true diagnosis selected is considered the gold standard or a reasonable \nalternative; (3) Reference standard applied to all patients; (4) Actual cases included appropriate spectrum of symptom severity; (5) Noncases might reasonably present for diagnosis; \n(6) Noncases included appropriate spectrum of patients with alternative diagnosis; (7) Adequate sample size; (8) Description of the test maneuver described in sufficient detail to \npermit replication; (9) Exact criteria for interpreting test results provided; (10) Reliability of the test documented; (11) Number of positive and negative results reported for both cases \nand noncases; (12) Appropriate statistics (sensitivity, specificity, likelihood ratios) presented; (13) If test required examiner interpretation, qualifications and skills of examiner were \nprovided; (14) Training, skills, and experience of the examiner were appropriate to the test conducted. Sensory Testing Measures: Reliability\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\nTotal\nCheung et al64\n2\n2\n1\n2\n2\n1\n2\n2\n2\n2\n2\n2\n22\nGrunert et al†\n2\n1\n1\n2\n0\n2\n2\n1\n2\n0\n0\n1\n14\nHubbard et al‡\n2\n2\n1\n0\n0\n1\n2\n1\n2\n2\n2\n2\n17\nMarx et al183\n2\n2\n1\n1\n0\n2\n0\n2\n2\n2\n2\n2\n18\nRaji et al235\n2\n2\n2\n2\n0\n2\n2\n1\n2\n2\n2\n2\n21\n*Criteria from Law M, MacDermid J.",
    "chunk_id": 707,
    "sentence_start": 4534,
    "sentence_end": 4539,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, \nmarginally met criterion; 2, met criterion. Items: (1) Comprehensive literature review to justify the research question; (2) Specific inclusion/exclusion criteria; (3) Specific hypotheses; \n(4) Appropriate scope of measurement properties; (5) Sample-size justification; (6) Minimal loss to follow-up; (7) Detailing the test procedures; (8) Standardization of measurement \ntechniques; (9) Data presented for each hypothesis; (10) Appropriate statistical tests; (11) Range of analyses for each measurement property; (12) Proper presentation of the conclu­\nsions and clinical recommendations. †Grunert BK, Wertsch JJ, Matloub HS, McCallum-Burke S. Reliability of sensory threshold measurement using a digital vibrogram. See TABLE 6 and \nAPPENDIX E. ‡Hubbard MC, MacDermid JC, Kramer JF, Birmingham TB. Quantitative vibration threshold testing in carpal tunnel syndrome: analysis strategies for \noptimizing reliability. See TABLE 6 and APPENDIX E.",
    "chunk_id": 708,
    "sentence_start": 4538,
    "sentence_end": 4552,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "See TABLE 6 and APPENDIX E. APPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nnd Provocative Tests: Reliability\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n2\n2\n2\n2\n0\n1\n2\n1\n2\n2\n2\n2\n2\n1\n1\n0\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n0\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n0\n1\n2\n2\n2\n2\n2\nmid J. Items are scored as follows\nt criterion. Items: (1) Comprehensive literature review to justify the research question; (2) Specific inclusion/exclusion crit\nurement properties; (5) Sample-size justification; (6) Minimal loss to follow-up; (7) Detailing the test procedures; (8) Stan\nfor each hypothesis; (10) Appropriate statistical tests; (11) Range of analyses for each measurement property; (12) Prope\ntions.",
    "chunk_id": 709,
    "sentence_start": 4551,
    "sentence_end": 4563,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows\nt criterion. Items: (1) Comprehensive literature review to justify the research question; (2) Specific inclusion/exclusion crit\nurement properties; (5) Sample-size justification; (6) Minimal loss to follow-up; (7) Detailing the test procedures; (8) Stan\nfor each hypothesis; (10) Appropriate statistical tests; (11) Range of analyses for each measurement property; (12) Prope\ntions. ures\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n0\n1\n0\n0\n0\n0\n0\n1\n0\n0\n1\n1\n0\n1\n1\n0\n0\n0\n1\n1\n1\n0\n1\n1\n1\n1\n1\n0\n1\n0\n0\n1\n0\n0\n0\n0\n1\n1\n1\n1\n1\n0\n1\n1\n1\n0\n1\n0\n1\n1\n1\n1\n1\n1\n1\n0\n1\n0\n0\n0\n0\n1\n0\n1\n1\n0\n1\n0\n1\n0\n0\n0\n1\n1\n1\n1\n1\n1\n0\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n0\n1\n1\n1\n1\n0\n1\n1\n1\n0\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n1\n0\n1\n1\n1\n0\n1\n1\n1\n1\n1\n0\n1\n0\n1\n1\nmid J.",
    "chunk_id": 710,
    "sentence_start": 4562,
    "sentence_end": 4567,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows\nndent blind comparison with a reference standard test; (2) Reference standard/true diagnosis selected is considered the \nard applied to all patients; (4) Actual cases included appropriate spectrum of symptom severity; (5) Noncases might rea\niate spectrum of patients with alternative diagnosis; (7) Adequate sample size; (8) Description of the test maneuver desc\nteria for interpreting test results provided; (10) Reliability of the test documented; (11) Number of positive and negative re\nstatistics (sensitivity, specificity, likelihood ratios) presented; (13) If test required examiner interpretation, qualifications a\nnd experience of the examiner were appropriate to the test conducted.",
    "chunk_id": 711,
    "sentence_start": 4566,
    "sentence_end": 4568,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows\nndent blind comparison with a reference standard test; (2) Reference standard/true diagnosis selected is considered the \nard applied to all patients; (4) Actual cases included appropriate spectrum of symptom severity; (5) Noncases might rea\niate spectrum of patients with alternative diagnosis; (7) Adequate sample size; (8) Description of the test maneuver desc\nteria for interpreting test results provided; (10) Reliability of the test documented; (11) Number of positive and negative re\nstatistics (sensitivity, specificity, likelihood ratios) presented; (13) If test required examiner interpretation, qualifications a\nnd experience of the examiner were appropriate to the test conducted. ures: Reliability\nAPPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n\n\n--- Page 72 ---\nCOLUMN 1:\nOutcome Measures\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\nTotal\nAlderson and McGall4\n1\n1\n1\n1\n0\n1\n2\n2\n2\n2\n1\n1\n15\nAmadio et al6\n2\n1\n2\n1\n0\n1\n2\n2\n2\n2\n1\n2\n18\nAmirfeyz et al10\n2\n1\n2\n2\n0\n1\n0\n0\n2\n1\n1\n2\n14\nAmirjani et al12\n2\n2\n2\n1\n0\n0\n2\n2\n2\n2\n2\n2\n19\nAmirjani et al13\n2\n2\n2\n1\n1\n0\n2\n2\n2\n2\n0\n2\n18\nAppleby et al16\n2\n2\n1\n1\n0\n2\n2\n2\n2\n2\n1\n1\n18\nAstifidis et al19\n2\n1\n2\n2\n2\n2\n2\n2\n2\n1\n0\n2\n20\nAtalay et al20\n1\n2\n1\n2\n2\n2\n2\n0\n2\n1\n0\n1\n16\nAtroshi et al22\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n23\nAtroshi et al23\n2\n1\n2\n2\n2\n1\n2\n1\n2\n2\n2\n2\n21\nAtroshi et al25\n2\n2\n1\n2\n1\n1\n1\n2\n2\n2\n2\n2\n20\nAtroshi et al26\n2\n1\n2\n1\n1\n0\n2\n1\n2\n2\n2\n2\n18\nBaker et al28\n2\n2\n0\n0\n0\n2\n2\n2\n2\n1\n1\n2\n16\nBaker and Livengood27\n1\n1\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n21\nBakhsh et al30\n2\n2\n0\n2\n0\n1\n1\n1\n2\n2\n2\n2\n17\nBessette et al38\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n0\n2\n20\nBoyd et al43\n2\n2\n2\n2\n0\n2\n2\n1\n2\n2\n1\n2\n20\nChatterjee and Price58\n2\n2\n0\n0\n0\n0\n1\n1\n2\n2\n0\n2\n12\nCheung et al64\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n23\nColdham et al72\n2\n1\n2\n1\n2\n2\n2\n2\n2\n2\n1\n2\n21\nde la Llave-Rincón et al81\n2\n2\n2\n2\n1\n0\n2\n1\n2\n2\n2\n2\n20\nDhong et al83\n1\n1\n2\n2\n2\n2\n1\n1\n2\n2\n2\n2\n20\nFernández-de-las-Peñas et al95\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n23\nGay et al101\n2\n2\n2\n1\n0\n2\n1\n2\n2\n2\n1\n2\n19\nGreenslade et al118\n2\n2\n2\n1\n0\n0\n1\n2\n2\n2\n2\n2\n18\nHobby et al134\n1\n1\n0\n2\n0\n1\n2\n2\n2\n2\n1\n2\n16\nHsu et al135\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n1\n1\n21\nJerosch-Herold et al138\n2\n1\n1\n2\n1\n2\n2\n2\n1\n2\n1\n2\n19\nKatz et al145\n2\n2\n1\n0\n0\n1\n2\n0\n2\n2\n1\n1\n14\nKaye and Reynolds147\n2\n1\n2\n2\n1\n2\n1\n2\n2\n2\n1\n2\n20\nKotsis and Chung154\n1\n2\n0\n0\n0\n2\n2\n1\n2\n2\n1\n1\n14\nLevine et al162\n2\n1\n1\n2\n0\n0\n2\n2\n2\n2\n1\n2\n17\nLyrén and Atroshi167\n2\n1\n2\n2\n1\n1\n2\n1\n2\n2\n2\n1\n19\nMcMillan and Binhammer187\n2\n0\n1\n0\n0\n0\n2\n2\n2\n2\n1\n2\n14\nOllivere et al212\n2\n1\n2\n2\n1\n2\n2\n1\n2\n2\n2\n2\n21\nOlsen and Knudson213\n2\n0\n2\n1\n0\n2\n1\n0\n2\n1\n1\n2\n14\nOzer et al216\n2\n2\n2\n1\n1\n2\n2\n1\n2\n2\n2\n2\n21\nÖzyürekoğlu et al219\n2\n2\n1\n0\n0\n2\n1\n2\n2\n2\n2\n2\n18\nPransky et al230\n2\n1\n1\n2\n1\n0\n2\n1\n2\n2\n1\n2\n17\nPriganc and Henry232\n2\n2\n1\n0\n0\n0\n2\n2\n2\n2\n0\n2\n15\nSears and Chung254\n2\n1\n1\n1\n0\n2\n2\n1\n1\n2\n2\n2\n17\nSmith-Forbes et al263\n2\n2\n2\n2\n2\n0\n0\n0\n2\n2\n2\n2\n18\nTulipan et al276\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n24\nZyluk and Piotuch303\n1\n1\n1\n2\n0\n1\n1\n1\n2\n2\n0\n2\n14\nAPPENDIX D\nEvaluation Criteria*\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 712,
    "sentence_start": 4567,
    "sentence_end": 4569,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows\nndent blind comparison with a reference standard test; (2) Reference standard/true diagnosis selected is considered the \nard applied to all patients; (4) Actual cases included appropriate spectrum of symptom severity; (5) Noncases might rea\niate spectrum of patients with alternative diagnosis; (7) Adequate sample size; (8) Description of the test maneuver desc\nteria for interpreting test results provided; (10) Reliability of the test documented; (11) Number of positive and negative re\nstatistics (sensitivity, specificity, likelihood ratios) presented; (13) If test required examiner interpretation, qualifications a\nnd experience of the examiner were appropriate to the test conducted. ures: Reliability\nAPPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n\n\n--- Page 72 ---\nCOLUMN 1:\nOutcome Measures\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\nTotal\nAlderson and McGall4\n1\n1\n1\n1\n0\n1\n2\n2\n2\n2\n1\n1\n15\nAmadio et al6\n2\n1\n2\n1\n0\n1\n2\n2\n2\n2\n1\n2\n18\nAmirfeyz et al10\n2\n1\n2\n2\n0\n1\n0\n0\n2\n1\n1\n2\n14\nAmirjani et al12\n2\n2\n2\n1\n0\n0\n2\n2\n2\n2\n2\n2\n19\nAmirjani et al13\n2\n2\n2\n1\n1\n0\n2\n2\n2\n2\n0\n2\n18\nAppleby et al16\n2\n2\n1\n1\n0\n2\n2\n2\n2\n2\n1\n1\n18\nAstifidis et al19\n2\n1\n2\n2\n2\n2\n2\n2\n2\n1\n0\n2\n20\nAtalay et al20\n1\n2\n1\n2\n2\n2\n2\n0\n2\n1\n0\n1\n16\nAtroshi et al22\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n23\nAtroshi et al23\n2\n1\n2\n2\n2\n1\n2\n1\n2\n2\n2\n2\n21\nAtroshi et al25\n2\n2\n1\n2\n1\n1\n1\n2\n2\n2\n2\n2\n20\nAtroshi et al26\n2\n1\n2\n1\n1\n0\n2\n1\n2\n2\n2\n2\n18\nBaker et al28\n2\n2\n0\n0\n0\n2\n2\n2\n2\n1\n1\n2\n16\nBaker and Livengood27\n1\n1\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n21\nBakhsh et al30\n2\n2\n0\n2\n0\n1\n1\n1\n2\n2\n2\n2\n17\nBessette et al38\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n0\n2\n20\nBoyd et al43\n2\n2\n2\n2\n0\n2\n2\n1\n2\n2\n1\n2\n20\nChatterjee and Price58\n2\n2\n0\n0\n0\n0\n1\n1\n2\n2\n0\n2\n12\nCheung et al64\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n23\nColdham et al72\n2\n1\n2\n1\n2\n2\n2\n2\n2\n2\n1\n2\n21\nde la Llave-Rincón et al81\n2\n2\n2\n2\n1\n0\n2\n1\n2\n2\n2\n2\n20\nDhong et al83\n1\n1\n2\n2\n2\n2\n1\n1\n2\n2\n2\n2\n20\nFernández-de-las-Peñas et al95\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n23\nGay et al101\n2\n2\n2\n1\n0\n2\n1\n2\n2\n2\n1\n2\n19\nGreenslade et al118\n2\n2\n2\n1\n0\n0\n1\n2\n2\n2\n2\n2\n18\nHobby et al134\n1\n1\n0\n2\n0\n1\n2\n2\n2\n2\n1\n2\n16\nHsu et al135\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n1\n1\n21\nJerosch-Herold et al138\n2\n1\n1\n2\n1\n2\n2\n2\n1\n2\n1\n2\n19\nKatz et al145\n2\n2\n1\n0\n0\n1\n2\n0\n2\n2\n1\n1\n14\nKaye and Reynolds147\n2\n1\n2\n2\n1\n2\n1\n2\n2\n2\n1\n2\n20\nKotsis and Chung154\n1\n2\n0\n0\n0\n2\n2\n1\n2\n2\n1\n1\n14\nLevine et al162\n2\n1\n1\n2\n0\n0\n2\n2\n2\n2\n1\n2\n17\nLyrén and Atroshi167\n2\n1\n2\n2\n1\n1\n2\n1\n2\n2\n2\n1\n19\nMcMillan and Binhammer187\n2\n0\n1\n0\n0\n0\n2\n2\n2\n2\n1\n2\n14\nOllivere et al212\n2\n1\n2\n2\n1\n2\n2\n1\n2\n2\n2\n2\n21\nOlsen and Knudson213\n2\n0\n2\n1\n0\n2\n1\n0\n2\n1\n1\n2\n14\nOzer et al216\n2\n2\n2\n1\n1\n2\n2\n1\n2\n2\n2\n2\n21\nÖzyürekoğlu et al219\n2\n2\n1\n0\n0\n2\n1\n2\n2\n2\n2\n2\n18\nPransky et al230\n2\n1\n1\n2\n1\n0\n2\n1\n2\n2\n1\n2\n17\nPriganc and Henry232\n2\n2\n1\n0\n0\n0\n2\n2\n2\n2\n0\n2\n15\nSears and Chung254\n2\n1\n1\n1\n0\n2\n2\n1\n1\n2\n2\n2\n17\nSmith-Forbes et al263\n2\n2\n2\n2\n2\n0\n0\n0\n2\n2\n2\n2\n18\nTulipan et al276\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n24\nZyluk and Piotuch303\n1\n1\n1\n2\n0\n1\n1\n1\n2\n2\n0\n2\n14\nAPPENDIX D\nEvaluation Criteria*\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 713,
    "sentence_start": 4568,
    "sentence_end": 4570,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "ures: Reliability\nAPPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n\n\n--- Page 72 ---\nCOLUMN 1:\nOutcome Measures\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\nTotal\nAlderson and McGall4\n1\n1\n1\n1\n0\n1\n2\n2\n2\n2\n1\n1\n15\nAmadio et al6\n2\n1\n2\n1\n0\n1\n2\n2\n2\n2\n1\n2\n18\nAmirfeyz et al10\n2\n1\n2\n2\n0\n1\n0\n0\n2\n1\n1\n2\n14\nAmirjani et al12\n2\n2\n2\n1\n0\n0\n2\n2\n2\n2\n2\n2\n19\nAmirjani et al13\n2\n2\n2\n1\n1\n0\n2\n2\n2\n2\n0\n2\n18\nAppleby et al16\n2\n2\n1\n1\n0\n2\n2\n2\n2\n2\n1\n1\n18\nAstifidis et al19\n2\n1\n2\n2\n2\n2\n2\n2\n2\n1\n0\n2\n20\nAtalay et al20\n1\n2\n1\n2\n2\n2\n2\n0\n2\n1\n0\n1\n16\nAtroshi et al22\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n23\nAtroshi et al23\n2\n1\n2\n2\n2\n1\n2\n1\n2\n2\n2\n2\n21\nAtroshi et al25\n2\n2\n1\n2\n1\n1\n1\n2\n2\n2\n2\n2\n20\nAtroshi et al26\n2\n1\n2\n1\n1\n0\n2\n1\n2\n2\n2\n2\n18\nBaker et al28\n2\n2\n0\n0\n0\n2\n2\n2\n2\n1\n1\n2\n16\nBaker and Livengood27\n1\n1\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n21\nBakhsh et al30\n2\n2\n0\n2\n0\n1\n1\n1\n2\n2\n2\n2\n17\nBessette et al38\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n0\n2\n20\nBoyd et al43\n2\n2\n2\n2\n0\n2\n2\n1\n2\n2\n1\n2\n20\nChatterjee and Price58\n2\n2\n0\n0\n0\n0\n1\n1\n2\n2\n0\n2\n12\nCheung et al64\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n23\nColdham et al72\n2\n1\n2\n1\n2\n2\n2\n2\n2\n2\n1\n2\n21\nde la Llave-Rincón et al81\n2\n2\n2\n2\n1\n0\n2\n1\n2\n2\n2\n2\n20\nDhong et al83\n1\n1\n2\n2\n2\n2\n1\n1\n2\n2\n2\n2\n20\nFernández-de-las-Peñas et al95\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n23\nGay et al101\n2\n2\n2\n1\n0\n2\n1\n2\n2\n2\n1\n2\n19\nGreenslade et al118\n2\n2\n2\n1\n0\n0\n1\n2\n2\n2\n2\n2\n18\nHobby et al134\n1\n1\n0\n2\n0\n1\n2\n2\n2\n2\n1\n2\n16\nHsu et al135\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n1\n1\n21\nJerosch-Herold et al138\n2\n1\n1\n2\n1\n2\n2\n2\n1\n2\n1\n2\n19\nKatz et al145\n2\n2\n1\n0\n0\n1\n2\n0\n2\n2\n1\n1\n14\nKaye and Reynolds147\n2\n1\n2\n2\n1\n2\n1\n2\n2\n2\n1\n2\n20\nKotsis and Chung154\n1\n2\n0\n0\n0\n2\n2\n1\n2\n2\n1\n1\n14\nLevine et al162\n2\n1\n1\n2\n0\n0\n2\n2\n2\n2\n1\n2\n17\nLyrén and Atroshi167\n2\n1\n2\n2\n1\n1\n2\n1\n2\n2\n2\n1\n19\nMcMillan and Binhammer187\n2\n0\n1\n0\n0\n0\n2\n2\n2\n2\n1\n2\n14\nOllivere et al212\n2\n1\n2\n2\n1\n2\n2\n1\n2\n2\n2\n2\n21\nOlsen and Knudson213\n2\n0\n2\n1\n0\n2\n1\n0\n2\n1\n1\n2\n14\nOzer et al216\n2\n2\n2\n1\n1\n2\n2\n1\n2\n2\n2\n2\n21\nÖzyürekoğlu et al219\n2\n2\n1\n0\n0\n2\n1\n2\n2\n2\n2\n2\n18\nPransky et al230\n2\n1\n1\n2\n1\n0\n2\n1\n2\n2\n1\n2\n17\nPriganc and Henry232\n2\n2\n1\n0\n0\n0\n2\n2\n2\n2\n0\n2\n15\nSears and Chung254\n2\n1\n1\n1\n0\n2\n2\n1\n1\n2\n2\n2\n17\nSmith-Forbes et al263\n2\n2\n2\n2\n2\n0\n0\n0\n2\n2\n2\n2\n18\nTulipan et al276\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n24\nZyluk and Piotuch303\n1\n1\n1\n2\n0\n1\n1\n1\n2\n2\n0\n2\n14\nAPPENDIX D\nEvaluation Criteria*\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 714,
    "sentence_start": 4569,
    "sentence_end": 4571,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nOutcome Measures\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\nTotal\nAlderson and McGall4\n1\n1\n1\n1\n0\n1\n2\n2\n2\n2\n1\n1\n15\nAmadio et al6\n2\n1\n2\n1\n0\n1\n2\n2\n2\n2\n1\n2\n18\nAmirfeyz et al10\n2\n1\n2\n2\n0\n1\n0\n0\n2\n1\n1\n2\n14\nAmirjani et al12\n2\n2\n2\n1\n0\n0\n2\n2\n2\n2\n2\n2\n19\nAmirjani et al13\n2\n2\n2\n1\n1\n0\n2\n2\n2\n2\n0\n2\n18\nAppleby et al16\n2\n2\n1\n1\n0\n2\n2\n2\n2\n2\n1\n1\n18\nAstifidis et al19\n2\n1\n2\n2\n2\n2\n2\n2\n2\n1\n0\n2\n20\nAtalay et al20\n1\n2\n1\n2\n2\n2\n2\n0\n2\n1\n0\n1\n16\nAtroshi et al22\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n23\nAtroshi et al23\n2\n1\n2\n2\n2\n1\n2\n1\n2\n2\n2\n2\n21\nAtroshi et al25\n2\n2\n1\n2\n1\n1\n1\n2\n2\n2\n2\n2\n20\nAtroshi et al26\n2\n1\n2\n1\n1\n0\n2\n1\n2\n2\n2\n2\n18\nBaker et al28\n2\n2\n0\n0\n0\n2\n2\n2\n2\n1\n1\n2\n16\nBaker and Livengood27\n1\n1\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n21\nBakhsh et al30\n2\n2\n0\n2\n0\n1\n1\n1\n2\n2\n2\n2\n17\nBessette et al38\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n0\n2\n20\nBoyd et al43\n2\n2\n2\n2\n0\n2\n2\n1\n2\n2\n1\n2\n20\nChatterjee and Price58\n2\n2\n0\n0\n0\n0\n1\n1\n2\n2\n0\n2\n12\nCheung et al64\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n23\nColdham et al72\n2\n1\n2\n1\n2\n2\n2\n2\n2\n2\n1\n2\n21\nde la Llave-Rincón et al81\n2\n2\n2\n2\n1\n0\n2\n1\n2\n2\n2\n2\n20\nDhong et al83\n1\n1\n2\n2\n2\n2\n1\n1\n2\n2\n2\n2\n20\nFernández-de-las-Peñas et al95\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n23\nGay et al101\n2\n2\n2\n1\n0\n2\n1\n2\n2\n2\n1\n2\n19\nGreenslade et al118\n2\n2\n2\n1\n0\n0\n1\n2\n2\n2\n2\n2\n18\nHobby et al134\n1\n1\n0\n2\n0\n1\n2\n2\n2\n2\n1\n2\n16\nHsu et al135\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n1\n1\n21\nJerosch-Herold et al138\n2\n1\n1\n2\n1\n2\n2\n2\n1\n2\n1\n2\n19\nKatz et al145\n2\n2\n1\n0\n0\n1\n2\n0\n2\n2\n1\n1\n14\nKaye and Reynolds147\n2\n1\n2\n2\n1\n2\n1\n2\n2\n2\n1\n2\n20\nKotsis and Chung154\n1\n2\n0\n0\n0\n2\n2\n1\n2\n2\n1\n1\n14\nLevine et al162\n2\n1\n1\n2\n0\n0\n2\n2\n2\n2\n1\n2\n17\nLyrén and Atroshi167\n2\n1\n2\n2\n1\n1\n2\n1\n2\n2\n2\n1\n19\nMcMillan and Binhammer187\n2\n0\n1\n0\n0\n0\n2\n2\n2\n2\n1\n2\n14\nOllivere et al212\n2\n1\n2\n2\n1\n2\n2\n1\n2\n2\n2\n2\n21\nOlsen and Knudson213\n2\n0\n2\n1\n0\n2\n1\n0\n2\n1\n1\n2\n14\nOzer et al216\n2\n2\n2\n1\n1\n2\n2\n1\n2\n2\n2\n2\n21\nÖzyürekoğlu et al219\n2\n2\n1\n0\n0\n2\n1\n2\n2\n2\n2\n2\n18\nPransky et al230\n2\n1\n1\n2\n1\n0\n2\n1\n2\n2\n1\n2\n17\nPriganc and Henry232\n2\n2\n1\n0\n0\n0\n2\n2\n2\n2\n0\n2\n15\nSears and Chung254\n2\n1\n1\n1\n0\n2\n2\n1\n1\n2\n2\n2\n17\nSmith-Forbes et al263\n2\n2\n2\n2\n2\n0\n0\n0\n2\n2\n2\n2\n18\nTulipan et al276\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n24\nZyluk and Piotuch303\n1\n1\n1\n2\n0\n1\n1\n1\n2\n2\n0\n2\n14\n*Criteria from Law M, MacDermid J.",
    "chunk_id": 715,
    "sentence_start": 4572,
    "sentence_end": 4574,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nOutcome Measures\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\nTotal\nAlderson and McGall4\n1\n1\n1\n1\n0\n1\n2\n2\n2\n2\n1\n1\n15\nAmadio et al6\n2\n1\n2\n1\n0\n1\n2\n2\n2\n2\n1\n2\n18\nAmirfeyz et al10\n2\n1\n2\n2\n0\n1\n0\n0\n2\n1\n1\n2\n14\nAmirjani et al12\n2\n2\n2\n1\n0\n0\n2\n2\n2\n2\n2\n2\n19\nAmirjani et al13\n2\n2\n2\n1\n1\n0\n2\n2\n2\n2\n0\n2\n18\nAppleby et al16\n2\n2\n1\n1\n0\n2\n2\n2\n2\n2\n1\n1\n18\nAstifidis et al19\n2\n1\n2\n2\n2\n2\n2\n2\n2\n1\n0\n2\n20\nAtalay et al20\n1\n2\n1\n2\n2\n2\n2\n0\n2\n1\n0\n1\n16\nAtroshi et al22\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n23\nAtroshi et al23\n2\n1\n2\n2\n2\n1\n2\n1\n2\n2\n2\n2\n21\nAtroshi et al25\n2\n2\n1\n2\n1\n1\n1\n2\n2\n2\n2\n2\n20\nAtroshi et al26\n2\n1\n2\n1\n1\n0\n2\n1\n2\n2\n2\n2\n18\nBaker et al28\n2\n2\n0\n0\n0\n2\n2\n2\n2\n1\n1\n2\n16\nBaker and Livengood27\n1\n1\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n21\nBakhsh et al30\n2\n2\n0\n2\n0\n1\n1\n1\n2\n2\n2\n2\n17\nBessette et al38\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n0\n2\n20\nBoyd et al43\n2\n2\n2\n2\n0\n2\n2\n1\n2\n2\n1\n2\n20\nChatterjee and Price58\n2\n2\n0\n0\n0\n0\n1\n1\n2\n2\n0\n2\n12\nCheung et al64\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n23\nColdham et al72\n2\n1\n2\n1\n2\n2\n2\n2\n2\n2\n1\n2\n21\nde la Llave-Rincón et al81\n2\n2\n2\n2\n1\n0\n2\n1\n2\n2\n2\n2\n20\nDhong et al83\n1\n1\n2\n2\n2\n2\n1\n1\n2\n2\n2\n2\n20\nFernández-de-las-Peñas et al95\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n23\nGay et al101\n2\n2\n2\n1\n0\n2\n1\n2\n2\n2\n1\n2\n19\nGreenslade et al118\n2\n2\n2\n1\n0\n0\n1\n2\n2\n2\n2\n2\n18\nHobby et al134\n1\n1\n0\n2\n0\n1\n2\n2\n2\n2\n1\n2\n16\nHsu et al135\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n1\n1\n21\nJerosch-Herold et al138\n2\n1\n1\n2\n1\n2\n2\n2\n1\n2\n1\n2\n19\nKatz et al145\n2\n2\n1\n0\n0\n1\n2\n0\n2\n2\n1\n1\n14\nKaye and Reynolds147\n2\n1\n2\n2\n1\n2\n1\n2\n2\n2\n1\n2\n20\nKotsis and Chung154\n1\n2\n0\n0\n0\n2\n2\n1\n2\n2\n1\n1\n14\nLevine et al162\n2\n1\n1\n2\n0\n0\n2\n2\n2\n2\n1\n2\n17\nLyrén and Atroshi167\n2\n1\n2\n2\n1\n1\n2\n1\n2\n2\n2\n1\n19\nMcMillan and Binhammer187\n2\n0\n1\n0\n0\n0\n2\n2\n2\n2\n1\n2\n14\nOllivere et al212\n2\n1\n2\n2\n1\n2\n2\n1\n2\n2\n2\n2\n21\nOlsen and Knudson213\n2\n0\n2\n1\n0\n2\n1\n0\n2\n1\n1\n2\n14\nOzer et al216\n2\n2\n2\n1\n1\n2\n2\n1\n2\n2\n2\n2\n21\nÖzyürekoğlu et al219\n2\n2\n1\n0\n0\n2\n1\n2\n2\n2\n2\n2\n18\nPransky et al230\n2\n1\n1\n2\n1\n0\n2\n1\n2\n2\n1\n2\n17\nPriganc and Henry232\n2\n2\n1\n0\n0\n0\n2\n2\n2\n2\n0\n2\n15\nSears and Chung254\n2\n1\n1\n1\n0\n2\n2\n1\n1\n2\n2\n2\n17\nSmith-Forbes et al263\n2\n2\n2\n2\n2\n0\n0\n0\n2\n2\n2\n2\n18\nTulipan et al276\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n24\nZyluk and Piotuch303\n1\n1\n1\n2\n0\n1\n1\n1\n2\n2\n0\n2\n14\n*Criteria from Law M, MacDermid J. Appendix A: quality appraisal for clinical measurement studies.",
    "chunk_id": 716,
    "sentence_start": 4573,
    "sentence_end": 4578,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, marginally met criterion; 2, met criterion. Items: (1) Comprehensive literature review to justify the research \nquestion; (2) Specific inclusion/exclusion criteria; (3) Specific hypotheses; (4) Appropriate scope of measurement properties; (5) Sample-size justification; (6) Minimal loss to follow-\nup; (7) Detailing the test procedures; (8) Standardization of measurement techniques; (9) Data presented for each hypothesis; (10) Appropriate statistical tests; (11) Range of analyses \nfor each measurement property; (12) Proper presentation of the conclusions and clinical recommendations. APPENDIX D\nEvaluation Criteria*\n\n\n--- Page 73 ---\nCOLUMN 1:\nEvaluation Criteria*\nEvaluation Criteria*\nInterventions: Assistive Technology\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nSchmid et al253\n2\n0\n2\n2\n0\n0\n0\n0\n1\n2\n2\n2\n2\n1\n2\n2\n2\n0\n2\n2\n1\n1\n2\n2\n32\n*Criteria from Joy MacDermid (personal communication).",
    "chunk_id": 717,
    "sentence_start": 4577,
    "sentence_end": 4581,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Comprehensive literature review to justify the research \nquestion; (2) Specific inclusion/exclusion criteria; (3) Specific hypotheses; (4) Appropriate scope of measurement properties; (5) Sample-size justification; (6) Minimal loss to follow-\nup; (7) Detailing the test procedures; (8) Standardization of measurement techniques; (9) Data presented for each hypothesis; (10) Appropriate statistical tests; (11) Range of analyses \nfor each measurement property; (12) Proper presentation of the conclusions and clinical recommendations. APPENDIX D\nEvaluation Criteria*\n\n\n--- Page 73 ---\nCOLUMN 1:\nEvaluation Criteria*\nEvaluation Criteria*\nInterventions: Assistive Technology\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nSchmid et al253\n2\n0\n2\n2\n0\n0\n0\n0\n1\n2\n2\n2\n2\n1\n2\n2\n2\n0\n2\n2\n1\n1\n2\n2\n32\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 718,
    "sentence_start": 4580,
    "sentence_end": 4582,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "APPENDIX D\nEvaluation Criteria*\n\n\n--- Page 73 ---\nCOLUMN 1:\nEvaluation Criteria*\nEvaluation Criteria*\nInterventions: Assistive Technology\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nSchmid et al253\n2\n0\n2\n2\n0\n0\n0\n0\n1\n2\n2\n2\n2\n1\n2\n2\n2\n0\n2\n2\n1\n1\n2\n2\n32\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22)\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 719,
    "sentence_start": 4581,
    "sentence_end": 4583,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22)\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Orthoses\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nBulut et al47\n2\n2\n2\n2\n1\n0\n0\n0\n0\n2\n2\n1\n1\n0\n2\n1\n1\n0\n2\n2\n1\n0\n2\n1\n27\nChesterton et al63\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n1\n2\n1\n1\n42\nCourts75\n1\n2\n2\n2\n0\n0\n0\n0\n2\n2\n0\n0\n1\n0\n2\n1\n1\n1\n1\n0\n0\n0\n2\n1\n21\nEkman-Ordeberg et al86\n1\n0\n2\n2\n0\n0\n0\n0\n0\n2\n0\n2\n1\n0\n0\n1\n1\n2\n0\n0\n1\n2\n1\n1\n19\nGelberman et al103\n1\n2\n1\n2\n0\n0\n0\n0\n0\n0\n0\n2\n2\n1\n1\n2\n1\n1\n1\n0\n0\n2\n2\n2\n23\nGerritsen et al108\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n0\n2\n2\n2\n2\n1\n2\n2\n2\n0\n2\n2\n2\n2\n42\nGolriz et al114\n2\n2\n2\n2\n1\n2\n0\n0\n1\n2\n1\n2\n2\n0\n2\n0\n1\n1\n2\n0\n2\n2\n2\n1\n32\nHall et al125\n2\n2\n2\n2\n2\n0\n0\n0\n1\n2\n2\n1\n2\n0\n2\n2\n1\n1\n1\n2\n1\n0\n2\n1\n31\nKeir et al148\n2\n0\n0\n2\n0\n0\n0\n0\n2\n2\n0\n2\n2\n0\n0\n2\n0\n0\n2\n0\n2\n2\n2\n2\n24\nKuo et al156\n1\n0\n0\n2\n0\n0\n0\n0\n2\n1\n1\n0\n2\n0\n0\n2\n1\n0\n1\n0\n2\n2\n1\n1\n19\nMadjdinasab et al176\n2\n2\n2\n2\n1\n2\n2\n0\n1\n2\n2\n2\n2\n0\n2\n2\n0\n2\n2\n0\n2\n0\n2\n2\n36\nManente et al179\n1\n0\n0\n2\n0\n0\n0\n0\n0\n1\n0\n2\n2\n0\n0\n1\n1\n0\n2\n0\n1\n1\n1\n2\n17\nMishra et al192\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n0\n1\n2\n0\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n39\nÖzgen et al217\n2\n1\n2\n2\n0\n2\n2\n0\n0\n2\n0\n2\n2\n0\n2\n1\n1\n2\n2\n0\n2\n0\n2\n2\n31\nRempel et al237\n2\n2\n2\n2\n0\n0\n0\n0\n1\n2\n0\n2\n1\n1\n2\n1\n0\n1\n1\n0\n1\n1\n2\n2\n26\nSchmid et al252\n2\n2\n1\n2\n2\n0\n0\n2\n2\n2\n0\n2\n1\n2\n2\n2\n2\n0\n2\n0\n2\n1\n2\n1\n34\nSo et al264\n1\n2\n2\n2\n2\n1\n0\n0\n2\n2\n2\n0\n1\n1\n2\n2\n2\n1\n2\n2\n1\n0\n2\n2\n34\nUcan et al277\n2\n2\n2\n2\n2\n0\n0\n0\n1\n2\n0\n1\n1\n1\n2\n2\n1\n1\n2\n0\n1\n0\n2\n1\n28\nWalker et al284\n2\n2\n2\n2\n2\n0\n0\n0\n2\n2\n0\n1\n2\n0\n2\n2\n1\n1\n2\n0\n2\n1\n2\n1\n31\nWang et al285\n2\n2\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n45\nWeiss et al287\n2\n1\n0\n1\n0\n0\n0\n0\n1\n1\n0\n2\n2\n0\n2\n2\n1\n0\n2\n0\n2\n2\n1\n1\n23\n*Criteria from Joy MacDermid (personal communication).",
    "chunk_id": 720,
    "sentence_start": 4582,
    "sentence_end": 4584,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22)\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Orthoses\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nBulut et al47\n2\n2\n2\n2\n1\n0\n0\n0\n0\n2\n2\n1\n1\n0\n2\n1\n1\n0\n2\n2\n1\n0\n2\n1\n27\nChesterton et al63\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n1\n2\n1\n1\n42\nCourts75\n1\n2\n2\n2\n0\n0\n0\n0\n2\n2\n0\n0\n1\n0\n2\n1\n1\n1\n1\n0\n0\n0\n2\n1\n21\nEkman-Ordeberg et al86\n1\n0\n2\n2\n0\n0\n0\n0\n0\n2\n0\n2\n1\n0\n0\n1\n1\n2\n0\n0\n1\n2\n1\n1\n19\nGelberman et al103\n1\n2\n1\n2\n0\n0\n0\n0\n0\n0\n0\n2\n2\n1\n1\n2\n1\n1\n1\n0\n0\n2\n2\n2\n23\nGerritsen et al108\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n0\n2\n2\n2\n2\n1\n2\n2\n2\n0\n2\n2\n2\n2\n42\nGolriz et al114\n2\n2\n2\n2\n1\n2\n0\n0\n1\n2\n1\n2\n2\n0\n2\n0\n1\n1\n2\n0\n2\n2\n2\n1\n32\nHall et al125\n2\n2\n2\n2\n2\n0\n0\n0\n1\n2\n2\n1\n2\n0\n2\n2\n1\n1\n1\n2\n1\n0\n2\n1\n31\nKeir et al148\n2\n0\n0\n2\n0\n0\n0\n0\n2\n2\n0\n2\n2\n0\n0\n2\n0\n0\n2\n0\n2\n2\n2\n2\n24\nKuo et al156\n1\n0\n0\n2\n0\n0\n0\n0\n2\n1\n1\n0\n2\n0\n0\n2\n1\n0\n1\n0\n2\n2\n1\n1\n19\nMadjdinasab et al176\n2\n2\n2\n2\n1\n2\n2\n0\n1\n2\n2\n2\n2\n0\n2\n2\n0\n2\n2\n0\n2\n0\n2\n2\n36\nManente et al179\n1\n0\n0\n2\n0\n0\n0\n0\n0\n1\n0\n2\n2\n0\n0\n1\n1\n0\n2\n0\n1\n1\n1\n2\n17\nMishra et al192\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n0\n1\n2\n0\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n39\nÖzgen et al217\n2\n1\n2\n2\n0\n2\n2\n0\n0\n2\n0\n2\n2\n0\n2\n1\n1\n2\n2\n0\n2\n0\n2\n2\n31\nRempel et al237\n2\n2\n2\n2\n0\n0\n0\n0\n1\n2\n0\n2\n1\n1\n2\n1\n0\n1\n1\n0\n1\n1\n2\n2\n26\nSchmid et al252\n2\n2\n1\n2\n2\n0\n0\n2\n2\n2\n0\n2\n1\n2\n2\n2\n2\n0\n2\n0\n2\n1\n2\n1\n34\nSo et al264\n1\n2\n2\n2\n2\n1\n0\n0\n2\n2\n2\n0\n1\n1\n2\n2\n2\n1\n2\n2\n1\n0\n2\n2\n34\nUcan et al277\n2\n2\n2\n2\n2\n0\n0\n0\n1\n2\n0\n1\n1\n1\n2\n2\n1\n1\n2\n0\n1\n0\n2\n1\n28\nWalker et al284\n2\n2\n2\n2\n2\n0\n0\n0\n2\n2\n0\n1\n2\n0\n2\n2\n1\n1\n2\n0\n2\n1\n2\n1\n31\nWang et al285\n2\n2\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n45\nWeiss et al287\n2\n1\n0\n1\n0\n0\n0\n0\n1\n1\n0\n2\n2\n0\n2\n2\n1\n0\n2\n0\n2\n2\n1\n1\n23\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 721,
    "sentence_start": 4583,
    "sentence_end": 4585,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Interventions: Orthoses\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nBulut et al47\n2\n2\n2\n2\n1\n0\n0\n0\n0\n2\n2\n1\n1\n0\n2\n1\n1\n0\n2\n2\n1\n0\n2\n1\n27\nChesterton et al63\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n1\n2\n1\n1\n42\nCourts75\n1\n2\n2\n2\n0\n0\n0\n0\n2\n2\n0\n0\n1\n0\n2\n1\n1\n1\n1\n0\n0\n0\n2\n1\n21\nEkman-Ordeberg et al86\n1\n0\n2\n2\n0\n0\n0\n0\n0\n2\n0\n2\n1\n0\n0\n1\n1\n2\n0\n0\n1\n2\n1\n1\n19\nGelberman et al103\n1\n2\n1\n2\n0\n0\n0\n0\n0\n0\n0\n2\n2\n1\n1\n2\n1\n1\n1\n0\n0\n2\n2\n2\n23\nGerritsen et al108\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n0\n2\n2\n2\n2\n1\n2\n2\n2\n0\n2\n2\n2\n2\n42\nGolriz et al114\n2\n2\n2\n2\n1\n2\n0\n0\n1\n2\n1\n2\n2\n0\n2\n0\n1\n1\n2\n0\n2\n2\n2\n1\n32\nHall et al125\n2\n2\n2\n2\n2\n0\n0\n0\n1\n2\n2\n1\n2\n0\n2\n2\n1\n1\n1\n2\n1\n0\n2\n1\n31\nKeir et al148\n2\n0\n0\n2\n0\n0\n0\n0\n2\n2\n0\n2\n2\n0\n0\n2\n0\n0\n2\n0\n2\n2\n2\n2\n24\nKuo et al156\n1\n0\n0\n2\n0\n0\n0\n0\n2\n1\n1\n0\n2\n0\n0\n2\n1\n0\n1\n0\n2\n2\n1\n1\n19\nMadjdinasab et al176\n2\n2\n2\n2\n1\n2\n2\n0\n1\n2\n2\n2\n2\n0\n2\n2\n0\n2\n2\n0\n2\n0\n2\n2\n36\nManente et al179\n1\n0\n0\n2\n0\n0\n0\n0\n0\n1\n0\n2\n2\n0\n0\n1\n1\n0\n2\n0\n1\n1\n1\n2\n17\nMishra et al192\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n0\n1\n2\n0\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n39\nÖzgen et al217\n2\n1\n2\n2\n0\n2\n2\n0\n0\n2\n0\n2\n2\n0\n2\n1\n1\n2\n2\n0\n2\n0\n2\n2\n31\nRempel et al237\n2\n2\n2\n2\n0\n0\n0\n0\n1\n2\n0\n2\n1\n1\n2\n1\n0\n1\n1\n0\n1\n1\n2\n2\n26\nSchmid et al252\n2\n2\n1\n2\n2\n0\n0\n2\n2\n2\n0\n2\n1\n2\n2\n2\n2\n0\n2\n0\n2\n1\n2\n1\n34\nSo et al264\n1\n2\n2\n2\n2\n1\n0\n0\n2\n2\n2\n0\n1\n1\n2\n2\n2\n1\n2\n2\n1\n0\n2\n2\n34\nUcan et al277\n2\n2\n2\n2\n2\n0\n0\n0\n1\n2\n0\n1\n1\n1\n2\n2\n1\n1\n2\n0\n1\n0\n2\n1\n28\nWalker et al284\n2\n2\n2\n2\n2\n0\n0\n0\n2\n2\n0\n1\n2\n0\n2\n2\n1\n1\n2\n0\n2\n1\n2\n1\n31\nWang et al285\n2\n2\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n45\nWeiss et al287\n2\n1\n0\n1\n0\n0\n0\n0\n1\n1\n0\n2\n2\n0\n2\n2\n1\n0\n2\n0\n2\n2\n1\n1\n23\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) S bj\nt bli d d (7) P\nid\nbli d d (8) I d\nd\nt\nt\nl\nt\n(9) Mi i\nl\nl / l\nti\nbi\n(10) D fi\nd i\nl\ni\n/\nl\ni\nit i\n(11) E\nll\nt bt i\nd\nAPPENDIX D\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 722,
    "sentence_start": 4584,
    "sentence_end": 4586,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) S bj\nt bli d d (7) P\nid\nbli d d (8) I d\nd\nt\nt\nl\nt\n(9) Mi i\nl\nl / l\nti\nbi\n(10) D fi\nd i\nl\ni\n/\nl\ni\nit i\n(11) E\nll\nt bt i\nd\nAPPENDIX D\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 723,
    "sentence_start": 4585,
    "sentence_end": 4590,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nEvaluation Criteria*\nEvaluation Criteria*\nInterventions: Assistive Technology\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nSchmid et al253\n2\n0\n2\n2\n0\n0\n0\n0\n1\n2\n2\n2\n2\n1\n2\n2\n2\n0\n2\n2\n1\n1\n2\n2\n32\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 724,
    "sentence_start": 4589,
    "sentence_end": 4592,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nEvaluation Criteria*\nEvaluation Criteria*\nInterventions: Assistive Technology\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nSchmid et al253\n2\n0\n2\n2\n0\n0\n0\n0\n1\n2\n2\n2\n2\n1\n2\n2\n2\n0\n2\n2\n1\n1\n2\n2\n32\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 725,
    "sentence_start": 4591,
    "sentence_end": 4593,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Orthoses\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nBulut et al47\n2\n2\n2\n2\n1\n0\n0\n0\n0\n2\n2\n1\n1\n0\n2\n1\n1\n0\n2\n2\n1\n0\n2\n1\n27\nChesterton et al63\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n1\n2\n1\n1\n42\nCourts75\n1\n2\n2\n2\n0\n0\n0\n0\n2\n2\n0\n0\n1\n0\n2\n1\n1\n1\n1\n0\n0\n0\n2\n1\n21\nEkman-Ordeberg et al86\n1\n0\n2\n2\n0\n0\n0\n0\n0\n2\n0\n2\n1\n0\n0\n1\n1\n2\n0\n0\n1\n2\n1\n1\n19\nGelberman et al103\n1\n2\n1\n2\n0\n0\n0\n0\n0\n0\n0\n2\n2\n1\n1\n2\n1\n1\n1\n0\n0\n2\n2\n2\n23\nGerritsen et al108\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n0\n2\n2\n2\n2\n1\n2\n2\n2\n0\n2\n2\n2\n2\n42\nGolriz et al114\n2\n2\n2\n2\n1\n2\n0\n0\n1\n2\n1\n2\n2\n0\n2\n0\n1\n1\n2\n0\n2\n2\n2\n1\n32\nHall et al125\n2\n2\n2\n2\n2\n0\n0\n0\n1\n2\n2\n1\n2\n0\n2\n2\n1\n1\n1\n2\n1\n0\n2\n1\n31\nKeir et al148\n2\n0\n0\n2\n0\n0\n0\n0\n2\n2\n0\n2\n2\n0\n0\n2\n0\n0\n2\n0\n2\n2\n2\n2\n24\nKuo et al156\n1\n0\n0\n2\n0\n0\n0\n0\n2\n1\n1\n0\n2\n0\n0\n2\n1\n0\n1\n0\n2\n2\n1\n1\n19\nMadjdinasab et al176\n2\n2\n2\n2\n1\n2\n2\n0\n1\n2\n2\n2\n2\n0\n2\n2\n0\n2\n2\n0\n2\n0\n2\n2\n36\nManente et al179\n1\n0\n0\n2\n0\n0\n0\n0\n0\n1\n0\n2\n2\n0\n0\n1\n1\n0\n2\n0\n1\n1\n1\n2\n17\nMishra et al192\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n0\n1\n2\n0\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n39\nÖzgen et al217\n2\n1\n2\n2\n0\n2\n2\n0\n0\n2\n0\n2\n2\n0\n2\n1\n1\n2\n2\n0\n2\n0\n2\n2\n31\nRempel et al237\n2\n2\n2\n2\n0\n0\n0\n0\n1\n2\n0\n2\n1\n1\n2\n1\n0\n1\n1\n0\n1\n1\n2\n2\n26\nSchmid et al252\n2\n2\n1\n2\n2\n0\n0\n2\n2\n2\n0\n2\n1\n2\n2\n2\n2\n0\n2\n0\n2\n1\n2\n1\n34\nSo et al264\n1\n2\n2\n2\n2\n1\n0\n0\n2\n2\n2\n0\n1\n1\n2\n2\n2\n1\n2\n2\n1\n0\n2\n2\n34\nUcan et al277\n2\n2\n2\n2\n2\n0\n0\n0\n1\n2\n0\n1\n1\n1\n2\n2\n1\n1\n2\n0\n1\n0\n2\n1\n28\nWalker et al284\n2\n2\n2\n2\n2\n0\n0\n0\n2\n2\n0\n1\n2\n0\n2\n2\n1\n1\n2\n0\n2\n1\n2\n1\n31\nWang et al285\n2\n2\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n45\nWeiss et al287\n2\n1\n0\n1\n0\n0\n0\n0\n1\n1\n0\n2\n2\n0\n2\n2\n1\n0\n2\n0\n2\n2\n1\n1\n23\n*Criteria from Joy MacDermid (personal communication).",
    "chunk_id": 726,
    "sentence_start": 4592,
    "sentence_end": 4594,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Orthoses\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nBulut et al47\n2\n2\n2\n2\n1\n0\n0\n0\n0\n2\n2\n1\n1\n0\n2\n1\n1\n0\n2\n2\n1\n0\n2\n1\n27\nChesterton et al63\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n1\n2\n1\n1\n42\nCourts75\n1\n2\n2\n2\n0\n0\n0\n0\n2\n2\n0\n0\n1\n0\n2\n1\n1\n1\n1\n0\n0\n0\n2\n1\n21\nEkman-Ordeberg et al86\n1\n0\n2\n2\n0\n0\n0\n0\n0\n2\n0\n2\n1\n0\n0\n1\n1\n2\n0\n0\n1\n2\n1\n1\n19\nGelberman et al103\n1\n2\n1\n2\n0\n0\n0\n0\n0\n0\n0\n2\n2\n1\n1\n2\n1\n1\n1\n0\n0\n2\n2\n2\n23\nGerritsen et al108\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n0\n2\n2\n2\n2\n1\n2\n2\n2\n0\n2\n2\n2\n2\n42\nGolriz et al114\n2\n2\n2\n2\n1\n2\n0\n0\n1\n2\n1\n2\n2\n0\n2\n0\n1\n1\n2\n0\n2\n2\n2\n1\n32\nHall et al125\n2\n2\n2\n2\n2\n0\n0\n0\n1\n2\n2\n1\n2\n0\n2\n2\n1\n1\n1\n2\n1\n0\n2\n1\n31\nKeir et al148\n2\n0\n0\n2\n0\n0\n0\n0\n2\n2\n0\n2\n2\n0\n0\n2\n0\n0\n2\n0\n2\n2\n2\n2\n24\nKuo et al156\n1\n0\n0\n2\n0\n0\n0\n0\n2\n1\n1\n0\n2\n0\n0\n2\n1\n0\n1\n0\n2\n2\n1\n1\n19\nMadjdinasab et al176\n2\n2\n2\n2\n1\n2\n2\n0\n1\n2\n2\n2\n2\n0\n2\n2\n0\n2\n2\n0\n2\n0\n2\n2\n36\nManente et al179\n1\n0\n0\n2\n0\n0\n0\n0\n0\n1\n0\n2\n2\n0\n0\n1\n1\n0\n2\n0\n1\n1\n1\n2\n17\nMishra et al192\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n0\n1\n2\n0\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n39\nÖzgen et al217\n2\n1\n2\n2\n0\n2\n2\n0\n0\n2\n0\n2\n2\n0\n2\n1\n1\n2\n2\n0\n2\n0\n2\n2\n31\nRempel et al237\n2\n2\n2\n2\n0\n0\n0\n0\n1\n2\n0\n2\n1\n1\n2\n1\n0\n1\n1\n0\n1\n1\n2\n2\n26\nSchmid et al252\n2\n2\n1\n2\n2\n0\n0\n2\n2\n2\n0\n2\n1\n2\n2\n2\n2\n0\n2\n0\n2\n1\n2\n1\n34\nSo et al264\n1\n2\n2\n2\n2\n1\n0\n0\n2\n2\n2\n0\n1\n1\n2\n2\n2\n1\n2\n2\n1\n0\n2\n2\n34\nUcan et al277\n2\n2\n2\n2\n2\n0\n0\n0\n1\n2\n0\n1\n1\n1\n2\n2\n1\n1\n2\n0\n1\n0\n2\n1\n28\nWalker et al284\n2\n2\n2\n2\n2\n0\n0\n0\n2\n2\n0\n1\n2\n0\n2\n2\n1\n1\n2\n0\n2\n1\n2\n1\n31\nWang et al285\n2\n2\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n45\nWeiss et al287\n2\n1\n0\n1\n0\n0\n0\n0\n1\n1\n0\n2\n2\n0\n2\n2\n1\n0\n2\n0\n2\n2\n1\n1\n23\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 727,
    "sentence_start": 4593,
    "sentence_end": 4595,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Interventions: Orthoses\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nBulut et al47\n2\n2\n2\n2\n1\n0\n0\n0\n0\n2\n2\n1\n1\n0\n2\n1\n1\n0\n2\n2\n1\n0\n2\n1\n27\nChesterton et al63\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n1\n2\n1\n1\n42\nCourts75\n1\n2\n2\n2\n0\n0\n0\n0\n2\n2\n0\n0\n1\n0\n2\n1\n1\n1\n1\n0\n0\n0\n2\n1\n21\nEkman-Ordeberg et al86\n1\n0\n2\n2\n0\n0\n0\n0\n0\n2\n0\n2\n1\n0\n0\n1\n1\n2\n0\n0\n1\n2\n1\n1\n19\nGelberman et al103\n1\n2\n1\n2\n0\n0\n0\n0\n0\n0\n0\n2\n2\n1\n1\n2\n1\n1\n1\n0\n0\n2\n2\n2\n23\nGerritsen et al108\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n0\n2\n2\n2\n2\n1\n2\n2\n2\n0\n2\n2\n2\n2\n42\nGolriz et al114\n2\n2\n2\n2\n1\n2\n0\n0\n1\n2\n1\n2\n2\n0\n2\n0\n1\n1\n2\n0\n2\n2\n2\n1\n32\nHall et al125\n2\n2\n2\n2\n2\n0\n0\n0\n1\n2\n2\n1\n2\n0\n2\n2\n1\n1\n1\n2\n1\n0\n2\n1\n31\nKeir et al148\n2\n0\n0\n2\n0\n0\n0\n0\n2\n2\n0\n2\n2\n0\n0\n2\n0\n0\n2\n0\n2\n2\n2\n2\n24\nKuo et al156\n1\n0\n0\n2\n0\n0\n0\n0\n2\n1\n1\n0\n2\n0\n0\n2\n1\n0\n1\n0\n2\n2\n1\n1\n19\nMadjdinasab et al176\n2\n2\n2\n2\n1\n2\n2\n0\n1\n2\n2\n2\n2\n0\n2\n2\n0\n2\n2\n0\n2\n0\n2\n2\n36\nManente et al179\n1\n0\n0\n2\n0\n0\n0\n0\n0\n1\n0\n2\n2\n0\n0\n1\n1\n0\n2\n0\n1\n1\n1\n2\n17\nMishra et al192\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n0\n1\n2\n0\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n39\nÖzgen et al217\n2\n1\n2\n2\n0\n2\n2\n0\n0\n2\n0\n2\n2\n0\n2\n1\n1\n2\n2\n0\n2\n0\n2\n2\n31\nRempel et al237\n2\n2\n2\n2\n0\n0\n0\n0\n1\n2\n0\n2\n1\n1\n2\n1\n0\n1\n1\n0\n1\n1\n2\n2\n26\nSchmid et al252\n2\n2\n1\n2\n2\n0\n0\n2\n2\n2\n0\n2\n1\n2\n2\n2\n2\n0\n2\n0\n2\n1\n2\n1\n34\nSo et al264\n1\n2\n2\n2\n2\n1\n0\n0\n2\n2\n2\n0\n1\n1\n2\n2\n2\n1\n2\n2\n1\n0\n2\n2\n34\nUcan et al277\n2\n2\n2\n2\n2\n0\n0\n0\n1\n2\n0\n1\n1\n1\n2\n2\n1\n1\n2\n0\n1\n0\n2\n1\n28\nWalker et al284\n2\n2\n2\n2\n2\n0\n0\n0\n2\n2\n0\n1\n2\n0\n2\n2\n1\n1\n2\n0\n2\n1\n2\n1\n31\nWang et al285\n2\n2\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n45\nWeiss et al287\n2\n1\n0\n1\n0\n0\n0\n0\n1\n1\n0\n2\n2\n0\n2\n2\n1\n0\n2\n0\n2\n2\n1\n1\n23\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 728,
    "sentence_start": 4594,
    "sentence_end": 4596,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. APPENDIX D\n\n\n--- Page 74 ---\nCOLUMN 1:\nInterventions: Biophysical Agents (Thermotherapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nChang et al57\n2\n0\n1\n2\n2\n0\n2\n2\n2\n2\n2\n1\n2\n1\n2\n2\n2\n1\n2\n2\n2\n2\n2\n1\n39\nFrasca et al99\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n42\nIncebiyik et al136\n2\n2\n2\n2\n2\n0\n2\n2\n1\n2\n0\n2\n2\n0\n2\n1\n2\n0\n2\n0\n2\n0\n1\n1\n32\nMichlovitz et al191\n2\n2\n2\n2\n1\n1\n2\n2\n2\n2\n0\n2\n2\n2\n2\n1\n0\n0\n2\n2\n2\n2\n1\n2\n38\n*Criteria from Joy MacDermid (personal communication).",
    "chunk_id": 729,
    "sentence_start": 4595,
    "sentence_end": 4597,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. APPENDIX D\n\n\n--- Page 74 ---\nCOLUMN 1:\nInterventions: Biophysical Agents (Thermotherapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nChang et al57\n2\n0\n1\n2\n2\n0\n2\n2\n2\n2\n2\n1\n2\n1\n2\n2\n2\n1\n2\n2\n2\n2\n2\n1\n39\nFrasca et al99\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n42\nIncebiyik et al136\n2\n2\n2\n2\n2\n0\n2\n2\n1\n2\n0\n2\n2\n0\n2\n1\n2\n0\n2\n0\n2\n0\n1\n1\n32\nMichlovitz et al191\n2\n2\n2\n2\n1\n1\n2\n2\n2\n2\n0\n2\n2\n2\n2\n1\n0\n0\n2\n2\n2\n2\n1\n2\n38\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 730,
    "sentence_start": 4596,
    "sentence_end": 4598,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "APPENDIX D\n\n\n--- Page 74 ---\nCOLUMN 1:\nInterventions: Biophysical Agents (Thermotherapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nChang et al57\n2\n0\n1\n2\n2\n0\n2\n2\n2\n2\n2\n1\n2\n1\n2\n2\n2\n1\n2\n2\n2\n2\n2\n1\n39\nFrasca et al99\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n42\nIncebiyik et al136\n2\n2\n2\n2\n2\n0\n2\n2\n1\n2\n0\n2\n2\n0\n2\n1\n2\n0\n2\n0\n2\n0\n1\n1\n32\nMichlovitz et al191\n2\n2\n2\n2\n1\n1\n2\n2\n2\n2\n0\n2\n2\n2\n2\n1\n0\n0\n2\n2\n2\n2\n1\n2\n38\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 731,
    "sentence_start": 4597,
    "sentence_end": 4599,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Electrotherapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nKoca et al150\n2\n2\n2\n2\n1\n0\n0\n2\n1\n2\n0\n2\n2\n0\n2\n2\n2\n1\n2\n0\n2\n0\n1\n1\n31\n*Criteria from Joy MacDermid (personal communication).",
    "chunk_id": 732,
    "sentence_start": 4598,
    "sentence_end": 4600,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Electrotherapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nKoca et al150\n2\n2\n2\n2\n1\n0\n0\n2\n1\n2\n0\n2\n2\n0\n2\n2\n2\n1\n2\n0\n2\n0\n1\n1\n31\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 733,
    "sentence_start": 4599,
    "sentence_end": 4601,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Interventions: Biophysical Agents (Electrotherapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nKoca et al150\n2\n2\n2\n2\n1\n0\n0\n2\n1\n2\n0\n2\n2\n0\n2\n2\n2\n1\n2\n0\n2\n0\n1\n1\n31\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 734,
    "sentence_start": 4600,
    "sentence_end": 4602,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Light Agents)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nRaeissadat et al234\n1\n2\n2\n2\n2\n0\n0\n1\n0\n2\n0\n2\n2\n0\n2\n1\n1\n1\n1\n0\n1\n0\n0\n0\n23\nStasinopoulos et al268\n1\n0\n2\n2\n0\n0\n0\n2\n0\n2\n0\n2\n2\n0\n0\n1\n0\n2\n1\n0\n0\n2\n1\n1\n21\n*Criteria from Joy MacDermid (personal communication).",
    "chunk_id": 735,
    "sentence_start": 4601,
    "sentence_end": 4603,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Light Agents)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nRaeissadat et al234\n1\n2\n2\n2\n2\n0\n0\n1\n0\n2\n0\n2\n2\n0\n2\n1\n1\n1\n1\n0\n1\n0\n0\n0\n23\nStasinopoulos et al268\n1\n0\n2\n2\n0\n0\n0\n2\n0\n2\n0\n2\n2\n0\n0\n1\n0\n2\n1\n0\n0\n2\n1\n1\n21\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 736,
    "sentence_start": 4602,
    "sentence_end": 4604,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Interventions: Biophysical Agents (Light Agents)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nRaeissadat et al234\n1\n2\n2\n2\n2\n0\n0\n1\n0\n2\n0\n2\n2\n0\n2\n1\n1\n1\n1\n0\n1\n0\n0\n0\n23\nStasinopoulos et al268\n1\n0\n2\n2\n0\n0\n0\n2\n0\n2\n0\n2\n2\n0\n0\n1\n0\n2\n1\n0\n0\n2\n1\n1\n21\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 737,
    "sentence_start": 4603,
    "sentence_end": 4605,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. APPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 738,
    "sentence_start": 4604,
    "sentence_end": 4606,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. APPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 739,
    "sentence_start": 4605,
    "sentence_end": 4607,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "APPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nInterventions: Biophysical Agents (Thermotherapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nChang et al57\n2\n0\n1\n2\n2\n0\n2\n2\n2\n2\n2\n1\n2\n1\n2\n2\n2\n1\n2\n2\n2\n2\n2\n1\n39\nFrasca et al99\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n42\nIncebiyik et al136\n2\n2\n2\n2\n2\n0\n2\n2\n1\n2\n0\n2\n2\n0\n2\n1\n2\n0\n2\n0\n2\n0\n1\n1\n32\nMichlovitz et al191\n2\n2\n2\n2\n1\n1\n2\n2\n2\n2\n0\n2\n2\n2\n2\n1\n0\n0\n2\n2\n2\n2\n1\n2\n38\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 740,
    "sentence_start": 4606,
    "sentence_end": 4612,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nInterventions: Biophysical Agents (Thermotherapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nChang et al57\n2\n0\n1\n2\n2\n0\n2\n2\n2\n2\n2\n1\n2\n1\n2\n2\n2\n1\n2\n2\n2\n2\n2\n1\n39\nFrasca et al99\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n1\n2\n2\n1\n2\n2\n2\n42\nIncebiyik et al136\n2\n2\n2\n2\n2\n0\n2\n2\n1\n2\n0\n2\n2\n0\n2\n1\n2\n0\n2\n0\n2\n0\n1\n1\n32\nMichlovitz et al191\n2\n2\n2\n2\n1\n1\n2\n2\n2\n2\n0\n2\n2\n2\n2\n1\n0\n0\n2\n2\n2\n2\n1\n2\n38\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 741,
    "sentence_start": 4611,
    "sentence_end": 4613,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Electrotherapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nKoca et al150\n2\n2\n2\n2\n1\n0\n0\n2\n1\n2\n0\n2\n2\n0\n2\n2\n2\n1\n2\n0\n2\n0\n1\n1\n31\n*Criteria from Joy MacDermid (personal communication).",
    "chunk_id": 742,
    "sentence_start": 4612,
    "sentence_end": 4614,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Electrotherapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nKoca et al150\n2\n2\n2\n2\n1\n0\n0\n2\n1\n2\n0\n2\n2\n0\n2\n2\n2\n1\n2\n0\n2\n0\n1\n1\n31\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 743,
    "sentence_start": 4613,
    "sentence_end": 4615,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Interventions: Biophysical Agents (Electrotherapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nKoca et al150\n2\n2\n2\n2\n1\n0\n0\n2\n1\n2\n0\n2\n2\n0\n2\n2\n2\n1\n2\n0\n2\n0\n1\n1\n31\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 744,
    "sentence_start": 4614,
    "sentence_end": 4616,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Light Agents)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nRaeissadat et al234\n1\n2\n2\n2\n2\n0\n0\n1\n0\n2\n0\n2\n2\n0\n2\n1\n1\n1\n1\n0\n1\n0\n0\n0\n23\nStasinopoulos et al268\n1\n0\n2\n2\n0\n0\n0\n2\n0\n2\n0\n2\n2\n0\n0\n1\n0\n2\n1\n0\n0\n2\n1\n1\n21\n*Criteria from Joy MacDermid (personal communication).",
    "chunk_id": 745,
    "sentence_start": 4615,
    "sentence_end": 4617,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Light Agents)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nRaeissadat et al234\n1\n2\n2\n2\n2\n0\n0\n1\n0\n2\n0\n2\n2\n0\n2\n1\n1\n1\n1\n0\n1\n0\n0\n0\n23\nStasinopoulos et al268\n1\n0\n2\n2\n0\n0\n0\n2\n0\n2\n0\n2\n2\n0\n0\n1\n0\n2\n1\n0\n0\n2\n1\n1\n21\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 746,
    "sentence_start": 4616,
    "sentence_end": 4618,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Interventions: Biophysical Agents (Light Agents)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nRaeissadat et al234\n1\n2\n2\n2\n2\n0\n0\n1\n0\n2\n0\n2\n2\n0\n2\n1\n1\n1\n1\n0\n1\n0\n0\n0\n23\nStasinopoulos et al268\n1\n0\n2\n2\n0\n0\n0\n2\n0\n2\n0\n2\n2\n0\n0\n1\n0\n2\n1\n0\n0\n2\n1\n1\n21\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 747,
    "sentence_start": 4617,
    "sentence_end": 4619,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. APPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n\n\n--- Page 75 ---\nCOLUMN 1:\nInterventions: Biophysical Agents (Sound Agents)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nArmagan et al17\n2\n2\n2\n2\n1\n2\n0\n2\n0\n2\n0\n2\n2\n0\n2\n1\n1\n0\n2\n2\n1\n2\n2\n2\n34\nBaysal et al35\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n1\n2\n0\n0\n0\n0\n2\n2\n0\n2\n0\n2\n0\n31\nChang et al57\n2\n2\n2\n2\n2\n0\n0\n2\n2\n2\n2\n1\n2\n0\n2\n2\n2\n2\n2\n1\n2\n0\n1\n2\n37\nEbenbichler et al85\n2\n2\n2\n2\n2\n2\n0\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n44\nOztas et al218\n2\n2\n1\n2\n2\n0\n0\n0\n2\n2\n0\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n1\n1\n34\n*Criteria from Joy MacDermid (personal communication).",
    "chunk_id": 748,
    "sentence_start": 4618,
    "sentence_end": 4620,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. APPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n\n\n--- Page 75 ---\nCOLUMN 1:\nInterventions: Biophysical Agents (Sound Agents)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nArmagan et al17\n2\n2\n2\n2\n1\n2\n0\n2\n0\n2\n0\n2\n2\n0\n2\n1\n1\n0\n2\n2\n1\n2\n2\n2\n34\nBaysal et al35\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n1\n2\n0\n0\n0\n0\n2\n2\n0\n2\n0\n2\n0\n31\nChang et al57\n2\n2\n2\n2\n2\n0\n0\n2\n2\n2\n2\n1\n2\n0\n2\n2\n2\n2\n2\n1\n2\n0\n1\n2\n37\nEbenbichler et al85\n2\n2\n2\n2\n2\n2\n0\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n44\nOztas et al218\n2\n2\n1\n2\n2\n0\n0\n0\n2\n2\n0\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n1\n1\n34\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 749,
    "sentence_start": 4619,
    "sentence_end": 4621,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "APPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n\n\n--- Page 75 ---\nCOLUMN 1:\nInterventions: Biophysical Agents (Sound Agents)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nArmagan et al17\n2\n2\n2\n2\n1\n2\n0\n2\n0\n2\n0\n2\n2\n0\n2\n1\n1\n0\n2\n2\n1\n2\n2\n2\n34\nBaysal et al35\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n1\n2\n0\n0\n0\n0\n2\n2\n0\n2\n0\n2\n0\n31\nChang et al57\n2\n2\n2\n2\n2\n0\n0\n2\n2\n2\n2\n1\n2\n0\n2\n2\n2\n2\n2\n1\n2\n0\n1\n2\n37\nEbenbichler et al85\n2\n2\n2\n2\n2\n2\n0\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n44\nOztas et al218\n2\n2\n1\n2\n2\n0\n0\n0\n2\n2\n0\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n1\n1\n34\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 750,
    "sentence_start": 4620,
    "sentence_end": 4622,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Transdermal Drug Delivery)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nAmirjani et al14\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n46\nBakhtiary et al31\n2\n1\n2\n2\n2\n1\n0\n2\n2\n2\n0\n2\n2\n0\n1\n2\n2\n1\n1\n0\n2\n2\n2\n2\n35\nGökoğlu et al112\n1\n2\n2\n2\n1\n0\n0\n0\n2\n2\n0\n2\n2\n0\n1\n1\n1\n1\n2\n0\n2\n2\n2\n2\n30\nKaratay et al142\n1\n2\n2\n2\n1\n0\n0\n0\n0\n0\n0\n0\n1\n0\n2\n1\n1\n2\n1\n0\n1\n0\n1\n0\n18\nSoyupek et al266\n2\n2\n2\n2\n0\n0\n2\n2\n1\n2\n0\n2\n2\n0\n1\n1\n1\n1\n1\n0\n1\n0\n1\n1\n27\nSoyupek et al267\n2\n2\n2\n2\n0\n0\n0\n2\n0\n2\n0\n1\n1\n0\n2\n1\n1\n1\n2\n0\n1\n0\n2\n1\n25\nYildiz et al301\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n46\n*Criteria from Joy MacDermid (personal communication).",
    "chunk_id": 751,
    "sentence_start": 4621,
    "sentence_end": 4623,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Transdermal Drug Delivery)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nAmirjani et al14\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n46\nBakhtiary et al31\n2\n1\n2\n2\n2\n1\n0\n2\n2\n2\n0\n2\n2\n0\n1\n2\n2\n1\n1\n0\n2\n2\n2\n2\n35\nGökoğlu et al112\n1\n2\n2\n2\n1\n0\n0\n0\n2\n2\n0\n2\n2\n0\n1\n1\n1\n1\n2\n0\n2\n2\n2\n2\n30\nKaratay et al142\n1\n2\n2\n2\n1\n0\n0\n0\n0\n0\n0\n0\n1\n0\n2\n1\n1\n2\n1\n0\n1\n0\n1\n0\n18\nSoyupek et al266\n2\n2\n2\n2\n0\n0\n2\n2\n1\n2\n0\n2\n2\n0\n1\n1\n1\n1\n1\n0\n1\n0\n1\n1\n27\nSoyupek et al267\n2\n2\n2\n2\n0\n0\n0\n2\n0\n2\n0\n1\n1\n0\n2\n1\n1\n1\n2\n0\n1\n0\n2\n1\n25\nYildiz et al301\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n46\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 752,
    "sentence_start": 4622,
    "sentence_end": 4624,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Interventions: Biophysical Agents (Transdermal Drug Delivery)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nAmirjani et al14\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n46\nBakhtiary et al31\n2\n1\n2\n2\n2\n1\n0\n2\n2\n2\n0\n2\n2\n0\n1\n2\n2\n1\n1\n0\n2\n2\n2\n2\n35\nGökoğlu et al112\n1\n2\n2\n2\n1\n0\n0\n0\n2\n2\n0\n2\n2\n0\n1\n1\n1\n1\n2\n0\n2\n2\n2\n2\n30\nKaratay et al142\n1\n2\n2\n2\n1\n0\n0\n0\n0\n0\n0\n0\n1\n0\n2\n1\n1\n2\n1\n0\n1\n0\n1\n0\n18\nSoyupek et al266\n2\n2\n2\n2\n0\n0\n2\n2\n1\n2\n0\n2\n2\n0\n1\n1\n1\n1\n1\n0\n1\n0\n1\n1\n27\nSoyupek et al267\n2\n2\n2\n2\n0\n0\n0\n2\n0\n2\n0\n1\n1\n0\n2\n1\n1\n1\n2\n0\n1\n0\n2\n1\n25\nYildiz et al301\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n46\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 753,
    "sentence_start": 4623,
    "sentence_end": 4625,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Magnet Therapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nCarter et al54\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n0\n1\n2\n2\n1\n0\n0\n1\n2\n2\n2\n1\n1\n36\nColbert et al71\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n0\n2\n2\n2\n1\n42\nAPPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 754,
    "sentence_start": 4624,
    "sentence_end": 4626,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Magnet Therapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nCarter et al54\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n0\n1\n2\n2\n1\n0\n0\n1\n2\n2\n2\n1\n1\n36\nColbert et al71\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n0\n2\n2\n2\n1\n42\nAPPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 755,
    "sentence_start": 4625,
    "sentence_end": 4627,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Interventions: Biophysical Agents (Magnet Therapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nCarter et al54\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n0\n1\n2\n2\n1\n0\n0\n1\n2\n2\n2\n1\n1\n36\nColbert et al71\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n0\n2\n2\n2\n1\n42\nAPPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 756,
    "sentence_start": 4626,
    "sentence_end": 4630,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nInterventions: Biophysical Agents (Sound Agents)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nArmagan et al17\n2\n2\n2\n2\n1\n2\n0\n2\n0\n2\n0\n2\n2\n0\n2\n1\n1\n0\n2\n2\n1\n2\n2\n2\n34\nBaysal et al35\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n1\n2\n0\n0\n0\n0\n2\n2\n0\n2\n0\n2\n0\n31\nChang et al57\n2\n2\n2\n2\n2\n0\n0\n2\n2\n2\n2\n1\n2\n0\n2\n2\n2\n2\n2\n1\n2\n0\n1\n2\n37\nEbenbichler et al85\n2\n2\n2\n2\n2\n2\n0\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n44\nOztas et al218\n2\n2\n1\n2\n2\n0\n0\n0\n2\n2\n0\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n1\n1\n34\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 757,
    "sentence_start": 4629,
    "sentence_end": 4632,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nInterventions: Biophysical Agents (Sound Agents)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nArmagan et al17\n2\n2\n2\n2\n1\n2\n0\n2\n0\n2\n0\n2\n2\n0\n2\n1\n1\n0\n2\n2\n1\n2\n2\n2\n34\nBaysal et al35\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n1\n2\n0\n0\n0\n0\n2\n2\n0\n2\n0\n2\n0\n31\nChang et al57\n2\n2\n2\n2\n2\n0\n0\n2\n2\n2\n2\n1\n2\n0\n2\n2\n2\n2\n2\n1\n2\n0\n1\n2\n37\nEbenbichler et al85\n2\n2\n2\n2\n2\n2\n0\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n44\nOztas et al218\n2\n2\n1\n2\n2\n0\n0\n0\n2\n2\n0\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n1\n1\n34\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 758,
    "sentence_start": 4631,
    "sentence_end": 4633,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Transdermal Drug Delivery)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nAmirjani et al14\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n46\nBakhtiary et al31\n2\n1\n2\n2\n2\n1\n0\n2\n2\n2\n0\n2\n2\n0\n1\n2\n2\n1\n1\n0\n2\n2\n2\n2\n35\nGökoğlu et al112\n1\n2\n2\n2\n1\n0\n0\n0\n2\n2\n0\n2\n2\n0\n1\n1\n1\n1\n2\n0\n2\n2\n2\n2\n30\nKaratay et al142\n1\n2\n2\n2\n1\n0\n0\n0\n0\n0\n0\n0\n1\n0\n2\n1\n1\n2\n1\n0\n1\n0\n1\n0\n18\nSoyupek et al266\n2\n2\n2\n2\n0\n0\n2\n2\n1\n2\n0\n2\n2\n0\n1\n1\n1\n1\n1\n0\n1\n0\n1\n1\n27\nSoyupek et al267\n2\n2\n2\n2\n0\n0\n0\n2\n0\n2\n0\n1\n1\n0\n2\n1\n1\n1\n2\n0\n1\n0\n2\n1\n25\nYildiz et al301\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n46\n*Criteria from Joy MacDermid (personal communication).",
    "chunk_id": 759,
    "sentence_start": 4632,
    "sentence_end": 4634,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Transdermal Drug Delivery)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nAmirjani et al14\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n46\nBakhtiary et al31\n2\n1\n2\n2\n2\n1\n0\n2\n2\n2\n0\n2\n2\n0\n1\n2\n2\n1\n1\n0\n2\n2\n2\n2\n35\nGökoğlu et al112\n1\n2\n2\n2\n1\n0\n0\n0\n2\n2\n0\n2\n2\n0\n1\n1\n1\n1\n2\n0\n2\n2\n2\n2\n30\nKaratay et al142\n1\n2\n2\n2\n1\n0\n0\n0\n0\n0\n0\n0\n1\n0\n2\n1\n1\n2\n1\n0\n1\n0\n1\n0\n18\nSoyupek et al266\n2\n2\n2\n2\n0\n0\n2\n2\n1\n2\n0\n2\n2\n0\n1\n1\n1\n1\n1\n0\n1\n0\n1\n1\n27\nSoyupek et al267\n2\n2\n2\n2\n0\n0\n0\n2\n0\n2\n0\n1\n1\n0\n2\n1\n1\n1\n2\n0\n1\n0\n2\n1\n25\nYildiz et al301\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n46\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 760,
    "sentence_start": 4633,
    "sentence_end": 4635,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Interventions: Biophysical Agents (Transdermal Drug Delivery)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nAmirjani et al14\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n46\nBakhtiary et al31\n2\n1\n2\n2\n2\n1\n0\n2\n2\n2\n0\n2\n2\n0\n1\n2\n2\n1\n1\n0\n2\n2\n2\n2\n35\nGökoğlu et al112\n1\n2\n2\n2\n1\n0\n0\n0\n2\n2\n0\n2\n2\n0\n1\n1\n1\n1\n2\n0\n2\n2\n2\n2\n30\nKaratay et al142\n1\n2\n2\n2\n1\n0\n0\n0\n0\n0\n0\n0\n1\n0\n2\n1\n1\n2\n1\n0\n1\n0\n1\n0\n18\nSoyupek et al266\n2\n2\n2\n2\n0\n0\n2\n2\n1\n2\n0\n2\n2\n0\n1\n1\n1\n1\n1\n0\n1\n0\n1\n1\n27\nSoyupek et al267\n2\n2\n2\n2\n0\n0\n0\n2\n0\n2\n0\n1\n1\n0\n2\n1\n1\n1\n2\n0\n1\n0\n2\n1\n25\nYildiz et al301\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n46\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 761,
    "sentence_start": 4634,
    "sentence_end": 4636,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Magnet Therapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nCarter et al54\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n0\n1\n2\n2\n1\n0\n0\n1\n2\n2\n2\n1\n1\n36\nColbert et al71\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n0\n2\n2\n2\n1\n42\n*Criteria from Joy MacDermid (personal communication).",
    "chunk_id": 762,
    "sentence_start": 4635,
    "sentence_end": 4637,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Interventions: Biophysical Agents (Magnet Therapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nCarter et al54\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n0\n1\n2\n2\n1\n0\n0\n1\n2\n2\n2\n1\n1\n36\nColbert et al71\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n0\n2\n2\n2\n1\n42\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 763,
    "sentence_start": 4636,
    "sentence_end": 4638,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Interventions: Biophysical Agents (Magnet Therapy)\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nCarter et al54\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n2\n0\n1\n2\n2\n1\n0\n0\n1\n2\n2\n2\n1\n1\n36\nColbert et al71\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n1\n2\n0\n2\n2\n2\n1\n42\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 764,
    "sentence_start": 4637,
    "sentence_end": 4639,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. APPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n\n\n--- Page 76 ---\nCOLUMN 1:\nInterventions: Manual Therapy and Stretching\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nBaker et al29\n2\n2\n2\n2\n2\n0\n2\n2\n1\n2\n0\n1\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n1\n1\n38\nMaddali Bongi et al175\n1\n1\n2\n2\n0\n0\n2\n0\n0\n2\n0\n2\n2\n0\n0\n1\n0\n2\n2\n0\n2\n2\n1\n1\n25\nFernández-de-las-Peñas et al94\n1\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n1\n0\n0\n0\n2\n2\n2\n2\n0\n2\n2\n1\n36\nFernández-de-las-Peñas et al93\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n0\n0\n2\n2\n2\n2\n1\n2\n1\n2\n1\n1\n38\nWolny and Linek293\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n0\n2\n1\n2\n2\n2\n1\n2\n2\n2\n0\n1\n2\n40\nWolny and Linek294\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n1\n2\n2\n2\n2\n2\n2\n1\n2\n2\n1\n44\n*Criteria from Joy MacDermid (personal communication).",
    "chunk_id": 765,
    "sentence_start": 4638,
    "sentence_end": 4640,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. APPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n\n\n--- Page 76 ---\nCOLUMN 1:\nInterventions: Manual Therapy and Stretching\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nBaker et al29\n2\n2\n2\n2\n2\n0\n2\n2\n1\n2\n0\n1\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n1\n1\n38\nMaddali Bongi et al175\n1\n1\n2\n2\n0\n0\n2\n0\n0\n2\n0\n2\n2\n0\n0\n1\n0\n2\n2\n0\n2\n2\n1\n1\n25\nFernández-de-las-Peñas et al94\n1\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n1\n0\n0\n0\n2\n2\n2\n2\n0\n2\n2\n1\n36\nFernández-de-las-Peñas et al93\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n0\n0\n2\n2\n2\n2\n1\n2\n1\n2\n1\n1\n38\nWolny and Linek293\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n0\n2\n1\n2\n2\n2\n1\n2\n2\n2\n0\n1\n2\n40\nWolny and Linek294\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n1\n2\n2\n2\n2\n2\n2\n1\n2\n2\n1\n44\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 766,
    "sentence_start": 4639,
    "sentence_end": 4641,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "APPENDIX D\nEvaluation Criteria*\nEvaluation Criteria*\nEvaluation Criteria*\n\n\n--- Page 76 ---\nCOLUMN 1:\nInterventions: Manual Therapy and Stretching\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nBaker et al29\n2\n2\n2\n2\n2\n0\n2\n2\n1\n2\n0\n1\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n1\n1\n38\nMaddali Bongi et al175\n1\n1\n2\n2\n0\n0\n2\n0\n0\n2\n0\n2\n2\n0\n0\n1\n0\n2\n2\n0\n2\n2\n1\n1\n25\nFernández-de-las-Peñas et al94\n1\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n1\n0\n0\n0\n2\n2\n2\n2\n0\n2\n2\n1\n36\nFernández-de-las-Peñas et al93\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n0\n0\n2\n2\n2\n2\n1\n2\n1\n2\n1\n1\n38\nWolny and Linek293\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n0\n2\n1\n2\n2\n2\n1\n2\n2\n2\n0\n1\n2\n40\nWolny and Linek294\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n1\n2\n2\n2\n2\n2\n2\n1\n2\n2\n1\n44\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 767,
    "sentence_start": 4640,
    "sentence_end": 4642,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Systematic Reviews Assessed Using AMSTAR*\nStudy\nSection of CPG\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\nTotal\nAndersen et al15\nRisk Factors\nYes\nYes\nYes\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nNo\n9\nBasson et al34\nInterventions\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n9\nGeere et al102\nOutcome Measures\nYes\nYes\nNo\nNo\nNo\nNo\nNo\nYes\nYes\nNo\nYes\n5\nHagberg et al123\nRisk Factors\nYes\nNo\nNo\nYes\nNo\nYes\nNo\nNo\nYes\nYes\nNo\n5\nMacDermid and Wessel173\nDifferential Diagnosis\nYes\nYes\nYes\nYes\nYes\nNo\nYes\nNo\nYes\nYes\nNo\n8\nMassy-Westropp et al184\nDifferential Diagnosis\nYes\nYes\nNo\nYes\nNo\nNo\nYes\nYes\nNo\nYes\nNo\n6\nO’Connor et al210\nInterventions (Ergonomic)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n10\nPage et al222\nInterventions (Therapeutic \nExercise)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\n11\nPage et al221\nInterventions (Orthoses)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n10\nPalmer et al223\nRisk Factors\nYes\nNo\nYes\nYes\nNo\nYes\nNo\nNo\nNo\nYes\nNo\n5\nRankin et al236\nInterventions\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\n11\nSakthiswary and Singh250\nRisk Factors\nYes\nNo\nYes\nYes\nNo\nYes\nNo\nNo\nYes\nNo\nYes\n6\nvan Rijn et al279\nRisk Factors\nYes\nYes\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nYes\nNo\n9\nAbbreviations: AMSTAR, A Measurement Tool to Assess Systematic Reviews; CPG, clinical practice guideline.",
    "chunk_id": 768,
    "sentence_start": 4641,
    "sentence_end": 4643,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization;\n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtaine\n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22\nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Systematic Reviews Assessed Using AMSTAR*\nStudy\nSection of CPG\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\nTotal\nAndersen et al15\nRisk Factors\nYes\nYes\nYes\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nNo\n9\nBasson et al34\nInterventions\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n9\nGeere et al102\nOutcome Measures\nYes\nYes\nNo\nNo\nNo\nNo\nNo\nYes\nYes\nNo\nYes\n5\nHagberg et al123\nRisk Factors\nYes\nNo\nNo\nYes\nNo\nYes\nNo\nNo\nYes\nYes\nNo\n5\nMacDermid and Wessel173\nDifferential Diagnosis\nYes\nYes\nYes\nYes\nYes\nNo\nYes\nNo\nYes\nYes\nNo\n8\nMassy-Westropp et al184\nDifferential Diagnosis\nYes\nYes\nNo\nYes\nNo\nNo\nYes\nYes\nNo\nYes\nNo\n6\nO’Connor et al210\nInterventions (Ergonomic)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n10\nPage et al222\nInterventions (Therapeutic \nExercise)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\n11\nPage et al221\nInterventions (Orthoses)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n10\nPalmer et al223\nRisk Factors\nYes\nNo\nYes\nYes\nNo\nYes\nNo\nNo\nNo\nYes\nNo\n5\nRankin et al236\nInterventions\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\n11\nSakthiswary and Singh250\nRisk Factors\nYes\nNo\nYes\nYes\nNo\nYes\nNo\nNo\nYes\nNo\nYes\n6\nvan Rijn et al279\nRisk Factors\nYes\nYes\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nYes\nNo\n9\nAbbreviations: AMSTAR, A Measurement Tool to Assess Systematic Reviews; CPG, clinical practice guideline. *Criteria from Shea BJ, Grimshaw JM, Wells GA, et al.",
    "chunk_id": 769,
    "sentence_start": 4642,
    "sentence_end": 4644,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Systematic Reviews Assessed Using AMSTAR*\nStudy\nSection of CPG\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\nTotal\nAndersen et al15\nRisk Factors\nYes\nYes\nYes\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nNo\n9\nBasson et al34\nInterventions\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n9\nGeere et al102\nOutcome Measures\nYes\nYes\nNo\nNo\nNo\nNo\nNo\nYes\nYes\nNo\nYes\n5\nHagberg et al123\nRisk Factors\nYes\nNo\nNo\nYes\nNo\nYes\nNo\nNo\nYes\nYes\nNo\n5\nMacDermid and Wessel173\nDifferential Diagnosis\nYes\nYes\nYes\nYes\nYes\nNo\nYes\nNo\nYes\nYes\nNo\n8\nMassy-Westropp et al184\nDifferential Diagnosis\nYes\nYes\nNo\nYes\nNo\nNo\nYes\nYes\nNo\nYes\nNo\n6\nO’Connor et al210\nInterventions (Ergonomic)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n10\nPage et al222\nInterventions (Therapeutic \nExercise)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\n11\nPage et al221\nInterventions (Orthoses)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n10\nPalmer et al223\nRisk Factors\nYes\nNo\nYes\nYes\nNo\nYes\nNo\nNo\nNo\nYes\nNo\n5\nRankin et al236\nInterventions\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\n11\nSakthiswary and Singh250\nRisk Factors\nYes\nNo\nYes\nYes\nNo\nYes\nNo\nNo\nYes\nNo\nYes\n6\nvan Rijn et al279\nRisk Factors\nYes\nYes\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nYes\nNo\n9\nAbbreviations: AMSTAR, A Measurement Tool to Assess Systematic Reviews; CPG, clinical practice guideline. *Criteria from Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.",
    "chunk_id": 770,
    "sentence_start": 4643,
    "sentence_end": 4645,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "*Criteria from Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Meth­\nodol. Items: 1, Was an a priori design provided? 2, Was there duplicate study selection and data extraction? 3, Was a comprehensive literature search performed? 4, Was the status \nof publication (ie, gray literature) used as an inclusion criterion? 5, Was a list of studies (included and excluded) provided? 6, Were the characteristics of the included studies provided\n? 9\nAPPENDIX D\nEvaluation Criteria*\nEvaluation Criteria† \n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 771,
    "sentence_start": 4644,
    "sentence_end": 4660,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nInterventions: Manual Therapy and Stretching\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nBaker et al29\n2\n2\n2\n2\n2\n0\n2\n2\n1\n2\n0\n1\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n1\n1\n38\nMaddali Bongi et al175\n1\n1\n2\n2\n0\n0\n2\n0\n0\n2\n0\n2\n2\n0\n0\n1\n0\n2\n2\n0\n2\n2\n1\n1\n25\nFernández-de-las-Peñas et al94\n1\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n1\n0\n0\n0\n2\n2\n2\n2\n0\n2\n2\n1\n36\nFernández-de-las-Peñas et al93\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n0\n0\n2\n2\n2\n2\n1\n2\n1\n2\n1\n1\n38\nWolny and Linek293\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n0\n2\n1\n2\n2\n2\n1\n2\n2\n2\n0\n1\n2\n40\nWolny and Linek294\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n1\n2\n2\n2\n2\n2\n2\n1\n2\n2\n1\n44\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met.",
    "chunk_id": 772,
    "sentence_start": 4659,
    "sentence_end": 4662,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nInterventions: Manual Therapy and Stretching\nStudy\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\n12\n13\n14\n15\n16\n17\n18\n19\n20\n21\n22\n23\n24\nTotal\nBaker et al29\n2\n2\n2\n2\n2\n0\n2\n2\n1\n2\n0\n1\n2\n2\n2\n2\n2\n2\n2\n0\n2\n2\n1\n1\n38\nMaddali Bongi et al175\n1\n1\n2\n2\n0\n0\n2\n0\n0\n2\n0\n2\n2\n0\n0\n1\n0\n2\n2\n0\n2\n2\n1\n1\n25\nFernández-de-las-Peñas et al94\n1\n2\n2\n2\n2\n1\n2\n2\n2\n2\n2\n2\n1\n0\n0\n0\n2\n2\n2\n2\n0\n2\n2\n1\n36\nFernández-de-las-Peñas et al93\n2\n2\n2\n2\n2\n0\n2\n2\n2\n2\n2\n2\n0\n0\n2\n2\n2\n2\n1\n2\n1\n2\n1\n1\n38\nWolny and Linek293\n2\n2\n2\n2\n2\n2\n1\n2\n2\n2\n2\n0\n2\n1\n2\n2\n2\n1\n2\n2\n2\n0\n1\n2\n40\nWolny and Linek294\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n2\n1\n2\n1\n2\n2\n2\n2\n2\n2\n1\n2\n2\n1\n44\n*Criteria from Joy MacDermid (personal communication). Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results.",
    "chunk_id": 773,
    "sentence_start": 4661,
    "sentence_end": 4663,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items are scored as follows: 0, criterion not met; 1, criterion partially met; 2, criterion met. Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Systematic Reviews Assessed Using AMSTAR*\nStudy\nSection of CPG\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\nTotal\nAndersen et al15\nRisk Factors\nYes\nYes\nYes\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nNo\n9\nBasson et al34\nInterventions\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n9\nGeere et al102\nOutcome Measures\nYes\nYes\nNo\nNo\nNo\nNo\nNo\nYes\nYes\nNo\nYes\n5\nHagberg et al123\nRisk Factors\nYes\nNo\nNo\nYes\nNo\nYes\nNo\nNo\nYes\nYes\nNo\n5\nMacDermid and Wessel173\nDifferential Diagnosis\nYes\nYes\nYes\nYes\nYes\nNo\nYes\nNo\nYes\nYes\nNo\n8\nMassy-Westropp et al184\nDifferential Diagnosis\nYes\nYes\nNo\nYes\nNo\nNo\nYes\nYes\nNo\nYes\nNo\n6\nO’Connor et al210\nInterventions (Ergonomic)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n10\nPage et al222\nInterventions (Therapeutic \nExercise)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\n11\nPage et al221\nInterventions (Orthoses)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n10\nPalmer et al223\nRisk Factors\nYes\nNo\nYes\nYes\nNo\nYes\nNo\nNo\nNo\nYes\nNo\n5\nRankin et al236\nInterventions\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\n11\nSakthiswary and Singh250\nRisk Factors\nYes\nNo\nYes\nYes\nNo\nYes\nNo\nNo\nYes\nNo\nYes\n6\nvan Rijn et al279\nRisk Factors\nYes\nYes\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nYes\nNo\n9\nAbbreviations: AMSTAR, A Measurement Tool to Assess Systematic Reviews; CPG, clinical practice guideline.",
    "chunk_id": 774,
    "sentence_start": 4662,
    "sentence_end": 4664,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Items: (1) Relevant background \nwork cited, leading to a clear research question; (2) Use of comparison group; (3) Consideration of patient status more than once; (4) Prospective data collection; (5) Randomization; \n(6) Subjects blinded; (7) Providers blinded; (8) Independent outcomes evaluator; (9) Minimal sample/selection bias; (10) Defined inclusion/exclusion criteria; (11) Enrollment obtained; \n(12) Appropriate retention; (13) Intervention applied per established principles; (14) Treatment provider biases minimized; (15) Intervention compared to appropriate comparator; \n(16) Primary outcome defined/appropriate; (17) Secondary outcomes considered; (18) Appropriate follow-up period; (19) Appropriate statistical tests performed, demonstrating \nintervention-related differences; (20) Establishment of sufficient power for identifying treatment effects; (21) Size and clinical importance of treatment group differences reported; (22) \nMissing data accounted for in analysis; (23) Clinical and practical significance considered when interpreting results; (24) Conclusions/clinical recommendations supported by the \nstudy objectives, analysis, and results. Systematic Reviews Assessed Using AMSTAR*\nStudy\nSection of CPG\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\nTotal\nAndersen et al15\nRisk Factors\nYes\nYes\nYes\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nNo\n9\nBasson et al34\nInterventions\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n9\nGeere et al102\nOutcome Measures\nYes\nYes\nNo\nNo\nNo\nNo\nNo\nYes\nYes\nNo\nYes\n5\nHagberg et al123\nRisk Factors\nYes\nNo\nNo\nYes\nNo\nYes\nNo\nNo\nYes\nYes\nNo\n5\nMacDermid and Wessel173\nDifferential Diagnosis\nYes\nYes\nYes\nYes\nYes\nNo\nYes\nNo\nYes\nYes\nNo\n8\nMassy-Westropp et al184\nDifferential Diagnosis\nYes\nYes\nNo\nYes\nNo\nNo\nYes\nYes\nNo\nYes\nNo\n6\nO’Connor et al210\nInterventions (Ergonomic)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n10\nPage et al222\nInterventions (Therapeutic \nExercise)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\n11\nPage et al221\nInterventions (Orthoses)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n10\nPalmer et al223\nRisk Factors\nYes\nNo\nYes\nYes\nNo\nYes\nNo\nNo\nNo\nYes\nNo\n5\nRankin et al236\nInterventions\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\n11\nSakthiswary and Singh250\nRisk Factors\nYes\nNo\nYes\nYes\nNo\nYes\nNo\nNo\nYes\nNo\nYes\n6\nvan Rijn et al279\nRisk Factors\nYes\nYes\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nYes\nNo\n9\nAbbreviations: AMSTAR, A Measurement Tool to Assess Systematic Reviews; CPG, clinical practice guideline. *Criteria from Shea BJ, Grimshaw JM, Wells GA, et al.",
    "chunk_id": 775,
    "sentence_start": 4663,
    "sentence_end": 4665,
    "section_type": "introduction",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Systematic Reviews Assessed Using AMSTAR*\nStudy\nSection of CPG\n1\n2\n3\n4\n5\n6\n7\n8\n9\n10\n11\nTotal\nAndersen et al15\nRisk Factors\nYes\nYes\nYes\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nNo\n9\nBasson et al34\nInterventions\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n9\nGeere et al102\nOutcome Measures\nYes\nYes\nNo\nNo\nNo\nNo\nNo\nYes\nYes\nNo\nYes\n5\nHagberg et al123\nRisk Factors\nYes\nNo\nNo\nYes\nNo\nYes\nNo\nNo\nYes\nYes\nNo\n5\nMacDermid and Wessel173\nDifferential Diagnosis\nYes\nYes\nYes\nYes\nYes\nNo\nYes\nNo\nYes\nYes\nNo\n8\nMassy-Westropp et al184\nDifferential Diagnosis\nYes\nYes\nNo\nYes\nNo\nNo\nYes\nYes\nNo\nYes\nNo\n6\nO’Connor et al210\nInterventions (Ergonomic)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n10\nPage et al222\nInterventions (Therapeutic \nExercise)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\n11\nPage et al221\nInterventions (Orthoses)\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nNo\nYes\n10\nPalmer et al223\nRisk Factors\nYes\nNo\nYes\nYes\nNo\nYes\nNo\nNo\nNo\nYes\nNo\n5\nRankin et al236\nInterventions\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\nYes\n11\nSakthiswary and Singh250\nRisk Factors\nYes\nNo\nYes\nYes\nNo\nYes\nNo\nNo\nYes\nNo\nYes\n6\nvan Rijn et al279\nRisk Factors\nYes\nYes\nYes\nYes\nNo\nYes\nYes\nYes\nYes\nYes\nNo\n9\nAbbreviations: AMSTAR, A Measurement Tool to Assess Systematic Reviews; CPG, clinical practice guideline. *Criteria from Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.",
    "chunk_id": 776,
    "sentence_start": 4664,
    "sentence_end": 4666,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "*Criteria from Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Meth­\nodol. Items: 1, Was an a priori design provided? 2, Was there duplicate study selection and data extraction? 3, Was a comprehensive literature search performed? 4, Was the status \nof publication (ie, gray literature) used as an inclusion criterion? 5, Was a list of studies (included and excluded) provided? 6, Were the characteristics of the included studies provided? 7, Was the scientific quality of the included studies assessed and documented? 8, Was the scientific quality of the included studies used appropriately in formulating conclusions? 9, \nWere the methods used to combine the findings of studies appropriate? 10, Was the likelihood of publication bias assessed? 11, Was the conflict of interest included?",
    "chunk_id": 777,
    "sentence_start": 4665,
    "sentence_end": 4680,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "10, Was the likelihood of publication bias assessed? 11, Was the conflict of interest included? APPENDIX D\nEvaluation Criteria*\nEvaluation Criteria†\n\n\n--- Page 77 ---\nCOLUMN 1:\nARTICLES USED IN DEVELOPING RECOMMENDATIONS\nDiagnosis\n\t 1. Hand elevation: a new test for carpal tunnel syndrome. Ann Plast Surg. Sensitivity and specificity of Pha­\nlen’s test and Tinel’s test in patients with carpal tunnel syndrome. \u0007Amirfeyz R, Gozzard C, Leslie IJ. Hand elevation test for assess­\nment of carpal tunnel syndrome. J Hand Surg Br. \u0007Amirfeyz R, Clark D, Parsons B, et al. Clinical tests for carpal \ntunnel syndrome in contemporary practice. Arch Orthop Trauma \nSurg. \u0007Baselgia LT, Bennett DL, Silbiger RM, Schmid AB. Negative neuro­\ndynamic tests do not exclude neural dysfunction in patients with \nentrapment neuropathies. Arch Phys Med Rehabil. \u0007Blok RD, Becker SJ, Ring DC. Diagnosis of carpal tunnel syn­\ndrome: interobserver reliability of the blinded scratch-collapse \ntest.",
    "chunk_id": 778,
    "sentence_start": 4679,
    "sentence_end": 4712,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Assessing the accuracy of a combina­\ntion of clinical tests for identifying carpal tunnel syndrome. Validity \nof the Upper Limb Neurodynamic Test 1 for the diagnosis of carpal \ntunnel syndrome. The role of structural differentiation. \u0007Calfee RP, Dale AM, Ryan D, Descatha A, Franzblau A, Evanoff B. Performance of simplified scoring systems for hand diagrams in \ncarpal tunnel syndrome screening. J Hand Surg Am. \u0007Checkosky CM, Bolanowski SJ, Cohen JC. Assessment of vibro­\ntactile sensitivity in patients with carpal tunnel syndrome. J Occup \nEnviron Med. \u0007Cheng CJ, Mackinnon-Patterson B, Beck JL, Mackinnon SE. Scratch collapse test for evaluation of carpal and cubital tunnel \nsyndrome. J Hand Surg Am. \u0007Clark D, Amirfeyz R, Leslie I, Bannister G. The distribution of sensory disturbance in carpal tunnel syn­\ndrome. Ann R Coll Surg Engl. \u0007Elfar JC, Yaseen Z, Stern PJ, Kiefhaber TR. Individual finger sensi­\nbility in carpal tunnel syndrome. J Hand Surg Am.",
    "chunk_id": 779,
    "sentence_start": 4711,
    "sentence_end": 4764,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007M\ni\nc\nAPPENDIX E\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nDEVELOPING RECOMMENDATIONS\non: a new test for carpal tunnel syndrome. Sensitivity and specificity of Pha­\ntest in patients with carpal tunnel syndrome. Hand elevation test for assess­\nl syndrome. J Hand Surg Br. Clinical tests for carpal \ncontemporary practice. Arch Orthop Trauma \n74. Negative neuro­\nt exclude neural dysfunction in patients with \nthies. Arch Phys Med Rehabil. Diagnosis of carpal tunnel syn­\nr reliability of the blinded scratch-collapse \nrg. Assessing the accuracy of a combina­\nor identifying carpal tunnel syndrome. Validity \neurodynamic Test 1 for the diagnosis of carpal \ne role of structural differentiation.",
    "chunk_id": 780,
    "sentence_start": 4763,
    "sentence_end": 4793,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Validity \neurodynamic Test 1 for the diagnosis of carpal \ne role of structural differentiation. ps://doi.org/10.1016/j.math.2015.12.007\nRyan D, Descatha A, Franzblau A, Evanoff B. lified scoring systems for hand diagrams in \nme screening. J Hand Surg Am. 16/j.jhsa.2011.08.016\nnowski SJ, Cohen JC. Assessment of vibro­\npatients with carpal tunnel syndrome. n-Patterson B, Beck JL, Mackinnon SE. for evaluation of carpal and cubital tunnel \nurg Am. 008.05.022\nLeslie I, Bannister G. ensory disturbance in carpal tunnel syn­\nurg Engl. 8411X586191\nern PJ, Kiefhaber TR. Individual finger sensi­\n syndrome. J Hand Surg Am. \u0007El Miedany Y, Ashour S, Youssef S, Mehanna A, Meky FA. Clinical \ndiagnosis of carpal tunnel syndrome: old tests–new concepts. Joint Bone Spine. \u0007Fertl E, Wöber C, Zeitlhofer J. The serial use of two pro­\nvocative tests in the clinical diagnosis of carpal tunnel syn­\ndrome. Acta Neurol Scand.",
    "chunk_id": 781,
    "sentence_start": 4792,
    "sentence_end": 4826,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The sensitivity and specificity of tests for carpal tun­\nnel syndrome vary with the comparison subjects. J Hand Surg Br. Provocative test for carpal tunnel syndrome. \u0007Grunert BK, Wertsch JJ, Matloub HS, McCallum-Burke S. Reliabil­\nity of sensory threshold measurement using a digital vibrogram. \u0007Hardy M, Jimenez S, Jabaley M, Horch K. Evaluation of nerve \ncompression with the Automated Tactile Tester. J Hand Surg Am. \u0007Hubbard MC, MacDermid JC, Kramer JF, Birmingham TB. Quanti­\ntative vibration threshold testing in carpal tunnel syndrome: analy­\nsis strategies for optimizing reliability. Use of vibration testing in the early evaluation of work­\ners with carpal tunnel syndrome. \u0007Kasundra GM, Sood I, Bhargava AN, et al. Carpal tunnel syn­\ndrome: analyzing efficacy and utility of clinical tests and various \ndiagnostic modalities. J Neurosci Rural Pract. \u0007Koris M, Gelberman RH, Duncan K, Boublick M, Smith B. Carpal \ntunnel syndrome.",
    "chunk_id": 782,
    "sentence_start": 4825,
    "sentence_end": 4863,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Koris M, Gelberman RH, Duncan K, Boublick M, Smith B. Carpal \ntunnel syndrome. Evaluation of a quantitative provocational diag­\nnostic test. Clin Orthop Relat Res. \u0007LaJoie AS, McCabe SJ, Thomas B, Edgell SE. Determining \nthe sensitivity and specificity of common diagnostic tests \nfor carpal tunnel syndrome using latent class analysis. Plast \nReconstr Surg. The diagnostic assessment of hand elevation test in \ncarpal tunnel syndrome. J Korean Neurosurg Soc. \u0007MacDermid JC, Kramer JF, McFarlane RM, Roth JH. Inter-rater \nagreement and accuracy of clinical tests used in diagnosis of car­\npal tunnel syndrome. \u0007MacDermid JC, Kramer JF, Roth JH. Decision making in detect­\ning abnormal Semmes-Weinstein monofilament thresholds in \ncarpal tunnel syndrome. org/10.1016/s0894-1130(12)80057-3\nAPPENDIX E\n\n\n--- Page 78 ---\nCOLUMN 1:\n28. Clinical diagnosis of carpal tunnel \nsyndrome: a systematic review. \u0007Makanji HS, Becker SJ, Mudgal CS, Jupiter JB, Ring D.",
    "chunk_id": 783,
    "sentence_start": 4862,
    "sentence_end": 4895,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Makanji HS, Becker SJ, Mudgal CS, Jupiter JB, Ring D. Evalua­\ntion of the scratch collapse test for the diagnosis of carpal tunnel \nsyndrome. J Hand Surg Eur Vol. \u0007Marlowe ES, Bonner FJ, Jr., Berkowitz AR. Correlation between \ntwo-point discrimination and median nerve sensory response. \u0007Marx RG, Hudak PL, Bombardier C, Graham B, Goldsmith C, \nWright JG. The reliability of physical examination for carpal tun­\nnel syndrome. J Hand Surg Br. \u0007Massy-Westropp N, Grimmer K, Bain G. A systematic review of \nthe clinical diagnostic tests for carpal tunnel syndrome. J Hand \nSurg Am. \u0007Mondelli M, Passero S, Giannini F. Provocative tests in dif­\nferent stages of carpal tunnel syndrome. Clin Neurol \nNeurosurg. \u0007Ntani G, Palmer KT, Linaker C, et al. Symptoms, signs and nerve \nconduction velocities in patients with suspected carpal tunnel \nsyndrome. BMC Musculoskelet Disord. The relationship among five common car­\npal tunnel syndrome tests and the severity of carpal tunnel syn­\ndrome.",
    "chunk_id": 784,
    "sentence_start": 4894,
    "sentence_end": 4933,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Raji P, Ansari NN, Naghdi S, Forogh B, Hasson S. Relationship \nbetween Semmes-Weinstein monofilaments perception test and \nsensory nerve conduction studies in carpal tunnel syndrome. \u0007Salerno DF, Franzblau A, Werner RA, et al. Reliability of physical \nexamination of the upper extremity among keyboard opera­\ntors. \u0007Thüngen T, Sadowski M, El Kazzi W, Schuind F. Value of Gilliatt’s \npneumatic tourniquet test for diagnosis of carpal tunnel syn­\ndrome. \u0007Vanti C, Bonfiglioli R, Calabrese M, et al. Upper Limb Neurody­\nnamic Test 1 and symptoms reproduction in carpal tunnel syn­\ndrome. A\nAPPENDIX E\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nsel J. Clinical diagnosis of carpal tunnel \natic review.",
    "chunk_id": 785,
    "sentence_start": 4932,
    "sentence_end": 4976,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "97/j.jht.2004.02.015\nSJ, Mudgal CS, Jupiter JB, Ring D. Evalua­\nollapse test for the diagnosis of carpal tunnel \nurg Eur Vol. Correlation between \ntion and median nerve sensory response. 7681(98)80132-0\nGrimmer K, Bain G. A systematic review of \nc tests for carpal tunnel syndrome. Provocative tests in dif­\nal tunnel syndrome. Clin Neurol \n:178-183. Symptoms, signs and nerve \ns in patients with suspected carpal tunnel \nsculoskelet Disord. The relationship among five common car­\ntests and the severity of carpal tunnel syn­\n2003;16:225-236. Relationship \neinstein monofilaments perception test and \nction studies in carpal tunnel syndrome. Reliability of physical \npper extremity among keyboard opera­\n2000;37:423-430. Value of Gilliatt’s \net test for diagnosis of carpal tunnel syn­\n012;31:152-156. Upper Limb Neurody­\nmptoms reproduction in carpal tunnel syn­\ndy. \u0007Vanti C, Bonfiglioli R, Calabrese M, Marinelli F, Violante FS, Pil­\nlastrini P.",
    "chunk_id": 786,
    "sentence_start": 4975,
    "sentence_end": 5014,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Vanti C, Bonfiglioli R, Calabrese M, Marinelli F, Violante FS, Pil­\nlastrini P. Relationship between interpretation and accuracy \nof the Upper Limb Neurodynamic Test 1 in carpal tunnel syn­\ndrome. J Manipulative Physiol Ther. \u0007Wainner RS, Fritz JM, Irrgang JJ, Delitto A, Allison S, Boninger ML. Development of a clinical prediction rule for the diagnosis of car­\npal tunnel syndrome. Arch Phys Med Rehabil. \u0007Werner RA, Franzblau A, Johnston E. Comparison of multiple \nfrequency vibrometry testing and sensory nerve conduction \nmeasures in screening for carpal tunnel syndrome in an industrial \nsetting. Am J Phys Med Rehabil. \u0007Williams TM, Mackinnon SE, Novak CB, McCabe S, Kelly L. Verifi­\ncation of the pressure provocative test in carpal tunnel syndrome. Ann Plast Surg. \u0007Wolny T, Saulicz E, Linek P, Myśliwiec A, Saulicz M. Effect of manu­\nal therapy and neurodynamic techniques vs ultrasound and laser \non 2PD in patients with CTS: a randomized controlled trial.",
    "chunk_id": 787,
    "sentence_start": 5013,
    "sentence_end": 5040,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "What is the role of Semmes-Weinstein \nmonofilament testing in the diagnosis of electrophysiologically \ngraded carpal tunnel syndrome? J Phys Ther Sci. \u0007Agnew J, Bolla-Wilson K, Kawas CH, Bleecker ML. Pur­\ndue Pegboard age and sex norms for people 40 years old \nand older. The Alderson-McGall hand function ques­\ntionnaire for patients with carpal tunnel syndrome: a pilot evalua­\ntion of a future outcome measure. \u0007Amadio PC, Silverstein MD, Ilstrup DM, Schleck CD, Jensen LM. Outcome assessment for carpal tunnel surgery: the relative re­\nsponsiveness of generic, arthritis-specific, disease-specific, and \nphysical examination measures. J Hand Surg Am. \u0007Amirfeyz R, Pentlow A, Foote J, Leslie I. Assessing the clini­\ncal significance of change scores following carpal tunnel sur­\ngery. \u0007Amirjani N, Ashworth NL, Gordon T, Edwards DC, Chan KM. Nor­\nmative values and the effects of age, gender, and handedness on \nthe Moberg Pick-Up Test. \u0007Amirjani N, Ashworth NL, Olson JL, Morhart M, Chan KM.",
    "chunk_id": 788,
    "sentence_start": 5039,
    "sentence_end": 5071,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Amirjani N, Ashworth NL, Olson JL, Morhart M, Chan KM. Valid­\nity and reliability of the Purdue Pegboard Test in carpal tunnel \nsyndrome. \u0007Amirjani N, Ashworth NL, Olson JL, Morhart M, Chan KM. Discriminative validity and test-retest reliability of the Dellon-\nmodified Moberg pick-up test in carpal tunnel syndrome \npatients. J Peripher Nerv Syst. Functional outcomes \npost carpal tunnel release: a modified replication of a previous \nstudy. \u0007Astifidis RP, Koczan BJ, Dubin NH, Burke FD, Wilgis EFS. Patient \nsatisfaction with carpal tunnel surgery: self-administered ques­\ntionnaires versus physical testing. \u0007Atalay NS, Sarsan A, Akkaya N, Yildiz N, Topuz O. The impact \nof disease severity in carpal tunnel syndrome on grip strength, \npinch strength, fine motor skill and depression. J Phys Ther Sci. \u0007Atroshi I, Gummesson C, McCabe SJ, Ornstein E. The SF-6D health \nutility index in carpal tunnel syndrome. J Hand Surg Eur Vol. \u0007Atroshi I, Gummesson C, Johnsson R, Sprinchorn A.",
    "chunk_id": 789,
    "sentence_start": 5070,
    "sentence_end": 5103,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Atroshi I, Gummesson C, Johnsson R, Sprinchorn A. Symp­\ntoms, disability, and quality of life in patients with carpal tunnel \nsyndrome. J Hand Surg Am. \u0007Atroshi I, Lyrén PE, Gummesson C. The 6-item CTS symptoms \nscale: a brief outcomes measure for carpal tunnel syndrome. \u0007Atroshi I, Lyrén PE, Ornstein E, Gummesson C. The six-item CTS \nsymptoms scale and palmar pain scale in carpal tunnel syndrome. J Hand Surg Am. \u0007Baker NA, Moehling KK, Desai AR, Gustafson NP. Effect of carpal \ntunnel syndrome on grip and pinch strength compared with sex- \nand age-matched normative data. Arthritis Care Res (Hoboken). Symptom severity and conservative \ntreatment for carpal tunnel syndrome in association with even­\ntual carpal tunnel release. J Hand Surg Am. \u0007Bakhsh H, Ibrahim I, Khan W, Smitham P, Goddard N. Assessment \nof validity, reliability, responsiveness and bias of three commonly \nused patient-reported outcome measures in carpal tunnel syn­\ndrome. Ortop Traumatol Rehabil.",
    "chunk_id": 790,
    "sentence_start": 5102,
    "sentence_end": 5135,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Bessette L, Sangha O, Kuntz KM, et al. Comparative re­\nsponsiveness of generic versus disease-specific and \nweighted versus unweighted health status measures in carpal \ntunnel syndrome. \u0007G\nB\no\nAPPENDIX E\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nh NL, Olson JL, Morhart M, Chan KM. y and test-retest reliability of the Dellon-\nk-up test in carpal tunnel syndrome \nNerv Syst. 027.2011.00312.x\nSmith M, Parrott MW. Functional outcomes \nlease: a modified replication of a previous \n2009;22:240-248; quiz 249. 09.03.001\nBJ, Dubin NH, Burke FD, Wilgis EFS. Patient \npal tunnel surgery: self-administered ques­\nysical testing. 58/ht.2009.009007\nAkkaya N, Yildiz N, Topuz O.",
    "chunk_id": 791,
    "sentence_start": 5134,
    "sentence_end": 5169,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "58/ht.2009.009007\nAkkaya N, Yildiz N, Topuz O. The impact \ncarpal tunnel syndrome on grip strength, \nmotor skill and depression. J Phys Ther Sci. s://doi.org/10.1589/jpts.23.115\nn C, McCabe SJ, Ornstein E. The SF-6D health \ntunnel syndrome. J Hand Surg Eur Vol. ps://doi.org/10.1016/J.JHSB.2006.11.002\nn C, Johnsson R, Sprinchorn A. Symp­\nquality of life in patients with carpal tunnel \nurg Am. The 6-item CTS symptoms \nmes measure for carpal tunnel syndrome. The six-item CTS \npalmar pain scale in carpal tunnel syndrome. KK, Desai AR, Gustafson NP. Effect of carpal \ngrip and pinch strength compared with sex- \nrmative data. Arthritis Care Res (Hoboken). Symptom severity and conservative \ntunnel syndrome in association with even­\nease. J Hand Surg Am. 16/j.jhsa.2014.04.034\nKhan W, Smitham P, Goddard N. Assessment \nresponsiveness and bias of three commonly \nd outcome measures in carpal tunnel syn­\natol Rehabil.",
    "chunk_id": 792,
    "sentence_start": 5168,
    "sentence_end": 5197,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Comparative re­\neric versus disease-specific and \neighted health status measures in carpal \n\t19. \u0007Boyd KU, Gan BS, Ross DC, Richards RS, Roth JH, MacDermid JC. Outcomes in carpal tunnel syndrome: symptom severity, conser­\nvative management and progression to surgery. Clin Invest Med. Comparative responsiveness of the \nMichigan Hand Outcomes Questionnaire and the Carpal Tun­\nnel Questionnaire after carpal tunnel release. J Hand Surg Am. \u0007Cheung DK, MacDermid J, Walton D, Grewal R. The construct va­\nlidity and responsiveness of sensory tests in patients with carpal \ntunnel syndrome. \u0007Coldham F, Lewis J, Lee H. The reliability of one vs. three grip \ntrials in symptomatic and asymptomatic subjects. \u0007de la Llave-Rincón AI, Fernández-de-las-Peñas C, Pérez-de-Here­\ndia-Torres M, Martínez-Perez A, Valenza MC, Pareja JA. Bilateral \ndeficits in fine motor control and pinch grip force are not associ­\nated with electrodiagnostic findings in women with carpal tunnel \nsyndrome.",
    "chunk_id": 793,
    "sentence_start": 5196,
    "sentence_end": 5223,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007de la Llave-Rincón AI, Fernández-de-las-Peñas C, Pérez-de-Here­\ndia-Torres M, Martínez-Perez A, Valenza MC, Pareja JA. Bilateral \ndeficits in fine motor control and pinch grip force are not associ­\nated with electrodiagnostic findings in women with carpal tunnel \nsyndrome. Am J Phys Med Rehabil. \u0007Desrosiers J, Hébert R, Bravo G, Dutil E. The Purdue Pegboard \nTest: normative data for people aged 60 and over. \u0007Dhong ES, Han SK, Lee BI, Kim WK. Correlation of electrodiagnos­\ntic findings with subjective symptoms in carpal tunnel syndrome. Ann Plast Surg. \u0007Fernández-de-las-Peñas C, Pérez-de-Heredia-Torres M, Martínez-\nPiédrola R, de la Llave-Rincón AI, Cleland JA. Bilateral deficits in \nfine motor control and pinch grip force in patients with unilateral \ncarpal tunnel syndrome. \u0007Gay RE, Amadio PC, Johnson JC. Comparative responsiveness of \nthe Disabilities of the Arm, Shoulder, and Hand, the Carpal Tun­\nnel Questionnaire, and the SF-36 to clinical change after carpal \ntunnel release.",
    "chunk_id": 794,
    "sentence_start": 5222,
    "sentence_end": 5244,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Gay RE, Amadio PC, Johnson JC. Comparative responsiveness of \nthe Disabilities of the Arm, Shoulder, and Hand, the Carpal Tun­\nnel Questionnaire, and the SF-36 to clinical change after carpal \ntunnel release. J Hand Surg Am. \u0007Geere J, Chester R, Kale S, Jerosch-Herold C. Power grip, pinch \ngrip, manual muscle testing or thenar atrophy – which should be \nassessed as a motor outcome after carpal tunnel decompres­\nsion? BMC Musculoskelet Disord. \u0007Gerritsen AA, Korthals-de Bos IB, Laboyrie PM, de Vet HC, \nScholten RJ, Bouter LM. Splinting for carpal tunnel syndrome: \nprognostic indicators of success. J Neurol Neurosurg Psychiatry. \u0007Greenslade JR, Mehta RL, Belward P, Warwick DJ. DASH and \nAPPENDIX E\n\n\n--- Page 80 ---\nCOLUMN 1:\n31. \u0007Hobby JL, Watts C, Elliot D. Validity and responsiveness of the \npatient evaluation measure as an outcome measure for carpal \ntunnel syndrome. J Hand Surg Br. \u0007Hsu HY, Su FC, Kuo YL, Jou IM, Chiu HY, Kuo LC.",
    "chunk_id": 795,
    "sentence_start": 5243,
    "sentence_end": 5268,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Hsu HY, Su FC, Kuo YL, Jou IM, Chiu HY, Kuo LC. Assessment from \nfunctional perspectives: using sensorimotor control in the hand \nas an outcome indicator in the surgical treatment of carpal tunnel \nsyndrome. \u0007Jerosch-Herold C, Shepstone L, Miller L, Chapman P. The respon­\nsiveness of sensibility and strength tests in patients undergo­\ning carpal tunnel decompression. BMC Musculoskelet Disord. \u0007Katz JN, Gelberman RH, Wright EA, Lew RA, Liang MH. Respon­\nsiveness of self-reported and objective measures of disease sever­\nity in carpal tunnel syndrome. Carpal tunnel syndrome: using self-report \nmeasures of disease to predict treatment response. Am J Orthop \n(Belle Mead NJ). Responsiveness of the Michigan Hand Out­\ncomes Questionnaire and the Disabilities of the Arm, Shoulder \nand Hand questionnaire in carpal tunnel surgery. J Hand Surg Am. \u0007Levine DW, Simmons BP, Koris MJ, et al.",
    "chunk_id": 796,
    "sentence_start": 5267,
    "sentence_end": 5293,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Levine DW, Simmons BP, Koris MJ, et al. A self-administered \nquestionnaire for the assessment of severity of symptoms and \nfunctional status in carpal tunnel syndrome. J Bone Joint Surg \nAm. Using item response theory improved re­\nsponsiveness of patient-reported outcomes measures in carpal \ntunnel syndrome. Which outcome measure is the \nbest? Evaluating responsiveness of the Disabilities of the Arm, \nShoulder, and Hand Questionnaire, the Michigan Hand Question­\nnaire and the Patient-Specific Functional Scale following hand and \nwrist surgery. \u0007Ollivere BJ, Logan K, Ellahee N, Miller-Jones JC, Wood M, Nairn \nDS. Severity scoring in carpal tunnel syndrome helps predict the \nvalue of conservative therapy. J Hand Surg Eur Vol. Change in strength and dexterity after \nopen carpal tunnel release. Int J Sports Med. \u0007Ozer K, Malay S, Toker S, Chung KC. Minimal clinically important \ndifference of carpal tunnel release in diabetic and nondiabetic \npatients. Plast Reconstr Surg.",
    "chunk_id": 797,
    "sentence_start": 5292,
    "sentence_end": 5325,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Özyürekoğlu T, McCabe SJ, Goldsmith LJ, LaJoie AS. The minimal f\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nliot D. Validity and responsiveness of the \neasure as an outcome measure for carpal \nHand Surg Br. 005.03.009\nL, Jou IM, Chiu HY, Kuo LC. Assessment from \nves: using sensorimotor control in the hand \nator in the surgical treatment of carpal tunnel \ne. The respon­\ny and strength tests in patients undergo­\ncompression. BMC Musculoskelet Disord. /doi.org/10.1186/1471-2474-12-244\nRH, Wright EA, Lew RA, Liang MH. Respon­\nrted and objective measures of disease sever­\nyndrome. Carpal tunnel syndrome: using self-report \nto predict treatment response.",
    "chunk_id": 798,
    "sentence_start": 5324,
    "sentence_end": 5348,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Carpal tunnel syndrome: using self-report \nto predict treatment response. Responsiveness of the Michigan Hand Out­\ne and the Disabilities of the Arm, Shoulder \naire in carpal tunnel surgery. J Hand Surg Am. A self-administered \n assessment of severity of symptoms and \narpal tunnel syndrome. J Bone Joint Surg \n92. sing item response theory improved re­\nent-reported outcomes measures in carpal \nClin Epidemiol. Which outcome measure is the \nponsiveness of the Disabilities of the Arm, \nQuestionnaire, the Michigan Hand Question­\nt-Specific Functional Scale following hand and \nN Y). J Hand Surg Eur Vol. Change in strength and dexterity after \nelease. Int J Sports Med. Minimal clinically important \nunnel release in diabetic and nondiabetic \nnstr Surg. \u0007Pransky G, Feuerstein M, Himmelstein J, Katz JN, Vickers-Lahti M. Measuring functional outcomes in work-related upper extremity \ndisorders. Development and validation of the Upper Extremity \nFunction Scale. J Occup Environ Med.",
    "chunk_id": 799,
    "sentence_start": 5347,
    "sentence_end": 5377,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The relationship among five common car­\npal tunnel syndrome tests and the severity of carpal tunnel syn­\ndrome. Validity and responsiveness of the Jebsen-\nTaylor Hand Function Test. J Hand Surg Am. \u0007Smith-Forbes EV, Howell DM, Willoughby J, Pitts DG, Uhl TL. Speci­\nficity of the minimal clinically important difference of the quick \nDisabilities of the Arm, Shoulder and Hand (QDASH) for distal \nupper extremity conditions. \u0007Tulipan JE, Lutsky KF, Maltenfort MG, Freedman MK, Beredjiklian \nPK. Patient-reported disability measures do not correlate with \nelectrodiagnostic severity in carpal tunnel syndrome. Plast Re­\nconstr Surg Glob Open. \u0007Yeudall LT, Fromm D, Reddon JR, Stefanyk WO. Normative data \nstratified by age and sex for 12 neuropsychological tests. A comparison of DASH, PEM and Levine \nquestionnaires in outcome measurement of carpal tunnel release. Handchir Mikrochir Plast Chir. org/10.1055/s-0031-1273686\nInterventions: Assistive Technology\n\t 1.",
    "chunk_id": 800,
    "sentence_start": 5376,
    "sentence_end": 5407,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "org/10.1055/s-0031-1273686\nInterventions: Assistive Technology\n\t 1. \u0007O’Connor D, Page MJ, Marshall SC, Massy-Westropp N. Ergonomic \npositioning or equipment for treating carpal tunnel syndrome. Cochrane Database Syst Rev. \u0007Schmid AB, Kubler PA, Johnston V, Coppieters MW. A vertical \nmouse and ergonomic mouse pads alter wrist position but do \nnot reduce carpal tunnel pressure in patients with carpal tunnel \nsyndrome. \u0007Bulut GT, Caglar NS, Aytekin E, Ozgonenel L, Tutun S, Demir SE. Comparison of static wrist splint with static wrist and metacarpo­\nphalangeal splint in carpal tunnel syndrome. J Back Musculoskelet \nRehabil. The \nAPPENDIX E\n\n\n--- Page 81 ---\nCOLUMN 1:\n3. Splinting for symptoms of carpal tunnel syndrome dur­\ning pregnancy. \u0007Ekman-Ordeberg G, Sälgeback S, Ordeberg G. Carpal tun­\nnel syndrome in pregnancy. Acta \nObstet Gynecol Scand. \u0007Gelberman RH, Hergenroeder PT, Hargens AR, Lundborg GN, \nAkeson WH. The carpal tunnel syndrome. A study of carpal canal \npressures.",
    "chunk_id": 801,
    "sentence_start": 5406,
    "sentence_end": 5441,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "The carpal tunnel syndrome. A study of carpal canal \npressures. J Bone Joint Surg Am. \u0007Gerritsen AA, de Vet HC, Scholten RJ, Bertelsmann FW, de \nKrom MC, Bouter LM. Splinting vs surgery in the treatment of \ncarpal tunnel syndrome: a randomized controlled trial. \u0007Golriz B, Ahmadi Bani M, Arazpour M, et al. Comparison of the \nefficacy of a neutral wrist splint and a wrist splint incorporating \na lumbrical unit for the treatment of patients with carpal tunnel \nsyndrome. Prosthet Orthot Int. \u0007Hall B, Lee HC, Fitzgerald H, Byrne B, Barton A, Lee AH. Investigat­\ning the effectiveness of full-time wrist splinting and education in \nthe treatment of carpal tunnel syndrome: a randomized controlled \ntrial. \u0007Keir PJ, Bach JM, Rempel DM. Effects of finger posture \non carpal tunnel pressure during wrist motion. J Hand \nSurg Am. \u0007Kuo MH, Leong CP, Cheng YF, Chang HW. Static wrist position \nassociated with least median nerve compression: sonographic \nevaluation. Am J Phys Med Rehabil.",
    "chunk_id": 802,
    "sentence_start": 5440,
    "sentence_end": 5471,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Madjdinasab N, Zadeh NS, Assarzadegan F, Ali AMA, Pipelzadeh \nM. Efficacy comparison of splint and oral steroid therapy in nerve \nconduction velocity and latency median nerve in carpal tunnel \nsyndrome. \u0007Manente G, Melchionda D, Staniscia T, D’Archivio C, Mazzone \nV, Macarini L. Changes in the carpal tunnel while wearing the \nManu soft hand brace: a sonographic study. J Hand Surg Eur Vol. \u0007Mishra S, Prabhakar S, Lal V, Modi M, Das CP, Khurana D. Efficacy \nof splinting and oral steroids in the treatment of carpal tunnel syn­\ndrome: a prospective randomized clinical and electrophysiological \nstudy. \u0007Özgen M, Güngen G, Sarsan A, et al. Determination of the position \non which the median nerve compression is at the lowest in carpal \ntunnel syndrome and clinical effectiveness of custom splint appli­\ncation. \u0007I\nw\nf\nn\nh\nAPPENDIX E\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission.",
    "chunk_id": 803,
    "sentence_start": 5470,
    "sentence_end": 5506,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nfor symptoms of carpal tunnel syndrome dur­\nd Ther. 48709020753\nenroeder PT, Hargens AR, Lundborg GN, \npal tunnel syndrome. A study of carpal canal \nint Surg Am. HC, Scholten RJ, Bertelsmann FW, de \nM. Splinting vs surgery in the treatment of \nme: a randomized controlled trial. Comparison of the \nwrist splint and a wrist splint incorporating \nhe treatment of patients with carpal tunnel \nOrthot Int. 4615592695\nerald H, Byrne B, Barton A, Lee AH. Investigat­\nof full-time wrist splinting and education in \npal tunnel syndrome: a randomized controlled \ner. Effects of finger posture \nssure during wrist motion. Static wrist position \nt median nerve compression: sonographic \nys Med Rehabil.",
    "chunk_id": 804,
    "sentence_start": 5505,
    "sentence_end": 5536,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "060-200104000-00004\neh NS, Assarzadegan F, Ali AMA, Pipelzadeh \non of splint and oral steroid therapy in nerve \nand latency median nerve in carpal tunnel \nd Sci. da D, Staniscia T, D’Archivio C, Mazzone \nes in the carpal tunnel while wearing the \ne: a sonographic study. J Hand Surg Eur Vol. ://doi.org/10.1177/1753193412446112\nS, Lal V, Modi M, Das CP, Khurana D. Efficacy \nsteroids in the treatment of carpal tunnel syn­\ne randomized clinical and electrophysiological \n2006;54:286-290. Determination of the position \nn nerve compression is at the lowest in carpal \nd clinical effectiveness of custom splint appli­\nt. \u0007Rempel D, Bach JM, Gordon L, So Y. Effects of forearm prona­\ntion/supination on carpal tunnel pressure. J Hand Surg Am. \u0007Rojviroj S, Sirichativapee W, Kowsuwon W, Wongwiwattananon J, \nTamnanthong N, Jeeravipoolvarn P. Pressures in the carpal tunnel. A comparison between patients with carpal tunnel syndrome and \nnormal subjects. J Bone Joint Surg Br.",
    "chunk_id": 805,
    "sentence_start": 5535,
    "sentence_end": 5557,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Schmid AB, Elliott JM, Strudwick MW, Little M, Coppieters MW. Ef­\nfect of splinting and exercise on intraneural edema of the median \nnerve in carpal tunnel syndrome—an MRI study to reveal thera­\npeutic mechanisms. \u0007So H, Chung VCH, Cheng JCK, Yip RML. Local steroid injection \nversus wrist splinting for carpal tunnel syndrome: a random­\nized clinical trial. Int J Rheum Dis. \u0007Ucan H, Yagci I, Yilmaz L, Yagmurlu F, Keskin D, Bodur H. Com­\nparison of splinting, splinting plus local steroid injection and \nopen carpal tunnel release outcomes in idiopathic carpal tunnel \nsyndrome. \u0007Walker WC, Metzler M, Cifu DX, Swartz Z. Neutral wrist splinting in \ncarpal tunnel syndrome: a comparison of night-only versus full-\ntime wear instructions. Arch Phys Med Rehabil. \u0007Wang JC, Liao KK, Lin KP, et al. Efficacy of combined ultrasound-\nguided steroid injection and splinting in patients with carpal tunnel \nsyndrome: a randomized controlled trial. Arch Phys Med Rehabil.",
    "chunk_id": 806,
    "sentence_start": 5556,
    "sentence_end": 5584,
    "section_type": "general",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Weiss ND, Gordon L, Bloom T, So Y, Rempel DM. Position of the \nwrist associated with the lowest carpal-tunnel pressure: implica­\ntions for splint design. J Bone Joint Surg Am. Interventions: Biophysical Agents (Thermotherapy)\n\t 1. \u0007Chang YW, Hsieh SF, Horng YS, Chen HL, Lee KC, Horng \nYS. Comparative effectiveness of ultrasound and paraffin \ntherapy in patients with carpal tunnel syndrome: a random­\nized trial. BMC Musculoskelet Disord. \u0007Frasca G, Maggi L, Padua L, et al. Short-term effects of local mi­\ncrowave hyperthermia on pain and function in patients with mild \nto moderate carpal tunnel syndrome: a double blind randomized \nsham-controlled trial. \u0007Incebiyik S, Boyaci A, Tutoglu A. Short-term effectiveness of short-\nwave diathermy treatment on pain, clinical symptoms, and hand \nfunction in patients with mild or moderate idiopathic carpal tun­\nnel syndrome. J Back Musculoskelet Rehabil. \u0007Michlovitz S, Hun L, Erasala GN, Hengehold DA, Weingand KW.",
    "chunk_id": 807,
    "sentence_start": 5583,
    "sentence_end": 5607,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Michlovitz S, Hun L, Erasala GN, Hengehold DA, Weingand KW. Continuous low-level heat wrap therapy is effective for treating \nwrist pain. Arch Phys Med Rehabil. \u0007Koca I, Boyaci A, Tutoglu A, Ucar M, Kocaturk O. Assessment of \nthe effectiveness of interferential current therapy and TENS in the \nmanagement of carpal tunnel syndrome: a randomized controlled \nstudy. \u0007Raeissadat SA, Rayegani SM, Rezaei S, et al. The effect of polarized \npolychromatic noncoherent light (Bioptron) therapy on patients \nwith carpal tunnel syndrome. J Lasers Med Sci. \u0007Rankin IA, Sargeant H, Rehman H, Gurusamy KF. Low‐level laser \ntherapy for carpal tunnel syndrome. Cochrane Database Syst Rev. \u0007Stasinopoulos D, Stasinopoulos I, Johnson MI. Treatment of carpal \ntunnel syndrome with polarized polychromatic noncoherent light \n(Bioptron light): a preliminary, prospective, open clinical trial. Photomed Laser Surg. \u0007Armagan O, Bakilan F, Ozgen M, Mehmetoglu O, Oner S.",
    "chunk_id": 808,
    "sentence_start": 5606,
    "sentence_end": 5632,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Armagan O, Bakilan F, Ozgen M, Mehmetoglu O, Oner S. Effects of \nplacebo-controlled continuous and pulsed ultrasound treatments \non carpal tunnel syndrome: a randomized trial. \u0007Baysal O, Altay Z, Ozcan C, Ertem K, Yologlu S, Kayhan A. Com­\nparison of three conservative treatment protocols in carpal tun­\nnel syndrome. Int J Clin Pract. \u0007Chang YW, Hsieh SF, Horng YS, Chen HL, Lee KC, Horng \nYS. Comparative effectiveness of ultrasound and paraffin \ntherapy in patients with carpal tunnel syndrome: a random­\nized trial. BMC Musculoskelet Disord. \u0007Ebenbichler GR, Resch KL, Nicolakis P, et al. Ultrasound treatment \nfor treating the carpal tunnel syndrome: randomised “sham” \ncontrolled trial. \u0007Oztas O, Turan B, Bora I, Karakaya MK. Ultrasound therapy effect \nin carpal tunnel syndrome. Arch Phys Med Rehabil. \u0007Amirjani N, Ashworth NL, Watt MJ, Gordon T, Chan KM. Corticoste­\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 809,
    "sentence_start": 5631,
    "sentence_end": 5660,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Amirjani N, Ashworth NL, Watt MJ, Gordon T, Chan KM. Corticoste­\n Journal of Orthopaedic & Sports Physical Therapy® \n Downloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nErasala GN, Hengehold DA, Weingand KW. heat wrap therapy is effective for treating \ns Med Rehabil. Assessment of \nnterferential current therapy and TENS in the \nal tunnel syndrome: a randomized controlled \n. The effect of polarized \noherent light (Bioptron) therapy on patients \nndrome. J Lasers Med Sci. H, Rehman H, Gurusamy KF. Low‐level laser \nnnel syndrome. Cochrane Database Syst Rev. s://doi.org/10.1002/14651858.CD012765\nsinopoulos I, Johnson MI. Treatment of carpal \nh polarized polychromatic noncoherent light \neliminary, prospective, open clinical trial.",
    "chunk_id": 810,
    "sentence_start": 5659,
    "sentence_end": 5682,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Effects of \nontinuous and pulsed ultrasound treatments \ndrome: a randomized trial. Com­\nservative treatment protocols in carpal tun­\nClin Pract. 41.2006.00867.x\nHorng YS, Chen HL, Lee KC, Horng f\nctiveness of ultrasound and paraffin \nwith carpal tunnel syndrome: a random­\nuloskelet Disord. Ultrasound treatment \nal tunnel syndrome: randomised “sham” \n 1998;316:731-735. Ultrasound therapy effect \nrome. Arch Phys Med Rehabil. 1998;79:1540-\n/10.1016/S0003-9993(98)90416-6\nical Agents (Transdermal Drug Delivery)\nh NL, Watt MJ, Gordon T, Chan KM. Corticoste­\ntreat carpal tunnel syndrome: a double-blind \ned trial Muscle Nerve 2009;39:627-633\n\t 2. \u0007Bakhtiary AH, Fatemi E, Emami M, Malek M. Phonophoresis \nof dexamethasone sodium phosphate may manage pain and \nsymptoms of patients with carpal tunnel syndrome. \u0007Gökoğlu F, Fndkoğlu G, Yorgancoğlu ZR, Okumuş M, Ceceli E, \nKocaoğlu S. Evaluation of iontophoresis and local corticoste­\nroid injection in the treatment of carpal tunnel syndrome.",
    "chunk_id": 811,
    "sentence_start": 5681,
    "sentence_end": 5705,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Gökoğlu F, Fndkoğlu G, Yorgancoğlu ZR, Okumuş M, Ceceli E, \nKocaoğlu S. Evaluation of iontophoresis and local corticoste­\nroid injection in the treatment of carpal tunnel syndrome. Am J \nPhys Med Rehabil. \u0007Gurcay E, Unlu E, Gurcay AG, Tuncay R, Cakci A. Assessment \nof phonophoresis and iontophoresis in the treatment of carpal \ntunnel syndrome: a randomized controlled trial. \u0007Karatay S, Aygul R, Melikoglu MA, et al. The comparison of phono­\nphoresis, iontophoresis and local steroid injection in carpal tunnel \nsyndrome treatment [letter]. Joint Bone Spine. \u0007Soyupek F, Kutluhan S, Uslusoy G, Ilgun E, Eris S, Askin A. The efficacy of phonophoresis on electrophysiological studies \nof the patients with carpal tunnel syndrome. \u0007Soyupek F, Yesildag A, Kutluhan S, et al. Determining the effective­\nness of various treatment modalities in carpal tunnel syndrome \nby ultrasonography and comparing ultrasonographic findings with \nother outcomes.",
    "chunk_id": 812,
    "sentence_start": 5704,
    "sentence_end": 5730,
    "section_type": "diagnosis",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Yildiz N, Atalay NS, Gungen GO, Sanal E, Akkaya N, Topuz O. Com­\nparison of ultrasound and ketoprofen phonophoresis in the treatment \nof carpal tunnel syndrome. J Back Musculoskelet Rehabil. \u0007Carter R, Aspy CB, Mold J. The effectiveness of magnet therapy \nfor treatment of wrist pain attributed to carpal tunnel syndrome. \u0007Colbert AP, Markov MS, Carlson N, Gregory WL, Carlson H, Elmer \nPJ. Static magnetic field therapy for carpal tunnel syndrome: a fea­\nsibility study. Arch Phys Med Rehabil. \u0007Baker NA, Moehling KK, Rubinstein EN, Wollstein R, Gustafson NP, \nBaratz M. The comparative effectiveness of combined lumbrical \nmuscle splints and stretches on symptoms and function in carpal \ntunnel syndrome. Arch Phys Med Rehabil. \u0007Basson A, Olivier B, Ellis R, Coppieters M, Stewart A, Mudzi W. The effectiveness of neural mobilization for neuromusculoskeletal \nconditions: a systematic review and meta-analysis. J Orthop \nSports Phys Ther.",
    "chunk_id": 813,
    "sentence_start": 5729,
    "sentence_end": 5755,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "\u0007Maddali Bongi S, Signorini M, Bassetti M, Del Rosso A, Orlandi \nM, De Scisciolo G. A manual therapy intervention improves \nsymptoms in patients with carpal tunnel syndrome: a pilot study. Manual physical therapy versus surgery for carpal tunnel \nsyndrome: a randomized parallel-group trial. \u0007Fernández-de-las-Peñas C, Cleland J, Palacios-Ceña M, Fuen­\nsalida-Novo S, Pareja JA, Alonso-Blanco C. The effectiveness of \nmanual therapy versus surgery on self-reported function, cervical \nrange of motion, and pinch grip force in carpal tunnel syndrome: a \nrandomized clinical trial. J Orthop Sports Phys Ther. \u0007W\nn\nr\nd\nAPPENDIX E\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 814,
    "sentence_start": 5754,
    "sentence_end": 5777,
    "section_type": "treatment",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nnorini M, Bassetti M, Del Rosso A, Orlandi \nmanual therapy intervention improves \ns with carpal tunnel syndrome: a pilot study. 2015;16:1087-\n/10.1016/j.jpain.2015.07.012\nñas C, Cleland J, Palacios-Ceña M, Fuen­\na JA, Alonso-Blanco C. The effectiveness of \nus surgery on self-reported function, cervical \n\t 6. Exercise \nand mobilisation interventions for carpal tunnel syndrome. Cochrane Database Syst Rev. Neurodynamic techniques versus “sham” \ntherapy in the treatment of carpal tunnel syndrome: a randomized \nplacebo-controlled trial. Arch Phys Med Rehabil. Is manual therapy based on neurodynamic tech­\nniques effective in the treatment of carpal tunnel syndrome? A \nrandomized controlled trial. *Adapted from Phillips et al.226 See also APPENDIX G.",
    "chunk_id": 815,
    "sentence_start": 5776,
    "sentence_end": 5801,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "*Adapted from Phillips et al.226 See also APPENDIX G. †High quality includes RCTs with greater than 80% follow-up, blinding, and appropriate randomization procedures. ‡High-quality cohort study includes greater than 80% follow-up. §High-quality diagnostic study includes consistently applied reference standard and blinding. ‖High-quality prevalence study is a cross-sectional study that uses a local and current random sample or censuses. ¶Weaker diagnostic criteria and reference standards, improper randomization, no blinding, and less than 80% follow-up may add bias and threats to validity. APPENDIX F\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 816,
    "sentence_start": 5800,
    "sentence_end": 5811,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nLEVELS OF EVIDENCE TABLE*\nLevel\nIntervention/Prevention\nPathoanatomic/Risk/ \nClinical Course/Prognosis/ \nDifferential Diagnosis\nDiagnosis/Diagnostic \nAccuracy\nPrevalence of Condition/\nDisorder\nExam/Outcomes\nI\nSystematic review of high-\nquality RCTs\nHigh-quality RCT†\nSystematic review of pro­\nspective cohort studies\nHigh-quality prospective \ncohort study‡\nSystematic review of high-\nquality diagnostic studies\nHigh-quality diagnostic \nstudy§ with validation\nSystematic review, high-\nquality cross-sectional \nstudies\nHigh-quality cross-sectional \nstudy‖\nSystematic review of pro­\nspective cohort studies\nHigh-quality prospective \ncohort study\nII\nSystematic review of high-\nquality cohort studies\nHigh-quality cohort study‡\nOutcomes study or ecologi­\ncal study\nLower-quality RCT¶\nSystematic review of retro­\nspective cohort study\nLower-quality prospective \ncohort study\nHigh-quality retrospective \ncohort study\nConsecutive cohort\nOutcomes study or ecologi­\ncal study\nSystematic review of explor­\natory diagnostic studies \nor consecutive cohort \nstudies\nHigh-quality exploratory \ndiagnostic studies\nConsecutive retrospective \ncohort\nSystematic review of stud­\nies that allows relevant \nestimate\nLower-quality cross-section­\nal study\nSystematic review of lower-\nquality prospective co­\nhort studies\nLower-quality prospective \ncohort study\nIII\nSystematic reviews of case-\ncontrol studies\nHigh-quality case-control \nstudy\nLower-quality cohort study\nLower-quality retrospective \ncohort study\nHigh-quality cross-sectional \nstudy\nCase-control study\nLower-quality exploratory \ndiagnostic studies\nNonconsecutive retrospec­\ntive cohort\nLocal nonrandom study\nHigh-quality cross-sectional \nstudy\nIV\nCase series\nCase series\nCase-control study\n…\nLower-quality cross-sectional \nstudy\nAPPENDIX F\n\n\n--- Page 85 ---\nCOLUMN 1:\nAPPENDIX G\nPROCEDURES FOR ASSIGNING LEVELS OF EVIDENCE\n•  \u0007Level of evidence is assigned based on the study design using \nthe Levels of Evidence table (APPENDIX F), assuming high quality \n(eg, for intervention, randomized clinical trial starts at level I)\n•  \u0007Study quality is assessed using the critical appraisal tool, and \nthe study is assigned 1 of 4 overall quality ratings based on the \ncritical appraisal results\n•  \u0007Level of evidence assignment is adjusted based on the overall \nquality rating:\n-  \u0007High quality (high confidence in the estimate/results): study \nremains at assigned level of evidence (eg, if the randomized \nclinical trial is rated high quality, its final assignment is level \nI).",
    "chunk_id": 817,
    "sentence_start": 5810,
    "sentence_end": 5812,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nLEVELS OF EVIDENCE TABLE*\nLevel\nIntervention/Prevention\nPathoanatomic/Risk/ \nClinical Course/Prognosis/ \nDifferential Diagnosis\nDiagnosis/Diagnostic \nAccuracy\nPrevalence of Condition/\nDisorder\nExam/Outcomes\nI\nSystematic review of high-\nquality RCTs\nHigh-quality RCT†\nSystematic review of pro­\nspective cohort studies\nHigh-quality prospective \ncohort study‡\nSystematic review of high-\nquality diagnostic studies\nHigh-quality diagnostic \nstudy§ with validation\nSystematic review, high-\nquality cross-sectional \nstudies\nHigh-quality cross-sectional \nstudy‖\nSystematic review of pro­\nspective cohort studies\nHigh-quality prospective \ncohort study\nII\nSystematic review of high-\nquality cohort studies\nHigh-quality cohort study‡\nOutcomes study or ecologi­\ncal study\nLower-quality RCT¶\nSystematic review of retro­\nspective cohort study\nLower-quality prospective \ncohort study\nHigh-quality retrospective \ncohort study\nConsecutive cohort\nOutcomes study or ecologi­\ncal study\nSystematic review of explor­\natory diagnostic studies \nor consecutive cohort \nstudies\nHigh-quality exploratory \ndiagnostic studies\nConsecutive retrospective \ncohort\nSystematic review of stud­\nies that allows relevant \nestimate\nLower-quality cross-section­\nal study\nSystematic review of lower-\nquality prospective co­\nhort studies\nLower-quality prospective \ncohort study\nIII\nSystematic reviews of case-\ncontrol studies\nHigh-quality case-control \nstudy\nLower-quality cohort study\nLower-quality retrospective \ncohort study\nHigh-quality cross-sectional \nstudy\nCase-control study\nLower-quality exploratory \ndiagnostic studies\nNonconsecutive retrospec­\ntive cohort\nLocal nonrandom study\nHigh-quality cross-sectional \nstudy\nIV\nCase series\nCase series\nCase-control study\n…\nLower-quality cross-sectional \nstudy\nAPPENDIX F\n\n\n--- Page 85 ---\nCOLUMN 1:\nAPPENDIX G\nPROCEDURES FOR ASSIGNING LEVELS OF EVIDENCE\n•  \u0007Level of evidence is assigned based on the study design using \nthe Levels of Evidence table (APPENDIX F), assuming high quality \n(eg, for intervention, randomized clinical trial starts at level I)\n•  \u0007Study quality is assessed using the critical appraisal tool, and \nthe study is assigned 1 of 4 overall quality ratings based on the \ncritical appraisal results\n•  \u0007Level of evidence assignment is adjusted based on the overall \nquality rating:\n-  \u0007High quality (high confidence in the estimate/results): study \nremains at assigned level of evidence (eg, if the randomized \nclinical trial is rated high quality, its final assignment is level \nI). High quality should include:\n•  \u0007Randomized clinical trial with greater than 80% follow-up, \nblinding, and appropriate randomization procedures\n-  \u0007A\nh\nc\n-  \u0007L\ns\nl\n-  \u0007U\ns\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025.",
    "chunk_id": 818,
    "sentence_start": 5811,
    "sentence_end": 5813,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nLEVELS OF EVIDENCE TABLE*\nLevel\nIntervention/Prevention\nPathoanatomic/Risk/ \nClinical Course/Prognosis/ \nDifferential Diagnosis\nDiagnosis/Diagnostic \nAccuracy\nPrevalence of Condition/\nDisorder\nExam/Outcomes\nI\nSystematic review of high-\nquality RCTs\nHigh-quality RCT†\nSystematic review of pro­\nspective cohort studies\nHigh-quality prospective \ncohort study‡\nSystematic review of high-\nquality diagnostic studies\nHigh-quality diagnostic \nstudy§ with validation\nSystematic review, high-\nquality cross-sectional \nstudies\nHigh-quality cross-sectional \nstudy‖\nSystematic review of pro­\nspective cohort studies\nHigh-quality prospective \ncohort study\nII\nSystematic review of high-\nquality cohort studies\nHigh-quality cohort study‡\nOutcomes study or ecologi­\ncal study\nLower-quality RCT¶\nSystematic review of retro­\nspective cohort study\nLower-quality prospective \ncohort study\nHigh-quality retrospective \ncohort study\nConsecutive cohort\nOutcomes study or ecologi­\ncal study\nSystematic review of explor­\natory diagnostic studies \nor consecutive cohort \nstudies\nHigh-quality exploratory \ndiagnostic studies\nConsecutive retrospective \ncohort\nSystematic review of stud­\nies that allows relevant \nestimate\nLower-quality cross-section­\nal study\nSystematic review of lower-\nquality prospective co­\nhort studies\nLower-quality prospective \ncohort study\nIII\nSystematic reviews of case-\ncontrol studies\nHigh-quality case-control \nstudy\nLower-quality cohort study\nLower-quality retrospective \ncohort study\nHigh-quality cross-sectional \nstudy\nCase-control study\nLower-quality exploratory \ndiagnostic studies\nNonconsecutive retrospec­\ntive cohort\nLocal nonrandom study\nHigh-quality cross-sectional \nstudy\nIV\nCase series\nCase series\nCase-control study\n…\nLower-quality cross-sectional \nstudy\nAPPENDIX F\n\n\n--- Page 85 ---\nCOLUMN 1:\nAPPENDIX G\nPROCEDURES FOR ASSIGNING LEVELS OF EVIDENCE\n•  \u0007Level of evidence is assigned based on the study design using \nthe Levels of Evidence table (APPENDIX F), assuming high quality \n(eg, for intervention, randomized clinical trial starts at level I)\n•  \u0007Study quality is assessed using the critical appraisal tool, and \nthe study is assigned 1 of 4 overall quality ratings based on the \ncritical appraisal results\n•  \u0007Level of evidence assignment is adjusted based on the overall \nquality rating:\n-  \u0007High quality (high confidence in the estimate/results): study \nremains at assigned level of evidence (eg, if the randomized \nclinical trial is rated high quality, its final assignment is level \nI). High quality should include:\n•  \u0007Randomized clinical trial with greater than 80% follow-up, \nblinding, and appropriate randomization procedures\n-  \u0007A\nh\nc\n-  \u0007L\ns\nl\n-  \u0007U\ns\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only.",
    "chunk_id": 819,
    "sentence_start": 5812,
    "sentence_end": 5814,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "High quality should include:\n•  \u0007Randomized clinical trial with greater than 80% follow-up, \nblinding, and appropriate randomization procedures\n-  \u0007A\nh\nc\n-  \u0007L\ns\nl\n-  \u0007U\ns\n Journal of Orthopaedic & Sports Physical Therapy® \nDownloaded from www.jospt.org at on July 18, 2025. For personal use only. No other uses without permission. Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved.",
    "chunk_id": 820,
    "sentence_start": 5813,
    "sentence_end": 5817,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  },
  {
    "text": "Copyright © 2019 Journal of Orthopaedic & Sports Physical Therapy®. All rights reserved. COLUMN 2:\nCarpal Tunnel Syndrome: Clinical Practice Guidelines\nAPPENDIX G\nASSIGNING LEVELS OF EVIDENCE\nssigned based on the study design using \ne table (APPENDIX F), assuming high quality \nandomized clinical trial starts at level I)\nssed using the critical appraisal tool, and \n 1 of 4 overall quality ratings based on the \nults\nignment is adjusted based on the overall \nconfidence in the estimate/results): study \nd level of evidence (eg, if the randomized \nd high quality, its final assignment is level \nuld include:\nical trial with greater than 80% follow-up, \npropriate randomization procedures\n•  \u0007Cohort study includes greater than 80% follow-up\n•  \u0007Diagnostic study includes consistently applied reference \nstandard and blinding\n•  \u0007Prevalence study is a cross-sectional study that uses a lo­\ncal and current random sample or censuses\n-  \u0007Acceptable quality (the study does not meet requirements for \nhigh quality and weaknesses limit the confidence in the ac­\ncuracy of the estimate): downgrade 1 level\n•  \u0007Based on critical appraisal results\n-  \u0007Low quality: the study has significant limitations that sub­\nstantially limit confidence in the estimate: downgrade 2 \nlevels\n•  \u0007Based on critical appraisal results\n-  \u0007Unacceptable quality: serious limitations—exclude from con­\nsideration in the guideline\n•  \u0007Based on critical appraisal results",
    "chunk_id": 821,
    "sentence_start": 5816,
    "sentence_end": 5818,
    "section_type": "methods",
    "source_file": "Carpal_Tunnel_Syndrome.pdf"
  }
]